Gene NN O
expression NN O
studies NNS O
in IN O
isolated VBN O
mitochondria NN O
: : O
Solanum NN B-Species
tuberosum NN I-Species
rps10 NN O
is VBZ O
recognized VBN O
by IN O
cognate JJ O
potato NN B-Species
but CC O
not RB O
by IN O
the DT O
transcription NN O
, , O
splicing NN O
and CC O
editing VBG O
machinery NN O
of IN O
wheat NN B-Species
mitochondria NN O

Abstract JJ O

The DT O
complex JJ O
gene NN O
expression NN O
mechanisms NNS O
that WDT O
occur VBP O
in IN O
plant NN O
mitochondria NN O
, , O
such JJ O
as IN O
RNA NN O
editing NN O
and CC O
splicing NN O
, , O
are VBP O
not RB O
yet RB O
well RB O
understood VBN O
. . O

RNA NNP O
editing NN O
in IN O
higher JJR O
plant NN O
mitochondria NN O
is VBZ O
a DT O
highly RB O
specific JJ O
process NN O
which WDT O
modifies VBZ O
mRNA NNP O
sequences NNS O
by IN O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
conversions NNS O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
in IN O
some DT O
cases NNS O
this DT O
process NN O
is VBZ O
required VBN O
for IN O
splicing NN O
. . O

Here RB O
, , O
we PRP O
use VBP O
an DT O
experimental JJ O
model NN O
based VBN O
on IN O
the DT O
introduction NN O
of IN O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
by IN O
electroporation NN O
to TO O
study VB O
organellar JJ O
gene NN O
expression NN O
events NNS O
. . O

Our PRP$ O
aim NN O
was VBD O
to TO O
compare VB O
processing NN O
and CC O
editing NN O
of IN O
potato NN B-Species
small JJ O
ribosomal NN O
protein NN O
10 CD O
gene NN O
( -LRB- O
rps10 NN O
) -RRB- O
transcripts NNS O
in IN O
heterologous JJ O
( , O
wheat NN B-Species
mitochondria NN O
) NFP O
and CC O
homologous JJ O
( , O
potato NN B-Species
mitochondria NN O
) -RRB- O
contexts NNS O
. . O

rps10 NN O
is VBZ O
a DT O
suitable JJ O
model NN O
because IN O
it PRP O
contains VBZ O
a DT O
group NN O
II NN O
intron NN O
, , O
is VBZ O
absent JJ O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
is VBZ O
actively RB O
expressed VBN O
in IN O
potato NN B-Species
mitochondria NN O
, , O
where WRB O
transcripts NNS O
are VBP O
spliced VBN O
and CC O
undergo VBP O
five CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
. . O

For IN O
this DT O
purpose NN O
, , O
conditions NNS O
for IN O
electroporating VBG O
isolated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
established VBN O
. . O

rps10 NN O
was VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
either CC O
potato NN B-Species
or CC O
wheat NN B-Species
cox2 NN O
promoters NNS O
. . O

We PRP O
found VBD O
that IN O
rps10 NN O
was VBD O
only RB O
transcribed VBN O
under IN O
the DT O
control NN O
of IN O
a DT O
cognate JJ O
promoter NN O
. . O

In IN O
wheat NN B-Species
mitochondria NN O
, , O
rps10 NN O
transcripts NNS O
were VBD O
neither CC O
spliced VBN O
nor CC O
edited VBN O
while IN O
they PRP O
are VBP O
correctly RB O
processed VBN O
in IN O
potato NN B-Species
mitochondria NN O
. . O

Interestingly RB O
, , O
a DT O
wheat NN B-Species
editing NN O
site NN O
grafted VBD O
into IN O
rps10 NN O
was VBD O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NNS O
but CC O
was VBD O
correctly RB O
edited VBN O
in IN O
potato NN B-Species
mitochondria NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
editing NN O
might MD O
occur VB O
only RB O
when WRB O
the DT O
transcripts NNS O
are VBP O
engaged VBN O
in IN O
processing NN O
and CC O
that IN O
they PRP O
would MD O
not RB O
be VB O
available JJ O
to IN O
editing VBG O
factors NNS O
outside RB O
of IN O
a DT O
putative JJ O
RNA NNP O
maturation NN O
machinery NN O
complex NN O
. . O

INTRODUCTION NN O

Gene NN O
expression NN O
in IN O
plant NN O
mitochondria NN O
is VBZ O
a DT O
complex JJ O
process NN O
involving VBG O
multiple JJ O
steps NNS O
such JJ O
as IN O
transcription NN O
, , O
cis NN O
- HYPH O
and CC O
trans NN O
- HYPH O
splicing NN O
, , O
RNA NNP O
trimming NN O
and CC O
RNA NN O
editing NN O
on IN O
the DT O
way NN O
to IN O
translation NN O
( , O
1 CD O
) -RRB- O
. . O

RNA NNP O
editing NN O
has VBZ O
been VBN O
found VBN O
in IN O
a DT O
variety NN O
of IN O
organisms NNS O
and CC O
occurs VBZ O
through IN O
different JJ O
mechanisms NNS O
such JJ O
as IN O
insertion NN O
or CC O
deletion NN O
of IN O
nucleotides NNS O
, , O
or CC O
base NN O
conversions NNS O
[ -LRB- O
for IN O
details NNS O
see VB O
reference NN O
( -LRB- O
2 CD O
) -RRB- O
] -RRB- O
. . O

In IN O
higher JJR O
plant NN O
organelles NNS O
, , O
RNA NNP O
editing NN O
is VBZ O
an DT O
important JJ O
post NN O
- HYPH O
transcriptional JJ O
event NN O
characterized VBN O
by IN O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
changes VBZ O
via IN O
a DT O
deamination NN O
mechanism NN O
( , O
3 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

In IN O
Arabidopsis NN B-Species
thaliana NN I-Species
456 CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
have VBP O
been VBN O
described VBN O
( , O
6 CD O
) -RRB- O
. . O

RNA NNP O
editing NN O
occurs VBZ O
mostly RB O
in IN O
the DT O
coding VBG O
regions NNS O
which WDT O
alter VBP O
the DT O
identity NN O
of IN O
the DT O
encoded VBN O
amino NN O
acid NN O
, , O
but CC O
some DT O
editing NN O
events NNS O
occur VBP O
in IN O
highly RB O
structured JJ O
regions NNS O
of IN O
introns NNS O
( SYM O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

Like IN O
other JJ O
maturation NN O
processes NNS O
, , O
RNA NNP O
editing NN O
is VBZ O
an DT O
essential JJ O
post NN O
- HYPH O
transcriptional JJ O
event NN O
in IN O
plant NN O
mitochondrial JJ O
gene NN O
expression NN O
( , O
9 CD O
- HYPH O
11 CD O
) -RRB- O
required VBN O
for IN O
the DT O
synthesis NN O
of IN O
functional JJ O
proteins NNS O
( , O
12 CD O
, , O
13 CD O
) -RRB- O
. . O

The DT O
introduction NN O
of IN O
foreign JJ O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
is VBZ O
a DT O
novel JJ O
experimental JJ O
model NN O
which WDT O
has VBZ O
provided VBN O
important JJ O
information NN O
on IN O
RNA NNP O
editing NN O
and CC O
RNA NN O
splicing NN O
enabling VBG O
the DT O
use NN O
of IN O
a DT O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
approach NN O
( , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

Using VBG O
a DT O
cognate JJ O
cox2 NN O
chimeric NN O
gene NN O
construct NN O
, , O
the DT O
cis NN O
- HYPH O
recognition NN O
elements NNS O
required VBN O
for IN O
plant NN O
mitochondria NN O
RNA NNP O
editing NN O
have VBP O
been VBN O
determined VBN O
( SYM O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

Using VBG O
the DT O
same JJ O
approach NN O
, , O
Staudinger NNP O
and CC O
Kempken NNP O
( : O
18 CD O
) -RRB- O
have VBP O
reported VBN O
that IN O
transcripts NNS O
from IN O
A NN B-Species
. . I-Species
thaliana NN I-Species
cox2 NN O
, , O
but CC O
not RB O
Sorghum NN B-Species
bicolor NN I-Species
atp6 NN O
, , O
are VBP O
edited VBN O
when WRB O
the DT O
genes NNS O
are VBP O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
. . O

Interestingly RB O
, , O
higher JJR O
plant NN O
mitochondrial JJ O
genomes NNS O
differ VBP O
in IN O
their PRP$ O
gene NN O
contents NNS O
due IN O
to IN O
an DT O
evolutionary JJ O
information NN O
transfer NN O
from IN O
the DT O
organelle NN O
to IN O
the DT O
nucleus NN O
( SYM O
19 CD O
) -RRB- O
. . O

Of IN O
particular JJ O
interest NN O
is VBZ O
the DT O
situation NN O
of IN O
the DT O
small JJ O
ribosomal JJ O
protein NN O
10 CD O
gene NN O
( HYPH O
rps10 NN O
) -RRB- O
, , O
a DT O
group NN O
II NNP O
intron NN O
- HYPH O
bearing VBG O
gene NN O
which WDT O
is VBZ O
encoded VBN O
in IN O
Solanum NNP B-Species
tuberosum NN I-Species
mitochondrial NN O
DNA NN O
but CC O
is VBZ O
absent JJ O
from IN O
the DT O
wheat NN B-Species
mitochondrial JJ O
genome NN O
( , O
20 CD O
) -RRB- O
. . O

Higher JJR O
plant NN O
mitochondria NN O
contain VBP O
group NN O
II NN O
introns NNS O
either CC O
in IN O
cis NN O
- HYPH O
or CC O
trans NN O
- HYPH O
configuration NN O
( : O
1 CD O
) -RRB- O
which WDT O
can MD O
be VB O
folded VBN O
in IN O
a DT O
characteristic JJ O
secondary JJ O
structure NN O
( SYM O
21 CD O
) -RRB- O
. . O

Intron NN O
removal NN O
in IN O
plant NN O
mitochondrial JJ O
mRNAs NNS O
is VBZ O
not RB O
well RB O
documented VBN O
because IN O
such JJ O
introns NNS O
are VBP O
unable JJ O
to TO O
self NN O
- HYPH O
splice NN O
. . O

Previously RB O
, , O
we PRP O
described VBD O
that IN O
electroporated VBN O
cox2 NN O
constructs NNS O
were VBD O
a DT O
good JJ O
model NN O
for IN O
the DT O
study NN O
of IN O
the DT O
splicing NN O
process NN O
. . O

Using VBG O
this DT O
model NN O
, , O
we PRP O
found VBD O
that IN O
editing NN O
and CC O
splicing NN O
of IN O
cox2 NN O
transcripts NNS O
were VBD O
not RB O
linked VBN O
in IN O
wheat NN B-Species
mitochondria NN O
( SYM O
15 CD O
) -RRB- O
. . O

To TO O
challenge VB O
the DT O
ability NN O
of IN O
mitochondrial JJ O
gene NN O
expression NN O
machinery NN O
to TO O
recognize VB O
genetic JJ O
information NN O
which WDT O
has VBZ O
been VBN O
lost VBN O
during IN O
evolution NN O
, , O
we PRP O
decided VBD O
to TO O
introduce VB O
the DT O
S NN B-Species
. . I-Species
tuberosum NN I-Species
non JJ O
- HYPH O
cognate NN O
rps10 NN O
gene NN O
into IN O
wheat NN B-Species
mitochondria NN O
. . O

Five CD O
C NN O
residues NNS O
are VBP O
changed VBN O
to IN O
U NNP O
in IN O
potato NN B-Species
mitochondria NN O
rps10 NN O
transcripts NNS O
by IN O
editing NN O
. . O

Two CD O
of IN O
them PRP O
have VBP O
been VBN O
postulated VBN O
as IN O
being VBG O
necessary JJ O
for IN O
acquisition NN O
of IN O
a DT O
proper JJ O
secondary JJ O
and CC O
/ SYM O
or CC O
tertiary JJ O
structure NN O
for IN O
splicing NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
the DT O
conditions NNS O
for IN O
electroporation NN O
of IN O
foreign JJ O
DNA NN O
into IN O
S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
a DT O
potato NN B-Species
rps10 NN O
construct NN O
is VBZ O
transcribed VBN O
when WRB O
introduced VBN O
into IN O
wheat NN B-Species
mitochondria NN O
, , O
but CC O
transcripts NNS O
are VBP O
not RB O
recognized VBN O
by IN O
the DT O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
machinery NN O
. . O

In IN O
contrast NN O
, , O
a DT O
rps10 NN O
construct NN O
is VBZ O
correctly RB O
expressed VBN O
and CC O
processed VBN O
in IN O
cognate JJ O
potato NN B-Species
mitochondria NN O
. . O

Moreover RB O
, , O
we PRP O
present VBP O
evidence NN O
that IN O
transcript NN O
editing NN O
might MD O
be VB O
linked VBN O
to IN O
overall JJ O
RNA NNP O
processing NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
on IN O
DNA NN O
electroporation NN O
into IN O
potato NN B-Species
mitochondria NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Plasmids NNS O

All DT O
plasmids NNS O
used VBN O
in IN O
this DT O
study NN O
are VBP O
based VBN O
on IN O
the DT O
previously RB O
described VBN O
pCOXII NNP O
vector NN O
( HYPH O
14 CD O
) -RRB- O
. . O

An DT O
NsiI NNP O
restriction NN O
site NN O
was VBD O
introduced VBN O
at IN O
the DT O
initiation NN O
codon NN O
of IN O
the DT O
wheat NN B-Species
cox2 NN O
open JJ O
reading NN O
frame NN O
( , O
ORF NNP O
) -RRB- O
. . O

Then RB O
, , O
NsiI NNP O
was VBD O
used VBN O
in IN O
combination NN O
with IN O
a DT O
SpeI NNP O
restriction NN O
site NN O
present JJ O
in IN O
the DT O
original JJ O
vector NN O
after IN O
the DT O
stop NN O
codon NN O
, , O
to TO O
produce VB O
the DT O
chimeric JJ O
vectors NNS O
. . O

S NN B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
gene NN O
, , O
including VBG O
a DT O
727 CD O
bp NN O
non JJ O
- HYPH O
coding VBG O
upstream JJ O
region NN O
, , O
was VBD O
isolated VBN O
by IN O
PCR NNP O
from IN O
total JJ O
DNA NNP O
using VBG O
the DT O
primer NN O
A NN O
designed VBN O
from IN O
partial JJ O
sequences NNS O
reported VBN O
by IN O
L NNP O
o FW O
essl FW O
et FW O
al NNP O
. . O

( : O
22 CD O
) -RRB- O
, , O
accession NN O
no UH O
. . O

AF096321 NN O
, , O
containing VBG O
the DT O
KpnI NNP O
restriction NN O
sequence NN O
, , O
and CC O
primer NN O
B NN O
derived VBN O
from IN O
Triticum NNP B-Species
timopheevi NNP I-Species
cox2 NN O
( : O
AF336134 CD O
) -RRB- O
. . O

A DT O
fragment NN O
of IN O
2888 CD O
bp NN O
was VBD O
obtained VBN O
and CC O
cloned VBN O
on IN O
pGEM NNP O
- HYPH O
T NNP O
vector NN O
. . O

The DT O
complete JJ O
sequence NN O
of IN O
the DT O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
was VBD O
determined VBN O
( : O
accession NN O
no UH O
. . O
DQ18064 NN O
) -RRB- O
. . O

To TO O
generate VB O
the DT O
plasmid NN O
pCOXIISt NN O
containing VBG O
the DT O
S NN B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
gene NN O
, , O
a DT O
KpnI NNP O
/ SYM O
SpeI NNP O
fragment NN O
containing VBG O
the DT O
727 CD O
bp NN O
upstream JJ O
region NN O
and CC O
the DT O
complete JJ O
coding VBG O
region NN O
was VBD O
used VBN O
to TO O
replace VB O
the DT O
wheat NN B-Species
gene NN O
from IN O
pCOXII NNP O
. . O

As IN O
for IN O
pCOXII NNP O
, , O
a DT O
NsiI NNP O
site NN O
was VBD O
inserted VBN O
at IN O
the DT O
ATG NNP O
start NN O
codon NN O
and CC O
a DT O
23 CD O
bp NN O
fragment NN O
was VBD O
inserted VBN O
at IN O
position NN O
- HYPH O
20 CD O
. . O

This DT O
23 CD O
bp NN O
insertion NN O
provides VBZ O
a DT O
specific JJ O
sequence NN O
allowing VBG O
isolation NN O
of IN O
potato NN B-Species
cox2 NN O
transcripts NNS O
originating VBG O
from IN O
the DT O
introduced VBN O
DNA NNP O
by IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

The DT O
chimeric JJ O
wheat NN B-Species
/ SYM O
potato NN B-Species
cox2 NN O
gene NN O
was VBD O
constructed VBN O
by IN O
replacing VBG O
727 CD O
bp NN O
KpnI NNP O
/ SYM O
NsiI NNP O
promoter NN O
sequence NN O
from IN O
pCOXIISt NN O
with IN O
the DT O
880 CD O
bp NN O
wheat NN B-Species
upstream JJ O
region NN O
from IN O
pCOXII NNP O
. . O

The DT O
vectors NNS O
pRPS10W NNP O
and CC O
the DT O
pRPS10St NN O
derivative JJ O
, , O
containing VBG O
wheat NN B-Species
and CC O
potato NN B-Species
cox2 NN O
promoters NNS O
, , O
respectively RB O
, , O
were VBD O
constructed VBN O
by IN O
inserting VBG O
the DT O
1178 CD O
bp NN O
rps10 NN O
sequence NN O
containing VBG O
two CD O
exons NNS O
separated VBN O
by IN O
a DT O
777 CD O
bp NN O
intronic JJ O
sequence NN O
[ -LRB- O
( SYM O
23 CD O
) -RRB- O
, , O
accession NN O
no UH O
. . O
X74826 CD O
] -RRB- O
. . O

The DT O
coding VBG O
region NN O
was VBD O
isolated VBN O
from IN O
total JJ O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
DNA NNP O
by IN O
PCR NNP O
using VBG O
primers NNS O
D1 NNP O
and CC O
D2 NNP O
containing VBG O
the DT O
restriction NN O
sites NNS O
NsiI NNP O
and CC O
SpeI NNP O
, , O
respectively RB O
. . O

The DT O
fragment NN O
NsiI NNP O
/ SYM O
SpeI NNP O
was VBD O
purified VBN O
and CC O
cloned VBN O
into IN O
pCOXII NNP O
and CC O
pCOXIISt NN O
, , O
replacing VBG O
the DT O
respective JJ O
cox2 NN O
coding VBG O
regions NNS O
. . O

Since IN O
all DT O
vectors NNS O
used VBN O
here RB O
were VBD O
based VBN O
on IN O
pCOXII NNP O
, , O
they PRP O
contain VBP O
the DT O
downstream JJ O
region NN O
from IN O
the DT O
wheat NN B-Species
cob NN O
gene NN O
( , O
Ir NN O
- HYPH O
cob NN O
) -RRB- O
( , O
accession NN O
no UH O
. . O
AF337547 CD O
) -RRB- O
( SYM O
14 CD O
) -RRB- O
. . O

This DT O
sequence NN O
, , O
combined VBN O
with IN O
the DT O
23 CD O
bp NN O
upstream NN O
insert NN O
sequence NN O
served VBD O
to TO O
distinguish VB O
, , O
using VBG O
primers NNS O
1a CD O
and CC O
1b NN O
, , O
foreign JJ O
from IN O
endogenous JJ O
transcripts NNS O
. . O

All DT O
mutants NNS O
were VBD O
obtained VBN O
using VBG O
QuickChange NNP O
( -LRB- O
R NNP O
) -RRB- O
Site NN O
- HYPH O
Directed NNP O
Mutagenesis NNP O
kit NN O
( : O
Stratagene NNP O
) -RRB- O
. . O

PCR NN O
product NN O
purifications NNS O
were VBD O
carried VBN O
out RP O
with IN O
the DT O
Wizard NNP O
( -LRB- O
R NNP O
) -RRB- O
Clean NNP O
- HYPH O
Up NNP O
System NNP O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

PCR NN O
primers NNS O
used VBD O

Oligonucleotides NNS O
sequences NNS O
are VBP O
in IN O
5 CD O
' '' O
to TO O
3 CD O
' '' O
orientation NN O
. . O

( : O
1a CD O
) NFP O
, , O
GCGGTGCAGTCATACAGATC NNP O
; : O
( : O
1b ADD O
) NFP O
, , O
TATCCAGATTTGGTACCAAA NNP O
; : O
( : O
2a CD O
) NFP O
, , O
GCAGTCATACAGATCTGCCA NNP O
; : O
( : O
2b LS O
) -RRB- O
, , O
AGATTTGGTACCAAACCCGG NNP O
; : O
( : O
A NNP O
) -RRB- O
, , O
TATAGGTACCTCTCAGGTGT NNP O
; : O
( -LRB- O
B NNP O
) -RRB- O
, , O
TATAACTAGTTTAAGCTTCC NNP O
; : O
( : O
D1 NNP O
) -RRB- O
, , O
TATAATGCATAGACAAAGGA NNP O
; : O
( : O
D2 NNP O
) -RRB- O
, , O
TATAACTAGTTCAGGAAAGG NNP O
. . O

Restriction NN O
sites NNS O
are VBP O
underlined VBN O
. . O

Mutagenesis NN O
primers NNS O
( , O
only RB O
sense NN O
primers NNS O
in IN O
5 CD O
' '' O
- HYPH O
3 CD O
' '' O
orientation NN O
are VBP O
indicated VBN O
) . O

Single NNP O
C2 NNP O
, , O
C3 NNP O
and CC O
C2 NNP O
+ CC O
C3 NN O
double JJ O
mutant NN O
plasmids NNS O
were VBD O
constructed VBN O
with IN O
primers NNS O
( -LRB- O
C2 NNP O
) -RRB- O
AAGAAGTTCTTTTGGTTAAA NN O
and CC O
( , O
C3 NN O
) -RRB- O
CGCCGTGCGACTTGGAGGAC NN O
. . O

NsiI NNP O
- HYPH O
pCOXII NNP O
: : O
GGAAATCCAATGCATCTTCG NNP O
and CC O
NsiI NNP O
- HYPH O
pCOXIISt NNP O
: : O
CCAAACCAAATGCATGTTCT NNP O
. . O

Construct VB O
pCOXIISt NN O
containing VBG O
a DT O
23 CD O
nt NN O
insertion NN O
in IN O
the DT O
promoter NN O
region NN O
, , O
was VBD O
carried VBN O
out RP O
into IN O
two CD O
consecutive JJ O
insertions NNS O
using VBG O
primers NNS O
: : O
TGGGGGGAGCAGAGCAGTGC NNP O
and CC O
GCAGTGCGGTGCAGTCATAC NNP O
. . O

For IN O
constructs NNS O
MA NNP O
and CC O
MAB NNP O
containing VBG O
the DT O
wheat NN B-Species
cox2 NN O
C259 CD O
editing NN O
site NN O
, , O
two CD O
consecutive JJ O
insertions NNS O
were VBD O
carried VBN O
out RP O
using VBG O
primers NNS O
: : O
GGAAGATTGGATTACTATCG NNP O
and CC O
TACTATCGAAATTATTCGGA NNP O
. . O

For IN O
ME6 NNP O
and CC O
ME6b NNP O
constructs NNS O
, , O
primers NNS O
CCGCGAGGAATCAACTACTA NNP O
and CC O
CAACTACTATCGAAATTATT NNP O
were VBD O
used VBN O
. . O

Inserted VBN O
nucleotides NNS O
are VBP O
underlined VBN O
and CC O
the DT O
modified VBN O
residues NNS O
are VBP O
indicated VBN O
in IN O
bold JJ O
. . O

Mitochondria NN O
purification NN O

S UH B-Species
. . I-Species
tuberosum NN I-Species
cv NN O
. . O

Rosevalt NNP O
tubers NNS O
and CC O
T NN B-Species
. . I-Species
aestivum NN I-Species
var NN I-Species
Fortal NNP I-Species
seeds NNS O
were VBD O
used VBN O
. . O

Potato NN B-Species
mitochondria NNS O
were VBD O
prepared VBN O
from IN O
2 CD O
kg NNS O
of IN O
tubers NNS O
in IN O
batches NNS O
of IN O
200 CD O
g NNS O
with IN O
200 CD O
ml NNS O
of IN O
a DT O
homogenization NN O
buffer NN O
containing VBG O
0 CD O
. . O
4 CD O
M NN O
mannitol NN O
, , O
25 CD O
mM NN O
MOPS NNS O
( , O
pH NN O
7 CD O
. . O
8 CD O
) -RRB- O
, , O
1 CD O
mM NN O
EGTA NN O
, , O
8 CD O
mM NN O
cysteine NN O
and CC O
1 CD O
mg NN O
/ SYM O
ml NN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

Homogenization NN O
was VBD O
carried VBN O
out RP O
for IN O
15 CD O
s NNS O
in IN O
a DT O
Waring NNP O
blendor NN O
at IN O
full JJ O
speed NN O
. . O

Homogenate NNP O
was VBD O
centrifuged VBN O
in IN O
a DT O
Sorvall NNP O
GSA NNP O
rotor NN O
at IN O
1500 CD O
g NN O
for IN O
10 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

Supernatant NNP O
was VBD O
centrifuged VBN O
in IN O
a DT O
GSA NNP O
rotor NN O
at IN O
12 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
. . O

The DT O
mitochondrial JJ O
pellet NN O
was VBD O
resuspended VBN O
in IN O
50 CD O
ml NNS O
of IN O
homogenization NN O
buffer NN O
and CC O
centrifuged VBN O
at IN O
1500 CD O
g NN O
. . O

The DT O
supernatant NN O
was VBD O
centrifuged VBN O
in IN O
a DT O
Sorvall NNP O
SS NNP O
- HYPH O
34 CD O
rotor NN O
at IN O
15 CD O
0 CD O
g CD O
for IN O
10 CD O
min NN O
, , O
the DT O
pellet NN O
was VBD O
resuspended VBN O
in IN O
12 CD O
ml NNS O
of IN O
homogenization NN O
buffer NN O
and CC O
mitochondria NN O
were VBD O
purified VBN O
by IN O
centrifugation NN O
on IN O
a DT O
sucrose JJ O
gradient NN O
essentially RB O
as IN O
described VBN O
for IN O
wheat NN B-Species
embryo NN O
mitochondria NN O
( SYM O
14 CD O
) -RRB- O
. . O

Electroporation NN O

Electrotransfer NN O
experiments NNS O
were VBD O
carried VBN O
out RP O
with IN O
1 CD O
mg NN O
of IN O
purified JJ O
wheat NN B-Species
embryo NN O
or CC O
potato NN B-Species
tuber NN O
mitochondria NN O
in IN O
50 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
33 CD O
M NN O
sucrose NN O
and CC O
1 CD O
micro JJ O
g NN O
of IN O
recombinant JJ O
plasmid NN O
as IN O
described VBN O
( SYM O
14 CD O
) -RRB- O
. . O

The DT O
electroporated JJ O
mitochondria NN O
were VBD O
incubated VBN O
for IN O
18 CD O
h NNS O
at IN O
25 CD O
degrees NNS O
C NN O
, , O
then RB O
recovered VBN O
by IN O
centrifugation NN O
in IN O
a DT O
Sigma NNP O
N NNP O
degrees NNS O
12024 CD O
rotor NN O
( HYPH O
Sigma NNP O
1K15 CD O
refrigerated VBN O
centrifuge NN O
) -RRB- O
at IN O
15 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

In IN O
the DT O
case NN O
of IN O
potato NN B-Species
mitochondria NN O
the DT O
incubation NN O
mixture NN O
was VBD O
supplemented VBN O
with IN O
1 CD O
mg CD O
/ SYM O
ml NN O
of IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

RNA NNP O
was VBD O
purified VBN O
with IN O
200 CD O
micro JJ O
l NN O
of IN O
TRIzol NNP O
( -LRB- O
TM NNP O
) -RRB- O
reagent NN O
( , O
Gibco NNP O
- HYPH O
BRL NNP O
) -RRB- O
according VBG O
to IN O
the DT O
supplier NN O
' POS O
s NN O
protocol NN O
. . O

DNAse NNP O
I NN O
protection NN O
assay NN O
and CC O
DNA NN O
purification NN O

After IN O
electroporation NN O
and CC O
centrifugation NN O
, , O
the DT O
mitochondrial JJ O
pellet NN O
was VBD O
resuspended VBN O
in IN O
100 CD O
micro NN O
l NN O
of IN O
buffer NN O
[ -LRB- O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
2 CD O
mM NN O
magnesium NN O
acetate NN O
and CC O
0 CD O
. . O
33 CD O
M NN O
sucrose NN O
] -RRB- O
containing VBG O
60 CD O
U NN O
of IN O
DNase NNP O
I NNP O
( , O
Gibco NNP O
- HYPH O
BRL NNP O
) -RRB- O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
room NN O
temperature NN O
. . O

The DT O
DNase NNP O
reaction NN O
was VBD O
stopped VBN O
by IN O
adding VBG O
4 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
5 CD O
M NN O
EDTA NN O
and CC O
then RB O
heating NN O
for IN O
10 CD O
min NN O
at IN O
65 CD O
degrees NNS O
C NN O
. . O

Mitochondria NNS O
were VBD O
incubated VBN O
with IN O
100 CD O
micro NN O
g NN O
of IN O
Proteinase NNP O
K NNP O
( SYM O
Merck NNP O
) -RRB- O
for IN O
4 CD O
h NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

One CD O
microliter NN O
of IN O
20 CD O
% NN O
SDS NNP O
was VBD O
added VBN O
to TO O
achieve VB O
mitochondrial JJ O
lysis NN O
and CC O
the DT O
DNA NN O
was VBD O
extracted VBN O
with IN O
phenol NN O
/ SYM O
chloroform NN O
, , O
precipitated VBN O
with IN O
0 CD O
. . O
1 CD O
vol NN O
of IN O
3 CD O
M NN O
Sodium NNP O
Acetate NNP O
( , O
pH NN O
5 CD O
. . O
2 CD O
) -RRB- O
, , O
3 CD O
vol NN O
of IN O
100 CD O
% NN O
ethanol NN O
and CC O
100 CD O
ng NN O
of IN O
carrier NN O
yeast NN B-Species
tRNA NN O
and CC O
left VBN O
overnight RB O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
. . O

After IN O
centrifugation NN O
, , O
the DT O
DNA NNP O
pellet NN O
was VBD O
resuspended VBN O
in IN O
TE NNP O
buffer NN O
[ -LRB- O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( -LRB- O
pH NN O
8 CD O
) -RRB- O
and CC O
1 CD O
mM NN O
EDTA NNP O
] -RRB- O
. . O

RT NNP O
- HYPH O
PCR NNP O

RNA NNP O
( : O
1 CD O
micro NN O
g NN O
) -RRB- O
was VBD O
treated VBN O
with IN O
2 CD O
U NN O
of IN O
Amplification NN O
grade NN O
DNase NNP O
I NNP O
( , O
Promega NNP O
) -RRB- O
. . O

cDNA NNP O
synthesis NN O
was VBD O
performed VBN O
with IN O
200 CD O
U NNP O
of IN O
Superscript NNP O
II NNP O
RT NNP O
using VBG O
100 CD O
ng NNS O
of IN O
random JJ O
hexamers NNS O
. . O

The DT O
PCR NNP O
were VBD O
performed VBN O
with IN O
primers NNS O
1a CD O
and CC O
1b NN O
using VBG O
Advantage NNP O
( -LRB- O
R NNP O
) -RRB- O
2 CD O
Polymerase NNP O
Mix NNP O
( -LRB- O
Clontech NNP O
) -RRB- O
as IN O
follows VBZ O
: : O
95 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
; : O
5 CD O
cycles NNS O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
and CC O
68 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
; : O
30 CD O
cycles NNS O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
, , O
58 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
and CC O
68 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
, , O
and CC O
finally RB O
68 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
. . O

Primers NNS O
2a CD O
and CC O
2b NN O
were VBD O
used VBN O
for IN O
nested VBN O
PCR NN O
from IN O
1 CD O
micro NN O
l NN O
of IN O
the DT O
first JJ O
PCR NNP O
. . O

No DT O
RT NNP O
- HYPH O
PCR NN O
amplification NN O
products NNS O
were VBD O
obtained VBN O
with IN O
RNA NNP O
from IN O
non RB O
- HYPH O
electroporated VBN O
mitochondria NN O
. . O

DNA NN O
sequencing NN O

Sequence NN O
analyses NNS O
were VBD O
performed VBN O
directly RB O
on IN O
the DT O
RT NNP O
- HYPH O
PCR NNP O
product NN O
using VBG O
an DT O
automatic JJ O
DNA NN O
sequencing VBG O
equipment NN O
with IN O
the DT O
BigDye NNP O
( -LRB- O
R NNP O
) -RRB- O
Terminator NNP O
Cycle NNP O
Sequencing NNP O
Kit NNP O
( , O
Applied NNP O
Biosystem NNP O
) -RRB- O
. . O

RESULTS NNS O

S NN B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
transcripts NNS O
are VBP O
not RB O
processed VBN O
in IN O
wheat NN B-Species
mitochondria NN O

The DT O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
construct NN O
under IN O
control NN O
of IN O
a DT O
wheat NN B-Species
cox2 NN O
promoter NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
was VBD O
incorporated VBN O
into IN O
purified JJ O
wheat NN B-Species
mitochondria NN O
by IN O
electroporation NN O
as IN O
indicated VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

After IN O
electroporation NN O
and CC O
incubation NN O
in IN O
expression NN O
medium NN O
, , O
mitochondrial JJ O
RNA NNP O
was VBD O
extracted VBN O
and CC O
analysed VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

The DT O
primers NNS O
used VBD O
allowed VBN O
detection NN O
of IN O
the DT O
transcripts NNS O
generated VBN O
by IN O
the DT O
constructs NNS O
introduced VBN O
and CC O
excluded VBN O
any DT O
product NN O
from IN O
endogenous JJ O
cox2 NN O
( , O
or CC O
rps10 NN O
in IN O
the DT O
potato NN B-Species
system NN O
) -RRB- O
. . O

Two CD O
bands NNS O
of IN O
1204 CD O
and CC O
427 CD O
bp NN O
were VBD O
expected VBN O
from IN O
precursor NN O
and CC O
mature JJ O
rps10 NN O
mRNAs NNS O
, , O
respectively RB O
. . O

Only JJ O
precursor NN O
rps10 NN O
molecules NNS O
were VBD O
detected VBN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
. . O

As IN O
a DT O
control NN O
, , O
a DT O
cognate JJ O
cox2 NN O
construct NN O
( , O
16 CD O
) -RRB- O
was VBD O
used VBN O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
2048 CD O
and CC O
827 CD O
bp NN O
RT NNP O
- HYPH O
PCR NN O
bands NNS O
representing VBG O
the DT O
precursor NN O
and CC O
spliced VBN O
cox2 NN O
products NNS O
, , O
respectively RB O
were VBD O
observed VBN O
( : O
Figure NNP O
1B NNP O
) -RRB- O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
PCR NNP O
bands NNS O
actually RB O
represent VBP O
transcription NN O
products NNS O
since IN O
when WRB O
PCR NNP O
was VBD O
performed VBN O
without IN O
the DT O
RT NNP O
step NN O
we PRP O
observed VBD O
no DT O
amplification NN O
products NNS O
. . O

Previously RB O
, , O
five CD O
C NNP O
residues NNS O
, , O
two CD O
in IN O
exon NN O
1 CD O
, , O
one CD O
in IN O
the DT O
intron NN O
and CC O
two CD O
in IN O
exon NN O
2 CD O
have VBP O
been VBN O
reported VBN O
to TO O
be VB O
changed VBN O
to IN O
U NNP O
by IN O
editing VBG O
in IN O
potato NN B-Species
mitochondria NN O
( SYM O
23 CD O
) -RRB- O
. . O

To TO O
determine VB O
if IN O
the DT O
non AFX O
- HYPH O
cognate NN O
transcript NN O
could MD O
be VB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
RNA NNP O
editing NN O
machinery NN O
, , O
the DT O
1204 CD O
bp NN O
RT NNP O
- HYPH O
PCR NNP O
product NN O
was VBD O
sequenced VBN O
. . O

While IN O
wheat NN B-Species
cox2 NN O
editing NN O
sites NNS O
were VBD O
correctly RB O
edited VBN O
in IN O
control NN O
as IN O
expected VBN O
( : O
Figure NNP O
1C NNP O
, , O
only RB O
site NN O
C77 NNP O
is VBZ O
shown VBN O
) -RRB- O
, , O
all DT O
five CD O
editable JJ O
residues NNS O
in IN O
potato NN B-Species
rps10 NN O
transcript NN O
remain VBP O
unchanged JJ O
. . O

cox2 NN O
C77 CD O
editing NN O
sites NNS O
are VBP O
identical JJ O
in IN O
potato NN B-Species
and CC O
wheat NN B-Species
. . O

Failure NN O
of IN O
rps10 NN O
transcript NN O
splicing NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
not RB O
linked VBN O
to IN O
the DT O
absence NN O
of IN O
editing NN O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
residues NNS O
C2 NNP O
and CC O
C3 NNP O
participate VBP O
in IN O
the DT O
secondary JJ O
structure NN O
of IN O
the DT O
intron NN O
necessary JJ O
for IN O
splicing NN O
( SYM O
23 CD O
) -RRB- O
. . O

A DT O
possible JJ O
explanation NN O
to IN O
the DT O
failure NN O
observed VBN O
in IN O
precursor NN O
rps10 NN O
splicing NN O
could MD O
be VB O
that IN O
the DT O
absence NN O
of IN O
edition NN O
of IN O
C2 NNP O
and CC O
C3 NNP O
prevent VB O
the DT O
intron NN O
from IN O
organizing VBG O
itself PRP O
in IN O
a DT O
catalytically RB O
competent JJ O
conformation NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
single JJ O
C2 NN O
and CC O
C3 NNP O
mutants NNS O
and CC O
a DT O
C2 NNP O
+ SYM O
C3 NN O
double JJ O
mutant NN O
were VBD O
constructed VBN O
by IN O
changing VBG O
the DT O
C NNP O
residues NNS O
to IN O
T NN O
. . O

Neither CC O
single JJ O
nor CC O
double JJ O
mutants NNS O
were VBD O
able JJ O
to TO O
undergo VB O
splicing NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Electroporation NN O
of IN O
S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O

Since IN O
two CD O
important JJ O
post NN O
- HYPH O
transcriptional JJ O
processes NNS O
, , O
RNA NNP O
editing NN O
and CC O
splicing NN O
, , O
were VBD O
inoperative JJ O
when WRB O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
was VBD O
expressed VBN O
in IN O
wheat NN B-Species
mitochondria NN O
, , O
we PRP O
decided VBD O
to TO O
verify VB O
whether IN O
the DT O
negative JJ O
results NNS O
were VBD O
inherent JJ O
to IN O
the DT O
rps10 NN O
chimeric JJ O
constructs NNS O
or CC O
due IN O
to IN O
the DT O
lack NN O
of IN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
in IN O
wheat NN B-Species
mitochondria NN O
. . O

For IN O
this DT O
purpose NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
an DT O
electroporation NN O
protocol NN O
adapted VBN O
to IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Purified JJ O
organelles NNS O
were VBD O
prepared VBN O
from IN O
potato NN B-Species
tubers NNS O
as IN O
indicated VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Electric JJ O
pulses NNS O
in IN O
the DT O
range NN O
between IN O
8 CD O
and CC O
20 CD O
kV NNS O
were VBD O
performed VBN O
. . O

Internalization NN O
of IN O
exogenous JJ O
DNA NNP O
was VBD O
measured VBN O
by IN O
DNAse NNP O
protection NN O
assays NNS O
( SYM O
14 CD O
) -RRB- O
. . O

Potato NN B-Species
mitochondria NN O
show VBP O
a DT O
broad JJ O
range NN O
response NN O
with IN O
a DT O
maximum NN O
around IN O
13 CD O
kV NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

This DT O
voltage NN O
setting NN O
was VBD O
therefore RB O
used VBN O
for IN O
further JJ O
experiments NNS O
. . O

S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
does VBZ O
not RB O
recognize VB O
the DT O
wheat NN B-Species
cox2 NN O
promoter NN O

To TO O
ascertain VB O
the DT O
ability NN O
of IN O
electroporated VBN O
mitochondria NN O
to TO O
perform VB O
expression NN O
of IN O
the DT O
exogenous JJ O
gene NN O
construct NN O
, , O
we PRP O
used VBD O
a DT O
plasmid NN O
containing VBG O
the DT O
potato NN B-Species
cox2 NN O
gene NN O
controlled VBN O
either CC O
by IN O
T NN B-Species
. . I-Species
aestivum NN I-Species
or CC O
S NN B-Species
. . I-Species
tuberosum NN I-Species
promoters NNS O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4 CD O
, , O
the DT O
construct NN O
containing VBG O
the DT O
wheat NN B-Species
or CC O
potato NN B-Species
promoters NNS O
was VBD O
transcribed VBN O
only RB O
in IN O
cognate JJ O
mitochondria NN O
. . O

In IN O
potato NN B-Species
, , O
the DT O
mature JJ O
product NN O
is VBZ O
barely RB O
detectable JJ O
. . O

In IN O
contrast NN O
to IN O
wheat NN B-Species
mitochondria NN O
, , O
the DT O
821 CD O
nt NN O
mature JJ O
transcript NN O
was VBD O
only RB O
detected VBN O
when WRB O
the DT O
electroporated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
incubated VBN O
in IN O
the DT O
presence NN O
of IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

A DT O
cognate NN O
rps10 NN O
construct NN O
is VBZ O
correctly RB O
expressed VBN O
, , O
edited VBN O
and CC O
processed VBN O
in IN O
potato NN B-Species
mitochondria NN O

The DT O
construct NN O
expressing VBG O
potato NN B-Species
rps10 NN O
under IN O
the DT O
control NN O
of IN O
potato NN B-Species
cox2 NN O
promoter NN O
was VBD O
introduced VBN O
into IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
isolated VBN O
mitochondria NN O
. . O

After IN O
incubation NN O
, , O
the DT O
precursor NN O
and CC O
mature JJ O
transcripts NNS O
were VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
and CC O
sequenced VBN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5B NNP O
, , O
the DT O
four CD O
editing NN O
sites NNS O
C1 NNP O
, , O
C2 NNP O
, , O
C4 NNP O
and CC O
C5 NNP O
, , O
described VBN O
previously RB O
in IN O
endogenous JJ O
transcripts NNS O
, , O
were VBD O
found VBN O
edited VBN O
in IN O
mature JJ O
mRNA NN O
. . O

The DT O
presence NN O
of IN O
spliced VBN O
molecules NNS O
containing VBG O
unedited JJ O
residues NNS O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
indicates VBZ O
that IN O
rps10 NN O
transcripts NNS O
could MD O
be VB O
spliced VBN O
before IN O
editing NN O
. . O

To TO O
confirm VB O
this DT O
observation NN O
, , O
the DT O
PCR NNP O
product NN O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

One CD O
half NN O
of IN O
the DT O
individual JJ O
clones NNS O
were VBD O
found VBN O
edited VBN O
at IN O
sites NNS O
C1 NNP O
and CC O
C2 NNP O
; : O
65 CD O
% NN O
were VBD O
edited VBN O
at IN O
site NN O
C4 NN O
and CC O
25 CD O
% NN O
were VBD O
edited VBN O
at IN O
site NN O
C5 NNP O
. . O

A DT O
cognate JJ O
editing NN O
site NN O
in IN O
a DT O
non JJ O
- HYPH O
native JJ O
context NN O
is VBZ O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NNS O
but CC O
is VBZ O
recognized VBN O
in IN O
heterologous JJ O
mitochondria NN O

To TO O
test VB O
whether IN O
wheat NN B-Species
mitochondria NN O
are VBP O
able JJ O
to TO O
edit VB O
a DT O
cognate JJ O
site NN O
when WRB O
placed VBN O
in IN O
the DT O
context NN O
of IN O
a DT O
potato NN B-Species
transcript NN O
, , O
we PRP O
introduced VBD O
the DT O
C259 CD O
- HYPH O
16 CD O
/ SYM O
+ SYM O
6 CD O
region NN O
from IN O
wheat NN B-Species
cox2 NN O
into IN O
potato NN B-Species
rps10 NN O
exon NN O
1 CD O
or CC O
intron NN O
( -LRB- O
Figure NNP O
6A NNP O
, , O
construct VB O
MA NNP O
and CC O
ME6 NNP O
, , O
respectively RB O
) -RRB- O
. . O

As IN O
reported VBN O
previously RB O
, , O
the DT O
23 CD O
nt NN O
region NN O
forming VBG O
the DT O
C259 CD O
editing NN O
site NN O
from IN O
wheat NN B-Species
cox2 NN O
was VBD O
efficiently RB O
edited VBN O
when WRB O
grafted VBN O
into IN O
a DT O
different JJ O
context NN O
in IN O
a DT O
wheat NN B-Species
transcript NN O
( SYM O
17 CD O
) -RRB- O
. . O

Wild JJ O
- HYPH O
type NN O
rps10 NN O
( : O
pRPS10W NNP O
) -RRB- O
and CC O
the DT O
MA NNP O
and CC O
ME6 NNP O
mutants NNS O
were VBD O
expressed VBN O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
no DT O
splicing NN O
was VBD O
observed VBN O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
. . O

Unexpectedly RB O
, , O
wheat NN B-Species
mitochondria NNS O
appear VBP O
to TO O
be VB O
unable JJ O
to TO O
edit VB O
the DT O
cognate JJ O
C259 CD O
site NN O
when WRB O
the DT O
- HYPH O
16 CD O
/ SYM O
+ NN O
6 CD O
region NN O
is VBZ O
located VBN O
on IN O
a DT O
potato NN B-Species
rps10 NN O
precursor NN O
. . O

The DT O
control NN O
CM NNP O
construct NN O
, , O
containing VBG O
the DT O
C259 NNP O
site NN O
grafted VBN O
in IN O
a DT O
different JJ O
context NN O
but CC O
in IN O
its PRP$ O
own JJ O
cox2 NN O
gene NN O
, , O
was VBD O
expressed VBN O
, , O
spliced VBN O
and CC O
edited VBN O
as IN O
expected VBN O
[ -LRB- O
( , O
17 CD O
) -RRB- O
, , O
Figure NNP O
6B NNP O
and CC O
D NNP O
] -RRB- O
. . O

To TO O
compare VB O
the DT O
editing NN O
status NN O
of IN O
RNAs NNS O
at IN O
the DT O
same JJ O
stage NN O
of IN O
processing NN O
, , O
the DT O
editing NN O
status NN O
of IN O
the DT O
inserted VBN O
C259 CD O
site NN O
in IN O
precursor NN O
cox2 NN O
transcripts NNS O
is VBZ O
shown VBN O
( -LRB- O
Figure NN O
6D NN O
) -RRB- O
. . O

The DT O
analogous JJ O
MAb NNP O
and CC O
ME6b NNP O
constructs NNS O
, , O
containing VBG O
the DT O
S NNP B-Species
. , I-Species
tuberosum NN I-Species
cox2 NN O
promoter NN O
and CC O
the DT O
C259 NNP O
region NN O
inserted VBN O
into IN O
rps10 CD O
exon NN O
1 CD O
and CC O
intron NN O
were VBD O
used VBN O
to TO O
electroporate VB O
potato NN B-Species
mitochondria NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
6C NNP O
, , O
MAb NNP O
and CC O
ME6b NNP O
were VBD O
expressed VBN O
and CC O
spliced VBN O
at IN O
the DT O
same JJ O
level NN O
as IN O
the DT O
control NN O
in IN O
the DT O
homologous JJ O
context NN O
, , O
indicating VBG O
that IN O
insertion NN O
does VBZ O
not RB O
affect VB O
the DT O
splicing NN O
process NN O
. . O

Interestingly RB O
, , O
while IN O
C259 NNP O
insertion NN O
was VBD O
not RB O
recognized VBN O
in IN O
wheat NN B-Species
mitochondria NN O
( -LRB- O
Figure NNP O
6D NNP O
) -RRB- O
, , O
the DT O
potato NN B-Species
RNA NNP O
editing NN O
machinery NN O
edited VBD O
the DT O
inserted VBN O
C259 CD O
region NN O
( -LRB- O
Figure NNP O
6E CD O
) -RRB- O
. . O

The DT O
C259 NNP O
region NN O
inserted VBN O
in IN O
the DT O
rps10 NN O
intron NN O
( , O
construct NN O
ME6b NNP O
) -RRB- O
was VBD O
also RB O
edited VBN O
, , O
although IN O
at IN O
a DT O
very RB O
low JJ O
level NN O
, , O
showing VBG O
that IN O
editing NN O
may MD O
precede VB O
intron NN O
removal NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

DISCUSSION NN O

Plant NN O
mitochondria NN O
undergo VBP O
complex JJ O
expression NN O
mechanisms NNS O
which WDT O
are VBP O
poorly RB O
understood VBN O
. . O

Most JJS O
studies NNS O
are VBP O
based VBN O
on IN O
analysis NN O
of IN O
in IN O
vivo NN O
mature NN O
or CC O
intermediate JJ O
gene NN O
products NNS O
giving VBG O
clues NNS O
on IN O
possible JJ O
mechanisms NNS O
and CC O
suggesting VBG O
pathways NNS O
operating VBG O
in IN O
gene NN O
expression NN O
. . O

Direct JJ O
tests NNS O
using VBG O
in FW O
vitro FW O
approaches NNS O
have VBP O
been VBN O
fruitful JJ O
( , O
4 CD O
, , O
5 CD O
, , O
24 CD O
) -RRB- O
, , O
but CC O
are VBP O
hampered VBN O
by IN O
the DT O
difficulty NN O
of IN O
obtaining VBG O
active JJ O
mitochondrial JJ O
extracts NNS O
. . O

Previously RB O
, , O
we PRP O
devised VBD O
an DT O
experimental JJ O
model NN O
based VBN O
on IN O
electroporation NN O
of IN O
isolated VBN O
mitochondria NN O
that WDT O
allows VBZ O
us PRP O
to TO O
test VB O
gene NN O
expression NN O
of IN O
wild JJ O
- HYPH O
type NN O
and CC O
mutant JJ O
genes NNS O
. . O

This DT O
approach NN O
has VBZ O
been VBN O
very RB O
useful JJ O
in IN O
elucidating VBG O
the DT O
process NN O
of IN O
RNA NNP O
maturation NN O
in IN O
plant NN O
mitochondria NN O
, , O
in IN O
particular JJ O
splicing NN O
and CC O
editing NN O
( , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

The DT O
aim NN O
of IN O
this DT O
work NN O
was VBD O
to TO O
analyse VB O
different JJ O
gene NN O
expression NN O
events NNS O
when WRB O
a DT O
foreign JJ O
gene NN O
was VBD O
expressed VBN O
in IN O
a DT O
heterologous JJ O
context NN O
. . O

rps10 NN O
was VBD O
chosen VBN O
precisely RB O
because IN O
this DT O
genetic JJ O
information NN O
is VBZ O
lacking VBG O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
is VBZ O
active JJ O
in IN O
potato NN B-Species
mitochondria NN O
( , O
20 CD O
, , O
23 CD O
, , O
25 CD O
) -RRB- O
. . O

Moreover RB O
, , O
rps10 CD O
transcripts NNS O
undergo VBP O
five CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
in IN O
potato NN B-Species
mitochondria NN O
and CC O
rps10 NN O
contains VBZ O
an DT O
intron NN O
, , O
thus RB O
facilitating VBG O
the DT O
analysis NN O
of IN O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
. . O

To TO O
best RBS O
evaluate VB O
the DT O
expression NN O
of IN O
rps10 NN O
in IN O
the DT O
non JJ O
- HYPH O
cognate NN O
mitochondria NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
electroporation NN O
conditions NNS O
for IN O
introducing VBG O
foreign JJ O
DNA NN O
into IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Potato NN B-Species
tuber NN O
mitochondria NN O
were VBD O
able JJ O
to TO O
incorporate VB O
DNA NN O
essentially RB O
under IN O
the DT O
same JJ O
conditions NNS O
described VBN O
for IN O
wheat NN B-Species
embryo NN O
organelles NNS O
( SYM O
14 CD O
) -RRB- O
, , O
except IN O
that IN O
the DT O
optimal JJ O
voltage NN O
range NN O
was VBD O
larger JJR O
. . O

A DT O
major JJ O
difference NN O
to IN O
wheat NN B-Species
was VBD O
that IN O
isolated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
viable JJ O
for IN O
3 CD O
- SYM O
4 CD O
h NN O
as IN O
measured VBN O
by IN O
oxygen NN O
consumption NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Thus RB O
, , O
to TO O
observe VB O
transcript NN O
maturation NN O
after IN O
electroporation NN O
the DT O
incubation NN O
mixture NN O
needed VBD O
to TO O
be VB O
supplemented VBN O
with IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
( : O
see VB O
Figure NNP O
4 CD O
) -RRB- O
. . O

This DT O
behaviour NN O
probably RB O
reflects VBZ O
the DT O
uncoupling NN O
of IN O
oxidative JJ O
phosphorylation NN O
by IN O
fatty NN O
acids NNS O
during IN O
incubation NN O
of IN O
potato NN B-Species
mitochondria NN O
( SYM O
26 CD O
) -RRB- O
. . O

In IN O
fact NN O
, , O
previously RB O
we PRP O
found VBD O
that IN O
proper JJ O
gene NN O
expression NN O
in IN O
isolated VBN O
mitochondria NN O
requires VBZ O
a DT O
functional JJ O
organelle NN O
able JJ O
to TO O
generate VB O
ATP NN O
from IN O
ADP NNP O
and CC O
succinate VB O
( SYM O
14 CD O
) -RRB- O
. . O

An DT O
interesting JJ O
observation NN O
was VBD O
that IN O
neither CC O
the DT O
wheat NN B-Species
nor CC O
the DT O
potato NN B-Species
cox2 NN O
promoters NNS O
were VBD O
recognized VBN O
in IN O
a DT O
heterologous JJ O
context NN O
( -LRB- O
Figure NN O
4A NN O
and CC O
B NN O
) -RRB- O
. . O

This DT O
situation NN O
might MD O
by IN O
explained VBN O
by IN O
the DT O
fact NN O
that IN O
potato NN B-Species
and CC O
wheat NN B-Species
promoter NN O
sequences NNS O
have VBP O
no DT O
recognizable JJ O
homologous JJ O
motifs NNS O
. . O

Plant NN O
mitochondria NN O
promoters NNS O
are VBP O
characterized VBN O
by IN O
a DT O
conserved VBN O
core NN O
CRTA NNP O
sequence NN O
with IN O
differences NNS O
in IN O
the DT O
extent NN O
and CC O
the DT O
composition NN O
of IN O
sequences NNS O
around IN O
the DT O
consensus NN O
motif NN O
( SYM O
27 CD O
, , O
28 CD O
) -RRB- O
. . O

While IN O
the DT O
transcription NN O
initiation NN O
site NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
located VBN O
at IN O
position NN O
- HYPH O
170 CD O
( SYM O
29 CD O
) -RRB- O
, , O
the DT O
potato NN B-Species
promoter NN O
has VBZ O
not RB O
yet RB O
been VBN O
described VBN O
. . O

Transcription NN O
may MD O
be VB O
initiated VBN O
at IN O
numerous JJ O
sites NNS O
suggesting VBG O
a DT O
relaxed VBN O
promoter NN O
recognition NN O
by IN O
the DT O
transcription NN O
machinery NN O
( , O
28 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
lack NN O
of IN O
crossed JJ O
recognition NN O
of IN O
cox2 NN O
promoters NNS O
in IN O
wheat NN B-Species
and CC O
potato NN B-Species
is VBZ O
not RB O
a DT O
general JJ O
situation NN O
since IN O
the DT O
A NNP B-Species
. . I-Species
thaliana NN I-Species
cox2 NN O
gene NN O
is VBZ O
expressed VBN O
and CC O
spliced VBN O
when WRB O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
, , O
indicating VBG O
that IN O
the DT O
Arabidopsis NNP B-Species
gene NN O
shares VBZ O
some DT O
signals NNS O
with IN O
maize NN B-Species
cox2 NN O
promoter NN O
that WDT O
are VBP O
sufficient JJ O
for IN O
transcription NN O
( , O
18 CD O
) -RRB- O
. . O

The DT O
sites NNS O
required VBN O
for IN O
transcript NN O
initiation NN O
have VBP O
been VBN O
recently RB O
described VBN O
in IN O
A NNP B-Species
. . I-Species
thaliana NN I-Species
mitochondrial NN O
genes NNS O
( SYM O
28 CD O
) -RRB- O
. . O

Three CD O
regions NNS O
were VBD O
described VBN O
as IN O
important JJ O
for IN O
transcription NN O
initiation NN O
. . O

We PRP O
found VBD O
no DT O
such JJ O
homologous JJ O
sequences NNS O
in IN O
the DT O
potato NN B-Species
cox2 NN O
upstream JJ O
region NN O
indicating VBG O
that IN O
the DT O
two CD O
dicot NN O
promoters NNS O
do VBP O
not RB O
have VB O
the DT O
same JJ O
origin NN O
. . O

This DT O
in IN O
turn NN O
may MD O
reflect VB O
the DT O
natural JJ O
history NN O
of IN O
this DT O
particular JJ O
mitochondrial JJ O
gene NN O
evolving VBG O
in IN O
its PRP$ O
own JJ O
context NN O
. . O

It PRP O
should MD O
be VB O
mentioned VBN O
that IN O
the DT O
presence NN O
of IN O
a DT O
conserved VBN O
sequence NN O
is VBZ O
not RB O
sufficient JJ O
for IN O
expression NN O
since IN O
a DT O
region NN O
that WDT O
acts VBZ O
as IN O
promoter NN O
in IN O
Arabidopsis NNP B-Species
, , O
potato NN B-Species
and CC O
Oenothera NNP O
is VBZ O
inactive JJ O
in IN O
vivo NN O
in IN O
pea NN B-Species
( SYM O
30 CD O
) -RRB- O
. . O

Further JJ O
studies NNS O
will MD O
be VB O
required VBN O
to TO O
understand VB O
the DT O
transcriptional JJ O
events NNS O
in IN O
plant NN O
mitochondria NN O
. . O

Electroporation NN O
of IN O
foreign JJ O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
provides VBZ O
an DT O
interesting JJ O
functional JJ O
model NN O
, , O
complementary JJ O
to IN O
in FW O
vitro FW O
transcription NN O
assay NN O
, , O
for IN O
answering VBG O
these DT O
questions NNS O
. . O

The DT O
potato NN B-Species
rps10 NN O
gene NN O
controlled VBN O
by IN O
a DT O
T NN B-Species
. . I-Species
aestivum NN I-Species
promoter NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
was VBD O
transcribed VBN O
as IN O
a DT O
1204 CD O
nt NN O
precursor NN O
in IN O
wheat NN B-Species
mitochondria NN O
, , O
but CC O
no DT O
traces NNS O
of IN O
mature JJ O
RNA NNP O
were VBD O
observed VBN O
. . O

Moreover RB O
, , O
the DT O
five CD O
C NN O
residues NNS O
reported VBN O
as IN O
RNA NNP O
editing NN O
targets NNS O
in IN O
vivo NN O
( : O
23 CD O
) -RRB- O
remain VBP O
unchanged JJ O
, , O
indicating VBG O
that IN O
rps10 NN O
transcript NN O
was VBD O
not RB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
splicing NN O
and CC O
editing NN O
machinery NN O
. . O

A DT O
control NN O
using VBG O
the DT O
cognate JJ O
cox2 NN O
construct NN O
demonstrates VBZ O
that IN O
electroporated VBN O
organelles NNS O
were VBD O
competent JJ O
for IN O
splicing NN O
and CC O
editing NN O
( -LRB- O
Figure NNP O
1B NNP O
and CC O
C NN O
) -RRB- O
. . O

Some DT O
editing NN O
events NNS O
occur VBP O
in IN O
highly RB O
structured JJ O
domains NNS O
of IN O
introns NNS O
. . O

Because IN O
in IN O
some DT O
cases NNS O
, , O
editing NN O
corrects VBZ O
A NNP O
- HYPH O
C NN O
mispairing VBG O
improving VBG O
conformation NN O
of IN O
the DT O
intron NN O
, , O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
the DT O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
change NN O
might MD O
be VB O
necessary JJ O
for IN O
efficient JJ O
splicing NN O
( , O
8 CD O
, , O
9 CD O
, , O
23 CD O
, , O
31 CD O
) -RRB- O
. . O

Based VBN O
on IN O
the DT O
canonical JJ O
structure NN O
of IN O
group NN O
II NNP O
mitochondrial JJ O
introns NNS O
( , O
21 CD O
) -RRB- O
, , O
two CD O
editing NN O
sites NNS O
, , O
C2 NNP O
located VBN O
at IN O
the DT O
Intron NNP O
Binding NNP O
Site NNP O
2 CD O
( , O
IBS2 NNP O
) -RRB- O
and CC O
C3 NN O
located VBN O
in IN O
the DT O
intron NN O
, , O
nine CD O
residues NNS O
downstream RB O
from IN O
the DT O
end NN O
of IN O
exon NN O
1 CD O
in IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
are VBP O
of IN O
particular JJ O
interest NN O
. . O

It PRP O
has VBZ O
been VBN O
predicted VBN O
that IN O
both CC O
edited VBN O
residues NNS O
participate VBP O
in IN O
base NN O
- HYPH O
pair NN O
interactions NNS O
in IN O
the DT O
putative JJ O
secondary JJ O
structure NN O
. . O

Of IN O
particular JJ O
interest NN O
is VBZ O
the DT O
site NN O
C3 NNP O
located VBN O
in IN O
intron NN O
domain NN O
I NNP O
( HYPH O
23 CD O
) -RRB- O
. . O

This DT O
position NN O
may MD O
be VB O
crucial JJ O
for IN O
splicing VBG O
as IN O
inferred VBN O
from IN O
mutants NNS O
of IN O
a DT O
yeast NN B-Species
mitochondrial JJ O
intron NN O
( SYM O
32 CD O
) -RRB- O
. . O

We PRP O
addressed VBD O
this DT O
question NN O
by IN O
introducing VBG O
rps10 CD O
mutant JJ O
genes NNS O
presenting VBG O
C2 NNP O
, , O
C3 NNP O
or CC O
both DT O
positions NNS O
in IN O
the DT O
edited VBN O
form NN O
into IN O
mitochondria NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
2 CD O
, , O
transcription NN O
was VBD O
as RB O
efficient JJ O
as IN O
for IN O
the DT O
cognate JJ O
cox2 NN O
construct NN O
but CC O
neither CC O
wild JJ O
- HYPH O
type NN O
rps10 NN O
nor CC O
the DT O
C NNP O
- HYPH O
U NNP O
mutants NNS O
underwent VBD O
splicing NN O
. . O

These DT O
results NNS O
clearly RB O
demonstrate VBP O
that IN O
C2 NNP O
and CC O
C3 NNP O
editing NN O
is VBZ O
not RB O
sufficient JJ O
for IN O
splicing NN O
of IN O
rps10 NN O
precursor NN O
in IN O
wheat NN B-Species
mitochondria NN O
and CC O
lead VB O
us PRP O
to TO O
conclude VB O
that IN O
splicing VBG O
failure NN O
is VBZ O
probably RB O
linked VBN O
to IN O
the DT O
lack NN O
of IN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
. . O

One CD O
may MD O
speculate VB O
that IN O
these DT O
trans NNS O
- HYPH O
acting VBG O
factors NNS O
, , O
for IN O
instance NN O
nuclear NN O
- HYPH O
encoded VBN O
maturases NNS O
, , O
were VBD O
lost VBN O
after IN O
rps10 NN O
was VBD O
transferred VBN O
to IN O
the DT O
nucleus NN O
in IN O
monocots NNS O
( , O
20 CD O
, , O
25 CD O
) -RRB- O
. . O

The DT O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
mutants NNS O
were VBD O
also RB O
tested VBN O
in IN O
potato NN B-Species
mitochondria NN O
; , O
no DT O
significant JJ O
differences NNS O
were VBD O
detected VBN O
in IN O
splicing VBG O
efficiency NN O
when WRB O
compared VBN O
to IN O
the DT O
unedited JJ O
construct NN O
( , O
D NNP O
. . O
Choury NNP O
, , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
the DT O
lack NN O
of IN O
splicing NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
not RB O
a DT O
general JJ O
feature NN O
of IN O
potato NN B-Species
introns NNS O
, , O
since IN O
the DT O
potato NN B-Species
cox2 NN O
intron NN O
is VBZ O
removed VBN O
efficiently RB O
( : O
Figure NNP O
4B NNP O
) -RRB- O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
hypothesis NN O
that IN O
potato NN B-Species
and CC O
wheat NN B-Species
mitochondria NN O
have VBP O
similar JJ O
trans NNS O
- HYPH O
acting VBG O
factors NNS O
for IN O
cox2 NN O
intron NN O
removal NN O
. . O

A DT O
possible JJ O
link NN O
between IN O
intron NN O
removal NN O
and CC O
editing NN O
has VBZ O
been VBN O
proposed VBN O
for IN O
splicing NN O
of IN O
nad1e NN O
and CC O
nad5III NN O
trans NNS O
- HYPH O
introns NNS O
where WRB O
domain NN O
six CD O
may MD O
require VB O
editing NN O
to TO O
be VB O
structured VBN O
in IN O
a DT O
catalytic JJ O
competent JJ O
secondary JJ O
conformation NN O
( : O
8 CD O
) -RRB- O
. . O

In IN O
rice NN B-Species
, , O
failure NN O
of IN O
RNA NNP O
maturation NN O
and CC O
editing NN O
has VBZ O
been VBN O
correlated VBN O
with IN O
cytoplasmic JJ O
male NN O
sterile JJ O
phenotype NN O
. . O

In IN O
this DT O
model NN O
, , O
the DT O
absence NN O
of IN O
the DT O
nuclear JJ O
gene NN O
Rf NNP O
- HYPH O
1 CD O
affects VBZ O
B NN O
- HYPH O
atp6 NNP O
RNA NNP O
cleavage NN O
and CC O
editing NN O
( SYM O
33 CD O
) -RRB- O
. . O

In IN O
organello NN O
studies NNS O
have VBP O
shown VBN O
that IN O
S NNP B-Species
. . I-Species
bicolor NN I-Species
atp6 NN O
- HYPH O
1 CD O
gene NN O
was VBD O
transcribed VBN O
but CC O
not RB O
edited VBN O
when WRB O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
( SYM O
18 CD O
) -RRB- O
. . O

However RB O
, , O
partially RB O
edited VBN O
molecules NNS O
were VBD O
detected VBN O
in IN O
sorghum NN B-Species
- HYPH O
maize NN B-Species
atp6 NN O
chimeric JJ O
transcripts NNS O
when WRB O
they PRP O
included VBD O
the DT O
maize NN B-Species
atp6 NN O
5 CD O
' '' O
- HYPH O
untranslated JJ O
sequence NN O
, , O
suggesting VBG O
that IN O
the DT O
5 CD O
' '' O
non AFX O
- HYPH O
coding VBG O
region NN O
provides VBZ O
a DT O
structural JJ O
motif NN O
or CC O
binding VBG O
site NN O
for IN O
a DT O
transcript NN O
- HYPH O
specific JJ O
editing NN O
factor NN O
( : O
34 CD O
) -RRB- O
. . O

Unfortunately RB O
, , O
no DT O
data NNS O
on IN O
atp6 NN O
processing NN O
was VBD O
reported VBN O
to TO O
determine VB O
whether IN O
this DT O
region NN O
is VBZ O
directly RB O
involved VBN O
in IN O
editing NN O
or CC O
some DT O
other JJ O
maturation NN O
event NN O
. . O

Since IN O
wheat NN B-Species
mitochondria NN O
do VBP O
not RB O
have VB O
rps10 NN O
encoded VBN O
in IN O
the DT O
mitochondrial JJ O
genome NN O
( , O
20 CD O
) -RRB- O
, , O
it PRP O
was VBD O
interesting JJ O
to TO O
test VB O
whether IN O
wheat NN B-Species
mitochondria NN O
were VBD O
able JJ O
to TO O
recognize VB O
editing NN O
sites NNS O
which WDT O
had VBD O
been VBN O
lost VBN O
during IN O
evolution NN O
. . O

In IN O
other JJ O
words NNS O
, , O
whether IN O
the DT O
mitochondrial JJ O
trans NN O
- HYPH O
recognition NN O
elements NNS O
are VBP O
specific JJ O
for IN O
each DT O
site NN O
or CC O
whether IN O
they PRP O
are VBP O
operating VBG O
on IN O
a DT O
subset NN O
of IN O
editing NN O
sites NNS O
. . O

This DT O
question NN O
is VBZ O
important JJ O
since IN O
to IN O
date NN O
the DT O
factors NNS O
responsible JJ O
for IN O
RNA NNP O
editing NN O
in IN O
plant NN O
mitochondria NN O
remain VBP O
unknown JJ O
. . O

Solving VBG O
this DT O
issue NN O
may MD O
provide VB O
clues NNS O
to TO O
uncover VB O
such JJ O
factors NNS O
. . O

As IN O
described VBN O
above RB O
, , O
the DT O
rps10 NN O
transcript NN O
was VBD O
not RB O
processed VBN O
in IN O
wheat NN B-Species
but CC O
it PRP O
was VBD O
correctly RB O
spliced VBN O
in IN O
cognate NN O
mitochondria NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Indeed RB O
, , O
the DT O
mature JJ O
transcript NN O
had VBD O
identical JJ O
exon1 NN O
and CC O
exon2 NN O
junction NN O
as IN O
found VBN O
in IN O
endogenous JJ O
rps10 NN O
mRNA NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

More RBR O
importantly RB O
, , O
all DT O
editing NN O
sites NNS O
, , O
C1 NNP O
, , O
C2 NNP O
, , O
C4 NNP O
and CC O
C5 NNP O
were VBD O
significantly RB O
converted VBN O
to IN O
Us NNP O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
the DT O
four CD O
editing NN O
sites NNS O
were VBD O
found VBN O
either CC O
edited VBN O
or CC O
unedited VBN O
in IN O
spliced JJ O
rps10 NN O
mRNA NN O
is VBZ O
an DT O
indication NN O
that IN O
editing NN O
does VBZ O
not RB O
precede VB O
splicing NN O
as IN O
was VBD O
previously RB O
found VBN O
for IN O
cox2 NN O
in IN O
wheat NN B-Species
( SYM O
15 CD O
) -RRB- O
. . O

It PRP O
may MD O
be VB O
argued VBN O
that IN O
the DT O
absence NN O
of IN O
splicing NN O
precluded VBD O
editing NN O
. . O

This DT O
possibility NN O
can MD O
be VB O
discarded VBN O
since IN O
potato NN B-Species
rps10 NN O
precursor NN O
mRNA NNP O
was VBD O
found VBN O
to TO O
be VB O
edited VBN O
in IN O
vivo NN O
( SYM O
23 CD O
) -RRB- O
. . O

These DT O
data NNS O
clearly RB O
show VBP O
that IN O
splicing NN O
is VBZ O
not RB O
required VBN O
for IN O
rps10 NN O
editing NN O
, , O
similar JJ O
to IN O
previous JJ O
findings NNS O
for IN O
cox2 NN O
mRNA NN O
and CC O
also RB O
in IN O
cox2 NN O
mutant JJ O
derivatives NNS O
unable JJ O
to TO O
remove VB O
the DT O
intron NN O
( HYPH O
15 CD O
) -RRB- O
. . O

This DT O
led VBD O
us PRP O
to TO O
postulate VB O
that IN O
the DT O
inability NN O
of IN O
wheat NN B-Species
mitochondria NN O
to TO O
recognize VB O
rps10 NN O
editing NN O
sites NNS O
is VBZ O
likely JJ O
due IN O
to IN O
the DT O
fact NN O
that IN O
wheat NN B-Species
mitochondria NN O
have VBP O
lost VBN O
the DT O
editing NN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
which WDT O
become VBP O
dispensable JJ O
after IN O
transfer NN O
of IN O
rps10 NN O
to IN O
the DT O
nucleus NN O
. . O

To TO O
test VB O
this DT O
possibility NN O
, , O
rps10 CD O
chimeric JJ O
plasmids NNS O
containing VBG O
editing NN O
site NN O
C259 NN O
from IN O
wheat NN B-Species
cox2 NN O
inserted VBN O
either CC O
in IN O
exon1 NN O
or CC O
the DT O
intron NN O
were VBD O
constructed VBN O
. . O

Site NN O
C259 CD O
is VBZ O
formed VBN O
by IN O
23 CD O
nt IN O
corresponding VBG O
to IN O
the DT O
- HYPH O
16 CD O
/ SYM O
+ SYM O
6 CD O
sequence NN O
embedding VBG O
the DT O
target NN O
C NN O
. . O

Previously RB O
we PRP O
found VBD O
that IN O
this DT O
small JJ O
region NN O
could MD O
be VB O
recognized VBN O
by IN O
the DT O
RNA NNP O
editing NN O
machinery NN O
when WRB O
placed VBN O
outside IN O
of IN O
its PRP$ O
natural JJ O
context NN O
( , O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

The DT O
wheat NN B-Species
C259 CD O
editing NN O
site NN O
in IN O
the DT O
chimeric JJ O
construct NN O
was VBD O
correctly RB O
edited VBN O
by IN O
potato NN B-Species
mitochondria NNS O
. . O

This DT O
result NN O
is VBZ O
not RB O
unexpected JJ O
since IN O
the DT O
corresponding VBG O
region NN O
in IN O
endogenous JJ O
potato NN B-Species
cox2 NN O
mRNA NN O
, , O
which WDT O
presents VBZ O
two CD O
differences NNS O
at IN O
positions NNS O
- : O
3 CD O
( SYM O
C NN O
instead RB O
of IN O
A NN O
) -RRB- O
and CC O
- HYPH O
7 CD O
( HYPH O
G NN O
instead RB O
of IN O
A NN O
) -RRB- O
, , O
is VBZ O
edited VBN O
. . O

Furthermore RB O
, , O
these DT O
positions NNS O
were VBD O
not RB O
crucial JJ O
for IN O
editing NN O
of IN O
C259 NNP O
( SYM O
17 CD O
) -RRB- O
. . O

Surprisingly RB O
, , O
the DT O
C259 NNP O
editing NN O
site NN O
grafted VBD O
in IN O
rps10 NN O
was VBD O
not RB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
editing NN O
machinery NN O
. . O

We PRP O
cannot MD O
exclude VB O
the DT O
possibility NN O
that IN O
editing VBG O
efficiency NN O
in IN O
precursor NN O
molecules NNS O
is VBZ O
very RB O
low JJ O
and CC O
so RB O
is VBZ O
undetectable JJ O
when WRB O
sequencing VBG O
RT NNP O
- HYPH O
PCR NNP O
products NNS O
representing VBG O
a DT O
pool NN O
of IN O
transcripts NNS O
. . O

However RB O
, , O
analysis NN O
of IN O
the DT O
same JJ O
region NN O
in IN O
cox2 NN O
precursors NNS O
indicates VBZ O
that IN O
this DT O
was VBD O
not RB O
the DT O
case NN O
since IN O
significant JJ O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
conversion NN O
was VBD O
observed VBN O
( -LRB- O
Figure NNP O
6D NNP O
) -RRB- O
. . O

These DT O
observations NNS O
lead VBP O
us PRP O
to TO O
postulate VB O
that IN O
editing NN O
is VBZ O
occurring VBG O
only RB O
when WRB O
the DT O
transcript NN O
is VBZ O
engaged VBN O
in IN O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
, , O
suggesting VBG O
that IN O
rps10 NN O
transcripts NNS O
are VBP O
not RB O
available JJ O
to IN O
editing NN O
factors NNS O
independently RB O
of IN O
the DT O
RNA NNP O
maturation NN O
machinery NN O
. . O

The DT O
fact NN O
that IN O
the DT O
wheat NN B-Species
editing NN O
site NN O
C259 CD O
inserted VBN O
in IN O
chimeric JJ O
rps10 NN O
transcripts NNS O
was VBD O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
a DT O
strong JJ O
argument NN O
for IN O
this DT O
hypothesis NN O
. . O

One PRP O
might MD O
speculate VB O
that IN O
in IN O
plant NN O
mitochondria NN O
, , O
transcripts NNS O
have VBP O
to TO O
be VB O
engaged VBN O
in IN O
a DT O
kind NN O
of IN O
multiprotein NN O
processing NN O
complex NN O
. . O

A DT O
failure NN O
to TO O
be VB O
recognized VBN O
at IN O
some DT O
early JJ O
stage NN O
will MD O
lead VB O
to IN O
their PRP$ O
accumulation NN O
as IN O
unmodified JJ O
precursors NNS O
. . O

Rap1p NN O
and CC O
other JJ O
transcriptional JJ O
regulators NNS O
can MD O
function VB O
in IN O
defining VBG O
distinct JJ O
domains NNS O
of IN O
gene NN O
expression NN O

Abstract JJ O

Barrier NN O
elements NNS O
that WDT O
are VBP O
able JJ O
to TO O
block VB O
the DT O
propagation NN O
of IN O
transcriptional JJ O
silencing NN O
in IN O
yeast NN B-Species
are VBP O
functionally RB O
similar JJ O
to IN O
chromatin NN O
boundary NN O
/ SYM O
insulator NN O
elements NNS O
in IN O
metazoans NNS O
that WDT O
delimit VBP O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

We PRP O
show VBP O
that IN O
the DT O
upstream JJ O
activating VBG O
sequences NNS O
of IN O
many JJ O
highly RB O
expressed VBN O
ribosome NN O
protein NN O
genes NNS O
and CC O
glycolytic JJ O
genes NNS O
exhibit VBP O
barrier NN O
activity NN O
. . O

Analyses NNS O
of IN O
these DT O
barriers NNS O
indicate VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Rap1p NNP O
, , O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
and CC O
Gcn4p NNP O
may MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

We PRP O
also RB O
present VBP O
evidence NN O
suggesting VBG O
that IN O
Rap1p NNP O
is VBZ O
directly RB O
involved VBN O
in IN O
barrier NN O
activity NN O
, , O
and CC O
its PRP$ O
barrier NN O
function NN O
correlates VBZ O
with IN O
local JJ O
changes NNS O
in IN O
chromatin NN O
structure NN O
. . O

We PRP O
further RB O
demonstrate VBP O
that IN O
tethering VBG O
the DT O
transcriptional JJ O
activation NN O
domain NN O
of IN O
Rap1p NNP O
to IN O
DNA NNP O
is VBZ O
sufficient JJ O
to TO O
recapitulate VB O
barrier NN O
activity NN O
. . O

Moreover RB O
, , O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
also RB O
establishes VBZ O
a DT O
barrier NN O
to IN O
silencing NN O
. . O

These DT O
results NNS O
support VBP O
the DT O
notion NN O
that IN O
transcriptional JJ O
regulators NNS O
could MD O
also RB O
participate VB O
in IN O
delimiting VBG O
functional JJ O
domains NNS O
in IN O
the DT O
genome NN O
. . O

INTRODUCTION NN O

The DT O
eukaryotic JJ O
genome NN O
is VBZ O
organized VBN O
into IN O
discrete JJ O
functional JJ O
domains NNS O
in IN O
which WDT O
gene NN O
expression NN O
is VBZ O
either CC O
permitted VBN O
or CC O
repressed VBN O
. . O

Domains NNS O
permissive JJ O
for IN O
gene NN O
expression NN O
are VBP O
usually RB O
defined VBN O
as IN O
euchromatin NN O
or CC O
active JJ O
chromatin NN O
, , O
and CC O
domains NNS O
that WDT O
repress VBP O
gene NN O
expression NN O
heterochromatin NN O
or CC O
silent JJ O
chromatin NN O
. . O

The DT O
HML NNP O
and CC O
HMR NNP O
loci NN O
in IN O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
are VBP O
silent JJ O
chromatin NN O
domains NNS O
( , O
1 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
active JJ O
chromatin NN O
, , O
silent JJ O
chromatin NN O
is VBZ O
more RBR O
compact JJ O
and CC O
its PRP$ O
histone NN O
components NNS O
are VBP O
hypoacetylated VBN O
( SYM O
2 CD O
) -RRB- O
. . O

The DT O
SIR NNP O
complex NN O
consisting VBG O
of IN O
Sir2p NNP O
through IN O
Sir4p NNP O
is VBZ O
an DT O
integral JJ O
part NN O
of IN O
yeast NN B-Species
silent JJ O
chromatin NN O
. . O

Sir3p NNP O
and CC O
Sir4p NNP O
interact VBP O
with IN O
the DT O
N NN O
- HYPH O
terminal JJ O
tails NNS O
of IN O
histones NNS O
H3 NNP O
and CC O
H4 NNP O
providing VBG O
the DT O
structural JJ O
basis NN O
of IN O
silent JJ O
chromatin NN O
( : O
1 CD O
) -RRB- O
. . O

Sir2p NNP O
was VBD O
recently RB O
found VBN O
to TO O
be VB O
an DT O
NAD NNP O
- HYPH O
dependent JJ O
histone NN O
deacetylase NN O
and CC O
was VBD O
suggested VBN O
to TO O
be VB O
responsible JJ O
for IN O
histone NN O
hypoacetylation NN O
in IN O
silent JJ O
chromatin NN O
( HYPH O
3 CD O
) -RRB- O
. . O

Silent JJ O
chromatin NN O
is VBZ O
initiated VBN O
at IN O
small JJ O
cis NN O
- HYPH O
acting VBG O
DNA NN O
elements NNS O
known VBN O
as IN O
the DT O
E NN O
and CC O
I NNP O
silencers NNS O
flanking VBG O
each DT O
of IN O
the DT O
HM NNP O
loci NN O
( HYPH O
4 CD O
) -RRB- O
. . O

Increasing VBG O
evidence NN O
indicates VBZ O
that IN O
histone NN O
deacetylation NN O
is VBZ O
key JJ O
to IN O
the DT O
propagation NN O
of IN O
silent JJ O
chromatin NN O
( , O
4 CD O
) -RRB- O
. . O

In IN O
vertebrates NNS O
and CC O
fission NN O
yeast NN B-Species
, , O
spread NN O
of IN O
silent JJ O
chromatin NN O
involves VBZ O
a DT O
chain NN O
of IN O
events NNS O
of IN O
histone NN O
H3 NN O
deacetylation NN O
- HYPH O
- : O
> SYM O
H3 CD O
methylation NN O
- HYPH O
- HYPH O
> XX O
binding NN O
of IN O
methylated VBN O
H3 NN O
by IN O
HP1 NN O
( : O
heterochromatin NN O
protein NN O
1 CD O
) -RRB- O
or CC O
swi6 NN O
( HYPH O
4 CD O
) -RRB- O
. . O

In IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
, , O
there EX O
is VBZ O
evidence NN O
that IN O
Sir3p NNP O
( , O
hence RB O
the DT O
SIR NNP O
complex NN O
) -RRB- O
has VBZ O
much RB O
higher JJR O
affinity NN O
to IN O
unacetylated JJ O
histone NN O
H4 NN O
than IN O
acetylated VBN O
H4 NNP O
( SYM O
5 CD O
) -RRB- O
. . O

Based VBN O
on IN O
this DT O
and CC O
the DT O
fact NN O
that IN O
Sir2p NNP O
is VBZ O
a DT O
histone NN O
deacetylase NN O
, , O
a DT O
refined JJ O
model NN O
for IN O
the DT O
propagation NN O
of IN O
silent JJ O
chromatin NN O
can MD O
be VB O
proposed VBN O
. . O

In IN O
this DT O
model NN O
, , O
Sir2p NNP O
recruited VBD O
to IN O
the DT O
silencer NN O
deacetylates VBZ O
histones NNS O
in IN O
an DT O
adjacent JJ O
nucleosome NN O
enabling VBG O
it PRP O
to TO O
bind VB O
another DT O
SIR NNP O
complex NN O
with IN O
high JJ O
affinity NN O
. . O

The DT O
nucleosome NN O
- HYPH O
bound VBN O
SIR NNP O
complex NN O
in IN O
turn NN O
deacetylates VBZ O
the DT O
neighboring VBG O
nucleosome NN O
allowing VBG O
it PRP O
to TO O
recruit VB O
a DT O
new JJ O
SIR NNP O
complex NN O
. . O

In IN O
this DT O
manner NN O
, , O
the DT O
SIR NNP O
complex NN O
promotes VBZ O
its PRP$ O
own JJ O
propagation NN O
along IN O
an DT O
array NN O
of IN O
nucleosomes NNS O
( , O
4 CD O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
transcriptionally RB O
silent JJ O
chromatin NN O
can MD O
encroach VB O
upon IN O
active JJ O
chromatin NN O
poses VBZ O
the DT O
question NN O
of IN O
how WRB O
interspersed JJ O
domains NNS O
of IN O
silent JJ O
and CC O
active JJ O
chromatin NN O
are VBP O
demarcated VBN O
. . O

Studies NNS O
of IN O
the DT O
Drosophila NNP O
and CC O
vertebrate JJ O
genomes NNS O
demonstrated VBD O
that IN O
some DT O
domains NNS O
are VBP O
delimited VBN O
by IN O
boundary NN O
or CC O
insulator NN O
elements NNS O
( , O
6 CD O
) -RRB- O
. . O

These DT O
elements NNS O
are VBP O
specialized JJ O
DNA NN O
sequences NNS O
that WDT O
act VBP O
as IN O
barriers NNS O
to IN O
enhancers NNS O
and CC O
/ SYM O
or CC O
silent JJ O
chromatin NN O
. . O

One CD O
of IN O
the DT O
best RBS O
characterized VBN O
insulators NNS O
is VBZ O
the DT O
chicken NN B-Species
HS4 NNP O
insulator NN O
at IN O
the DT O
beta NN O
- HYPH O
globin NN O
locus NN O
. . O

Histones NNS O
surrounding VBG O
this DT O
insulator NN O
are VBP O
hyperacetylated VBN O
indicating VBG O
the DT O
presence NN O
of IN O
histone NN O
acetyltransferase NN O
( , O
HAT NN O
) -RRB- O
activity NN O
at IN O
the DT O
insulator NN O
( , O
6 CD O
) -RRB- O
. . O

Recently RB O
, , O
sequences NNS O
that WDT O
could MD O
block VB O
the DT O
spread NN O
of IN O
silent JJ O
chromatin NN O
have VBP O
been VBN O
discovered VBN O
in IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
( , O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

These DT O
sequences NNS O
( , O
referred VBN O
to IN O
as IN O
silent JJ O
chromatin NN O
barriers NNS O
) , O
include VBP O
sub JJ O
- HYPH O
telomeric JJ O
anti JJ O
- HYPH O
silencing VBG O
regions NNS O
( , O
STARs NNPS O
) -RRB- O
, , O
the DT O
right JJ O
boundary NN O
of IN O
HMR NNP O
, , O
and CC O
the DT O
upstream JJ O
activating VBG O
sequence NN O
( , O
UAS NNP O
) -RRB- O
of IN O
the DT O
highly RB O
expressed VBN O
TEF2 NNP O
gene NN O
( : O
9 CD O
- SYM O
11 CD O
) -RRB- O
. . O

The DT O
mechanisms NNS O
underlying VBG O
barrier NN O
functions NNS O
in IN O
yeast NN B-Species
are VBP O
not RB O
known VBN O
. . O

TEF2 NNP O
- HYPH O
UAS NNP O
contains VBZ O
three CD O
tandem NN O
repressor NN O
activator NN O
protein NN O
1 CD O
( SYM O
Rap1p NNP O
) -RRB- O
- HYPH O
binding VBG O
sites NNS O
that WDT O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
for IN O
its PRP$ O
barrier NN O
function NN O
( , O
11 CD O
) -RRB- O
. . O

Rap1p NN O
is VBZ O
an DT O
abundant JJ O
sequence NN O
- HYPH O
specific JJ O
DNA NN O
- HYPH O
binding VBG O
protein NN O
( : O
12 CD O
) -RRB- O
. . O

Variants NNS O
of IN O
the DT O
13 CD O
bp NN O
consensus NN O
sequence NN O
for IN O
Rap1p NNP O
binding NN O
( -LRB- O
ACACC NNP O
CRYACAYM NNP O
) -RRB- O
( , O
13 CD O
) -RRB- O
lie VBP O
not RB O
only RB O
in IN O
the DT O
UASs NNS O
of IN O
numerous JJ O
genes NNS O
but CC O
also RB O
in IN O
the DT O
silencers NNS O
of IN O
the DT O
HM NNP O
loci NN O
and CC O
in IN O
telomeric JJ O
C1 NN O
- HYPH O
3A NN O
repeats NNS O
. . O

Accordingly RB O
, , O
Rap1p NNP O
functions VBZ O
as IN O
a DT O
global JJ O
regulator NN O
of IN O
transcriptional JJ O
activation NN O
and CC O
repression NN O
, , O
silencing NN O
, , O
as RB O
well RB O
as IN O
telomere NN O
length NN O
( SYM O
12 CD O
) -RRB- O
. . O

Rap1p NNP O
performs VBZ O
these DT O
diverse JJ O
functions NNS O
by IN O
interacting VBG O
with IN O
different JJ O
factors NNS O
in IN O
respective JJ O
contexts NNS O
. . O

As IN O
an DT O
activator NN O
, , O
Rap1p NNP O
binds VBZ O
to IN O
the DT O
promoters NNS O
of IN O
362 CD O
ORFs NNS O
( SYM O
13 CD O
) -RRB- O
and CC O
can MD O
function VB O
via IN O
at RB O
least RBS O
three CD O
mechanisms NNS O
. . O

First RB O
, , O
Rap1p NN O
binding NN O
can MD O
' `` O
open VB O
up RP O
' '' O
local JJ O
chromatin NN O
structure NN O
at IN O
a DT O
promoter NN O
to TO O
help VB O
another DT O
activator NN O
to TO O
bind VB O
( SYM O
14 CD O
) -RRB- O
. . O

Secondly RB O
, , O
Rap1p NNP O
bound VBN O
to IN O
DNA NNP O
can MD O
help VB O
Gcr1p NNP O
bind VB O
to IN O
an DT O
adjacent JJ O
site NN O
in IN O
the DT O
promoter NN O
through IN O
physical JJ O
interaction NN O
( : O
15 CD O
) -RRB- O
. . O

Thirdly RB O
, , O
Rap1p NNP O
is VBZ O
involved VBN O
in IN O
the DT O
recruitment NN O
of IN O
the DT O
NuA4 NNP O
HAT NNP O
complex NN O
and CC O
TFIID NNP O
to IN O
ribosome NN O
protein NN O
genes NNS O
( -LRB- O
RPGs NNS O
) -RRB- O
( : O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

As IN O
a DT O
silencing VBG O
factor NN O
, , O
Rap1p NNP O
binds VBZ O
to IN O
silencers NNS O
or CC O
telomeric JJ O
repeats NNS O
and CC O
recruits VBZ O
Sir3p NNP O
/ SYM O
Sir4p NNP O
through IN O
direct JJ O
interactions NNS O
( , O
18 CD O
) -RRB- O
. . O

Rap1p NNP O
also RB O
interacts VBZ O
with IN O
telomere NN O
- HYPH O
specific JJ O
proteins NNS O
in IN O
executing VBG O
its PRP$ O
role NN O
in IN O
regulating VBG O
telomere NN O
length NN O
( SYM O
19 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
puzzling JJ O
that IN O
a DT O
protein NN O
that WDT O
helps VBZ O
establish VB O
silent JJ O
chromatin NN O
could MD O
also RB O
act VB O
as IN O
a DT O
barrier NN O
to IN O
its PRP$ O
propagation NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
in IN O
addition NN O
to IN O
TEF2 NNP O
- HYPH O
UAS NNP O
, , O
UASs NNP O
of IN O
many JJ O
yeast NN B-Species
genes NNS O
exhibit VBP O
barrier NN O
activity NN O
. . O

Analyses NNS O
of IN O
these DT O
UASs NNS O
indicate VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
, , O
Gcn4p NNP O
, , O
as RB O
well RB O
as IN O
Rap1p NNP O
, , O
may MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

These DT O
UASs NNS O
are VBP O
dispersed VBN O
across IN O
the DT O
genome NN O
and CC O
might MD O
play VB O
a DT O
role NN O
in IN O
defining VBG O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

Moreover RB O
, , O
we PRP O
demonstrated VBD O
that IN O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
alone RB O
, , O
led VBD O
to IN O
barrier NN O
function NN O
. . O

Since IN O
the DT O
activation NN O
domain NN O
of IN O
an DT O
activator NN O
was VBD O
usually RB O
involved VBN O
in IN O
interacting VBG O
with IN O
co NN O
- HYPH O
activators NNS O
and CC O
/ SYM O
or CC O
components NNS O
of IN O
the DT O
transcriptional JJ O
machinery NN O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
other JJ O
factors NNS O
might MD O
also RB O
be VB O
involved VBN O
in IN O
barrier NN O
function NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Plasmids NNS O
and CC O
strains NNS O

Plasmids NNP O
1 CD O
- HYPH O
53 CD O
were VBD O
used VBN O
to TO O
make VB O
strains NNS O
1 CD O
- SYM O
53 CD O
, , O
respectively RB O
( , O
see VB O
Figs NNP O
1 CD O
- HYPH O
6 CD O
) -RRB- O
. . O

Plasmid NN O
1 CD O
was VBD O
previously RB O
named VBN O
pMB22 NN O
- : O
a DT O
that WDT O
contained VBD O
a DT O
HindIII NNP O
- HYPH O
BamHI NNP O
fragment NN O
of IN O
chromosome NN O
III NNP O
( , O
coordinates VBZ O
14838 CD O
- HYPH O
16263 CD O
) -RRB- O
with IN O
a DT O
URA3 NNP O
gene NN O
inserted VBN O
at IN O
its PRP$ O
EcoRV NNP O
site NN O
( SYM O
20 CD O
) -RRB- O
. . O

Plasmid NN O
2 CD O
was VBD O
derived VBN O
from IN O
1 CD O
by IN O
inserting VBG O
TEF2 NNP O
- HYPH O
UAS NNP O
( : O
- HYPH O
511 CD O
to IN O
- HYPH O
407 CD O
bp NN O
relative JJ O
to IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmids NNP O
3 CD O
- SYM O
38 CD O
were VBD O
identical JJ O
to IN O
2 CD O
except IN O
that IN O
different JJ O
fragments NNS O
from IN O
various JJ O
promoters NNS O
( , O
see VB O
Figs NNP O
1 CD O
and CC O
2 CD O
) -RRB- O
were VBD O
inserted VBN O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmid NNP O
29 CD O
had VBD O
a DT O
sequence NN O
of IN O
chromosome NN O
III NNP O
( : O
295327 CD O
- HYPH O
295713 CD O
) -RRB- O
containing VBG O
the DT O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
( SYM O
21 CD O
) -RRB- O
inserted VBN O
at IN O
the DT O
SnaBI NNP O
site NN O
of IN O
plasmid NN O
1 CD O
. . O

Plasmids NNS O
39 CD O
and CC O
40 CD O
were VBD O
previously RB O
named VBN O
pYXB26 NN O
and CC O
pYXB59 CD O
, , O
respectively RB O
( : O
11 CD O
) -RRB- O
. . O

Plasmid NN O
41 CD O
was VBD O
identical JJ O
to IN O
pYXB59 CD O
except IN O
bearing VBG O
mutations NNS O
illustrated VBN O
in IN O
Figure NNP O
3A NNP O
. . O

Plasmids NNP O
42 CD O
- SYM O
48 CD O
were VBD O
previously RB O
described VBN O
as IN O
pYXB29 NN O
, , O
48 CD O
, , O
28 CD O
, , O
27 CD O
, , O
59 CD O
, , O
31 CD O
and CC O
37 CD O
, , O
respectively RB O
( : O
11 CD O
) -RRB- O
. . O

Plasmid NN O
50 CD O
was VBD O
derived VBN O
from IN O
plasmid NN O
1 CD O
by IN O
inserting VBG O
two CD O
copies NNS O
of IN O
a DT O
sequence NN O
bearing VBG O
the DT O
consensus NN O
binding VBG O
sequence NN O
of IN O
LexA NNP O
( : O
bold JJ O
) -RRB- O
( , O
22 CD O
) -RRB- O
, , O
GGGGTACGTACTGTATGTAC NNP O
, , O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmid NN O
51 CD O
was VBD O
identical JJ O
to IN O
50 CD O
except IN O
having VBG O
only RB O
one CD O
copy NN O
of IN O
the DT O
LexA NNP O
- HYPH O
binding VBG O
sequence NN O
. . O

Plasmid NN O
52 CD O
was VBD O
derived VBN O
from IN O
pYXB26 NNP O
( SYM O
11 CD O
) -RRB- O
by IN O
inserting VBG O
a DT O
SpeI NNP O
- HYPH O
ADE2 NNP O
- HYPH O
AvrII NNP O
sequence NN O
at IN O
the DT O
SpeI NNP O
site NN O
. . O

Plasmid NN O
53 CD O
was VBD O
derived VBN O
from IN O
plasmid NN O
52 CD O
by IN O
inserting VBG O
TEF2 NNP O
- HYPH O
UAS NNP O
( : O
- HYPH O
511 CD O
to IN O
- HYPH O
407 CD O
bp NN O
relative JJ O
to IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
at IN O
the DT O
SpeI NNP O
site NN O
. . O

Plasmid NNP O
L1 NNP O
( , O
see VB O
Fig NNP O
. . O
5A NNP O
) -RRB- O
was VBD O
made VBN O
by IN O
inserting VBG O
LEU2 NNP O
into IN O
pBTM116 CD O
( SYM O
23 CD O
) -RRB- O
carrying VBG O
the DT O
LexA NNP O
gene NN O
flanked VBN O
by IN O
the DT O
promoter NN O
and CC O
terminator NN O
of IN O
ADH1 NNP O
. . O

L2 NNP O
through IN O
L8 NNP O
were VBD O
derived VBN O
from IN O
L1 NNP O
by IN O
fusing VBG O
various JJ O
sequences NNS O
to IN O
LexA NNP O
( , O
see VB O
Fig NNP O
. . O
5A NN O
and CC O
B NN O
) -RRB- O
. . O

Plasmid NNP O
pRS425 NNP O
( -LRB- O
24 CD O
) -RRB- O
carried VBD O
the DT O
2 CD O
micro JJ O
m NN O
origin NN O
and CC O
LEU2 NNP O
. . O

Strain NN O
YXB76 CD O
was VBD O
MATa NNP O
ura3 CD O
- HYPH O
52 CD O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
ade2 CD O
- HYPH O
1 CD O
lys1 CD O
- HYPH O
1 CD O
his5 CD O
- HYPH O
2 CD O
can1 NN O
- HYPH O
100 CD O
, , O
E NNP O
- HYPH O
HML NNP O
alpha NN O
- HYPH O
Iinverted NNP O
( HYPH O
20 CD O
) -RRB- O
. . O

Y2047b NN O
was VBD O
MATa NNP O
HMRa NNP O
HML NNP O
alpha NN O
E NN O
Delta NNP O
79 CD O
- HYPH O
113 CD O
: : O
: : O
SUP4 CD O
- HYPH O
o -LRB- O
I NNP O
Delta NNP O
242 CD O
LEU2 NNP O
- HYPH O
GAL10 NNP O
- HYPH O
FLP1 CD O
ura3 CD O
- HYPH O
52 CD O
ade2 CD O
- HYPH O
1 CD O
lys1 CD O
- HYPH O
1 CD O
his5 CD O
- HYPH O
1 CD O
can1 NN O
- HYPH O
100 CD O
[ -LRB- O
cir0 NN O
] -RRB- O
( : O
25 CD O
) -RRB- O
. . O

Strain NN O
1 CD O
was VBD O
made VBN O
by IN O
transforming VBG O
YXB76 NNP O
to IN O
Ura NNP O
+ CC O
with IN O
HindIII NNP O
+ CC O
BamHI NNP O
digested VBN O
plasmid NN O
1 CD O
. . O

Strains NNS O
2 CD O
- SYM O
38 CD O
, , O
50 CD O
and CC O
51 CD O
were VBD O
similarly RB O
made VBN O
with IN O
corresponding JJ O
plasmids NNS O
, , O
respectively RB O
( : O
e LS O
. . O
g LS O
. . O
strain NN O
2 CD O
was VBD O
made VBN O
with IN O
plasmid NN O
2 CD O
) -RRB- O
. . O

Strains NNS O
39 CD O
, , O
40 CD O
and CC O
42 CD O
- SYM O
48 CD O
were VBD O
previously RB O
described VBN O
as IN O
YXB26 NNP O
, , O
48 CD O
, , O
29 CD O
, , O
48 CD O
, , O
28 CD O
, , O
27 CD O
, , O
59 CD O
, , O
31 CD O
and CC O
37 CD O
, , O
respectively RB O
( SYM O
11 CD O
) -RRB- O
. . O

Strains NNS O
41 CD O
, , O
52 CD O
and CC O
53 CD O
( , O
see VBP O
Figs NNP O
3C NNP O
and CC O
6 CD O
) -RRB- O
were VBD O
made VBN O
by IN O
transforming VBG O
Y2047b NN O
to IN O
canavanine NN O
- HYPH O
resistant JJ O
by IN O
BamHI NNP O
- HYPH O
digested VBN O
plasmids NNS O
41 CD O
, , O
52 CD O
and CC O
53 CD O
, , O
respectively RB O
. . O

Strains NNS O
40 CD O
' '' O
- HYPH O
48 CD O
' '' O
were VBD O
sir3 NN O
: : O
: : O
URA3 NNP O
derivatives NNS O
of IN O
strains NNS O
40 CD O
- SYM O
48 CD O
, , O
respectively RB O
. . O

The DT O
relevant JJ O
genotypes NNS O
of IN O
all PDT O
the DT O
strains NNS O
were VBD O
confirmed VBN O
by IN O
Southern JJ O
blotting NN O
. . O

Quantitative JJ O
mating NN O
assay NN O

Quantitative JJ O
mating NN O
was VBD O
performed VBN O
as IN O
described VBN O
( SYM O
11 CD O
) -RRB- O
. . O

Electrophoresis NN O
mobility NN O
shift NN O
assay NN O
( : O
EMSA NNP O
) -RRB- O

Rap1p NN O
was VBD O
expressed VBN O
in IN O
Escherichia NNP B-Species
coli NNP I-Species
BL21 NNP I-Species
( -LRB- I-Species
DE3 NNP I-Species
) -RRB- I-Species
from IN O
pL3S5 NN O
, , O
a DT O
pET NN O
vector NN O
carrying VBG O
the DT O
RAP1 NNP O
gene NN O
downstream NN O
of IN O
a DT O
T7 NNP O
promoter NN O
( SYM O
26 CD O
) -RRB- O
. . O

Crude JJ O
protein NN O
extracts NNS O
were VBD O
prepared VBN O
from IN O
40 CD O
ml CD O
cultures NNS O
harvested VBN O
after IN O
3 CD O
h NN O
of IN O
IPTG NNP O
induction NN O
and CC O
resuspended VBN O
in IN O
1 CD O
ml NNS O
of IN O
lysis NN O
buffer NN O
( : O
50 CD O
mM NN O
NaH2PO4 NN O
, , O
300 CD O
mM NN O
NaCl NN O
, , O
pH NN O
8 CD O
. . O
0 CD O
) -RRB- O
. . O

A DT O
control NN O
extract NN O
was VBD O
prepared VBN O
from IN O
a DT O
culture NN O
without IN O
IPTG NNP O
induction NN O
. . O

Western JJ O
blotting NN O
revealed VBD O
that IN O
Rap1p NNP O
protein NN O
was VBD O
present JJ O
in IN O
the DT O
induced VBN O
extract NN O
but CC O
not RB O
the DT O
uninduced JJ O
one CD O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

DNA NN O
fragments NNS O
of IN O
26 CD O
bp NN O
in IN O
length NN O
( , O
see VBP O
Fig NNP O
. . O
3A NNP O
) -RRB- O
were VBD O
end NN O
- HYPH O
labeled VBN O
with IN O
32P CD O
- HYPH O
phosphate NN O
. . O

Fifteen CD O
microliter NN O
binding NN O
reactions NNS O
were VBD O
prepared VBN O
, , O
each DT O
consisting VBG O
of IN O
20 CD O
0 CD O
c NN O
. . O
p NN O
. . O
m NN O
. . O
radiolabeled VBN O
DNA NN O
probe NN O
, , O
5 CD O
micro NN O
g NN O
of IN O
crude JJ O
protein NN O
extract NN O
, , O
non JJ O
- HYPH O
specific JJ O
competitor NN O
DNAs NNS O
( : O
0 CD O
. . O
3 CD O
micro NN O
g NN O
of IN O
yeast NN B-Species
tRNA NN O
, , O
0 CD O
. . O
3 CD O
micro NN O
g NN O
of IN O
salmon NN B-Species
sperm NN O
DNA NN O
and CC O
0 CD O
. . O
5 CD O
micro NN O
g NN O
of IN O
E NN B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
) -RRB- O
, , O
10 CD O
micro NN O
g NN O
of IN O
BSA NNP O
, , O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
8 CD O
. . O
0 CD O
) -RRB- O
, , O
10 CD O
mM NN O
MgCl2 NN O
and CC O
8 CD O
% NN O
glycerol NN O
. . O

The DT O
reactions NNS O
were VBD O
incubated VBN O
at IN O
25 CD O
degrees NNS O
C NN O
for IN O
20 CD O
min NN O
and CC O
loaded VBN O
onto IN O
non JJ O
- HYPH O
denaturing VBG O
polyacrylamide NN O
gels NNS O
( : O
4 CD O
- SYM O
5 CD O
% NN O
) -RRB- O
. . O

Gels NNS O
were VBD O
run VBN O
at IN O
40 CD O
mA NN O
for IN O
1 CD O
h NNS O
in IN O
0 CD O
. . O
5 CD O
x SYM O
TBE NN O
buffer NN O
. . O

Analysis NN O
of IN O
the DT O
supercoiling NN O
of IN O
DNA NNP O
circles NNS O

Cells NNS O
were VBD O
grown VBN O
in IN O
YPR NN O
( : O
yeast NN B-Species
extract NN O
+ CC O
bacto NN O
peptone NN O
+ SYM O
2 CD O
% NN O
raffinose NN O
) -RRB- O
to IN O
early JJ O
log NN O
phase NN O
. . O

Galactose NNP O
( : O
2 CD O
% NN O
) -RRB- O
was VBD O
then RB O
added VBN O
to IN O
the DT O
culture NN O
to TO O
induce VB O
the DT O
expression NN O
of IN O
FLP1 NNP O
. . O

After IN O
2 CD O
. . O
5 CD O
h NN O
of IN O
incubation NN O
, , O
nucleic JJ O
acid NN O
was VBD O
isolated VBN O
using VBG O
the DT O
glass NN O
bead NN O
method NN O
and CC O
fractionated VBN O
on IN O
agarose JJ O
gels NNS O
with IN O
30 CD O
micro JJ O
g NN O
/ SYM O
ml NN O
chloroquine NN O
. . O

DNA NN O
circles NNS O
were VBD O
detected VBN O
by IN O
Southern JJ O
blotting NN O
. . O

RESULTS NNS O

UASs NNP O
of IN O
many JJ O
highly RB O
expressed VBN O
genes NNS O
can MD O
function VB O
as IN O
barriers NNS O
to IN O
the DT O
spread NN O
of IN O
silencing NN O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
TEF2 NNP O
- HYPH O
UAS NNP O
was VBD O
able JJ O
to TO O
block VB O
the DT O
spread NN O
of IN O
silencing NN O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
( SYM O
11 CD O
) -RRB- O
. . O

Such PDT O
an DT O
assay NN O
tested VBD O
if IN O
a DT O
sequence NN O
had VBD O
the DT O
ability NN O
to TO O
prevent VB O
a DT O
silencer NN O
from IN O
silencing VBG O
a DT O
reporter NN O
gene NN O
when WRB O
it PRP O
was VBD O
positioned VBN O
between IN O
the DT O
silencer NN O
and CC O
the DT O
reporter NN O
. . O

In IN O
this DT O
report NN O
we PRP O
used VBD O
a DT O
new JJ O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
to TO O
identify VB O
more JJR O
barrier NN O
elements NNS O
. . O

This DT O
assay NN O
employed VBD O
the DT O
URA3 NNP O
gene NN O
and CC O
an DT O
inverted JJ O
HML NNP O
- HYPH O
I NNP O
that WDT O
could MD O
silence VB O
sequences NNS O
to IN O
the DT O
right NN O
of IN O
HML NNP O
( SYM O
20 CD O
) -RRB- O
( , O
Fig NNP O
. . O
1 CD O
, , O
strain NN O
1 CD O
) -RRB- O
. . O

URA3 NNP O
expression NN O
makes VBZ O
cells NNS O
sensitive JJ O
to IN O
5 CD O
- HYPH O
fluoroorotic NN O
acid NN O
( -LRB- O
FOA NNP O
) -RRB- O
thus RB O
URA3 NNP O
silencing NN O
could MD O
be VB O
measured VBN O
by IN O
cell NN O
growth NN O
on IN O
FOA NNP O
medium NN O
( : O
Fig NNP O
. . O
1 CD O
, , O
strain NN O
1 CD O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
and CC O
another DT O
known VBN O
barrier NN O
element NN O
, , O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
( , O
21 CD O
) -RRB- O
exhibited VBD O
barrier NN O
activity NN O
in IN O
this DT O
assay NN O
as IN O
indicated VBN O
by IN O
the DT O
lack NN O
of IN O
silencing NN O
of IN O
URA3 NNP O
in IN O
strains NNS O
2 CD O
and CC O
29 CD O
( SYM O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

TEF2 NN O
encoding VBG O
translation NN O
elongation NN O
factor NN O
1 CD O
alpha NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
highly RB O
expressed VBN O
genes NNS O
in IN O
yeast NN B-Species
( SYM O
27 CD O
) -RRB- O
. . O

Other JJ O
highly RB O
expressed VBN O
genes NNS O
include VBP O
ribosome NN O
protein NN O
genes NNS O
( , O
RPGs NNS O
) -RRB- O
and CC O
genes NNS O
coding VBG O
for IN O
glycolytic JJ O
enzymes NNS O
( SYM O
27 CD O
) -RRB- O
. . O

The DT O
coordinated JJ O
regulation NN O
of IN O
most JJS O
of IN O
these DT O
genes NNS O
requires VBZ O
the DT O
so RB O
- HYPH O
called VBN O
general JJ O
regulatory JJ O
factors NNS O
Rap1p NNP O
, , O
Abf1p NNP O
and CC O
Reb1p NNP O
( SYM O
28 CD O
, , O
29 CD O
) -RRB- O
. . O

Using VBG O
the DT O
above JJ O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
, , O
we PRP O
tested VBD O
if IN O
the DT O
UASs NNS O
of IN O
other JJ O
highly RB O
expressed VBN O
genes NNS O
could MD O
also RB O
block VB O
URA3 NNP O
silencing NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Seventeen JJ O
new JJ O
barrier NN O
elements NNS O
were VBD O
identified VBN O
from IN O
a DT O
total NN O
of IN O
26 CD O
UASs NNS O
tested VBN O
. . O

These DT O
17 CD O
elements NNS O
were VBD O
UASs NNS O
of IN O
eight CD O
RPGs NNS O
( , O
see VB O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
3 CD O
- SYM O
10 CD O
) -RRB- O
, , O
eight CD O
glycolytic JJ O
genes NNS O
( , O
strains NNS O
18 CD O
- SYM O
25 CD O
) -RRB- O
and CC O
the DT O
HIS3 NN O
gene NN O
( , O
strain NN O
26 CD O
) -RRB- O
. . O

All DT O
17 CD O
elements NNS O
except IN O
ADH2 NNP O
- HYPH O
UAS NNP O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
exhibited VBD O
very RB O
strong JJ O
barrier NN O
activity NN O
as IN O
evidenced VBN O
by IN O
the DT O
absence NN O
of IN O
URA3 NNP O
- HYPH O
silencing NN O
in IN O
strains NNS O
3 CD O
- SYM O
10 CD O
and CC O
18 CD O
- SYM O
24 CD O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Seven CD O
of IN O
the DT O
eight CD O
RPG NNP O
- HYPH O
UASs NNS O
that WDT O
had VBD O
barrier NN O
activity NN O
, , O
contained VBD O
a DT O
single JJ O
or CC O
a DT O
pair NN O
of IN O
tandem NN O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
3 CD O
- SYM O
9 CD O
) -RRB- O
. . O

Three CD O
of IN O
them PRP O
also RB O
contained VBD O
an DT O
Abf1p NNP O
or CC O
Reb1p NNP O
site NN O
( : O
strains NNS O
6 CD O
, , O
8 CD O
and CC O
9 CD O
) -RRB- O
. . O

One CD O
barrier NN O
RPG NNP O
- HYPH O
UAS NNP O
( HYPH O
strain NN O
10 CD O
) -RRB- O
had VBD O
only RB O
a DT O
predicted VBN O
Abf1p NNP O
site NN O
. . O

Of IN O
the DT O
seven CD O
RPG NNP O
- HYPH O
UASs NNS O
that WDT O
had VBD O
no DT O
barrier NN O
activity NN O
( : O
Fig NNP O
. . O
1 CD O
, , O
11 CD O
- HYPH O
17 CD O
) -RRB- O
, , O
only RB O
two CD O
bore VBD O
no DT O
site NN O
for IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
( SYM O
11 CD O
and CC O
12 CD O
) -RRB- O
. . O

The DT O
remaining VBG O
five CD O
each DT O
contained VBD O
one CD O
to TO O
three CD O
Rap1p NNP O
sites NNS O
( : O
strains NNS O
13 CD O
- HYPH O
17 CD O
) -RRB- O
. . O

RPL15A NNP O
- HYPH O
UAS NNP O
( : O
17 CD O
) -RRB- O
also RB O
contained VBD O
an DT O
Abf1p NNP O
site NN O
. . O

For IN O
most JJS O
of IN O
the DT O
15 CD O
RPG NNP O
- HYPH O
UASs NNP O
tested VBN O
( : O
3 CD O
- HYPH O
17 CD O
) -RRB- O
, , O
the DT O
presence NN O
or CC O
absence NN O
of IN O
predicted VBN O
Rap1p NNP O
sites NNS O
correlated VBN O
with IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
Rap1p NN O
association NN O
in IN O
vivo NN O
as IN O
previously RB O
examined VBN O
by IN O
chromatin NN O
immunoprecipitation NN O
assays NNS O
( SYM O
13 CD O
) -RRB- O
. . O

Exceptions NNS O
were VBD O
the DT O
UASs NNP O
of IN O
RPS24B NNP O
, , O
RPS28A NNP O
and CC O
RPL15A NNP O
( SYM O
13 CD O
) -RRB- O
. . O

Of IN O
the DT O
eight CD O
UASs NNS O
of IN O
glycolytic JJ O
genes NNS O
tested VBN O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
18 CD O
- HYPH O
25 CD O
) -RRB- O
, , O
seven CD O
exhibited VBD O
strong JJ O
barrier NN O
activity NN O
( , O
18 CD O
- SYM O
24 CD O
) -RRB- O
and CC O
one CD O
had VBD O
weaker JJR O
but CC O
detectable JJ O
barrier NN O
activity NN O
( , O
strain NN O
25 CD O
) -RRB- O
. . O

Glycolytic NN O
genes NNS O
are VBP O
among IN O
the DT O
most RBS O
highly RB O
expressed VBN O
genes NNS O
and CC O
their PRP$ O
high JJ O
expression NN O
depends VBZ O
on IN O
the DT O
functions NNS O
of IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
as RB O
well RB O
as IN O
Gcr1p NNP O
( : O
29 CD O
, , O
30 CD O
) -RRB- O
. . O

The DT O
seven CD O
strong JJ O
glycolytic JJ O
barriers NNS O
all DT O
consist VBP O
of IN O
one CD O
or CC O
two CD O
Rap1p NNP O
sites NNS O
plus CC O
one CD O
or CC O
two CD O
Reb1p NN O
or CC O
Abf1p NNP O
sites NNS O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
18 CD O
- HYPH O
24 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
one CD O
or CC O
more JJR O
Gcr1p NNP O
- HYPH O
binding VBG O
sites NNS O
are VBP O
found VBN O
adjacent JJ O
to IN O
each DT O
Rap1p NNP O
site NN O
. . O

It PRP O
was VBD O
proposed VBN O
that IN O
the DT O
function NN O
of IN O
Rap1p NNP O
was VBD O
to TO O
facilitate VB O
the DT O
binding NN O
of IN O
Gcr1p NNP O
to IN O
the DT O
UAS NNP O
( SYM O
15 CD O
) -RRB- O
. . O

Abf1p NNP O
or CC O
Reb1p NNP O
was VBD O
shown VBN O
to TO O
play VB O
a DT O
role NN O
similar JJ O
to IN O
that DT O
of IN O
Rap1p NNP O
in IN O
activating VBG O
glycolytic JJ O
genes NNS O
( SYM O
31 CD O
- SYM O
33 CD O
) -RRB- O
. . O

Although IN O
the DT O
above JJ O
data NNS O
reinforced VBD O
the DT O
notion NN O
that IN O
certain JJ O
Rap1p NNP O
- HYPH O
binding VBG O
UASs NNP O
could MD O
serve VB O
as IN O
barriers NNS O
to IN O
silencing NN O
, , O
they PRP O
raised VBD O
new JJ O
questions NNS O
about IN O
the DT O
essential JJ O
components NNS O
of IN O
a DT O
barrier NN O
element NN O
. . O

For IN O
example NN O
, , O
some DT O
of IN O
the DT O
UASs NNS O
that WDT O
contained VBD O
only RB O
a DT O
single JJ O
Rap1p NNP O
site NN O
had VBD O
barrier NN O
activity NN O
( : O
e LS O
. . O
g LS O
. . O
RPL19B NN O
- HYPH O
UAS NNP O
, , O
strain NN O
3 CD O
) -RRB- O
whereas IN O
others NNS O
that WDT O
contained VBD O
two CD O
or CC O
three CD O
sites NNS O
had VBD O
no DT O
activity NN O
( : O
e LS O
. . O
g LS O
. . O
RPL39 NN O
, , O
strain NN O
16 CD O
) -RRB- O
. . O

One CD O
explanation NN O
was VBD O
that IN O
sequences NNS O
flanking VBG O
the DT O
Rap1p NNP O
site NN O
( , O
s FW O
) -RRB- O
in IN O
a DT O
particular JJ O
UAS NNP O
could MD O
positively RB O
or CC O
negatively RB O
influence VB O
barrier NN O
function NN O
. . O

Moreover RB O
, , O
the DT O
presence NN O
of IN O
Abf1p NNP O
or CC O
Reb1p NNP O
sites NNS O
in IN O
11 CD O
of IN O
the DT O
17 CD O
new JJ O
barriers NNS O
made VBD O
us PRP O
wonder VB O
if IN O
they PRP O
also RB O
participated VBD O
in IN O
barrier NN O
function NN O
. . O

We PRP O
began VBD O
to TO O
address VB O
these DT O
issues NNS O
by IN O
analyzing VBG O
three CD O
new JJ O
barrier NN O
elements NNS O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

RPS10A NNP O
- HYPH O
UAS NNP O
containing VBG O
an DT O
Abf1p NNP O
- HYPH O
binding VBG O
site NN O
and CC O
a DT O
pair NN O
of IN O
Rap1p NNP O
sites NNS O
was VBD O
divided VBN O
into IN O
three CD O
fragments NNS O
that WDT O
were VBD O
tested VBN O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
( -LRB- O
Fig NNP O
. . O
2 CD O
, , O
strains NNS O
30 CD O
- HYPH O
32 CD O
) -RRB- O
. . O

It PRP O
was VBD O
clear JJ O
that IN O
only RB O
the DT O
fragment NN O
containing VBG O
Rap1p NNP O
sites NNS O
functioned VBD O
as IN O
a DT O
barrier NN O
( , O
strain NN O
31 CD O
) -RRB- O
. . O

TPI1 NNP O
- HYPH O
UAS NNP O
bearing VBG O
a DT O
Reb1p NNP O
site NN O
and CC O
a DT O
Rap1p NNP O
site NN O
was VBD O
divided VBN O
into IN O
two CD O
parts NNS O
with IN O
one CD O
containing VBG O
the DT O
Rap1p NNP O
site NN O
( : O
Fig NNP O
. . O
2 CD O
, , O
strain NN O
34 CD O
) -RRB- O
and CC O
the DT O
other JJ O
Reb1p NN O
site NN O
( HYPH O
strain NN O
33 CD O
) -RRB- O
. . O

Neither DT O
of IN O
these DT O
fragments NNS O
alone RB O
retained VBD O
barrier NN O
activity NN O
indicating VBG O
that IN O
concerted JJ O
action NN O
of IN O
Reb1p NNP O
and CC O
Rap1p NNP O
was VBD O
required VBN O
for IN O
barrier NN O
activity NN O
. . O

Duplicating VBG O
the DT O
Reb1p NNP O
- HYPH O
bearing VBG O
part NN O
of IN O
TPI1 NNP O
- HYPH O
UAS NNP O
didn VBD O
' '' O
t RB O
restore VB O
barrier NN O
activity NN O
( , O
strain NN O
35 CD O
) -RRB- O
. . O

However RB O
, , O
triplicating VBG O
the DT O
Rap1p NNP O
- HYPH O
containing VBG O
part NN O
did VBD O
re RB O
- HYPH O
create VB O
barrier NN O
function NN O
( , O
strain NN O
36 CD O
) -RRB- O
. . O

RPS28A NNP O
- HYPH O
UAS NNP O
bore VBD O
, , O
in IN O
addition NN O
to IN O
a DT O
Rap1p NNP O
site NN O
, , O
an DT O
Abf1p NNP O
site NN O
and CC O
an DT O
adjacent JJ O
T NNP O
- HYPH O
rich JJ O
region NN O
that WDT O
are VBP O
required VBN O
for IN O
efficient JJ O
transcription NN O
of IN O
RPS28A NNP O
( SYM O
34 CD O
) -RRB- O
. . O

A DT O
sequence NN O
of IN O
RPS28A NNP O
- HYPH O
UAS NNP O
deleted VBN O
for IN O
a DT O
fragment NN O
bearing VBG O
the DT O
Rap1p NNP O
site NN O
lost VBD O
the DT O
barrier NN O
activity NN O
( : O
Fig NNP O
. . O
2 CD O
, , O
strain NN O
37 CD O
) -RRB- O
. . O

However RB O
, , O
duplicating VBG O
this DT O
sequence NN O
restored VBD O
barrier NN O
activity NN O
( , O
strain NN O
38 CD O
) -RRB- O
. . O

The DT O
above JJ O
results NNS O
indicated VBD O
again RB O
that IN O
Rap1p NNP O
sites NNS O
could MD O
form VB O
barriers NNS O
( , O
strains NNS O
31 CD O
and CC O
36 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
they PRP O
also RB O
suggested VBD O
that IN O
synergistic JJ O
actions NNS O
of IN O
Abf1p NNP O
sites NNS O
( -LRB- O
strain NN O
38 CD O
) -RRB- O
, , O
Reb1p NNP O
site NN O
+ CC O
Rap1p NNP O
site NN O
( -LRB- O
strain NN O
18 CD O
) -RRB- O
, , O
or CC O
Abf1p NN O
site NN O
+ CC O
Rap1p NN O
site NN O
( -LRB- O
strain NN O
16 CD O
) -RRB- O
could MD O
all DT O
lead VB O
to IN O
barrier NN O
function NN O
. . O

This DT O
was VBD O
not RB O
very RB O
surprising JJ O
since IN O
Rap1p NNP O
, , O
Abf1p NNP O
and CC O
Reb1p NNP O
could MD O
perform VB O
similar JJ O
and CC O
sometimes RB O
interchangeable JJ O
functions NNS O
in IN O
gene NN O
regulation NN O
( : O
16 CD O
, , O
35 CD O
, , O
36 CD O
) -RRB- O
. . O

Note VB O
, , O
however RB O
, , O
we PRP O
haven VBP O
' '' O
t VBZ O
ruled VBN O
out RP O
the DT O
possibility NN O
that IN O
other JJ O
factors NNS O
( , O
e LS O
. . O
g LS O
. . O
Gcr1p NN O
) -RRB- O
or CC O
structure NN O
features NNS O
of IN O
DNA NN O
( : O
e LS O
. . O
g LS O
. . O
T NNP O
- HYPH O
tracks NNS O
) -RRB- O
were VBD O
also RB O
involved VBN O
in IN O
barrier NN O
function NN O
. . O

It PRP O
was VBD O
interesting JJ O
that IN O
ADH2 NNP O
- HYPH O
UAS NNP O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
bearing VBG O
no DT O
site NN O
for IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
exhibited VBD O
detectable JJ O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
25 CD O
and CC O
26 CD O
) -RRB- O
. . O

However RB O
, , O
binding VBG O
sites NNS O
for IN O
other JJ O
transcriptional JJ O
activators NNS O
existed VBD O
in IN O
these DT O
UASs NNS O
. . O

The DT O
major JJ O
regulator NN O
that WDT O
binds VBZ O
to IN O
ADH2 NNP O
- HYPH O
UAS NNP O
is VBZ O
Adr1p NNP O
( : O
37 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
Gcn4p NNP O
binds VBZ O
to IN O
multiple JJ O
sites NNS O
in IN O
HIS3 NNP O
- HYPH O
UAS NNP O
and CC O
activates VBZ O
HIS3 NNP O
transcription NN O
( , O
38 CD O
) -RRB- O
. . O

The DT O
possible JJ O
involvement NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
in IN O
barrier NN O
function NN O
was VBD O
examined VBN O
below RB O
. . O

Note NN O
Adr1p NN O
function NN O
was VBD O
subject JJ O
to IN O
glucose NN O
repression NN O
( : O
37 CD O
) -RRB- O
, , O
which WDT O
might MD O
explain VB O
why WRB O
ADH2 NNP O
- HYPH O
UAS NNP O
only RB O
exhibited VBD O
limited JJ O
barrier NN O
activity NN O
since IN O
glucose NN O
was VBD O
used VBN O
in IN O
the DT O
media NNS O
used VBN O
in IN O
our PRP$ O
assay NN O
. . O

Effect NN O
of IN O
mutating VBG O
Rap1p NN O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
on IN O
barrier NN O
function NN O

Although IN O
we PRP O
had VBD O
shown VBN O
that IN O
the DT O
three CD O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
were VBD O
necessary JJ O
and CC O
sufficient JJ O
for IN O
its PRP$ O
barrier NN O
activity NN O
( : O
11 CD O
) -RRB- O
, , O
we PRP O
had VBD O
not RB O
shown VBN O
if IN O
binding NN O
of IN O
Rap1p NNP O
to IN O
these DT O
sites NNS O
was VBD O
required VBN O
. . O

To TO O
address VB O
this DT O
we PRP O
performed VBD O
mutational JJ O
analysis NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
3A NNP O
and CC O
B NN O
, , O
the DT O
three CD O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
( , O
designated VBN O
as IN O
R1 NNP O
, , O
R2 NNP O
and CC O
R3 CD O
) -RRB- O
were VBD O
all DT O
able JJ O
to TO O
bind VB O
Rap1p NNP O
in IN O
an DT O
EMSA NNP O
( -LRB- O
Fig NNP O
. . O
3B NN O
) -RRB- O
. . O

Single JJ O
or CC O
double JJ O
C NN O
- HYPH O
- HYPH O
> : O
A DT O
mutations NNS O
were VBD O
introduced VBN O
into IN O
R1 NNP O
, , O
R2 NNP O
and CC O
R3 NNP O
resulting VBG O
in IN O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
, , O
respectively RB O
( : O
Fig NNP O
. . O
3A NN O
) -RRB- O
. . O

The DT O
m2 NN O
and CC O
m3 NNP O
sites NNS O
had VBD O
both DT O
lost VBN O
the DT O
ability NN O
to TO O
bind VB O
Rap1p NNP O
, , O
whereas IN O
m1 CD O
still RB O
bound VBD O
Rap1p NNP O
( , O
Fig NNP O
. . O
3B NN O
) -RRB- O
, , O
which WDT O
could MD O
be VB O
predicted VBN O
from IN O
the DT O
specific JJ O
mutations NNS O
in IN O
each DT O
site NN O
( -LRB- O
Fig NNP O
. . O
3A NN O
, , O
compare VB O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
to IN O
the DT O
consensus NN O
sequence NN O
) -RRB- O
. . O

We PRP O
then RB O
tested VBD O
a DT O
mutated VBN O
TEF2 NNP O
- HYPH O
UAS NNP O
containing VBG O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
using VBG O
the DT O
HML NNP O
- HYPH O
E NNP O
silencer NN O
and CC O
the DT O
HML NNP O
alpha NN O
genes NNS O
( -LRB- O
Fig NNP O
. . O
3C NNP O
) -RRB- O
. . O

In IN O
this DT O
assay NN O
, , O
the DT O
HML NNP O
- HYPH O
I NNP O
silencer NN O
was VBD O
deleted VBN O
but CC O
the DT O
HML NNP O
- HYPH O
E NN O
silencer NN O
was VBD O
sufficient JJ O
to TO O
silence VB O
the DT O
HML NNP O
alpha NN O
genes NNS O
( -LRB- O
Fig NNP O
. . O
3C NNP O
, , O
strain NN O
39 CD O
) -RRB- O
( SYM O
11 CD O
) -RRB- O
. . O

Silencing VBG O
in IN O
strain NN O
39 CD O
( HYPH O
a DT O
- HYPH O
type NN O
) , O
was VBD O
measured VBN O
by IN O
its PRP$ O
ability NN O
to TO O
mate VB O
with IN O
an DT O
alpha NN O
- HYPH O
type NN O
strain NN O
( , O
Fig NNP O
. . O
3C NN O
) -RRB- O
. . O

As IN O
predicted VBN O
, , O
the DT O
wild JJ O
- HYPH O
type NN O
TEF2 NNP O
- HYPH O
UAS NNP O
blocked VBD O
HML NNP O
alpha NN O
silencing NN O
( SYM O
11 CD O
) -RRB- O
( , O
Fig NNP O
. . O
3C NNP O
, , O
strain NN O
40 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
mutated VBN O
TEF2 NNP O
- HYPH O
UAS NNP O
containing VBG O
m1 NNP O
, , O
m2 CD O
and CC O
m3 CD O
had VBD O
lost VBN O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
3C NNP O
, , O
compare VB O
the DT O
mating NN O
efficiencies NNS O
of IN O
strains NNS O
41 CD O
and CC O
40 CD O
) -RRB- O
. . O

Therefore RB O
, , O
mutations NNS O
that WDT O
prevented VBD O
Rap1p NNP O
from IN O
binding VBG O
two CD O
of IN O
the DT O
three CD O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
abolished VBD O
its PRP$ O
barrier NN O
activity NN O
, , O
indicating VBG O
that IN O
association NN O
of IN O
Rap1p NNP O
with IN O
TEF2 NNP O
- HYPH O
UAS NNP O
at IN O
more JJR O
than IN O
one CD O
site NN O
was VBD O
required VBN O
for IN O
barrier NN O
function NN O
. . O

The DT O
barrier NN O
TEF2 NNP O
- HYPH O
UAS NNP O
alters VBZ O
local JJ O
chromatin NN O
structure NN O

In IN O
eukaryotic JJ O
cells NNS O
, , O
the DT O
topology NN O
of IN O
local JJ O
DNA NNP O
reflects VBZ O
the DT O
chromatin NN O
structure NN O
in IN O
which WDT O
it PRP O
resides VBZ O
. . O

We PRP O
had VBD O
previously RB O
developed VBN O
a DT O
DNA NNP O
topology NN O
- HYPH O
based VBN O
assay NN O
to TO O
examine VB O
chromatin NN O
structure NN O
in IN O
vivo NN O
, , O
which WDT O
involved VBD O
excising VBG O
a DT O
chromosomal JJ O
region NN O
of IN O
interest NN O
from IN O
its PRP$ O
genomic JJ O
location NN O
as IN O
a DT O
circle NN O
using VBG O
site NN O
- HYPH O
specific JJ O
recombination NN O
( SYM O
39 CD O
) -RRB- O
. . O

Using VBG O
this DT O
strategy NN O
, , O
we PRP O
demonstrated VBD O
that IN O
DNA NN O
in IN O
silenced JJ O
chromatin NN O
was VBD O
more RBR O
negatively RB O
supercoiled VBN O
than IN O
that DT O
in IN O
active JJ O
chromatin NN O
( : O
39 CD O
) -RRB- O
. . O

In IN O
this DT O
report NN O
we PRP O
used VBD O
the DT O
topology NN O
assay NN O
to TO O
address VB O
if IN O
barrier NN O
elements NNS O
altered VBD O
local JJ O
chromatin NN O
structure NN O
as IN O
Drosophila NNP B-Species
or CC O
chicken NN B-Species
insulators NNS O
did VBD O
( : O
40 CD O
, , O
41 CD O
) -RRB- O
. . O

Various JJ O
sequences NNS O
( , O
designated VBN O
X NNP O
) , O
from IN O
UASs NNP O
of IN O
TEF2 NNP O
, , O
AgTEF NNP O
( , O
TEF NNP O
gene NN O
from IN O
Ashbya NNP B-Species
gossypii NN I-Species
) , O
and CC O
ADE2 NN O
were VBD O
inserted VBN O
between IN O
HML NNP O
- HYPH O
E NNP O
and CC O
HML NNP O
alpha NN O
at IN O
HML NNP O
Delta NNP O
I NNP O
( -LRB- O
HML NNP O
locus NN O
deleted VBN O
for IN O
the DT O
I NNP O
silencer NN O
) -RRB- O
flanked VBN O
by IN O
the DT O
FRT NNP O
sites NNS O
for IN O
the DT O
Flp1p NNP O
site NN O
- HYPH O
specific JJ O
recombinase NN O
( , O
Fig NNP O
. . O
4A NN O
and CC O
B NN O
) -RRB- O
. . O

The DT O
FLP1 NNP O
gene NN O
was VBD O
under IN O
the DT O
control NN O
of IN O
the DT O
inducible JJ O
GAL10 NNP O
promoter NN O
( SYM O
39 CD O
) -RRB- O
. . O

The DT O
mating NN O
efficiency NN O
of IN O
each DT O
strain NN O
measured VBD O
silencing NN O
of IN O
HML NNP O
alpha NN O
( , O
Fig NNP O
. . O
4C NNP O
) -RRB- O
. . O

In IN O
strains NNS O
40 CD O
, , O
42 CD O
, , O
44 CD O
and CC O
47 CD O
, , O
silencing NN O
was VBD O
restricted VBN O
to IN O
the DT O
left NN O
of IN O
the DT O
X NNP O
insertions NNS O
and CC O
HML NNP O
alpha NN O
was VBD O
derepressed VBN O
( : O
Fig NNP O
. . O
4C NNP O
) -RRB- O
. . O

Consistently RB O
, , O
the DT O
proportion NN O
of IN O
silent JJ O
chromatin NN O
in IN O
the DT O
region NN O
flanked VBN O
by IN O
the DT O
FRT NNP O
sites NNS O
in IN O
each DT O
of IN O
these DT O
strains NNS O
was VBD O
decreased VBN O
, , O
as IN O
indicated VBN O
by IN O
the DT O
reduced VBN O
negative JJ O
supercoiling NN O
of IN O
the DT O
excised VBN O
circle NN O
( SYM O
11 CD O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Note VB O
that IN O
the DT O
above JJ O
effect NN O
of IN O
a DT O
barrier NN O
on IN O
HML NNP O
chromatin NN O
reflected VBD O
both DT O
change NN O
in IN O
the DT O
scope NN O
of IN O
silencing NN O
caused VBN O
by IN O
the DT O
barrier NN O
activity NN O
and CC O
alteration NN O
( , O
if IN O
any DT O
) , O
in IN O
chromatin NN O
structure NN O
at IN O
the DT O
barrier NN O
independent JJ O
of IN O
the DT O
silencing VBG O
state NN O
of IN O
the DT O
locus NN O
. . O

To TO O
exclusively RB O
examine VB O
the DT O
latter JJ O
, , O
we PRP O
analyzed VBD O
the DT O
topology NN O
of IN O
HML NNP O
DNA NNP O
in IN O
a DT O
silencing VBG O
- HYPH O
deficient JJ O
background NN O
. . O

The DT O
SIR3 NNP O
gene NN O
in IN O
strains NNS O
described VBN O
in IN O
Figure NN O
4B NNP O
was VBD O
disrupted VBN O
rendering VBG O
them PRP O
defective JJ O
in IN O
silencing NN O
( , O
strains NNS O
40 CD O
' '' O
- HYPH O
48 CD O
' '' O
in IN O
Fig NNP O
. . O
4D CD O
) -RRB- O
. . O

Recombination NN O
mediated VBN O
by IN O
Flp1p NNP O
in IN O
these DT O
strains NNS O
led VBD O
to IN O
the DT O
excision NN O
of IN O
a DT O
group NN O
of IN O
chromosomal JJ O
circles NNS O
that WDT O
differed VBD O
only RB O
in IN O
the DT O
X NN O
insertion NN O
. . O

The DT O
supercoiling NN O
of IN O
these DT O
circles NNS O
was VBD O
analyzed VBN O
as IN O
a DT O
function NN O
of IN O
the DT O
length NN O
of IN O
the DT O
insertion NN O
( , O
Fig NNP O
. . O
4D NN O
) -RRB- O
. . O

If IN O
an DT O
insertion NN O
simply RB O
lengthened VBD O
a DT O
circle NN O
without IN O
causing VBG O
abnormal JJ O
changes NNS O
in IN O
nucleosomal JJ O
structure NN O
and CC O
/ SYM O
or CC O
density NN O
, , O
the DT O
topoisomers NNS O
of IN O
this DT O
circle NN O
would MD O
migrate VB O
slower RBR O
relative JJ O
to IN O
those DT O
of IN O
a DT O
similar JJ O
circle NN O
with IN O
a DT O
smaller JJR O
size NN O
. . O

Otherwise RB O
, , O
migration NN O
of IN O
the DT O
topoisomers NNS O
would MD O
deviate VB O
from IN O
that DT O
predicted VBN O
based VBN O
on IN O
the DT O
size NN O
of IN O
the DT O
circle NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4D CD O
, , O
the DT O
circle NN O
from IN O
strain NN O
40 CD O
' '' O
bearing VBG O
a DT O
104 CD O
bp NN O
barrier NN O
element NN O
migrated VBD O
faster RBR O
rather RB O
than IN O
slower JJR O
than IN O
the DT O
circle NN O
from IN O
strain NN O
46 CD O
' '' O
bearing VBG O
a DT O
91 CD O
bp NN O
non JJ O
- HYPH O
barrier NN O
element NN O
. . O

Circles NNS O
bearing VBG O
other JJ O
barrier NN O
elements NNS O
also RB O
exhibited VBD O
unexpected JJ O
faster JJR O
migration NN O
( , O
compare VBP O
strains NNS O
44 CD O
' '' O
to IN O
45 CD O
' '' O
, , O
47 CD O
' '' O
to TO O
43 CD O
' '' O
, , O
42 CD O
' '' O
to TO O
48 CD O
' '' O
, , O
respectively RB O
) -RRB- O
. . O

Therefore RB O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
barrier NN O
function NN O
correlated VBD O
with IN O
altered VBN O
topology NN O
of IN O
local JJ O
DNA NNP O
. . O

This DT O
was VBD O
further RB O
demonstrated VBN O
by IN O
that DT O
mutations NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
that WDT O
abolished VBD O
its PRP$ O
barrier NN O
activity NN O
also RB O
abolished VBD O
its PRP$ O
effect NN O
on IN O
DNA NNP O
topology NN O
( , O
Fig NNP O
. . O
4D CD O
, , O
compare VB O
41 CD O
' '' O
to IN O
40 CD O
' '' O
; : O
note VB O
that IN O
circles NNS O
from IN O
both DT O
strains NNS O
had VBD O
the DT O
same JJ O
size NN O
) -RRB- O
. . O

Since IN O
in IN O
our PRP$ O
gel NN O
assay NN O
more RBR O
negatively RB O
supercoiled VBN O
DNA NNP O
migrate VBP O
slower RBR O
, , O
we PRP O
concluded VBD O
that IN O
every DT O
fragment NN O
with IN O
barrier NN O
activity NN O
caused VBD O
a DT O
reduction NN O
in IN O
negative JJ O
supercoiling NN O
of IN O
approximately RB O
one CD O
to TO O
two CD O
turns NNS O
in IN O
HML NNP O
Delta NNP O
I NNP O
DNA NNP O
( : O
Fig NNP O
. . O
4D CD O
, , O
compare VB O
the DT O
centers NNS O
of IN O
distributions NNS O
of IN O
topoisomers NNS O
in IN O
pairs NNS O
of IN O
lanes NNS O
, , O
e FW O
. . O
g LS O
. . O
40 CD O
' '' O
and CC O
41 CD O
' '' O
) -RRB- O
. . O

The DT O
topology NN O
of IN O
eukaryotic JJ O
DNA NNP O
reflects VBZ O
mainly RB O
the DT O
wrapping NN O
of IN O
DNA NN O
into IN O
nucleosomes NNS O
( , O
approximately RB O
one CD O
negative JJ O
superhelical JJ O
turn NN O
is VBZ O
associated VBN O
with IN O
each DT O
nucleosome NN O
) -RRB- O
( , O
42 CD O
) -RRB- O
. . O

Therefore RB O
, , O
removal NN O
of IN O
one CD O
nucleosome NN O
would MD O
eliminate VB O
approximately RB O
one CD O
turn NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
histone NN O
acetylation NN O
can MD O
reduce VB O
negative JJ O
supercoiling NN O
associated VBN O
with IN O
a DT O
nucleosome NN O
by IN O
approximately RB O
0 CD O
. . O
2 CD O
turns NNS O
( SYM O
43 CD O
) -RRB- O
. . O

Therefore RB O
, , O
acetylating VBG O
five CD O
nucleosomes NNS O
would MD O
reduce VB O
negative JJ O
supercoiling NN O
by IN O
approximately RB O
one CD O
turn NN O
. . O

Consequently RB O
, , O
the DT O
linking VBG O
number NN O
change NN O
of IN O
one CD O
to IN O
two CD O
brought VBN O
about RP O
by IN O
TEF2 NNP O
- HYPH O
UAS NNP O
can MD O
be VB O
accounted VBN O
for IN O
by IN O
either CC O
the DT O
loss NN O
of IN O
one CD O
to TO O
two CD O
nucleosomes NNS O
or CC O
acetylation NN O
of IN O
five CD O
to TO O
10 CD O
nucleosomes NNS O
. . O

Further JJ O
experiments NNS O
are VBP O
under IN O
way NN O
to TO O
clarify VB O
the DT O
nature NN O
of IN O
change NN O
in IN O
chromatin NN O
induced VBN O
by IN O
a DT O
barrier NN O
. . O

Targeting VBG O
the DT O
transcription NN O
activation NN O
domain NN O
of IN O
Rap1p NNP O
recapitulates VBZ O
its PRP$ O
barrier NN O
activity NN O

The DT O
multifunctional JJ O
Rap1p NNP O
can MD O
be VB O
divided VBN O
into IN O
at RB O
least RBS O
four CD O
functional JJ O
domains NNS O
( -LRB- O
Fig NNP O
. . O
5A NNP O
) -RRB- O
( : O
12 CD O
) -RRB- O
. . O

We PRP O
were VBD O
interested JJ O
in IN O
defining VBG O
which WDT O
of IN O
these DT O
domains NNS O
might MD O
be VB O
involved VBN O
in IN O
the DT O
barrier NN O
activity NN O
of IN O
Rap1p NNP O
. . O

To IN O
this DT O
end NN O
, , O
we PRP O
fused VBD O
various JJ O
parts NNS O
of IN O
Rap1p NNP O
to IN O
the DT O
bacterial JJ O
LexA NNP O
protein NN O
and CC O
tested VBD O
if IN O
targeting VBG O
any DT O
of IN O
the DT O
fusion NN O
proteins NNS O
to IN O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
could MD O
re VB O
- HYPH O
create VB O
a DT O
barrier NN O
to IN O
silencing NN O
( , O
Fig NNP O
. . O
5A NN O
) -RRB- O
. . O

The DT O
LexA NNP O
- HYPH O
RAP1 NNP O
fusion NN O
genes NNS O
were VBD O
carried VBN O
on IN O
2 CD O
micro NN O
m NN O
based VBN O
plasmids NNS O
marked VBN O
by IN O
LEU2 NNP O
( -LRB- O
designated VBN O
L1 NNP O
- HYPH O
L6 NNP O
, , O
Fig NNP O
. . O
5A NNP O
) -RRB- O
. . O

When WRB O
introduced VBN O
into IN O
strain NN O
50 CD O
in IN O
which WDT O
two CD O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
had VBD O
been VBN O
inserted VBN O
between IN O
the DT O
inverted VBN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
, , O
LexA NNP O
alone RB O
had VBD O
no DT O
effect NN O
on IN O
URA3 NNP O
silencing NN O
( , O
Fig NNP O
. . O
5A NN O
, , O
plasmid NN O
L1 NNP O
) -RRB- O
. . O

Targeting VBG O
the DT O
DNA NN O
binding VBG O
domain NN O
, , O
DNA NN O
bending VBG O
domain NN O
, , O
silencing VBG O
domain NN O
, , O
or CC O
the DT O
activating VBG O
+ CC O
silencing NN O
domain NN O
of IN O
Rap1p NNP O
also RB O
did VBD O
not RB O
affect VB O
URA3 NNP O
silencing NN O
( : O
L2 NNP O
- HYPH O
L5 NNP O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
targeting VBG O
the DT O
activation NN O
domain NN O
alone RB O
recapitulated VBD O
the DT O
barrier NN O
activity NN O
of IN O
Rap1p NNP O
( : O
L6 NNP O
) -RRB- O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
was VBD O
involved VBN O
in IN O
barrier NN O
activity NN O
. . O

The DT O
inability NN O
of IN O
the DT O
Rap1p NNP O
- HYPH O
silencing VBG O
domain NN O
to TO O
block VB O
URA3 NNP O
silencing NN O
in IN O
our PRP$ O
assay NN O
did VBD O
not RB O
necessarily RB O
mean VB O
that IN O
this DT O
domain NN O
had VBD O
no DT O
barrier NN O
function NN O
, , O
since IN O
such PDT O
a DT O
function NN O
might MD O
be VB O
suppressed VBN O
by IN O
much RB O
stronger JJR O
silencing NN O
activity NN O
associated VBN O
with IN O
the DT O
silencing NN O
domain NN O
. . O

Was VBD O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
fusion NN O
constructs VBZ O
L2 NNP O
- HYPH O
L5 NNP O
due IN O
to IN O
a DT O
lack NN O
of IN O
expression NN O
of IN O
these DT O
proteins NNS O
? . O

To TO O
address VB O
this DT O
possibility NN O
, , O
we PRP O
examined VBD O
the DT O
levels NNS O
of IN O
L1 NNP O
- HYPH O
L6 NNP O
proteins NNS O
as RB O
well RB O
as IN O
L7 NNP O
and CC O
L8 CD O
proteins NNS O
described VBN O
in IN O
Figure NNP O
5B NNP O
by IN O
western JJ O
blotting NN O
using VBG O
an DT O
antibody NN O
against IN O
LexA NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5C NNP O
, , O
L5 NNP O
was VBD O
expressed VBN O
at IN O
a DT O
level NN O
comparable JJ O
to IN O
L6 NNP O
, , O
and CC O
L4 NNP O
was VBD O
expressed VBN O
at IN O
a DT O
higher JJR O
level NN O
than IN O
L6 NNP O
. . O

Therefore RB O
, , O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
L4 NNP O
and CC O
L6 NNP O
was VBD O
not RB O
the DT O
result NN O
of IN O
their PRP$ O
lack NN O
of IN O
expression NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
level NN O
of IN O
L2 NNP O
or CC O
L3 NNP O
was VBD O
significantly RB O
lower JJR O
than IN O
that DT O
of IN O
L6 NNP O
, , O
hence RB O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
L2 NNP O
and CC O
L3 NNP O
might MD O
be VB O
due IN O
to IN O
their PRP$ O
insufficient JJ O
expression NN O
. . O

As IN O
an DT O
important JJ O
control NN O
for IN O
the DT O
above JJ O
targeting NN O
experiments NNS O
, , O
we PRP O
showed VBD O
that IN O
plasmids NNS O
L1 NNP O
- HYPH O
L6 NNP O
( -LRB- O
Fig NNP O
. . O
5A NN O
) -RRB- O
as RB O
well RB O
as IN O
L7 NNP O
and CC O
L8 NNP O
( -LRB- O
Fig NNP O
. . O
5B NN O
) -RRB- O
bearing VBG O
LexA NNP O
- HYPH O
fusion NN O
genes NNS O
had VBD O
no DT O
effect NN O
on IN O
URA3 NNP O
silencing NN O
in IN O
strain NN O
1 CD O
( SYM O
Fig NNP O
. . O
1 CD O
) -RRB- O
in IN O
which WDT O
there EX O
was VBD O
no DT O
binding VBG O
site NN O
for IN O
LexA NNP O
present JJ O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Hence RB O
, , O
the DT O
effect NN O
of IN O
the DT O
fusion NN O
proteins NNS O
on IN O
URA3 NNP O
silencing NN O
was VBD O
the DT O
result NN O
of IN O
their PRP$ O
targeting NN O
to IN O
specific JJ O
loci NN O
, , O
not RB O
the DT O
consequence NN O
of IN O
non AFX O
- HYPH O
specific JJ O
, , O
indirect JJ O
functions NNS O
( , O
if IN O
any DT O
) -RRB- O
of IN O
these DT O
proteins NNS O
. . O

Targeted VBN O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
can MD O
also RB O
act VB O
as IN O
a DT O
barrier NN O
factor NN O

We PRP O
have VBP O
shown VBN O
above IN O
that DT O
ADH2 NNP O
- HYPH O
UAS NNP O
bearing VBG O
Adr1p NNP O
- HYPH O
binding VBG O
sites NNS O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
bearing VBG O
Gcn4p NNP O
sites NNS O
both DT O
had VBD O
detectable JJ O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
25 CD O
and CC O
26 CD O
) -RRB- O
. . O

Given VBN O
that IN O
tethering VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
is VBZ O
sufficient JJ O
for IN O
barrier NN O
function NN O
, , O
we PRP O
tested VBD O
if IN O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
could MD O
also RB O
establish VB O
a DT O
barrier NN O
. . O

Adr1p NNP O
contains VBZ O
four CD O
separate JJ O
activation NN O
domains NNS O
( , O
TADI NNP O
- HYPH O
TADIV NNP O
) -RRB- O
that WDT O
can MD O
contact VB O
Ada2p NNP O
, , O
Gcn5p NNP O
and CC O
/ SYM O
or CC O
TFIIB NNP O
( SYM O
45 CD O
) -RRB- O
. . O

TAD NNP O
III NNP O
( : O
415 CD O
- HYPH O
467 CD O
) -RRB- O
interacts VBZ O
with IN O
only RB O
Gcn5p NNP O
but CC O
not RB O
Ada2p NNP O
or CC O
TFIIB NNP O
. . O

We PRP O
fused VBD O
this DT O
domain NN O
of IN O
Adr1p NNP O
and CC O
the DT O
activation NN O
domain NN O
of IN O
Gcn4p NNP O
( : O
102 CD O
- HYPH O
149 CD O
) -RRB- O
to IN O
LexA NNP O
, , O
respectively RB O
( , O
Fig NNP O
. . O
5B NN O
, , O
L7 NNP O
and CC O
L8 NNP O
) -RRB- O
. . O

Targeting VBG O
these DT O
fusion NN O
proteins NNS O
to IN O
two CD O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
in IN O
strain NN O
50 CD O
dramatically RB O
reduced VBD O
URA3 NNP O
silencing NN O
( : O
Fig NNP O
. . O
5B NN O
, , O
compare VBP O
L7 NN O
and CC O
L8 CD O
to IN O
L1 NN O
) -RRB- O
. . O

Therefore RB O
, , O
like IN O
LexA NNP O
- HYPH O
Rap1p NNP O
( : O
627 CD O
- HYPH O
695 CD O
) -RRB- O
, , O
both CC O
LexA NNP O
- HYPH O
Adr1p NNP O
( : O
415 CD O
- HYPH O
467 CD O
) -RRB- O
and CC O
LexA NNP O
- HYPH O
Gcn4p NNP O
( : O
102 CD O
- HYPH O
149 CD O
) -RRB- O
also RB O
had VBD O
barrier NN O
activity NN O
. . O

Barrier NN O
function NN O
of IN O
these DT O
fusion NN O
proteins NNS O
was VBD O
significantly RB O
decreased VBN O
in IN O
strain NN O
51 CD O
in IN O
which WDT O
only RB O
one CD O
LexA NNP O
site NN O
was VBD O
inserted VBN O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
( , O
compare VBP O
strains NNS O
50 CD O
and CC O
51 CD O
carrying VBG O
plasmid NN O
L7 NNP O
) -RRB- O
, , O
indicating VBG O
that IN O
the DT O
potency NN O
of IN O
such JJ O
barriers NNS O
was VBD O
dependent JJ O
on IN O
the DT O
amount NN O
of IN O
tethered VBN O
fusion NN O
proteins NNS O
. . O

DISCUSSION NN O

We PRP O
have VBP O
shown VBN O
in IN O
this DT O
report NN O
that IN O
UASs NNP O
of IN O
many JJ O
highly RB O
expressed VBN O
genes NNS O
could MD O
function VB O
as IN O
barriers NNS O
to IN O
the DT O
spread NN O
of IN O
transcriptional JJ O
silencing NN O
. . O

These DT O
newly RB O
identified VBN O
barrier NN O
elements NNS O
together RB O
with IN O
previously RB O
described VBN O
barrier NN O
elements NNS O
( , O
STARs NNPS O
, , O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
and CC O
CHA1 NNP O
- HYPH O
UAS NNP O
) -RRB- O
( , O
9 CD O
- SYM O
11 CD O
, , O
21 CD O
) -RRB- O
are VBP O
scattered VBN O
across IN O
the DT O
yeast NN B-Species
genome NN O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
dividing VBG O
the DT O
genome NN O
into IN O
functional JJ O
domains NNS O
. . O

Analyses NNS O
of IN O
the DT O
barrier NN O
UASs NNS O
suggest VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Rap1p NNP O
, , O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
and CC O
Gcn4p NNP O
can MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

Barrier NN O
activity NN O
often RB O
requires VBZ O
concerted JJ O
actions NNS O
of IN O
more JJR O
than IN O
one CD O
factor NN O
- HYPH O
binding VBG O
site NN O
. . O

Our PRP$ O
mutational JJ O
analysis NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
suggests VBZ O
a DT O
direct JJ O
involvement NN O
of IN O
Rap1p NNP O
in IN O
its PRP$ O
barrier NN O
function NN O
. . O

It PRP O
is VBZ O
noteworthy JJ O
that IN O
not RB O
all DT O
UASs NNPS O
of IN O
highly RB O
expressed VBN O
genes NNS O
have VBP O
barrier NN O
activity NN O
. . O

Many JJ O
non JJ O
- HYPH O
barrier NN O
UASs NNPS O
also RB O
consist VBP O
of IN O
multiple JJ O
regulator NN O
binding VBG O
sites NNS O
, , O
therefore RB O
other JJ O
unknown JJ O
factors NNS O
might MD O
determine VB O
whether IN O
a DT O
UAS NNP O
could MD O
act VB O
as IN O
a DT O
barrier NN O
. . O

How WRB O
Rap1p NNP O
and CC O
the DT O
other JJ O
transcriptional JJ O
regulators NNS O
act VBP O
to TO O
block VB O
silencing NN O
is VBZ O
not RB O
clear JJ O
. . O

Since IN O
they PRP O
can MD O
all RB O
act VB O
as IN O
transcriptional JJ O
activators NNS O
, , O
one CD O
natural JJ O
explanation NN O
is VBZ O
that IN O
they PRP O
may MD O
overcome VB O
the DT O
silencing NN O
effect NN O
of IN O
a DT O
silencer NN O
and CC O
directly RB O
activate VB O
the DT O
reporter NN O
gene NN O
. . O

However RB O
, , O
it PRP O
has VBZ O
been VBN O
well RB O
documented VBN O
that IN O
Rap1p NNP O
and CC O
the DT O
other JJ O
transcriptional JJ O
regulators NNS O
usually RB O
act VBP O
at IN O
relatively RB O
short JJ O
distances NNS O
( : O
less JJR O
than IN O
~ $ O
600 CD O
bp NN O
upstream RB O
of IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
( : O
28 CD O
, , O
29 CD O
, , O
46 CD O
) -RRB- O
, , O
but CC O
the DT O
binding VBG O
sites NNS O
for IN O
these DT O
regulators NNS O
were VBD O
> SYM O
800 CD O
bp NN O
from IN O
the DT O
translation NN O
start VBP O
codon NN O
in IN O
most JJS O
of IN O
the DT O
silencing NN O
- HYPH O
blocking VBG O
tests NNS O
in IN O
this DT O
report NN O
( : O
Figs NNP O
1 CD O
and CC O
2 CD O
) -RRB- O
. . O

In IN O
the DT O
test NN O
shown VBN O
in IN O
Figure NNP O
6 CD O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
blocked VBD O
ADE2 NNP O
silencing NN O
when WRB O
it PRP O
was VBD O
~ $ O
2 CD O
kb NN O
downstream RB O
from IN O
the DT O
translation NN O
start NN O
codon NN O
of IN O
the DT O
gene NN O
. . O

Moreover RB O
, , O
Fourel NNP O
et FW O
al NNP O
. . O

( : O
44 CD O
) , O
demonstrated VBD O
that IN O
the DT O
barrier NN O
function NN O
( , O
or CC O
anti JJ O
- HYPH O
silencing VBG O
function NN O
) -RRB- O
of IN O
an DT O
activator NN O
was VBD O
independent JJ O
of IN O
its PRP$ O
role NN O
in IN O
activating VBG O
transcription NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
unlikely JJ O
that IN O
the DT O
ability NN O
of IN O
a DT O
UAS NNP O
to TO O
prevent VB O
gene NN O
silencing NN O
is VBZ O
due JJ O
to IN O
its PRP$ O
direct JJ O
activation NN O
of IN O
the DT O
gene NN O
. . O

In IN O
light NN O
of IN O
this DT O
, , O
our PRP$ O
results NNS O
are VBP O
in IN O
agreement NN O
with IN O
the DT O
notion NN O
that IN O
transcriptional JJ O
regulators NNS O
can MD O
also RB O
participate VB O
in IN O
defining VBG O
the DT O
boundaries NNS O
of IN O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

A DT O
few JJ O
models NNS O
have VBP O
been VBN O
proposed VBN O
for IN O
the DT O
barrier NN O
functions NNS O
of IN O
transcriptional JJ O
regulators NNS O
. . O

One CD O
model NN O
proposed VBD O
that IN O
binding NN O
of IN O
a DT O
regulator NN O
to IN O
a DT O
barrier NN O
led VBD O
to IN O
the DT O
formation NN O
of IN O
a DT O
nucleosome NN O
- HYPH O
free JJ O
region NN O
thereby RB O
disrupting VBG O
a DT O
continuous JJ O
nucleosome NN O
array NN O
( SYM O
11 CD O
) -RRB- O
. . O

Since IN O
the DT O
SIR NNP O
complexes NNS O
spread VBP O
by IN O
self NN O
- HYPH O
interaction NN O
and CC O
interacting VBG O
with IN O
adjacent JJ O
nucleosmes NNS O
in IN O
a DT O
stepwise JJ O
fashion NN O
( , O
4 CD O
) -RRB- O
, , O
a DT O
nucleosome NN O
- HYPH O
free JJ O
gap NN O
could MD O
present VB O
a DT O
barrier NN O
to IN O
the DT O
spreading VBG O
SIR NNP O
complex NN O
. . O

This DT O
' `` O
nucleosome JJ O
gap NN O
' '' O
hypothesis NN O
is VBZ O
consistent JJ O
with IN O
that DT O
certain JJ O
barrier NN O
factors NNS O
such JJ O
as IN O
Rap1p NNP O
and CC O
Reb1p NNP O
could MD O
indeed RB O
prevent VB O
nucleosome JJ O
formation NN O
around IN O
their PRP$ O
binding VBG O
sites NNS O
( : O
14 CD O
) -RRB- O
and CC O
the DT O
barrier NN O
function NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
correlated VBN O
with IN O
its PRP$ O
ability NN O
to TO O
alter VB O
local JJ O
chromatin NN O
structure NN O
( : O
this DT O
report NN O
) -RRB- O
. . O

In IN O
fact NN O
, , O
many JJ O
insulator NN O
/ SYM O
boundary JJ O
elements NNS O
in IN O
higher JJR O
organisms NNS O
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
alter VB O
local JJ O
chromatin NN O
structure NN O
. . O

For IN O
instance NN O
, , O
the DT O
chicken NN B-Species
beta NN O
- HYPH O
globin NN O
insulator NN O
was VBD O
linked VBN O
to IN O
changes NNS O
in IN O
nucleosome NN O
positioning NN O
, , O
and CC O
the DT O
Drosophila NN B-Species
scs NNS O
and CC O
scs NNS O
' POS O
boundary NN O
elements NNS O
are VBP O
associated VBN O
with IN O
unusual JJ O
chromatin NN O
structures NNS O
that WDT O
are VBP O
hypersensitive JJ O
to IN O
nucleases NNS O
( : O
40 CD O
, , O
41 CD O
) -RRB- O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
any DT O
chromatin NN O
change NN O
associated VBN O
with IN O
barrier NN O
function NN O
in IN O
yeast NN B-Species
or CC O
insulator NN O
function NN O
in IN O
higher JJR O
cells NNS O
is VBZ O
the DT O
cause NN O
or CC O
effect NN O
of IN O
the DT O
function NN O
. . O

Another DT O
model NN O
for IN O
barrier NN O
action NN O
proposed VBN O
by IN O
R NNP O
. . O

Kamakaka NNP O
and CC O
colleagues NNS O
( , O
21 CD O
) -RRB- O
proposed VBD O
that IN O
barrier NN O
factors NNS O
recruit VBP O
chromatin NN O
modifying NN O
and CC O
/ SYM O
or CC O
remodeling NN O
complexes NNS O
to TO O
counteract VB O
the DT O
more RBR O
compact JJ O
, , O
hypoacetylated JJ O
silent JJ O
chromatin NN O
. . O

In IN O
agreement NN O
with IN O
this DT O
hypothesis NN O
, , O
targeted VBN O
HATs NNP O
SAS2 NNP O
, , O
GCN5 NNP O
and CC O
ESA1 NNP O
all DT O
had VBD O
barrier NN O
activity NN O
( : O
21 CD O
; : O
Y NN O
. . O
- HYPH O
H NN O
. . O
Chiu NNP O
, , O
Q NNP O
. . O
Yu NNP O
and CC O
X NNP O
. . O
Bi NNP O
, , O
unpublished JJ O
results NNS O
) -RRB- O
. . O

Interestingly RB O
, , O
Rap1p NNP O
, , O
Adr1p NNP O
, , O
Gcn4p NNP O
and CC O
Abf1p NNP O
share VBP O
the DT O
ability NN O
to TO O
recruit VB O
HAT NNP O
complexes NNS O
NuA4 NNP O
and CC O
/ SYM O
or CC O
SAGA NNP O
to TO O
target VB O
genes NNS O
( : O
16 CD O
, , O
45 CD O
, , O
47 CD O
- HYPH O
49 CD O
) -RRB- O
. . O

Therefore RB O
, , O
these DT O
factors NNS O
that WDT O
are VBP O
capable JJ O
of IN O
binding NN O
to IN O
the DT O
newly RB O
identified VBN O
barriers NNS O
may MD O
function VB O
as IN O
barrier NN O
factors NNS O
by IN O
recruiting VBG O
HAT NNP O
complexes NNS O
. . O

In IN O
fact NN O
, , O
recruitment NN O
of IN O
HAT NNP O
activity NN O
has VBZ O
also RB O
been VBN O
suggested VBN O
to TO O
be VB O
the DT O
mechanism NN O
underlying VBG O
the DT O
function NN O
of IN O
the DT O
chicken NN B-Species
beta NN O
- HYPH O
globin NN O
insulator NN O
( , O
6 CD O
) -RRB- O
, , O
although IN O
it PRP O
was VBD O
not RB O
known VBN O
what WP O
HAT NNP O
might MD O
be VB O
involved VBN O
. . O

Our PRP$ O
demonstration NN O
that IN O
tethering VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
alone RB O
recapitulates VBZ O
barrier NN O
activity NN O
is VBZ O
consistent JJ O
with IN O
the DT O
above JJ O
HAT NNP O
model NN O
for IN O
barrier NN O
function NN O
, , O
since IN O
at IN O
least JJS O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
directly RB O
interact VB O
with IN O
HAT NNP O
complexes NNS O
( SYM O
45 CD O
) -RRB- O
. . O

However RB O
, , O
we PRP O
haven VBP O
' `` O
t VB O
ruled VBN O
out RP O
the DT O
possibility NN O
that IN O
the DT O
barrier NN O
function NN O
of IN O
the DT O
targeted VBN O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
is VBZ O
not RB O
related VBN O
to IN O
the DT O
barrier NN O
function NN O
of IN O
the DT O
native JJ O
protein NN O
. . O

Note VB O
that IN O
the DT O
' `` O
nucleosome JJ O
gap NN O
' '' O
model NN O
and CC O
the DT O
HAT NNP O
model NN O
are VBP O
not RB O
mutually RB O
exclusive JJ O
since IN O
the DT O
nucleosome JJ O
gap NN O
could MD O
result VB O
from IN O
destabilization NN O
of IN O
nucelosomes NNS O
caused VBN O
by IN O
HAT NNP O
function NN O
. . O

A DT O
recent JJ O
intriguing JJ O
study NN O
showed VBD O
that IN O
targeting VBG O
proteins NNS O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
( -LRB- O
NPC NNP O
) -RRB- O
could MD O
also RB O
establish VB O
a DT O
boundary NN O
for IN O
silent JJ O
chromatin NN O
, , O
and CC O
that IN O
tethering VBG O
to IN O
NPC NNP O
was VBD O
required VBN O
for IN O
boundary NN O
activity NN O
( : O
50 CD O
) -RRB- O
. . O

This DT O
led VBD O
to IN O
a DT O
revisit NN O
to IN O
the DT O
looping VBG O
model NN O
for IN O
the DT O
function NN O
of IN O
boundary NN O
/ SYM O
insulator NN O
elements NNS O
( SYM O
51 CD O
) -RRB- O
. . O

However RB O
, , O
an DT O
alternative JJ O
explanation NN O
was VBD O
that IN O
the DT O
NPC NNP O
compartment NN O
could MD O
simply RB O
be VB O
rich JJ O
in IN O
transcriptional JJ O
activating VBG O
factors NNS O
or CC O
poor JJ O
in IN O
silencing VBG O
factors NNS O
like IN O
the DT O
SIR NNP O
proteins NNS O
( SYM O
50 CD O
) -RRB- O
. . O

In IN O
summary NN O
, , O
results NNS O
from IN O
this DT O
and CC O
other JJ O
studies NNS O
indicate VBP O
that IN O
factors NNS O
previously RB O
identified VBN O
as IN O
positive JJ O
and CC O
/ SYM O
or CC O
negative JJ O
regulators NNS O
of IN O
gene NN O
activation NN O
could MD O
also RB O
function VB O
in IN O
demarcating VBG O
distinct JJ O
domains NNS O
of IN O
gene NN O
activity NN O
. . O

How WRB O
these DT O
factors NNS O
carry VBP O
out RP O
their PRP$ O
boundary JJ O
function NN O
is VBZ O
not RB O
resolved VBN O
but CC O
recruitment NN O
of IN O
other JJ O
factors NNS O
( : O
e LS O
. . O
g LS O
. . O
chromatin NN O
modifying VBG O
complexes NNS O
) -RRB- O
is VBZ O
likely JJ O
to TO O
be VB O
involved VBN O
. . O

NOTE NN O
ADDED VBN O
IN IN O
PROOF NN O

After IN O
this DT O
work NN O
was VBD O
completed VBN O
and CC O
submitted VBN O
for IN O
publication NN O
the DT O
first JJ O
time NN O
, , O
Fourel NNP O
et FW O
al NNP O
. . O

( HYPH O
52 CD O
) , O
reported VBD O
that IN O
targeted VBN O
activation NN O
domains NNS O
of IN O
Rap1p NNP O
and CC O
Abf1p NNP O
had VBD O
insulating VBG O
capacity NN O
. . O

Comparison NN O
of IN O
age NN O
- HYPH O
specific JJ O
cataract NN O
prevalence NN O
in IN O
two CD O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O

Abstract JJ O

Background NN O

In IN O
this DT O
study NN O
, , O
we PRP O
aimed VBD O
to TO O
compare VB O
age NN O
- HYPH O
specific JJ O
cortical JJ O
, , O
nuclear JJ O
and CC O
posterior JJ O
subcapsular NN O
( , O
PSC NNP O
) -RRB- O
cataract NN O
prevalence NN O
in IN O
two CD O
surveys NNS O
6 CD O
years NNS O
apart RB O
. . O

Methods NNS O

The DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
examined VBD O
3654 CD O
participants NNS B-Species
( , O
82 CD O
. . O
4 CD O
% NN O
of IN O
those DT O
eligible JJ O
) -RRB- O
in IN O
cross JJ O
- HYPH O
section NN O
I CD O
( , O
1992 CD O
- SYM O
4 CD O
) -RRB- O
and CC O
3509 CD O
participants NNS B-Species
( SYM O
75 CD O
. . O
1 CD O
% NN O
of IN O
survivors NNS O
and CC O
85 CD O
. . O
2 CD O
% NN O
of IN O
newly RB O
eligible JJ O
) -RRB- O
in IN O
cross JJ O
- HYPH O
section NN O
II CD O
( , O
1997 CD O
- SYM O
2000 CD O
, , O
66 CD O
. . O
5 CD O
% NN O
overlap NN O
with IN O
cross JJ O
- HYPH O
section NN O
I NN O
) -RRB- O
. . O

Cataract NN O
was VBD O
assessed VBN O
from IN O
lens NN O
photographs NNS O
following VBG O
the DT O
Wisconsin NNP O
Cataract NNP O
Grading NNP O
System NNP O
. . O

Cortical JJ O
cataract NN O
was VBD O
defined VBN O
if IN O
cortical JJ O
opacity NN O
comprised VBN O
> : O
= SYM O
5 CD O
% NN O
of IN O
lens NN O
area NN O
. . O

Nuclear JJ O
cataract NN O
was VBD O
defined VBN O
if IN O
nuclear JJ O
opacity NN O
> NFP O
= SYM O
Wisconsin NNP O
standard NN O
4 CD O
. . O

PSC NNP O
was VBD O
defined VBN O
if IN O
any DT O
present JJ O
. . O

Any DT O
cataract NN O
was VBD O
defined VBN O
to TO O
include VB O
persons NNS B-Species
who WP O
had VBD O
previous JJ O
cataract NN O
surgery NN O
. . O

Weighted JJ O
kappa NN O
for IN O
inter JJ O
- HYPH O
grader NN O
reliability NN O
was VBD O
0 CD O
. . O
82 CD O
, , O
0 CD O
. . O
55 CD O
and CC O
0 CD O
. . O
82 CD O
for IN O
cortical JJ O
, , O
nuclear JJ O
and CC O
PSC NNP O
cataract NN O
, , O
respectively RB O
. . O

We PRP O
assessed VBD O
age NN O
- HYPH O
specific JJ O
prevalence NN O
using VBG O
an DT O
interval NN O
of IN O
5 CD O
years NNS O
, , O
so IN O
that IN O
participants NNS B-Species
within IN O
each DT O
age NN O
group NN O
were VBD O
independent JJ O
between IN O
the DT O
two CD O
surveys NNS O
. . O

Results NNS O

Age NN O
and CC O
gender NN O
distributions NNS O
were VBD O
similar JJ O
between IN O
the DT O
two CD O
populations NNS O
. . O

The DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
of IN O
cortical JJ O
( : O
23 CD O
. . O
8 CD O
% NN O
in IN O
1st NN O
, , O
23 CD O
. . O
7 CD O
% NN O
in IN O
2nd CD O
) -RRB- O
and CC O
PSC NNP O
cataract NN O
( : O
6 CD O
. . O
3 CD O
% NN O
, , O
6 CD O
. . O
0 CD O
% NN O
) -RRB- O
was VBD O
similar JJ O
. . O

The DT O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
increased VBD O
slightly RB O
from IN O
18 CD O
. . O
7 CD O
% NN O
to IN O
23 CD O
. . O
9 CD O
% NN O
. . O

After IN O
age NN O
standardization NN O
, , O
the DT O
similar JJ O
prevalence NN O
of IN O
cortical JJ O
( : O
23 CD O
. . O
8 CD O
% NN O
, , O
23 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
PSC NNP O
cataract NN O
( , O
6 CD O
. . O
3 CD O
% NN O
, , O
5 CD O
. . O
9 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
( : O
18 CD O
. . O
7 CD O
% NN O
, , O
24 CD O
. . O
2 CD O
% NN O
) -RRB- O
remained VBD O
. . O

Conclusion NN O

In IN O
two CD O
surveys NNS O
of IN O
two CD O
population NN O
- HYPH O
based VBN O
samples NNS O
with IN O
similar JJ O
age NN O
and CC O
gender NN O
distributions NNS O
, , O
we PRP O
found VBD O
a DT O
relatively RB O
stable JJ O
cortical JJ O
and CC O
PSC NNP O
cataract NN O
prevalence NN O
over IN O
a DT O
6 CD O
- HYPH O
year NN O
period NN O
. . O

The DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
deserves VBZ O
further JJ O
study NN O
. . O

Background NN O

Age NN O
- HYPH O
related VBN O
cataract NN O
is VBZ O
the DT O
leading VBG O
cause NN O
of IN O
reversible JJ O
visual JJ O
impairment NN O
in IN O
older JJR O
persons NNS B-Species
[ -LRB- O
1 CD O
- SYM O
6 CD O
] -RRB- O
. . O

In IN O
Australia NNP O
, , O
it PRP O
is VBZ O
estimated VBN O
that IN O
by IN O
the DT O
year NN O
2021 CD O
, , O
the DT O
number NN O
of IN O
people NNS B-Species
affected VBN O
by IN O
cataract NN O
will MD O
increase VB O
by IN O
63 CD O
% NN O
, , O
due IN O
to IN O
population NN O
aging NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Surgical JJ O
intervention NN O
is VBZ O
an DT O
effective JJ O
treatment NN O
for IN O
cataract NN O
and CC O
normal JJ O
vision NN O
( : O
> SYM O
20 CD O
/ SYM O
40 CD O
) -RRB- O
can MD O
usually RB O
be VB O
restored VBN O
with IN O
intraocular JJ O
lens NN O
( -LRB- O
IOL NN O
) -RRB- O
implantation NN O
. . O

Cataract JJ O
surgery NN O
with IN O
IOL NN O
implantation NN O
is VBZ O
currently RB O
the DT O
most RBS O
commonly RB O
performed VBN O
, , O
and CC O
is VBZ O
, , O
arguably RB O
, , O
the DT O
most RBS O
cost RBS O
effective JJ O
surgical JJ O
procedure NN O
worldwide RB O
. . O

Performance NN O
of IN O
this DT O
surgical JJ O
procedure NN O
has VBZ O
been VBN O
continuously RB O
increasing VBG O
in IN O
the DT O
last JJ O
two CD O
decades NNS O
. . O

Data NNS O
from IN O
the DT O
Australian NNP O
Health NNP O
Insurance NNP O
Commission NNP O
has VBZ O
shown VBN O
a DT O
steady JJ O
increase NN O
in IN O
Medicare NNP O
claims NNS O
for IN O
cataract NN O
surgery NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

A DT O
2 CD O
. . O
6 CD O
- HYPH O
fold NN O
increase NN O
in IN O
the DT O
total JJ O
number NN O
of IN O
cataract NN O
procedures NNS O
from IN O
1985 CD O
to IN O
1994 CD O
has VBZ O
been VBN O
documented VBN O
in IN O
Australia NNP O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
rate NN O
of IN O
cataract NN O
surgery NN O
per IN O
thousand CD O
persons NNS B-Species
aged VBN O
65 CD O
years NNS O
or CC O
older JJR O
has VBZ O
doubled VBN O
in IN O
the DT O
last JJ O
20 CD O
years NNS O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

In IN O
the DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
population NN O
, , O
we PRP O
observed VBD O
a DT O
one CD O
- HYPH O
third NN O
increase NN O
in IN O
cataract NN O
surgery NN O
prevalence NN O
over IN O
a DT O
mean JJ O
6 CD O
- HYPH O
year NN O
interval NN O
, , O
from IN O
6 CD O
% NN O
to IN O
nearly RB O
8 CD O
% NN O
in IN O
two CD O
cross JJ O
- HYPH O
sectional JJ O
population NN O
- HYPH O
based VBN O
samples NNS O
with IN O
a DT O
similar JJ O
age NN O
range NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Further JJ O
increases NNS O
in IN O
cataract NN O
surgery NN O
performance NN O
would MD O
be VB O
expected VBN O
as IN O
a DT O
result NN O
of IN O
improved VBN O
surgical JJ O
skills NNS O
and CC O
technique NN O
, , O
together RB O
with IN O
extending VBG O
cataract NN O
surgical JJ O
benefits NNS O
to IN O
a DT O
greater JJR O
number NN O
of IN O
older JJR O
people NNS B-Species
and CC O
an DT O
increased VBN O
number NN O
of IN O
persons NNS B-Species
with IN O
surgery NN O
performed VBN O
on IN O
both DT O
eyes NNS O
. . O

Both CC O
the DT O
prevalence NN O
and CC O
incidence NN O
of IN O
age NN O
- HYPH O
related VBN O
cataract NN O
link NN O
directly RB O
to IN O
the DT O
demand NN O
for IN O
, , O
and CC O
the DT O
outcome NN O
of IN O
, , O
cataract NN O
surgery NN O
and CC O
eye NN O
health NN O
care NN O
provision NN O
. . O

This DT O
report NN O
aimed VBD O
to TO O
assess VB O
temporal JJ O
changes NNS O
in IN O
the DT O
prevalence NN O
of IN O
cortical JJ O
and CC O
nuclear JJ O
cataract NN O
and CC O
posterior JJ O
subcapsular NN O
cataract NN O
( -LRB- O
PSC NNP O
) -RRB- O
in IN O
two CD O
cross JJ O
- HYPH O
sectional JJ O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O
. . O

Methods NNS O

The DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
( , O
BMES NNP O
) -RRB- O
is VBZ O
a DT O
population NN O
- HYPH O
based VBN O
cohort NN O
study NN O
of IN O
common JJ O
eye NN O
diseases NNS O
and CC O
other JJ O
health NN O
outcomes NNS O
. . O

The DT O
study NN O
involved VBD O
eligible JJ O
permanent JJ O
residents NNS O
aged JJ O
49 CD O
years NNS O
and CC O
older JJR O
, , O
living VBG O
in IN O
two CD O
postcode NN O
areas NNS O
in IN O
the DT O
Blue NNP O
Mountains NNPS O
, , O
west NN O
of IN O
Sydney NNP O
, , O
Australia NNP O
. . O

Participants NNS B-Species
were VBD O
identified VBN O
through IN O
a DT O
census NN O
and CC O
were VBD O
invited VBN O
to TO O
participate VB O
. . O

The DT O
study NN O
was VBD O
approved VBN O
at IN O
each DT O
stage NN O
of IN O
the DT O
data NNS O
collection NN O
by IN O
the DT O
Human NNP B-Species
Ethics NNP O
Committees NNPS O
of IN O
the DT O
University NNP O
of IN O
Sydney NNP O
and CC O
the DT O
Western NNP O
Sydney NNP O
Area NNP O
Health NNP O
Service NNP O
and CC O
adhered VBN O
to IN O
the DT O
recommendations NNS O
of IN O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
. . O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
each DT O
participant NN B-Species
. . O

Details NNS O
of IN O
the DT O
methods NNS O
used VBN O
in IN O
this DT O
study NN O
have VBP O
been VBN O
described VBN O
previously RB O
[ -LRB- O
11 CD O
] -RRB- O
. . O

The DT O
baseline NN O
examinations NNS O
( , O
BMES NNP O
cross JJ O
- HYPH O
section NN O
I NNP O
) -RRB- O
were VBD O
conducted VBN O
during IN O
1992 CD O
- SYM O
1994 CD O
and CC O
included VBD O
3654 CD O
( SYM O
82 CD O
. . O
4 CD O
% NN O
) -RRB- O
of IN O
4433 CD O
eligible JJ O
residents NNS O
. . O

Follow VB O
- HYPH O
up NN O
examinations NNS O
( , O
BMES NNP O
IIA NNP O
) -RRB- O
were VBD O
conducted VBN O
during IN O
1997 CD O
- SYM O
1999 CD O
, , O
with IN O
2335 CD O
( SYM O
75 CD O
. . O
0 CD O
% NN O
of IN O
BMES NNP O
cross NN O
section NN O
I PRP O
survivors NNS O
) -RRB- O
participating VBG O
. . O

A DT O
repeat NN O
census NN O
of IN O
the DT O
same JJ O
area NN O
was VBD O
performed VBN O
in IN O
1999 CD O
and CC O
identified VBD O
1378 CD O
newly RB O
eligible JJ O
residents NNS O
who WP O
moved VBD O
into IN O
the DT O
area NN O
or CC O
the DT O
eligible JJ O
age NN O
group NN O
. . O

During IN O
1999 CD O
- SYM O
2000 CD O
, , O
1174 CD O
( : O
85 CD O
. . O
2 CD O
% NN O
) -RRB- O
of IN O
this DT O
group NN O
participated VBD O
in IN O
an DT O
extension NN O
study NN O
( , O
BMES NNP O
IIB NNP O
) -RRB- O
. . O

BMES NNP O
cross JJ O
- HYPH O
section NN O
II NNP O
thus RB O
includes VBZ O
BMES NNP O
IIA NNP O
( : O
66 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
BMES NNP O
IIB NNP O
( : O
33 CD O
. . O
5 CD O
% NN O
) -RRB- O
participants NNS B-Species
( : O
n CD O
= SYM O
3509 CD O
) -RRB- O
. . O

Similar JJ O
procedures NNS O
were VBD O
used VBN O
for IN O
all DT O
stages NNS O
of IN O
data NNS O
collection NN O
at IN O
both DT O
surveys NNS O
. . O

A DT O
questionnaire NN O
was VBD O
administered VBN O
including VBG O
demographic JJ O
, , O
family NN O
and CC O
medical JJ O
history NN O
. . O

A DT O
detailed JJ O
eye NN O
examination NN O
included VBD O
subjective JJ O
refraction NN O
, , O
slit NN O
- HYPH O
lamp NN O
( , O
Topcon NNP O
SL NNP O
- HYPH O
7e CD O
camera NN O
, , O
Topcon NNP O
Optical NNP O
Co NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) , O
and CC O
retroillumination NN O
( , O
Neitz NNP O
CT NNP O
- HYPH O
R NN O
camera NN O
, , O
Neitz NNP O
Instrument NNP O
Co NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) , O
photography NN O
of IN O
the DT O
lens NN O
. . O

Grading NN O
of IN O
lens NNS O
photographs NNS O
in IN O
the DT O
BMES NNP O
has VBZ O
been VBN O
previously RB O
described VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Briefly RB O
, , O
masked VBN O
grading NN O
was VBD O
performed VBN O
on IN O
the DT O
lens NN O
photographs NNS O
using VBG O
the DT O
Wisconsin NNP O
Cataract NNP O
Grading NNP O
System NNP O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Cortical JJ O
cataract NN O
and CC O
PSC NNP O
were VBD O
assessed VBN O
from IN O
the DT O
retroillumination NN O
photographs NNS O
by IN O
estimating VBG O
the DT O
percentage NN O
of IN O
the DT O
circular JJ O
grid NN O
involved VBN O
. . O

Cortical JJ O
cataract NN O
was VBD O
defined VBN O
when WRB O
cortical JJ O
opacity NN O
involved VBD O
at RB O
least RBS O
5 CD O
% NN O
of IN O
the DT O
total JJ O
lens NN O
area NN O
. . O

PSC NNP O
was VBD O
defined VBN O
when WRB O
opacity NN O
comprised VBD O
at RB O
least RBS O
1 CD O
% NN O
of IN O
the DT O
total JJ O
lens NN O
area NN O
. . O

Slit JJ O
- HYPH O
lamp NN O
photographs NNS O
were VBD O
used VBN O
to TO O
assess VB O
nuclear JJ O
cataract NN O
using VBG O
the DT O
Wisconsin NNP O
standard JJ O
set NN O
of IN O
four CD O
lens NNS O
photographs NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Nuclear JJ O
cataract NN O
was VBD O
defined VBN O
when WRB O
nuclear JJ O
opacity NN O
was VBD O
at IN O
least JJS O
as RB O
great JJ O
as IN O
the DT O
standard JJ O
4 CD O
photograph NN O
. . O

Any DT O
cataract NN O
was VBD O
defined VBN O
to TO O
include VB O
persons NNS B-Species
who WP O
had VBD O
previous JJ O
cataract JJ O
surgery NN O
as RB O
well RB O
as IN O
those DT O
with IN O
any DT O
of IN O
three CD O
cataract NN O
types NNS O
. . O

Inter NN O
- HYPH O
grader NN O
reliability NN O
was VBD O
high JJ O
, , O
with IN O
weighted JJ O
kappa NN O
0 CD O
. . O
82 CD O
for IN O
cortical JJ O
cataract NN O
, , O
0 CD O
. . O
55 CD O
( HYPH O
simple JJ O
kappa NN O
0 CD O
. . O
75 CD O
) -RRB- O
for IN O
nuclear JJ O
cataract NN O
and CC O
0 CD O
. . O
82 CD O
for IN O
PSC NNP O
grading NN O
. . O

The DT O
intra NN O
- HYPH O
grader NN O
reliability NN O
for IN O
nuclear JJ O
cataract NN O
was VBD O
assessed VBN O
with IN O
simple JJ O
kappa NN O
0 CD O
. . O
83 CD O
for IN O
the DT O
senior JJ O
grader NN O
who WP O
graded VBD O
nuclear JJ O
cataract NN O
at IN O
both DT O
surveys NNS O
. . O

All DT O
PSC NNP O
cases NNS O
were VBD O
confirmed VBN O
by IN O
an DT O
ophthalmologist NN O
( -LRB- O
PM NN O
) -RRB- O
. . O

In IN O
cross JJ O
- HYPH O
section NN O
I PRP O
, , O
219 CD O
persons NNS B-Species
( , O
6 CD O
. . O
0 CD O
% NN O
) -RRB- O
had VBD O
missing JJ O
or CC O
ungradable JJ O
Neitz NNP O
photographs NNS O
, , O
leaving VBG O
3435 CD O
with IN O
photographs NNS O
available JJ O
for IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
assessment NN O
, , O
while IN O
1153 CD O
( SYM O
31 CD O
. . O
6 CD O
% NN O
) -RRB- O
had VBD O
randomly RB O
missing VBG O
or CC O
ungradable JJ O
Topcon NNP O
photographs NNS O
due IN O
to IN O
a DT O
camera NN O
malfunction NN O
, , O
leaving VBG O
2501 CD O
with IN O
photographs NNS O
available JJ O
for IN O
nuclear JJ O
cataract NN O
assessment NN O
. . O

Comparison NN O
of IN O
characteristics NNS O
between IN O
participants NNS B-Species
with IN O
and CC O
without IN O
Neitz NNP O
or CC O
Topcon NNP O
photographs NNS O
in IN O
cross JJ O
- HYPH O
section NN O
I PRP O
showed VBD O
no DT O
statistically RB O
significant JJ O
differences NNS O
between IN O
the DT O
two CD O
groups NNS O
, , O
as IN O
reported VBN O
previously RB O
[ -LRB- O
12 CD O
] -RRB- O
. . O

In IN O
cross JJ O
- HYPH O
section NN O
II CD O
, , O
441 CD O
persons NNS B-Species
( , O
12 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
missing JJ O
or CC O
ungradable JJ O
Neitz NNP O
photographs NNS O
, , O
leaving VBG O
3068 CD O
for IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
assessment NN O
, , O
and CC O
648 CD O
( SYM O
18 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
missing VBG O
or CC O
ungradable JJ O
Topcon NNP O
photographs NNS O
, , O
leaving VBG O
2860 CD O
for IN O
nuclear JJ O
cataract NN O
assessment NN O
. . O

Data NN O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
Statistical NNP O
Analysis NNP O
System NNP O
( : O
SAS NNP O
, , O
SAS NNP O
Institute NNP O
, , O
Cary NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
. . O

Age NN O
- HYPH O
adjusted VBN O
prevalence NN O
was VBD O
calculated VBN O
using VBG O
direct JJ O
standardization NN O
of IN O
the DT O
cross JJ O
- HYPH O
section NN O
II NNP O
population NN O
to IN O
the DT O
cross JJ O
- HYPH O
section NN O
I PRP O
population NN O
. . O

We PRP O
assessed VBD O
age NN O
- HYPH O
specific JJ O
prevalence NN O
using VBG O
an DT O
interval NN O
of IN O
5 CD O
years NNS O
, , O
so IN O
that IN O
participants NNS B-Species
within IN O
each DT O
age NN O
group NN O
were VBD O
independent JJ O
between IN O
the DT O
two CD O
cross JJ O
- HYPH O
sectional JJ O
surveys NNS O
. . O

Results NNS O

Characteristics NNS O
of IN O
the DT O
two CD O
survey NN O
populations NNS O
have VBP O
been VBN O
previously RB O
compared VBN O
[ -LRB- O
14 CD O
] -RRB- O
and CC O
showed VBD O
that IN O
age NN O
and CC O
sex NN O
distributions NNS O
were VBD O
similar JJ O
. . O

Table NN O
1 CD O
compares VBZ O
participant NN B-Species
characteristics NNS O
between IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
. . O

Cross JJ O
- HYPH O
section NN O
II NN O
participants NNS B-Species
generally RB O
had VBD O
higher JJR O
rates NNS O
of IN O
diabetes NNS O
, , O
hypertension NN O
, , O
myopia NN O
and CC O
more JJR O
users NNS O
of IN O
inhaled VBN O
steroids NNS O
. . O

Cataract NN O
prevalence NN O
rates NNS O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NN O
are VBP O
shown VBN O
in IN O
Figure NN O
1 CD O
. . O

The DT O
overall JJ O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
was VBD O
23 CD O
. . O
8 CD O
% NN O
and CC O
23 CD O
. . O
7 CD O
% NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II CD O
, , O
respectively RB O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
= SYM O
0 CD O
. . O
81 CD O
) -RRB- O
. . O

Corresponding VBG O
prevalence NN O
of IN O
PSC NNP O
was VBD O
6 CD O
. . O
3 CD O
% NN O
and CC O
6 CD O
. . O
0 CD O
% NN O
for IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
= SYM O
0 CD O
. . O
60 CD O
) -RRB- O
. . O

There EX O
was VBD O
an DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
, , O
from IN O
18 CD O
. . O
7 CD O
% NN O
in IN O
cross JJ O
- HYPH O
section NN O
I CD O
to IN O
23 CD O
. . O
9 CD O
% NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
persons NNS B-Species
who WP O
had VBD O
cataract NN O
surgery NN O
) -RRB- O
, , O
however RB O
, , O
was VBD O
relatively RB O
stable JJ O
( : O
46 CD O
. . O
9 CD O
% NN O
and CC O
46 CD O
. . O
8 CD O
% NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NN O
, , O
respectively RB O
) -RRB- O
. . O

After IN O
age NN O
- HYPH O
standardization NN O
, , O
these DT O
prevalence NN O
rates NNS O
remained VBD O
stable JJ O
for IN O
cortical JJ O
cataract NN O
( , O
23 CD O
. . O
8 CD O
% NN O
and CC O
23 CD O
. . O
5 CD O
% NN O
in IN O
the DT O
two CD O
surveys NNS O
) , O
and CC O
PSC NNP O
( : O
6 CD O
. . O
3 CD O
% NN O
and CC O
5 CD O
. . O
9 CD O
% NN O
) -RRB- O
. . O

The DT O
slightly RB O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
( , O
from IN O
18 CD O
. . O
7 CD O
% NN O
to IN O
24 CD O
. . O
2 CD O
% NN O
) -RRB- O
was VBD O
not RB O
altered VBN O
. . O

Table NN O
2 CD O
shows VBZ O
the DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
rates NNS O
for IN O
cortical JJ O
cataract NN O
, , O
PSC NNP O
and CC O
nuclear JJ O
cataract NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NNP O
. . O

A DT O
similar JJ O
trend NN O
of IN O
increasing VBG O
cataract JJ O
prevalence NN O
with IN O
increasing VBG O
age NN O
was VBD O
evident JJ O
for IN O
all DT O
three CD O
types NNS O
of IN O
cataract NN O
in IN O
both DT O
surveys NNS O
. . O

Comparing VBG O
the DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
between IN O
the DT O
two CD O
surveys NNS O
, , O
a DT O
reduction NN O
in IN O
PSC NNP O
prevalence NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
was VBD O
observed VBN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> : O
= SYM O
75 CD O
years NNS O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
was VBD O
observed VBN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> : O
= SYM O
70 CD O
years NNS O
) -RRB- O
. . O

Age NN O
- HYPH O
specific JJ O
cortical JJ O
cataract NN O
prevalence NN O
was VBD O
relatively RB O
consistent JJ O
between IN O
the DT O
two CD O
surveys NNS O
, , O
except IN O
for IN O
a DT O
reduction NN O
in IN O
prevalence NN O
observed VBN O
in IN O
the DT O
80 CD O
- SYM O
84 CD O
age NN O
group NN O
and CC O
an DT O
increasing VBG O
prevalence NN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> NFP O
= SYM O
85 CD O
years NNS O
) -RRB- O
. . O

Similar JJ O
gender NN O
differences NNS O
in IN O
cataract NN O
prevalence NN O
were VBD O
observed VBN O
in IN O
both DT O
surveys NNS O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
. . O

Higher JJR O
prevalence NN O
of IN O
cortical JJ O
and CC O
nuclear JJ O
cataract NN O
in IN O
women NNS B-Species
than IN O
men NNS B-Species
was VBD O
evident JJ O
but CC O
the DT O
difference NN O
was VBD O
only RB O
significant JJ O
for IN O
cortical JJ O
cataract NN O
( , O
age NN O
- HYPH O
adjusted VBN O
odds NNS O
ratio NN O
, , O
OR CC O
, , O
for IN O
women NNS B-Species
1 CD O
. . O
3 CD O
, , O
95 CD O
% NN O
confidence NN O
intervals NNS O
, , O
CI NN O
, , O
1 CD O
. . O
1 CD O
- SYM O
1 CD O
. . O
5 CD O
in IN O
cross JJ O
- HYPH O
section NN O
I NN O
and CC O
OR NN O
1 CD O
. . O
4 CD O
, , O
95 CD O
% NN O
CI NN O
1 CD O
. . O
1 CD O
- SYM O
1 CD O
. . O
6 CD O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
men NNS B-Species
had VBD O
slightly RB O
higher JJR O
PSC NNP O
prevalence NN O
than IN O
women NNS B-Species
in IN O
both DT O
cross JJ O
- HYPH O
sections NNS O
but CC O
the DT O
difference NN O
was VBD O
not RB O
significant JJ O
( : O
OR CC O
1 CD O
. . O
1 CD O
, , O
95 CD O
% NN O
CI NN O
0 CD O
. . O
8 CD O
- SYM O
1 CD O
. . O
4 CD O
for IN O
men NNS B-Species
in IN O
cross JJ O
- HYPH O
section NN O
I NN O
and CC O
OR NN O
1 CD O
. . O
2 CD O
, , O
95 CD O
% NN O
0 CD O
. . O
9 CD O
- SYM O
1 CD O
. . O
6 CD O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
) -RRB- O
. . O

Discussion NN O

Findings NNS O
from IN O
two CD O
surveys NNS O
of IN O
BMES NNP O
cross JJ O
- HYPH O
sectional JJ O
populations NNS O
with IN O
similar JJ O
age NN O
and CC O
gender NN O
distribution NN O
showed VBD O
that IN O
the DT O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
remained VBD O
stable JJ O
, , O
while IN O
the DT O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
appeared VBD O
to TO O
have VB O
increased VBN O
. . O

Comparison NN O
of IN O
age NN O
- HYPH O
specific JJ O
prevalence NN O
, , O
with IN O
totally RB O
independent JJ O
samples NNS O
within IN O
each DT O
age NN O
group NN O
, , O
confirmed VBD O
the DT O
robustness NN O
of IN O
our PRP$ O
findings NNS O
from IN O
the DT O
two CD O
survey NN O
samples NNS O
. . O

Although IN O
lens NNS O
photographs NNS O
taken VBN O
from IN O
the DT O
two CD O
surveys NNS O
were VBD O
graded VBN O
for IN O
nuclear JJ O
cataract NN O
by IN O
the DT O
same JJ O
graders NNS O
, , O
who WP O
documented VBD O
a DT O
high JJ O
inter JJ O
- HYPH O
and CC O
intra NN O
- HYPH O
grader NN O
reliability NN O
, , O
we PRP O
cannot MD O
exclude VB O
the DT O
possibility NN O
that IN O
variations NNS O
in IN O
photography NN O
, , O
performed VBN O
by IN O
different JJ O
photographers NNS O
, , O
may MD O
have VB O
contributed VBN O
to IN O
the DT O
observed VBN O
difference NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

However RB O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
cataract NN O
surgery NN O
) , O
was VBD O
relatively RB O
stable JJ O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
. . O

Although IN O
different JJ O
population NN O
- HYPH O
based VBN O
studies NNS O
used VBD O
different JJ O
grading NN O
systems NNS O
to TO O
assess VB O
cataract NN O
[ -LRB- O
15 CD O
] -RRB- O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
the DT O
three CD O
cataract NN O
types NNS O
were VBD O
similar JJ O
across IN O
different JJ O
study NN O
populations NNS O
[ -LRB- O
12 CD O
, , O
16 CD O
- SYM O
23 CD O
] -RRB- O
. . O

Most JJS O
studies NNS O
have VBP O
suggested VBN O
that IN O
nuclear JJ O
cataract NN O
is VBZ O
the DT O
most RBS O
prevalent JJ O
type NN O
of IN O
cataract NN O
, , O
followed VBN O
by IN O
cortical JJ O
cataract NN O
[ -LRB- O
16 CD O
- SYM O
20 CD O
] -RRB- O
. . O

Ours PRP O
and CC O
other JJ O
studies NNS O
reported VBD O
that IN O
cortical JJ O
cataract NN O
was VBD O
the DT O
most RBS O
prevalent JJ O
type NN O
[ -LRB- O
12 CD O
, , O
21 CD O
- SYM O
23 CD O
] -RRB- O
. . O

Our PRP$ O
age NN O
- HYPH O
specific JJ O
prevalence NN O
data NNS O
show VBP O
a DT O
reduction NN O
of IN O
15 CD O
. . O
9 CD O
% NN O
in IN O
cortical JJ O
cataract NN O
prevalence NN O
for IN O
the DT O
80 CD O
- SYM O
84 CD O
year NN O
age NN O
group NN O
, , O
concordant JJ O
with IN O
an DT O
increase NN O
in IN O
cataract NN O
surgery NN O
prevalence NN O
by IN O
9 CD O
% NN O
in IN O
those DT O
aged VBN O
80 CD O
+ CD O
years NNS O
observed VBN O
in IN O
the DT O
same JJ O
study NN O
population NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Although IN O
cortical JJ O
cataract NN O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
least RBS O
likely JJ O
cataract NN O
type NN O
leading VBG O
to IN O
a DT O
cataract NN O
surgery NN O
, , O
this DT O
may MD O
not RB O
be VB O
the DT O
case NN O
in IN O
all DT O
older JJR O
persons NNS B-Species
. . O

A DT O
relatively RB O
stable JJ O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
prevalence NN O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
is VBZ O
expected VBN O
. . O

We PRP O
cannot MD O
offer VB O
a DT O
definitive JJ O
explanation NN O
for IN O
the DT O
increase NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

A DT O
possible JJ O
explanation NN O
could MD O
be VB O
that IN O
a DT O
moderate JJ O
level NN O
of IN O
nuclear JJ O
cataract NN O
causes VBZ O
less JJR O
visual JJ O
disturbance NN O
than IN O
the DT O
other JJ O
two CD O
types NNS O
of IN O
cataract NN O
, , O
thus RB O
for IN O
the DT O
oldest JJS O
age NN O
groups NNS O
, , O
persons NNS B-Species
with IN O
nuclear JJ O
cataract NN O
could MD O
have VB O
been VBN O
less RBR O
likely JJ O
to TO O
have VB O
surgery NN O
unless IN O
it PRP O
is VBZ O
very RB O
dense JJ O
or CC O
co NN O
- HYPH O
existing VBG O
with IN O
cortical JJ O
cataract NN O
or CC O
PSC NNP O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
functional JJ O
vision NN O
and CC O
reading NN O
performance NN O
were VBD O
high JJ O
in IN O
patients NNS B-Species
undergoing VBG O
cataract JJ O
surgery NN O
who WP O
had VBD O
nuclear JJ O
cataract NN O
only RB O
compared VBN O
to IN O
those DT O
with IN O
mixed JJ O
type NN O
of IN O
cataract NN O
( , O
nuclear JJ O
and CC O
cortical JJ O
) -RRB- O
or CC O
PSC NNP O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
cataract NN O
surgery NN O
) , O
was VBD O
similar JJ O
in IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
, , O
which WDT O
appears VBZ O
to TO O
support VB O
our PRP$ O
speculation NN O
that IN O
in IN O
the DT O
oldest JJS O
age NN O
group NN O
, , O
nuclear JJ O
cataract NN O
may MD O
have VB O
been VBN O
less RBR O
likely JJ O
to TO O
be VB O
operated VBN O
than IN O
the DT O
other JJ O
two CD O
types NNS O
of IN O
cataract NN O
. . O

This DT O
could MD O
have VB O
resulted VBN O
in IN O
an DT O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
( , O
due IN O
to IN O
less RBR O
being VBG O
operated VBN O
) -RRB- O
, , O
compensated VBN O
by IN O
the DT O
decreased VBN O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
( , O
due IN O
to IN O
these DT O
being VBG O
more RBR O
likely JJ O
to TO O
be VB O
operated VBN O
) -RRB- O
, , O
leading VBG O
to IN O
stable JJ O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
. . O

Possible JJ O
selection NN O
bias NN O
arising VBG O
from IN O
selective JJ O
survival NN O
among IN O
persons NNS B-Species
without IN O
cataract NN O
could MD O
have VB O
led VBN O
to IN O
underestimation NN O
of IN O
cataract NN O
prevalence NN O
in IN O
both DT O
surveys NNS O
. . O

We PRP O
assume VBP O
that IN O
such PDT O
an DT O
underestimation NN O
occurred VBD O
equally RB O
in IN O
both DT O
surveys NNS O
, , O
and CC O
thus RB O
should MD O
not RB O
have VB O
influenced VBN O
our PRP$ O
assessment NN O
of IN O
temporal JJ O
changes NNS O
. . O

Measurement NN O
error NN O
could MD O
also RB O
have VB O
partially RB O
contributed VBN O
to IN O
the DT O
observed VBN O
difference NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

Assessment NN O
of IN O
nuclear JJ O
cataract NN O
from IN O
photographs NNS O
is VBZ O
a DT O
potentially RB O
subjective JJ O
process NN O
that WDT O
can MD O
be VB O
influenced VBN O
by IN O
variations NNS O
in IN O
photography NN O
( , O
light JJ O
exposure NN O
, , O
focus NN O
and CC O
the DT O
slit NN O
- HYPH O
lamp NN O
angle NN O
when WRB O
the DT O
photograph NN O
was VBD O
taken VBN O
) , O
and CC O
grading NN O
. . O

Although IN O
we PRP O
used VBD O
the DT O
same JJ O
Topcon NNP O
slit NN O
- HYPH O
lamp NN O
camera NN O
and CC O
the DT O
same JJ O
two CD O
graders NNS O
who WP O
graded VBD O
photos NNS O
from IN O
both DT O
surveys NNS O
, , O
we PRP O
are VBP O
still RB O
not RB O
able JJ O
to TO O
exclude VB O
the DT O
possibility NN O
of IN O
a DT O
partial JJ O
influence NN O
from IN O
photographic JJ O
variation NN O
on IN O
this DT O
result NN O
. . O

A DT O
similar JJ O
gender NN O
difference NN O
( , O
women NNS B-Species
having VBG O
a DT O
higher JJR O
rate NN O
than IN O
men NNS B-Species
) , O
in IN O
cortical JJ O
cataract NN O
prevalence NN O
was VBD O
observed VBN O
in IN O
both DT O
surveys NNS O
. . O

Our PRP$ O
findings NNS O
are VBP O
in IN O
keeping NN O
with IN O
observations NNS O
from IN O
the DT O
Beaver NNP O
Dam NNP O
Eye NNP O
Study NNP O
[ -LRB- O
18 CD O
] -RRB- O
, , O
the DT O
Barbados NNP O
Eye NNP O
Study NNP O
[ -LRB- O
22 CD O
] -RRB- O
and CC O
the DT O
Lens NNP O
Opacities NNP O
Case NNP O
- HYPH O
Control NNP O
Group NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
the DT O
difference NN O
could MD O
be VB O
related VBN O
to IN O
hormonal JJ O
factors NNS O
[ -LRB- O
18 CD O
, , O
22 CD O
] -RRB- O
. . O

A DT O
previous JJ O
study NN O
on IN O
biochemical JJ O
factors NNS O
and CC O
cataract NN O
showed VBD O
that IN O
a DT O
lower JJR O
level NN O
of IN O
iron NN O
was VBD O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
cortical JJ O
cataract NN O
[ -LRB- O
27 CD O
] -RRB- O
. . O

No DT O
interaction NN O
between IN O
sex NN O
and CC O
biochemical JJ O
factors NNS O
were VBD O
detected VBN O
and CC O
no DT O
gender NN O
difference NN O
was VBD O
assessed VBN O
in IN O
this DT O
study NN O
[ -LRB- O
27 CD O
] -RRB- O
. . O

The DT O
gender NN O
difference NN O
seen VBN O
in IN O
cortical JJ O
cataract NN O
could MD O
be VB O
related VBN O
to IN O
relatively RB O
low JJ O
iron NN O
levels NNS O
and CC O
low JJ O
hemoglobin NN O
concentration NN O
usually RB O
seen VBN O
in IN O
women NNS B-Species
[ -LRB- O
28 CD O
] -RRB- O
. . O

Diabetes NN O
is VBZ O
a DT O
known JJ O
risk NN O
factor NN O
for IN O
cortical JJ O
cataract NN O
but CC O
in IN O
this DT O
particular JJ O
population NN O
diabetes NN O
is VBZ O
more RBR O
prevalent JJ O
in IN O
men NNS B-Species
than IN O
women NNS B-Species
in IN O
all DT O
age NN O
groups NNS O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Differential JJ O
exposures NNS O
to IN O
cataract NN O
risk NN O
factors NNS O
or CC O
different JJ O
dietary JJ O
or CC O
lifestyle NN O
patterns NNS O
between IN O
men NNS B-Species
and CC O
women NNS B-Species
may MD O
also RB O
be VB O
related VBN O
to IN O
these DT O
observations NNS O
and CC O
warrant VB O
further JJ O
study NN O
. . O

Conclusion NN O

In IN O
summary NN O
, , O
in IN O
two CD O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O
, , O
we PRP O
have VBP O
documented VBN O
a DT O
relatively RB O
stable JJ O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
over IN O
the DT O
period NN O
. . O

The DT O
observed VBN O
overall JJ O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
by IN O
5 CD O
% NN O
over IN O
a DT O
6 CD O
- HYPH O
year NN O
period NN O
needs VBZ O
confirmation NN O
by IN O
future JJ O
studies NNS O
, , O
and CC O
reasons NNS O
for IN O
such PDT O
an DT O
increase NN O
deserve VBP O
further JJ O
study NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

AGT NNP O
graded VBD O
the DT O
photographs NNS O
, , O
performed VBD O
literature NN O
search NN O
and CC O
wrote VBD O
the DT O
first JJ O
draft NN O
of IN O
the DT O
manuscript NN O
. . O

JJW NNP O
graded VBD O
the DT O
photographs NNS O
, , O
critically RB O
reviewed VBD O
and CC O
modified VBD O
the DT O
manuscript NN O
. . O

ER NNP O
performed VBD O
the DT O
statistical JJ O
analysis NN O
and CC O
critically RB O
reviewed VBD O
the DT O
manuscript NN O
. . O

PM NN O
designed VBD O
and CC O
directed VBD O
the DT O
study NN O
, , O
adjudicated VBD O
cataract NN O
cases NNS O
and CC O
critically RB O
reviewed VBD O
and CC O
modified VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

QGRS NNP O
Mapper NNP O
: : O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
for IN O
predicting VBG O
G NN O
- HYPH O
quadruplexes NNS O
in IN O
nucleotide NN O
sequences NNS O

Abstract JJ O

The DT O
quadruplex NN O
structures NNS O
formed VBN O
by IN O
guanine NN O
- HYPH O
rich JJ O
nucleic JJ O
acid NN O
sequences NNS O
have VBP O
received VBN O
significant JJ O
attention NN O
recently RB O
because IN O
of IN O
growing VBG O
evidence NN O
for IN O
their PRP$ O
role NN O
in IN O
important JJ O
biological JJ O
processes NNS O
and CC O
as IN O
therapeutic JJ O
targets NNS O
. . O

G NNP O
- HYPH O
quadruplex NNP O
DNA NNP O
has VBZ O
been VBN O
suggested VBN O
to TO O
regulate VB O
DNA NN O
replication NN O
and CC O
may MD O
control VB O
cellular JJ O
proliferation NN O
. . O

Sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
RNA NNP O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
significant JJ O
roles NNS O
in IN O
regulation NN O
of IN O
polyadenylation NN O
and CC O
splicing VBG O
events NNS O
in IN O
mammalian JJ O
transcripts NNS O
. . O

Whether IN O
quadruplex NN O
structure NN O
directly RB O
plays VBZ O
a DT O
role NN O
in IN O
regulating VBG O
RNA NNP O
processing NN O
requires VBZ O
investigation NN O
. . O

Computational JJ O
approaches NNS O
to IN O
study NN O
G NN O
- HYPH O
quadruplexes NNS O
allow VBP O
detailed JJ O
analysis NN O
of IN O
mammalian JJ O
genomes NNS O
. . O

There EX O
are VBP O
no DT O
known VBN O
easily RB O
accessible JJ O
user NN O
- HYPH O
friendly JJ O
tools NNS O
that WDT O
can MD O
compute VB O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
nucleotide NN O
sequences NNS O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
, , O
QGRS NNP O
Mapper NNP O
, , O
that WDT O
predicts VBZ O
quadruplex NN O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
( , O
QGRS NNP O
) -RRB- O
in IN O
nucleotide NN O
sequences NNS O
. . O

It PRP O
is VBZ O
a DT O
user NN O
- HYPH O
friendly JJ O
application NN O
that WDT O
provides VBZ O
many JJ O
options NNS O
for IN O
defining VBG O
and CC O
studying VBG O
G NNP O
- HYPH O
quadruplexes NNS O
. . O

It PRP O
performs VBZ O
analysis NN O
of IN O
the DT O
user NN O
provided VBN O
genomic JJ O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
promoter NN O
and CC O
telomeric JJ O
regions NNS O
, , O
as RB O
well RB O
as IN O
RNA NNP O
sequences NNS O
. . O

It PRP O
is VBZ O
also RB O
useful JJ O
for IN O
predicting VBG O
G NNP O
- HYPH O
quadruplex NN O
structures NNS O
in IN O
oligonucleotides NNS O
. . O

The DT O
program NN O
provides VBZ O
options NNS O
to TO O
search VB O
and CC O
retrieve VB O
desired JJ O
gene NN O
/ SYM O
nucleotide NN O
sequence NN O
entries NNS O
from IN O
NCBI NNP O
databases NNS O
for IN O
mapping VBG O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
context NN O
of IN O
RNA NNP O
processing NN O
sites NNS O
. . O

This DT O
feature NN O
is VBZ O
very RB O
useful JJ O
for IN O
investigating VBG O
the DT O
functional JJ O
relevance NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
in IN O
particular JJ O
its PRP$ O
role NN O
in IN O
regulating VBG O
the DT O
gene NN O
expression NN O
by IN O
alternative JJ O
processing NN O
. . O

In IN O
addition NN O
to IN O
providing VBG O
data NNS O
on IN O
composition NN O
and CC O
locations NNS O
of IN O
QGRS NNP O
relative JJ O
to IN O
the DT O
processing NN O
sites NNS O
in IN O
the DT O
pre JJ O
- HYPH O
mRNA NN O
sequence NN O
, , O
QGRS NNP O
Mapper NNP O
features VBZ O
interactive JJ O
graphic JJ O
representation NN O
of IN O
the DT O
data NNS O
. . O

The DT O
user NN O
can MD O
also RB O
use VB O
the DT O
graphics NNS O
module NN O
to TO O
visualize VB O
QGRS NNP O
distribution NN O
patterns NNS O
among IN O
all PDT O
the DT O
alternative JJ O
RNA NNP O
products NNS O
of IN O
a DT O
gene NN O
simultaneously RB O
on IN O
a DT O
single JJ O
screen NN O
. . O

QGRS NNP O
Mapper NNP O
can MD O
be VB O
accessed VBN O
at IN O
. . O

INTRODUCTION NN O

The DT O
quadruplex NN O
structures NNS O
formed VBN O
by IN O
guanine NN O
- HYPH O
rich JJ O
nucleic JJ O
acid NN O
sequences NNS O
have VBP O
received VBN O
significant JJ O
attention NN O
recently RB O
because IN O
of IN O
increasing VBG O
evidence NN O
for IN O
their PRP$ O
role NN O
in IN O
important JJ O
biological JJ O
processes NNS O
and CC O
as IN O
therapeutic JJ O
targets NNS O
( : O
1 CD O
- SYM O
5 CD O
) -RRB- O
. . O

The DT O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
also RB O
known VBN O
as IN O
a DT O
G NNP O
- HYPH O
quartet NN O
, , O
is VBZ O
formed VBN O
by IN O
repeated VBN O
folding NN O
of IN O
either CC O
the DT O
single JJ O
polynucleotide NN O
molecule NN O
or CC O
by IN O
association NN O
of IN O
two CD O
or CC O
four CD O
molecules NNS O
. . O

The DT O
structure NN O
consists VBZ O
of IN O
stacked VBN O
G NNP O
- HYPH O
tetrads NNS O
, , O
which WDT O
are VBP O
square JJ O
co NN O
- HYPH O
planar NN O
arrays NNS O
of IN O
four CD O
guanine NN O
bases NNS O
each DT O
( , O
6 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplex NN O
is VBZ O
stabilized VBN O
with IN O
cyclic JJ O
Hoogsteen NNP O
hydrogen NN O
bonding NN O
between IN O
the DT O
four CD O
guanines NNS O
within IN O
each DT O
tetrad NN O
. . O

The DT O
present JJ O
work NN O
focuses VBZ O
only RB O
on IN O
the DT O
unimolecular JJ O
quadruplexes NNS O
, , O
since IN O
it PRP O
is VBZ O
more RBR O
likely JJ O
to TO O
be VB O
encountered VBN O
in IN O
physiological JJ O
conditions NNS O
( , O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

Guanine NNP O
- HYPH O
rich JJ O
sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
are VBP O
found VBN O
in IN O
telomeres NNS O
, , O
promoter NN O
regions NNS O
, , O
transcribed VBN O
and CC O
other JJ O
biologically RB O
important JJ O
regions NNS O
of IN O
the DT O
mammalian JJ O
genomes NNS O
. . O

G NNP O
- HYPH O
quadruplex NNP O
DNA NNP O
has VBZ O
been VBN O
suggested VBN O
to TO O
regulate VB O
DNA NN O
replication NN O
in IN O
retinoblastoma NN O
susceptibility NN O
gene NN O
( -LRB- O
Rb NN O
) -RRB- O
region NN O
( : O
9 CD O
) -RRB- O
. . O

This DT O
structure NN O
may MD O
control VB O
cellular JJ O
proliferation NN O
at IN O
telomeric JJ O
level NN O
and CC O
by IN O
transcriptional JJ O
regulation NN O
of IN O
oncogenes NNS O
like IN O
c NN O
- HYPH O
myc NNP O
( : O
2 CD O
, , O
10 CD O
, , O
11 CD O
) -RRB- O
and CC O
c NN O
- HYPH O
kit NN O
( SYM O
12 CD O
) -RRB- O
. . O

Formation NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
seems VBZ O
to TO O
be VB O
regulated VBN O
through IN O
interactions NNS O
with IN O
cellular JJ O
proteins NNS O
. . O

While IN O
some DT O
proteins NNS O
help VBP O
stabilize VB O
the DT O
structure NN O
( , O
13 CD O
) -RRB- O
, , O
others NNS O
are VBP O
known VBN O
to TO O
resolve VB O
it PRP O
( , O
1 CD O
, , O
4 CD O
, , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

Proteins NNS O
and CC O
chemicals NNS O
that WDT O
stabilize VBP O
the DT O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
can MD O
inhibit VB O
telomerase NN O
action NN O
and CC O
, , O
therefore RB O
, , O
are VBP O
being VBG O
evaluated VBN O
as IN O
anticancer NN O
therapeutic JJ O
agents NNS O
( : O
16 CD O
- HYPH O
20 CD O
) -RRB- O
. . O

Chemical JJ O
compounds NNS O
that WDT O
inhibit VBP O
G NN O
- HYPH O
quadruplex NN O
helicase NN O
activity NN O
may MD O
also RB O
be VB O
capable JJ O
of IN O
regulating VBG O
cellular JJ O
proliferation NN O
( : O
4 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplexes NNS O
are VBP O
also RB O
being VBG O
eyed VBN O
as IN O
potential JJ O
antimicrobial JJ O
agents NNS O
due IN O
to IN O
their PRP$ O
ability NN O
to TO O
transport VB O
monovalent JJ O
anions NNS O
( SYM O
21 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplex NN O
motifs NNS O
in IN O
the DT O
RNA NNP O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
significant JJ O
roles NNS O
in IN O
mRNA NNP O
turnover NN O
( : O
1 CD O
) -RRB- O
, , O
FMRP NNP O
binding NN O
( : O
22 CD O
) -RRB- O
, , O
translation NN O
initiation NN O
( SYM O
23 CD O
) -RRB- O
as RB O
well RB O
as IN O
repression NN O
( SYM O
24 CD O
) -RRB- O
. . O

We PRP O
have VBP O
shown VBN O
previously RB O
that IN O
a DT O
G NNP O
- HYPH O
rich JJ O
sequence NN O
( , O
GRS NNP O
) -RRB- O
can MD O
mediate VB O
3 CD O
' '' O
end NN O
processing NN O
of IN O
mammalian JJ O
pre NN O
- HYPH O
mRNAs NNS O
by IN O
interacting VBG O
with IN O
DSEF NNP O
- HYPH O
1 CD O
/ SYM O
hnRNPH NNP O
/ SYM O
H NN O
' '' O
protein NN O
( , O
25 CD O
- HYPH O
27 CD O
) -RRB- O
. . O

Members NNS O
of IN O
the DT O
hnRNP NNP O
H NNP O
protein NN O
family NN O
recognize VBP O
G NNP O
- HYPH O
rich JJ O
motifs NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
and CC O
are VBP O
known VBN O
to TO O
regulate VB O
polyadenylation NN O
and CC O
splicing VBG O
events NNS O
in IN O
mammalian JJ O
transcripts NNS O
( : O
28 CD O
- HYPH O
30 CD O
) -RRB- O
. . O

Regulated VBN O
RNA NNP O
processing NN O
is VBZ O
an DT O
essential JJ O
component NN O
of IN O
differential JJ O
gene NN O
expression NN O
which WDT O
is VBZ O
central JJ O
to IN O
many JJ O
important JJ O
biologically RB O
processes NNS O
. . O

More JJR O
than IN O
half NN O
of IN O
human JJ B-Species
genes NNS O
are VBP O
known VBN O
to TO O
have VB O
alternative JJ O
polyadenylation NN O
( SYM O
31 CD O
) -RRB- O
. . O

Over IN O
two CD O
- HYPH O
thirds NNS O
of IN O
human JJ B-Species
genes NNS O
are VBP O
thought VBN O
to TO O
undergo VB O
alternative JJ O
splicing NN O
( SYM O
32 CD O
) -RRB- O
. . O

Sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
found VBN O
in IN O
the DT O
vicinity NN O
of IN O
polyadenylation NN O
and CC O
splice NN O
sites NNS O
act VBP O
as IN O
regulators NNS O
by IN O
interacting VBG O
with IN O
hnRNP NNP O
F NNP O
and CC O
H NNP O
proteins NNS O
( , O
25 CD O
- SYM O
27 CD O
, , O
30 CD O
, , O
33 CD O
) -RRB- O
. . O

Whether IN O
quadruplex NN O
structure NN O
directly RB O
plays VBZ O
a DT O
role NN O
in IN O
regulating VBG O
RNA NNP O
processing NN O
events NNS O
requires VBZ O
investigation NN O
. . O

Computational JJ O
approaches NNS O
to IN O
study NN O
G NN O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
mammalian JJ O
genomes NNS O
allow VBP O
large JJ O
- HYPH O
scale NN O
and CC O
detailed JJ O
analysis NN O
of IN O
mammalian JJ O
genes NNS O
. . O

Although IN O
, , O
G NNP O
- HYPH O
quadruplexes NNS O
have VBP O
been VBN O
surveyed VBN O
in IN O
the DT O
human JJ B-Species
genome NN O
with IN O
such JJ O
techniques NNS O
( , O
34 CD O
, , O
35 CD O
) -RRB- O
, , O
there EX O
are VBP O
no DT O
known VBN O
user NN O
- HYPH O
friendly JJ O
computational JJ O
tools NNS O
easily RB O
accessible JJ O
to IN O
the DT O
public NN O
. . O

We PRP O
had VBD O
previously RB O
built VBN O
a DT O
database NN O
of IN O
mapped VBN O
G NNP O
- HYPH O
quadruplex NN O
sequences NNS O
in IN O
selected VBN O
alternatively RB O
processed VBN O
human JJ B-Species
and CC O
mouse NN B-Species
genes NNS O
( SYM O
36 CD O
) -RRB- O
. . O

Our PRP$ O
preliminary JJ O
analysis NN O
of IN O
the DT O
database NN O
suggests VBZ O
prevalence NN O
of IN O
such JJ O
motifs NNS O
near IN O
alternative JJ O
splice NN O
and CC O
poly NN O
( HYPH O
A NN O
) -RRB- O
sites NNS O
. . O

We PRP O
have VBP O
now RB O
developed VBN O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
, , O
QGRS NNP O
Mapper NNP O
, , O
that WDT O
generates VBZ O
detailed JJ O
information NN O
on IN O
composition NN O
and CC O
distribution NN O
of IN O
putative JJ O
quadruplex NN O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
( , O
QGRS NNP O
) -RRB- O
in IN O
any DT O
NCBI NNP O
nucleotide NN O
sequence NN O
identified VBN O
or CC O
provided VBN O
by IN O
the DT O
user NN O
. . O

The DT O
program NN O
is VBZ O
also RB O
designed VBN O
to TO O
handle VB O
the DT O
analysis NN O
of IN O
mammalian JJ O
pre NN O
- HYPH O
mRNA NN O
sequences NNS O
, , O
including VBG O
those DT O
that WDT O
are VBP O
alternatively RB O
processed VBN O
( , O
alternatively RB O
spliced VBN O
or CC O
alternatively RB O
polyadenylated VBN O
) -RRB- O
. . O

Researchers NNS O
interested JJ O
in IN O
predicting VBG O
the DT O
ability NN O
of IN O
a DT O
nucleotide NN O
sequence NN O
to TO O
form VB O
G NN O
- HYPH O
quadruplex NN O
structure NN O
will MD O
find VB O
QGRS NNP O
Mapper NNP O
to TO O
be VB O
a DT O
user NN O
- HYPH O
friendly JJ O
application NN O
that WDT O
provides VBZ O
many JJ O
options NNS O
for IN O
analysis NN O
. . O

The DT O
user NN O
can MD O
define VB O
the DT O
minimum JJ O
number NN O
of IN O
tetrads NNS O
, , O
maximum NN O
length NN O
of IN O
the DT O
G NN O
- HYPH O
quadruplex NN O
motif NN O
, , O
and CC O
size NN O
as RB O
well RB O
as IN O
composition NN O
of IN O
the DT O
loops NNS O
. . O

The DT O
program NN O
can MD O
map VB O
unimolecular JJ O
QGRS NNS O
in IN O
the DT O
entire JJ O
nucleotide NN O
sequence NN O
provided VBN O
in IN O
the DT O
raw JJ O
or CC O
FASTA NNP O
format NN O
by IN O
the DT O
user NN O
. . O

This DT O
method NN O
can MD O
be VB O
used VBN O
for IN O
the DT O
analysis NN O
of IN O
genomic JJ O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
promoter NN O
and CC O
telomeric JJ O
regions NNS O
, , O
as RB O
well RB O
as IN O
RNA NNP O
sequences NNS O
. . O

It PRP O
is VBZ O
also RB O
useful JJ O
for IN O
predicting VBG O
G NNP O
- HYPH O
quadruplex NN O
structures NNS O
in IN O
oligonucleotides NNS O
. . O

Alternatively RB O
, , O
the DT O
program NN O
provides VBZ O
options NNS O
to TO O
search VB O
the DT O
entire JJ O
NCBI NNP O
Gene NNP O
Entrez NNP O
, , O
RefSeq NNP O
and CC O
GenBank NNP O
databases NNS O
in IN O
order NN O
to TO O
retrieve VB O
the DT O
desired VBN O
gene NN O
/ SYM O
nucleotide NN O
sequence NN O
entries NNS O
for IN O
analysis NN O
of IN O
their PRP$ O
transcribed VBN O
regions NNS O
. . O

Furthermore RB O
, , O
QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
unique JJ O
tool NN O
for IN O
mapping VBG O
G NN O
- HYPH O
quadruplex NNP O
forming VBG O
sequences NNS O
in IN O
the DT O
context NN O
of IN O
RNA NNP O
processing NN O
sites NNS O
. . O

This DT O
feature NN O
is VBZ O
very RB O
useful JJ O
for IN O
investigating VBG O
the DT O
functional JJ O
relevance NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
in IN O
particular JJ O
its PRP$ O
role NN O
in IN O
regulating VBG O
the DT O
gene NN O
expression NN O
by IN O
alternative JJ O
processing NN O
. . O

In IN O
addition NN O
to IN O
providing VBG O
data NNS O
on IN O
composition NN O
and CC O
locations NNS O
of IN O
QGRS NNP O
relative JJ O
to IN O
the DT O
processing NN O
sites NNS O
in IN O
the DT O
pre JJ O
- HYPH O
mRNA NN O
sequence NN O
, , O
QGRS NNP O
Mapper NNP O
offers VBZ O
interactive JJ O
graphic JJ O
representation NN O
of IN O
the DT O
data NNS O
. . O

The DT O
user NN O
can MD O
also RB O
use VB O
a DT O
graphics NNS O
module NN O
to TO O
visualize VB O
QGRS NNP O
distribution NN O
patterns NNS O
among IN O
all PDT O
the DT O
alternative JJ O
RNA NNP O
products NNS O
of IN O
a DT O
gene NN O
simultaneously RB O
on IN O
a DT O
single JJ O
screen NN O
. . O

METHODS NNS O

QGRS NNP O
definition NN O

The DT O
main JJ O
goal NN O
of IN O
the DT O
QGRS NNP O
Mapper NNP O
program NN O
is VBZ O
to TO O
predict VB O
the DT O
presence NN O
of IN O
QGRS NNP O
in IN O
nucleotide NN O
entries NNS O
. . O

These DT O
putative JJ O
G NNP O
- HYPH O
quadruplexes NNS O
are VBP O
identified VBN O
using VBG O
the DT O
following VBG O
motif NN O
. . O

GxNy1GxNy2GxNy3Gx NNP O

Here RB O
x NN O
= : O
number NN O
of IN O
guanine NN O
tetrads NNS O
in IN O
the DT O
G NN O
- HYPH O
quadruplex NN O
and CC O
y1 CD O
, , O
y2 CD O
, , O
y3 CD O
= , O
length NN O
of IN O
gaps NNS O
( : O
i LS O
. . O
e LS O
. . O
the DT O
length NN O
of IN O
the DT O
loops NNS O
connecting VBG O
the DT O
guanine NN O
tetrads NNS O
) -RRB- O
. . O

The DT O
motif NN O
consists VBZ O
of IN O
four CD O
equal JJ O
length NN O
sets NNS O
of IN O
guanines NNS O
( : O
which WDT O
we PRP O
call VBP O
G NNP O
- HYPH O
groups NNS O
) -RRB- O
, , O
separated VBN O
by IN O
arbitrary JJ O
nucleotide NN O
sequences NNS O
, , O
with IN O
the DT O
following VBG O
restrictions NNS O
. . O

The DT O
sequence NN O
must MD O
contain VB O
at IN O
least JJS O
two CD O
tetrads NNS O
( : O
i PRP O
. . O
e NN O
. . O
x SYM O
> NFP O
= SYM O
2 CD O
) -RRB- O
. . O

Although IN O
structures NNS O
with IN O
three CD O
or CC O
more JJR O
G NNP O
- HYPH O
tetrads NNS O
are VBP O
considered VBN O
to TO O
be VB O
more RBR O
stable JJ O
, , O
many JJ O
nucleotide NN O
sequences NNS O
are VBP O
known VBN O
to TO O
form VB O
quadruplexes NNS O
with IN O
two CD O
G NNP O
- HYPH O
tetrads NNS O
( SYM O
37 CD O
, , O
38 CD O
) -RRB- O
. . O

QGRS NNP O
Mapper NNP O
is VBZ O
meant VBN O
to TO O
be VB O
a DT O
flexible JJ O
and CC O
comprehensive JJ O
tool NN O
for IN O
investigating VBG O
G NNP O
- HYPH O
quadruplexes NNS O
; : O
hence RB O
it PRP O
considers VBZ O
sequences NNS O
with IN O
two CD O
tetrads NNS O
. , O
By IN O
default NN O
, , O
only RB O
QGRS NNP O
of IN O
maximum JJ O
length NN O
of IN O
30 CD O
bases NNS O
are VBP O
considered VBN O
. . O

However RB O
, , O
the DT O
program NN O
gives VBZ O
the DT O
user NN O
the DT O
option NN O
to TO O
search VB O
for IN O
sequences NNS O
up IN O
to TO O
45 CD O
bases NNS O
. . O

This DT O
restriction NN O
on IN O
the DT O
length NN O
of IN O
the DT O
sequences NNS O
being VBG O
considered VBN O
is VBZ O
in IN O
agreement NN O
with IN O
recent JJ O
literature NN O
( , O
34 CD O
, , O
35 CD O
) -RRB- O
. . O

The DT O
maximum JJ O
length NN O
of IN O
30 CD O
bases NNS O
restricts VBZ O
G NNP O
- HYPH O
groups NNS O
to IN O
a DT O
maximum JJ O
size NN O
of IN O
6 CD O
. , O
The DT O
gaps NNS O
or CC O
loops NNS O
between IN O
the DT O
G NNP O
- HYPH O
groups NNS O
may MD O
be VB O
arbitrary JJ O
in IN O
composition NN O
or CC O
length NN O
( , O
within IN O
the DT O
overall JJ O
restrictions NNS O
on IN O
the DT O
length NN O
of IN O
QGRS NNP O
) -RRB- O
. . O

The DT O
program NN O
gives VBZ O
the DT O
user NN O
the DT O
option NN O
to TO O
search VB O
for IN O
QGRS NNP O
having VBG O
loops NNS O
with IN O
a DT O
specified JJ O
length NN O
range NN O
( : O
e LS O
. . O
g LS O
. . O
the DT O
user NN O
can MD O
search VB O
for IN O
QGRS NNP O
with IN O
loops NNS O
of IN O
lengths NNS O
between IN O
1 CD O
and CC O
4 CD O
) -RRB- O
. . O

The DT O
user NN O
can MD O
also RB O
specify VB O
a DT O
string NN O
that IN O
one CD O
or CC O
more JJR O
loops NNS O
of IN O
each DT O
QGRS NNP O
must MD O
contain VB O
. . O

This DT O
string NN O
can MD O
be VB O
given VBN O
as IN O
a DT O
regular JJ O
expression NN O
. . O

For IN O
example NN O
, , O
entering VBG O
the DT O
regular JJ O
expression NN O
' '' O
T NNP O
{ SYM O
3 CD O
, , O
5 CD O
} , O
' '' O
will MD O
search VB O
for IN O
QGRS NNP O
having VBG O
one CD O
or CC O
more JJR O
loops NNS O
that WDT O
contain VBP O
three CD O
to IN O
five CD O
consecutive JJ O
T NN O
' '' O
s NNS O
. , O
Also RB O
, , O
at IN O
most JJS O
one CD O
of IN O
the DT O
gaps NNS O
is VBZ O
allowed VBN O
to TO O
be VB O
of IN O
zero CD O
length NN O

Table NN O
1 CD O
shows VBZ O
some DT O
examples NNS O
of IN O
valid JJ O
QGRS NNP O
. . O

The DT O
guanine NN O
groups NNS O
which WDT O
form VBP O
the DT O
tetrads NNS O
are VBP O
underlined VBN O
. . O

The DT O
first JJ O
sequence NN O
has VBZ O
four CD O
tetrads NNS O
and CC O
equal JJ O
length NN O
gaps NNS O
. . O

This DT O
would MD O
seem VB O
to TO O
provide VB O
a DT O
G NNP O
- HYPH O
quadruplex NN O
that WDT O
is VBZ O
the DT O
most RBS O
stable JJ O
of IN O
the DT O
three CD O
sequences NNS O
. . O

The DT O
second JJ O
sequence NN O
is VBZ O
notable JJ O
for IN O
the DT O
significant JJ O
differences NNS O
in IN O
the DT O
size NN O
of IN O
its PRP$ O
loops NNS O
. . O

The DT O
third JJ O
sequence NN O
has VBZ O
two CD O
tetrads NNS O
, , O
even RB O
though IN O
three CD O
of IN O
the DT O
G NNP O
- HYPH O
groups NNS O
could MD O
have VB O
included VBN O
another DT O
G NNP O
( , O
since IN O
all DT O
G NNP O
- HYPH O
groups NNS O
must MD O
be VB O
equal JJ O
in IN O
size NN O
) -RRB- O
. . O

G NNP O
- HYPH O
scores NNS O

We PRP O
have VBP O
devised VBN O
a DT O
scoring NN O
system NN O
that WDT O
evaluates VBZ O
a DT O
QGRS NNP O
for IN O
its PRP$ O
likelihood NN O
to TO O
form VB O
a DT O
stable JJ O
G NN O
- HYPH O
quadruplex NN O
. . O

Higher JJR O
scoring NN O
sequences NNS O
will MD O
make VB O
better JJR O
candidates NNS O
for IN O
G NNP O
- HYPH O
quadruplexes NNS O
. . O

The DT O
scoring NN O
method NN O
uses VBZ O
the DT O
following VBG O
principles NNS O
which WDT O
are VBP O
based VBN O
on IN O
previous JJ O
studies NNS O
( , O
34 CD O
, , O
35 CD O
, , O
39 CD O
- HYPH O
42 CD O
) -RRB- O
. . O

Shorter JJR O
loops NNS O
are VBP O
more RBR O
common JJ O
than IN O
longer JJR O
loops NNS O
. . O
G NN O
- HYPH O
quadruplexes NNS O
tend VBP O
to TO O
have VB O
loops NNS O
roughly RB O
equal JJ O
in IN O
size NN O
. , O
The DT O
greater JJR O
the DT O
number NN O
of IN O
guanine NN O
tetrads NNS O
, , O
the DT O
more RBR O
stable JJ O
the DT O
quadruplex NN O
. . O

The DT O
computed VBN O
G NNP O
- HYPH O
scores NNS O
are VBP O
dependent JJ O
on IN O
the DT O
user NN O
selected VBN O
maximum JJ O
QGRS NNP O
length NN O
. . O

The DT O
highest JJS O
possible JJ O
G NNP O
- HYPH O
score NN O
, , O
using VBG O
the DT O
default NN O
maximum JJ O
QGRS NNP O
length NN O
of IN O
30 CD O
, , O
is VBZ O
105 CD O
. . O

Here RB O
is VBZ O
a DT O
sequence NN O
attaining VBG O
that DT O
score NN O
: : O

GGGGGGTGGGGGGTGGGGGG NN O
. . O

Eliminating VBG O
QGRS NNP O
overlaps VBZ O

Two CD O
QGRS NNP O
are VBP O
said VBN O
to TO O
overlap VB O
if IN O
their PRP$ O
positions NNS O
in IN O
the DT O
nucleotide NN O
sequence NN O
overlap VBP O
. . O

QGRS NNP O
Mapper NNP O
will MD O
start VB O
with IN O
a DT O
nucleotide NN O
sequence NN O
, , O
find VB O
all DT O
QGRS NNS O
occurring VBG O
in IN O
the DT O
sequence NN O
and CC O
then RB O
produce VB O
a DT O
non AFX O
- HYPH O
overlapping VBG O
set NN O
of IN O
QGRS NNP O
. . O

Overlaps NNS O
are VBP O
eliminated VBN O
by IN O
selecting VBG O
the DT O
higher JJR O
scoring VBG O
QGRS NNP O
. . O

In IN O
the DT O
non RB O
- HYPH O
overlapping JJ O
view NN O
, , O
only RB O
this DT O
sequence NN O
will MD O
be VB O
displayed VBN O
, , O
although IN O
the DT O
user NN O
can MD O
request VB O
that IN O
all DT O
overlapping JJ O
sequences NNS O
be VB O
displayed VBN O
. . O

Please UH O
see VB O
supplementary JJ O
materials NNS O
at IN O
NAR NNP O
online RB O
for IN O
more JJR O
details NNS O
on IN O
the DT O
elimination NN O
of IN O
overlapping VBG O
QGRS NNP O
. . O

FEATURES NNS O

Design NN O
and CC O
implementation NN O

QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
web NN O
- HYPH O
based VBN O
program NN O
, , O
written VBN O
in IN O
PHP NNP O
, , O
with IN O
Java NNP O
being VBG O
used VBN O
for IN O
some DT O
of IN O
its PRP$ O
graphics NNS O
. . O

The DT O
program NN O
takes VBZ O
a DT O
nucleotide NN O
sequence NN O
from IN O
NCBI NNP O
( : O
or CC O
as IN O
provided VBN O
by IN O
the DT O
user NN O
) -RRB- O
and CC O
analyzes VBZ O
it PRP O
for IN O
the DT O
presence NN O
of IN O
putative JJ O
G NN O
- HYPH O
quadruplexes NNS O
. . O

The DT O
structure NN O
of IN O
QGRS NNP O
Mapper NNP O
is VBZ O
summarized VBN O
in IN O
Table NNP O
2 CD O
. . O

Search NN O
and CC O
analysis NN O

QGRS NNP O
Mapper NNP O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
for IN O
putative JJ O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
a DT O
variety NN O
of IN O
ways NNS O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
enter VB O
a DT O
nucleotide NN O
sequence NN O
in IN O
raw JJ O
or CC O
FASTA NNP O
format NN O
for IN O
analysis NN O
. . O

One PRP O
can MD O
search VB O
and CC O
analyze VB O
gene NN O
sequences NNS O
by IN O
Gene NNP O
ID NNP O
, , O
Gene NNP O
name NN O
or CC O
symbol NN O
, , O
accession NN O
number NN O
or CC O
GI NNP O
number NN O
for IN O
an DT O
NCBI NNP O
nucleotide NN O
sequence NN O
entry NN O
. . O

The DT O
user NN O
can MD O
opt VB O
to TO O
change VB O
the DT O
maximum JJ O
length NN O
of IN O
QGRS NNP O
that WDT O
will MD O
be VB O
searched VBN O
for IN O
( : O
the DT O
default NN O
maximum JJ O
length NN O
being VBG O
30 CD O
) -RRB- O
and CC O
change VB O
the DT O
minimum JJ O
sized JJ O
G NNP O
- HYPH O
group NN O
( : O
which WDT O
is VBZ O
two CD O
by IN O
default NN O
) -RRB- O
. . O

Also RB O
, , O
the DT O
user NN O
can MD O
specify VB O
that IN O
the DT O
loops NNS O
in IN O
the DT O
QGRS NNP O
fall VBP O
within IN O
a DT O
given VBN O
size NN O
range NN O
and CC O
that IN O
one CD O
or CC O
more JJR O
loops NNS O
of IN O
the DT O
QGRS NNP O
contain VBP O
a DT O
given VBN O
string NN O
( : O
for IN O
which WDT O
the DT O
user NN O
may MD O
enter VB O
a DT O
regular JJ O
expression NN O
) -RRB- O
. . O

The DT O
web NN O
page NN O
for IN O
QGRS NNP O
analysis NN O
can MD O
be VB O
seen VBN O
in IN O
Figure NNP O
1 CD O
. . O

After IN O
entering VBG O
a DT O
sequence NN O
in IN O
raw JJ O
or CC O
FASTA NNP O
format NN O
, , O
QGRS NNP O
Mapper NNP O
will MD O
search VB O
the DT O
sequence NN O
for IN O
occurrences NNS O
of IN O
QGRS NNP O
. . O

The DT O
user NN O
may MD O
enter VB O
any DT O
combination NN O
of IN O
the DT O
letters NNS O
A NNP O
, , O
C NNP O
, , O
T NNP O
, , O
G NNP O
, , O
U NNP O
, , O
N NNP O
. . O

The DT O
Gene NNP O
ID NN O
field NN O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
the DT O
NCBI NNP O
Entrez NNP O
Gene NNP O
database NN O
. . O

QGRS NNP O
Mapper NNP O
will MD O
connect VB O
to IN O
NCBI NNP O
, , O
download VB O
and CC O
parse VB O
the DT O
gene NN O
entry NN O
, , O
and CC O
then RB O
analyze VB O
the DT O
transcribed VBN O
region NN O
of IN O
its PRP$ O
nucleotide NN O
sequence NN O
for IN O
the DT O
presence NN O
of IN O
QGRS NNP O
. . O

For IN O
example NN O
, , O
entering VBG O
the DT O
gene NN O
ID NN O
403437 CD O
results NNS O
in IN O
downloading VBG O
the DT O
Brca1 NNP O
gene NN O
sequence NN O
for IN O
Canis NNP B-Species
familiaris NNS I-Species
. . O

Using VBG O
the DT O
default JJ O
QGRS NNP O
search NN O
parameters NNS O
, , O
QGRS NNP O
Mapper NNP O
finds VBZ O
156 CD O
non AFX O
- HYPH O
overlapping VBG O
QGRS NNP O
and CC O
3394 CD O
overlapping VBG O
QGRS NNS O
in IN O
the DT O
transcribed VBN O
region NN O
of IN O
this DT O
gene NN O
. . O

The DT O
Gene NNP O
Name NNP O
or CC O
Gene NNP O
Symbol NNP O
field NN O
also RB O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
the DT O
NCBI NNP O
databases NNS O
for IN O
all DT O
such JJ O
genes NNS O
. . O

Entering VBG O
the DT O
gene NN O
name NN O
Bcl2 NNP O
results VBZ O
in IN O
nine CD O
different JJ O
hits NNS O
which WDT O
are VBP O
displayed VBN O
in IN O
Table NNP O
3 CD O
. . O

All DT O
nine CD O
of IN O
these DT O
entries NNS O
can MD O
be VB O
analyzed VBN O
for IN O
the DT O
occurrence NN O
of IN O
QGRS NNP O
. . O

Clicking VBG O
on IN O
the DT O
Gene NNP O
ID NNP O
takes VBZ O
the DT O
user NN O
to IN O
the DT O
respective JJ O
Entrez NNP O
Gene NNP O
entry NN O
. . O

Clicking VBG O
on IN O
the DT O
last JJ O
column NN O
initiates VBZ O
analysis NN O
of IN O
the DT O
selection NN O
by IN O
QGRS NNP O
Mapper NNP O
. . O

Similarly RB O
, , O
the DT O
user NN O
can MD O
also RB O
enter VB O
an DT O
NCBI NNP O
accession NN O
number NN O
to TO O
search VB O
for IN O
gene NN O
sequences NNS O
. . O

For IN O
example NN O
, , O
searching VBG O
the DT O
accession NN O
number NN O
AF312033 NN O
results VBZ O
in IN O
12 CD O
hits NNS O
being VBG O
displayed VBN O
for IN O
this DT O
GenBank NNP O
nucleotide NN O
sequence NN O
entry NN O
. . O

The DT O
search NN O
phase NN O
of IN O
the DT O
program NN O
is VBZ O
followed VBN O
by IN O
an DT O
analysis NN O
of IN O
the DT O
QGRS NNP O
contained VBN O
in IN O
the DT O
query NN O
sequence NN O
. . O

In IN O
this DT O
phase NN O
of IN O
QGRS NNP O
Mapper NNP O
, , O
the DT O
sequence NN O
data NNS O
downloaded VBN O
previously RB O
is VBZ O
analyzed VBN O
to TO O
identify VB O
and CC O
map VB O
all DT O
QGRS NNP O
relative JJ O
to IN O
locations NNS O
such JJ O
as IN O
splice NN O
sites NNS O
in IN O
exons NNS O
/ SYM O
introns NNS O
, , O
and CC O
poly NN O
( , O
A NN O
) -RRB- O
site NN O
( , O
if IN O
these DT O
locations NNS O
are VBP O
known VBN O
) -RRB- O
. . O

Furthermore RB O
the DT O
QGRS NNP O
are VBP O
scored VBN O
by IN O
the DT O
method NN O
described VBN O
above RB O
. . O

The DT O
computed VBN O
G NNP O
- HYPH O
score NN O
is VBZ O
used VBN O
to TO O
eliminate VB O
overlapping JJ O
QGRS NNS O
. . O

At IN O
times NNS O
, , O
QGRS NNP O
Mapper NNP O
must MD O
analyze VB O
a DT O
considerable JJ O
amount NN O
of IN O
data NNS O
. . O

For IN O
example NN O
, , O
the DT O
mouse NN B-Species
version NN O
of IN O
the DT O
gene NN O
PTPRU NNP O
, , O
which WDT O
is VBZ O
69822 CD O
bases NNS O
long JJ O
, , O
contains VBZ O
94681 CD O
QGRS NNS O
of IN O
length NN O
up IN O
to TO O
45 CD O
bases NNS O
. . O

QGRS NNP O
Mapper NNP O
will MD O
find VB O
, , O
analyze VB O
and CC O
map VB O
all DT O
of IN O
these DT O
sequences NNS O
. . O

During IN O
this DT O
analysis NN O
a DT O
message NN O
is VBZ O
displayed VBN O
indicating VBG O
the DT O
estimated VBN O
time NN O
left VBN O
to IN O
completion NN O
. . O

QGRS NNP O
Mapper NNP O
output NN O

After IN O
the DT O
analysis NN O
of IN O
overlaps NNS O
is VBZ O
completed VBN O
, , O
QGRS NNP O
Mapper NNP O
displays VBZ O
a DT O
summary NN O
of IN O
its PRP$ O
findings NNS O
, , O
in IN O
the DT O
Gene NNP O
View NNP O
. . O

This DT O
summary NN O
includes VBZ O
basic JJ O
gene NN O
information NN O
such JJ O
as IN O
the DT O
gene NN O
ID NN O
, , O
gene NN O
symbol NN O
, , O
gene NN O
name NN O
, , O
a DT O
link NN O
to IN O
the DT O
NCBI NNP O
entry NN O
, , O
organism NN O
name NN O
, , O
chromosome NN O
number NN O
and CC O
number NN O
of IN O
products NNS O
and CC O
poly NN O
( , O
A NN O
) -RRB- O
signals NNS O
. . O

Information NN O
is VBZ O
also RB O
given VBN O
for IN O
each DT O
product NN O
, , O
such JJ O
as IN O
the DT O
number NN O
of IN O
exons NNS O
and CC O
introns NNS O
, , O
number NN O
of IN O
QGRS NNP O
( , O
non NN O
- HYPH O
overlapping JJ O
and CC O
overlapping JJ O
) -RRB- O
, , O
number NN O
of IN O
QGRS NNP O
found VBN O
near IN O
RNA NNP O
processing NN O
sites NNS O
, , O
and CC O
a DT O
visual JJ O
map NN O
of IN O
the DT O
product NN O
. . O

As IN O
an DT O
example NN O
, , O
the DT O
Gene NNP O
View NNP O
for IN O
the DT O
human JJ B-Species
GREB1 NN O
is VBZ O
displayed VBN O
in IN O
Figure NNP O
2 CD O
, , O
showing VBG O
the DT O
table NN O
of IN O
gene NN O
information NN O
and CC O
product NN O
information NN O
for IN O
the DT O
first JJ O
product NN O
( , O
the DT O
output NN O
for IN O
all DT O
products NNS O
may MD O
be VB O
seen VBN O
in IN O
the DT O
supplementary JJ O
material NN O
) -RRB- O
. . O

At IN O
this DT O
stage NN O
in IN O
the DT O
analysis NN O
the DT O
user NN O
can MD O
choose VB O
among IN O
three CD O
further JJ O
displays NNS O
: : O
' '' O
Data NNP O
View NNP O
' '' O
, , O
' '' O
Data NNP O
View NNP O
( , O
with IN O
overlaps NNS O
) , O
' '' O
and CC O
' `` O
Graphics NNS O
View NNP O
' '' O
. . O

This DT O
can MD O
be VB O
done VBN O
for IN O
the DT O
entire JJ O
gene NN O
or CC O
for IN O
any DT O
particular JJ O
product NN O
. . O

In IN O
the DT O
Data NNP O
View NNP O
, , O
a DT O
table NN O
is VBZ O
displayed VBN O
showing VBG O
information NN O
for IN O
each DT O
of IN O
the DT O
set NN O
of IN O
non AFX O
- HYPH O
overlapping VBG O
QGRS NNP O
. . O

This DT O
table NN O
displays VBZ O
the DT O
position NN O
of IN O
the DT O
QGRS NNP O
, , O
which WDT O
exon NN O
/ SYM O
intron NN O
it PRP O
appears VBZ O
in IN O
, , O
its PRP$ O
distance NN O
from IN O
3 CD O
' '' O
and CC O
5 CD O
' '' O
splice NN O
sites NNS O
, , O
the DT O
QGRS NNP O
sequence NN O
( , O
with IN O
each DT O
G NNP O
- HYPH O
group NN O
underlined VBN O
) -RRB- O
and CC O
the DT O
corresponding VBG O
G NNP O
- HYPH O
score NN O
. . O

Similar JJ O
display NN O
is VBZ O
also RB O
shown VBN O
for IN O
each DT O
QGRS NNP O
mapped VBN O
to IN O
poly JJ O
( , O
A NNP O
) -RRB- O
region NN O
in IN O
the DT O
product NN O
. . O

If IN O
the DT O
user NN O
requests VBZ O
the DT O
Data NNP O
View NNP O
for IN O
the DT O
entire JJ O
gene NN O
, , O
then RB O
the DT O
QGRS NNP O
information NN O
is VBZ O
shown VBN O
for IN O
each DT O
product NN O
. . O

The DT O
' '' O
Data NNP O
View NNP O
( , O
with IN O
overlaps NNS O
) -RRB- O
' '' O
gives VBZ O
the DT O
same JJ O
information NN O
but CC O
shows VBZ O
the DT O
locations NNS O
of IN O
all DT O
QGRS NNP O
. . O

Figure NN O
3 CD O
shows VBZ O
the DT O
Data NNP O
View NNP O
for IN O
product NN O
1 CD O
of IN O
the DT O
GREB1 NNP O
gene NN O
. . O

The DT O
user NN O
can MD O
also RB O
choose VB O
the DT O
Graphics NNP O
View NNP O
to TO O
give VB O
a DT O
visual JJ O
display NN O
of IN O
the DT O
location NN O
of IN O
QGRS NNP O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
see VB O
the DT O
location NN O
of IN O
QGRS NNP O
relative JJ O
to IN O
exons NNS O
and CC O
introns NNS O
( , O
if IN O
that DT O
information NN O
is VBZ O
available JJ O
) -RRB- O
. . O

The DT O
Graphics NNP O
View NNP O
has VBZ O
the DT O
following VBG O
components NNS O
. . O

A DT O
graphic JJ O
display NN O
of IN O
the DT O
entire JJ O
gene NN O
( , O
showing VBG O
the DT O
location NN O
of IN O
the DT O
exons NNS O
) -RRB- O
. . O

This DT O
display NN O
includes VBZ O
a DT O
sliding VBG O
window NN O
that WDT O
can MD O
be VB O
used VBN O
to TO O
focus VB O
on IN O
any DT O
particular JJ O
segment NN O
of IN O
the DT O
gene NN O
. . O

This DT O
window NN O
may MD O
be VB O
dragged VBN O
to IN O
the DT O
left NN O
or CC O
right JJ O
to TO O
change VB O
position NN O
within IN O
the DT O
gene NN O
. , O
A DT O
magnified JJ O
view NN O
of IN O
the DT O
fragment NN O
of IN O
the DT O
gene NN O
within IN O
the DT O
sliding VBG O
window NN O
. , O
A DT O
graph NN O
showing VBG O
the DT O
location NN O
of IN O
QGRS NNP O
within IN O
the DT O
fragment NN O
, , O
with IN O
each DT O
QGRS NNP O
being VBG O
displayed VBN O
by IN O
a DT O
bar NN O
whose WP$ O
height NN O
represents VBZ O
its PRP$ O
G NN O
- HYPH O
score NN O
. . O
A DT O
vertical JJ O
slider NN O
that WDT O
allows VBZ O
the DT O
user NN O
to TO O
change VB O
the DT O
size NN O
of IN O
the DT O
window NN O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
zoom VB O
in RP O
or CC O
out RB O
on IN O
any DT O
part NN O
of IN O
the DT O
gene NN O
. . O

The DT O
sliding VBG O
window NN O
on IN O
the DT O
gene NN O
expands VBZ O
or CC O
contracts VBZ O
as IN O
one CD O
zooms VBZ O
in IN O
or CC O
out RB O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
see VB O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
product NN O
at IN O
maximum JJ O
zoom NN O
levels NNS O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
entire JJ O
gene NN O
shows VBZ O
the DT O
G NN O
- HYPH O
score NN O
graph NN O
together RB O
with IN O
an DT O
exon NN O
/ SYM O
intron NN O
map NN O
for IN O
each DT O
product NN O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
visually RB O
compare VB O
the DT O
location NN O
of IN O
QGRS NNP O
for IN O
each DT O
product NN O
relative JJ O
to IN O
that DT O
of IN O
splice NN O
sites NNS O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
first JJ O
product NN O
of IN O
the DT O
GREB1 NNP O
gene NN O
is VBZ O
represented VBN O
in IN O
Figure NN O
4 CD O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
entire JJ O
GREB1 NN O
gene NN O
may MD O
be VB O
seen VBN O
in IN O
the DT O
Supplementary NNP O
Data NNP O
. . O

CONCLUSIONS NNS O

QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
user NN O
- HYPH O
friendly JJ O
web NN O
- HYPH O
based VBN O
server NN O
that WDT O
provides VBZ O
computational JJ O
tools NNS O
for IN O
prediction NN O
of IN O
Quadruplex NNP O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
in IN O
the DT O
nucleotide NN O
sequences NNS O
identified VBN O
or CC O
provided VBN O
by IN O
the DT O
user NN O
. . O

The DT O
program NN O
offers VBZ O
many JJ O
options NNS O
, , O
including VBG O
user NN O
- HYPH O
defined VBN O
composition NN O
of IN O
the DT O
quadruplex NN O
. . O

It PRP O
can MD O
analyze VB O
DNA NN O
or CC O
RNA NN O
sequence NN O
provided VBN O
by IN O
the DT O
user NN O
in IN O
the DT O
raw JJ O
or CC O
FASTA NNP O
format NN O
. . O

The DT O
application NN O
also RB O
provides VBZ O
tools NNS O
for IN O
searching VBG O
and CC O
retrieving VBG O
gene NN O
/ SYM O
nucleotide NN O
entries NNS O
from IN O
a DT O
variety NN O
of IN O
NCBI NNP O
databases NNS O
. . O

There EX O
are VBP O
several JJ O
options NNS O
for IN O
data NN O
output NN O
format NN O
, , O
including VBG O
an DT O
interactive JJ O
graphic JJ O
module NN O
. . O

Researchers NNS O
interested JJ O
in IN O
evaluating VBG O
the DT O
ability NN O
of IN O
nucleotide JJ O
sequences NNS O
to TO O
form VB O
unimolecular JJ O
G NNP O
- HYPH O
quadruplexes NNS O
will MD O
find VB O
QGRS NNP O
Mapper NNP O
to TO O
be VB O
very RB O
useful JJ O
. . O

Owing VBG O
to IN O
the DT O
flexible JJ O
and CC O
comprehensive JJ O
nature NN O
of IN O
the DT O
design NN O
, , O
it PRP O
is VBZ O
expected VBN O
to TO O
serve VB O
a DT O
variety NN O
of IN O
scientists NNS O
. . O

The DT O
application NN O
will MD O
be VB O
especially RB O
attractive JJ O
to IN O
individuals NNS O
interested JJ O
in IN O
exploring VBG O
the DT O
role NN O
of IN O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
regulated VBN O
RNA NNP O
processing NN O
. . O

We PRP O
are VBP O
using VBG O
the DT O
server NN O
to TO O
perform VB O
a DT O
large JJ O
- HYPH O
scale NN O
analysis NN O
of IN O
alternatively RB O
processed VBN O
mammalian JJ O
transcripts NNS O
. . O

We PRP O
are VBP O
particularly RB O
interested JJ O
in IN O
studying VBG O
the DT O
composition NN O
and CC O
distribution NN O
patterns NNS O
of IN O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
transcribed VBN O
regions NNS O
of IN O
mammalian JJ O
genes NNS O
. . O

SUPPLEMENTARY NNP O
DATA NNP O

Supplementary JJ O
Data NNS O
are VBP O
available JJ O
at IN O
NAR NNP O
online RB O
. . O

Drug NN O
information NN O
resources NNS O
used VBN O
by IN O
nurse NN O
practitioners NNS O
and CC O
collaborating VBG O
physicians NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
in IN O
Nova NNP O
Scotia NNP O
, , O
Canada NNP O
: : O
a DT O
survey NN O
and CC O
review NN O
of IN O
the DT O
literature NN O

Abstract JJ O

Background NN O

Keeping VBG O
current JJ O
with IN O
drug NN O
therapy NN O
information NN O
is VBZ O
challenging JJ O
for IN O
health NN O
care NN O
practitioners NNS O
. . O

Technologies NNS O
are VBP O
often RB O
implemented VBN O
to TO O
facilitate VB O
access NN O
to IN O
current JJ O
and CC O
credible JJ O
drug NN O
information NN O
sources NNS O
. . O

In IN O
the DT O
Canadian JJ O
province NN O
of IN O
Nova NNP O
Scotia NNP O
, , O
legislation NN O
was VBD O
passed VBN O
in IN O
2002 CD O
to TO O
allow VB O
nurse NN O
practitioners NNS O
( , O
NPs NNPS O
) -RRB- O
to TO O
practice VB O
collaboratively RB O
with IN O
physician JJ O
partners NNS O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
current JJ O
utilization NN O
patterns NNS O
of IN O
information NN O
technologies NNS O
by IN O
these DT O
groups NNS O
of IN O
practitioners NNS O
. . O

Methods NNS O

Nurse NN O
practitioners NNS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
in IN O
Nova NNP O
Scotia NNP O
were VBD O
sent VBN O
a DT O
survey NN O
in IN O
February NNP O
2005 CD O
to TO O
determine VB O
the DT O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
of IN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NNP O
) -RRB- O
, , O
computer NN O
, , O
and CC O
print NN O
drug NN O
information NN O
resources NNS O
. . O

Two CD O
surveys NNS O
were VBD O
developed VBN O
( , O
one CD O
for IN O
PDA NNP O
users NNS O
and CC O
one CD O
for IN O
computer NN O
users NNS O
) -RRB- O
and CC O
revised VBN O
based VBN O
on IN O
a DT O
literature NN O
search NN O
, , O
stakeholder NN O
consultation NN O
, , O
and CC O
pilot NN O
- HYPH O
testing VBG O
results NNS O
. . O

A DT O
second JJ O
distribution NN O
to IN O
nonresponders NNS O
occurred VBD O
two CD O
weeks NNS O
following VBG O
the DT O
first JJ O
. . O

Data NNS O
were VBD O
entered VBN O
and CC O
analysed VBN O
with IN O
SPSS NNP O
. . O

Results NNS O

Twenty CD O
- HYPH O
seven CD O
( , O
14 CD O
NPs NNS O
and CC O
13 CD O
physicians NNS O
) -RRB- O
of IN O
36 CD O
( SYM O
75 CD O
% NN O
) -RRB- O
recipients NNS O
responded VBD O
. . O

22 CD O
% NN O
( SYM O
6 CD O
) SYM O
returned VBN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NNP O
) -RRB- O
surveys NNS O
. . O

Respondents NNS O
reported VBD O
print NN O
, , O
health NN O
professionals NNS O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
as IN O
the DT O
most RBS O
to IN O
least JJS O
preferred VBN O
means NNS O
to TO O
access VB O
drug NN O
information NN O
, , O
respectively RB O
. . O

37 CD O
% NN O
and CC O
35 CD O
% NN O
of IN O
respondents NNS O
reported VBN O
using VBG O
"""" `` O
both CC O
print NN O
and CC O
electronic JJ O
but CC O
print NN O
more JJR O
than IN O
electronic JJ O
"""" '' O
and CC O
"""" `` O
print NN O
only RB O
"""" '' O
, , O
respectively RB O
, , O
to TO O
search VB O
monograph NN O
- HYPH O
related VBN O
drug NN O
information NN O
queries NNS O
whereas IN O
4 CD O
% NN O
reported VBD O
using VBG O
"""" `` O
PDA NNP O
only RB O
"""" '' O
. . O

Analysis NN O
of IN O
respondent NN O
ratings NNS O
for IN O
all DT O
resources NNS O
in IN O
the DT O
categories NNS O
print NN O
, , O
health NN O
professionals NNS O
and CC O
other JJ O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
, , O
indicated VBD O
that IN O
the DT O
Compendium NNP O
of IN O
Pharmaceuticals NNPS O
and CC O
Specialties NNPS O
and CC O
pharmacists NNS O
ranked VBD O
highly RB O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
by IN O
both DT O
groups NNS O
of IN O
practitioners NNS O
. . O

Respondents NNS O
' POS O
preferences NNS O
and CC O
resource NN O
ratings NNS O
were VBD O
consistent JJ O
with IN O
self NN O
- HYPH O
reported VBN O
methods NNS O
for IN O
conducting VBG O
drug NN O
information NN O
queries NNS O
. . O

Few JJ O
differences NNS O
existed VBD O
between IN O
NP NNP O
and CC O
physician NN O
rankings NNS O
of IN O
resources NNS O
. . O

Conclusion NN O

The DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
remains VBZ O
limited JJ O
, , O
which WDT O
is VBZ O
also RB O
consistent JJ O
with IN O
preferred JJ O
and CC O
frequent JJ O
use NN O
of IN O
print NN O
resources NNS O
. . O

Education NN O
for IN O
these DT O
practitioners NNS O
regarding VBG O
available JJ O
electronic JJ O
drug NN O
information NN O
resources NNS O
may MD O
facilitate VB O
future JJ O
computer NN O
and CC O
PDA NN O
use NN O
. . O

Further JJ O
research NN O
is VBZ O
needed VBN O
to TO O
determine VB O
methods NNS O
to TO O
increase VB O
computer NN O
and CC O
PDA NN O
use NN O
and CC O
whether IN O
these DT O
technologies NNS O
affect VBP O
prescribing NN O
and CC O
patient NN B-Species
outcomes NNS O
. . O

Background NN O

Challenges NNS O
with IN O
knowledge NN O
management NN O
for IN O
health NN O
care NN O
professionals NNS O

In IN O
1986 CD O
, , O
Haynes NNP O
et FW O
al NNP O
. , O
published VBD O
a DT O
series NN O
of IN O
6 CD O
articles NNS O
entitled VBN O
"""" `` O
how WRB O
to TO O
keep VB O
up RP O
with IN O
the DT O
medical JJ O
literature NN O
"""" '' O
in IN O
an DT O
effort NN O
to TO O
help VB O
clinicians NNS O
with IN O
information NN O
management NN O
, , O
but CC O
this DT O
challenge NN O
has VBZ O
not RB O
decreased VBN O
in IN O
last JJ O
two CD O
decades NNS O
[ -LRB- O
1 CD O
- SYM O
6 CD O
] -RRB- O
. . O

Alper NNP O
et FW O
al JJ O
. . O
suggest VBP O
that IN O
maintaining VBG O
currency NN O
with IN O
relevant JJ O
literature NN O
in IN O
primary JJ O
care NN O
would MD O
"""" `` O
require VB O
627 CD O
. . O
5 CD O
hours NNS O
per IN O
month NN O
, , O
or CC O
about RB O
29 CD O
hours NNS O
per IN O
weekday NN O
, , O
or CC O
3 CD O
. . O
6 CD O
full JJ O
- HYPH O
time NN O
equivalents NNS O
of IN O
physician NN O
effort NN O
"""" '' O
[ -LRB- O
7 CD O
] -RRB- O
. . O

The DT O
volume NN O
of IN O
information NN O
associated VBN O
with IN O
keeping VBG O
up RP O
to IN O
date NN O
is VBZ O
frequently RB O
cited VBN O
as IN O
a DT O
barrier NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
estimated VBN O
that IN O
annually RB O
there EX O
are VBP O
approximately RB O
10 CD O
, , O
0 CD O
new JJ O
randomized JJ O
trials NNS O
in IN O
MEDLINE NNP O
and CC O
over IN O
450 CD O
, , O
0 CD O
clinical JJ O
trials NNS O
identified VBN O
by IN O
the DT O
Cochrane NNP O
Collaboration NNP O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

Keeping VBG O
up RP O
to IN O
date NN O
has VBZ O
been VBN O
described VBN O
with IN O
several JJ O
analogies NNS O
including VBG O
clinicians NNS O
attempting VBG O
to TO O
drink VB O
water NN O
from IN O
a DT O
fire NN O
hose NN O
and CC O
swimming VBG O
in IN O
rivers NNS O
of IN O
clinical JJ O
research NN O
with IN O
unprecedented JJ O
depth NN O
, , O
velocity NN O
, , O
and CC O
turbulence NN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

Difficulties NNS O
with IN O
dissemination NN O
of IN O
research NN O
evidence NN O
and CC O
keeping VBG O
up RP O
to IN O
date NN O
on IN O
pharmacotherapeutic JJ O
interventions NNS O
are VBP O
reported VBN O
despite IN O
the DT O
development NN O
of IN O
tools NNS O
such JJ O
as IN O
clinical JJ O
practice NN O
guidelines NNS O
and CC O
systematic JJ O
reviews NNS O
that WDT O
are VBP O
intended VBN O
to TO O
reduce VB O
the DT O
need NN O
for IN O
practitioners NNS O
to TO O
evaluate VB O
original JJ O
research NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

To TO O
complicate VB O
matters NNS O
further RB O
, , O
there EX O
are VBP O
often RB O
issues NNS O
of IN O
credibility NN O
, , O
timeliness NN O
, , O
and CC O
volume NN O
of IN O
clinical JJ O
practice NN O
guidelines NNS O
and CC O
reviews NNS O
. . O

Many JJ O
guidelines NNS O
are VBP O
criticized VBN O
for IN O
their PRP$ O
methodological JJ O
development NN O
. . O

Shaneyfelt NNP O
et FW O
al NNP O
. . O
reviewed VBD O
279 CD O
guidelines NNS O
for IN O
methodological JJ O
standards NNS O
from IN O
peer NN O
reviewed VBN O
medical JJ O
literature NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

These DT O
authors NNS O
found VBD O
that IN O
only RB O
51 CD O
% NN O
, , O
33 CD O
. . O
6 CD O
% NN O
, , O
and CC O
46 CD O
% NN O
adhered VBN O
to IN O
standards NNS O
on IN O
guideline NN O
development NN O
and CC O
format NN O
, , O
evidence NN O
identification NN O
and CC O
summary NN O
, , O
and CC O
formulation NN O
of IN O
recommendations NNS O
, , O
respectively RB O
[ -LRB- O
14 CD O
] -RRB- O
. . O

A DT O
Canadian JJ O
review NN O
on IN O
drug NN O
therapy NN O
guidelines NNS O
found VBD O
significant JJ O
variation NN O
in IN O
quality NN O
depending VBG O
on IN O
the DT O
developer NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Approximately RB O
25 CD O
% NN O
of IN O
guidelines NNS O
were VBD O
not RB O
recommended VBN O
for IN O
use NN O
in IN O
practice NN O
by IN O
the DT O
appraisers NNS O
' POS O
criteria NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

As IN O
an DT O
example NN O
of IN O
the DT O
volume NN O
of IN O
clinical JJ O
practice NN O
guidelines NNS O
available JJ O
, , O
eleven CD O
recent JJ O
guidelines NNS O
on IN O
community NN O
acquired VBN O
pneumonia NN O
exist VBP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

To TO O
add VB O
to IN O
the DT O
complexities NNS O
involved VBN O
with IN O
keeping VBG O
current JJ O
with IN O
pharmacotherapeutic JJ O
management NN O
strategies NNS O
, , O
as IN O
of IN O
2000 CD O
, , O
there EX O
were VBD O
over IN O
22 CD O
, , O
0 CD O
drug NN O
products NNS O
approved VBN O
for IN O
sale NN O
in IN O
Canada NNP O
for IN O
human JJ B-Species
use NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

There EX O
is VBZ O
also RB O
considerable JJ O
debate NN O
regarding VBG O
what WP O
constitutes VBZ O
"""" `` O
evidence NN O
"""" '' O
in IN O
practice NN O
, , O
which WDT O
contributes VBZ O
to IN O
confusion NN O
for IN O
clinicians NNS O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

Sim NNP O
et FW O
al NNP O
. . O
succinctly RB O
describe VBP O
the DT O
gap NN O
between IN O
evidence NN O
and CC O
action NN O
as IN O
difficulties NNS O
with IN O
obtaining VBG O
, , O
systematically RB O
reviewing VBG O
, , O
applying VBG O
in IN O
context NN O
, , O
and CC O
measuring VBG O
the DT O
outcome NN O
following VBG O
application NN O
of IN O
evidence NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Maintaining VBG O
competence NN O
- HYPH O
nurse NN O
practitioners NNS O
as IN O
a DT O
new JJ O
group NN O
of IN O
prescribers NNS O

Competencies NNS O
for IN O
nurse NN O
practitioners NNS O
( -LRB- O
NPs NNS O
) -RRB- O
on IN O
a DT O
local JJ O
and CC O
international JJ O
level NN O
include VBP O
critically RB O
appraising VBG O
and CC O
applying VBG O
literature NN O
and CC O
research NN O
findings NNS O
in IN O
practice NN O
[ -LRB- O
20 CD O
- SYM O
23 CD O
] -RRB- O
. . O

The DT O
Canadian NNP O
Nurses NNPS O
Association NNP O
( : O
CNA NNP O
) -RRB- O
has VBZ O
developed VBN O
the DT O
Canadian NNP O
Nurse NNP O
Practitioner NNP O
Core NNP O
Competency NNP O
Framework NNP O
that WDT O
describes VBZ O
the DT O
knowledge NN O
, , O
skills NNS O
, , O
judgment NN O
, , O
and CC O
attributes NNS O
required VBN O
for IN O
practice NN O
. . O

Evidence NN O
based VBN O
practice NN O
is VBZ O
integral JJ O
to IN O
pharmacotherapeutic JJ O
interventions NNS O
and CC O
prescribing NN O
competencies NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

The DT O
National NNP O
Prescribing NNP O
Centre NNP O
, , O
an DT O
organization NN O
of IN O
the DT O
National NNP O
Health NNP O
Service NNP O
in IN O
the DT O
UK NNP O
, , O
describes VBZ O
several JJ O
competencies NNS O
around IN O
information NN O
needs NNS O
relevant JJ O
to IN O
prescribing NN O
and CC O
emphasis NN O
is VBZ O
placed VBN O
on IN O
using VBG O
relevant JJ O
and CC O
up IN O
to IN O
date NN O
information NN O
in IN O
various JJ O
formats NNS O
( , O
e LS O
. . O
g LS O
. . O
print NN O
, , O
electronic JJ O
, , O
verbal JJ O
) -RRB- O
. . O

Several JJ O
related JJ O
competencies NNS O
include VBP O
understanding VBG O
advantages NNS O
and CC O
disadvantages NNS O
of IN O
information NN O
sources NNS O
and CC O
the DT O
currency NN O
of IN O
resources NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Researchers NNS O
in IN O
the DT O
US NNP O
developed VBD O
NP NNP O
informatics NNS O
competencies NNS O
for IN O
integration NN O
into IN O
advanced JJ O
nursing NN O
practice NN O
curricula NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Competencies NNS O
related VBN O
to IN O
informatics NNS O
knowledge NN O
include VBP O
critical JJ O
analysis NN O
of IN O
data NNS O
and CC O
information NN O
for IN O
use NN O
in IN O
evidence NN O
based VBN O
practice NN O
, , O
evaluating VBG O
and CC O
applying VBG O
relevant JJ O
information NN O
, , O
synthesizing VBG O
best JJS O
evidence NN O
, , O
and CC O
using VBG O
optimal JJ O
search NN O
strategies NNS O
to TO O
locate VB O
clinically RB O
sound JJ O
and CC O
useful JJ O
studies NNS O
from IN O
information NN O
resources NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Achieving VBG O
and CC O
maintaining VBG O
competence NN O
in IN O
these DT O
domains NNS O
as RB O
well RB O
as IN O
a DT O
solid JJ O
foundation NN O
in IN O
pharmacology NN O
is VBZ O
necessary JJ O
to TO O
support VB O
NPs NNPS O
in IN O
their PRP$ O
relatively RB O
new JJ O
role NN O
as IN O
a DT O
prescriber NN O
[ -LRB- O
25 CD O
- SYM O
27 CD O
] -RRB- O
. . O

Knowledge NN O
management NN O
and CC O
information NN O
seeking VBG O
behaviours NNS O
among IN O
nurse NN O
practitioners NNS O
and CC O
physicians NNS O

Information NN O
seeking VBG O
behaviours NNS O
of IN O
physicians NNS O
are VBP O
better RBR O
documented VBN O
than IN O
NPs NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Information NN O
related VBN O
to IN O
diagnosis NN O
is VBZ O
important JJ O
to IN O
both DT O
groups NNS O
but CC O
drug NN O
therapy NN O
queries NNS O
may MD O
occur VB O
more RBR O
frequently RB O
with IN O
NPs NNS O
[ -LRB- O
28 CD O
- SYM O
33 CD O
] -RRB- O
. . O

Research NN O
on IN O
nurses NNS O
' POS O
behaviours NNS O
related VBN O
to IN O
information NN O
seeking VBG O
is VBZ O
available JJ O
from IN O
the DT O
hospital NN O
setting NN O
[ -LRB- O
33 CD O
- HYPH O
35 CD O
] -RRB- O
but CC O
the DT O
generalizability NN O
of IN O
these DT O
behaviours NNS O
to IN O
NPs NNPS O
with IN O
a DT O
prescribing VBG O
role NN O
is VBZ O
unclear JJ O
. . O

Differences NNS O
in IN O
nursing NN O
roles NNS O
, , O
responsibilities NNS O
, , O
and CC O
legislation NN O
, , O
including VBG O
prescriptive JJ O
authority NN O
, , O
exist VBP O
depending VBG O
on IN O
the DT O
country NN O
of IN O
practice NN O
. . O

Nurse NN O
practitioners NNS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
in IN O
Nova NNP O
Scotia NNP O

Nova NNP O
Scotia NNP O
is VBZ O
a DT O
Canadian JJ O
province NN O
with IN O
a DT O
population NN O
of IN O
approximately RB O
942 CD O
, , O
0 CD O
[ SYM O
36 CD O
] -RRB- O
. . O

The DT O
province NN O
is VBZ O
divided VBN O
into IN O
six CD O
health NN O
zones NNS O
that WDT O
include VBP O
nine CD O
district NN O
health NN O
authorities NNS O
, , O
one CD O
of IN O
which WDT O
includes VBZ O
the DT O
provincial JJ O
capital NN O
and CC O
is VBZ O
considered VBN O
to TO O
be VB O
urban JJ O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
. . O

Health NN O
care NN O
service NN O
delivery NN O
is VBZ O
challenging JJ O
due IN O
to IN O
many JJ O
factors NNS O
including VBG O
the DT O
rural JJ O
nature NN O
of IN O
the DT O
province NN O
, , O
which WDT O
is VBZ O
estimated VBN O
to TO O
be VB O
60 CD O
% NN O
of IN O
population NN O
[ -LRB- O
37 CD O
, , O
39 CD O
] -RRB- O
. . O

Starting VBG O
in IN O
1998 CD O
, , O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
led VBD O
an DT O
initiative NN O
to TO O
explore VB O
different JJ O
methods NNS O
of IN O
delivering VBG O
, , O
managing VBG O
, , O
and CC O
funding VBG O
primary JJ O
care NN O
services NNS O
. . O

The DT O
Strengthening NNP O
Primary NNP O
Care NNP O
in IN O
Nova NNP O
Scotia NNP O
Communities NNPS O
Initiative NNP O
( -LRB- O
SPCI NNP O
) -RRB- O
was VBD O
established VBN O
with IN O
the DT O
selection NN O
of IN O
four CD O
primary JJ O
care NN O
demonstration NN O
sites NNS O
where WRB O
a DT O
primary JJ O
health NN O
care NN O
NP NNP O
was VBD O
hired VBN O
to TO O
practice VB O
collaboratively RB O
with IN O
one CD O
or CC O
more JJR O
family NN O
/ SYM O
general JJ O
physicians NNS O
and CC O
other JJ O
members NNS O
of IN O
an DT O
interdisciplinary JJ O
team NN O
. . O

Each DT O
demonstration NN O
site NN O
adopted VBD O
alternative JJ O
( , O
non JJ O
fee NN O
- HYPH O
for IN O
- HYPH O
service NN O
) -RRB- O
physician NN O
payment NN O
mechanisms NNS O
and CC O
used VBD O
electronic JJ O
patient NN B-Species
records NNS O
( -LRB- O
EPRs NNS O
) -RRB- O
to TO O
support VB O
service NN O
delivery NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Demonstration NN O
sites NNS O
participated VBD O
in IN O
project NN O
evaluation NN O
components NNS O
that WDT O
included VBD O
, , O
but CC O
were VBD O
not RB O
limited VBN O
to IN O
, , O
NP NNP O
roles NNS O
, , O
alternative JJ O
fee NN O
structures NNS O
, , O
consumer NN O
satisfaction NN O
, , O
and CC O
implementation NN O
and CC O
integration NN O
of IN O
EPRs NNS O
[ -LRB- O
41 CD O
, , O
42 CD O
] -RRB- O
. . O

Legislation NN O
to TO O
allow VB O
NPs NNPS O
to TO O
practice VB O
collaboratively RB O
with IN O
physicians NNS O
in IN O
Nova NNP O
Scotia NNP O
was VBD O
passed VBN O
in IN O
2002 CD O
, , O
part NN O
way NN O
through IN O
the DT O
SPCI NNP O
project NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

Prescriptive JJ O
authority NN O
granted VBN O
through IN O
legislation NN O
authorizes VBZ O
NPs NNPS O
to TO O
prescribe VB O
from IN O
a DT O
schedule NN O
of IN O
drugs NNS O
[ -LRB- O
43 CD O
, , O
44 CD O
] -RRB- O
. . O

At IN O
the DT O
time NN O
of IN O
conducting VBG O
this DT O
research NN O
project NN O
, , O
16 CD O
primary JJ O
health NN O
care NN O
NPs NNS O
were VBD O
in IN O
active JJ O
practice NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

The DT O
EPR NNP O
component NN O
of IN O
the DT O
SPCI NNP O
project NN O
evaluation NN O
provided VBD O
information NN O
on IN O
the DT O
use NN O
of IN O
technologies NNS O
in IN O
the DT O
community NN O
context NN O
. . O

Results NNS O
from IN O
the DT O
implementation NN O
process NN O
indicated VBD O
that IN O
considerable JJ O
attention NN O
is VBZ O
required VBN O
for IN O
technology NN O
literacy NN O
, , O
time NN O
for IN O
training NN O
, , O
and CC O
selection NN O
of IN O
software NN O
for IN O
EPRs NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Although IN O
the DT O
majority NN O
of IN O
community NN O
- HYPH O
based VBN O
, , O
non JJ O
- HYPH O
institutional JJ O
clinical JJ O
practice NN O
settings NNS O
in IN O
Nova NNP O
Scotia NNP O
primarily RB O
operate VBP O
with IN O
paper NN O
- HYPH O
based VBN O
charting NN O
systems NNS O
, , O
there EX O
is VBZ O
a DT O
movement NN O
toward IN O
integrating VBG O
electronic JJ O
technologies NNS O
, , O
including VBG O
the DT O
EPR NNP O
, , O
in IN O
practice NN O
among IN O
health NN O
care NN O
providers NNS O
, , O
administrators NNS O
, , O
and CC O
the DT O
provincial JJ O
government NN O
. . O

In IN O
addition NN O
to IN O
recording VBG O
patient JJ B-Species
visit NN O
information NN O
, , O
a DT O
component NN O
of IN O
the DT O
EPR NNP O
package NN O
serves VBZ O
to TO O
provide VB O
drug NN O
information NN O
resources NNS O
. . O

Drug NN O
therapy NN O
information NN O
resources NNS O
for IN O
NPs NNS O
and CC O
nurse NN O
prescribers NNS O
have VBP O
frequently RB O
been VBN O
described VBN O
as IN O
essential JJ O
in IN O
supporting VBG O
practice NN O
[ -LRB- O
25 CD O
, , O
28 CD O
, , O
29 CD O
] -RRB- O
. . O

The DT O
role NN O
of IN O
NPs NNPS O
is VBZ O
relatively RB O
new JJ O
in IN O
Canada NNP O
[ -LRB- O
39 CD O
] -RRB- O
and CC O
there EX O
is VBZ O
limited JJ O
information NN O
available JJ O
to TO O
indicate VB O
the DT O
type NN O
of IN O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
print NN O
, , O
electronic JJ O
, , O
EPR NN O
based VBN O
) -RRB- O
these DT O
prescribers NNS O
use VBP O
for IN O
drug NN O
and CC O
therapeutic JJ O
information NN O
queries NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

It PRP O
is VBZ O
unknown JJ O
as IN O
to IN O
whether IN O
differences NNS O
exist VBP O
regarding VBG O
types NNS O
of IN O
resources NNS O
used VBN O
, , O
drug NN O
information NN O
needs NNS O
, , O
and CC O
utilization NN O
patterns NNS O
among IN O
NPs NNS O
and CC O
collaborating VBG O
physician NN O
partners NNS O
. . O

Some DT O
research NN O
has VBZ O
suggested VBN O
that IN O
the DT O
degree NN O
of IN O
multidisciplinary JJ O
team NN O
functioning NN O
relates VBZ O
to IN O
the DT O
adoption NN O
of IN O
technology NN O
or CC O
innovations NNS O
in IN O
practice NN O
but CC O
more JJR O
research NN O
is VBZ O
required VBN O
to TO O
determine VB O
the DT O
extent NN O
of IN O
these DT O
relationships NNS O
[ -LRB- O
45 CD O
, , O
46 CD O
] -RRB- O
. . O

The DT O
use NN O
of IN O
EPR NNP O
technology NN O
is VBZ O
increasing VBG O
in IN O
Nova NNP O
Scotia NNP O
but CC O
little JJ O
information NN O
is VBZ O
available JJ O
regarding VBG O
the DT O
readiness NN O
of IN O
practitioners NNS O
for IN O
use NN O
of IN O
specific JJ O
features NNS O
such JJ O
as IN O
drug NN O
information NN O
resources NNS O
. . O

Based VBN O
on IN O
the DT O
EPR NNP O
related VBN O
results NNS O
of IN O
the DT O
SPCI NNP O
evaluation NN O
, , O
use NN O
of IN O
these DT O
functions NNS O
could MD O
be VB O
challenging JJ O
without IN O
proper JJ O
facilitation NN O
. . O

The DT O
purpose NN O
of IN O
the DT O
survey NN O
for IN O
this DT O
research NN O
was VBD O
to TO O
describe VB O
drug NN O
information NN O
resources NNS O
used VBN O
by IN O
NPs NNPS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

The DT O
results NNS O
of IN O
the DT O
survey NN O
will MD O
be VB O
used VBN O
to TO O
guide VB O
further JJ O
technology NN O
implementation NN O
strategies NNS O
and CC O
stimulate VB O
further JJ O
discussion NN O
around IN O
drug NN O
information NN O
resource NN O
usage NN O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

Methods NNS O

Survey NN O
development NN O

Survey NN O
development NN O
involved VBD O
three CD O
stages NNS O
including VBG O
identification NN O
of IN O
important JJ O
content NN O
areas NNS O
, , O
development NN O
of IN O
draft NN O
questions NNS O
, , O
and CC O
survey NN O
refinement NN O
. . O

Identifying VBG O
important JJ O
content NN O
areas NNS O
for IN O
inclusion NN O
in IN O
the DT O
survey NN O
involved VBD O
conducting VBG O
a DT O
comprehensive JJ O
English NNP O
language NN O
literature NN O
search NN O
, , O
consultation NN O
with IN O
relevant JJ O
stakeholders NNS O
( , O
e LS O
. . O
g LS O
. . O
members NNS O
of IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
) -RRB- O
, , O
and CC O
input NN O
from IN O
subject NN O
matter NN O
experts NNS O
at IN O
Dalhousie NNP O
University NNP O
. . O

The DT O
literature NN O
review NN O
was VBD O
conducted VBN O
using VBG O
the DT O
following VBG O
bibliographic JJ O
databases NNS O
: : O
PubMed NNP O
, , O
Cumulative NNP O
Index NNP O
to IN O
Nursing NNP O
and CC O
Allied NNP O
Health NNP O
Literature NNP O
( , O
CINAHL NNP O
) -RRB- O
, , O
International NNP O
Pharmaceutical NNP O
Abstracts NNPS O
( : O
IPA NNP O
) -RRB- O
, , O
and CC O
Web NNP O
of IN O
Science NNP O
Citation NNP O
Databases NNPS O
. . O

Hand NN O
and CC O
electronic JJ O
searching NN O
of IN O
relevant JJ O
journals NNS O
was VBD O
also RB O
conducted VBN O
. . O

Broad JJ O
search NN O
terms NNS O
were VBD O
used VBN O
without IN O
limits NNS O
on IN O
publication NN O
date NN O
or CC O
place NN O
as IN O
nurse NN O
practitioner NN O
titles NNS O
, , O
roles NNS O
and CC O
scopes NNS O
of IN O
practice NN O
, , O
and CC O
terminology NN O
regarding VBG O
technology NN O
vary VBP O
nationally RB O
and CC O
internationally RB O
. . O

Some DT O
examples NNS O
of IN O
terms NNS O
used VBN O
included VBD O
nurse NN O
practitioner NN O
, , O
nurse NN O
prescriber NN O
, , O
nurse NN O
clinicians NNS O
, , O
district NN O
nurse NN O
, , O
health NN O
visitor NN O
, , O
drug NN O
information NN O
resources NNS O
, , O
drug NN O
information NN O
services NNS O
, , O
information NN O
needs NNS O
, , O
and CC O
information NN O
technology NN O
. . O

The DT O
draft NN O
survey NN O
was VBD O
reviewed VBN O
by IN O
the DT O
research NN O
team NN O
to TO O
reduce VB O
the DT O
number NN O
of IN O
items NNS O
and CC O
improve VB O
clarity NN O
. . O

The DT O
layout NN O
of IN O
the DT O
questionnaire NN O
was VBD O
carefully RB O
examined VBN O
to TO O
ensure VB O
that IN O
it PRP O
was VBD O
easy JJ O
to TO O
follow VB O
and CC O
complete VB O
. . O

Research NN O
results NNS O
from IN O
a DT O
previous JJ O
investigation NN O
of IN O
Nova NNP O
Scotian NNP O
physicians NNS O
' POS O
behaviours NNS O
regarding VBG O
drug NN O
information NN O
were VBD O
also RB O
used VBN O
to TO O
further RB O
revise VB O
the DT O
survey NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

This DT O
draft NN O
questionnaire NN O
was VBD O
pilot NN O
tested VBN O
by IN O
two CD O
out IN O
of IN O
province NN O
NPs NNS O
and CC O
one CD O
physician NN O
. . O

The DT O
results NNS O
of IN O
the DT O
pilot NN O
were VBD O
used VBN O
to TO O
make VB O
final JJ O
revisions NNS O
to IN O
the DT O
survey NN O
. . O

Based VBN O
on IN O
pilot NN O
- HYPH O
testing VBG O
feedback NN O
and CC O
investigator NN O
consensus NN O
, , O
the DT O
final JJ O
survey NN O
was VBD O
divided VBN O
into IN O
2 CD O
versions NNS O
, , O
one CD O
for IN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NN O
) -RRB- O
users NNS O
and CC O
one CD O
for IN O
computer NN O
users NNS O
. . O

The DT O
10 CD O
page NN O
surveys NNS O
for IN O
PDA NNP O
and CC O
computer NN O
users NNS O
had VBD O
5 CD O
or CC O
6 CD O
sections NNS O
, , O
respectively RB O
, , O
and CC O
37 CD O
questions NNS O
, , O
many JJ O
with IN O
multiple JJ O
parts NNS O
. . O

The DT O
survey NN O
content NN O
included VBD O
demographics NNS O
, , O
computer NN O
or CC O
PDA NN O
use NN O
and CC O
experience NN O
, , O
drug NN O
and CC O
therapeutic JJ O
resource NN O
use NN O
and CC O
preferences NNS O
, , O
PDA NNP O
future JJ O
use NN O
, , O
perceived VBN O
barriers NNS O
and CC O
facilitators NNS O
to IN O
PDA NN O
use NN O
, , O
and CC O
technology NN O
training NN O
preferences NNS O
. . O

Section NN O
one CD O
contained VBD O
demographic JJ O
questions NNS O
such JJ O
as IN O
gender NN O
, , O
age NN O
, , O
job NN O
title NN O
, , O
volume NN O
of IN O
patients NNS B-Species
, , O
and CC O
EPR NN O
availability NN O
in IN O
the DT O
practice NN O
setting NN O
. . O

Section NN O
two CD O
was VBD O
designed VBN O
to TO O
determine VB O
PDA NN O
or CC O
computer NN O
use NN O
and CC O
experience NN O
in IN O
the DT O
practice NN O
setting NN O
with IN O
questions NNS O
regarding VBG O
length NN O
of IN O
use NN O
, , O
costs NNS O
, , O
and CC O
work NN O
versus IN O
home NN O
usage NN O
. . O

This DT O
section NN O
also RB O
addressed VBD O
usage NN O
and CC O
rating NN O
of IN O
different JJ O
drug NN O
information NN O
resources NNS O
. . O

Resource NN O
ratings NNS O
were VBD O
based VBN O
on IN O
the DT O
frequency NN O
of IN O
usage NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
. . O

Resources NNS O
were VBD O
grouped VBN O
as IN O
print NN O
( : O
i LS O
. . O
e ADD O
. . O
books NNS O
, , O
journals NNS O
, , O
and CC O
clinical JJ O
practice NN O
guidelines NNS O
) -RRB- O
, , O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
, , O
and CC O
health NN O
professionals NNS O
and CC O
other JJ O
. . O

Respondents NNS O
used VBD O
5 CD O
- HYPH O
point NN O
Likert NNP O
scales NNS O
( , O
strongly RB O
agree VB O
to TO O
strongly RB O
disagree VB O
) , O
for IN O
rating VBG O
opinions NNS O
related VBN O
to IN O
resources NNS O
. . O

A DT O
rating NN O
of IN O
6 CD O
( : O
not RB O
applicable JJ O
, , O
I PRP O
do VBP O
not RB O
use VB O
this DT O
resource NN O
) -RRB- O
was VBD O
also RB O
included VBN O
for IN O
respondents NNS O
who WP O
did VBD O
not RB O
use VB O
a DT O
particular JJ O
resource NN O
. . O

Frequency NN O
of IN O
searching VBG O
for IN O
specific JJ O
information NN O
was VBD O
rated VBN O
on IN O
a DT O
3 CD O
- HYPH O
point NN O
Likert NNP O
scale NN O
( : O
frequently RB O
to IN O
never RB O
) -RRB- O
. . O

The DT O
final JJ O
sections NNS O
of IN O
the DT O
survey NN O
included VBD O
categorical JJ O
, , O
open RB O
- HYPH O
ended JJ O
, , O
and CC O
Likert NNP O
scale NN O
questions NNS O
regarding VBG O
preferred JJ O
resources NNS O
, , O
technology NN O
barriers NNS O
, , O
PDA NNP O
future JJ O
use NN O
, , O
and CC O
technology NN O
training NN O
preferences NNS O
. . O

Copies NNS O
of IN O
the DT O
surveys NNS O
are VBP O
attached VBN O
as IN O
an DT O
appendix NN O
in IN O
PDF NNP O
format NN O
[ -LRB- O
see VBP O
additional JJ O
file NN O
1 CD O
and CC O
2 CD O
] -RRB- O
or CC O
can MD O
also RB O
be VB O
accessed VBN O
from IN O
the DT O
Initiative NNP O
for IN O
Medication NNP O
Management NNP O
, , O
Policy NNP O
Analysis NNP O
, , O
Research NNP O
& CC O
Training NNP O
( , O
IMPART NNP O
) -RRB- O
website NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Ethics NNS O
approval NN O
for IN O
the DT O
survey NN O
was VBD O
granted VBN O
through IN O
Dalhousie NNP O
University NNP O
Research NNP O
Ethics NNP O
Board NNP O
on IN O
February NNP O
3 CD O
, , O
2005 CD O
. . O

Survey NN O
population NN O

Licensed VBN O
, , O
actively RB O
practicing VBG O
, , O
primary JJ O
health NN O
care NN O
NPs NNS O
( : O
n -LRB- O
= SYM O
16 CD O
) -RRB- O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
( : O
n CD O
= SYM O
21 CD O
) -RRB- O
were VBD O
eligible JJ O
to TO O
participate VB O
. . O

Survey NN O
procedures NNS O

The DT O
survey NN O
recruitment NN O
procedures NNS O
were VBD O
based VBN O
on IN O
the DT O
methods NNS O
of IN O
Dillman NNP O
[ -LRB- O
49 CD O
] -RRB- O
and CC O
Salant NNP O
and CC O
Dillman NNP O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Survey NN O
packages NNS O
contained VBD O
a DT O
cover NN O
letter NN O
, , O
separate JJ O
surveys NNS O
for IN O
PDA NNP O
and CC O
computer NN O
users NNS O
, , O
and CC O
a DT O
return NN O
self NN O
- HYPH O
addressed VBN O
stamped VBN O
envelope NN O
. . O

The DT O
covering VBG O
letter NN O
instructed VBD O
respondents NNS O
to TO O
self VB O
- HYPH O
select VB O
the DT O
appropriate JJ O
survey NN O
( , O
either CC O
PDA NNP O
or CC O
computer NN O
) -RRB- O
based VBN O
on IN O
their PRP$ O
drug NN O
information NN O
seeking VBG O
behaviours NNS O
. . O

Participants NNS B-Species
who WP O
had VBD O
used VBN O
a DT O
PDA NNP O
at IN O
any DT O
time NN O
were VBD O
instructed VBN O
to TO O
complete VB O
the DT O
PDA NNP O
version NN O
of IN O
the DT O
survey NN O
. . O

Those DT O
who WP O
had VBD O
never RB O
used VBN O
a DT O
PDA NNP O
for IN O
drug NN O
information NN O
were VBD O
instructed VBN O
to TO O
complete VB O
the DT O
computer NN O
version NN O
of IN O
the DT O
survey NN O
. . O

Several JJ O
strategies NNS O
were VBD O
used VBN O
to TO O
optimize VB O
response NN O
rate NN O
and CC O
included VBD O
: : O
personalized JJ O
cover NN O
letters NNS O
, , O
coloured VBN O
paper NN O
for IN O
surveys NNS O
, , O
stamped VBN O
return NN O
envelopes NNS O
, , O
follow VB O
- HYPH O
up NN O
mailing NN O
, , O
and CC O
a DT O
priority NN O
post NN O
mailing NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

The DT O
covering VBG O
letter NN O
included VBD O
coloured JJ O
logos NNS O
of IN O
Dalhousie NNP O
University NNP O
and CC O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
representing VBG O
the DT O
investigator NN O
affiliations NNS O
and CC O
endorsement NN O
of IN O
the DT O
project NN O
. . O

A DT O
master NN O
mailing NN O
list NN O
with IN O
names NNS O
and CC O
addresses NNS O
of IN O
NPs NNPS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
was VBD O
created VBN O
. . O

To TO O
maintain VB O
confidentiality NN O
of IN O
respondents NNS O
, , O
a DT O
number NN O
placed VBN O
on IN O
the DT O
bottom JJ O
right JJ O
corner NN O
of IN O
each DT O
survey NN O
corresponded VBD O
to IN O
a DT O
name NN O
on IN O
the DT O
confidential JJ O
master NN O
mailing NN O
sheet NN O
. . O

The DT O
postage NN O
paid VBN O
return NN O
envelopes NNS O
were VBD O
addressed VBN O
to IN O
the DT O
research NN O
coordinator NN O
at IN O
the DT O
School NNP O
of IN O
Nursing NNP O
, , O
Dalhousie NNP O
University NNP O
, , O
who WP O
matched VBD O
respondents NNS O
to IN O
the DT O
mailing NN O
list NN O
from IN O
the DT O
first JJ O
distribution NN O
. . O

The DT O
cross NN O
- HYPH O
referenced VBN O
mailing NN O
list NN O
was VBD O
not RB O
accessible JJ O
to IN O
those DT O
entering VBG O
or CC O
analysing VBG O
data NNS O
. . O

The DT O
research NN O
coordinator NN O
sent VBD O
the DT O
second JJ O
distribution NN O
to IN O
those DT O
who WP O
had VBD O
not RB O
initially RB O
responded VBN O
. . O

A DT O
fluorescent JJ O
coloured VBN O
page NN O
was VBD O
included VBN O
in IN O
the DT O
second JJ O
mailing NN O
to TO O
notify VB O
recipients NNS O
of IN O
the DT O
second JJ O
and CC O
final JJ O
mailing NN O
status NN O
. . O

The DT O
second JJ O
mailing NN O
followed VBD O
2 CD O
weeks NNS O
after IN O
the DT O
initial JJ O
mailing NN O
( , O
February NNP O
2005 CD O
) -RRB- O
. . O

The DT O
surveys NNS O
were VBD O
sent VBN O
via IN O
Xpresspost NNP O
( -LRB- O
TM NNP O
) -RRB- O
through IN O
Canada NNP O
Post NNP O
. . O

Data NN O
analyses NNS O

Quantitative JJ O

Data NNS O
were VBD O
entered VBN O
and CC O
analysed VBN O
in IN O
Statistical NNP O
Package NNP O
for IN O
Social NNP O
Sciences NNPS O
( : O
SPSS NNP O
) -RRB- O
( , O
version NN O
11 CD O
. . O
5 CD O
for IN O
Windows NNS O
) -RRB- O
. . O

Five CD O
surveys NNS O
were VBD O
randomly RB O
selected VBN O
as IN O
a DT O
check NN O
for IN O
accuracy NN O
of IN O
data NN O
entry NN O
. . O

Descriptive JJ O
statistics NNS O
were VBD O
used VBN O
to TO O
describe VB O
resource NN O
usage NN O
by IN O
practitioners NNS O
. . O

Chi NNP O
Square NNP O
( : O
Fisher NNP O
' '' O
s POS O
Exact NNP O
when WRB O
cell NN O
count VBP O
less JJR O
than IN O
5 CD O
) -RRB- O
analyses NNS O
were VBD O
used VBN O
to TO O
determine VB O
differences NNS O
in IN O
computer NN O
or CC O
PDA NN O
use NN O
based VBN O
on IN O
predetermined VBN O
variables NNS O
( : O
e LS O
. . O
g LS O
. . O
high JJ O
speed NN O
Internet NN O
connection NN O
, , O
number NN O
of IN O
patients NNS B-Species
per IN O
day NN O
) -RRB- O
. . O

Mann NNP O
Whitney NNP O
U NNP O
tests NNS O
were VBD O
used VBN O
to TO O
compare VB O
physician NN O
and CC O
NPs NNP O
Likert NNP O
scale NN O
ratings NNS O
( : O
1 CD O
= SYM O
strongly RB O
agree VB O
to IN O
5 CD O
= SYM O
strongly RB O
disagree VB O
) -RRB- O
of IN O
resource NN O
use NN O
. . O

Physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
all DT O
resources NNS O
( , O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professionals NNS O
and CC O
other JJ O
) -RRB- O
were VBD O
determined VBN O
from IN O
means NNS O
of IN O
Likert NNP O
scale NN O
ratings NNS O
( , O
1 CD O
= SYM O
strongly RB O
agree VB O
, , O
5 CD O
= SYM O
strongly RB O
disagree VB O
) , O
for IN O
each DT O
of IN O
the DT O
pre JJ O
- HYPH O
specified VBN O
characteristics NNS O
( : O
e LS O
. . O
g LS O
. . O
frequency NN O
of IN O
use NN O
, , O
accessibility NN O
, , O
etc FW O
. . O
) -RRB- O
and CC O
the DT O
frequency NN O
of IN O
use NN O
of IN O
the DT O
resources NNS O
. . O

The DT O
best JJS O
rankings NNS O
were VBD O
assigned VBN O
for IN O
the DT O
lowest JJS O
mean JJ O
scores NNS O
and CC O
the DT O
largest JJS O
number NN O
of IN O
the DT O
sample NN O
using VBG O
a DT O
resource NN O
. . O

These DT O
rankings NNS O
( , O
ranks NNS O
based VBN O
on IN O
mean JJ O
and CC O
ranks NNS O
based VBN O
on IN O
sample NN O
) -RRB- O
were VBD O
then RB O
entered VBN O
into IN O
a DT O
formula NN O
to TO O
calculate VB O
an DT O
overall JJ O
rank NN O
. . O

The DT O
formula NN O
includes VBZ O
: : O
rank NN O
= : O
[ -LRB- O
( , O
rank VB O
according VBG O
to IN O
% NN O
of IN O
sample NN O
using VBG O
the DT O
resource NN O
+ CC O
rank NN O
based VBN O
on IN O
mean JJ O
score NN O
) NFP O
/ SYM O
2 CD O
] -RRB- O
. . O

This DT O
formula NN O
was VBD O
used VBN O
to TO O
account VB O
for IN O
mean JJ O
scores NNS O
based VBN O
on IN O
small JJ O
samples NNS O
as IN O
these DT O
numbers NNS O
could MD O
potentially RB O
over RB O
or CC O
underestimate VB O
the DT O
value NN O
of IN O
a DT O
resource NN O
. . O

Ratings NNS O
of IN O
6 CD O
( : O
i PRP O
. . O
e UH O
. . O
not RB O
applicable JJ O
, , O
I PRP O
do VBP O
not RB O
use VB O
this DT O
resource NN O
) -RRB- O
were VBD O
excluded VBN O
from IN O
the DT O
analyses NNS O
. . O

Qualitative JJ O

Comments NNS O
were VBD O
entered VBN O
in IN O
a DT O
word NN O
- HYPH O
processing NN O
program NN O
and CC O
organized VBN O
by IN O
type NN O
of IN O
respondent NN O
( : O
PDA NNP O
versus IN O
computer NN O
) -RRB- O
and CC O
question NN O
number NN O
. . O

The DT O
coded VBN O
survey NN O
number NN O
and CC O
respondent NN O
type NN O
( -LRB- O
NP NNP O
or CC O
physician NN O
) -RRB- O
were VBD O
also RB O
included VBN O
next RB O
to IN O
comments NNS O
. . O

Investigators NNS O
determined VBD O
themes NNS O
and CC O
categorized VBN O
comments NNS O
based VBN O
on IN O
previous JJ O
experience NN O
, , O
knowledge NN O
, , O
and CC O
familiarity NN O
with IN O
the DT O
topic NN O
. . O

Results NNS O

Surveys NNS O
were VBD O
completed VBN O
and CC O
returned VBN O
by IN O
75 CD O
% NN O
of IN O
eligible JJ O
participants NNS B-Species
( : O
27 CD O
of IN O
36 CD O
) -RRB- O
. . O

One CD O
physician NN O
survey NN O
was VBD O
undeliverable JJ O
. . O

The DT O
response NN O
rates NNS O
from IN O
within IN O
the DT O
NP NNP O
and CC O
physician NN O
samples NNS O
were VBD O
88 CD O
% NN O
and CC O
65 CD O
% NN O
, , O
respectively RB O
. . O

Complete JJ O
demographic JJ O
information NN O
is VBZ O
available JJ O
in IN O
Table NNP O
1 CD O
. . O

Methods NNS O
for IN O
accessing VBG O
resources NNS O
and CC O
self NN O
- HYPH O
reported VBN O
resource NN O
use NN O

Resource NN O
use NN O
was VBD O
similar JJ O
amongst IN O
practitioners NNS O
. . O

Respondents NNS O
indicated VBD O
that IN O
print NN O
resources NNS O
( , O
mean VBP O
4 CD O
. . O
56 CD O
, , O
SD NN O
0 CD O
. . O
80 CD O
) -RRB- O
, , O
health NN O
professionals NNS O
( , O
mean JJ O
3 CD O
. . O
26 CD O
, , O
SD NN O
0 CD O
. . O
90 CD O
) -RRB- O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
( , O
mean JJ O
2 CD O
. . O
70 CD O
, , O
SD NN O
1 CD O
. . O
20 CD O
) -RRB- O
were VBD O
the DT O
preferred JJ O
method NN O
( : O
1 CD O
= SYM O
least RBS O
preferred VBN O
to IN O
5 CD O
= SYM O
most RBS O
preferred VBN O
) -RRB- O
for IN O
accessing VBG O
drug NN O
information NN O
. . O

Thirty CD O
- HYPH O
seven CD O
percent NN O
of IN O
respondents NNS O
reported VBD O
that IN O
searching VBG O
for IN O
specific JJ O
questions NNS O
related VBN O
to IN O
drug NN O
information NN O
( : O
e LS O
. . O
g LS O
. . O
usual JJ O
dosage NN O
, , O
duration NN O
of IN O
therapy NN O
) , O
was VBD O
conducted VBN O
using VBG O
both CC O
print NN O
and CC O
electronic JJ O
resources NNS O
( , O
but CC O
print NN O
use NN O
greater JJR O
than IN O
electronic JJ O
) -RRB- O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

The DT O
preferred JJ O
means NN O
( : O
i LS O
. . O
e ADD O
. . O
print NN O
) -RRB- O
to TO O
access VB O
resources NNS O
was VBD O
consistent JJ O
with IN O
the DT O
most RBS O
common JJ O
means NN O
of IN O
conducting VBG O
searches NNS O
for IN O
specific JJ O
drug NN O
information NN O
queries NNS O
. . O

Respondents NNS O
' POS O
ratings NNS O
for IN O
pre JJ O
- HYPH O
specified VBN O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
professional JJ O
resources NNS O
and CC O
other JJ O
, , O
based VBN O
on IN O
means NNS O
from IN O
Likert NNP O
scales NNS O
and CC O
number NN O
of IN O
respondents NNS O
using VBG O
the DT O
resources NNS O
, , O
are VBP O
presented VBN O
in IN O
Tables NNP O
3 CD O
, , O
4 CD O
, , O
and CC O
5 CD O
. . O

Of IN O
all DT O
resources NNS O
within IN O
the DT O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professionals NNS O
or CC O
other JJ O
categories NNS O
, , O
NPs NNS O
and CC O
physicians NNS O
rated VBD O
the DT O
Compendium NNP O
of IN O
Pharmaceuticals NNPS O
and CC O
Specialties NNPS O
( -LRB- O
CPS NNP O
) -RRB- O
[ -LRB- O
52 CD O
] -RRB- O
and CC O
pharmacists NNS O
as IN O
the DT O
top JJ O
two CD O
most RBS O
frequently RB O
used VBN O
resources NNS O
for IN O
providing VBG O
drug NN O
and CC O
therapeutic JJ O
information NN O
. . O

Physicians NNS O
rated VBD O
other JJ O
physicians NNS O
as IN O
the DT O
third RB O
most RBS O
frequently RB O
used VBN O
resource NN O
. . O

The DT O
book NN O
Therapeutic NNP O
Choices NNPS O
[ -LRB- O
53 CD O
] -RRB- O
ranked VBD O
third RB O
for IN O
NPs NNPS O
. . O

Based VBN O
on IN O
written VBN O
feedback NN O
, , O
physicians NNS O
and CC O
NPs NNP O
consulted VBD O
pharmacists NNS O
and CC O
other JJ O
physicians NNS O
most RBS O
frequently RB O
. . O

The DT O
CPS NNP O
and CC O
pharmacists NNS O
were VBD O
also RB O
ranked VBN O
as IN O
the DT O
top JJ O
two CD O
resources NNS O
overall RB O
in IN O
terms NNS O
of IN O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
for IN O
physicians NNS O
. . O

Rankings NNS O
by IN O
NPs NNPS O
were VBD O
similar JJ O
for IN O
usefulness NN O
, , O
accessibility NN O
, , O
and CC O
credibility NN O
. . O

NPs NNP O
ranked VBD O
pharmacists NNS O
, , O
Therapeutic NNP O
Choices NNPS O
, , O
and CC O
academic JJ O
detailing NN O
first RB O
and CC O
the DT O
CPS NNP O
as IN O
second JJ O
for IN O
current JJ O
/ SYM O
timeliness NN O
. . O

Within IN O
the DT O
online JJ O
/ SYM O
electronic JJ O
category NN O
, , O
electronic JJ O
clinical JJ O
practice NN O
guidelines NNS O
( , O
eCPGs NNS O
) -RRB- O
were VBD O
rated VBN O
the DT O
highest JJS O
for IN O
all DT O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
usefulness NN O
, , O
credibility NN O
) -RRB- O
. . O

Although IN O
eCPGs NNS O
were VBD O
highly RB O
ranked VBN O
, , O
approximately RB O
30 CD O
% NN O
of IN O
the DT O
sample NN O
reported VBD O
not RB O
using VBG O
this DT O
resource NN O
. . O

Other JJ O
resources NNS O
in IN O
this DT O
category NN O
were VBD O
infrequently RB O
used VBN O
based VBN O
on IN O
respondents NNS O
' POS O
self NN O
- HYPH O
reports NNS O
. . O

Pharmaceutical JJ O
industry NN O
representatives NNS O
were VBD O
used VBN O
as IN O
a DT O
source NN O
of IN O
drug NN O
information NN O
by IN O
85 CD O
% NN O
and CC O
86 CD O
% NN O
of IN O
physicians NNS O
and CC O
NPs NNS O
, , O
respectively RB O
( : O
Table NNP O
5 CD O
) -RRB- O
. . O

This DT O
was VBD O
higher JJR O
than IN O
regional JJ O
drug NN O
information NN O
services NNS O
( , O
used VBN O
by IN O
23 CD O
% NN O
of IN O
physicians NNS O
and CC O
50 CD O
% NN O
of IN O
NPs NNPS O
) -RRB- O
. . O

After IN O
exclusion NN O
of IN O
traditional JJ O
health NN O
professionals NNS O
( : O
i PRP O
. . O
e LS O
. . O
physicians NNS O
, , O
nurses NNS O
, , O
pharmacists NNS O
, , O
allied JJ O
health NN O
) -RRB- O
in IN O
the DT O
health NN O
professionals NNS O
and CC O
other JJ O
category NN O
, , O
pharmaceutical NN O
industry NN O
representatives NNS O
received VBD O
rankings NNS O
for IN O
second JJ O
or CC O
third JJ O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
, , O
based VBN O
on IN O
means NN O
and CC O
number NN O
of IN O
respondents NNS O
using VBG O
this DT O
resource NN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Differences NNS O
between IN O
nurse NN O
practitioners NNS O
and CC O
physicians NNS O

A DT O
series NN O
of IN O
Mann NNP O
Whitney NNP O
U NNP O
tests NNS O
were VBD O
used VBN O
to TO O
compare VB O
the DT O
responses NNS O
of IN O
NPs NNPS O
and CC O
physicians NNS O
on IN O
their PRP$ O
use NN O
of IN O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professional JJ O
resources NNS O
. . O

In IN O
total JJ O
95 CD O
statistical JJ O
tests NNS O
were VBD O
conducted VBN O
. . O

The DT O
large JJ O
number NN O
of IN O
tests NNS O
increases VBZ O
the DT O
likelihood NN O
of IN O
a DT O
type NN O
I NN O
error NN O
as IN O
five CD O
significant JJ O
differences NNS O
would MD O
be VB O
expected VBN O
by IN O
chance NN O
alone RB O
at IN O
an DT O
alpha NN O
threshold NN O
of IN O
0 CD O
. . O
5 CD O
. . O

It PRP O
is VBZ O
therefore RB O
important JJ O
to TO O
treat VB O
these DT O
results NNS O
with IN O
caution NN O
. . O

A DT O
limited JJ O
number NN O
of IN O
statistically RB O
significant JJ O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
differences NNS O
were VBD O
identified VBN O
between IN O
physicians NNS O
and CC O
NPs NNS O
and CC O
are VBP O
reported VBN O
in IN O
Table NNP O
6 CD O
. . O

Therapeutic JJ O
Choices NNS O
differed VBD O
significantly RB O
for IN O
frequency NN O
of IN O
use NN O
with IN O
more JJR O
NPs NNS O
making VBG O
use NN O
of IN O
this DT O
resource NN O
. . O

Allied JJ O
health NN O
professionals NNS O
significantly RB O
differed VBD O
between IN O
NPs NNS O
and CC O
physicians NNS O
for IN O
accessibility NN O
and CC O
current JJ O
/ SYM O
timeliness NN O
while IN O
NPs NNPS O
were VBD O
more RBR O
in IN O
agreement NN O
with IN O
these DT O
characteristics NNS O
of IN O
the DT O
resource NN O
. . O

Nurse NN O
colleague NN O
credibility NN O
and CC O
current JJ O
/ SYM O
timeliness NN O
was VBD O
rated VBN O
significantly RB O
higher JJR O
by IN O
NPs NNPS O
versus IN O
physicians NNS O
. . O

Factors NNS O
influencing VBG O
electronic JJ O
technology NN O
use NN O
at IN O
the DT O
point NN O
of IN O
care NN O

Factors NNS O
such JJ O
as IN O
gender NN O
, , O
age NN O
, , O
practitioner NN O
type NN O
( , O
NP NNP O
vs IN O
physician NN O
) -RRB- O
, , O
accessibility NN O
, , O
technical JJ O
support NN O
, , O
Internet NN O
connection NN O
speed NN O
, , O
patient NN B-Species
volume NN O
, , O
presence NN O
of IN O
an DT O
EPR NN O
, , O
and CC O
home NN O
computer NN O
use NN O
were VBD O
examined VBN O
to TO O
determine VB O
if IN O
they PRP O
were VBD O
associated VBN O
with IN O
the DT O
use NN O
of IN O
a DT O
work NN O
computer NN O
to TO O
search VB O
for IN O
drug NN O
information NN O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

No DT O
statistically RB O
significant JJ O
associations NNS O
were VBD O
found VBN O
( : O
Fisher NNP O
' POS O
s POS O
Exact NNP O
) -RRB- O
. . O

Additional JJ O
resources NNS O
from IN O
respondent NN O
comments NNS O

Respondents NNS O
indicated VBD O
other JJ O
resources NNS O
and CC O
programs NNS O
, , O
such JJ O
as IN O
clinical JJ O
calculators NNS O
, , O
that IN O
they PRP O
would MD O
like VB O
to TO O
access VB O
from IN O
their PRP$ O
computer NN O
or CC O
PDA NNP O
. . O

The DT O
top JJ O
three CD O
resources NNS O
that WDT O
were VBD O
desired VBN O
included VBD O
Canadian JJ O
clinical JJ O
practice NN O
guidelines NNS O
, , O
patient JJ B-Species
education NN O
information NN O
, , O
and CC O
ability NN O
to TO O
track VB O
clinical JJ O
activities NNS O
/ SYM O
statistics NNS O
. . O

Further JJ O
comments NNS O
from IN O
two CD O
NP NNP O
computer NN O
survey NN O
respondents NNS O
revealed VBD O
that IN O
a DT O
resource NN O
on IN O
drug NN O
interactions NNS O
and CC O
dosages NNS O
would MD O
be VB O
desired VBN O
. . O

One CD O
other JJ O
NP NNP O
also RB O
indicated VBD O
"""" `` O
up IN O
to IN O
date NN O
info NN O
[ -LRB- O
sic NN O
] -RRB- O
on IN O
drugs NNS O
to TO O
treat VB O
various JJ O
illnesses NNS O
ie IN O
doseage NN O
[ -LRB- O
sic NN O
] -RRB- O
, , O
length NN O
of IN O
use NN O
etc FW O
. . O
"""" '' O

Computer NN O
or CC O
personal JJ O
digital JJ O
assistant NN O
use NN O
in IN O
practice NN O

Approximately RB O
50 CD O
% NN O
of IN O
computer NN O
survey NN O
respondents NNS O
reported VBD O
using VBG O
their PRP$ O
work NN O
computers NNS O
for IN O
searching VBG O
drug NN O
or CC O
therapeutic JJ O
information NN O
related VBN O
to IN O
patient JJ B-Species
care NN O
. . O

Of IN O
those DT O
respondents NNS O
, , O
just RB O
over IN O
half DT O
( : O
54 CD O
% NN O
) -RRB- O
also RB O
reported VBD O
using VBG O
their PRP$ O
home NN O
computer NN O
for IN O
this DT O
purpose NN O
. . O

Sixty CD O
- HYPH O
seven CD O
and CC O
17 CD O
% NN O
of IN O
PDA NNP O
survey NN O
respondents NNS O
reported VBD O
using VBG O
their PRP$ O
PDA NNP O
for IN O
searching VBG O
drug NN O
or CC O
therapeutic JJ O
information NN O
related VBN O
to IN O
patient JJ B-Species
care NN O
at IN O
work NN O
and CC O
home NN O
, , O
respectively RB O
. . O

Searching VBG O
on IN O
a DT O
weekly JJ O
basis NN O
for IN O
specific JJ O
information NN O
related VBN O
to IN O
drugs NNS O

Of IN O
the DT O
24 CD O
specified VBN O
categories NNS O
of IN O
drug NN O
information NN O
included VBN O
in IN O
the DT O
survey NN O
, , O
the DT O
majority NN O
were VBD O
reported VBN O
as IN O
infrequently RB O
searched VBN O
and CC O
a DT O
smaller JJR O
percentage NN O
as IN O
never RB O
searched VBN O
by IN O
respondents NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

The DT O
top JJ O
three CD O
categories NNS O
rated VBD O
as IN O
frequently RB O
searched VBN O
were VBD O
side JJ O
effects NNS O
, , O
adult NN O
or CC O
usual JJ O
drug NN O
dosage NN O
, , O
and CC O
most RBS O
appropriate JJ O
drug NN O
for IN O
an DT O
indication NN O
. . O

( -LRB- O
Table NN O
7 CD O
) -RRB- O

Issues NNS O
related VBN O
to IN O
personal JJ O
digital JJ O
assistants NNS O

Respondents NNS O
reported VBD O
their PRP$ O
level NN O
of IN O
agreement NN O
with IN O
statements NNS O
related VBN O
to IN O
how WRB O
PDAs NNPS O
may MD O
influence VB O
their PRP$ O
practice NN O
. . O

The DT O
statements NNS O
included VBD O
aspects NNS O
of IN O
workload NN O
( , O
organization NN O
and CC O
paper NN O
work NN O
) -RRB- O
, , O
convenience NN O
, , O
and CC O
improving VBG O
quality NN O
of IN O
care NN O
and CC O
patient JJ B-Species
outcomes NNS O
. . O

( -LRB- O
Table NNP O
8 CD O
) -RRB- O
Respondents NNS O
agreed VBD O
that IN O
PDAs NNS O
are VBP O
a DT O
convenient JJ O
resource NN O
but CC O
indicated VBD O
that IN O
PDAs NNS O
would MD O
not RB O
decrease VB O
paperwork NN O
or CC O
improve VB O
patient JJ B-Species
health NN O
outcomes NNS O
. . O

Barriers NNS O
and CC O
facilitators NNS O
to IN O
personal JJ O
digital JJ O
assistants NNS O
: : O
themes NNS O
from IN O
written VBN O
comments NNS O

Peer NN O
support NN O
from IN O
colleagues NNS O
, , O
convenience NN O
, , O
standardized JJ O
usage NN O
, , O
and CC O
financial JJ O
and CC O
technical JJ O
support NN O
were VBD O
the DT O
main JJ O
perceived VBN O
facilitators NNS O
to IN O
PDA NNP O
use NN O
reported VBN O
by IN O
respondents NNS O
. . O

The DT O
main JJ O
perceived VBN O
barrier NN O
to IN O
PDA NNP O
use NN O
reported VBN O
by IN O
respondents NNS O
( : O
n CD O
= SYM O
10 CD O
) -RRB- O
included VBD O
cost NN O
. . O

Other JJ O
factors NNS O
such JJ O
as IN O
technology NN O
literacy NN O
, , O
time NN O
, , O
lack NN O
of IN O
peer NN O
support NN O
, , O
no DT O
high JJ O
speed NN O
internet NN O
for IN O
downloads NNS O
, , O
lack NN O
of IN O
needed VBN O
resources NNS O
, , O
keeping VBG O
up IN O
to IN O
date NN O
on IN O
resources NNS O
, , O
and CC O
searching NN O
speed NN O
were VBD O
also RB O
reported VBN O
. . O

Future JJ O
use NN O
of IN O
personal JJ O
digital JJ O
assistants NNS O

Fifty CD O
- HYPH O
two CD O
percent NN O
, , O
including VBG O
current JJ O
PDA NNP O
users NNS O
, , O
reported VBD O
that IN O
they PRP O
would MD O
use VB O
a DT O
PDA NNP O
in IN O
the DT O
future NN O
. . O

Twenty CD O
two CD O
percent NN O
were VBD O
uncertain JJ O
and CC O
19 CD O
% NN O
reported VBD O
that IN O
they PRP O
would MD O
not RB O
use VB O
a DT O
PDA NNP O
in IN O
the DT O
future NN O
. . O

Two CD O
people NNS B-Species
did VBD O
not RB O
respond VB O
. . O

Confidentiality NN O

Fifty CD O
two CD O
percent NN O
of IN O
respondents NNS O
indicated VBD O
that IN O
patient JJ B-Species
confidentiality NN O
with IN O
PDAs NNS O
was VBD O
no RB O
more RBR O
concerning JJ O
compared VBN O
to IN O
use NN O
of IN O
other JJ O
technologies NNS O
. . O

Forty CD O
- HYPH O
four CD O
percent NN O
did VBD O
not RB O
know VB O
if IN O
they PRP O
had VBD O
a DT O
policy NN O
on IN O
patient JJ B-Species
confidentiality NN O
with IN O
regard NN O
to IN O
technologies NNS O
. . O

Technology NN O
training NN O
and CC O
reimbursement NN O

Respondents NNS O
rated VBD O
( : O
1 CD O
= SYM O
least RBS O
preferred VBN O
to TO O
5 CD O
= SYM O
most RBS O
preferred VBN O
) -RRB- O
one CD O
on IN O
one CD O
instruction NN O
and CC O
group NN O
learning NN O
led VBN O
by IN O
an DT O
expert JJ O
facilitator NN O
as IN O
the DT O
most RBS O
preferred VBN O
( , O
mean JJ O
4 CD O
. . O
32 CD O
, , O
SD NN O
0 CD O
. . O
99 CD O
) -RRB- O
means NNS O
by IN O
which WDT O
to TO O
receive VB O
instruction NN O
on IN O
a DT O
new JJ O
technology NN O
. . O

Least JJS O
preferred JJ O
methods NNS O
included VBD O
online JJ O
discussions NNS O
/ SYM O
chatrooms NNS O
( , O
mean JJ O
1 CD O
. . O
52 CD O
, , O
SD NN O
1 CD O
. . O
4 CD O
) -RRB- O
, , O
internet NN O
videos NNS O
( , O
live JJ O
: : O
mean JJ O
1 CD O
. . O
70 CD O
, , O
SD NN O
1 CD O
. . O
10 CD O
, , O
or CC O
static JJ O
: : O
mean VB O
1 CD O
. . O
87 CD O
, , O
SD NN O
1 CD O
. . O
14 CD O
) -RRB- O
, , O
video NN O
cassettes NNS O
( , O
mean JJ O
2 CD O
. . O
30 CD O
, , O
SD NN O
1 CD O
. . O
55 CD O
) -RRB- O
, , O
trial NN O
and CC O
error NN O
learning NN O
( , O
mean JJ O
2 CD O
. . O
32 CD O
, , O
SD NN O
1 CD O
. . O
28 CD O
) -RRB- O
, , O
and CC O
written VBN O
manuals NNS O
( , O
mean JJ O
2 CD O
. . O
92 CD O
, , O
SD NN O
1 CD O
. . O
44 CD O
) -RRB- O
. . O

Paid VBN O
leave NN O
for IN O
attendance NN O
at IN O
technology NN O
training NN O
sessions NNS O
was VBD O
the DT O
preferred VBN O
means NN O
( , O
mean JJ O
1 CD O
. . O
77 CD O
, , O
SD NN O
0 CD O
. . O
86 CD O
; : O
1 CD O
= SYM O
strongly RB O
agree VB O
to IN O
5 CD O
= SYM O
strongly RB O
disagree VB O
) -RRB- O
of IN O
remuneration NN O
for IN O
respondents NNS O
. . O

Respondents NNS O
also RB O
indicated VBD O
that IN O
if IN O
financial JJ O
remuneration NN O
was VBD O
to TO O
occur VB O
, , O
it PRP O
should MD O
correspond VB O
to IN O
the DT O
amount NN O
of IN O
time NN O
for IN O
training NN O
that WDT O
is VBZ O
required VBN O
( , O
versus IN O
a DT O
flat JJ O
rate NN O
) -RRB- O
( , O
mean JJ O
1 CD O
. . O
96 CD O
, , O
SD NN O
1 CD O
. . O
8 CD O
) -RRB- O
. . O

Continuing VBG O
education NN O
credits NNS O
were VBD O
not RB O
viewed VBN O
as IN O
an DT O
incentive NN O
( , O
mean JJ O
2 CD O
. . O
69 CD O
, , O
SD NN O
1 CD O
. . O
44 CD O
) -RRB- O
. . O

Discussion NN O

Preferred JJ O
resources NNS O

In IN O
our PRP$ O
study NN O
, , O
printed VBN O
materials NNS O
( , O
e LS O
. . O
g LS O
. . O
compendia NN O
, , O
journals NNS O
, , O
textbook NN O
resources NNS O
) , O
and CC O
professionals NNS O
( , O
e LS O
. . O
g LS O
. . O
pharmacists NNS O
) -RRB- O
were VBD O
the DT O
most RBS O
preferred VBN O
and CC O
frequently RB O
used VBN O
means NNS O
to TO O
access VB O
information NN O
. . O

Physician NN O
reliance NN O
on IN O
text NN O
and CC O
compendia NN O
relative JJ O
to IN O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
has VBZ O
been VBN O
frequently RB O
reported VBN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
a DT O
study NN O
examining VBG O
family NN O
doctors NNS O
' POS O
use NN O
of IN O
information NN O
sources NNS O
to TO O
answer VB O
clinical JJ O
questions NNS O
, , O
human JJ B-Species
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
doctor NN O
, , O
pharmacist NN O
) -RRB- O
, , O
non JJ O
- HYPH O
prescribing VBG O
print NN O
information NN O
( : O
e LS O
. . O
g LS O
. . O
textbooks NNS O
and CC O
journal NN O
articles NNS O
) -RRB- O
, , O
and CC O
prescribing VBG O
texts NNS O
were VBD O
used VBN O
36 CD O
% NN O
, , O
32 CD O
% NN O
, , O
and CC O
25 CD O
% NN O
of IN O
the DT O
time NN O
, , O
respectively RB O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Books NNS O
from IN O
the DT O
workplace NN O
were VBD O
reported VBN O
by IN O
approximately RB O
79 CD O
% NN O
of IN O
UK NNP O
primary JJ O
care NN O
nurses NNS O
as IN O
a DT O
commonly RB O
used VBN O
source NN O
of IN O
knowledge NN O
and CC O
information NN O
used VBN O
to TO O
support VB O
practice NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Fewer JJR O
than IN O
one CD O
- HYPH O
third NN O
( , O
31 CD O
% NN O
) -RRB- O
reported VBD O
using VBG O
electronic JJ O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
Internet NNP O
, , O
electronic JJ O
journals NNS O
) -RRB- O
for IN O
this DT O
purpose NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Results NNS O
of IN O
a DT O
postal JJ O
questionnaire NN O
to IN O
NPs NNPS O
demonstrated VBD O
that IN O
61 CD O
% NN O
and CC O
51 CD O
% NN O
of IN O
respondents NNS O
reported VBD O
using VBG O
drug NN O
reference NN O
manuals NNS O
and CC O
textbooks NNS O
, , O
respectively RB O
, , O
a DT O
few JJ O
times NNS O
a DT O
week NN O
or CC O
more JJR O
[ -LRB- O
29 CD O
] -RRB- O
. . O

These DT O
frequencies NNS O
were VBD O
second JJ O
and CC O
third RB O
only RB O
to IN O
consulting VBG O
with IN O
their PRP$ O
physician NN O
supervisor NN O
( : O
63 CD O
% NN O
) -RRB- O
. . O

Data NNS O
from IN O
structured VBN O
interviews NNS O
of IN O
a DT O
sample NN O
of IN O
22 CD O
community NN O
nurse NN O
prescribers NNS O
reported VBN O
by IN O
Hall NNP O
et FW O
al NNP O
. , O
revealed VBD O
that IN O
the DT O
majority NN O
relied VBD O
on IN O
print NN O
materials NNS O
to TO O
access VB O
information NN O
, , O
namely RB O
the DT O
British NNP O
National NNP O
Formulary NNP O
[ -LRB- O
32 CD O
] -RRB- O
. . O

A DT O
survey NN O
of IN O
a DT O
primary JJ O
care NN O
practice NN O
- HYPH O
based VBN O
research NN O
network NN O
in IN O
the DT O
US NNP O
that WDT O
included VBD O
physicians NNS O
, , O
physician NN O
assistants NNS O
, , O
and CC O
nurse NN O
practitioners NNS O
, , O
revealed VBD O
that IN O
interpersonal JJ O
and CC O
rapidly RB O
accessed VBN O
print NN O
resources NNS O
were VBD O
preferred VBN O
. . O

Sixty CD O
- HYPH O
one CD O
and CC O
58 CD O
% NN O
of IN O
respondents NNS O
reported VBD O
using VBG O
drug NN O
reference NN O
sources NNS O
such JJ O
as IN O
the DT O
Physician NNP O
' POS O
s NNP O
Desk NNP O
Reference NNP O
( -LRB- O
PDR NNP O
) -RRB- O
and CC O
medical JJ O
textbooks NNS O
, , O
respectively RB O
, , O
a DT O
few JJ O
times NNS O
a DT O
day NN O
or CC O
daily RB O
[ -LRB- O
56 CD O
] -RRB- O
. . O

The DT O
clinicians NNS O
in IN O
our PRP$ O
sample NN O
perceived VBD O
the DT O
Canadian JJ O
compendium NN O
, , O
the DT O
CPS NNP O
, , O
to TO O
be VB O
useful JJ O
, , O
accessible JJ O
, , O
credible JJ O
, , O
and CC O
current JJ O
/ SYM O
timely JJ O
. . O

The DT O
CPS NNP O
, , O
is VBZ O
described VBN O
as IN O
"""" `` O
the DT O
Canadian JJ O
drug NN O
reference NN O
for IN O
health NN O
professionals NNS O
"""" '' O
and CC O
is VBZ O
intended VBN O
to TO O
provide VB O
a DT O
central JJ O
source NN O
of IN O
drug NN O
information NN O
on IN O
drug NN O
products NNS O
available JJ O
in IN O
Canada NNP O
[ -LRB- O
52 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
available JJ O
in IN O
print NN O
( , O
English NNP O
and CC O
French NNP O
) -RRB- O
and CC O
became VBD O
available JJ O
online RB O
in IN O
June NNP O
2004 CD O
. . O

The DT O
CPS NNP O
includes VBZ O
drug NN O
monographs NNS O
for IN O
commonly RB O
used VBN O
products NNS O
approved VBN O
for IN O
use NN O
in IN O
Canada NNP O
, , O
but CC O
it PRP O
does VBZ O
not RB O
include VB O
all DT O
drugs NNS O
available JJ O
on IN O
the DT O
Canadian JJ O
market NN O
[ -LRB- O
57 CD O
] -RRB- O
. . O

The DT O
majority NN O
of IN O
these DT O
product NN O
monographs NNS O
are VBP O
based VBN O
on IN O
monographs NNS O
submitted VBN O
by IN O
pharmaceutical JJ O
manufacturers NNS O
and CC O
approved VBN O
by IN O
Health NNP O
Canada NNP O
. . O

Some DT O
of IN O
the DT O
monographs NNS O
are VBP O
written VBN O
by IN O
the DT O
Canadian NNP O
Pharmacists NNPS O
Association NNP O
and CC O
are VBP O
described VBN O
as IN O
being VBG O
evidence NN O
- HYPH O
based VBN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

The DT O
CPS NNP O
also RB O
includes VBZ O
more JJR O
than IN O
100 CD O
pages NNS O
of IN O
clinical JJ O
tools NNS O
[ -LRB- O
52 CD O
] -RRB- O
. . O

The DT O
CPS NNP O
has VBZ O
been VBN O
criticized VBN O
for IN O
including VBG O
pharmaceutical JJ O
company NN O
advertising NN O
and CC O
requiring VBG O
manufacturer NN O
payment NN O
for IN O
inclusion NN O
of IN O
product NN O
monographs NNS O
[ -LRB- O
58 CD O
] -RRB- O
. . O

The DT O
accuracy NN O
of IN O
particular JJ O
components NNS O
of IN O
CPS NNP O
monographs NNS O
has VBZ O
also RB O
been VBN O
investigated VBN O
. . O

A DT O
review NN O
of IN O
overdose NN O
management NN O
in IN O
119 CD O
monographs NNS O
from IN O
the DT O
2001 CD O
CPS NNP O
revealed VBD O
considerable JJ O
variability NN O
in IN O
the DT O
utility NN O
of IN O
information NN O
with IN O
50 CD O
% NN O
of IN O
the DT O
monographs NNS O
containing VBG O
misleading JJ O
or CC O
dangerous JJ O
advice NN O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Since IN O
2004 CD O
, , O
the DT O
CPS NNP O
has VBZ O
included VBN O
an DT O
alert NN O
box NN O
in IN O
the DT O
overdose NN O
section NN O
of IN O
monographs NNS O
notifying VBG O
users NNS O
to TO O
contact VB O
Poison NNP O
Control NNP O
Centres NNPS O
for IN O
overdose NN O
management NN O
information NN O
. . O

Some DT O
authors NNS O
have VBP O
criticized VBN O
references NNS O
that WDT O
are VBP O
similar JJ O
to IN O
the DT O
CPS NNP O
as IN O
being VBG O
inadequate JJ O
with IN O
regard NN O
to IN O
inclusion NN O
of IN O
evidence NN O
based VBN O
information NN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

The DT O
NPs NNPS O
in IN O
our PRP$ O
sample NN O
also RB O
rated VBD O
Therapeutic NNP O
Choices NNPS O
highly RB O
for IN O
all DT O
characteristics NNS O
. . O

This DT O
finding NN O
is VBZ O
most RBS O
likely JJ O
attributable JJ O
to IN O
the DT O
fact NN O
that IN O
it PRP O
is VBZ O
a DT O
recommended VBN O
resource NN O
for IN O
coursework NN O
associated VBN O
with IN O
the DT O
Dalhousie NNP O
NP NNP O
university NN O
program NN O
curriculum NN O
. . O

Therapeutic JJ O
Choices NNPS O
is VBZ O
a DT O
concise JJ O
therapeutics NNS O
reference NN O
text NN O
published VBN O
by IN O
the DT O
Canadian NNP O
Pharmacists NNPS O
Association NNP O
. . O

The DT O
text NN O
contains VBZ O
approximately RB O
120 CD O
extensively RB O
referenced VBN O
chapters NNS O
with IN O
a DT O
disease NN O
management NN O
approach NN O
including VBG O
easy JJ O
to TO O
use VB O
algorithms NNS O
and CC O
tables NNS O
. . O

An DT O
editorial JJ O
board NN O
is VBZ O
responsible JJ O
for IN O
extensively RB O
reviewing VBG O
the DT O
content NN O
to TO O
ensure VB O
unbiased JJ O
and CC O
objective JJ O
information NN O
is VBZ O
presented VBN O
[ -LRB- O
53 CD O
] -RRB- O
. . O

Health NN O
professionals NNS O

Reliance NN O
on IN O
other JJ O
health NN O
professionals NNS O
, , O
especially RB O
pharmacists NNS O
and CC O
physicians NNS O
, , O
as IN O
a DT O
resource NN O
for IN O
information NN O
was VBD O
evident JJ O
from IN O
our PRP$ O
study NN O
and CC O
concurs VBZ O
with IN O
the DT O
findings NNS O
of IN O
others NNS O
[ -LRB- O
28 CD O
, , O
32 CD O
, , O
55 CD O
, , O
61 CD O
] -RRB- O
. . O

Nurse NN O
practitioners NNS O
have VBP O
reported VBN O
that IN O
collaborative JJ O
relationships NNS O
with IN O
pharmacists NNS O
increase VBP O
NP NNP O
role NN O
satisfaction NN O
[ -LRB- O
61 CD O
] -RRB- O
. . O

NPs NNS O
frequently RB O
consult VBP O
with IN O
allied JJ O
health NN O
care NN O
professionals NNS O
in IN O
their PRP$ O
primary JJ O
health NN O
care NN O
provider NN O
role NN O
and CC O
this DT O
is VBZ O
supported VBN O
by IN O
written VBN O
feedback NN O
from IN O
our PRP$ O
sample NN O
regarding VBG O
frequently RB O
consulted VBN O
health NN O
professionals NNS O
. . O

Nursing NN O
colleagues NNS O
are VBP O
also RB O
likely JJ O
to TO O
be VB O
rated VBN O
highly RB O
by IN O
NPs NNPS O
due IN O
to IN O
their PRP$ O
affiliation NN O
with IN O
peers NNS O
from IN O
the DT O
same JJ O
profession NN O
. . O

Some DT O
investigators NNS O
have VBP O
shown VBN O
that IN O
non JJ O
- HYPH O
human JJ B-Species
references NNS O
( : O
e LS O
. . O
g LS O
. . O
textbook NN O
) -RRB- O
are VBP O
sought VBN O
for IN O
more JJR O
technical JJ O
aspects NNS O
of IN O
prescribing NN O
( : O
e LS O
. . O
g LS O
. . O
dose NN O
) -RRB- O
, , O
whereas IN O
guidance NN O
regarding VBG O
selection NN O
of IN O
agents NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
right JJ O
drug NN O
for IN O
an DT O
indication NN O
) -RRB- O
is VBZ O
sought VBN O
from IN O
human JJ B-Species
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
pharmacists NNS O
or CC O
physicians NNS O
) -RRB- O
[ -LRB- O
62 CD O
] -RRB- O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
determine VB O
what WDT O
kinds NNS O
of IN O
resources NNS O
were VBD O
used VBN O
for IN O
specific JJ O
purposes NNS O
from IN O
our PRP$ O
study NN O
. . O

Online JJ O
and CC O
electronic JJ O
resources NNS O
, , O
computers NNS O
, , O
and CC O
personal JJ O
digital JJ O
assistants NNS O

From IN O
our PRP$ O
study NN O
, , O
computer NN O
survey NN O
respondents NNS O
ranked VBD O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
third RB O
in IN O
preference NN O
following VBG O
print NN O
and CC O
health NN O
professionals NNS O
. . O

Various JJ O
barriers NNS O
and CC O
facilitators NNS O
to IN O
accessing VBG O
information NN O
online RB O
/ SYM O
electronically RB O
or CC O
via IN O
the DT O
Internet NN O
have VBP O
been VBN O
described VBN O
in IN O
the DT O
literature NN O
[ -LRB- O
55 CD O
, , O
63 CD O
- HYPH O
66 CD O
] -RRB- O
. . O

Variables NNS O
that WDT O
have VBP O
been VBN O
described VBN O
by IN O
others NNS O
as IN O
barriers NNS O
such JJ O
as IN O
accessibility NN O
, , O
high JJ O
speed NN O
internet NN O
access NN O
, , O
patient NN B-Species
volume NN O
, , O
age NN O
, , O
practitioner NN O
type NN O
, , O
and CC O
technology NN O
support NN O
did VBD O
not RB O
appear VB O
to TO O
influence VB O
computer NN O
searching NN O
for IN O
information NN O
on IN O
drugs NNS O
or CC O
therapeutics NNS O
related VBN O
to IN O
patient JJ B-Species
care NN O
in IN O
our PRP$ O
results NNS O
. . O

Some DT O
qualitative JJ O
feedback NN O
does VBZ O
however RB O
support VB O
this DT O
notion NN O
. . O

As IN O
an DT O
example NN O
, , O
in IN O
response NN O
to IN O
a DT O
request NN O
for IN O
a DT O
rationale NN O
for IN O
not RB O
using VBG O
computers NNS O
one CD O
physician NN O
commented VBD O
: : O
"""" `` O
Retro VB O
tech NN O
[ -LRB- O
sic NN O
] -RRB- O
/ SYM O
old JJ O
fashion NN O
. . O

I PRP O
still RB O
like VBP O
to TO O
use VB O
my PRP$ O
mind NN O
and CC O
have VBP O
always RB O
been VBN O
a DT O
fan NN O
of IN O
pen NN O
and CC O
paper NN O
"""" '' O
. . O

Barriers NNS O
that WDT O
were VBD O
identified VBN O
with IN O
our PRP$ O
sample NN O
regarding VBG O
the DT O
use NN O
of IN O
handheld JJ O
technologies NNS O
such JJ O
as IN O
PDAs NNS O
included VBD O
cost NN O
, , O
time NN O
, , O
and CC O
issues NNS O
related VBN O
to IN O
technology NN O
literacy NN O
. . O

Several JJ O
people NNS B-Species
questioned VBD O
the DT O
value NN O
of IN O
PDAs NNS O
. . O

One CD O
GP NNP O
stated VBD O
when WRB O
referring VBG O
to IN O
a DT O
PDA NNP O
: : O
"""" `` O
So RB O
far RB O
I PRP O
have VBP O
not RB O
discovered VBN O
a DT O
use NN O
for IN O
one CD O
"""" '' O
. . O

Other JJ O
respondents NNS O
reinforced VBD O
their PRP$ O
preferences NNS O
for IN O
other JJ O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
books NNS O
) -RRB- O
and CC O
resistance NN O
to IN O
technology NN O
. . O

When WRB O
responding VBG O
to IN O
barriers NNS O
for IN O
the DT O
use NN O
of IN O
PDAs NNS O
, , O
one CD O
NP NNP O
commented VBD O
, , O
"""" `` O
My PRP$ O
huge JJ O
dislike NN O
for IN O
machinery NN O
that WDT O
frequently RB O
requires VBZ O
updating NN O
and CC O
patience NN O
"""" '' O
. . O

A DT O
physician NN O
responded VBD O
, , O
"""" `` O
as IN O
stated VBN O
, , O
I PRP O
like VBP O
to TO O
use VB O
my PRP$ O
own JJ O
mind NN O
, , O
and CC O
can MD O
get VB O
all PDT O
the DT O
info NN O
I PRP O
need VBP O
from IN O
books NNS O
relatively RB O
quickly RB O
"""" '' O
. . O

Facilitators NNS O
to IN O
the DT O
use NN O
of IN O
PDAs NNS O
mainly RB O
included VBD O
convenience NN O
factors NNS O
such JJ O
as IN O
having VBG O
resources NNS O
all RB O
in IN O
one CD O
place NN O
, , O
faster JJR O
means NNS O
to TO O
get VB O
information NN O
, , O
and CC O
portability NN O
. . O

Our PRP$ O
sample NN O
was VBD O
not RB O
in IN O
agreement NN O
with IN O
some DT O
convenience NN O
factors NNS O
in IN O
that IN O
they PRP O
did VBD O
not RB O
feel VB O
that IN O
PDAs NNPS O
would MD O
decrease VB O
paperwork NN O
. . O

Practitioners NNS O
from IN O
our PRP$ O
sample NN O
felt VBD O
relatively RB O
neutral JJ O
about IN O
PDAs NNS O
improving VBG O
patient NN B-Species
' '' O
s POS O
health NN O
outcomes NNS O
with IN O
41 CD O
% NN O
responding VBG O
in IN O
this DT O
manner NN O
. . O

Results NNS O
from IN O
a DT O
sample NN O
of IN O
primary JJ O
care NN O
practitioners NNS O
in IN O
the DT O
US NNP O
revealed VBD O
that IN O
76 CD O
% NN O
agreed VBD O
that IN O
the DT O
use NN O
of IN O
handheld JJ O
devices NNS O
for IN O
electronic JJ O
prescribing NN O
would MD O
substantially RB O
reduce VB O
medical JJ O
errors NNS O
and CC O
improve VB O
the DT O
quality NN O
of IN O
health NN O
care NN O
[ -LRB- O
67 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
also RB O
suggests VBZ O
that IN O
resources NNS O
such JJ O
as IN O
the DT O
Cochrane NNP O
Library NNP O
and CC O
its PRP$ O
Database NNP O
of IN O
Systematic NNP O
Reviews NNPS O
were VBD O
not RB O
frequently RB O
used VBN O
. . O

This DT O
finding NN O
is VBZ O
similar JJ O
to IN O
that DT O
of IN O
other JJ O
investigators NNS O
[ -LRB- O
30 CD O
, , O
35 CD O
, , O
64 CD O
] -RRB- O
. . O

Despite IN O
the DT O
desire NN O
of IN O
some DT O
clinicians NNS O
to TO O
use VB O
these DT O
resources NNS O
, , O
lack NN O
of IN O
confidence NN O
and CC O
ability NN O
to TO O
use VB O
them PRP O
appropriately RB O
has VBZ O
been VBN O
found VBN O
[ -LRB- O
30 CD O
, , O
64 CD O
, , O
68 CD O
, , O
69 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
suggests VBZ O
that IN O
although IN O
this DT O
resource NN O
is VBZ O
perceived VBN O
as IN O
credible JJ O
, , O
current JJ O
/ SYM O
timely JJ O
, , O
and CC O
useful JJ O
, , O
it PRP O
is VBZ O
also RB O
perceived VBN O
to TO O
be VB O
somewhat RB O
inaccessible JJ O
. . O

The DT O
Cochrane NNP O
Library NNP O
is VBZ O
available JJ O
to IN O
the DT O
health NN O
professionals NNS O
( , O
e LS O
. . O
g LS O
. . O
nurses NNS O
, , O
physicians NNS O
, , O
pharmacists NNS O
, , O
occupational JJ O
therapists NNS O
, , O
physiotherapists NNS O
, , O
etc FW O
. . O
) -RRB- O
in IN O
our PRP$ O
sample NN O
through IN O
professional JJ O
bodies NNS O
via IN O
the DT O
Atlantic NNP O
Health NNP O
Knowledge NNP O
Partnership NNP O
[ -LRB- O
70 CD O
] -RRB- O
. . O

Technology NN O
training NN O
: : O
preferences NNS O
and CC O
incentives NNS O

With IN O
regard NN O
to IN O
receiving VBG O
training NN O
for IN O
a DT O
new JJ O
technology NN O
, , O
our PRP$ O
study NN O
demonstrates VBZ O
that IN O
in IN O
person NN B-Species
conferences NNS O
or CC O
one CD O
on IN O
one CD O
training NN O
sessions NNS O
are VBP O
the DT O
preferred JJ O
means NNS O
to TO O
receive VB O
continuing VBG O
education NN O
. . O

Person NN B-Species
to IN O
person NN B-Species
interaction NN O
has VBZ O
been VBN O
reported VBN O
as IN O
the DT O
preferred VBN O
and CC O
most RBS O
frequently RB O
used VBN O
means NNS O
to TO O
access VB O
continuing VBG O
education NN O
or CC O
training NN O
by IN O
other JJ O
investigators NNS O
[ -LRB- O
55 CD O
, , O
71 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
also RB O
indicates VBZ O
that IN O
this DT O
group NN O
of IN O
practitioners NNS O
may MD O
benefit VB O
from IN O
accessing VBG O
resources NNS O
[ -LRB- O
72 CD O
- SYM O
80 CD O
] -RRB- O
that WDT O
provide VBP O
guidance NN O
on IN O
useful JJ O
drug NN O
information NN O
resources NNS O
available JJ O
for IN O
devices NNS O
such JJ O
as IN O
PDAs NNS O
. . O

This DT O
is VBZ O
exemplified VBN O
by IN O
one CD O
respondent NN O
' POS O
s POS O
statement NN O
"""" `` O
knowledge NN O
regarding VBG O
good JJ O
software NN O
programs NNS O
"""" '' O
as IN O
a DT O
barrier NN O
to IN O
the DT O
use NN O
of IN O
PDAs NNS O
. . O

Pharmaceutical JJ O
industry NN O

The DT O
influence NN O
of IN O
the DT O
pharmaceutical JJ O
industry NN O
on IN O
physician NN O
prescribing NN O
and CC O
research NN O
outcomes NNS O
has VBZ O
been VBN O
documented VBN O
[ -LRB- O
81 CD O
, , O
82 CD O
] -RRB- O
. . O

Although IN O
NP NNP O
use NN O
of IN O
industry NN O
representatives NNS O
as IN O
a DT O
source NN O
of IN O
pharmacological JJ O
information NN O
has VBZ O
been VBN O
documented VBN O
, , O
the DT O
influence NN O
on IN O
prescribing NN O
is VBZ O
largely RB O
uninvestigated JJ O
[ -LRB- O
32 CD O
, , O
61 CD O
, , O
83 CD O
- HYPH O
85 CD O
] -RRB- O
. . O

The DT O
CNA NNP O
competency NN O
framework NN O
includes VBZ O
a DT O
statement NN O
regarding VBG O
prescribing NN O
and CC O
industry NN O
relations NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
the DT O
physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
industry NN O
representatives NNS O
were VBD O
similar JJ O
. . O

Within IN O
the DT O
health NN O
professionals NNS O
and CC O
other JJ O
category NN O
, , O
pharmaceutical NN O
representatives NNS O
were VBD O
used VBN O
as IN O
a DT O
resource NN O
by IN O
more JJR O
of IN O
the DT O
sample NN O
than IN O
regional JJ O
drug NN O
information NN O
services NNS O
and CC O
comparably RB O
to IN O
academic JJ O
detailing NN O
services NNS O
. . O

Academic JJ O
detailing NN O
is VBZ O
a DT O
form NN O
of IN O
continuing VBG O
medical JJ O
education NN O
where WRB O
a DT O
trained VBN O
health NN O
professional NN O
visits VBZ O
prescribers NNS O
for IN O
a DT O
fifteen CD O
to TO O
twenty CD O
minute NN O
session NN O
to TO O
provide VB O
objective JJ O
information NN O
regarding VBG O
a DT O
therapeutic JJ O
topic NN O
based VBN O
on IN O
best RB O
available JJ O
evidence NN O
[ -LRB- O
86 CD O
, , O
87 CD O
] -RRB- O
. . O

Following VBG O
academic JJ O
detailing NN O
, , O
physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
pharmaceutical JJ O
industry NN O
representatives NNS O
were VBD O
second JJ O
or CC O
third JJ O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
. . O

Limitations NNS O

We PRP O
do VBP O
not RB O
have VB O
demographics NNS O
or CC O
information NN O
regarding VBG O
the DT O
reasons NNS O
why WRB O
survey NN O
recipients NNS O
did VBD O
not RB O
respond VB O
. . O

As IN O
per IN O
ethical JJ O
requirements NNS O
to TO O
maintain VB O
confidentiality NN O
of IN O
respondents NNS O
, , O
we PRP O
were VBD O
not RB O
able JJ O
to TO O
match VB O
respondents NNS O
from IN O
their PRP$ O
respective JJ O
place NN O
of IN O
practice NN O
and CC O
therefore RB O
cannot MD O
conclude VB O
whether IN O
the DT O
practitioners NNS O
within IN O
a DT O
practice NN O
setting NN O
influenced VBD O
the DT O
others NNS O
' POS O
responses NNS O
. . O

The DT O
sample NN O
size NN O
of IN O
the DT O
survey NN O
is VBZ O
small JJ O
although IN O
it PRP O
includes VBZ O
88 CD O
% NN O
response NN O
from IN O
community NN O
based VBN O
NPs NNPS O
in IN O
Nova NNP O
Scotia NNP O
. . O

The DT O
generalizability NN O
of IN O
the DT O
results NNS O
is VBZ O
limited JJ O
due IN O
to IN O
the DT O
variations NNS O
in IN O
NP NNP O
scopes NNS O
of IN O
practice NN O
nationally RB O
and CC O
internationally RB O
. . O

It PRP O
is VBZ O
unknown JJ O
whether IN O
the DT O
findings NNS O
are VBP O
generalizable JJ O
to IN O
nonresponding JJ O
physicians NNS O
within IN O
Nova NNP O
Scotia NNP O
collaborating VBG O
with IN O
NPs NNPS O
or CC O
to IN O
physicians NNS O
not RB O
in IN O
collaborative JJ O
practices NNS O
with IN O
NPs NNPS O
as IN O
they PRP O
were VBD O
not RB O
included VBN O
as IN O
a DT O
part NN O
of IN O
the DT O
sample NN O
. . O

Due IN O
to IN O
multiple JJ O
statistical JJ O
comparisons NNS O
( : O
Mann NNP O
Whitney NNP O
U NNP O
) -RRB- O
, , O
the DT O
results NNS O
comparing VBG O
NP NNP O
and CC O
physician NN O
ratings NNS O
of IN O
results NNS O
should MD O
be VB O
interpreted VBN O
with IN O
caution NN O
. . O

Conclusion NN O

Respondent NN O
ratings NNS O
of IN O
resources NNS O
and CC O
preferences NNS O
for IN O
resource NN O
use NN O
were VBD O
consistent JJ O
with IN O
self NN O
- HYPH O
reported VBN O
means NNS O
of IN O
conducting VBG O
searches NNS O
for IN O
specific JJ O
drug NN O
information NN O
queries NNS O
. . O

The DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
remains VBZ O
limited JJ O
and CC O
also RB O
matches VBZ O
preferences NNS O
and CC O
resource NN O
ratings NNS O
. . O

Education NN O
to IN O
this DT O
group NN O
of IN O
practitioners NNS O
regarding VBG O
available JJ O
drug NN O
information NN O
resources NNS O
may MD O
facilitate VB O
use NN O
of IN O
computer NN O
and CC O
PDA NNP O
resources NNS O
. . O

Further JJ O
research NN O
is VBZ O
needed VBN O
to TO O
determine VB O
methods NNS O
to TO O
increase VB O
the DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
and CC O
if IN O
use NN O
of IN O
these DT O
technologies NNS O
affects VBZ O
prescribing NN O
and CC O
patient NN B-Species
outcomes NNS O
. . O

Competing VBG O
interests NNS O

Ingrid NNP O
Sketris NNP O
holds VBZ O
a DT O
Chair NNP O
from IN O
Canadian NNP O
Institutes NNPS O
of IN O
Health NNP O
Research NNP O
( -LRB- O
CIHR NNP O
) -RRB- O
, , O
Canadian NNP O
Health NNP O
Services NNPS O
Research NNP O
Foundation NNP O
( , O
CHSRF NNP O
) , O
co NN O
- HYPH O
sponsored VBN O
by IN O
the DT O
Nova NNP O
Scotia NNP O
Health NNP O
Research NNP O
Foundation NNP O
( -LRB- O
NSHRF NNP O
) -RRB- O
. . O

Andrea NNP O
Murphy NNP O
received VBD O
salary NN O
support NN O
through IN O
this DT O
Chair NNP O
as IN O
a DT O
research NN O
fellow NN O
at IN O
the DT O
time NN O
of IN O
conducting VBG O
this DT O
research NN O
. . O

The DT O
survey NN O
was VBD O
performed VBN O
in IN O
fulfillment NN O
of IN O
the DT O
requirements NNS O
for IN O
the DT O
Drug NNP O
Use NNP O
Management NNP O
and CC O
Policy NNP O
Residency NNP O
that WDT O
Murphy NNP O
participated VBD O
in IN O
as IN O
a DT O
part NN O
of IN O
her PRP$ O
fellowship NN O
. . O

The DT O
residency NN O
was VBD O
conducted VBN O
with IN O
a DT O
decision NN O
making VBG O
partner NN O
from IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
. . O

The DT O
opinions NNS O
expressed VBN O
in IN O
this DT O
paper NN O
are VBP O
those DT O
of IN O
the DT O
authors NNS O
and CC O
do VBP O
not RB O
represent VB O
the DT O
opinions NNS O
of IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
, , O
CIHR NNP O
/ SYM O
CHSRF NNP O
or CC O
NSHRF NNP O
. . O

MF NNP O
, , O
MM NNP O
, , O
RMM NNP O
, , O
and CC O
DG NNP O
have VBP O
no DT O
competing VBG O
interests NNS O
to TO O
declare VB O
. . O

Authors NNS O
' POS O
contributions NNS O

AM NNP O
conceptualized VBD O
the DT O
design NN O
and CC O
composed VBD O
the DT O
survey NN O
instruments NNS O
, , O
carried VBD O
out RP O
the DT O
study NN O
, , O
entered VBD O
and CC O
analyzed VBD O
the DT O
data NNS O
, , O
drafted VBD O
the DT O
original JJ O
manuscript NN O
, , O
and CC O
modified VBD O
subsequent JJ O
drafts NNS O
based VBN O
on IN O
authors NNS O
' POS O
and CC O
reviewers NNS O
' POS O
feedback NN O
. . O

MF NNP O
, , O
RMM NNP O
, , O
IS NNP O
, , O
MM NNP O
, , O
and CC O
DG NNP O
reviewed VBD O
and CC O
suggested VBD O
revisions NNS O
to IN O
the DT O
survey NN O
tools NNS O
, , O
covering VBG O
letters NNS O
, , O
overall JJ O
study NN O
design NN O
, , O
and CC O
contributed VBD O
to IN O
feedback NN O
on IN O
the DT O
analysis NN O
and CC O
manuscript NN O
revisions NNS O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Supplementary JJ O
Material NN O

Expression NN O
of IN O
C NN O
- HYPH O
terminal NN O
deleted VBN O
p53 NN O
isoforms NNS O
in IN O
neuroblastoma NN O

Abstract JJ O

The DT O
tumor NN O
suppressor NN O
gene NN O
, , O
p53 NN O
, , O
is VBZ O
rarely RB O
mutated VBN O
in IN O
neuroblastomas NN O
( , O
NB NNP O
) -RRB- O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
, , O
but CC O
its PRP$ O
dysfunction NN O
could MD O
result VB O
from IN O
a DT O
nonfunctional JJ O
conformation NN O
or CC O
cytoplasmic JJ O
sequestration NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
p53 NN O
protein NN O
. . O

However RB O
, , O
p53 NN O
mutation NN O
, , O
when WRB O
it PRP O
occurs VBZ O
, , O
is VBZ O
found VBN O
in IN O
NB NNP O
tumors NNS O
with IN O
drug NN O
resistance NN O
acquired VBN O
over IN O
the DT O
course NN O
of IN O
chemotherapy NN O
. . O

As IN O
yet RB O
, , O
no DT O
study NN O
has VBZ O
been VBN O
devoted VBN O
to IN O
the DT O
function NN O
of IN O
the DT O
specific JJ O
p53 NN O
mutants NNS O
identified VBN O
in IN O
NB NNP O
cells NNS O
. . O

This DT O
study NN O
includes VBZ O
characterization NN O
and CC O
functional JJ O
analysis NN O
of IN O
p53 NN O
expressed VBN O
in IN O
eight CD O
cell NN O
lines NNS O
: : O
three CD O
wild JJ O
- HYPH O
type NN O
cell NN O
lines NNS O
and CC O
five CD O
cell NN O
lines NNS O
harboring VBG O
mutations NNS O
. . O

We PRP O
identified VBD O
two CD O
transcription NN O
- HYPH O
inactive JJ O
p53 NN O
variants NNS O
truncated VBN O
in IN O
the DT O
C NNP O
- HYPH O
terminus NN O
, , O
one CD O
of IN O
which WDT O
corresponded VBD O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
recently RB O
identified VBN O
in IN O
normal JJ O
tissue NN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

[ -LRB- O
J NNP O
. . O
C NNP O
. . O
Bourdon NNP O
, , O
K NNP O
. . O
Fernandes NNP O
, , O
F NNP O
. . O
Murray NNP O
- HYPH O
Zmijewski NNP O
, , O
G NNP O
. . O
Liu NNP O
, , O
A NNP O
. . O
Diot NNP O
, , O
D NNP O
. . O
P NN O
. . O
Xirodimas NNP O
, , O
M NNP O
. . O
K NNP O
. . O
Saville NNP O
and CC O
D NNP O
. . O
P NN O
. . O
Lane NNP O
( , O
2005 CD O
) SYM O
Genes NNP O
Dev NNP O
. . O
, , O
19 CD O
, , O
2122 CD O
- HYPH O
2137 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
show VBP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
that IN O
the DT O
p53 NN O
beta NN O
isoform NN O
is VBZ O
the DT O
only JJ O
p53 NN O
species NNS O
to TO O
be VB O
endogenously RB O
expressed VBN O
in IN O
the DT O
human JJ B-Species
NB NNP O
cell NN O
line NN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
suggesting VBG O
that IN O
the DT O
C NNP O
- HYPH O
terminus NN O
truncated VBN O
p53 NN O
isoforms NNS O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
NB NNP O
tumor NN O
development NN O
. . O

INTRODUCTION NN O

The DT O
p53 NN O
tumor NN O
suppressor NN O
gene NN O
remains VBZ O
the DT O
most RBS O
frequently RB O
altered VBN O
gene NN O
in IN O
human JJ B-Species
tumors NNS O
. . O

Several JJ O
p53 NN O
mutation NN O
databases NNS O
have VBP O
been VBN O
reported VBN O
previously RB O
( , O
1 CD O
- HYPH O
3 CD O
) -RRB- O
, , O
and CC O
to IN O
date NN O
, , O
more JJR O
than IN O
1500 CD O
different JJ O
p53 NN O
mutants NNS O
have VBP O
been VBN O
described VBN O
( SYM O
4 CD O
) -RRB- O
. . O

Functional JJ O
inactivation NN O
of IN O
p53 NN O
is VBZ O
usually RB O
due JJ O
to IN O
gene NN O
mutation NN O
, , O
deletion NN O
or CC O
protein NN O
degradation NN O
. . O

In IN O
general JJ O
, , O
the DT O
majority NN O
of IN O
p53 NN O
mutations NNS O
in IN O
human JJ B-Species
neoplasia NN O
are VBP O
missense JJ O
mutations NNS O
affecting VBG O
the DT O
DNA NNP O
- HYPH O
binding VBG O
domain NN O
( -LRB- O
DBD NNP O
) -RRB- O
. . O

Unlike IN O
other JJ O
human JJ B-Species
cancers NNS O
, , O
p53 NN O
in IN O
neuroblastoma NN O
( , O
NB NNP O
) -RRB- O
is VBZ O
rarely RB O
mutated VBN O
in IN O
the DT O
primary JJ O
tumor NN O
at IN O
diagnosis NN O
but CC O
high JJ O
levels NNS O
of IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
( -LRB- O
wt NN O
p53 NN O
) -RRB- O
protein NN O
expression NN O
have VBP O
been VBN O
found VBN O
in IN O
the DT O
cytoplasm NN O
of IN O
undifferentiated JJ O
tumors NNS O
( : O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

More RBR O
recently RB O
, , O
in IN O
normal JJ O
unstressed JJ O
cells NNS O
, , O
wt CD O
p53 NN O
protein NN O
was VBD O
found VBN O
to TO O
be VB O
retained VBN O
in IN O
the DT O
cytoplasm NN O
as IN O
a DT O
latent NN O
form NN O
, , O
in IN O
huge JJ O
, , O
p53 NN O
- HYPH O
associated VBN O
protein NN O
complexes NNS O
known VBN O
as IN O
' `` O
Parc NNP O
' '' O
( : O
7 CD O
) -RRB- O
. . O

The DT O
steady JJ O
- HYPH O
state NN O
concentration NN O
of IN O
p53 NN O
in IN O
normal JJ O
unstressed JJ O
cells NNS O
is VBZ O
usually RB O
very RB O
low JJ O
because IN O
of IN O
the DT O
short JJ O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
( HYPH O
wt NN O
) -RRB- O
protein NN O
. . O

Overexpression NN O
of IN O
p53 NN O
in IN O
most JJS O
of IN O
the DT O
transformed VBN O
cells NNS O
containing VBG O
a DT O
missense NN O
mutation NN O
within IN O
the DT O
p53 NN O
gene NN O
appears VBZ O
to TO O
be VB O
due IN O
to IN O
the DT O
increased VBN O
stability NN O
of IN O
mutated VBN O
p53 NN O
( SYM O
8 CD O
) -RRB- O
. . O

In IN O
unstressed JJ O
NB NNP O
cells NNS O
, , O
high JJ O
wt NN O
p53 NN O
expression NN O
may MD O
reflect VB O
the DT O
embryonic JJ O
origin NN O
of IN O
NBs NNP O
, , O
in IN O
which WDT O
precursor NN O
cells NNS O
fail VBP O
to TO O
mature VB O
( , O
9 CD O
) -RRB- O
. . O

p53 NN O
mutations NNS O
are VBP O
unusual JJ O
in IN O
human JJ B-Species
NB NNP O
but CC O
, , O
when WRB O
they PRP O
do VBP O
occur VB O
, , O
are VBP O
found VBN O
in IN O
post NN O
- HYPH O
chemotherapy NN O
tumors NNS O
. . O

In IN O
this DT O
respect NN O
, , O
Tweddle NNP O
et FW O
al NNP O
. . O

( : O
10 CD O
) , O
described VBD O
how WRB O
two CD O
NB NNP O
cell NN O
lines NNS O
derived VBN O
from IN O
the DT O
same JJ O
patient NN B-Species
can MD O
elicit VB O
a DT O
different JJ O
p53 NN O
status NN O
: : O
wt PRP O
p53 CD O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
1a CD O
) -RRB- O
established VBN O
before IN O
treatment NN O
, , O
and CC O
mutated VBN O
p53 NN O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
2c CD O
) -RRB- O
established VBN O
after IN O
relapse NN O
of IN O
the DT O
patient NN B-Species
under IN O
treatment NN O
with IN O
cytotoxic JJ O
agents NNS O
such JJ O
as IN O
cyclophosphamide NN O
, , O
doxorubicin NN O
, , O
vincristine NN O
and CC O
radiotherapy NN O
. . O

In IN O
NB NNP O
cell NN O
lines NNS O
, , O
p53 NN O
mutation NN O
has VBZ O
been VBN O
found VBN O
in IN O
multidrug NN O
- HYPH O
resistant JJ O
cells NNS O
( SYM O
11 CD O
) -RRB- O
. . O

Various JJ O
types NNS O
of IN O
p53 NN O
mutation NN O
have VBP O
been VBN O
detected VBN O
in IN O
NB NNP O
cells NNS O
and CC O
can MD O
lead VB O
to IN O
inactivation NN O
either CC O
by IN O
shut VBN O
- HYPH O
down RP O
of IN O
protein NN O
expression NN O
or CC O
production NN O
of IN O
aberrant JJ O
p53 NN O
products NNS O
. . O

Indeed RB O
, , O
in IN O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
p53 NN O
nonsense NN O
mutation NN O
at IN O
cysteine NN O
182 CD O
in IN O
exon NN O
5 CD O
leads VBZ O
to IN O
the DT O
absence NN O
of IN O
protein NN O
( , O
9 CD O
) -RRB- O
, , O
whereas IN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( , O
2 CD O
) -RRB- O
cells NNS O
, , O
missense NN O
mutation NN O
at IN O
codon NN O
135 CD O
( , O
C135F NN O
) -RRB- O
leads VBZ O
to IN O
stable JJ O
overexpressed JJ O
protein NN O
( SYM O
11 CD O
) -RRB- O
. . O

By IN O
analyzing VBG O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
a DT O
cell NN O
line NN O
established VBN O
in IN O
our PRP$ O
laboratory NN O
from IN O
the DT O
bone NN O
marrow NN O
of IN O
a DT O
patient NN B-Species
with IN O
metastatic JJ O
NB NNP O
after IN O
unsuccessful JJ O
Adriamycin NNP O
- HYPH O
vincristine NN O
chemotherapy NN O
( SYM O
12 CD O
) -RRB- O
, , O
we PRP O
identified VBD O
another DT O
type NN O
of IN O
aberrant JJ O
protein NN O
that WDT O
arises VBZ O
from IN O
the DT O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
. . O

This DT O
duplication NN O
spans VBZ O
from IN O
amino NN O
acids NNS O
225 CD O
to IN O
331 CD O
, , O
which WDT O
represent VBP O
part NN O
of IN O
the DT O
DBD NN O
and CC O
part NN O
of IN O
the DT O
oligomerization NN O
domain NN O
( -LRB- O
13 CD O
) -RRB- O
. . O

However RB O
, , O
each DT O
p53 NN O
mutant NN O
has VBZ O
been VBN O
described VBN O
in IN O
the DT O
literature NN O
as IN O
a DT O
case NN O
report NN O
, , O
and CC O
so RB O
far RB O
, , O
no DT O
comparative JJ O
study NN O
has VBZ O
been VBN O
undertaken VBN O
to TO O
link VB O
their PRP$ O
biochemical JJ O
features NNS O
with IN O
functional JJ O
properties NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
report VBP O
two CD O
novel JJ O
p53 NN O
C NN O
- HYPH O
terminus NN O
mutants NNS O
identified VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
human JJ B-Species
NB NNP O
cell NN O
lines NNS O
. . O

The DT O
biological JJ O
properties NNS O
of IN O
these DT O
two CD O
new JJ O
variants NNS O
were VBD O
analyzed VBN O
in IN O
comparison NN O
with IN O
p53 NN O
isolated VBN O
from IN O
six CD O
other JJ O
human JJ B-Species
NB NNP O
lines NNS O
: : O
three CD O
[ -LRB- O
LAN NNP O
- HYPH O
1 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
and CC O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
] -RRB- O
expressing VBG O
mutant JJ O
p53 NN O
and CC O
three CD O
( , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NN O
- HYPH O
32 CD O
) , O
expressing VBG O
the DT O
wt NN O
protein NN O
. . O

This DT O
characterization NN O
was VBD O
done VBN O
by IN O
using VBG O
a DT O
range NN O
of IN O
functional JJ O
assays NNS O
: : O
( : O
i PRP O
) -RRB- O
the DT O
ability NN O
of IN O
the DT O
protein NN O
to TO O
bind VB O
with IN O
p53 NN O
consensus NN O
sequence NN O
using VBG O
the DT O
functional JJ O
analysis NN O
of IN O
separated VBN O
allele NN O
in IN O
yeast NN B-Species
( , O
FASAY NNP O
) -RRB- O
; : O
( , O
ii FW O
) -RRB- O
the DT O
ability NN O
of IN O
the DT O
protein NN O
to TO O
transactivate VB O
the DT O
p53 NN O
- HYPH O
responsive JJ O
element NN O
( -LRB- O
RE NN O
) -RRB- O
identified VBN O
either CC O
in IN O
the DT O
promoter NN O
of IN O
p21 NN O
/ SYM O
WAF1 NNP O
or CC O
in IN O
the DT O
first JJ O
intron NN O
of IN O
BAX NNP O
, , O
using VBG O
luciferase NN O
reporter NN O
assay NN O
; : O
( , O
iii FW O
) -RRB- O
the DT O
induction NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
WAF1 NN O
gene NN O
expression NN O
under IN O
stress NN O
conditions NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Neuroblastoma NN O
cell NN O
lines NNS O
, , O
culture NN O
and CC O
drug NN O
treatments NNS O

The DT O
parental JJ O
human JJ B-Species
NB NNP O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS IN O
, , O
IMR NNP O
- HYPH O
32 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
lines NNS O
were VBD O
purchased VBN O
from IN O
the DT O
European NNP O
Collection NNP O
of IN O
Cell NNP O
Cultures NNP O
( : O
ECACC NNP O
, , O
Wiltshire NNP O
, , O
UK NNP O
) -RRB- O
. . O

The DT O
human JJ B-Species
IGR NNP O
- HYPH O
NB8 NNP O
cells NNS O
( , O
a DT O
gift NN O
of IN O
Prof NNP O
. . O
Gilles NNP O
Vassal NNP O
, , O
UPRES NNP O
EA NNP O
3535 CD O
, , O
Institut NNP O
Gustave NNP O
Roussy NNP O
, , O
Villejuif NNP O
) -RRB- O
were VBD O
derived VBN O
from IN O
a DT O
previously RB O
untreated JJ O
localized VBN O
NB NNP O
( SYM O
14 CD O
) -RRB- O
. . O

The DT O
LAN NNP O
- HYPH O
1 CD O
and CC O
LAN NNP O
- HYPH O
5 CD O
cell NN O
lines NNS O
were VBD O
provided VBN O
by IN O
Dr NNP O
Nicole NNP O
Gross NNP O
( : O
Pediatric NNP O
Oncology NNP O
Research NNP O
, , O
Lausanne NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

The DT O
human JJ B-Species
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
was VBD O
established VBN O
in IN O
our PRP$ O
laboratory NN O
from IN O
the DT O
bone NN O
marrow NN O
of IN O
a DT O
patient NN B-Species
with IN O
metastatic JJ O
NB NNP O
after IN O
unsuccessful JJ O
adriamycin NN O
- HYPH O
vincristin NN O
chemotherapy NN O
( : O
12 CD O
) -RRB- O
. . O

LAN NNP O
- HYPH O
1 CD O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
were VBD O
grown VBN O
in IN O
RPMI NNP O
medium NN O
supplemented VBN O
with IN O
2 CD O
mM NN O
l NN O
- HYPH O
glutamine NN O
and CC O
10 CD O
% NN O
fetal JJ O
calf NN O
serum NN O
and CC O
gentamicine NN O
10 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
. . O

Others NNS O
cell NN O
lines NNS O
were VBD O
cultured VBN O
in IN O
DMEM NNP O
. . O

For IN O
activation NN O
of IN O
endogenous JJ O
p53 NN O
, , O
cells NNS O
were VBD O
treated VBN O
with IN O
cis NN O
- HYPH O
platinum NN O
( -LRB- O
Sigma NNP O
) -RRB- O
( , O
10 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
for IN O
24 CD O
h NNS O
then RB O
lysed VBN O
for IN O
western JJ O
blot NN O
analysis NN O
. . O

Western JJ O
blot NN O
analysis NN O

This DT O
procedure NN O
was VBD O
carried VBN O
out RP O
as IN O
described VBN O
previously RB O
( : O
13 CD O
) -RRB- O
. . O

Protein NN O
lysates NNS O
( : O
50 CD O
mu NNS O
g NN O
) -RRB- O
were VBD O
submitted VBN O
to IN O
10 CD O
% NN O
SDS NN O
- HYPH O
PAGE NN O
, , O
and CC O
then RB O
transferred VBN O
onto IN O
nitrocellulose NN O
filters NNS O
. . O

After IN O
saturation NN O
, , O
the DT O
membranes NNS O
were VBD O
incubated VBN O
with IN O
primary JJ O
antibody NN O
diluted VBN O
in IN O
0 CD O
. . O
1 CD O
% NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
, , O
Tween NNP O
- HYPH O
20 CD O
and CC O
3 CD O
% NN O
skim NN O
milk NN O
. . O

The DT O
primary JJ O
antibodies NNS O
used VBN O
were VBD O
anti JJ O
- HYPH O
p53 NN O
monoclonal JJ O
antibody NN O
( , O
clone JJ O
DO NN O
- HYPH O
7 CD O
, , O
1 CD O
/ SYM O
1000 CD O
, , O
DAKO NNP O
) -RRB- O
, , O
anti JJ O
- HYPH O
p21 NN O
/ SYM O
WAF1 NNP O
monoclonal JJ O
antibody NN O
( , O
Ab NNP O
- HYPH O
1 CD O
, , O
1 CD O
/ SYM O
200 CD O
, , O
Oncogene NNP O
Research NNP O
) -RRB- O
and CC O
anti JJ O
- HYPH O
beta NN O
- HYPH O
actin NN O
monoclonal JJ O
antibody NN O
( , O
1 CD O
/ SYM O
1000 CD O
; : O
Chemicon NNP O
) -RRB- O
as IN O
internal JJ O
control NN O
. . O

Protein NN O
bands NNS O
were VBD O
detected VBN O
by IN O
ECL NNP O
system NN O
( : O
Amersham NNP O
) -RRB- O
. . O

PCR NN O
, , O
plasmids NNS O
cloning VBG O

Genomic JJ O
DNA NNP O
was VBD O
extracted VBN O
using VBG O
lysis NN O
buffer NN O
containing VBG O
20 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH NN O
7 CD O
. . O
5 CD O
; : O
0 CD O
. . O
4 CD O
M NN O
NaCl NN O
; : O
0 CD O
. . O
5 CD O
% NN O
SDS NN O
; : O
10 CD O
mM NN O
EDTA NNP O
, , O
treated VBN O
with IN O
proteinase NN O
K NNP O
( , O
200 CD O
mu NNS O
g NN O
/ SYM O
mu NN O
l NN O
) -RRB- O
, , O
purified VBN O
with IN O
phenol NN O
/ SYM O
chloroform NN O
, , O
precipitated VBN O
with IN O
ethanol NN O
and CC O
dissolved VBN O
in IN O
DNase NNP O
free JJ O
water NN O
. . O

Total JJ O
RNA NNP O
were VBD O
purified VBN O
using VBG O
RNAble NNP O
reagent NN O
( , O
Eurobio NNP O
) -RRB- O
, , O
precipitated VBN O
with IN O
isopropanol NN O
and CC O
dissolved VBN O
in IN O
RNase NNP O
free JJ O
water NN O
. . O

cDNA NNP O
was VBD O
obtained VBN O
by IN O
reverse JJ O
transcription NN O
of IN O
1 CD O
mu NNS O
g NN O
of IN O
total JJ O
RNA NNP O
using VBG O
Superscript NNP O
II NNP O
( -LRB- O
TM NNP O
) -RRB- O
RNase NNP O
H NNP O
- HYPH O
Reverse NNP O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
Oligo NNP O
- HYPH O
d NNP O
( -LRB- O
T NNP O
) -RRB- O
16 CD O
in IN O
conditions NNS O
specified VBN O
by IN O
the DT O
manufacturer NN O
. . O

Amplification NN O
of IN O
full JJ O
- HYPH O
length NN O
p53 NN O
coding VBG O
region NN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
cell NN O
lines NNS O
was VBD O
performed VBN O
using VBG O
forward JJ O
primer NN O
at IN O
position NN O
152 CD O
and CC O
reverse JJ O
primer NN O
at IN O
position NN O
1583 CD O
( SYM O
F1 CD O
and CC O
R7 CD O
, , O
respectively RB O
, , O
Table NNP O
1 CD O
; : O
GenBank NNP O
accession NN O
no UH O
. . O
K03199 CD O
) -RRB- O
. . O

p53 NN O
cDNA NN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
for IN O
cloning NN O
was VBD O
obtained VBN O
from IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
F1 NN O
and CC O
reverse JJ O
primer NN O
i9 CD O
+ SYM O
: : O
5 CD O
' '' O
- HYPH O
GCAAAGTCATAGAACCATTT NNP O
- HYPH O
3 CD O
' '' O
( -LRB- O
nucleotide NN O
position NN O
14989 CD O
, , O
GenBank NNP O
accession NN O
no NN O
. . O
X54156 CD O
) -RRB- O
primers NNS O
which WDT O
encompass VBP O
from IN O
exon NN O
1 CD O
to IN O
exon NN O
i9 CD O
+ SYM O
first RB O
identified VBN O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( : O
15 CD O
) NFP O
included VBN O
. . O

The DT O
PCR NNP O
was VBD O
done VBN O
in IN O
the DT O
presence NN O
of IN O
pfu NN O
Hotstart NNP O
DNA NNP O
polymerase NN O
( , O
Stratagene NNP O
) -RRB- O
for IN O
30 CD O
cycles NNS O
of IN O
1 CD O
min NN O
at IN O
90 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
at IN O
65 CD O
degrees NNS O
C NN O
and CC O
2 CD O
min NN O
30 CD O
s NNS O
at IN O
72 CD O
degrees NNS O
C NN O
using VBG O
PTC NNP O
- HYPH O
100 CD O
thermocycler NN O
( , O
MJ NNP O
- HYPH O
Research NNP O
) -RRB- O
. . O

The DT O
p53 NN O
cDNA NN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
were VBD O
then RB O
cloned VBN O
into IN O
pcDNA3 NN O
. . O
1 CD O
/ SYM O
V5 NNP O
- HYPH O
His PRP$ O
- HYPH O
Topo NN O
vector NN O
( , O
Invitrogen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instruction NN O
. . O

The DT O
p53 NN O
sequence NN O
of IN O
each DT O
cell NN O
line NN O
was VBD O
investigated VBN O
by IN O
sequencing NN O
of IN O
plasmids NNS O
after IN O
cloning NN O
. . O

Sequencing NN O
was VBD O
performed VBN O
by IN O
Genome NNP O
Express NNP O
( : O
Meylan NNP O
, , O
France NNP O
) -RRB- O
. . O

The DT O
pDDm NNP O
- HYPH O
TO NNP O
harboring VBG O
p53 NN O
dominant JJ O
negative JJ O
form NN O
( -LRB- O
p53DD NN O
) -RRB- O
pGL3 NNP O
- HYPH O
E1bTATA NNP O
and CC O
the DT O
pE1B NN O
- HYPH O
hWAF1 NNP O
firefly NN O
luciferase NN O
reporter NN O
containing VBG O
the DT O
p53 NN O
- HYPH O
responsive JJ O
element NN O
of IN O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
were VBD O
described VBN O
previously RB O
( : O
16 CD O
, , O
17 CD O
) , O
pE1B NN O
- HYPH O
BAXi NNP O
contains VBZ O
the DT O
p53RE NN O
identified VBN O
in IN O
the DT O
intron NN O
1 CD O
of IN O
the DT O
BAX NNP O
gene NN O
[ -LRB- O
( SYM O
18 CD O
) -RRB- O
and CC O
D NNP O
. . O
Munsch NNP O
, , O
personal JJ O
communication NN O
] -RRB- O
. . O

Oligonucleotides NNP O
TCGAGGGCAGGCCCGGGCTT NNP O
and CC O
CTAGCGACAAGCCCGGGCCT NNP O
were VBD O
annealed VBN O
and CC O
cloned VBN O
into IN O
pGL3 NNP O
- HYPH O
E1bTATA NNP O
digested VBN O
with IN O
NheI NNP O
and CC O
XhoI NNP O
to TO O
obtain VB O
pE1B NN O
- HYPH O
BAXi NNP O
. . O

The DT O
pcDNA3 NNP O
- HYPH O
Delta NNP O
Np73 NNP O
alpha NN O
expression NN O
plasmid NN O
was VBD O
a DT O
gift NN O
of IN O
Dr NNP O
Daniel NNP O
Caput NNP O
( : O
SANOFI NNP O
, , O
Lab NNP O
e FW O
ges FW O
, , O
France NNP O
) -RRB- O
. . O

Fluorescent JJ O
in IN O
situ NN O
hybridization NN O
( , O
FISH NNP O
) -RRB- O

Cytogenetic JJ O
preparations NNS O

Metaphase NN O
spreads VBZ O
from IN O
healthy JJ O
human JJ B-Species
male JJ O
lymphocytes NNS O
and CC O
tumor NN O
cell NN O
lines NNS O
were VBD O
prepared VBN O
as IN O
described VBN O
previously RB O
( : O
19 CD O
) -RRB- O
. . O

BAC NNP O
probe NN O
RP11 NNP O
- HYPH O
199F11 CD O
, , O
containing VBG O
a DT O
167 CD O
kb NN O
region NN O
spanning VBG O
TP53 NN O
gene NN O
, , O
was VBD O
labeled VBN O
by IN O
random JJ O
priming NN O
in IN O
the DT O
presence NN O
of IN O
Alexa NNP O
594 CD O
- HYPH O
dUTP NN O
( : O
Molecular NNP O
Probes NNPS O
) -RRB- O
. . O

A DT O
commercial JJ O
probe NN O
specific JJ O
for IN O
chromosome NN O
17 CD O
centromere NN O
, , O
and CC O
labeled VBN O
with IN O
spectrum NN O
green NN O
, , O
was VBD O
obtained VBN O
from IN O
Vysis NNP O
. . O

After IN O
over IN O
- HYPH O
night NN O
cohybridization NN O
of IN O
the DT O
probes NNS O
in IN O
the DT O
presence NN O
of IN O
Cot NNP O
- HYPH O
1 CD O
DNA NN O
, , O
the DT O
slides NNS O
were VBD O
washed VBN O
and CC O
DNA NNP O
counterstained VBN O
with IN O
DAPI NNP O
. . O

The DT O
preparations NNS O
were VBD O
observed VBN O
with IN O
an DT O
epifluorescence NN O
microscope NN O
and CC O
images NNS O
captured VBN O
with IN O
a DT O
Vysis NNP O
imaging NN O
station NN O
. . O

Between IN O
3 CD O
and CC O
14 CD O
metaphases NNS O
spreads VBZ O
and CC O
30 CD O
- SYM O
200 CD O
nuclei NNS O
were VBD O
examined VBN O
for IN O
each DT O
cell NN O
line NN O
. . O

Luciferase NNP O
reporter NN O
assays NNS O

LAN NNP O
- HYPH O
1 CD O
or CC O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
were VBD O
seeded VBN O
in IN O
duplicates NNS O
onto IN O
6 CD O
- HYPH O
well NN O
plates NNS O
at IN O
a DT O
density NN O
of IN O
2 CD O
x SYM O
104 CD O
cells NNS O
per IN O
cm2 CD O
and CC O
cotransfected VBN O
24 CD O
h NN O
later RB O
with IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
( : O
2 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
of IN O
pGL3 NN O
firefly JJ O
luciferase NN O
reporter NN O
gene NN O
plasmid NN O
under IN O
the DT O
control NN O
of IN O
either CC O
pE1B NN O
- HYPH O
hWAF1 NN O
or CC O
pE1B NN O
- HYPH O
BAX NN O
using VBG O
lipofectamine NN O
2000 CD O
and CC O
1 CD O
mu NN O
g NN O
of IN O
either CC O
a DT O
p53 NN O
expressing VBG O
plasmid NN O
or CC O
an DT O
empty JJ O
vector NN O
. . O

At IN O
24 CD O
h NN O
after IN O
transfection NN O
, , O
cells NNS O
were VBD O
lysed VBN O
with IN O
200 CD O
mu NNS O
l NN O
/ SYM O
well NN O
of IN O
passive JJ O
lysis NN O
buffer NN O
provided VBN O
with IN O
the DT O
' `` O
Luciferase NNP O
assay NN O
kit NN O
' '' O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

Luciferase NNP O
activity NN O
was VBD O
measured VBN O
using VBG O
Microlumat NNP O
LB96P NNP O
luminometer NN O
( , O
EG NNP O
& CC O
G NNP O
Berthold NNP O
Instrument NNP O
) -RRB- O
. . O

Functional JJ O
assay NN O
in IN O
yeast NN B-Species

cDNA NNP O
was VBD O
obtained VBN O
by IN O
RT NNP O
of IN O
1 CD O
mu NNS O
g NN O
of IN O
total JJ O
RNA NNP O
using VBG O
Superscript NNP O
II NNP O
( -LRB- O
TM NNP O
) -RRB- O
RNase NNP O
H NNP O
- HYPH O
Reverse NN O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
random JJ O
hexamers NNS O
to TO O
prime VB O
the DT O
synthesis NN O
in IN O
conditions NNS O
specified VBN O
by IN O
the DT O
manufacturer NN O
. . O

p53 NN O
cDNA NNP O
was VBD O
amplified VBN O
by IN O
PCR NNP O
and CC O
cotransformed VBN O
into IN O
yeast NN B-Species
, , O
IG397 NNP O
Ade2 NNP O
strain NN O
, , O
together RB O
with IN O
either CC O
pRDI NNP O
- HYPH O
22 CD O
vector NN O
for IN O
p53 CD O
- HYPH O
standard JJ O
assay NN O
or CC O
pFW35 NN O
and CC O
pFW34 NN O
plasmid NN O
for IN O
5 CD O
' '' O
or CC O
3 CD O
' '' O
split VBN O
assay NN O
, , O
respectively RB O
, , O
carrying VBG O
the DT O
ADE2 NNP O
open JJ O
reading NN O
frame NN O
under IN O
the DT O
control NN O
of IN O
a DT O
p53 NN O
- HYPH O
responsive JJ O
promoter NN O
( SYM O
20 CD O
) -RRB- O
. . O

In IN O
a DT O
selective JJ O
medium NN O
lacking VBG O
leucine NN O
, , O
wt PRP O
- HYPH O
p53 NN O
activates VBZ O
transcription NN O
of IN O
ADE2 NNP O
gene NN O
that WDT O
encodes VBZ O
enzyme NN O
- HYPH O
- HYPH O
phosphoribosylimidaz NN O
carboxylase NN O
- HYPH O
- HYPH O
implicated VBN O
in IN O
adenine JJ O
biosynthesis NN O
. . O

Therefore RB O
, , O
a DT O
colony NN O
of IN O
cells NNS O
that WDT O
expresses VBZ O
ADE2 NNP O
gene NN O
is VBZ O
white JJ O
whereas IN O
the DT O
one CD O
composed VBN O
of IN O
cells NNS O
where WRB O
ADE2 NN O
gene NN O
is VBZ O
not RB O
expressed VBN O
owing VBG O
p53 NN O
mutation NN O
is VBZ O
red JJ O
. . O

RESULTS NNS O

P53 NN O
status NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
cells NNS O

We PRP O
first RB O
compared VBD O
the DT O
migration NN O
profiles NNS O
of IN O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
with IN O
those DT O
expressed VBN O
in IN O
the DT O
other JJ O
six CD O
NB NNP O
cells NNS O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
, , O
LAN NNP O
- HYPH O
1 CD O
, , O
IMR NNP O
- HYPH O
32 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
and CC O
IGR NN O
- HYPH O
N NN O
- HYPH O
91 CD O
. . O

Western JJ O
blots NNS O
from IN O
50 CD O
mu NNS O
g NN O
of IN O
total JJ O
protein NN O
extracts NNS O
were VBD O
revealed VBN O
with IN O
p53 NN O
monoclonal JJ O
antibody NN O
( -LRB- O
DO NN O
- HYPH O
7 CD O
) -RRB- O
. . O

A DT O
range NN O
of IN O
profiles NNS O
was VBD O
identified VBN O
as IN O
shown VBN O
in IN O
Figure NNP O
1A CD O
. . O

As IN O
expected VBN O
, , O
p53 NN O
extracted VBN O
from IN O
the DT O
three CD O
cell NN O
lines NNS O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
, , O
expressing VBG O
wt NN O
protein NN O
( , O
13 CD O
, , O
21 CD O
) -RRB- O
migrated VBD O
at IN O
the DT O
wt JJ O
position NN O
. . O

Of IN O
particular JJ O
note NN O
in IN O
these DT O
three CD O
wt CD O
p53 NN O
cell NN O
lines NNS O
was VBD O
an DT O
additional JJ O
faint JJ O
band NN O
that WDT O
migrated VBD O
faster RBR O
than IN O
the DT O
full JJ O
- HYPH O
length NN O
protein NN O
. . O

The DT O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
found VBN O
to TO O
be VB O
p53 NN O
deficient JJ O
( : O
9 CD O
) -RRB- O
. . O

The DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
line NN O
showed VBD O
an DT O
intense JJ O
band NN O
reflecting VBG O
p53 NN O
stability NN O
due IN O
to IN O
a DT O
missense JJ O
mutation NN O
at IN O
codon NN O
135 CD O
( SYM O
11 CD O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
due IN O
to IN O
the DT O
previously RB O
identified VBN O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
( SYM O
13 CD O
) -RRB- O
, , O
p53 NN O
protein NN O
migration NN O
was VBD O
delayed VBN O
in IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cells NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
p53 NN O
protein NN O
in IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
migrated VBD O
noticeably RB O
faster RBR O
than IN O
the DT O
wt NN O
protein NN O
, , O
indicating VBG O
that IN O
it PRP O
was VBD O
smaller JJR O
in IN O
size NN O
. . O

The DT O
p53 NN O
protein NN O
in IN O
the DT O
IGR NNP O
- HYPH O
NB8 NNP O
cell NN O
line NN O
was VBD O
even RB O
smaller JJR O
than IN O
that DT O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
. . O

To TO O
analyze VB O
the DT O
coding VBG O
region NN O
of IN O
each DT O
of IN O
the DT O
p53 NN O
variants NNS O
, , O
RT NNP O
- HYPH O
PCR NNP O
was VBD O
performed VBN O
using VBG O
p53 NN O
- HYPH O
specific JJ O
F1 NNP O
- HYPH O
R7 NN O
primers NNS O
( -LRB- O
Table NN O
1 CD O
and CC O
Figure NNP O
1B NNP O
) -RRB- O
. . O

The DT O
expected VBN O
1430 CD O
bp NN O
for IN O
full JJ O
- HYPH O
length NN O
p53 NN O
was VBD O
amplified VBN O
from IN O
wt NN O
p53 CD O
- HYPH O
expressing VBG O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
cell NN O
lines NNS O
. . O

As IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
harbors VBZ O
a DT O
single JJ O
point NN O
mutation NN O
at IN O
codon NN O
135 CD O
( SYM O
C135F NNP O
) -RRB- O
, , O
the DT O
amplified VBN O
fragment NN O
analyzed VBN O
by IN O
electrophoresis NN O
migrated VBN O
as IN O
wt PRP O
p53 CD O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

The DT O
longer JJR O
RT NNP O
- HYPH O
PCR NNP O
fragment NN O
from IN O
the DT O
mutated VBN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
resulted VBD O
from IN O
the DT O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
, , O
as IN O
shown VBN O
in IN O
our PRP$ O
previous JJ O
data NN O
( : O
13 CD O
) -RRB- O
, , O
which WDT O
corresponds VBZ O
to IN O
extra JJ O
nucleic JJ O
material NN O
of IN O
321 CD O
nt NNS O
. . O

For IN O
the DT O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
no DT O
amplified JJ O
fragment NN O
was VBD O
observed VBN O
in IN O
accordance NN O
with IN O
published VBN O
data NNS O
, , O
which WDT O
demonstrates VBZ O
the DT O
extremely RB O
low JJ O
levels NNS O
of IN O
p53 NN O
mRNA NN O
and CC O
the DT O
undetectable JJ O
level NN O
of IN O
protein NN O
( : O
9 CD O
) -RRB- O
. . O

An DT O
amplified JJ O
fragment NN O
of IN O
the DT O
same JJ O
length NN O
as IN O
the DT O
wt NN O
protein NN O
was VBD O
observed VBN O
in IN O
the DT O
IGR NNP O
- HYPH O
NB8 NNP O
cell NN O
line NN O
( -LRB- O
Figure NNP O
1B NN O
) -RRB- O
. . O

Indeed RB O
, , O
complete JJ O
gene NN O
sequencing NN O
revealed VBD O
a DT O
point NN O
mutation NN O
E326STOP NN O
leading VBG O
to IN O
a DT O
truncated VBN O
protein NN O
at IN O
C NNP O
- HYPH O
terminus NN O
. . O

No DT O
fragment NN O
, , O
however RB O
, , O
was VBD O
amplified VBN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
with IN O
F1 NNP O
- HYPH O
R7 NNP O
primers NNS O
. . O

To TO O
further RB O
map VB O
the DT O
p53 NN O
mRNA NNP O
transcribed VBN O
in IN O
these DT O
cells NNS O
, , O
series NN O
of IN O
RT NNP O
- HYPH O
PCR NNP O
tests NNS O
were VBD O
performed VBN O
using VBG O
the DT O
forward JJ O
primer NN O
, , O
F2 NNP O
( HYPH O
exon NN O
8 CD O
position NN O
1008th NN O
according VBG O
to IN O
GenBank NNP O
accession NN O
no UH O
. , O
K03199 CD O
) -RRB- O
, , O
matched VBN O
with IN O
different JJ O
reverse JJ O
primers NNS O
, , O
R3 NNP O
( , O
at IN O
the DT O
junction NN O
of IN O
exon NN O
8 CD O
/ SYM O
9 CD O
, , O
nt CD O
position NN O
1124 CD O
) -RRB- O
, , O
R4 NNP O
, , O
R5 CD O
( , O
in IN O
exon NN O
9 CD O
at IN O
positions NNS O
1154 CD O
and CC O
1184 CD O
, , O
respectively RB O
) -RRB- O
, , O
and CC O
R6 CD O
( , O
in IN O
exon NN O
10 CD O
, , O
at IN O
position NN O
1230 CD O
) -RRB- O
. . O

The DT O
sequences NNS O
of IN O
these DT O
primers NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
and CC O
the DT O
results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
2A NNP O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cDNA NNP O
gave VBD O
an DT O
amplified JJ O
fragment NN O
of IN O
the DT O
same JJ O
size NN O
as IN O
SH NNP O
- HYPH O
SY5Y NNP O
cDNA NNP O
with IN O
the DT O
three CD O
primer NN O
pairs NNS O
, , O
F2 NNP O
/ SYM O
R3 NNP O
, , O
F2 NNP O
/ SYM O
R4 NNP O
and CC O
F3 NNP O
/ SYM O
R5 NNP O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
no DT O
fragment NN O
was VBD O
obtained VBN O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cDNA NNP O
using VBG O
the DT O
F2 NNP O
/ SYM O
R6 NNP O
primer NN O
pair NN O
, , O
which WDT O
suggests VBZ O
the DT O
absence NN O
of IN O
exon NN O
10 CD O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
mRNA NNP O
. . O

The DT O
p53 NN O
protein NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
is VBZ O
the DT O
p53 NN O
beta JJ O
isoform NN O

An DT O
alternatively RB O
spliced VBN O
form NN O
of IN O
human JJ B-Species
p53 NN O
mRNA NN O
with IN O
an DT O
additional JJ O
133 CD O
bp NN O
exon NN O
derived VBN O
from IN O
intron NN O
9 CD O
has VBZ O
been VBN O
detected VBN O
in IN O
normal JJ O
human JJ B-Species
lymphocytes NNS O
( SYM O
15 CD O
) -RRB- O
. . O

This DT O
spliced VBN O
variant NN O
named VBN O
' `` O
i9 CD O
+ NN O
' '' O
encodes VBZ O
a DT O
truncated VBN O
protein NN O
of IN O
341 CD O
amino NN O
acids NNS O
including VBG O
10 CD O
new JJ O
amino NN O
acids NNS O
derived VBN O
from IN O
the DT O
novel JJ O
exon NN O
, , O
the DT O
p53 NN O
beta NN O
isoform NN O
according VBG O
to IN O
Bourdon NNP O
et FW O
al NNP O
. . O
nomenclature NN O
( SYM O
22 CD O
) -RRB- O
. . O

This DT O
led VBD O
us PRP O
to TO O
hypothesize VB O
that IN O
the DT O
shorter JJR O
protein NN O
expressed VBN O
by IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
could MD O
be VB O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
RT NNP O
- HYPH O
PCRs NNS O
were VBD O
performed VBN O
using VBG O
primer NN O
sets NNS O
designed VBN O
to TO O
amplify VB O
the DT O
3 CD O
' '' O
region NN O
of IN O
p53 NN O
mRNA NN O
encoding VBG O
either CC O
the DT O
specific JJ O
C NN O
- HYPH O
terminal JJ O
part NN O
of IN O
the DT O
wt NN O
protein NN O
( , O
wt PRP$ O
C NN O
- HYPH O
ter NN O
) -RRB- O
or CC O
the DT O
specific JJ O
C NN O
- HYPH O
terminal JJ O
part NN O
of IN O
the DT O
beta NN O
isoform NN O
( , O
beta NN O
C NN O
- HYPH O
ter NN O
) -RRB- O
. . O

In IN O
parallel JJ O
amplification NN O
with IN O
a DT O
primer JJ O
pair NN O
amplifying VBG O
the DT O
DBD NNP O
was VBD O
used VBN O
as IN O
control NN O
. . O

The DT O
sequences NNS O
of IN O
these DT O
oligonucleotides NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

The DT O
results NNS O
presented VBN O
in IN O
Figure NNP O
2B NNP O
are VBP O
consistent JJ O
with IN O
the DT O
only JJ O
expression NN O
of IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
as IN O
no DT O
band NN O
was VBD O
observed VBN O
in IN O
lane NN O
using VBG O
specific JJ O
C NN O
- HYPH O
ter NN O
primer NN O
located VBN O
in IN O
exon NN O
10 CD O
. . O

Interestingly RB O
, , O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
SH NNP O
- HYPH O
SY5Y NNP O
( -LRB- O
SH NNP O
) -RRB- O
gave VBD O
an DT O
amplified JJ O
fragment NN O
not RB O
only RB O
with IN O
the DT O
primer JJ O
pair NN O
specific JJ O
to IN O
the DT O
C NNP O
- HYPH O
ter CD O
domain NN O
of IN O
wt NN O
p53 NN O
but CC O
also RB O
with IN O
the DT O
primer NN O
pair NN O
specific JJ O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

This DT O
result NN O
, , O
combined VBN O
with IN O
the DT O
presence NN O
of IN O
an DT O
additional JJ O
faint JJ O
band NN O
migrating VBG O
faster RBR O
than IN O
wt NN O
p53 NN O
in IN O
denaturing VBG O
polyacrylamide NN O
gel NN O
( , O
Figure NNP O
1A NNP O
) -RRB- O
, , O
strongly RB O
suggests VBZ O
that IN O
both CC O
the DT O
p53 NN O
full JJ O
- HYPH O
length NN O
protein NN O
and CC O
the DT O
beta NN O
isoform NN O
were VBD O
expressed VBN O
in IN O
the DT O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
. . O

The DT O
full JJ O
- HYPH O
length NN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
p53 CD O
cDNA NN O
was VBD O
then RB O
amplified VBN O
with IN O
the DT O
forward JJ O
primer NN O
F1 NN O
and CC O
a DT O
reverse JJ O
primer NN O
located VBN O
within IN O
the DT O
novel NN O
exon NN O
i9 CD O
+ NN O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

This DT O
amplified JJ O
fragment NN O
was VBD O
cloned VBN O
in IN O
pcDNA3 NN O
/ SYM O
V5 NNP O
- HYPH O
His NNP O
- HYPH O
Topo NNP O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Its PRP$ O
sequence NN O
analysis NN O
confirmed VBD O
that IN O
the DT O
truncated VBN O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
was VBD O
encoded VBN O
by IN O
the DT O
i9 CD O
+ SYM O
splice NN O
variant NN O
described VBN O
previously RB O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( : O
15 CD O
) NFP O
that DT O
encodes VBZ O
the DT O
p53 NN O
beta NN O
isoform NN O
characterized VBN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

A DT O
series NN O
of IN O
genomic JJ O
amplifications NNS O
were VBD O
performed VBN O
to TO O
identify VB O
a DT O
possible JJ O
deletion NN O
within IN O
the DT O
intron NN O
9 CD O
that WDT O
could MD O
account VB O
for IN O
the DT O
absence NN O
of IN O
normal JJ O
size NN O
p53 NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
. . O

The DT O
primer NN O
sequences NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

Amplifications NNS O
were VBD O
performed VBN O
in IN O
parallel NN O
with IN O
total JJ O
DNA NNP O
extracted VBN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
. . O

Results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
3 CD O
. . O

Normal JJ O
size NN O
fragments NNS O
that WDT O
encompass VBP O
the DT O
acceptor NN O
site NN O
of IN O
intron NN O
9 CD O
were VBD O
amplified VBN O
with IN O
SH NNP O
- HYPH O
SY5Y NNP O
as RB O
well RB O
as IN O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
DNA NNP O
. . O

On IN O
the DT O
contrary JJ O
amplification NN O
fragments NNS O
that WDT O
encompass VBP O
the DT O
intron NN O
9 CD O
donor NN O
site NN O
were VBD O
obtained VBN O
only RB O
with IN O
SH NNP O
- HYPH O
SY5Y NNP O
but CC O
not RB O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
DNA NNP O
. . O

These DT O
results NNS O
identify VBP O
a DT O
deletion NN O
of IN O
the DT O
intron NN O
9 CD O
/ SYM O
exon NN O
10 CD O
junction NN O
within IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
p53 NN O
gene NN O
. . O

A DT O
yeast NN B-Species
functional JJ O
assay NN O
confirmed VBD O
the DT O
absence NN O
of IN O
p53 CD O
full JJ O
- HYPH O
length NN O
expression NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O

It PRP O
is VBZ O
possible JJ O
to TO O
detect VB O
p53 NN O
mutation NN O
using VBG O
a DT O
simple JJ O
yeast NN B-Species
colony NN O
color NN O
assay NN O
as IN O
described VBN O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( SYM O
23 CD O
) -RRB- O
. . O

When WRB O
the DT O
strain NN O
is VBZ O
transformed VBN O
with IN O
a DT O
plasmid NN O
- HYPH O
encoding VBG O
wt NN O
p53 NN O
, , O
the DT O
cells NNS O
express VBP O
the DT O
ADE2 NNP O
gene NN O
and CC O
produce VBP O
white JJ O
colonies NNS O
( -LRB- O
Figure NNP O
4A NN O
, , O
a DT O
, , O
b2 NN O
and CC O
c1 NN O
, , O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
a NN O
) -RRB- O
. . O

Cells NNS O
containing VBG O
mutant JJ O
p53 NN O
fail VBP O
to TO O
express VB O
ADE2 NNP O
and CC O
form VB O
small JJ O
red JJ O
colonies NNS O
( -LRB- O
Figure NN O
4A NN O
, , O
b NN O
and CC O
b1 NN O
, , O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
c NN O
) -RRB- O
. . O

When WRB O
the DT O
p53 NN O
cDNA NN O
fragment NN O
is VBZ O
deleted VBN O
, , O
cells NNS O
are VBP O
unable JJ O
to TO O
form VB O
a DT O
colony NN O
( -LRB- O
Figure NNP O
4A NN O
, , O
c NN O
and CC O
c2 NN O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
2 CD O
, , O
FASAY NNP O
was VBD O
performed VBN O
as IN O
a DT O
p53 NN O
- HYPH O
standard JJ O
test NN O
with IN O
full JJ O
- HYPH O
length NN O
cDNA NN O
or CC O
with IN O
the DT O
split JJ O
version NN O
at IN O
the DT O
5 CD O
' '' O
and CC O
3 CD O
' '' O
end NN O
( SYM O
15 CD O
) -RRB- O
. . O

The DT O
background NN O
of IN O
FASAY NNP O
experiments NNS O
is VBZ O
around RB O
10 CD O
% NN O
. . O

p53 CD O
wt NN O
expressing VBG O
SH NNP O
- HYPH O
SY5Y NNP O
and CC O
LAN NNP O
- HYPH O
5 CD O
, , O
2 CD O
wt NN O
cell NN O
lines NNS O
, , O
yielded VBD O
~ $ O
92 CD O
- SYM O
97 CD O
% NN O
of IN O
white JJ O
colonies NNS O
( : O
Table NNP O
2 CD O
) -RRB- O
. . O

One CD O
hundred CD O
percent NN O
of IN O
the DT O
colonies NNS O
carrying VBG O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
p53 CD O
, , O
which WDT O
is VBZ O
homozygous JJ O
for IN O
the DT O
C135F NNP O
mutation NN O
, , O
turned VBD O
red JJ O
with IN O
the DT O
standard JJ O
or CC O
5 CD O
' '' O
split JJ O
assay NN O
, , O
whereas IN O
94 CD O
% NN O
of IN O
the DT O
colonies NNS O
turned VBD O
white JJ O
with IN O
the DT O
3 CD O
' '' O
split JJ O
assay NN O
since IN O
the DT O
missense NN O
mutation NN O
does VBZ O
not RB O
extend VB O
to IN O
the DT O
C NNP O
' '' O
- HYPH O
terminus NN O
of IN O
the DT O
gene NN O
( -LRB- O
Table NN O
2 CD O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
c NN O
) -RRB- O
. . O

No DT O
colonies NNS O
were VBD O
observed VBN O
with IN O
p53 NN O
- HYPH O
deficient JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
( , O
see VB O
also RB O
Figure NNP O
4A NNP O
, , O
c NN O
and CC O
c2 NN O
) -RRB- O
. . O

With IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
, , O
the DT O
split NN O
5 CD O
' '' O
assay NN O
gave VBD O
96 CD O
% NN O
white JJ O
colonies NNS O
, , O
while IN O
the DT O
p53 NN O
- HYPH O
standard NN O
and CC O
split VBN O
3 CD O
' '' O
assay NN O
did VBD O
not RB O
produce VB O
any DT O
colonies NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

This DT O
means VBZ O
that IN O
the DT O
5 CD O
' '' O
terminus NN O
was VBD O
intact JJ O
whereas IN O
the DT O
3 CD O
' '' O
terminus NN O
had VBD O
been VBN O
deleted VBN O
, , O
as IN O
was VBD O
confirmed VBN O
by IN O
nucleotide NN O
sequence NN O
analysis NN O
. . O

The DT O
IGR NNP O
- HYPH O
NB8 NNP O
colonies NNS O
, , O
however RB O
, , O
were VBD O
red JJ O
both CC O
with IN O
the DT O
p53 NN O
- HYPH O
standard JJ O
assay NN O
and CC O
the DT O
split NN O
3 CD O
' '' O
assay NN O
. . O

In IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
, , O
where WRB O
p53 NN O
harbors VBZ O
two CD O
contiguous JJ O
sets NNS O
of IN O
exons NNS O
7 CD O
- SYM O
9 CD O
, , O
spanning VBG O
the DT O
DBD NN O
and CC O
oligomerization NN O
domain NN O
, , O
it PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
the DT O
yeast NN B-Species
colonies NNS O
were VBD O
predominantly RB O
white JJ O
( , O
Figure NN O
4B NN O
, , O
dish NN O
b NN O
) , O
with IN O
the DT O
split JJ O
5 CD O
' '' O
and CC O
the DT O
split VBN O
3 CD O
' '' O
assay NN O
( : O
96 CD O
and CC O
87 CD O
% NN O
of IN O
white JJ O
colonies NNS O
, , O
respectively RB O
) , O
This DT O
suggests VBZ O
that IN O
the DT O
cells NNS O
express VBP O
a DT O
binding VBG O
ability NN O
that WDT O
is VBZ O
specific JJ O
to IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
rather RB O
than IN O
mutated VBN O
p53 NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

Transcription NN O
activity NN O
of IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
p53 CD O
variants NNS O
in IN O
mammalian JJ O
cells NNS O

To TO O
determine VB O
the DT O
transactivation NN O
ability NN O
of IN O
p53 NN O
variants NNS O
in IN O
mammalian JJ O
cells NNS O
, , O
we PRP O
used VBD O
a DT O
reporter NN O
gene NN O
strategy NN O
. . O

The DT O
p53RE NN O
located VBN O
within IN O
either CC O
the DT O
human JJ B-Species
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
or CC O
the DT O
intron NN O
1 CD O
of IN O
the DT O
mouse NN B-Species
and CC O
human JJ B-Species
BAX NN O
gene NN O
[ -LRB- O
( SYM O
18 CD O
) -RRB- O
and CC O
D NN O
. . O

Munsch NNP O
, , O
personnal JJ O
communication NN O
) , O
were VBD O
cloned VBN O
in IN O
a DT O
luciferase NN O
reporter NN O
gene NN O
plasmid NN O
upstream NN O
of IN O
the DT O
E1B NNP O
minimal JJ O
promoter NN O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

The DT O
p53 NN O
- HYPH O
negative JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
cotransfected VBN O
with IN O
the DT O
p53 NN O
vectors NNS O
expressing VBG O
the DT O
p53 NN O
cloned VBN O
from IN O
either CC O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
or CC O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
the DT O
luciferase NN O
reporter NN O
plasmids NNS O
. . O

Both DT O
p53RE NN O
were VBD O
strongly RB O
stimulated VBN O
in IN O
cells NNS O
cotransfected VBN O
with IN O
wt NN O
p53 NN O
cloned VBN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
as IN O
compared VBN O
to IN O
cells NNS O
cotransfected VBN O
with IN O
an DT O
empty JJ O
plasmid NN O
. . O

In IN O
contrast NN O
, , O
none NN O
of IN O
the DT O
p53 NN O
variants NNS O
was VBD O
able JJ O
to TO O
transactivate VB O
the DT O
expression NN O
of IN O
luciferase NN O
driven VBN O
by IN O
either CC O
p21 CD O
/ SYM O
WAF1 NNP O
or CC O
BAX NN O
p53RE NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

To TO O
test VB O
transactivation NN O
capability NN O
at IN O
the DT O
protein NN O
level NN O
, , O
each DT O
variant NN O
was VBD O
transfected VBN O
into IN O
p53 NN O
- HYPH O
negative JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
and CC O
the DT O
stimulation NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
Waf1 NNP O
gene NN O
expression NN O
was VBD O
analyzed VBN O
by IN O
western JJ O
blotting NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
6 CD O
, , O
in IN O
contrast NN O
to IN O
wt PRP O
p53 CD O
, , O
none NN O
of IN O
the DT O
p53 NN O
variants NNS O
was VBD O
able JJ O
to TO O
induce VB O
p21 NN O
protein NN O
accumulation NN O
. . O

We PRP O
then RB O
tested VBD O
for IN O
a DT O
possible JJ O
dominant JJ O
negative JJ O
effect NN O
of IN O
these DT O
various JJ O
mutants NNS O
on IN O
wt JJ O
p53 NN O
- HYPH O
dependent JJ O
transcriptional JJ O
activity NN O
. . O

To IN O
this DT O
end NN O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
were VBD O
cotransfected VBN O
with IN O
constructs NNS O
encoding VBG O
the DT O
luciferase NN O
gene NN O
driven VBN O
by IN O
either CC O
the DT O
p21 NNP O
/ SYM O
Waf1 NNP O
or CC O
BAX NNP O
p53RE NNP O
and CC O
the DT O
constructs NNS O
expressing VBG O
the DT O
various JJ O
p53s NNS O
cloned VBN O
from IN O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
NB NNP O
cells NNS O
or CC O
p53DD NN O
, , O
a DT O
dominant JJ O
negative JJ O
mutant NN O
of IN O
wt NN O
p53 CD O
( SYM O
24 CD O
) -RRB- O
. . O

The DT O
stress NN O
induced VBN O
by IN O
transfection NN O
activated VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
wt VBN O
p53 NN O
expressed VBN O
in IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
leading VBG O
to IN O
a DT O
p53 NN O
- HYPH O
dependent JJ O
expression NN O
of IN O
luciferase NN O
as IN O
illustrated VBN O
by IN O
the DT O
fact NN O
that IN O
coexpression NN O
of IN O
p53DD NN O
led VBD O
to IN O
a DT O
substantial JJ O
decrease NN O
in IN O
luciferase NN O
activity NN O
when WRB O
compared VBN O
to IN O
the DT O
luciferase JJ O
activity NN O
of IN O
cells NNS O
cotransfected VBN O
with IN O
an DT O
empty JJ O
plasmid NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
p53DD NN O
, , O
mutants NNS O
within IN O
the DT O
DBD NNP O
isolated VBN O
from IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
or CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
had VBD O
only RB O
a DT O
moderate JJ O
dominant JJ O
negative JJ O
effect NN O
on IN O
endogenous JJ O
wt NN O
p53 NN O
transcriptional JJ O
activity NN O
. . O

More RBR O
surprisingly RB O
, , O
the DT O
transfection NN O
of IN O
the DT O
C NNP O
- HYPH O
terminal NN O
truncated VBN O
variant JJ O
IGR NNP O
- HYPH O
NB8 NNP O
enhanced VBD O
both CC O
BAX NNP O
and CC O
p21 NN O
/ SYM O
WAF1 NNP O
p53RE NN O
activity NN O
. . O

The DT O
coexpression NN O
of IN O
p53 NN O
beta NN O
cloned VBN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
also RB O
enhanced VBN O
BAX NNP O
p53RE NN O
activity NN O
. . O

A DT O
similar JJ O
effect NN O
has VBZ O
been VBN O
reported VBN O
already RB O
for IN O
p53 NN O
beta NN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

When WRB O
combined VBN O
, , O
these DT O
results NNS O
show VBP O
that IN O
all PDT O
the DT O
p53 NN O
variants NNS O
isolated VBN O
from IN O
the DT O
NB NNP O
cells NNS O
had VBD O
lost VBN O
the DT O
ability NN O
to TO O
specifically RB O
transactivate VB O
the DT O
p53 NN O
target NN O
genes NNS O
. . O

Their PRP$ O
effect NN O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
endogenous JJ O
wt NN O
p53 NN O
expressed VBN O
in IN O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
, , O
however RB O
, , O
largely RB O
depended VBD O
on IN O
the DT O
p53 NN O
domain NN O
affected VBN O
by IN O
the DT O
modification NN O
. . O

All PDT O
the DT O
identified VBN O
p53 NN O
variants NNS O
inhibited VBD O
the DT O
induction NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
WAF1 NNP O
gene NN O
expression NN O
under IN O
stress NN O
conditions NNS O

We PRP O
further RB O
examined VBD O
whether IN O
the DT O
four CD O
p53 NN O
variants NNS O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
had VBD O
loss NN O
their PRP$ O
ability NN O
to TO O
stimulate VB O
the DT O
endogenous JJ O
expression NN O
of IN O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
gene NN O
, , O
the DT O
archetypical JJ O
cell NN O
cycle NN O
inhibitor NN O
and CC O
the DT O
true JJ O
target NN O
of IN O
p53 NN O
. . O

To IN O
this DT O
end NN O
, , O
cellular JJ O
response NN O
to IN O
genotoxic JJ O
stress NN O
was VBD O
analyzed VBN O
by IN O
western JJ O
blot NN O
following VBG O
treatment NN O
of IN O
the DT O
various JJ O
cell NN O
lines NNS O
with IN O
cisplatin NN O
, , O
one CD O
of IN O
the DT O
most RBS O
potent JJ O
antitumor NN O
agents NNS O
used VBN O
in IN O
neuroblastoma NN O
. . O

Results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
7 CD O
. . O

None NN O
of IN O
the DT O
mutant JJ O
cells NNS O
, , O
regardless RB O
of IN O
the DT O
type NN O
of IN O
mutation NN O
, , O
was VBD O
able JJ O
to TO O
induce VB O
p21 NN O
/ SYM O
WAF1 NN O
protein NN O
accumulation NN O
, , O
unlike IN O
the DT O
3 CD O
p53 CD O
wild JJ O
- HYPH O
type NN O
cells NNS O
( -LRB- O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IMR NNP O
- HYPH O
32 CD O
and CC O
LAN NN O
- HYPH O
5 CD O
) -RRB- O
. . O

Genomic JJ O
status NN O
of IN O
TP53 NN O
region NN O
in IN O
the DT O
various JJ O
cell NN O
lines NNS O

According VBG O
to IN O
Knudson NNP O
' POS O
s NNS O
' `` O
two CD O
hit NN O
' '' O
model NN O
of IN O
tumor NN O
suppressor NN O
gene NN O
functional JJ O
inactivation NN O
, , O
the DT O
mutation NN O
of IN O
one CD O
allele NN O
is VBZ O
supposed VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
deletion NN O
of IN O
the DT O
second JJ O
allele NN O
. . O

To TO O
assess VB O
this DT O
genetic JJ O
mechanism NN O
, , O
we PRP O
performed VBD O
FISH NNP O
experiments NNS O
to TO O
search VB O
for IN O
deletions NNS O
of IN O
one CD O
copy NN O
of IN O
the DT O
TP53 NNP O
region NN O
, , O
especially RB O
in IN O
cell NN O
lines NNS O
with IN O
a DT O
mutated VBN O
TP53 NN O
gene NN O
. . O

For IN O
this DT O
purpose NN O
, , O
metaphase NN O
preparations NNS O
of IN O
the DT O
studied VBN O
cell NN O
lines NNS O
were VBD O
cohybridized VBN O
with IN O
a DT O
p53 NN O
DNA NN O
probe NN O
labeled VBN O
in IN O
red JJ O
( HYPH O
BAC NNP O
clone NN O
RP11 NN O
- SYM O
199F11 CD O
) -RRB- O
as IN O
described VBN O
previously RB O
( : O
25 CD O
) -RRB- O
and CC O
a DT O
chromosome NN O
17 CD O
- HYPH O
specific JJ O
centromeric JJ O
probe NN O
labeled VBN O
in IN O
green NN O
. . O

The DT O
three CD O
cell NN O
lines NNS O
shown VBN O
previously RB O
to TO O
express VB O
a DT O
wt NN O
p53 NN O
protein NN O
( -LRB- O
LAN5 NNP O
, , O
IMR32 NNP O
and CC O
SH NNP O
- HYPH O
SY5Y NNP O
) -RRB- O
, , O
displayed VBN O
as IN O
expected VBN O
two CD O
signals NNS O
with IN O
each DT O
probe NN O
, , O
confirming VBG O
the DT O
presence NN O
of IN O
both DT O
TP53 NN O
alleles NNS O
in IN O
these DT O
cells NNS O
( -LRB- O
Figure NN O
8 CD O
and CC O
Table NN O
3 CD O
) -RRB- O
. . O

Conversely RB O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
lines NNS O
displayed VBD O
only RB O
one CD O
fluorescent JJ O
signal NN O
for IN O
each DT O
probe NN O
, , O
suggesting VBG O
a DT O
whole JJ O
chromosome NN O
17 CD O
lost VBN O
, , O
or CC O
at IN O
least JJS O
losses NNS O
of IN O
the DT O
17p CD O
arm NN O
and CC O
the DT O
centromeric JJ O
region NN O
. . O

The DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
cell NN O
line NN O
has VBZ O
been VBN O
described VBN O
as IN O
containing VBG O
only RB O
one CD O
chromosome NN O
17 CD O
and CC O
one CD O
TP53 NN O
signal NN O
( HYPH O
10 CD O
) -RRB- O
. . O

In IN O
our PRP$ O
analysis NN O
, , O
only RB O
10 CD O
% NN O
of IN O
the DT O
cells NNS O
displayed VBD O
this DT O
characteristic NN O
, , O
whilst IN O
most JJS O
of IN O
the DT O
cells NNS O
had VBD O
two CD O
copies NNS O
of IN O
both DT O
( -LRB- O
Figure NN O
8 CD O
and CC O
Table NN O
3 CD O
) -RRB- O
. . O

p53 NN O
sequencing NN O
, , O
however RB O
, , O
confirmed VBD O
the DT O
previously RB O
described VBN O
mutation NN O
, , O
and CC O
the DT O
absence NN O
of IN O
a DT O
normal JJ O
allele NN O
, , O
suggesting VBG O
that IN O
the DT O
cells NNS O
used VBN O
in IN O
our PRP$ O
study NN O
had VBD O
acquired VBN O
, , O
during IN O
culture NN O
, , O
an DT O
uniparental JJ O
disomy NN O
for IN O
the DT O
TP53 NNP O
- HYPH O
mutated VBN O
chromosome NN O
17 CD O
. . O

Finally RB O
, , O
the DT O
other JJ O
two CD O
cell NN O
lines NNS O
( , O
LAN NNP O
- HYPH O
1 CD O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
) -RRB- O
displayed VBD O
highly RB O
variable JJ O
genetic JJ O
heterogeneity NN O
from IN O
one CD O
cell NN O
to IN O
the DT O
next JJ O
( , O
Table NNP O
3 CD O
) -RRB- O
. . O

Surprisingly RB O
, , O
although IN O
p53 NN O
transcripts NNS O
are VBP O
extremely RB O
faintly RB O
expressed VBN O
in IN O
LAN NNP O
- HYPH O
1 CD O
cell NN O
line NN O
, , O
all DT O
cells NNS O
showed VBD O
several JJ O
FISH NNP O
signals NNS O
with IN O
the DT O
167 CD O
kb NN O
BAC NNP O
probe NN O
used VBN O
here RB O
. . O

To TO O
understand VB O
this DT O
apparent JJ O
contradiction NN O
, , O
an DT O
array JJ O
- HYPH O
CGH NNP O
experiment NN O
was VBD O
performed VBN O
on IN O
an DT O
oligo NN O
- HYPH O
array NN O
Agilent NNP O
, , O
which WDT O
indicated VBD O
a DT O
133 CD O
kb NN O
interstitial JJ O
deletion NN O
corresponding VBG O
to IN O
the DT O
p53 NN O
coding VBG O
region NN O
and CC O
the DT O
97 CD O
kb NN O
upstream JJ O
region NN O
. . O

Accordingly RB O
, , O
the DT O
fluorescent JJ O
spots NNS O
observed VBN O
in IN O
FISH NNP O
experiments NNS O
on IN O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
should MD O
be VB O
related VBN O
to IN O
the DT O
hybridization NN O
of IN O
the DT O
57 CD O
kb NN O
region NN O
downstream RB O
of IN O
p53 NN O
gene NN O
present JJ O
in IN O
the DT O
BAC NNP O
probe NN O
. . O

IGRN NNP O
- HYPH O
B8 NNP O
cell NN O
line NN O
displayed VBD O
a DT O
number NN O
of IN O
signals NNS O
of IN O
both DT O
colors NNS O
ranging VBG O
from IN O
0 CD O
to IN O
4 CD O
, , O
with IN O
87 CD O
% NN O
of IN O
cells NNS O
displaying VBG O
a DT O
loss NN O
for IN O
one CD O
TP53 NN O
allele NN O
. . O

Despite IN O
this DT O
genomic JJ O
variability NN O
, , O
analysis NN O
of IN O
the DT O
p53 NN O
protein NN O
showed VBD O
a DT O
single JJ O
shortened VBN O
form NN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
B8 NN O
cell NN O
line NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Consequently RB O
, , O
and CC O
as IN O
suggested VBN O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
line NN O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
B8 NNP O
cell NN O
line NN O
should MD O
contain VB O
a DT O
variable JJ O
number NN O
of IN O
copies NNS O
of IN O
chromosome NN O
17 CD O
with IN O
mutated VBN O
p53 NN O
. . O

DISCUSSION NN O

The DT O
p53 NN O
gene NN O
, , O
the DT O
' `` O
genome NN O
guardian NN O
' '' O
, , O
is VBZ O
mutated VBN O
in IN O
over IN O
50 CD O
% NN O
of IN O
human JJ B-Species
cancers NNS O
, , O
with IN O
the DT O
most RBS O
common JJ O
mutations NNS O
being VBG O
missense JJ O
mutations NNS O
( : O
> SYM O
2 CD O
/ SYM O
3 CD O
of IN O
mutations NNS O
) -RRB- O
( , O
26 CD O
) -RRB- O
. . O

In IN O
human JJ B-Species
neuroblastoma NN O
tumors NNS O
, , O
p53 NN O
mutations NNS O
are VBP O
rarely RB O
present JJ O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
( , O
5 CD O
, , O
27 CD O
) -RRB- O
; , O
however RB O
, , O
oncogenic JJ O
p53 NN O
mutations NNS O
can MD O
be VB O
found VBN O
in IN O
advanced JJ O
neuroblastomas NNS O
that WDT O
often RB O
relapse VBP O
following VBG O
high JJ O
- HYPH O
dose NN O
chemotherapy NN O
( SYM O
10 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
in IN O
breast NN O
cancers NNS O
, , O
it PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
p53 NN O
mutations NNS O
might MD O
improve VB O
response NN O
to IN O
high JJ O
- HYPH O
dose NN O
chemotherapy NN O
including VBG O
therapy NN O
with IN O
epirubicin NN O
and CC O
cyclophosphamide NN O
( SYM O
28 CD O
) -RRB- O
. . O

An DT O
investigation NN O
into IN O
the DT O
p53 NN O
genomic JJ O
status NN O
and CC O
functions NNS O
of IN O
eight CD O
human JJ B-Species
NB NNP O
lines NNS O
revealed VBD O
that IN O
all DT O
five CD O
of IN O
the DT O
mutated VBN O
cell NN O
lines NNS O
had VBD O
distinct JJ O
genetic JJ O
characteristics NNS O
as IN O
is VBZ O
schematically RB O
represented VBN O
in IN O
Figure NNP O
9 CD O
: : O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
2 CD O
) -RRB- O
with IN O
a DT O
single JJ O
missense NN O
mutation NN O
in IN O
the DT O
p53 NN O
gene NN O
, , O
encoding VBG O
a DT O
highly RB O
stable JJ O
full JJ O
- HYPH O
length NN O
protein NN O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 CD O
proteins NNS O
, , O
although IN O
they PRP O
have VBP O
intact JJ O
transactivation NN O
and CC O
DBDs NNS O
, , O
were VBD O
truncated VBN O
at IN O
the DT O
C NNP O
- HYPH O
terminus NN O
generating VBG O
341 CD O
and CC O
326 CD O
amino NN O
acids NNS O
respectively RB O
; : O
they PRP O
therefore RB O
lack VBP O
the DT O
tetramerization NN O
domain NN O
that WDT O
is VBZ O
essential JJ O
for IN O
an DT O
active JJ O
conformation NN O
. . O

Very RB O
recently RB O
, , O
Bourdon NNP O
et FW O
al NNP O
. . O

( : O
22 CD O
) , O
reported VBD O
the DT O
putative JJ O
occurrence NN O
of IN O
beta NN O
and CC O
gamma NN O
isoforms NNS O
from IN O
different JJ O
tissues NNS O
due IN O
to IN O
alternate JJ O
splicing NN O
that WDT O
indicates VBZ O
the DT O
similarity NN O
to IN O
those DT O
of IN O
p73 NN O
and CC O
p63 NN O
as IN O
identified VBN O
previously RB O
by IN O
Daniel NNP O
Caput NNP O
and CC O
co NN O
- HYPH O
workers NNS O
( SYM O
29 CD O
) -RRB- O
. . O

In IN O
the DT O
p53 NN O
isoforms NNS O
scheme NN O
proposed VBN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( : O
22 CD O
) -RRB- O
, , O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
that WDT O
elicits VBZ O
p53i9 NN O
protein NN O
expression NN O
is VBZ O
consistent JJ O
with IN O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

Genomic JJ O
analysis NN O
reveals VBZ O
that IN O
the DT O
only JJ O
occurrence NN O
of IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
results VBZ O
from IN O
a DT O
deletion NN O
spanning VBG O
the DT O
intron NN O
9 CD O
/ SYM O
exon NN O
10 CD O
junction NN O
. . O

Similar JJ O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
the DT O
p53 NN O
in IN O
IGR NNP O
- HYPH O
NB8 NNP O
that WDT O
lacks VBZ O
67 CD O
amino NN O
acids NNS O
at IN O
C NNP O
- HYPH O
terminus NN O
was VBD O
, , O
alone RB O
, , O
unable JJ O
to TO O
induce VB O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
activation NN O
except IN O
with IN O
endogenous JJ O
wt NN O
- HYPH O
p53 NN O
on IN O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
where WRB O
transfection NN O
with IN O
IGR NNP O
- HYPH O
NB8 NNP O
significantly RB O
augmented VBD O
the DT O
transcriptional JJ O
activation NN O
of IN O
the DT O
p21 NNP O
/ SYM O
Waf NNP O
- HYPH O
1 CD O
promoter NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Studies NNS O
by IN O
other JJ O
authors NNS O
have VBP O
reported VBN O
the DT O
interaction NN O
between IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
and CC O
another DT O
region NN O
that WDT O
impedes VBZ O
the DT O
active JJ O
conformation NN O
of IN O
p53 NN O
, , O
suggesting VBG O
an DT O
allosteric JJ O
model NN O
for IN O
p53 NN O
activity NN O
regulation NN O
( SYM O
30 CD O
) -RRB- O
. . O

Such JJ O
events NNS O
have VBP O
been VBN O
demonstrated VBN O
for IN O
the DT O
342 CD O
- HYPH O
stop NN O
mutant NN O
, , O
generated VBN O
by IN O
mutagenesis NN O
, , O
which WDT O
can MD O
modulate VB O
transactivation NN O
, , O
growth NN O
and CC O
apoptosis NN O
( SYM O
31 CD O
) -RRB- O
. . O

Moreover RB O
, , O
Harms NNP O
and CC O
Chen NNP O
( : O
32 CD O
) -RRB- O
reported VBD O
that IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
basic JJ O
domain NN O
inhibits VBZ O
induction NN O
of IN O
the DT O
proapoptotic JJ O
target NN O
gene NN O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
binding NN O
protein NN O
3 CD O
, , O
suggesting VBG O
that IN O
IGR NNP O
- HYPH O
NB8 NNP O
might MD O
induce VB O
this DT O
gene NN O
. . O

IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
had VBD O
an DT O
abnormally RB O
high JJ O
molecular JJ O
weight NN O
protein NN O
due IN O
to IN O
the DT O
duplication NN O
of IN O
wild JJ O
- HYPH O
type NN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
, , O
thus RB O
affecting VBG O
the DT O
DBD NNP O
and CC O
OD NN O
; : O
and CC O
LAN NNP O
- HYPH O
1 CD O
, , O
with IN O
a DT O
mutation NN O
at IN O
codon NN O
182 CD O
( , O
Cys NNP O
- HYPH O
- HYPH O
> SYM O
stop VB O
) -RRB- O
concurred VBN O
with IN O
an DT O
earlier JJR O
report NN O
showing VBG O
extremely RB O
low JJ O
levels NNS O
of IN O
mRNA NN O
and CC O
undetectable JJ O
protein NN O
expression NN O
( SYM O
9 CD O
) -RRB- O
. . O

Notably RB O
, , O
all PDT O
the DT O
p53 NN O
variants NNS O
, , O
including VBG O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
( : O
beta JJ O
isoform NN O
) -RRB- O
and CC O
IGR NN O
- HYPH O
NB8 NNP O
( : O
C NN O
- HYPH O
terminal NN O
truncated VBN O
p53 NN O
) -RRB- O
, , O
elicited VBD O
a DT O
total JJ O
lack NN O
of IN O
p21 NN O
promoter NN O
activation NN O
. . O

In IN O
particular JJ O
, , O
the DT O
p53 NN O
beta NN O
isoform NN O
was VBD O
unable JJ O
to TO O
induce VB O
endogenous JJ O
p21 NN O
expression NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
, , O
concurring VBG O
with IN O
data NNS O
obtained VBN O
from IN O
in FW O
vitro FW O
transfection NN O
experiments NNS O
in IN O
H1299 CD O
cells NNS O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

For IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cells NNS O
, , O
although IN O
p53 NN O
was VBD O
mutated VBN O
and CC O
unable JJ O
to TO O
transactivate VB O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
, , O
the DT O
FASAY NNP O
global JJ O
test NN O
was VBD O
not RB O
conclusive JJ O
since IN O
~ $ O
80 CD O
% NN O
of IN O
colonies NNS O
were VBD O
white JJ O
and CC O
nearly RB O
20 CD O
% NN O
( , O
see VBP O
also RB O
Table NNP O
2 CD O
) -RRB- O
, , O
though IN O
not RB O
enough RB O
, , O
were VBD O
red JJ O
. . O

Moreover RB O
, , O
in IN O
this DT O
particular JJ O
line NN O
, , O
standard JJ O
sequencing NN O
on IN O
cDNA NN O
using VBG O
primers NNS O
located VBN O
within IN O
each DT O
exon NN O
as IN O
used VBN O
for IN O
routine JJ O
tumor NN O
analysis NN O
was VBD O
unable JJ O
to TO O
detect VB O
any DT O
anomalies NNS O
in IN O
p53 NN O
genetic JJ O
status NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

These DT O
results NNS O
enlighten VBP O
the DT O
limit NN O
of IN O
the DT O
conventional JJ O
tests NNS O
to TO O
detect VB O
a DT O
transcription NN O
inactivation NN O
of IN O
p53 NN O
brought VBN O
by IN O
duplication NN O
within IN O
the DT O
DBD NNP O
. . O

Analysis NN O
of IN O
p53 NN O
genomic JJ O
status NN O
was VBD O
explored VBN O
by IN O
FISH NNP O
experiments NNS O
, , O
in IN O
search NN O
for IN O
a DT O
potential JJ O
biallelic JJ O
inactivation NN O
of IN O
p53 NN O
, , O
with IN O
a DT O
mutation NN O
of IN O
one CD O
allele NN O
and CC O
a DT O
deletion NN O
of IN O
the DT O
second JJ O
one NN O
. . O

This DT O
situation NN O
was VBD O
indeed RB O
clearly RB O
observed VBN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
lines NNS O
, , O
with IN O
an DT O
unambiguous JJ O
loss NN O
of IN O
one CD O
chromosome NN O
17p NN O
arm NN O
in IN O
all DT O
cells NNS O
of IN O
both DT O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
LAN NNP O
- HYPH O
1 CD O
and CC O
IGR NNP O
- HYPH O
NB NNP O
- HYPH O
8 CD O
cell NN O
lines NNS O
showed VBD O
a DT O
more RBR O
complex JJ O
genomic JJ O
situation NN O
which WDT O
should MD O
be VB O
relevant JJ O
of IN O
variable JJ O
copy NN O
numbers NNS O
of IN O
chromosome NN O
17 CD O
bearing NN O
in IN O
most JJS O
cases NNS O
( , O
LAN NNP O
- HYPH O
1 CD O
) -RRB- O
or CC O
in IN O
all DT O
cases NNS O
[ -LRB- O
SKN NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
] -RRB- O
the DT O
mutated JJ O
characteristic JJ O
p53 NN O
allele NN O
. . O

Our PRP$ O
data NNS O
therefore RB O
clearly RB O
demonstrate VBP O
that IN O
each DT O
technique NN O
has VBZ O
a DT O
role NN O
and CC O
a DT O
combination NN O
of IN O
techniques NNS O
is VBZ O
required VBN O
in IN O
order NN O
to TO O
correctly RB O
define VB O
the DT O
p53 NN O
phenotype NN O
and CC O
genotype NN O
in IN O
tumor NN O
and CC O
particularly RB O
in IN O
NB NNP O
cells NNS O
. . O

Our PRP$ O
data NNS O
enlighten VBP O
a DT O
high JJ O
frequency NN O
of IN O
the DT O
C NN O
- HYPH O
terminal JJ O
abnormalities NNS O
( , O
3 CD O
/ SYM O
5 CD O
mutated VBN O
) -RRB- O
in IN O
NB NNP O
cell NN O
lines NNS O
. . O

For IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
a DT O
part NN O
of IN O
the DT O
oligomerization NN O
domain NN O
was VBD O
lost VBN O
and CC O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
gained VBD O
an DT O
extra JJ O
oligomerization NN O
domain NN O
. . O

According VBG O
to IN O
FASAY NNP O
assay NN O
the DT O
p53 NN O
expressed VBN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
still RB O
specifically RB O
bind VBP O
DNA NN O
but CC O
not RB O
the DT O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
in IN O
agreement NN O
with IN O
previous JJ O
published VBN O
data NNS O
obtained VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
( SYM O
33 CD O
) -RRB- O
. . O

With IN O
regards NNS O
to IN O
biological JJ O
relevance NN O
, , O
different JJ O
mutants NNS O
within IN O
the DT O
DBD NNP O
vary VBP O
in IN O
their PRP$ O
oncogenicity NN O
. . O

They PRP O
are VBP O
classified VBN O
into IN O
two CD O
types NNS O
depending VBG O
of IN O
the DT O
location NN O
of IN O
the DT O
mutation NN O
, , O
mutations NNS O
of IN O
class NN O
I PRP O
occur VBP O
in IN O
the DT O
DNA NN O
contact NN O
areas NNS O
, , O
while IN O
class NN O
II NN O
mutations NNS O
occur VBP O
in IN O
areas NNS O
important JJ O
for IN O
the DT O
conformational JJ O
stability NN O
of IN O
p53 NN O
protein NN O
( SYM O
30 CD O
) -RRB- O
. . O

Although IN O
both DT O
class NN O
I PRP O
and CC O
class NN O
II NNP O
mutants NNS O
have VBP O
loss NN O
its PRP$ O
ability NN O
to TO O
specifically RB O
bind VB O
DNA NN O
, , O
class NN O
II NN O
mutations NNS O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
oncogenic JJ O
than IN O
class NN O
I PRP O
. . O

However RB O
, , O
to IN O
our PRP$ O
knowledge NN O
the DT O
oncogenicity NN O
of IN O
mutant NN O
affecting VBG O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
have VBP O
not RB O
been VBN O
studied VBN O
. . O

The DT O
biological JJ O
role NN O
of IN O
the DT O
C NN O
- HYPH O
terminal JJ O
mutants NNS O
needs VBZ O
now RB O
to TO O
be VB O
thoroughly RB O
investigated VBN O
in IN O
NB NNP O
tumors NNS O
. . O

MUC1 NNP O
alters VBZ O
oncogenic JJ O
events NNS O
and CC O
transcription NN O
in IN O
human JJ B-Species
breast NN O
cancer NN O
cells NNS O

Abstract JJ O

Introduction NN O

MUC1 NNP O
is VBZ O
an DT O
oncoprotein NN O
whose WP$ O
overexpression NN O
correlates VBZ O
with IN O
aggressiveness NN O
of IN O
tumors NNS O
and CC O
poor JJ O
survival NN O
of IN O
cancer NN O
patients NNS B-Species
. . O

Many JJ O
of IN O
the DT O
oncogenic JJ O
effects NNS O
of IN O
MUC1 NNP O
are VBP O
believed VBN O
to TO O
occur VB O
through IN O
interaction NN O
of IN O
its PRP$ O
cytoplasmic JJ O
tail NN O
with IN O
signaling VBG O
molecules NNS O
. . O

As IN O
expected VBN O
for IN O
a DT O
protein NN O
with IN O
oncogenic JJ O
functions NNS O
, , O
MUC1 NNP O
is VBZ O
linked VBN O
to IN O
regulation NN O
of IN O
proliferation NN O
, , O
apoptosis NN O
, , O
invasion NN O
, , O
and CC O
transcription NN O
. . O

Methods NNS O

To TO O
clarify VB O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
cancer NN O
, , O
we PRP O
transfected VBD O
two CD O
breast NN O
cancer NN O
cell NN O
lines NNS O
( : O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
) -RRB- O
with IN O
small JJ O
interfering VBG O
( , O
si NN O
) , O
RNA NN O
directed VBN O
against IN O
MUC1 NNP O
and CC O
analyzed VBN O
transcriptional JJ O
responses NNS O
and CC O
oncogenic JJ O
events NNS O
( , O
proliferation NN O
, , O
apoptosis NN O
and CC O
invasion NN O
) -RRB- O
. . O

Results NNS O

Transcription NN O
of IN O
several JJ O
genes NNS O
was VBD O
altered VBN O
after IN O
transfection NN O
of IN O
MUC1 NNP O
siRNA NNP O
, , O
including VBG O
decreased VBN O
MAP2K1 NNP O
( , O
MEK1 NNP O
) -RRB- O
, , O
JUN NNP O
, , O
PDGFA NNP O
, , O
CDC25A NNP O
, , O
VEGF NNP O
and CC O
ITGAV NNP O
( , O
integrin NN O
alpha NN O
v NN O
) -RRB- O
, , O
and CC O
increased VBN O
TNF NNP O
, , O
RAF1 NNP O
, , O
and CC O
MMP2 NNP O
. . O

Additional JJ O
changes NNS O
were VBD O
seen VBN O
at IN O
the DT O
protein NN O
level NN O
, , O
such JJ O
as IN O
increased VBN O
expression NN O
of IN O
c NN O
- HYPH O
Myc NNP O
, , O
heightened VBN O
phosphorylation NN O
of IN O
AKT NNP O
, , O
and CC O
decreased VBN O
activation NN O
of IN O
MEK1 NNP O
/ SYM O
2 CD O
and CC O
ERK1 NNP O
/ SYM O
2 CD O
. . O

These DT O
were VBD O
correlated VBN O
with IN O
cellular JJ O
events NNS O
, , O
as IN O
MUC1 NNP O
siRNA NNP O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
decreased VBD O
proliferation NN O
and CC O
invasion NN O
, , O
and CC O
increased VBD O
stress NN O
- HYPH O
induced VBN O
apoptosis NN O
. . O

Intriguingly RB O
, , O
BT NNP O
- HYPH O
20 CD O
cells NNS O
displayed VBD O
similar JJ O
levels NNS O
of IN O
apoptosis NN O
regardless RB O
of IN O
siRNA NNP O
, , O
and CC O
actually RB O
increased VBN O
proliferation NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

Conclusion NN O

These DT O
results NNS O
further RBR O
the DT O
growing VBG O
knowledge NN O
of IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
transcription NN O
, , O
and CC O
suggest VBP O
that IN O
the DT O
regulation NN O
of IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
may MD O
be VB O
more RBR O
complex JJ O
than IN O
previously RB O
appreciated VBN O
. . O

The DT O
differences NNS O
between IN O
these DT O
two CD O
cell NN O
lines NNS O
emphasize VBP O
the DT O
importance NN O
of IN O
understanding VBG O
the DT O
context NN O
of IN O
cell NN O
- HYPH O
specific JJ O
signaling VBG O
events NNS O
when WRB O
analyzing VBG O
the DT O
oncogenic JJ O
functions NNS O
of IN O
MUC1 NNP O
, , O
and CC O
caution VBP O
against IN O
generalizing VBG O
the DT O
results NNS O
of IN O
individual JJ O
cell NN O
lines NNS O
without IN O
adequate JJ O
confirmation NN O
in IN O
intact JJ O
biological JJ O
systems NNS O
. . O

Introduction NN O

MUC1 NNP O
is VBZ O
the DT O
founding VBG O
member NN O
of IN O
the DT O
mucin NN O
family NN O
: : O
proteins NNS O
characterized VBN O
by IN O
heavy JJ O
O NN O
- HYPH O
glycosylation NN O
centering VBG O
around IN O
a DT O
variable JJ O
number NN O
of IN O
tandem NN O
repeats NNS O
that WDT O
are VBP O
rich JJ O
in IN O
serine NN O
and CC O
threonine NN O
residues NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

MUC1 NNP O
is VBZ O
a DT O
transmembrane JJ O
heterodimer NN O
with IN O
one CD O
subunit NN O
solely RB O
extracellular JJ O
( , O
MUC1 NNP O
- HYPH O
EX NNP O
) -RRB- O
, , O
and CC O
the DT O
other JJ O
subunit NN O
composed VBN O
of IN O
a DT O
short JJ O
extracellular JJ O
stem NN O
, , O
a DT O
single JJ O
transmembrane NN O
domain NN O
, , O
and CC O
the DT O
cytoplasmic JJ O
tail NN O
( , O
together RB O
called VBN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
) -RRB- O
. . O

MUC1 NNP O
possesses VBZ O
both CC O
pro JJ O
- HYPH O
and CC O
anti JJ O
- HYPH O
adhesive JJ O
capacities NNS O
, , O
as IN O
the DT O
MUC1 NNP O
- HYPH O
EX NNP O
provides VBZ O
binding VBG O
sites NNS O
for IN O
a DT O
variety NN O
of IN O
adhesion NN O
proteins NNS O
, , O
while IN O
its PRP$ O
large JJ O
size NN O
and CC O
extended JJ O
structure NN O
prevents VBZ O
cell NN O
- HYPH O
cell NN O
contact NN O
[ -LRB- O
3 CD O
- HYPH O
5 CD O
] -RRB- O
. . O

Initially RB O
described VBN O
as IN O
a DT O
tumor NN O
antigen NN O
overexpressed VBN O
in IN O
> SYM O
90 CD O
% NN O
of IN O
breast NN O
cancers NNS O
, , O
MUC1 NNP O
is VBZ O
now RB O
known VBN O
to TO O
be VB O
an DT O
oncogene NN O
with IN O
roles NNS O
in IN O
both CC O
tumor NN O
formation NN O
and CC O
progression NN O
[ -LRB- O
1 CD O
, , O
6 CD O
] -RRB- O
. . O

Mouse NNP B-Species
studies NNS O
have VBP O
been VBN O
integral JJ O
to IN O
the DT O
current JJ O
understanding NN O
of IN O
MUC1 NNP O
in IN O
cancer NN O
. . O

Muc1 NNP O
knockout NN O
mice NNS B-Species
( -LRB- O
Muc1 NNP O
- HYPH O
/ : O
- : O
; : O
MUC1 NNP O
is VBZ O
human JJ B-Species
; : O
Muc1 NNP O
is VBZ O
mouse NN B-Species
) -RRB- O
show VBP O
a DT O
reduction NN O
in IN O
tumorigenic JJ O
phenotype NN O
when WRB O
crossed VBN O
onto IN O
mice NNS B-Species
overexpressing VBG O
the DT O
Wnt NNP O
- HYPH O
1 CD O
[ -LRB- O
7 CD O
] -RRB- O
or CC O
polyomavirus NN O
middle JJ O
T NN O
antigen NN O
[ -LRB- O
8 CD O
] -RRB- O
oncogenes NNS O
in IN O
the DT O
mammary NN O
gland NN O
. . O

In IN O
contrast NN O
, , O
MUC1 NNP O
overexpression NN O
in IN O
the DT O
mammary JJ O
gland NN O
drives VBZ O
tumor NN O
formation NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
MUC1 NN O
is VBZ O
a DT O
true JJ O
oncogene NN O
. . O

Many JJ O
of IN O
the DT O
oncogenic JJ O
effects NNS O
of IN O
MUC1 NNP O
stem VBP O
from IN O
its PRP$ O
cytoplasmic JJ O
tail NN O
, , O
which WDT O
binds VBZ O
to IN O
several JJ O
proteins NNS O
implicated VBN O
in IN O
cancer NN O
, , O
including VBG O
c NN O
- HYPH O
Src NNP O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
and CC O
the DT O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
( -LRB- O
EGFR NNP O
) -RRB- O
family NN O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
. . O

MUC1 NNP O
stimulates VBZ O
mitogen NN O
activated VBN O
protein NN O
kinase NN O
( -LRB- O
MAPK NNP O
) -RRB- O
signaling VBG O
through IN O
the DT O
extracellular JJ O
signal NN O
regulated VBN O
kinases NNS O
( -LRB- O
ERK1 NNP O
/ SYM O
2 CD O
) -RRB- O
[ -LRB- O
12 CD O
, , O
14 CD O
] -RRB- O
; , O
this DT O
can MD O
occur VB O
through IN O
MUC1 NNP O
association NN O
with IN O
Grb2 NNP O
and CC O
son NN O
of IN O
sevenless JJ O
to TO O
activate VB O
Ras NNP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

ERK1 NNP O
/ SYM O
2 CD O
signaling NN O
is VBZ O
commonly RB O
stimulated VBN O
by IN O
the DT O
Ras NNP O
- HYPH O
Raf NNP O
- HYPH O
MEK NNP O
( , O
MAPK NNP O
and CC O
ERK NNP O
kinase NN O
) -RRB- O
cascade NN O
downstream NN O
of IN O
mitogens NNS O
such JJ O
as IN O
EGFR NNP O
[ -LRB- O
16 CD O
] -RRB- O
, , O
and CC O
regulates VBZ O
transcription NN O
via IN O
factors NNS O
like IN O
the DT O
activator NN O
protein NN O
- HYPH O
1 CD O
complex NN O
. . O

Loss NN O
of IN O
MUC1 NNP O
can MD O
reduce VB O
EGFR NNP O
expression NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
providing VBG O
another DT O
means NN O
of IN O
affecting VBG O
MAPK NNP O
signaling VBG O
. . O

Our PRP$ O
results NNS O
describe VBP O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
MUC1 NNP O
regulates VBZ O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
pathway NN O
, , O
through IN O
modulating VBG O
transcription NN O
of IN O
the DT O
genes NNS O
encoding VBG O
MEK1 NNP O
, , O
Raf NNP O
- HYPH O
1 CD O
, , O
and CC O
c NN O
- HYPH O
Jun NNP O
. . O

MUC1 NNP O
expression NN O
correlates VBZ O
with IN O
increased VBN O
survival NN O
in IN O
response NN O
to IN O
cytotoxic JJ O
or CC O
oxidative JJ O
agents NNS O
[ -LRB- O
18 CD O
- SYM O
21 CD O
] -RRB- O
, , O
and CC O
can MD O
activate VB O
the DT O
phosphoinositol NN O
- HYPH O
3 CD O
kinase NN O
- HYPH O
AKT NN O
pathway NN O
as IN O
part NN O
of IN O
an DT O
anti AFX O
- HYPH O
apoptotic JJ O
response NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

MUC1 NNP O
has VBZ O
also RB O
recently RB O
been VBN O
linked VBN O
to IN O
transcription NN O
, , O
as IN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
localizes VBZ O
to IN O
the DT O
nucleus NN O
[ -LRB- O
22 CD O
] -RRB- O
and CC O
affects VBZ O
transcription NN O
by IN O
beta NN O
- HYPH O
catenin NN O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
, , O
FOXO3a NNP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
p53 NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
and CC O
estrogen NN O
receptor NN O
alpha NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

However RB O
, , O
there EX O
are VBP O
indications NNS O
that IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
oncogenesis NN O
is VBZ O
regulated VBN O
by IN O
cell NN O
type NN O
and CC O
signaling NN O
context NN O
. . O

For IN O
example NN O
, , O
MUC1 NNP O
can MD O
stimulate VB O
Fas NNP O
- HYPH O
mediated VBN O
apoptosis NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
while IN O
Muc1 NNP O
is VBZ O
specifically RB O
down RB O
- HYPH O
regulated VBN O
in IN O
c NN O
- HYPH O
neu NN O
- HYPH O
induced VBN O
mammary JJ O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

This DT O
report NN O
emphasizes VBZ O
the DT O
complexity NN O
of IN O
MUC1 NNP O
signaling NN O
in IN O
breast NN O
cancer NN O
by IN O
contrasting VBG O
results NNS O
from IN O
two CD O
established VBN O
breast NN O
cancer NN O
cell NN O
lines NNS O
. . O

To TO O
understand VB O
MUC1 NN O
function NN O
in IN O
cells NNS O
with IN O
high JJ O
endogenous JJ O
expression NN O
, , O
that RB O
is RB O
, , O
cells NNS O
likely JJ O
to TO O
have VB O
evolved VBN O
with IN O
active JJ O
MUC1 NNP O
signaling NN O
, , O
we PRP O
used VBD O
small JJ O
interfering VBG O
RNA NNP O
( -LRB- O
siRNA NNP O
) -RRB- O
to TO O
knock VB O
down RP O
MUC1 NNP O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
. . O

We PRP O
then RB O
analyzed VBD O
transcription NN O
of IN O
84 CD O
genes NNS O
involved VBN O
in IN O
cancer NN O
, , O
as RB O
well RB O
as IN O
the DT O
effects NNS O
upon IN O
cellular JJ O
events NNS O
linked VBN O
to IN O
oncogenesis NN O
, , O
such JJ O
as IN O
apoptosis NN O
and CC O
proliferation NN O
. . O

Though IN O
the DT O
cell NN O
lines NNS O
show VBP O
some DT O
similarity NN O
in IN O
transcriptional JJ O
alterations NNS O
after IN O
transfection NN O
with IN O
MUC1 NNP O
siRNA NNP O
, , O
their PRP$ O
phenotypes NNS O
are VBP O
quite RB O
dissimilar JJ O
: : O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
increases VBZ O
apoptosis NN O
and CC O
reduces VBZ O
proliferation NN O
and CC O
invasion NN O
, , O
while IN O
BT NNP O
- HYPH O
20 CD O
proliferates VBZ O
more RBR O
rapidly RB O
after IN O
loss NN O
of IN O
MUC1 NNP O
. . O

This DT O
last JJ O
may MD O
reflect VB O
the DT O
striking JJ O
amount NN O
of IN O
active JJ O
AKT NNP O
in IN O
BT NNP O
- HYPH O
20 CD O
; : O
AKT NNP O
activity NN O
is VBZ O
increased VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
which WDT O
agrees VBZ O
with IN O
a DT O
previous JJ O
study NN O
of IN O
MUC1 NNP O
siRNA NNP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
but CC O
disagrees VBZ O
with IN O
results NNS O
from IN O
3Y1 CD O
fibroblasts NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Recent JJ O
studies NNS O
have VBP O
emphasized VBN O
the DT O
complex JJ O
and CC O
context NN O
- HYPH O
specific JJ O
regulation NN O
of IN O
even RB O
such JJ O
classic JJ O
oncogenes NNS O
as IN O
AKT NNP O
[ -LRB- O
28 CD O
] -RRB- O
. . O

The DT O
differences NNS O
between IN O
the DT O
two CD O
breast NN O
cancer NN O
cell NN O
lines NNS O
in IN O
this DT O
study NN O
suggest VBP O
that IN O
MUC1 NNP O
oncogenic JJ O
functions NNS O
are VBP O
also RB O
subject JJ O
to IN O
cell NN O
- HYPH O
specific JJ O
regulation NN O
, , O
and CC O
stress VB O
the DT O
need NN O
for IN O
understanding VBG O
the DT O
cellular JJ O
signaling NN O
context NN O
when WRB O
interpreting VBG O
results NNS O
. . O

Materials NNS O
and CC O
methods NNS O

Cell NN O
culture NN O
and CC O
siRNA NN O
transfection NN O

MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
( , O
American NNP O
Type NNP O
Culture NNP O
Collection NNP O
) -RRB- O
were VBD O
cultured VBN O
in IN O
Dulbecco NNP O
' POS O
s NNP O
modified VBN O
Eagle NNP O
' POS O
s NN O
medium NN O
( , O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
plus CC O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
, , O
1 CD O
% NN O
Glutamax NNP O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
1 CD O
% NN O
penicillin NN O
/ SYM O
streptomycin NN O
. . O

Stable JJ O
cell NN O
lines NNS O
( : O
468 CD O
. . O
Neo NNP O
and CC O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
were VBD O
selected VBN O
with IN O
0 CD O
. . O
5 CD O
mg CD O
/ SYM O
ml NN O
G418 CD O
. . O

For IN O
epidermal JJ O
growth NN O
factor NN O
( -LRB- O
EGF NNP O
) -RRB- O
stimulation NN O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
were VBD O
serum NN O
- HYPH O
starved VBN O
overnight RB O
and CC O
treated VBN O
for IN O
10 CD O
minutes NNS O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
100 CD O
ng NNS O
/ SYM O
ml NN O
EGF NNP O
. . O

Transient JJ O
siRNA NNP O
transfection NN O
was VBD O
performed VBN O
with IN O
Lipofectamine2000 NNP O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
100 CD O
nM NN O
siRNA NNP O
oligonucleotides NNS O
. . O

The DT O
commercially RB O
available JJ O
siRNA NNP O
constructs NNS O
( , O
all DT O
from IN O
Dharmacon NNP O
, , O
Lafayette NNP O
, , O
CO NNP O
, , O
USA NNP O
) -RRB- O
were VBD O
scrambled VBN O
( : O
siCONTROL NNP O
non NN O
- HYPH O
targeting VBG O
siRNA NN O
# NN O
1 CD O
) -RRB- O
, , O
or CC O
directed VBN O
against IN O
firefly JJ O
luciferase NN O
( , O
siCONTROL NNP O
non NNP O
- HYPH O
targeting VBG O
siRNA NN O
# NN O
2 CD O
) -RRB- O
or CC O
MUC1 NNP O
( -LRB- O
siGENOME NN O
smartpool NN O
) -RRB- O
. . O

The DT O
independent JJ O
oligonucleotides NNS O
designed VBN O
in IN O
our PRP$ O
laboratory NN O
target NN O
sequences NNS O
beginning VBG O
at IN O
MUC1 NNP O
codons NNS O
882 CD O
and CC O
956 CD O
, , O
and CC O
have VBP O
been VBN O
described VBN O
previously RB O
[ -LRB- O
29 CD O
] -RRB- O
. . O

The DT O
scrambled VBN O
siRNA NNP O
construct NN O
was VBD O
used VBN O
only RB O
in IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
as IN O
it PRP O
causes VBZ O
a DT O
non AFX O
- HYPH O
specific JJ O
knockdown NN O
of IN O
MUC1 NNP O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
. . O

Cloning NN O
of IN O
MUC1 NN O
WT NN O
vector NN O
and CC O
stable JJ O
transfection NN O

Two CD O
silent JJ O
mutations NNS O
( -LRB- O
G891A NNP O
and CC O
T894C NNP O
) -RRB- O
were VBD O
introduced VBN O
into IN O
the DT O
MUC1 NNP O
cDNA NNP O
( , O
called VBN O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
to TO O
make VB O
it PRP O
resistant JJ O
to IN O
the DT O
882 CD O
siRNA NNP O
that WDT O
targets VBZ O
that DT O
region NN O
of IN O
the DT O
mRNA NNP O
. . O

The DT O
mutant JJ O
cDNA NN O
was VBD O
cloned VBN O
into IN O
the DT O
pLNCX NN O
. . O
1 CD O
vector NN O
with IN O
neomycin NN O
resistance NN O
( , O
gift NN O
of IN O
Joseph NNP O
Loftus NNP O
, , O
Mayo NNP O
Clinic NNP O
, , O
Arizona NNP O
, , O
USA NNP O
) -RRB- O
. . O

Stable JJ O
transfection NN O
was VBD O
performed VBN O
with IN O
Lipofectamine2000 NNP O
; : O
cells NNS O
were VBD O
selected VBN O
beginning VBG O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
and CC O
maintained VBN O
as IN O
a DT O
polyclonal JJ O
population NN O
. . O

Western JJ O
blots NNS O
and CC O
antibodies NNS O

Cells NNS O
were VBD O
lysed VBN O
in IN O
buffer NN O
( , O
20 CD O
mM NN O
HEPES NN O
pH NN O
8 CD O
. . O
0 CD O
, , O
150 CD O
mM NN O
sodium NN O
chloride NN O
, , O
1 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
2 CD O
mM NN O
EDTA NNP O
) , O
with IN O
commercial JJ O
protease NN O
( , O
Complete JJ O
inhibitor NN O
cocktail NN O
, , O
Roche NNP O
, , O
Pleasanton NNP O
, , O
CA NNP O
, , O
USA NNP O
) , O
and CC O
phosphatase NN O
inhibitors NNS O
( , O
10 CD O
mM NN O
sodium NN O
fluoride NN O
, , O
2 CD O
mM NN O
sodium NN O
vanadate NN O
, , O
50 CD O
mu NN O
M NN O
ammonium NN O
molybdate NN O
) -RRB- O
. . O

Protein NN O
concentration NN O
was VBD O
determined VBN O
by IN O
BCA NNP O
( : O
Pierce NNP O
, , O
Rockford NNP O
, , O
IL NNP O
, , O
USA NNP O
) -RRB- O
; : O
50 CD O
mu NNS O
g NN O
of IN O
lysate NN O
were VBD O
loaded VBN O
on IN O
SDS NNP O
- HYPH O
PAGE NNP O
gels NNS O
for IN O
each DT O
experiment NN O
, , O
except IN O
for IN O
the DT O
pMEK1 CD O
/ SYM O
2 CD O
blot NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
, , O
where WRB O
150 CD O
mu NNS O
g VBP O
were VBD O
used VBN O
. . O

Non JJ O
- HYPH O
commercial JJ O
antibodies NNS O
used VBN O
were VBD O
: : O
BC2 NNP O
, , O
a DT O
mouse NN B-Species
monoclonal JJ O
to IN O
the DT O
MUC1 NNP O
- HYPH O
EX NNP O
( , O
gift NN O
of IN O
Dr NNP O
McGuckin NNP O
, , O
Queensland NNP O
University NNP O
, , O
Queensland NNP O
, , O
Australia NNP O
) -RRB- O
, , O
and CC O
CT2 NNP O
, , O
an DT O
Armenian JJ B-Species
hamster NN I-Species
monoclonal JJ O
to IN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
developed VBN O
in IN O
our PRP$ O
lab NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Antibodies NNS O
to IN O
pMEK1 NN O
/ SYM O
2 CD O
, , O
MEK1 NNP O
/ , O
2 CD O
, , O
ERK1 NNP O
/ , O
2 CD O
, , O
Myc NNP O
, , O
pAKT NNP O
, , O
AKT NNP O
, , O
beta NN O
- HYPH O
tubulin NN O
( , O
all DT O
Cell NNP O
Signaling NNP O
, , O
Danvers NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
, , O
beta NN O
- HYPH O
actin NN O
and CC O
dpERK1 NNP O
/ SYM O
2 CD O
( , O
both DT O
Sigma NNP O
, , O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
were VBD O
used VBN O
according VBG O
to IN O
manufacturers NNS O
' POS O
recommendations NNS O
. . O

All DT O
antibodies NNS O
except IN O
beta NN O
- HYPH O
actin NN O
( : O
1 CD O
: SYM O
2 CD O
, , O
500 CD O
) -RRB- O
and CC O
dpERK1 CD O
/ SYM O
2 CD O
( SYM O
1 CD O
: SYM O
10 CD O
, , O
0 CD O
) -RRB- O
were VBD O
used VBN O
at IN O
1 CD O
: SYM O
1 CD O
, , O
0 CD O
dilution NN O
for IN O
western JJ O
blots NNS O
. . O

Flow NN O
cytometric JJ O
analysis NN O
of IN O
MUC1 NNP O
was VBD O
done VBN O
with IN O
HMPV NNP O
- HYPH O
FITC NNP O
, , O
which WDT O
recognizes VBZ O
the DT O
core NN O
peptide NN O
of IN O
the DT O
MUC1 NNP O
- HYPH O
EX NN O
tandem NN O
repeats NNS O
( , O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Bromodeoxyuridine NNP O
( -LRB- O
BrdU NNP O
) -RRB- O
staining NN O
was VBD O
performed VBN O
with IN O
a DT O
fluorescently RB O
conjugated VBN O
antibody NN O
to IN O
BrdU NNP O
( : O
BrdU NNP O
- HYPH O
PE NNP O
, , O
BD NNP O
Biosciences NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
as IN O
described VBN O
below RB O
. . O

Densitometry NNP O
was VBD O
performed VBN O
using VBG O
the DT O
public JJ O
domain NN O
ImageJ NNP O
program NN O
( , O
developed VBN O
at IN O
the DT O
NIH NNP O
and CC O
available JJ O
at IN O
[ $ O
30 CD O
] -RRB- O
. . O

Each DT O
band NN O
was VBD O
measured VBN O
in IN O
three CD O
places NNS O
; : O
the DT O
results NNS O
were VBD O
averaged VBN O
and CC O
normalized VBN O
to IN O
tubulin NN O
to TO O
control VB O
for IN O
loading NN O
. . O

Transwell NNP O
invasion NN O
assays NNS O

Cells NNS O
were VBD O
serum NN O
- HYPH O
starved VBN O
beginning VBG O
24 CD O
hours NNS O
post JJ O
- HYPH O
siRNA NNP O
transfection NN O
. . O

Cells NNS O
were VBD O
re RB O
- HYPH O
plated VBN O
in IN O
serum NN O
- HYPH O
free JJ O
medium NN O
48 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
at IN O
50 CD O
, , O
0 CD O
cells NNS O
per IN O
insert NN O
( , O
sized JJ O
for IN O
24 CD O
- HYPH O
well NN O
plates NNS O
) -RRB- O
, , O
with IN O
serum NN O
- HYPH O
containing VBG O
medium NN O
in IN O
the DT O
bottom NN O
of IN O
the DT O
growth NN O
well RB O
as IN O
an DT O
attractant NN O
. . O

Transwell NNP O
inserts VBZ O
( -LRB- O
BD NNP O
Biosciences NNP O
) -RRB- O
pre NN O
- HYPH O
coated VBN O
with IN O
laminin NN O
, , O
fibronectin NN O
, , O
collagen NN O
IV NN O
, , O
or CC O
control NN O
( , O
no DT O
matrix NN O
) -RRB- O
were VBD O
used VBN O
, , O
and CC O
cells NNS O
were VBD O
permitted VBN O
to TO O
invade VB O
for IN O
48 CD O
hours NNS O
. . O

At IN O
this DT O
point NN O
( , O
96 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
) -RRB- O
, , O
visual JJ O
inspection NN O
of IN O
the DT O
growth NN O
wells NNS O
confirmed VBD O
that IN O
negligible JJ O
numbers NNS O
of IN O
cells NNS O
went VBD O
through RB O
to IN O
the DT O
bottom NN O
of IN O
the DT O
plate NN O
. . O

Non NNP O
- HYPH O
invaded VBN O
cells NNS O
were VBD O
swabbed VBN O
from IN O
the DT O
tops NNS O
of IN O
half NN O
of IN O
the DT O
inserts NNS O
( , O
' `` O
samples NNS O
' '' O
, , O
containing VBG O
only RB O
invaded VBN O
cells NNS O
) -RRB- O
, , O
and CC O
retained VBN O
in IN O
the DT O
others NNS O
( , O
' `` O
controls NNS O
' '' O
, , O
all DT O
cells NNS O
) -RRB- O
. . O

Inserts NNS O
were VBD O
stained VBN O
for IN O
10 CD O
minutes NNS O
with IN O
crystal NN O
violet NN O
( , O
0 CD O
. . O
5 CD O
% NN O
in IN O
20 CD O
% NN O
methanol NN O
) -RRB- O
and CC O
washed VBN O
with IN O
water NN O
. . O

Membranes NNS O
were VBD O
cut VBN O
out RP O
and CC O
destained VBD O
for IN O
10 CD O
minutes NNS O
in IN O
10 CD O
% NN O
acetic JJ O
acid NN O
in IN O
a DT O
96 CD O
- HYPH O
well NN O
plate NN O
; : O
membranes NNS O
were VBD O
removed VBN O
and CC O
absorbance NN O
was VBD O
read VBN O
at IN O
570 CD O
nm NN O
. . O

Percent NN O
invasion NN O
is VBZ O
defined VBN O
as IN O
( , O
absorbance NN O
of IN O
samples NNS O
/ SYM O
absorbance NN O
of IN O
controls NNS O
) SYM O
x SYM O
100 CD O
. . O

[ -LRB- O
3H NN O
] -RRB- O
Thymidine NN O
incorporation NN O
assays NNS O

Cells NNS O
were VBD O
re RB O
- HYPH O
plated VBN O
in IN O
quadruplicate JJ O
24 CD O
hours NNS O
post NN O
- HYPH O
siRNA NN O
transfection NN O
at IN O
15 CD O
, , O
0 CD O
cells NNS O
/ SYM O
well NN O
( HYPH O
96 CD O
- HYPH O
well NN O
plate NN O
) -RRB- O
with IN O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
( , O
1 CD O
mu NN O
Ci NN O
/ SYM O
well NN O
) -RRB- O
, , O
then RB O
incubated VBN O
in IN O
normal JJ O
conditions NNS O
for IN O
24 CD O
hours NNS O
. . O

At IN O
this DT O
time NN O
( , O
48 CD O
hours NNS O
post NN O
- HYPH O
siRNA NNP O
transfection NN O
) , O
excess JJ O
radioactivity NN O
was VBD O
washed VBN O
off RP O
and CC O
the DT O
cells NNS O
were VBD O
harvested VBN O
and CC O
read VBN O
on IN O
a DT O
TopCount NNP O
plate NN O
reader NN O
. . O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
JMP NNP O
5 CD O
. . O
1 CD O
. . O
2 CD O
software NN O
( : O
SAS NNP O
Institute NNP O
, , O
Inc NNP O
. . O
, , O
Cary NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
; : O
the DT O
student NN O
' '' O
s POS O
t NN O
test NN O
was VBD O
used VBN O
to TO O
determine VB O
p NN O
values NNS O
and CC O
significance NN O
was VBD O
confirmed VBN O
with IN O
Wilcoxon NNP O
rank NN O
sum NN O
and CC O
Pearson NNP O
chi NN O
squared VBD O
analyses NNS O
. . O

BrdU NNP O
incorporation NN O

BrdU NNP O
( , O
50 CD O
mu NNS O
M NN O
) -RRB- O
was VBD O
given VBN O
to IN O
cells NNS O
48 CD O
hours NNS O
post JJ O
- HYPH O
siRNA NN O
transfection NN O
and CC O
permitted VBN O
to TO O
incorporate VB O
for IN O
1 CD O
. . O
5 CD O
hours NNS O
. . O

Cells NNS O
were VBD O
then RB O
washed VBN O
with IN O
PBS NNP O
, , O
trypsinized VBN O
, , O
and CC O
washed VBN O
again RB O
. . O

BrdU NNP O
staining NN O
was VBD O
performed VBN O
according VBG O
to IN O
an DT O
adaptation NN O
of IN O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
: : O
cells NNS O
were VBD O
re RB O
- HYPH O
suspended VBN O
in IN O
PBS NNP O
, , O
mixed JJ O
1 CD O
: SYM O
1 CD O
with IN O
- SYM O
20 CD O
degrees NNS O
C NN O
neat JJ O
ethanol NN O
, , O
and CC O
incubated VBN O
1 CD O
hour NN O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
to TO O
fix VB O
. . O

Fixed VBN O
cells NNS O
were VBD O
then RB O
washed VBN O
gently RB O
and CC O
denatured VBN O
in IN O
2 CD O
M NN O
HCl NNP O
for IN O
20 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
. . O

Following VBG O
washing NN O
and CC O
2 CD O
minute NN O
' POS O
s NNS O
incubation NN O
with IN O
0 CD O
. . O
1 CD O
M NN O
Tris NN O
to TO O
neutralize VB O
the DT O
acid NN O
, , O
cells NNS O
were VBD O
re RB O
- HYPH O
suspended VBN O
in IN O
FACS NNP O
buffer NN O
( : O
0 CD O
. . O
5 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
in IN O
PBS NNP O
) -RRB- O
and CC O
stained VBN O
with IN O
Phycoerythrin NNP O
( -LRB- O
PE NN O
) -RRB- O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
BrdU NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
for IN O
flow NN O
cytometry NN O
analysis NN O
on IN O
a DT O
FACScan NNP O
instrument NN O
. . O

Apoptosis NN O
and CC O
trypan NN O
blue JJ O
staining NN O

Apoptosis NN O
was VBD O
measured VBN O
using VBG O
a DT O
kit NN O
( , O
BD NNP O
Biosciences NNPS O
) , O
containing VBG O
propidium NN O
iodide NN O
( , O
PI NN O
) -RRB- O
and CC O
FITC NNP O
- HYPH O
conjugated VBN O
annexin NN O
V NN O
. . O

Cells NNS O
were VBD O
stained VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
and CC O
the DT O
level NN O
of IN O
apoptosis NN O
determined VBN O
by IN O
flow NN O
cytometry NN O
. . O

Quadrants NNS O
are VBP O
: : O
early JJ O
apoptosis NN O
( , O
annexin NN O
V NN O
+ CC O
/ SYM O
PI NN O
- HYPH O
, , O
lower RBR O
right JJ O
) , O
late JJ O
apoptosis NN O
( , O
annexin NN O
V NN O
+ CC O
/ SYM O
PI NN O
+ CC O
, , O
upper JJ O
right NN O
) NFP O
and CC O
non JJ O
- HYPH O
apoptotic JJ O
cell NN O
death NN O
( , O
annexin NN O
V NN O
- HYPH O
/ SYM O
PI NN O
+ CC O
, , O
upper JJ O
left NN O
) -RRB- O
. . O

Treatments NNS O
for IN O
the DT O
stress NN O
panel NN O
were VBD O
: : O
no DT O
treatment NN O
( HYPH O
control NN O
) -RRB- O
; , O
DMSO NNP O
as IN O
a DT O
control NN O
for IN O
celecoxib NN O
; : O
20 CD O
mM NN O
celecoxib NN O
, , O
brand NN O
name NN O
Celebrex NNP O
( -LRB- O
TM NNP O
) -RRB- O
( , O
dissolved VBN O
in IN O
DMSO NNP O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
; : O
0 CD O
. . O
2 CD O
mM NN O
H2O2 NNP O
[ -LRB- O
32 CD O
] -RRB- O
; : O
or CC O
1 CD O
mg NN O
/ SYM O
mL NN O
G418 CD O
( , O
Pfizer NNP O
, , O
New NNP O
York NNP O
, , O
NY NNP O
, , O
USA NNP O
) -RRB- O
. . O

Real JJ O
- HYPH O
time NN O
PCR NNP O
arrays VBZ O

Transcriptional JJ O
analysis NN O
using VBG O
Cancer NNP O
PathwayFinder NNP O
RT2 NNP O
profiler NN O
arrays NNS O
( , O
SuperArray NNP O
, , O
Frederick NNP O
, , O
MD NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
performed VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Briefly RB O
, , O
total JJ O
RNA NNP O
was VBD O
isolated VBN O
using VBG O
an DT O
RNeasy NNP O
extraction NN O
kit NN O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
; : O
1 CD O
mu NN O
g NN O
of IN O
RNA NNP O
was VBD O
reverse RB O
transcribed VBN O
with IN O
the DT O
cDNA NNP O
synthesis NN O
kit NN O
( , O
SuperArray NNP O
) -RRB- O
and CC O
cDNA NNP O
was VBD O
subjected VBN O
to IN O
real JJ O
- HYPH O
time NN O
PCR NN O
using VBG O
SYBR NN O
green NN O
to TO O
detect VB O
product NN O
. . O

Arrays NNS O
were VBD O
performed VBN O
independently RB O
at IN O
least JJS O
twice RB O
for IN O
each DT O
cell NN O
line NN O
; : O
all DT O
PCR NNP O
products NNS O
were VBD O
checked VBN O
on IN O
agarose JJ O
gels NNS O
. . O

Values NNS O
were VBD O
obtained VBN O
for IN O
the DT O
threshold NN O
cycle NN O
( -LRB- O
Ct NNP O
) -RRB- O
for IN O
each DT O
gene NN O
and CC O
normalized VBN O
using VBG O
the DT O
average NN O
of IN O
four CD O
housekeeping NN O
genes NNS O
on IN O
the DT O
same JJ O
array NN O
( , O
HPRT1 NNP O
, , O
RPL13A NNP O
, , O
GAPD NNP O
, , O
ACTB NNP O
) -RRB- O
. . O

Ct NN O
values NNS O
for IN O
housekeeping NN O
genes NNS O
and CC O
a DT O
dilution NN O
series NN O
of IN O
ACTB NNP O
were VBD O
monitored VBN O
for IN O
consistency NN O
between IN O
arrays NNS O
. . O

Change NNP O
( -LRB- O
Delta NNP O
Ct NNP O
) -RRB- O
between IN O
MUC1 NNP O
siRNA NNP O
and CC O
control NN O
siRNA NNP O
was VBD O
found VBN O
by IN O
: : O

Delta NNP O
Ct NNP O
= : O
Ct NNP O
( , O
MUC1 NNP O
siRNA NNP O
) -RRB- O
- : O
Ct NNP O
( HYPH O
control NN O
siRNA NNP O
) -RRB- O

and CC O
fold VB O
change NN O
by IN O
: : O

Fold NN O
change NN O
= SYM O
2 CD O
( SYM O
- HYPH O
Delta NNP O
Ct NNP O
) . O

Values NNS O
are VBP O
given VBN O
as IN O
fold NN O
change NN O
; , O
only RB O
genes NNS O
showing VBG O
two CD O
- HYPH O
fold NN O
or CC O
greater JJR O
change NN O
were VBD O
considered VBN O
. . O

Both DT O
luciferase NN O
and CC O
scrambled VBN O
siRNA NNP O
controls NNS O
were VBD O
used VBN O
in IN O
BT NNP O
- HYPH O
20 CD O
; : O
only RB O
genes NNS O
showing VBG O
consistent JJ O
alteration NN O
with IN O
both DT O
controls NNS O
were VBD O
included VBN O
in IN O
the DT O
results NNS O
reported VBN O
here RB O
. . O

The DT O
scrambled VBN O
siRNA NNP O
could MD O
be VB O
not RB O
used VBN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
as IN O
these DT O
cells NNS O
decrease VBP O
MUC1 NNP O
expression NN O
in IN O
response NN O
to IN O
this DT O
construct NN O
. . O

Results NNS O

siRNA NNP O
transfection NN O
decreases VBZ O
MUC1 NNP O
expression NN O
in IN O
breast NN O
cancer NN O
cell NN O
lines NNS O

Two CD O
human JJ B-Species
breast NN O
cancer NN O
cell NN O
lines NNS O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
, , O
were VBD O
transiently RB O
transfected VBN O
with IN O
a DT O
pool NN O
of IN O
four CD O
siRNA NNP O
oligonucleotides NNS O
directed VBN O
against IN O
the DT O
MUC1 NNP O
mRNA NNP O
( SYM O
468 CD O
. , O
siMUC1 NN O
and CC O
BT NN O
. . O
siMUC1 NNP O
) -RRB- O
, , O
or CC O
a DT O
control NN O
oligonucleotide NN O
directed VBN O
against IN O
luciferase NN O
( , O
468 CD O
. . O
siLuc NN O
and CC O
BT NN O
. . O
siLuc NNP O
) -RRB- O
. . O

Both DT O
cell NN O
lines NNS O
express VBP O
high JJ O
levels NNS O
of IN O
MUC1 NNP O
, , O
making VBG O
them PRP O
promising JJ O
targets NNS O
for IN O
this DT O
analysis NN O
. . O

Western JJ O
blots NNS O
( -LRB- O
Figure NNP O
1a NNP O
) -RRB- O
show VBP O
successful JJ O
knockdown NN O
of IN O
both CC O
the DT O
extracellular JJ O
domain NN O
and CC O
cytoplasmic JJ O
tail NN O
fragments NNS O
of IN O
MUC1 NNP O
; : O
luciferase NN O
siRNA NNP O
does VBZ O
not RB O
substantially RB O
change VB O
the DT O
level NN O
of IN O
MUC1 NNP O
compared VBN O
to IN O
parental JJ O
cells NNS O
. . O

468 CD O
. . O
siMUC1 NNP O
show VBP O
a DT O
substantial JJ O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
MUC1 NNP O
- HYPH O
CT NNP O
, , O
while IN O
BT NNP O
. . O
siMUC1 NNP O
show VBP O
slightly RB O
less JJR O
knockdown NN O
of IN O
MUC1 NNP O
- HYPH O
CT NNP O
. . O

Both CC O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
display VBP O
a DT O
less RBR O
dramatic JJ O
decrease NN O
of IN O
MUC1 NNP O
extracellular JJ O
domain NN O
compared VBN O
to IN O
MUC1 NNP O
- HYPH O
CT NNP O
( -LRB- O
Figure NNP O
1a CD O
) -RRB- O
; , O
this DT O
likely RB O
represents VBZ O
protein NN O
synthesized VBN O
prior RB O
to IN O
transfection NN O
, , O
and CC O
may MD O
reflect VB O
differences NNS O
in IN O
the DT O
turnover NN O
rates NNS O
of IN O
the DT O
two CD O
subunits NNS O
. . O

Analysis NN O
of IN O
the DT O
MUC1 NNP O
extracellular JJ O
domain NN O
by IN O
flow NN O
cytometry NN O
confirms VBZ O
that IN O
both DT O
cell NN O
lines NNS O
substantially RB O
decrease VBP O
MUC1 NNP O
expression NN O
after IN O
siRNA NNP O
( -LRB- O
Figure NNP O
1b NN O
) -RRB- O
. . O

By IN O
flow NN O
cytometry NN O
, , O
468 CD O
. , O
siMUC1 NN O
averaged VBD O
75 CD O
% NN O
knockdown NN O
of IN O
MUC1 NNP O
compared VBN O
to IN O
468 CD O
. . O
siLuc NNP O
; : O
and CC O
BT NNP O
. . O
siMUC1 NNP O
averaged VBD O
50 CD O
% NN O
knockdown NN O
relative JJ O
to IN O
BT NNP O
. . O
siLuc NNP O
. . O

These DT O
effects NNS O
could MD O
be VB O
titrated VBN O
with IN O
the DT O
concentration NN O
of IN O
siRNA NNP O
, , O
were VBD O
seen VBN O
as RB O
early RB O
as IN O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
( , O
data NNS O
not RB O
shown VBN O
) , O
and CC O
lasted VBN O
to IN O
at IN O
least JJS O
96 CD O
h CD O
post NN O
- HYPH O
transfection NN O
( -LRB- O
Figure NNP O
1b NN O
) -RRB- O
. . O

All DT O
experiments NNS O
were VBD O
conducted VBN O
within IN O
48 CD O
to TO O
96 CD O
hours NNS O
after IN O
siRNA NNP O
transfection NN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
using VBG O
two CD O
independent JJ O
oligonucleotides NNS O
designed VBN O
in IN O
our PRP$ O
lab NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
designated VBN O
' `` O
882 CD O
' '' O
and CC O
' `` O
956 CD O
' '' O
for IN O
the DT O
initial JJ O
codon NN O
recognized VBN O
by IN O
each DT O
. . O

Transcriptional JJ O
changes NNS O
are VBP O
seen VBN O
after IN O
MUC1 NNP O
siRNA NNP O

Recent JJ O
work NN O
indicates VBZ O
that IN O
MUC1 NNP O
may MD O
affect VB O
transcription NN O
both DT O
directly RB O
via IN O
interaction NN O
with IN O
transcription NN O
factors NNS O
and CC O
indirectly RB O
( , O
for IN O
example NN O
, , O
through IN O
modulating VBG O
signaling NN O
) -RRB- O
. . O

To TO O
study VB O
the DT O
effects NNS O
of IN O
MUC1 NNP O
knockdown NN O
in IN O
breast NN O
cancer NN O
cell NN O
lines NNS O
, , O
real JJ O
- HYPH O
time NN O
PCR NN O
arrays NNS O
were VBD O
used VBN O
to TO O
analyze VB O
transcription NN O
of IN O
84 CD O
genes NNS O
implicated VBN O
in IN O
cancer NN O
. . O

Only RB O
genes NNS O
with IN O
greater JJR O
than IN O
two CD O
- HYPH O
fold NN O
change NN O
were VBD O
considered VBN O
. . O

Three CD O
genes NNS O
( , O
MAP2K1 NNP O
, , O
VEGF NNP O
, , O
PDGFA NNP O
) -RRB- O
were VBD O
altered VBN O
two CD O
- HYPH O
fold NN O
or CC O
more JJR O
after IN O
MUC1 NNP O
siRNA NNP O
in IN O
both DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
; , O
two CD O
genes NNS O
( , O
ITGAV NNP O
, , O
MMP2 NNP O
) -RRB- O
changed VBN O
only RB O
in IN O
468 CD O
. , O
siMUC1 NNP O
; : O
and CC O
five CD O
genes NNS O
( , O
TIMP3 NNP O
, , O
RAF1 NNP O
, , O
JUN NNP O
, , O
TNF NNP O
, , O
CDC25A NNP O
) -RRB- O
only RB O
in IN O
BT NNP O
. . O
siMUC1 NNP O
. . O

This DT O
list NN O
represents VBZ O
all DT O
genes NNS O
affected VBN O
greater JJR O
than IN O
two CD O
- HYPH O
fold NN O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
rather RB O
than IN O
a DT O
select JJ O
group NN O
. . O

Three CD O
genes NNS O
whose WP$ O
transcription NN O
was VBD O
changed VBN O
by IN O
less JJR O
than IN O
two CD O
- HYPH O
fold NN O
are VBP O
shown VBN O
, , O
two CD O
of IN O
which WDT O
( , O
PDGFB NNP O
and CC O
ITGB1 NNP O
) -RRB- O
are VBP O
listed VBN O
because IN O
they PRP O
relate VBP O
closely RB O
to IN O
genes NNS O
altered VBN O
by IN O
two CD O
- HYPH O
fold NN O
( , O
PDGFA NNP O
and CC O
ITGAV NNP O
) -RRB- O
. . O

The DT O
third JJ O
, , O
MYC NNP O
, , O
is VBZ O
included VBN O
because IN O
western JJ O
blots NNS O
confirmed VBD O
a DT O
substantial JJ O
change NN O
at IN O
the DT O
protein NN O
level NN O
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
that WDT O
may MD O
reflect VB O
both CC O
transcriptional JJ O
and CC O
post NN O
- HYPH O
transcriptional JJ O
regulation NN O
. . O

Interestingly RB O
, , O
transcription NN O
of IN O
MAP2K1 NNP O
was VBD O
decreased VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

This DT O
gene NN O
encodes VBZ O
MEK1 NNP O
, , O
one CD O
of IN O
the DT O
primary JJ O
regulators NNS O
of IN O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
[ -LRB- O
33 CD O
] -RRB- O
, , O
a DT O
network NN O
that WDT O
has VBZ O
been VBN O
linked VBN O
several JJ O
times NNS O
to IN O
MUC1 NNP O
[ -LRB- O
12 CD O
, , O
34 CD O
- HYPH O
36 CD O
] -RRB- O
. . O

We PRP O
examined VBD O
MEK1 NNP O
and CC O
MEK2 NNP O
levels NNS O
by IN O
western JJ O
blot NN O
to TO O
confirm VB O
decreased VBN O
protein NN O
in IN O
MUC1 NNP O
siRNA NNP O
- HYPH O
treated VBN O
cells NNS O
( -LRB- O
Figure NNP O
3a NNP O
) -RRB- O
, , O
and CC O
found VBD O
that IN O
not RB O
only RB O
were VBD O
total JJ O
MEK1 NNP O
/ SYM O
2 CD O
levels NNS O
lower JJR O
in IN O
468 CD O
. , O
siMUC1 NN O
and CC O
BT NN O
. , O
siMUC1 NNP O
compared VBN O
to IN O
controls NNS O
( SYM O
0 CD O
. . O
48 CD O
and CC O
0 CD O
. SYM O
68 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
, , O
but CC O
so RB O
were VBD O
the DT O
basal JJ O
amounts NNS O
of IN O
active JJ O
( , O
phosphorylated VBN O
) SYM O
MEK1 CD O
/ SYM O
2 CD O
( SYM O
pMEK1 CD O
/ SYM O
2 CD O
; : O
0 CD O
. . O
12 CD O
and CC O
0 CD O
. . O
42 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
. . O

Both DT O
468 CD O
. , O
siMUC1 NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
also RB O
showed VBD O
reduced VBN O
activation NN O
of IN O
ERK1 NNP O
/ SYM O
2 CD O
( SYM O
dpERK1 CD O
/ SYM O
2 CD O
; : O
0 CD O
. . O
21 CD O
and CC O
0 CD O
. . O
27 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
, , O
as IN O
would MD O
be VB O
expected VBN O
with IN O
diminished VBN O
signaling NN O
through IN O
MEK1 NNP O
/ SYM O
2 CD O
; : O
total JJ O
ERK1 NNP O
/ SYM O
2 CD O
levels NNS O
remain VBP O
unchanged JJ O
. . O

As IN O
both DT O
lines NNS O
have VBP O
high JJ O
levels NNS O
of IN O
EGFR NNP O
and CC O
thus RB O
activate VBP O
the DT O
MEK NNP O
- HYPH O
ERK NNP O
cascade NN O
intensely RB O
when WRB O
stimulated VBN O
with IN O
EGF NNP O
[ -LRB- O
37 CD O
] -RRB- O
, , O
siRNA NNP O
- HYPH O
transfected VBN O
cells NNS O
were VBD O
treated VBN O
with IN O
EGF NNP O
. . O

Notably RB O
, , O
MUC1 NNP O
siRNA NNP O
impairs VBZ O
this DT O
important JJ O
oncogenic JJ O
pathway NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
, , O
as IN O
468 CD O
. , O
siMUC1 NNP O
display VBP O
less JJR O
pMEK1 NN O
/ SYM O
2 CD O
in IN O
response NN O
to IN O
EGF NNP O
than IN O
do VBP O
468 CD O
. . O
siLuc NN O
( -LRB- O
Figure NN O
3b NN O
) -RRB- O
. . O

Interestingly RB O
, , O
EGF NNP O
treatment NN O
of IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
results VBZ O
in IN O
slightly RB O
higher JJR O
pMEK1 NN O
/ SYM O
2 CD O
levels NNS O
in IN O
BT NNP O
. , O
siMUC1 NNP O
compared VBN O
to IN O
BT NNP O
. . O
siLuc NNP O
. . O

Though IN O
this DT O
result NN O
seems VBZ O
paradoxical JJ O
in IN O
light NN O
of IN O
decreased VBN O
MAP2K1 NN O
transcription NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
, , O
it PRP O
likely RB O
results VBZ O
from IN O
differential JJ O
functions NNS O
of IN O
Raf NNP O
isoforms NNS O
in IN O
combination NN O
with IN O
the DT O
increased VBN O
RAF1 NN O
transcription NN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
and CC O
protein NN O
level NN O
( -LRB- O
Figure NN O
3a CD O
) -RRB- O
in IN O
these DT O
cells NNS O
. . O

Specifically RB O
, , O
B NNP O
- HYPH O
Raf NNP O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
main JJ O
activator NN O
of IN O
MEK NNP O
under IN O
normal JJ O
conditions NNS O
; : O
Raf NNP O
- HYPH O
1 CD O
activates VBZ O
MEK NNP O
in IN O
response NN O
to IN O
stimulus NN O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Thus RB O
, , O
it PRP O
appears VBZ O
that IN O
basal JJ O
pMEK1 NN O
/ SYM O
2 CD O
levels NNS O
are VBP O
not RB O
greatly RB O
affected VBN O
by IN O
Raf NNP O
- HYPH O
1 CD O
overexpression NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
, , O
likely JJ O
because IN O
MEK NNP O
is VBZ O
regulated VBN O
primarily RB O
by IN O
B NNP O
- HYPH O
Raf NNP O
under IN O
normal JJ O
growth NN O
conditions NNS O
. . O

In IN O
contrast NN O
, , O
when WRB O
the DT O
cells NNS O
are VBP O
stimulated VBN O
( , O
EGF NNP O
) -RRB- O
, , O
increased VBN O
Raf NNP O
- HYPH O
1 CD O
levels NNS O
in IN O
BT NNP O
. . O
siMUC1 NNP O
leads VBZ O
to IN O
heightened VBN O
pMEK1 NN O
/ SYM O
2 CD O
( -LRB- O
Figure NN O
3b NN O
) -RRB- O
. . O

MUC1 NNP O
siRNA NNP O
increases VBZ O
apoptosis NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
but CC O
not RB O
BT NN O
- HYPH O
20 CD O

We PRP O
next RB O
examined VBD O
whether IN O
MUC1 NNP O
knockdown NN O
and CC O
its PRP$ O
associated JJ O
transcriptional JJ O
alterations NNS O
would MD O
affect VB O
overall JJ O
cellular JJ O
events NNS O
. . O

As IN O
several JJ O
of IN O
the DT O
genes NNS O
shown VBN O
in IN O
Figure NN O
2 CD O
are VBP O
important JJ O
in IN O
regulating VBG O
proliferation NN O
and CC O
survival NN O
, , O
and CC O
because IN O
of IN O
the DT O
recently RB O
described VBN O
role NN O
of IN O
MUC1 NNP O
in IN O
modulating VBG O
apoptosis NN O
in IN O
response NN O
to IN O
cellular JJ O
stresses NNS O
[ -LRB- O
20 CD O
, , O
21 CD O
, , O
24 CD O
] -RRB- O
, , O
we PRP O
first RB O
analyzed VBD O
whether IN O
MUC1 NNP O
siRNA NNP O
would MD O
alter VB O
apoptosis NN O
in IN O
these DT O
lines NNS O
. . O

Although IN O
there EX O
was VBD O
no DT O
change NN O
in IN O
basal JJ O
apoptosis NN O
in IN O
either DT O
line NN O
( -LRB- O
Figure NNP O
4a NNP O
) -RRB- O
, , O
we PRP O
observed VBD O
that IN O
the DT O
cell NN O
lines NNS O
responded VBD O
differently RB O
when WRB O
trypsinized VBN O
for IN O
re NN O
- HYPH O
plating VBG O
24 CD O
hours NNS O
after IN O
transfection NN O
( -LRB- O
Figure NN O
4b NN O
) -RRB- O
. . O

Interestingly RB O
, , O
468 CD O
. , O
siMUC1 CD O
cells NNS O
show VBP O
greater JJR O
apoptosis NN O
after IN O
trypsinization NN O
than IN O
do VBP O
468 CD O
. . O
siLuc NNP O
( : O
49 CD O
. . O
8 CD O
% NN O
versus IN O
34 CD O
. . O
0 CD O
% NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
from IN O
both DT O
siRNA NNP O
treatments NNS O
display VBP O
similar JJ O
levels NNS O
of IN O
apoptosis NN O
( : O
around IN O
22 CD O
% NN O
) -RRB- O
. . O

To TO O
examine VB O
whether IN O
this DT O
phenomenon NN O
is VBZ O
specific JJ O
to IN O
trypsin NN O
treatment NN O
or CC O
part NN O
of IN O
a DT O
general JJ O
stress NN O
response NN O
involving VBG O
MUC1 NNP O
, , O
we PRP O
subjected VBD O
cells NNS O
to IN O
a DT O
panel NN O
of IN O
stresses NNS O
and CC O
measured VBN O
cell NN O
death NN O
. . O

In IN O
agreement NN O
with IN O
the DT O
patterns NNS O
seen VBN O
with IN O
trypsinization NN O
, , O
BT NNP O
. . O
siLuc NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
respond VBP O
similarly RB O
to IN O
all DT O
treatments NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
while IN O
468 CD O
. , O
siMUC1 NN O
die VBP O
more RBR O
readily RB O
than IN O
468 CD O
. . O
siLuc NNP O
in IN O
response NN O
to IN O
trypsin NN O
, , O
G418 NNP O
, , O
hydrogen NN O
peroxide NN O
, , O
or CC O
celecoxib NN O
, , O
a DT O
chemotherapeutic NN O
that WDT O
targets VBZ O
the DT O
cyclooxygenase NN O
- HYPH O
2 CD O
( HYPH O
COX NN O
- HYPH O
2 CD O
) -RRB- O
pathway NN O
( -LRB- O
Figure NNP O
4c CD O
) -RRB- O
; : O
these DT O
data NNS O
were VBD O
confirmed VBN O
with IN O
two CD O
independent JJ O
siRNA NNP O
constructs NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Like IN O
the DT O
MAPK NNP O
pathway NN O
, , O
AKT NNP O
signaling NN O
has VBZ O
been VBN O
linked VBN O
to IN O
MUC1 NNP O
in IN O
cancer NN O
. . O

Although IN O
transcription NN O
of IN O
AKT NNP O
was VBD O
not RB O
altered VBN O
in IN O
MUC1 NNP O
siRNA NNP O
- HYPH O
treated VBN O
cells NNS O
, , O
the DT O
results NNS O
of IN O
our PRP$ O
apoptosis NN O
studies NNS O
prompted VBD O
us PRP O
to TO O
investigate VB O
levels NNS O
of IN O
AKT NNP O
further RB O
. . O

As IN O
expected VBN O
, , O
the DT O
total JJ O
AKT NNP O
protein NN O
level NN O
is VBZ O
not RB O
greatly RB O
changed VBN O
after IN O
MUC1 NNP O
siRNA NNP O
in IN O
either DT O
cell NN O
line NN O
, , O
though IN O
the DT O
active JJ O
form NN O
( : O
pAKT NN O
) -RRB- O
is VBZ O
increased VBN O
in IN O
both DT O
468 CD O
. , O
siMUC1 NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
compared VBN O
to IN O
controls NNS O
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
. . O

This DT O
result NN O
disagrees VBZ O
with IN O
MUC1 NNP O
activation NN O
of IN O
the DT O
AKT NNP O
pathway NN O
in IN O
rat NN B-Species
3Y1 CD O
cells NNS O
[ -LRB- O
18 CD O
] -RRB- O
, , O
and CC O
may MD O
reflect VB O
regulation NN O
more RBR O
appropriate JJ O
to IN O
breast NN O
cancer NN O
cells NNS O
; , O
this DT O
is VBZ O
supported VBN O
by IN O
activation NN O
of IN O
AKT NNP O
in IN O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
in IN O
other JJ O
lines NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
there EX O
is VBZ O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
relative JJ O
amounts NNS O
of IN O
AKT NN O
and CC O
pAKT NN O
in IN O
the DT O
two CD O
cell NN O
lines NNS O
( -LRB- O
Figure NNP O
4d NNP O
) -RRB- O
. . O

When WRB O
lysates NNS O
from IN O
both DT O
lines NNS O
are VBP O
exposed VBN O
to IN O
film NN O
for IN O
the DT O
same JJ O
length NN O
of IN O
time NN O
( , O
overexposure NN O
masks VBZ O
the DT O
differences NNS O
between IN O
BT NNP O
. . O
siLuc NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
that WDT O
are VBP O
apparent JJ O
in IN O
Figure NNP O
3a CD O
) -RRB- O
, , O
it PRP O
is VBZ O
clear JJ O
that IN O
pAKT NN O
levels NNS O
are VBP O
much RB O
higher JJR O
in IN O
BT NNP O
- HYPH O
20 CD O
than IN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
, , O
despite IN O
lower JJR O
total JJ O
AKT NNP O
expression NN O
. . O

This DT O
difference NN O
in IN O
AKT NNP O
activation NN O
between IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
likely RB O
contributes VBZ O
to IN O
the DT O
disparity NN O
in IN O
their PRP$ O
sensitivity NN O
to IN O
the DT O
increased JJ O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

MUC1 NNP O
siRNA NNP O
alters VBZ O
proliferation NN O
and CC O
invasion NN O

As IN O
MUC1 NNP O
is VBZ O
involved VBN O
in IN O
apoptosis NN O
, , O
we PRP O
next RB O
analyzed VBD O
its PRP$ O
effects NNS O
on IN O
proliferation NN O
. . O

BrdU NNP O
and CC O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
incorporation NN O
were VBD O
used VBN O
to TO O
analyze VB O
proliferation NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

468 CD O
. , O
siMUC1 NN O
cells NNS O
show VBP O
a DT O
significant JJ O
decrease NN O
in IN O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
incorporation NN O
compared VBN O
to IN O
468 CD O
. , O
siLuc NNP O
, , O
while IN O
intriguingly RB O
, , O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
show VBP O
a DT O
significant JJ O
increase NN O
in IN O
proliferation NN O
( -LRB- O
Figure NN O
5a CD O
) -RRB- O
. . O

Growth NN O
curves NNS O
mirror VBP O
these DT O
results NNS O
, , O
as IN O
do VBP O
experiments NNS O
with IN O
the DT O
two CD O
independent JJ O
MUC1 NNP O
siRNA NNP O
oligonucleotides NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Note VB O
that IN O
these DT O
assays NNS O
require VBP O
trypsinizing VBG O
cells NNS O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
; : O
therefore RB O
, , O
the DT O
results NNS O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
could MD O
stem VB O
from IN O
the DT O
changes NNS O
in IN O
apoptosis NN O
described VBN O
in IN O
the DT O
previous JJ O
section NN O
, , O
rather RB O
than IN O
a DT O
true JJ O
effect NN O
on IN O
proliferation NN O
. . O

To TO O
control VB O
for IN O
this DT O
, , O
we PRP O
incubated VBD O
non AFX O
- HYPH O
trypsinized JJ O
, , O
siRNA NNP O
- HYPH O
transfected VBN O
cells NNS O
at IN O
similar JJ O
confluence NN O
with IN O
BrdU NNP O
to TO O
measure VB O
incorporation NN O
. . O

The DT O
' `` O
clumped JJ O
' '' O
profile NN O
of IN O
cells NNS O
( , O
contrast NN O
to IN O
Figure NNP O
4b CD O
) -RRB- O
is VBZ O
likely RB O
a DT O
result NN O
of IN O
the DT O
acid NN O
denaturation NN O
( , O
recommended VBN O
by IN O
the DT O
antibody NN O
manufacturer NN O
) -RRB- O
, , O
as IN O
it PRP O
occurs VBZ O
uniformly RB O
in IN O
these DT O
experiments NNS O
. . O

BrdU NNP O
incorporation NN O
( -LRB- O
Figure NNP O
5b NNP O
) -RRB- O
confirms VBZ O
that IN O
the DT O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
results NNS O
are VBP O
not RB O
solely RB O
due JJ O
to IN O
alterations NNS O
in IN O
apoptosis NN O
, , O
as IN O
468 CD O
. , O
siMUC1 NN O
cells NNS O
incorporate VBP O
less JJR O
BrdU NNP O
than IN O
468 CD O
. . O
siLuc NNP O
; : O
once RB O
again RB O
, , O
BT NNP O
. , O
siMUC1 NNP O
cells NNS O
show VBP O
increased JJ O
proliferation NN O
over IN O
BT NNP O
. . O
siLuc NNP O
. . O

Given VBN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
adhesion NN O
, , O
we PRP O
examined VBD O
whether IN O
MUC1 NNP O
siRNA NNP O
affects VBZ O
cellular JJ O
invasion NN O
. . O

In IN O
transwell NN O
assays NNS O
, , O
BT NNP O
- HYPH O
20 CD O
cells NNS O
invaded VBD O
poorly RB O
, , O
regardless RB O
of IN O
the DT O
siRNA NNP O
used VBN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

However RB O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
invade VBP O
more RBR O
readily RB O
, , O
and CC O
were VBD O
analyzed VBN O
on IN O
a DT O
panel NN O
of IN O
three CD O
different JJ O
extracellular JJ O
matrix NN O
proteins NNS O
. . O

Interestingly RB O
, , O
468 CD O
. , O
siMUC1 CD O
cells NNS O
display VBP O
somewhat RB O
decreased VBN O
invasion NN O
on IN O
collagen NN O
IV NN O
, , O
laminin NN O
, , O
and CC O
fibronectin NN O
matrices NNS O
, , O
and CC O
on IN O
a DT O
no DT O
- HYPH O
matrix NN O
control NN O
( -LRB- O
Figure NNP O
5c NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
in IN O
agreement NN O
with IN O
the DT O
trend NN O
towards IN O
decreased VBN O
metastasis NN O
observed VBN O
in IN O
Muc1 NNP O
- HYPH O
/ SYM O
- HYPH O
x NNP O
MMTV NNP B-Species
- HYPH O
PyV NNP O
MT NNP O
mice NNS B-Species
[ -LRB- O
8 CD O
] -RRB- O
. . O

Transfection NN O
of IN O
MUC1 NNP O
rescues VBZ O
the DT O
468 CD O
. . O
siMUC1 NN O
phenotype NN O

To TO O
determine VB O
if IN O
the DT O
above JJ O
effects NNS O
are VBP O
specific JJ O
to IN O
MUC1 NNP O
, , O
we PRP O
created VBD O
stable JJ O
transfectants NNS O
of IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
using VBG O
empty JJ O
vector NN O
( , O
468 CD O
. . O
Neo NNP O
) -RRB- O
or CC O
a DT O
full JJ O
- HYPH O
length NN O
MUC1 NNP O
construct NN O
( : O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
that WDT O
is VBZ O
resistant JJ O
to IN O
one CD O
of IN O
the DT O
independent JJ O
MUC1 NN O
- HYPH O
directed VBN O
oligonucleotides NNS O
( : O
' `` O
882 CD O
' '' O
) -RRB- O
. . O

These DT O
cells NNS O
were VBD O
maintained VBN O
in IN O
G418 CD O
- HYPH O
containing VBG O
medium NN O
to TO O
retain VB O
transgene NN O
selection NN O
. . O

As IN O
expected VBN O
, , O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
show VBP O
higher JJR O
levels NNS O
of IN O
both DT O
the DT O
MUC1 NNP O
extracellular JJ O
domain NN O
and CC O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
than IN O
do VBP O
468 CD O
. . O
Neo NNP O
( -LRB- O
Figure NNP O
6a CD O
) -RRB- O
. . O

Note VB O
that IN O
468 CD O
. , O
Neo NNP O
have VBP O
MUC1 NNP O
expression NN O
comparable JJ O
to IN O
parental JJ O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
; : O
the DT O
exposures NNS O
in IN O
Figure NN O
6a CD O
are VBP O
lighter JJR O
than IN O
those DT O
in IN O
Figure NNP O
1a CD O
, , O
in IN O
order NN O
to TO O
clearly RB O
show VB O
the DT O
relative JJ O
levels NNS O
of IN O
MUC1 NN O
in IN O
the DT O
stable JJ O
transfectants NNS O
. . O

After IN O
MUC1 NNP O
siRNA NNP O
, , O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
lose VBP O
some DT O
MUC1 NNP O
( , O
likely JJ O
endogenous JJ O
protein NN O
, , O
which WDT O
is VBZ O
not RB O
siRNA NN O
- HYPH O
resistant JJ O
) -RRB- O
but CC O
retain VB O
high JJ O
- HYPH O
level NN O
expression NN O
, , O
while IN O
468 CD O
. , O
Neo NN O
show VBP O
a DT O
decrease NN O
in IN O
MUC1 NNP O
levels NNS O
similar JJ O
to IN O
parental JJ O
468 CD O
. . O
siMUC1 NN O
cells NNS O
( -LRB- O
Figures NNS O
6a CD O
, , O
b NN O
) -RRB- O
. . O

The DT O
difference NN O
in IN O
the DT O
amount NN O
of IN O
MUC1 NNP O
knockdown NN O
between IN O
468 CD O
. . O
Neo NNP O
and CC O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
is VBZ O
highlighted VBN O
by IN O
the DT O
purple JJ O
shading NN O
in IN O
Figure NN O
6b CD O
. . O

BrdU NNP O
incorporation NN O
( -LRB- O
Figure NNP O
6c NNP O
) -RRB- O
indicates VBZ O
that IN O
468 CD O
. , O
Neo NN O
show VBP O
decreased VBN O
nucleotide NN O
incorporation NN O
after IN O
MUC1 NNP O
siRNA NNP O
compared VBN O
to IN O
control NN O
( : O
3 CD O
. . O
3 CD O
% NN O
versus IN O
25 CD O
. . O
0 CD O
% NN O
, , O
respectively RB O
) -RRB- O
; , O
this DT O
is VBZ O
not RB O
seen VBN O
in IN O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
, , O
which WDT O
show VBP O
similar JJ O
levels NNS O
of IN O
BrdU NNP O
incorporation NN O
regardless RB O
of IN O
the DT O
siRNA NNP O
used VBN O
( SYM O
21 CD O
. . O
5 CD O
% NN O
for IN O
luciferase NN O
, , O
23 CD O
. . O
9 CD O
% NN O
for IN O
MUC1 NNP O
) -RRB- O
. . O

468 CD O
. , O
Neo NN O
cells NNS O
display VBP O
a DT O
more RBR O
dramatic JJ O
decrease NN O
in IN O
BrdU NNP O
incorporation NN O
after IN O
MUC1 NNP O
siRNA NNP O
than IN O
what WP O
is VBZ O
seen VBN O
in IN O
parental JJ O
468 CD O
. . O
siMUC1 NN O
cells NNS O
, , O
which WDT O
may MD O
reflect VB O
the DT O
additional JJ O
stress NN O
of IN O
being VBG O
maintained VBN O
in IN O
G418 NNP O
- HYPH O
containing VBG O
medium NN O
. . O

Similarly RB O
, , O
analysis NN O
of IN O
apoptosis NN O
in IN O
trypsinized VBN O
cells NNS O
indicates VBZ O
that IN O
the DT O
increased VBN O
apoptosis NN O
seen VBN O
in IN O
parental JJ O
468 CD O
. , O
siMUC1 NN O
cells NNS O
is VBZ O
also RB O
present JJ O
in IN O
the DT O
468 CD O
. , O
Neo NN O
line NN O
after IN O
MUC1 NNP O
siRNA NNP O
( -LRB- O
Figure NNP O
6d CD O
; : O
43 CD O
. . O
6 CD O
% NN O
in IN O
control NN O
versus IN O
59 CD O
. . O
6 CD O
% NN O
in IN O
MUC1 NNP O
siRNA NNP O
) -RRB- O
. . O

However RB O
, , O
in IN O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
, , O
the DT O
level NN O
of IN O
apoptosis NN O
after IN O
luciferase NN O
siRNA NNP O
( : O
34 CD O
. . O
1 CD O
% NN O
) -RRB- O
is VBZ O
lower JJR O
than IN O
that DT O
in IN O
468 CD O
. , O
Neo JJ O
cells NNS O
; : O
MUC1 NNP O
siRNA NNP O
increases VBZ O
the DT O
amount NN O
of IN O
apoptosis NN O
slightly RB O
( : O
42 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
restoring VBG O
it PRP O
to IN O
a DT O
level NN O
similar JJ O
to IN O
that DT O
seen VBN O
in IN O
luciferase NN O
siRNA NNP O
- HYPH O
treated VBN O
468 CD O
. . O
Neo JJ O
cells NNS O
. . O

Together RB O
, , O
these DT O
studies NNS O
suggest VBP O
that IN O
the DT O
above RB O
- HYPH O
described VBN O
results NNS O
are VBP O
specific JJ O
to IN O
MUC1 NNP O
, , O
as IN O
stable JJ O
transfection NN O
of IN O
an DT O
siRNA NNP O
- HYPH O
resistant JJ O
MUC1 NNP O
rescues VBZ O
the DT O
phenotype NN O
seen VBN O
in IN O
468 CD O
. . O
siMUC1 NN O
cells NNS O
. . O

Discussion NN O

This DT O
report NN O
describes VBZ O
both CC O
the DT O
transcriptional JJ O
alterations NNS O
seen VBN O
after IN O
transfection NN O
with IN O
MUC1 NNP O
siRNA NNP O
in IN O
human JJ B-Species
breast NN O
cancer NN O
cells NNS O
and CC O
the DT O
effects NNS O
on IN O
events NNS O
such JJ O
as IN O
apoptosis NN O
and CC O
proliferation NN O
. . O

The DT O
two CD O
cell NN O
lines NNS O
used VBN O
( , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
) -RRB- O
were VBD O
chosen VBN O
for IN O
high JJ O
expression NN O
of IN O
MUC1 NNP O
and CC O
a DT O
substantial JJ O
( : O
50 CD O
% NN O
to TO O
75 CD O
% NN O
) -RRB- O
, , O
consistent JJ O
decrease NN O
in IN O
MUC1 NNP O
expression NN O
after IN O
siRNA NNP O
. . O

Both DT O
lines NNS O
have VBP O
epithelial JJ O
morphology NN O
, , O
form NN O
tumors NNS O
slowly RB O
in IN O
nude JJ B-Species
mice NN I-Species
[ -LRB- O
37 CD O
] -RRB- O
, , O
have VBP O
mutant JJ O
p53 NN O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
, , O
express VBP O
EGFR NNP O
[ -LRB- O
37 CD O
] -RRB- O
, , O
and CC O
lack VBP O
estrogen NN O
receptor NN O
alpha NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

One CD O
striking VBG O
difference NN O
between IN O
these DT O
lines NNS O
, , O
however RB O
, , O
is VBZ O
their PRP$ O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
. . O

MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
behave VBP O
as IN O
expected VBN O
for IN O
loss NN O
of IN O
an DT O
oncogene NN O
: : O
MUC1 NNP O
siRNA NNP O
correlates VBZ O
with IN O
increased VBN O
apoptosis NN O
in IN O
response NN O
to IN O
stress NN O
, , O
decreased VBN O
proliferation NN O
, , O
and CC O
reduced VBN O
invasion NN O
. . O

In IN O
contrast NN O
, , O
BT NNP O
. . O
siMUC1 CD O
cells NNS O
proliferate VBP O
more RBR O
rapidly RB O
than IN O
BT NNP O
. . O
siLuc NNP O
cells NNS O
with IN O
little JJ O
effect NN O
on IN O
apoptosis NN O
. . O

Much JJ O
of IN O
the DT O
phenotype NN O
of IN O
these DT O
cells NNS O
can MD O
be VB O
understood VBN O
in IN O
light NN O
of IN O
protein NN O
levels NNS O
and CC O
transcriptional JJ O
activity NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

As IN O
mentioned VBN O
, , O
both CC O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
display VBP O
increased VBN O
pAKT NNP O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
but CC O
the DT O
ratio NN O
of IN O
active JJ O
to IN O
total JJ O
AKT NNP O
is VBZ O
considerably RB O
higher JJR O
in IN O
the DT O
BT NNP O
- HYPH O
20 CD O
line NN O
, , O
which WDT O
may MD O
help VB O
these DT O
cells NNS O
resist VB O
the DT O
increased JJ O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

Myc NN O
levels NNS O
are VBP O
also RB O
higher JJR O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
although IN O
the DT O
ability NN O
of IN O
Myc NNP O
to TO O
promote VB O
proliferation NN O
and CC O
apoptosis NN O
in IN O
different JJ O
cellular JJ O
contexts NNS O
[ -LRB- O
42 CD O
] -RRB- O
complicates VBZ O
the DT O
interpretation NN O
of IN O
this DT O
finding NN O
. . O

Both DT O
cell NN O
lines NNS O
show VBP O
reduced VBN O
transcription NN O
of IN O
VEGF NNP O
, , O
PDGFA NNP O
, , O
PDGFB NNP O
, , O
and CC O
MAP2K1 NNP O
( -LRB- O
MEK1 NNP O
) -RRB- O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

The DT O
genes NNS O
encoding VBG O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NNP O
) -RRB- O
and CC O
the DT O
A NN O
and CC O
B NN O
chains NNS O
of IN O
platelet NN O
- HYPH O
derived VBN O
growth NN O
factor NN O
( , O
PDGF NNP O
- HYPH O
A NN O
and CC O
PDGF NNP O
- HYPH O
B NN O
) -RRB- O
are VBP O
interesting JJ O
as IN O
these DT O
proteins NNS O
have VBP O
been VBN O
heavily RB O
implicated VBN O
in IN O
angiogenesis NN O
, , O
suggesting VBG O
a DT O
novel JJ O
function NN O
for IN O
MUC1 NNP O
in IN O
regulating VBG O
this DT O
process NN O
. . O

Vascular JJ O
endothelial JJ O
growth NN O
factor NN O
expression NN O
in IN O
cancer NN O
is VBZ O
linked VBN O
to IN O
tumor NN O
growth NN O
and CC O
metastasis NN O
[ -LRB- O
43 CD O
, , O
44 CD O
] -RRB- O
; , O
platelet NN O
- HYPH O
derived VBN O
growth NN O
factor NN O
is VBZ O
also RB O
angiogenic JJ O
, , O
but CC O
has VBZ O
an DT O
additional JJ O
role NN O
in IN O
stimulating VBG O
desmoplasia NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Reduced VBN O
transcription NN O
of IN O
these DT O
genes NNS O
after IN O
MUC1 NNP O
siRNA NNP O
suggests VBZ O
that IN O
MUC1 NNP O
may MD O
foster VB O
angiogenesis NN O
and CC O
stromal JJ O
proliferation NN O
, , O
although IN O
this DT O
must MD O
be VB O
confirmed VBN O
in IN O
a DT O
more RBR O
appropriate JJ O
model NN O
system NN O
. . O

Decreased VBN O
MAP2K1 NNP O
( -LRB- O
MEK1 NN O
) -RRB- O
transcription NN O
after IN O
MUC1 NNP O
siRNA NNP O
provides VBZ O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
MUC1 NNP O
can MD O
affect VB O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
. . O

MUC1 NNP O
has VBZ O
often RB O
been VBN O
linked VBN O
to IN O
the DT O
Ras NNP O
- HYPH O
Raf NNP O
- HYPH O
MEK NNP O
- HYPH O
ERK NNP O
cascade NN O
[ -LRB- O
12 CD O
, , O
34 CD O
- HYPH O
36 CD O
, , O
46 CD O
] -RRB- O
, , O
and CC O
at RB O
least RBS O
two CD O
mechanisms NNS O
by IN O
which WDT O
MUC1 NNP O
can MD O
alter VB O
MAPK NNP O
signaling NN O
have VBP O
been VBN O
described VBN O
: : O
MUC1 NN O
interaction NN O
with IN O
and CC O
phosphorylation NN O
by IN O
the DT O
EGFR NNP O
family NN O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
, , O
and CC O
MUC1 NNP O
binding NN O
to IN O
the DT O
Grb2 NNP O
/ SYM O
Sos NNP O
complex NN O
that WDT O
activates VBZ O
Ras NNP O
[ -LRB- O
46 CD O
] -RRB- O
. . O

Reduction NN O
of IN O
MEK1 NNP O
levels NNS O
after IN O
MUC1 NNP O
siRNA NNP O
agrees VBZ O
with IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
strengthening VBG O
MAPK NNP O
signaling NN O
, , O
and CC O
indicates VBZ O
that IN O
MUC1 NNP O
can MD O
regulate VB O
both CC O
the DT O
transcription NN O
and CC O
activity NN O
of IN O
members NNS O
of IN O
this DT O
pathway NN O
. . O

Two CD O
additional JJ O
MAPK NNP O
pathway NN O
members NNS O
are VBP O
altered VBN O
specifically RB O
in IN O
BT NNP O
. , O
siMUC1 NNP O
, , O
with IN O
no DT O
corresponding VBG O
change NN O
in IN O
468 CD O
. . O
siMUC1 NN O
cells NNS O
. . O

These DT O
genes NNS O
are VBP O
RAF1 NNP O
and CC O
JUN NNP O
which WDT O
are VBP O
increased VBN O
and CC O
decreased VBN O
, , O
respectively RB O
, , O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

Raf NNP O
- HYPH O
1 CD O
and CC O
c NN O
- HYPH O
Jun NNP O
both DT O
function NN O
outside IN O
of IN O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
, , O
which WDT O
may MD O
explain VB O
the DT O
seeming VBG O
paradox NN O
of IN O
increased VBN O
RAF1 NN O
transcription NN O
with IN O
simultaneous JJ O
decreases NNS O
in IN O
MAP2K1 NNP O
and CC O
JUN NNP O
. . O

Specifically RB O
, , O
Raf NNP O
- HYPH O
1 CD O
can MD O
inhibit VB O
ASK1 NNP O
( , O
apoptosis NN O
signal NN O
- HYPH O
regulated VBN O
kinase NN O
1 CD O
) -RRB- O
upstream RB O
of IN O
p38 NN O
and CC O
JNK NNP O
( -LRB- O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
) -RRB- O
[ -LRB- O
38 CD O
] -RRB- O
. . O

ASK1 NNP O
phosphorylates VBZ O
JNK NNP O
in IN O
response NN O
to IN O
stress NN O
, , O
resulting VBG O
in IN O
activation NN O
of IN O
c NN O
- HYPH O
Jun NN O
and CC O
stimulation NN O
of IN O
apoptosis NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
the DT O
coordinate NN O
up IN O
- HYPH O
regulation NN O
of IN O
RAF1 NNP O
and CC O
down RB O
- HYPH O
regulation NN O
of IN O
JUN NNP O
may MD O
provide VB O
a DT O
potent JJ O
anti AFX O
- HYPH O
apoptotic JJ O
effect NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
. . O

Regulation NN O
of IN O
life NN O
and CC O
death NN O
is VBZ O
also RB O
a DT O
hallmark NN O
of IN O
the DT O
CDC25A NNP O
and CC O
TNF NNP O
gene NN O
products NNS O
. . O

CDC25A NNP O
is VBZ O
a DT O
phosphatase NN O
that WDT O
stimulates VBZ O
cell NN O
cycle NN O
progression NN O
[ -LRB- O
48 CD O
] -RRB- O
, , O
thus RB O
the DT O
effects NNS O
of IN O
its PRP$ O
decrease NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
are VBP O
unclear JJ O
in IN O
light NN O
of IN O
the DT O
increased VBN O
proliferation NN O
of IN O
these DT O
cells NNS O
. . O

However RB O
, , O
the DT O
CDC25 NNP O
proteins NNS O
( , O
A NNP O
, , O
B NNP O
, , O
and CC O
C NNP O
) -RRB- O
were VBD O
recently RB O
shown VBN O
to TO O
have VB O
greater JJR O
functional JJ O
overlap NN O
than IN O
was VBD O
previously RB O
thought VBN O
[ -LRB- O
49 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
the DT O
other JJ O
two CD O
isoforms NNS O
may MD O
compensate VB O
for IN O
reduced VBN O
CDC25A NNP O
levels NNS O
. . O

TNF NNP O
encodes VBZ O
tumor NN O
necrosis NN O
factor NN O
( -LRB- O
TNF NNP O
) -RRB- O
alpha NN O
, , O
known VBN O
for IN O
its PRP$ O
potent JJ O
, , O
cell NN O
type NN O
- HYPH O
specific JJ O
control NN O
of IN O
life NN O
and CC O
death NN O
. . O

In IN O
tumor NN O
cells NNS O
, , O
TNF NNP O
alpha NN O
expression NN O
can MD O
promote VB O
proliferation NN O
and CC O
inhibit VB O
apoptosis NN O
[ -LRB- O
50 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
increased VBN O
TNF NN O
transcription NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
could MD O
contribute VB O
to IN O
the DT O
increased VBN O
proliferation NN O
seen VBN O
in IN O
these DT O
cells NNS O
. . O

Interestingly RB O
, , O
the DT O
increase NN O
in IN O
TNF NNP O
is VBZ O
accompanied VBN O
by IN O
decreased VBN O
transcription NN O
of IN O
TIMP3 NNP O
, , O
encoding VBG O
tissue NN O
inhibitor NN O
of IN O
metalloproteinases NNS O
( -LRB- O
TIMP NNP O
) -RRB- O
3 CD O
. . O

The DT O
TIMP NNP O
family NN O
disrupts VBZ O
the DT O
function NN O
of IN O
matrix NN O
metalloproteinases NNS O
( -LRB- O
MMPs NNS O
) -RRB- O
, , O
generally RB O
resulting VBG O
in IN O
decreased VBN O
invasion NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

TIMP3 NNP O
is VBZ O
unique JJ O
in IN O
that IN O
it PRP O
can MD O
also RB O
inhibit VB O
TNF NNP O
alpha NN O
converting VBG O
enzyme NN O
( , O
TACE NNP O
) -RRB- O
, , O
which WDT O
activates VBZ O
TNF NNP O
alpha NN O
by IN O
cleaving VBG O
it PRP O
from IN O
the DT O
cell NN O
surface NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Reduced VBN O
expression NN O
of IN O
TIMP3 NNP O
would MD O
, , O
therefore RB O
, , O
foster VB O
signaling VBG O
through IN O
TNF NNP O
alpha NN O
by IN O
releasing VBG O
inhibition NN O
of IN O
TNF NNP O
alpha NN O
converting NN O
enzyme NN O
. . O

In IN O
agreement NN O
with IN O
this DT O
, , O
TIMP3 NNP O
can MD O
promote VB O
apoptosis NN O
[ -LRB- O
52 CD O
] -RRB- O
; : O
thus RB O
, , O
its PRP$ O
down RB O
- HYPH O
regulation NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
provides VBZ O
another DT O
mechanism NN O
by IN O
which WDT O
these DT O
cells NNS O
are VBP O
able JJ O
to TO O
resist VB O
the DT O
increased VBN O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

Another DT O
TIMP NNP O
target NN O
responds VBZ O
to IN O
MUC1 NNP O
siRNA NNP O
, , O
as IN O
468 CD O
. , O
siMUC1 CD O
cells NNS O
show VBP O
significantly RB O
increased VBN O
expression NN O
of IN O
MMP2 NNP O
( , O
encoding VBG O
MMP NNP O
- HYPH O
2 CD O
/ SYM O
gelatinase NN O
A NNP O
) -RRB- O
, , O
the DT O
product NN O
of IN O
which WDT O
degrades VBZ O
type NN O
IV NN O
collagen NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

In IN O
breast NN O
cancer NN O
, , O
the DT O
ratio NN O
of IN O
active JJ O
to IN O
latent JJ O
MMP NNP O
- HYPH O
2 CD O
increases VBZ O
with IN O
tumor NN O
progression NN O
; : O
MMP NNP O
- HYPH O
2 CD O
may MD O
facilitate VB O
both CC O
angiogenesis NN O
and CC O
metastasis NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Its PRP$ O
increase NN O
after IN O
loss NN O
of IN O
MUC1 NNP O
is VBZ O
, , O
therefore RB O
, , O
unexpected JJ O
, , O
but CC O
at RB O
least RBS O
two CD O
factors NNS O
may MD O
clarify VB O
this DT O
result NN O
. . O

First RB O
, , O
though IN O
MMP NNP O
- HYPH O
2 CD O
levels NNS O
are VBP O
increased VBN O
in IN O
mouse NN B-Species
mammary NN O
tumors NNS O
, , O
its PRP$ O
expression NN O
is VBZ O
confined VBN O
to IN O
the DT O
stroma NN O
[ -LRB- O
53 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
increased VBN O
MMP2 NN O
transcription NN O
after IN O
loss NN O
of IN O
the DT O
epithelium NN O
- HYPH O
specific JJ O
MUC1 NNP O
might MD O
reflect VB O
a DT O
shift NN O
towards IN O
a DT O
more RBR O
mesenchymal JJ O
phenotype NN O
. . O

Second RB O
, , O
MMP NNP O
- HYPH O
2 CD O
levels NNS O
are VBP O
increased VBN O
by IN O
overexpression NN O
of IN O
erbB2 NN O
[ -LRB- O
52 CD O
] -RRB- O
; , O
previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
erbB2 NN O
and CC O
Muc1 NNP O
expression NN O
are VBP O
mutually RB O
exclusive JJ O
in IN O
mammary JJ O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
, , O
implying VBG O
that IN O
MMP2 NNP O
might MD O
be VB O
part NN O
of IN O
a DT O
transcriptional JJ O
profile NN O
linked VBN O
to IN O
low JJ O
MUC1 NNP O
levels NNS O
. . O

It PRP O
is VBZ O
intriguing JJ O
that IN O
, , O
despite IN O
increased JJ O
MMP2 NN O
transcription NN O
, , O
invasion NN O
is VBZ O
decreased VBN O
in IN O
468 CD O
. . O
siMUC1 CD O
cells NNS O
, , O
even RB O
on IN O
collagen NN O
IV NN O
. . O

This DT O
may MD O
reflect VB O
insufficient JJ O
activation NN O
of IN O
MMP NNP O
- HYPH O
2 CD O
, , O
as IN O
the DT O
precursor NN O
protein NN O
must MD O
be VB O
cleaved VBN O
for IN O
enzymatic JJ O
function NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Alternatively RB O
, , O
the DT O
slowed JJ O
invasion NN O
of IN O
these DT O
cells NNS O
may MD O
relate VB O
to IN O
impaired JJ O
adhesion NN O
resulting VBG O
from IN O
decreased VBN O
transcription NN O
of IN O
ITGAV NNP O
and CC O
ITGB1 NNP O
( , O
alpha NN O
v NN O
and CC O
beta NN O
1 CD O
integrins NNS O
, , O
respectively RB O
) -RRB- O
. . O

Integrin NN O
signaling NN O
is VBZ O
tied VBN O
to IN O
life NN O
- HYPH O
or CC O
- HYPH O
death NN O
decisions NNS O
in IN O
epithelial JJ O
cells NNS O
, , O
and CC O
integrin JJ O
expression NN O
is VBZ O
vital JJ O
for IN O
processes NNS O
from IN O
wound NN O
healing NN O
to IN O
metastasis NN O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Integrin NN O
alpha NN O
v IN O
beta NN O
3 CD O
is VBZ O
implicated VBN O
in IN O
facilitating VBG O
metastasis NN O
of IN O
breast NN O
cancer NN O
cells NNS O
to IN O
bone NN O
[ -LRB- O
55 CD O
] -RRB- O
; , O
decreased VBN O
transcription NN O
of IN O
ITGAV NN O
after IN O
MUC1 NNP O
siRNA NNP O
may MD O
, , O
therefore RB O
, , O
suggest VB O
that IN O
MUC1 NNP O
is VBZ O
involved VBN O
in IN O
this DT O
lethal JJ O
process NN O
as RB O
well RB O
. . O

The DT O
MUC1 NNP O
oncogene NN O
has VBZ O
been VBN O
linked VBN O
to IN O
apoptosis NN O
[ -LRB- O
18 CD O
, , O
20 CD O
, , O
26 CD O
] -RRB- O
, , O
proliferation NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
and CC O
transcription NN O
[ -LRB- O
21 CD O
, , O
23 CD O
- SYM O
25 CD O
] -RRB- O
in IN O
cancer NN O
. . O

However RB O
, , O
the DT O
two CD O
cell NN O
lines NNS O
chosen VBN O
for IN O
our PRP$ O
study NN O
display VBP O
very RB O
different JJ O
responses NNS O
to IN O
MUC1 NNP O
siRNA NNP O
, , O
indicating VBG O
that IN O
regulation NN O
of IN O
MUC1 NN O
in IN O
breast NN O
cancer NN O
is VBZ O
likely RB O
quite RB O
complex JJ O
and CC O
cautioning VBG O
against IN O
over IN O
- HYPH O
generalization NN O
of IN O
results NNS O
from IN O
individual JJ O
cell NN O
lines NNS O
. . O

Previous JJ O
reports NNS O
suggest VBP O
that IN O
, , O
though IN O
most JJS O
studies NNS O
outline VBP O
a DT O
clearly RB O
oncogenic JJ O
role NN O
for IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
, , O
the DT O
exact JJ O
details NNS O
may MD O
vary VB O
depending VBG O
on IN O
factors NNS O
such JJ O
as IN O
cell NN O
type NN O
and CC O
signaling NN O
context NN O
. . O

For IN O
example NN O
, , O
MUC1 NNP O
stimulates VBZ O
Fas NNP O
- HYPH O
mediated VBN O
apoptosis NN O
in IN O
CHO NNP O
cells NNS O
[ -LRB- O
26 CD O
] -RRB- O
, , O
quite RB O
unlike IN O
the DT O
inhibition NN O
of IN O
apoptosis NN O
seen VBN O
in IN O
other JJ O
cell NN O
lines NNS O
. . O

Similarly RB O
, , O
though IN O
MUC1 NNP O
drives VBZ O
mammary JJ O
oncogenesis NN O
in IN O
its PRP$ O
own JJ O
right NN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
facilitates VBZ O
tumorigenesis NN O
driven VBN O
by IN O
other JJ O
oncogenes NNS O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
, , O
Muc1 NNP O
is VBZ O
selectively RB O
down RB O
- HYPH O
regulated VBN O
in IN O
c NN O
- HYPH O
neu NN O
- HYPH O
induced VBN O
mouse NN B-Species
mammary NN O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
the DT O
context NN O
of IN O
oncogenic JJ O
signaling NN O
is VBZ O
vital JJ O
to IN O
understanding VBG O
the DT O
function NN O
of IN O
MUC1 NNP O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
consider VB O
the DT O
relative JJ O
levels NNS O
of IN O
knockdown NN O
of IN O
MUC1 NNP O
in IN O
the DT O
two CD O
cell NN O
lines NNS O
: : O
BT NNP O
- HYPH O
20 CD O
cells NNS O
reduce VBP O
MUC1 NN O
expression NN O
after IN O
siRNA NNP O
less RBR O
strongly RB O
than IN O
do VBP O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
( : O
50 CD O
% NN O
versus IN O
75 CD O
% NN O
knockdown NN O
, , O
respectively RB O
) -RRB- O
. . O

As IN O
MUC1 NNP O
serves VBZ O
as IN O
a DT O
scaffold NN O
[ -LRB- O
11 CD O
] -RRB- O
, , O
overexpression NN O
of IN O
MUC1 NNP O
relative JJ O
to IN O
its PRP$ O
associated JJ O
signaling NN O
proteins NNS O
might MD O
create VB O
a DT O
dilution NN O
effect NN O
, , O
sequestering VBG O
signal NN O
transducers NNS O
away RB O
from IN O
each DT O
other JJ O
; : O
this DT O
would MD O
be VB O
relieved VBN O
by IN O
MUC1 NNP O
siRNA NNP O
. . O

Thus RB O
, , O
enough JJ O
MUC1 NNP O
may MD O
be VB O
retained VBN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
for IN O
its PRP$ O
oncogenic JJ O
effects NNS O
, , O
while IN O
signaling VBG O
complex JJ O
formation NN O
would MD O
be VB O
enhanced VBN O
by IN O
lowering VBG O
the DT O
amount NN O
of IN O
MUC1 NNP O
relative JJ O
to IN O
other JJ O
signaling VBG O
proteins NNS O
. . O

Conclusion NN O

The DT O
contrast NN O
between IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
lines NNS O
in IN O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
serves VBZ O
as IN O
a DT O
reminder NN O
that IN O
simplified JJ O
models NNS O
such JJ O
as IN O
cell NN O
lines NNS O
fail VBP O
to TO O
encompass VB O
the DT O
complexity NN O
of IN O
intact JJ O
biological JJ O
systems NNS O
. . O

This DT O
report NN O
describes VBZ O
transcriptional JJ O
alterations NNS O
seen VBN O
after IN O
MUC1 NNP O
knockdown NN O
: : O
decreased VBN O
transcription NN O
of IN O
MAP2K1 NNP O
, , O
VEGF NNP O
, , O
PDGFA NNP O
, , O
ITGAV NNP O
, , O
TIMP3 NNP O
, , O
CDC25A NNP O
, , O
and CC O
JUN NNP O
, , O
and CC O
increased VBN O
transcription NN O
of IN O
MMP2 NNP O
, , O
TNF NNP O
, , O
and CC O
RAF1 NN O
. . O

The DT O
alterations NNS O
in IN O
MAP2K1 NNP O
, , O
RAF1 NNP O
, , O
and CC O
JUN NNP O
represent VBP O
a DT O
novel JJ O
means NN O
by IN O
which WDT O
MUC1 NNP O
can MD O
affect VB O
ERK1 NNP O
/ SYM O
2 CD O
signaling NN O
: : O
transcriptional JJ O
regulation NN O
of IN O
MAPK NNP O
pathway NN O
members NNS O
. . O

Oncogenic JJ O
events NNS O
are VBP O
also RB O
altered VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

These DT O
results NNS O
strengthen VBP O
the DT O
growing VBG O
ties NNS O
linking VBG O
MUC1 NNP O
and CC O
transcriptional JJ O
regulation NN O
, , O
and CC O
suggest VBP O
that IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
may MD O
be VB O
more RBR O
complex JJ O
than IN O
a DT O
direct JJ O
correlation NN O
between IN O
MUC1 NN O
level NN O
and CC O
oncogenic JJ O
function NN O
. . O

Abbreviations NNS O

BrdU NNP O
= : O
bromodeoxyuridine NN O
; : O
EGF NNP O
= : O
epidermal JJ O
growth NN O
factor NN O
; : O
EGFR NNP O
= : O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
; : O
ERK NNP O
= : O
extracellular JJ O
signal NN O
regulated VBN O
kinase NN O
; : O
MAPK NNP O
= , O
mitogen NN O
activated VBN O
protein NN O
kinase NN O
; , O
MEK NNP O
= , O
MAPK NNP O
and CC O
ERK NNP O
kinase NN O
; : O
MMP NNP O
= : O
matrix NN O
metalloproteinases NN O
; : O
MUC1 NNP O
- HYPH O
CT NNP O
= SYM O
MUC1 NN O
cytoplasmic JJ O
tail NN O
; : O
MUC1 NNP O
- HYPH O
EX NN O
= : O
MUC1 NN O
extracellular JJ O
subunit NN O
; : O
PBS NN O
= : O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
; : O
PI NN O
= , O
propidium NN O
iodide NN O
; : O
siRNA NNP O
= , O
small JJ O
interfering NN O
RNA NN O
; : O
TIMP NN O
= HYPH O
tissue NN O
inhibitor NN O
of IN O
metalloproteinases NNS O
; : O
TNF NN O
= : O
tumor NN O
necrosis NN O
factor NN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

CLH NNP O
performed VBD O
all DT O
studies NNS O
and CC O
composed VBD O
the DT O
manuscript NN O
. . O

SJG NNP O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
studies NNS O
and CC O
contributed VBD O
strongly RB O
to IN O
the DT O
revision NN O
of IN O
the DT O
manuscript NN O
. . O

Both DT O
authors NNS O
have VBP O
read VBN O
and CC O
approved VBN O
the DT O
manuscript NN O
. . O

The DT O
recombination NN O
- HYPH O
associated VBN O
protein NN O
RdgC NNP O
adopts VBZ O
a DT O
novel JJ O
toroidal JJ O
architecture NN O
for IN O
DNA NNP O
binding NN O

Abstract JJ O

RecA NNP O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
the DT O
nonmutagenic JJ O
repair NN O
of IN O
stalled VBN O
replication NN O
forks NNS O
in IN O
bacteria NNS O
. . O

RdgC NNP O
, , O
a DT O
recombination NN O
- HYPH O
associated VBN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
is VBZ O
a DT O
potential JJ O
negative JJ O
regulator NN O
of IN O
RecA NNP O
function NN O
. . O

Here RB O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
crystal NN O
structure NN O
of IN O
RdgC NNP O
from IN O
Pseudomonas NNP B-Species
aeruginosa NN I-Species
. . O

The DT O
J NNP O
- HYPH O
shaped JJ O
monomer NN O
has VBZ O
a DT O
unique JJ O
fold NN O
and CC O
can MD O
be VB O
divided VBN O
into IN O
three CD O
structural JJ O
domains NNS O
: : O
tip NN O
domain NN O
, , O
center NN O
domain NN O
and CC O
base NN O
domain NN O
. . O

Two CD O
such JJ O
monomers NNS O
dimerize VBP O
to TO O
form VB O
a DT O
ring NN O
- HYPH O
shaped JJ O
molecule NN O
of IN O
approximate JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
. . O

Of IN O
the DT O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
within IN O
the DT O
dimer NN O
, , O
one CD O
interface NN O
( , O
' `` O
interface NN O
A NN O
' '' O
) -RRB- O
between IN O
tip NN O
/ SYM O
center NN O
domains NNS O
is VBZ O
more RBR O
nonpolar JJ O
than IN O
the DT O
other JJ O
( , O
' `` O
interface NN O
B NN O
' '' O
) -RRB- O
between IN O
base NN O
domains NNS O
. . O

The DT O
structure NN O
allows VBZ O
us PRP O
to TO O
propose VB O
that IN O
the DT O
RdgC NNP O
dimer NN O
binds VBZ O
dsDNA NNP O
through IN O
the DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
proposed VBN O
model NN O
is VBZ O
supported VBN O
by IN O
our PRP$ O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
coupled VBN O
with IN O
mutagenesis NN O
, , O
which WDT O
indicate VBP O
that IN O
the DT O
conserved VBN O
positively RB O
charged VBN O
residues NNS O
on IN O
the DT O
protein NN O
surface VBP O
around IN O
the DT O
central JJ O
hole NN O
play VBP O
important JJ O
roles NNS O
in IN O
DNA NN O
binding NN O
. . O

The DT O
novel NN O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
has VBZ O
significant JJ O
implications NNS O
for IN O
its PRP$ O
role NN O
in IN O
homologous JJ O
recombination NN O
. . O

INTRODUCTION NN O

Homologous JJ O
recombination NN O
systems NNS O
contribute VBP O
to IN O
the DT O
maintenance NN O
of IN O
genome NN O
integrity NN O
and CC O
are VBP O
essential JJ O
for IN O
the DT O
repair NN O
of IN O
stalled VBN O
replication NN O
forks NNS O
( : O
1 CD O
) -RRB- O
. . O

Genetic JJ O
studies NNS O
of IN O
the DT O
recombination NN O
- HYPH O
dependent JJ O
growth NN O
C NN O
( -LRB- O
rdgC NN O
) -RRB- O
gene NN O
in IN O
bacterial JJ O
systems NNS O
have VBP O
suggested VBN O
that IN O
it PRP O
is VBZ O
involved VBN O
in IN O
DNA NN O
replication NN O
and CC O
recombination NN O
( , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

In IN O
Neisseria NNP B-Species
gonorrhoeae NN I-Species
( , O
the DT O
gonococcus NN O
) -RRB- O
, , O
RdgC NNP O
is VBZ O
required VBN O
for IN O
efficient JJ O
pilin NN O
antigenic JJ O
variation NN O
and CC O
plays VBZ O
some DT O
role NN O
in IN O
cell NN O
growth NN O
( , O
4 CD O
, , O
5 CD O
) -RRB- O
. . O

The DT O
Escherichia NNP B-Species
coli NN I-Species
rdgC NN O
gene NN O
encodes VBZ O
a DT O
DNA NN O
- HYPH O
binding VBG O
protein NN O
of IN O
34 CD O
kDa NN O
, , O
whose WP$ O
expression NN O
level NN O
was VBD O
at IN O
its PRP$ O
highest JJS O
during IN O
exponential JJ O
phase NN O
, , O
reaching VBG O
its PRP$ O
maximum NN O
at IN O
~ $ O
1000 CD O
dimers NNS O
per IN O
cell NN O
( SYM O
2 CD O
) -RRB- O
. . O

Its PRP$ O
level NN O
decreased VBD O
sharply RB O
to IN O
~ $ O
50 CD O
dimers NNS O
per IN O
cell NN O
in IN O
stationary JJ O
phase NN O
. . O

This DT O
profile NN O
suggests VBZ O
that IN O
RdgC NNP O
might MD O
function VB O
during IN O
the DT O
period NN O
of IN O
DNA NNP O
replication NN O
( : O
2 CD O
) -RRB- O
. . O

The DT O
RecA NNP O
proteins NNS O
and CC O
their PRP$ O
homologs NNS O
play VBP O
a DT O
key JJ O
role NN O
in IN O
recombinational JJ O
DNA NN O
repair NN O
in IN O
bacteria NNS O
and CC O
eukaryotes NNS O
. . O

Their PRP$ O
aberrant JJ O
reactions NNS O
could MD O
result VB O
in IN O
gross JJ O
chromosomal JJ O
rearrangements NNS O
that WDT O
lead VBP O
to IN O
human JJ B-Species
diseases NNS O
, , O
including VBG O
cancer NN O
. . O

Therefore RB O
, , O
their PRP$ O
functions NNS O
must MD O
be VB O
tightly RB O
regulated VBN O
, , O
and CC O
understanding VBG O
how WRB O
the DT O
RecA NNP O
family NN O
of IN O
recombinases NNS O
is VBZ O
regulated VBN O
is VBZ O
of IN O
utmost JJ O
importance NN O
( : O
1 CD O
) -RRB- O
. . O

The DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
protein NN O
is VBZ O
a DT O
potential JJ O
negative JJ O
regulator NN O
of IN O
the DT O
function NN O
of IN O
RecA NNP O
( : O
1 CD O
) -RRB- O
. . O

It PRP O
inhibits VBZ O
RecA NNP O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
, , O
RecA NNP O
- HYPH O
mediated VBN O
ATPase NNP O
activity NN O
and CC O
RecA NNP O
- HYPH O
dependent JJ O
LexA NNP O
cleavage NN O
( -LRB- O
1 CD O
) -RRB- O
. . O

Sedimentation NN O
equilibrium NN O
data NNS O
indicated VBD O
that IN O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
exists VBZ O
in IN O
solution NN O
as IN O
a DT O
mixture NN O
of IN O
oligomeric JJ O
states NNS O
in IN O
equilibrium NN O
, , O
most RBS O
likely JJ O
monomers NNS O
, , O
dimers NNS O
and CC O
tetramers NNS O
( , O
1 CD O
) -RRB- O
. . O

This DT O
concentration NN O
- HYPH O
dependent JJ O
change NN O
in IN O
the DT O
oligomeric JJ O
state NN O
appears VBZ O
to TO O
affect VB O
its PRP$ O
mode NN O
of IN O
binding NN O
to IN O
DNA NN O
and CC O
its PRP$ O
capacity NN O
to TO O
inhibit VB O
RecA NNP O
( -LRB- O
1 CD O
) -RRB- O
. . O

The DT O
primary JJ O
mechanism NN O
of IN O
RdgC NNP O
inhibition NN O
appears VBZ O
to TO O
involve VB O
a DT O
simple JJ O
competition NN O
for IN O
DNA NN O
- HYPH O
binding VBG O
sites NNS O
, , O
especially RB O
on IN O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
( -LRB- O
dsDNA NNP O
) -RRB- O
( -LRB- O
1 CD O
) -RRB- O
. . O

Deletion NN O
of IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
rdgC NN O
gene NN O
alone RB O
causes VBZ O
no DT O
obvious JJ O
phenotype NN O
but CC O
is VBZ O
highly RB O
deleterious JJ O
in IN O
strains NNS O
lacking VBG O
certain JJ O
enzymes NNS O
involved VBN O
in IN O
recombination NN O
and CC O
replication NN O
restart NN O
( , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

RdgC NNP O
is VBZ O
essential JJ O
for IN O
the DT O
growth NN O
of IN O
an DT O
E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
lacking VBG O
PriA NNP O
, , O
indicating VBG O
that IN O
it PRP O
might MD O
affect VB O
replication NN O
fork NN O
progression NN O
or CC O
fork NN O
rescue NN O
( , O
2 CD O
) -RRB- O
. . O

PriA NNP O
provides VBZ O
a DT O
means NN O
to TO O
load VB O
the DT O
DnaB NNP O
replicative JJ O
helicase NN O
at IN O
DNA NN O
replication NN O
fork NN O
and CC O
D NN O
loop NN O
structures NNS O
( , O
2 CD O
) -RRB- O
. . O

RdgC NNP O
is VBZ O
, , O
therefore RB O
, , O
a DT O
key JJ O
factor NN O
in IN O
the DT O
rescue NN O
of IN O
stalled VBN O
or CC O
broken VBN O
forks NNS O
and CC O
subsequent JJ O
replication NN O
restart NN O
. . O

dnaC NNP O
suppressors NNS O
of IN O
PriA NNP O
can MD O
overcome VB O
this DT O
inviability NN O
, , O
especially RB O
when WRB O
RecF NNP O
, , O
RecO NNP O
or CC O
RecR NNP O
is VBZ O
inactivated VBN O
, , O
which WDT O
indicates VBZ O
that IN O
RdgC NNP O
avoids VBZ O
or CC O
counters VBZ O
the DT O
toxic JJ O
effect NN O
of IN O
these DT O
proteins NNS O
by IN O
limiting VBG O
inappropriate JJ O
RecA NNP O
loading NN O
on IN O
SSB NNP O
- HYPH O
coated VBN O
ssDNA NNP O
( -LRB- O
2 CD O
) -RRB- O
. . O

The DT O
DNA NN O
- HYPH O
binding VBG O
ability NN O
of IN O
the DT O
RdgC NNP O
protein NN O
has VBZ O
been VBN O
demonstrated VBN O
clearly RB O
using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( -LRB- O
2 CD O
) -RRB- O
. . O

Escherichia NNP B-Species
coli NN I-Species
RdgC NNP O
binds VBZ O
non NNP O
- HYPH O
specifically RB O
to IN O
dsDNA NNP O
and CC O
with IN O
higher JJR O
affinity NN O
than IN O
ssDNA NNP O
( : O
2 CD O
) -RRB- O
. . O

RdgC NN O
from IN O
N NNP B-Species
. , I-Species
meningitidis NNP I-Species
also RB O
binds VBZ O
DNA NN O
with IN O
little JJ O
specificity NN O
for IN O
sequence NN O
or CC O
structure NN O
, , O
like IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
protein NN O
( , O
4 CD O
) -RRB- O
. . O

RdgC NNP O
exhibits VBZ O
no DT O
preference NN O
for IN O
DNA NN O
replication NN O
or CC O
recombination NN O
intermediates NNS O
( , O
2 CD O
) -RRB- O
. . O

However RB O
, , O
no DT O
detectable JJ O
domains NNS O
or CC O
nuclease JJ O
activity NN O
could MD O
be VB O
identified VBN O
for IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
protein NN O
( , O
2 CD O
, , O
6 CD O
) -RRB- O
. . O

The DT O
complexes NNS O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
with IN O
both CC O
linear JJ O
and CC O
supercoiled VBN O
circular JJ O
plasmid NN O
DNA NNP O
were VBD O
imaged VBN O
using VBG O
atomic JJ O
force NN O
microscopy NN O
( , O
7 CD O
) -RRB- O
. . O

RdgC NNP O
was VBD O
found VBN O
to TO O
have VB O
an DT O
increased VBN O
affinity NN O
to IN O
DNA NN O
ends NNS O
and CC O
to TO O
promote VB O
bending NN O
of IN O
DNA NNP O
( : O
7 CD O
) -RRB- O
. . O

RdgC NNP O
has VBZ O
the DT O
effect NN O
on IN O
DNA NNP O
superstructure NN O
; , O
the DT O
promotion NN O
of IN O
DNA NN O
condensation NN O
was VBD O
observed VBN O
at IN O
high JJ O
protein NN O
concentrations NNS O
( SYM O
7 CD O
) -RRB- O
. . O

Recombination NN O
is VBZ O
largely RB O
enhanced VBN O
by IN O
close JJ O
contacts NNS O
of IN O
distant JJ O
regions NNS O
along IN O
the DT O
DNA NN O
strands NNS O
through IN O
condensation NN O
( : O
7 CD O
) -RRB- O
. . O

Pseudomonas NNP B-Species
aeruginosa NN I-Species
is VBZ O
a DT O
ubiquitous JJ O
environmental JJ O
Gram NNP O
- HYPH O
negative JJ O
bacterium NN O
that WDT O
belongs VBZ O
to IN O
the DT O
gamma NN O
subdivision NN O
of IN O
the DT O
Proteobacteria NNP O
. . O

Orthologs NNS O
of IN O
the DT O
rdgC NN O
gene NN O
are VBP O
found VBN O
only RB O
in IN O
beta NN O
and CC O
gamma NN O
subdivisions NNS O
of IN O
the DT O
Proteobacteria NNP O
( -LRB- O
2 CD O
) -RRB- O
. . O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
a DT O
306 CD O
- HYPH O
residue NN O
protein NN O
, , O
shows VBZ O
46 CD O
and CC O
36 CD O
% NN O
identities NNS O
against IN O
those DT O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
and CC O
N NNP B-Species
. . I-Species
meningitidis NN I-Species
, , O
respectively RB O
. . O

Despite IN O
the DT O
importance NN O
of IN O
DNA NN O
- HYPH O
binding VBG O
ability NN O
of IN O
RdgC NNP O
in IN O
its PRP$ O
biological JJ O
roles NNS O
, , O
the DT O
structural JJ O
details NNS O
of IN O
RdgC NNP O
and CC O
the DT O
mechanism NN O
of IN O
its PRP$ O
action NN O
remain VBP O
unclear JJ O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
crystal NN O
structure NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
as IN O
determined VBN O
by IN O
the DT O
multiwavelength JJ O
anomalous JJ O
diffraction NN O
( -LRB- O
MAD NNP O
) -RRB- O
method NN O
of IN O
X NN O
- HYPH O
ray NN O
crystallography NN O
. . O

It PRP O
reveals VBZ O
that IN O
RdgC NNP O
dimer NN O
is VBZ O
ring NN O
- HYPH O
shaped JJ O
, , O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
inside JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
is VBZ O
rich JJ O
in IN O
conserved JJ O
, , O
positively RB O
charged VBN O
residues NNS O
, , O
which WDT O
are VBP O
implicated VBN O
in IN O
DNA NN O
- HYPH O
binding NN O
by IN O
mutagenesis NN O
. . O

We PRP O
propose VBP O
that IN O
dsDNA NNP O
binds NNS O
to IN O
RdgC NNP O
through IN O
this DT O
central JJ O
hole NN O
. . O

Our PRP$ O
structure NN O
provides VBZ O
a DT O
solid JJ O
structural JJ O
framework NN O
for IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
role NN O
of IN O
RdgC NNP O
in IN O
homologous JJ O
recombination NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Protein NN O
expression NN O
and CC O
purification NN O

The DT O
rdgC NN O
gene NN O
( -LRB- O
PA3263 NN O
) -RRB- O
was VBD O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( , O
PCR NN O
) -RRB- O
using VBG O
the DT O
genomic JJ O
DNA NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
strain NN O
PAO1 NN O
as IN O
a DT O
template NN O
. . O

The DT O
oligonucleotide NN O
primers NNS O
designed VBN O
using VBG O
the DT O
published VBN O
genome NN O
sequence NN O
( , O
8 CD O
) -RRB- O
were VBD O
5 CD O
' '' O
- HYPH O
G NNP O
GAA NNP O
TTC NNP O
CAT NNP O
ATG NNP O
TGG NNP O
TTC NNP O
CGC NNP O
AAT NNP O
CTG NNP O
CTC NNP O
G NNP O
- HYPH O
3 CD O
' '' O
( : O
forward RB O
) -RRB- O
and CC O
5 CD O
' '' O
- HYPH O
CCG NN O
CCG NN O
CTC NNP O
GAG NNP O
GAC NNP O
GCC NNP O
CTG NNP O
GGG NNP O
GAT NNP O
TTC NNP O
TTC NNP O
- HYPH O
3 CD O
' '' O
( : O
reverse NN O
) -RRB- O
. . O

The DT O
bases NNS O
in IN O
bold JJ O
denote VBP O
the DT O
NdeI NNP O
and CC O
XhoI NNP O
cleavage NN O
sites NNS O
, , O
respectively RB O
. . O

The DT O
PCR NNP O
product NN O
was VBD O
digested VBN O
with IN O
NdeI NNP O
and CC O
XhoI NNP O
, , O
and CC O
was VBD O
then RB O
inserted VBN O
into IN O
the DT O
NdeI NNP O
/ SYM O
XhoI NNP O
- HYPH O
digested VBN O
expression NN O
vector NN O
pET NN O
- HYPH O
21a CD O
( , O
+ CC O
) -RRB- O
( : O
Novagen NNP O
) -RRB- O
. . O

This DT O
vector NN O
construction NN O
adds VBZ O
an DT O
eight CD O
- HYPH O
residue NN O
tag NN O
( , O
LEHHHHHH NNP O
) -RRB- O
to IN O
the DT O
carboxyl NN O
terminus NN O
of IN O
the DT O
gene NN O
product NN O
to TO O
facilitate VB O
protein NN O
purification NN O
. . O

The DT O
protein NN O
was VBD O
expressed VBN O
in IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
C41 NNP O
( -LRB- O
DE3 NNP O
) -RRB- O
cells NNS O
( SYM O
9 CD O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
up IN O
to IN O
OD600 CD O
of IN O
0 CD O
. . O
6 CD O
in IN O
Luria NNP O
- HYPH O
Bertani NNP O
medium NN O
that WDT O
contained VBD O
50 CD O
mu NNS O
g NN O
ml NN O
- HYPH O
1 CD O
ampicillin NN O
, , O
and CC O
the DT O
protein NN O
expression NN O
was VBD O
induced VBN O
by IN O
0 CD O
. . O
5 CD O
mM NN O
isopropyl NN O
- HYPH O
beta NN O
- HYPH O
d NN O
- HYPH O
thiogalactopyranosid NN O
( : O
IPTG NNP O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
allowed VBN O
to TO O
grow VB O
at IN O
20 CD O
degrees NNS O
C NN O
for IN O
22 CD O
h NN O
after IN O
IPTG NNP O
induction NN O
and CC O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
at IN O
4200 CD O
g CD O
( SYM O
6000 CD O
rev NN O
min NN O
- HYPH O
1 CD O
; : O
Sorvall NNP O
GSA NNP O
rotor NN O
) -RRB- O
for IN O
10 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
cell NN O
pellet NN O
was VBD O
resuspended VBN O
in IN O
an DT O
ice NN O
- HYPH O
cold JJ O
lysis NN O
buffer NN O
[ -LRB- O
20 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
9 CD O
) -RRB- O
, , O
500 CD O
mM NN O
sodium NN O
chloride NN O
, , O
5 CD O
mM NN O
imidazole NN O
] -RRB- O
and CC O
was VBD O
then RB O
homogenized VBN O
with IN O
an DT O
ultrasonic JJ O
processor NN O
. . O

The DT O
crude JJ O
cell NN O
extract NN O
was VBD O
centrifuged VBN O
at IN O
36 CD O
0 CD O
g CD O
( SYM O
18 CD O
0 CD O
rev NN O
min NN O
- HYPH O
1 CD O
; : O
Hanil NNP O
Supra NNP O
21 CD O
K NN O
rotor NN O
) -RRB- O
for IN O
60 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
, , O
and CC O
the DT O
recombinant JJ O
protein NN O
in IN O
the DT O
supernatant JJ O
fraction NN O
was VBD O
purified VBN O
in IN O
three CD O
chromatographic JJ O
steps NNS O
. . O

The DT O
first JJ O
purification NN O
step NN O
utilized VBD O
the DT O
C NNP O
- HYPH O
terminal JJ O
hexahistidine NN O
- HYPH O
tag NN O
by IN O
Ni2 NNP O
+ SYM O
- HYPH O
chelated VBN O
HiTrap NNP O
chelating NN O
column NN O
( : O
GE NNP O
Healthcare NNP O
) -RRB- O
. . O

The DT O
eluent NN O
was VBD O
diluted VBN O
3 CD O
- HYPH O
fold NN O
with IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
at IN O
pH NN O
7 CD O
. . O
4 CD O
. . O

The DT O
diluted JJ O
solution NN O
was VBD O
applied VBN O
to IN O
a DT O
20 CD O
- HYPH O
ml NN O
heparin NN O
- HYPH O
Sepharose NNP O
column NN O
( : O
GE NNP O
Healthcare NNP O
) -RRB- O
, , O
which WDT O
was VBD O
previously RB O
equilibrated VBN O
with IN O
a DT O
buffer NN O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
and CC O
1 CD O
mM NN O
EDTA NNP O
. . O

The DT O
protein NN O
was VBD O
eluted VBN O
with IN O
a DT O
linear JJ O
gradient NN O
of IN O
0 CD O
- SYM O
2 CD O
. . O
0 CD O
M NN O
sodium NN O
chloride NN O
in IN O
the DT O
same JJ O
buffer NN O
. . O

The DT O
first JJ O
peak NN O
corresponded VBD O
to IN O
high JJ O
molecular JJ O
aggregates NNS O
of IN O
RdgC NNP O
and CC O
the DT O
second JJ O
peak NN O
to IN O
RdgC NNP O
dimers NNS O
, , O
which WDT O
was VBD O
also RB O
consistent JJ O
with IN O
our PRP$ O
dynamic JJ O
light JJ O
scattering NN O
measurements NNS O
. . O

When WRB O
the DT O
aggregates NNS O
were VBD O
not RB O
separated VBN O
from IN O
the DT O
dimers NNS O
, , O
the DT O
protein NN O
readily RB O
aggregated VBD O
within IN O
a DT O
day NN O
. . O

The DT O
dimer NN O
fractions NNS O
were VBD O
concentrated VBN O
to IN O
~ $ O
6 CD O
mg CD O
ml CD O
- HYPH O
1 CD O
concentration NN O
using VBG O
an DT O
YM10 NN O
ultrafiltration NN O
membrane NN O
( , O
Millipore NNP O
- HYPH O
Amicon NNP O
) -RRB- O
and CC O
further RB O
purified VBN O
by IN O
gel NN O
filtration NN O
on IN O
a DT O
HiLoad NNP O
XK NNP O
16 CD O
Superdex NNP O
200 CD O
prep NN O
- HYPH O
grade NN O
column NN O
( , O
GE NNP O
Healthcare NNP O
) -RRB- O
, , O
which WDT O
was VBD O
previously RB O
equilibrated VBN O
with IN O
a DT O
buffer NN O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
200 CD O
mM NN O
sodium NN O
chloride NN O
, , O
1 CD O
mM NN O
dithiothreitol NN O
and CC O
1 CD O
mM NN O
EDTA NNP O
. . O

The DT O
first JJ O
peak NN O
corresponding VBG O
to IN O
the DT O
high JJ O
molecular JJ O
aggregates NNS O
of IN O
RdgC NNP O
was VBD O
only RB O
a DT O
minor JJ O
component NN O
, , O
and CC O
the DT O
second JJ O
peak NN O
corresponding VBG O
to IN O
RdgC NNP O
dimers NNS O
was VBD O
stable JJ O
for IN O
several JJ O
weeks NNS O
when WRB O
frozen VBN O
at IN O
- HYPH O
70 CD O
degrees NNS O
C NN O
. . O

The DT O
procedure NN O
for IN O
purifying VBG O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
the DT O
same JJ O
, , O
except IN O
for IN O
the DT O
presence NN O
of IN O
10 CD O
mM NN O
dithiothreitol NN O
in IN O
all DT O
buffers NNS O
used VBN O
during IN O
purification NN O
steps NNS O
. . O

Dynamic JJ O
light JJ O
scattering NN O
experiments NNS O
were VBD O
performed VBN O
at IN O
24 CD O
degrees NNS O
C NN O
, , O
with IN O
the DT O
protein NN O
( , O
at IN O
2 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
concentration NN O
) , O
dissolved VBN O
in IN O
a DT O
buffer NN O
consisting VBG O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
, , O
1 CD O
mM NN O
EDTA NN O
and CC O
200 CD O
mM NN O
sodium NN O
chloride NN O
on IN O
a DT O
Model NNP O
DynaPro NNP O
- HYPH O
801 CD O
instrument NN O
( , O
Wyatt NNP O
, , O
Santa NNP O
Barbara NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
protein NN O
concentration NN O
was VBD O
estimated VBN O
by IN O
measuring VBG O
the DT O
absorbance NN O
at IN O
280 CD O
nm NN O
, , O
employing VBG O
the DT O
calculated VBN O
extinction NN O
coefficient NN O
of IN O
20 CD O
910 CD O
M NN O
- HYPH O
1 CD O
cm NN O
- HYPH O
1 CD O
( HYPH O
SWISS NNP O
- HYPH O
PROT NN O
; : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
expasy NN O
. . O
ch NN O
/ , O
) -RRB- O
. . O

Mutagenesis NN O
and CC O
electrophoretic JJ O
mobility NN O
shift VBP O
assay NN O

Point NN O
mutants NNS O
were VBD O
prepared VBN O
using VBG O
the DT O
QuikChange NNP O
Site NNP O
- HYPH O
Directed NNP O
Mutagenesis NNP O
kit NN O
( , O
Stratagene NNP O
) -RRB- O
, , O
and CC O
the DT O
mutations NNS O
were VBD O
confirmed VBN O
by IN O
DNA NNP O
sequencing NN O
. . O

The DT O
seven CD O
mutants NNS O
R4A NNP O
, , O
F120A NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
, , O
Q212A NNP O
and CC O
R252A NNP O
were VBD O
well RB O
expressed JJ O
and CC O
soluble JJ O
. . O

The DT O
three CD O
mutants NNS O
K70A NNP O
, , O
R81A NNP O
and CC O
R211A NNP O
were VBD O
not RB O
expressed VBN O
, , O
while IN O
R122A NNP O
mutant NN O
was VBD O
expressed VBN O
but CC O
was VBD O
not RB O
soluble JJ O
. . O

Therefore RB O
, , O
we PRP O
mutated VBD O
Lys70 NNP O
, , O
Arg81 NNP O
, , O
Arg122 NNP O
and CC O
Arg211 NNP O
into IN O
aspartate NN O
. . O

The DT O
K70D NNP O
, , O
R81D NNP O
, , O
R122D NNP O
and CC O
R211D NNP O
mutants NNS O
were VBD O
well RB O
expressed JJ O
and CC O
soluble JJ O
. . O

The DT O
soluble JJ O
mutants NNS O
were VBD O
expressed VBN O
and CC O
purified VBN O
under IN O
the DT O
conditions NNS O
identical JJ O
to IN O
those DT O
for IN O
the DT O
wild JJ O
type NN O
, , O
except IN O
that IN O
the DT O
heparin NN O
- HYPH O
Sepharose NNP O
column NN O
step NN O
was VBD O
omitted VBN O
. . O

All DT O
of IN O
the DT O
soluble JJ O
mutants NNS O
had VBD O
similar JJ O
elution NN O
profiles NNS O
as IN O
the DT O
wild JJ O
type NN O
upon IN O
gel NN O
filtration NN O
, , O
and CC O
the DT O
dimer NN O
fractions NNS O
were VBD O
used VBN O
for IN O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
. . O

We PRP O
mixed VBD O
5 CD O
mu NNS O
l NN O
of IN O
RdgC NNP O
( SYM O
1 CD O
. . O
1 CD O
mu NN O
g NN O
mu NN O
l NN O
- HYPH O
1 CD O
) SYM O
and CC O
5 CD O
mu NN O
l NN O
of IN O
a DT O
linear JJ O
dsDNA NN O
with IN O
414 CD O
bp NNS O
( SYM O
63 CD O
ng NN O
mu NNS O
l CC O
- HYPH O
1 CD O
) -RRB- O
, , O
corresponding VBG O
to IN O
the DT O
molar JJ O
ratio NN O
of IN O
64 CD O
: : O
1 CD O
for IN O
RdgC NNP O
dimer NN O
to IN O
dsDNA NNP O
. . O

The DT O
reaction NN O
mixtures NNS O
were VBD O
incubated VBN O
for IN O
10 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

RdgC NNP O
- HYPH O
DNA NNP O
complexes NNS O
were VBD O
analyzed VBN O
by IN O
1 CD O
. . O
5 CD O
% NN O
( HYPH O
w NN O
/ SYM O
v NN O
) , O
agarose JJ O
gel NN O
electrophoresis NN O
in IN O
1 CD O
x SYM O
TAE NNP O
buffer NN O
( SYM O
45 CD O
mM NN O
Tris NN O
- HYPH O
acetate NN O
at IN O
pH NN O
8 CD O
. . O
3 CD O
, , O
1 CD O
mM NN O
EDTA NNP O
) -RRB- O
. . O

DNA NN O
bands NNS O
were VBD O
visualized VBN O
by IN O
ethidium NN O
bromide NN O
staining VBG O
. . O

For IN O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
, , O
the DT O
protein NN O
concentration NN O
was VBD O
measured VBN O
with IN O
a DT O
Bio NNP O
- HYPH O
Rad NNP O
protein NN O
assay NN O
kit NN O
. . O

Crystallization NN O
and CC O
X NN O
- HYPH O
ray NN O
data NN O
collection NN O

Crystals NNS O
were VBD O
grown VBN O
by IN O
the DT O
hanging NN O
- HYPH O
drop NN O
vapor NN O
diffusion NN O
method NN O
at IN O
24 CD O
degrees NNS O
C NN O
by IN O
mixing VBG O
equal JJ O
volumes NNS O
( : O
2 CD O
mu NNS O
l NN O
each DT O
) -RRB- O
of IN O
the DT O
protein NN O
solution NN O
( , O
at IN O
19 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
concentration NN O
in IN O
a DT O
buffer NN O
consisting VBG O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
, , O
1 CD O
mM NN O
EDTA NN O
and CC O
200 CD O
mM NN O
sodium NN O
chloride NN O
) -RRB- O
and CC O
the DT O
reservoir NN O
solution NN O
. . O

To TO O
grow VB O
the DT O
native JJ O
crystals NNS O
, , O
we PRP O
used VBD O
a DT O
reservoir NN O
solution NN O
consisting VBG O
of IN O
0 CD O
. . O
1 CD O
M NN O
sodium NN O
HEPES NN O
( : O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
1 CD O
. . O
0 CD O
M NN O
tri NN O
- HYPH O
sodium NN O
citrate NN O
and CC O
1 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) SYM O
Anapoe NNP O
( -LRB- O
R NN O
) SYM O
35 CD O
as IN O
the DT O
detergent NN O
. . O

Native JJ O
crystals NNS O
grew VBD O
to IN O
approximate JJ O
dimensions NNS O
of IN O
0 CD O
. . O
2 CD O
mm NN O
x SYM O
0 CD O
. . O
1 CD O
mm NN O
x SYM O
0 CD O
. . O
1 CD O
mm NN O
within IN O
a DT O
few JJ O
days NNS O
. . O

The DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
crystallized VBN O
under IN O
conditions NNS O
identical JJ O
to IN O
those DT O
for IN O
the DT O
native JJ O
crystals NNS O
except IN O
for IN O
the DT O
presence NN O
of IN O
10 CD O
mM NN O
dithiothreitol NN O
in IN O
the DT O
protein NN O
solution NN O
. . O

A DT O
crystal NN O
of IN O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
dipped VBN O
into IN O
a DT O
cryoprotectant NN O
solution NN O
for IN O
a DT O
few JJ O
seconds NNS O
and CC O
was VBD O
flash NN O
- HYPH O
cooled VBN O
in IN O
the DT O
cold JJ O
nitrogen NN O
gas NN O
stream NN O
at IN O
100 CD O
K NN O
. . O

The DT O
cryoprotectant NN O
solution NN O
consisted VBD O
of IN O
0 CD O
. . O
1 CD O
M NN O
sodium NN O
HEPES NN O
( : O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
1 CD O
. . O
0 CD O
M NN O
tri NN O
- HYPH O
sodium NN O
citrate NN O
, , O
1 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) : O
Anapoe NN O
( -LRB- O
R NN O
) SYM O
35 CD O
as IN O
the DT O
detergent NN O
and CC O
10 CD O
% NN O
( , O
v NN O
/ SYM O
v NN O
) NFP O
glycerol NN O
. . O

A DT O
set NN O
of IN O
Se NNP O
MAD NNP O
data NNS O
was VBD O
collected VBN O
at IN O
100 CD O
K NN O
at IN O
three CD O
different JJ O
wavelengths NNS O
using VBG O
an DT O
Area NNP O
Detector NNP O
System NNP O
Corporation NNP O
Quantum NNP O
210 CD O
charge NN O
- HYPH O
coupled VBN O
device NN O
detector NN O
at IN O
the DT O
beamline NN O
NW12A NNP O
of IN O
Photon NNP O
Factory NNP O
, , O
Tsukuba NNP O
, , O
Japan NNP O
. . O

The DT O
crystal NN O
was VBD O
rotated VBN O
through IN O
a DT O
total NN O
of IN O
180 CD O
degrees NNS O
with IN O
a DT O
1 CD O
degrees NNS O
oscillation NN O
range NN O
per IN O
frame NN O
. . O

The DT O
raw JJ O
data NNS O
were VBD O
processed VBN O
and CC O
scaled VBN O
using VBG O
the DT O
program NN O
suit NN O
HKL2000 NNP O
( SYM O
10 CD O
) -RRB- O
. . O

The DT O
SeMet NNP O
- HYPH O
substituted VBN O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
4 CD O
A NN O
, , O
b NN O
= SYM O
115 CD O
. . O
60 CD O
A NN O
and CC O
c NN O
= SYM O
76 CD O
. . O
7 CD O
A NN O
. . O

The DT O
native JJ O
crystals NNS O
were VBD O
soaked VBN O
for IN O
10 CD O
min NN O
in IN O
10 CD O
mM NN O
ethyl NN O
mercury NN O
thiosalicylate NN O
( , O
EMTS NNP O
) -RRB- O
to TO O
collect VB O
a DT O
set NN O
of IN O
Hg NNP O
MAD NNP O
data NNS O
at IN O
four CD O
different JJ O
wavelengths NNS O
. . O

X NN O
- HYPH O
ray NN O
diffraction NN O
data NNS O
from IN O
the DT O
EMTS NNP O
- HYPH O
derivatized VBN O
crystal NN O
, , O
as RB O
well RB O
as IN O
a DT O
native JJ O
crystal NN O
, , O
were VBD O
collected VBN O
on IN O
a DT O
Bruker NNP O
charge NN O
- HYPH O
coupled VBN O
device NN O
detector NN O
at IN O
the DT O
beamline NN O
BL NNP O
- HYPH O
6B NNP O
of IN O
Pohang NNP O
Light NNP O
Source NNP O
, , O
Pohang NNP O
, , O
Korea NNP O
. . O

The DT O
EMTS NNP O
- HYPH O
soaked VBN O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
16 CD O
A NN O
, , O
b NN O
= SYM O
116 CD O
. . O
2 CD O
A NN O
and CC O
c NN O
= SYM O
74 CD O
. . O
97 CD O
A NN O
. . O

The DT O
native JJ O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
49 CD O
A NN O
, , O
b NN O
= SYM O
116 CD O
. . O
4 CD O
A NN O
and CC O
c NN O
= SYM O
76 CD O
. . O
3 CD O
A NN O
. . O

If IN O
the DT O
presence NN O
of IN O
a DT O
dimeric JJ O
molecule NN O
in IN O
the DT O
asymmetric JJ O
unit NN O
is VBZ O
assumed VBN O
, , O
the DT O
calculated VBN O
crystal NN O
volume NN O
per IN O
protein NN O
mass NN O
( -LRB- O
VM NN O
) -RRB- O
is VBZ O
2 CD O
. . O
75 CD O
A NN O
3 CD O
Da NN O
- HYPH O
1 CD O
and CC O
the DT O
solvent JJ O
content NN O
is VBZ O
55 CD O
. . O
3 CD O
% NN O
. . O

Supplementary JJ O
Table NN O
1 CD O
summarizes VBZ O
the DT O
statistics NNS O
of IN O
X NNP O
- HYPH O
ray NN O
diffraction NN O
data NNS O
collection NN O
. . O

Structure NN O
solution NN O
and CC O
refinement NN O

Heavy JJ O
atom NN O
sites NNS O
were VBD O
located VBN O
with IN O
the DT O
program NN O
SOLVE NNP O
( -LRB- O
11 CD O
) -RRB- O
. . O

Four CD O
Se JJ O
sites NNS O
from IN O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
crystal NN O
and CC O
two CD O
Hg JJ O
sites NNS O
from IN O
the DT O
EMTS NNP O
- HYPH O
soaked VBN O
crystal NN O
were VBD O
located VBN O
. . O

Two CD O
sets NNS O
of IN O
the DT O
initial JJ O
Se NNP O
and CC O
Hg NNP O
MAD NNP O
phases NNS O
were VBD O
separately RB O
improved VBN O
using VBG O
the DT O
program NN O
RESOLVE NNP O
( SYM O
12 CD O
) -RRB- O
. . O

Two CD O
electron NN O
density NN O
maps NNS O
were VBD O
independently RB O
interpreted VBN O
, , O
and CC O
the DT O
fragments NNS O
of IN O
the DT O
two CD O
models NNS O
were VBD O
combined VBN O
into IN O
a DT O
single JJ O
model NN O
, , O
since IN O
the DT O
two CD O
maps NNS O
were VBD O
complementary JJ O
to IN O
each DT O
other JJ O
. . O

Non JJ O
- HYPH O
crystallographic JJ O
symmetry NN O
( , O
NCS NNP O
) -RRB- O
matrices NNS O
were VBD O
found VBN O
from IN O
a DT O
partial JJ O
model NN O
built VBN O
from IN O
the DT O
initial JJ O
electron NN O
density NN O
map NN O
, , O
and CC O
phases NNS O
were VBD O
further RB O
improved VBN O
by IN O
the DT O
2 CD O
- HYPH O
fold NN O
NCS NNP O
averaging VBG O
, , O
solvent JJ O
flattening NN O
and CC O
histogram NN O
matching NN O
with IN O
the DT O
program NN O
DM NN O
( SYM O
13 CD O
) -RRB- O
. . O

The DT O
model NN O
was VBD O
built VBN O
with IN O
O NNP O
( HYPH O
14 CD O
) -RRB- O
. . O

The DT O
model NN O
was VBD O
refined VBN O
with IN O
the DT O
program NN O
CNS NNP O
( -LRB- O
15 CD O
) -RRB- O
, , O
including VBG O
the DT O
bulk NN O
solvent JJ O
correction NN O
. . O

10 CD O
% NN O
of IN O
the DT O
data NNS O
were VBD O
randomly RB O
set VBN O
aside RB O
as IN O
the DT O
test NN O
data NNS O
for IN O
the DT O
calculation NN O
of IN O
Rfree NNP O
( HYPH O
16 CD O
) -RRB- O
. . O

Several JJ O
rounds NNS O
of IN O
model NN O
building NN O
, , O
simulated VBN O
annealing NN O
, , O
positional JJ O
refinement NN O
and CC O
individual JJ O
B NN O
- HYPH O
factor NN O
refinement NN O
were VBD O
performed VBN O
. . O

Subsequently RB O
, , O
this DT O
model NN O
was VBD O
used VBN O
to TO O
refine VB O
the DT O
structure NN O
of IN O
the DT O
native JJ O
protein NN O
. . O

The DT O
model NN O
has VBZ O
excellent JJ O
stereochemistry NN O
, , O
as IN O
evaluated VBN O
by IN O
the DT O
program NN O
PROCHECK NNP O
( : O
17 CD O
) -RRB- O
. . O

Refinement NN O
statistics NNS O
are VBP O
summarized VBN O
in IN O
Supplementary NNP O
Table NNP O
1 CD O
. . O

RESULTS NNS O
AND CC O
DISCUSSION NN O

Model NN O
quality NN O
and CC O
monomer NN O
structure NN O

The DT O
structure NN O
of IN O
P NNP B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NNP O
was VBD O
solved VBN O
using VBG O
two CD O
sets NNS O
of IN O
MAD NNP O
data NNS O
collected VBN O
from IN O
a DT O
crystal NN O
of IN O
the DT O
selenomethionine NN O
( HYPH O
SeMet NNP O
) -RRB- O
- HYPH O
substituted VBN O
protein NN O
and CC O
from IN O
a DT O
mercury NN O
derivative JJ O
crystal NN O
of IN O
the DT O
native JJ O
protein NN O
( -LRB- O
Supplementary NNP O
Table NNP O
1 CD O
) -RRB- O
. . O

The DT O
model NN O
has VBZ O
subsequently RB O
been VBN O
refined VBN O
using VBG O
the DT O
20 CD O
. . O
0 CD O
- HYPH O
2 CD O
. . O
50 CD O
A NN O
data NN O
from IN O
a DT O
native JJ O
crystal NN O
to IN O
crystallographic JJ O
Rwork NN O
and CC O
Rfree JJ O
values NNS O
of IN O
23 CD O
. . O
4 CD O
and CC O
27 CD O
. . O
9 CD O
% NN O
, , O
respectively RB O
, , O
with IN O
no DT O
sigma NN O
cut VBN O
- HYPH O
off NN O
. . O

The DT O
refined JJ O
model NN O
contains VBZ O
612 CD O
residues NNS O
of IN O
the DT O
two CD O
monomers NNS O
in IN O
the DT O
asymmetric JJ O
unit NN O
of IN O
the DT O
crystal NN O
( , O
residues NNS O
1 CD O
- HYPH O
306 CD O
for IN O
both DT O
chains NNS O
A NN O
and CC O
B NN O
) -RRB- O
and CC O
87 CD O
water NN O
molecules NNS O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
eight CD O
- HYPH O
residue NN O
fusion NN O
tag NN O
has VBZ O
no DT O
electron NN O
density NN O
in IN O
both DT O
subunits NNS O
and CC O
has VBZ O
not RB O
been VBN O
modeled VBN O
. . O

Conformations NNS O
of IN O
the DT O
two CD O
monomers NNS O
in IN O
the DT O
asymmetric JJ O
unit NN O
are VBP O
similar JJ O
. . O

The DT O
root NN O
- HYPH O
mean JJ O
- HYPH O
square JJ O
( , O
r UH O
. . O
m UH O
. . O
s NN O
. . O
) -RRB- O
difference NN O
between IN O
the DT O
two CD O
monomers NNS O
is VBZ O
0 CD O
. . O
69 CD O
A NN O
for IN O
306 CD O
C NN O
alpha NN O
atom NN O
pairs NNS O
, , O
with IN O
a DT O
maximum JJ O
deviation NN O
of IN O
8 CD O
. . O
8 CD O
A NN O
for IN O
the DT O
C NN O
alpha NN O
atom NN O
of IN O
Gly305 CD O
. . O

The DT O
residues NNS O
giving VBG O
r DT O
. . O
m UH O
. . O
s NFP O
. . O
differences NNS O
larger JJR O
than IN O
2 CD O
. . O
0 CD O
A NN O
are VBP O
14 CD O
- SYM O
16 CD O
, , O
94 CD O
- HYPH O
96 CD O
, , O
201 CD O
- HYPH O
202 CD O
and CC O
303 CD O
- HYPH O
306 CD O
, , O
which WDT O
correspond VBP O
to IN O
loops NNS O
connecting VBG O
secondary JJ O
structure NN O
elements NNS O
or CC O
the DT O
C NNP O
- HYPH O
terminus NN O
. . O

They PRP O
are VBP O
located VBN O
on IN O
the DT O
surface NN O
of IN O
the DT O
dimer NN O
. . O

Subunit NNP O
A NNP O
has VBZ O
a DT O
better JJR O
map NN O
quality NN O
than IN O
subunit NN O
B NN O
, , O
and CC O
thus RB O
has VBZ O
a DT O
lower JJR O
mean JJ O
B NN O
- HYPH O
factor NN O
than IN O
subunit NN O
B NN O
( : O
40 CD O
. . O
3 CD O
A NN O
2 CD O
versus IN O
. . O
56 CD O
. . O
1 CD O
A NN O
2 CD O
for IN O
all DT O
4788 CD O
atoms NNS O
) -RRB- O
( : O
Supplementary JJ O
Figure NN O
1 CD O
) -RRB- O
. . O

Therefore RB O
, , O
subunit NN O
A NNP O
is VBZ O
chosen VBN O
for IN O
discussions NNS O
, , O
unless IN O
otherwise RB O
stated VBN O
. . O

The DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
monomer NN O
is VBZ O
J NN O
- HYPH O
shaped JJ O
and CC O
has VBZ O
approximate JJ O
dimensions NNS O
of IN O
72 CD O
A NN O
x SYM O
60 CD O
A NN O
x SYM O
40 CD O
A NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

It PRP O
can MD O
be VB O
divided VBN O
into IN O
three CD O
structural JJ O
domains NNS O
: : O
center NN O
domain NN O
, , O
tip NN O
domain NN O
and CC O
base NN O
domain NN O
. . O

Center NN O
domain NN O
( : O
residues NNS O
1 CD O
- HYPH O
73 CD O
and CC O
121 CD O
- HYPH O
167 CD O
) -RRB- O
includes VBZ O
a DT O
six CD O
- HYPH O
stranded JJ O
anti JJ O
- HYPH O
parallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
two CD O
flanking VBG O
alpha NN O
helices NNS O
( , O
alpha NN O
1 CD O
and CC O
alpha NN O
4 CD O
) -RRB- O
. . O

The DT O
helix NN O
alpha NN O
1 CD O
runs VBZ O
nearly RB O
parallel JJ O
to IN O
the DT O
two CD O
outermost JJ O
strands NNS O
beta NN O
2 CD O
and CC O
beta NN O
3 CD O
, , O
which WDT O
in IN O
turn NN O
lie VBP O
adjacent JJ O
to IN O
beta JJ O
4 CD O
. . O

Strands NNS O
beta JJ O
2 CD O
and CC O
beta NN O
3 CD O
are VBP O
separated VBN O
by IN O
a DT O
loop NN O
. . O

The DT O
helix NN O
alpha NN O
4 CD O
is VBZ O
nearly RB O
orthogonal JJ O
to IN O
the DT O
beta NN O
- HYPH O
strands NNS O
. . O

Tip NN O
domain NN O
( : O
residues NNS O
74 CD O
- HYPH O
120 CD O
) -RRB- O
contains VBZ O
two CD O
alpha NN O
helices NNS O
( , O
alpha NN O
2 CD O
and CC O
alpha NN O
3 CD O
) -RRB- O
and CC O
is VBZ O
inserted VBN O
between IN O
strands NNS O
beta NN O
4 CD O
and CC O
beta NN O
5 CD O
of IN O
the DT O
center NN O
domain NN O
. . O

It PRP O
sticks VBZ O
out RP O
from IN O
the DT O
center NN O
domain NN O
. . O

The DT O
two CD O
connections NNS O
between IN O
the DT O
center NN O
domain NN O
and CC O
the DT O
tip NN O
domain NN O
are VBP O
rich JJ O
in IN O
conserved JJ O
residues NNS O
, , O
hinting VBG O
at IN O
an DT O
important JJ O
functional JJ O
role NN O
of IN O
these DT O
joints NNS O
. . O

They PRP O
could MD O
act VB O
as IN O
a DT O
hinge NN O
for IN O
a DT O
possible JJ O
conformational JJ O
change NN O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
region NN O
of IN O
the DT O
polypeptide NN O
chain NN O
is VBZ O
folded VBN O
into IN O
the DT O
base NN O
domain NN O
( , O
residues NNS O
168 CD O
- HYPH O
306 CD O
) -RRB- O
, , O
which WDT O
consists VBZ O
of IN O
a DT O
five CD O
- HYPH O
stranded JJ O
anti JJ O
- HYPH O
parallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
four CD O
alpha NN O
- HYPH O
helices NNS O
, , O
three CD O
of IN O
which WDT O
( , O
alpha NN O
5 CD O
, , O
alpha NN O
6 CD O
and CC O
alpha NN O
8 CD O
) -RRB- O
cover VBP O
one CD O
side NN O
of IN O
the DT O
beta NN O
- HYPH O
sheet NN O
. . O

The DT O
long JJ O
helix NN O
alpha NN O
8 CD O
is VBZ O
slightly RB O
bent JJ O
. . O

Structural JJ O
similarity NN O
searches NNS O

When WRB O
we PRP O
searched VBD O
for IN O
structural JJ O
similarity NN O
against IN O
the DT O
Protein NNP O
Data NNP O
Bank NNP O
database NN O
using VBG O
the DT O
program NN O
DALI NNP O
( SYM O
18 CD O
) -RRB- O
, , O
the DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
monomer NN O
showed VBD O
no DT O
significant JJ O
similarity NN O
with IN O
a DT O
Z NN O
score NN O
above IN O
5 CD O
. . O

Therefore RB O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
overall JJ O
fold NN O
of IN O
the DT O
RdgC NNP O
polypeptide NN O
chain NN O
is VBZ O
unique JJ O
. . O

When WRB O
we PRP O
elaborated VBD O
the DT O
structural JJ O
comparisons NNS O
with IN O
individual JJ O
domains NNS O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
only RB O
the DT O
center NN O
domain NN O
gave VBD O
a DT O
Z NN O
score NN O
above IN O
5 CD O
. . O

Using VBG O
the DT O
center NN O
domain NN O
( , O
residues NNS O
1 CD O
- HYPH O
73 CD O
and CC O
121 CD O
- HYPH O
167 CD O
) -RRB- O
alone RB O
, , O
the DT O
highest JJS O
structural JJ O
similarity NN O
is VBZ O
found VBN O
with IN O
the DT O
human JJ B-Species
beta NN O
2 CD O
- HYPH O
adaptin NN O
appendage NN O
domain NN O
( , O
PDB NN O
code NN O
1E+042 CD O
, , O
Z NN O
score NN O
= SYM O
7 CD O
. . O
1 CD O
, , O
r NN O
. . O
m ADD O
. . O
s NFP O
. . O
deviation NN O
= SYM O
2 CD O
. . O
5 CD O
A NN O
for IN O
85 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
1 CD O
- HYPH O
12 CD O
, , O
14 CD O
- HYPH O
30 CD O
, , O
44 CD O
- HYPH O
47 CD O
, , O
58 CD O
- HYPH O
72 CD O
, , O
122 CD O
- HYPH O
133 CD O
and CC O
135 CD O
- SYM O
160 CD O
of IN O
P NN B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NN O
chain NN O
A NN O
and CC O
residues NN O
838 CD O
- HYPH O
841 CD O
, , O
848 CD O
- HYPH O
880 CD O
, , O
885 CD O
- HYPH O
906 CD O
and CC O
912 CD O
- HYPH O
967 CD O
of IN O
the DT O
human JJ B-Species
beta NN O
2 CD O
- HYPH O
adaptin NN O
appendage NN O
domain NN O
chain NN O
A NN O
) -RRB- O
( SYM O
19 CD O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
any DT O
functional JJ O
relatedness NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

The DT O
next JJ O
highest JJS O
similarity NN O
is VBZ O
found VBN O
with IN O
the DT O
yeast NN B-Species
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
( , O
PDB NNP O
code NN O
1YTB NN O
, , O
Z NN O
score NN O
= SYM O
5 CD O
. . O
7 CD O
, , O
r NN O
. . O
m UH O
. . O
s NFP O
. . O
deviation NN O
= SYM O
2 CD O
. . O
6 CD O
A NN O
for IN O
79 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
4 CD O
- HYPH O
12 CD O
, , O
14 CD O
- HYPH O
19 CD O
, , O
21 CD O
- HYPH O
27 CD O
, , O
56 CD O
- HYPH O
70 CD O
, , O
124 CD O
- HYPH O
132 CD O
and CC O
134 CD O
- SYM O
166 CD O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
69 CD O
- HYPH O
96 CD O
, , O
100 CD O
- SYM O
126 CD O
and CC O
132 CD O
- HYPH O
155 CD O
of IN O
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
, , O
N NNP O
- HYPH O
terminal JJ O
half NN O
of IN O
chain NN O
A NNP O
) -RRB- O
( SYM O
20 CD O
) -RRB- O
. . O

The DT O
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
is VBZ O
composed VBN O
of IN O
a DT O
ten CD O
- HYPH O
stranded VBN O
antiparallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
four CD O
flanking VBG O
alpha NN O
- HYPH O
helices NNS O
on IN O
the DT O
convex NN O
side NN O
of IN O
the DT O
beta NN O
- HYPH O
sheet NN O
( HYPH O
20 CD O
) -RRB- O
. . O

It PRP O
has VBZ O
an DT O
internal JJ O
quasi JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
, , O
and CC O
its PRP$ O
beta NN O
- HYPH O
strands NNS O
are VBP O
involved VBN O
in IN O
DNA NNP O
binding NN O
. . O

There EX O
is VBZ O
, , O
however RB O
, , O
no DT O
structural JJ O
similarity NN O
of IN O
functional JJ O
significance NN O
, , O
because IN O
the DT O
two CD O
center NN O
domains NNS O
of IN O
the DT O
RdgC NNP O
dimer NN O
are VBP O
well RB O
separated VBN O
and CC O
do VBP O
not RB O
associate VB O
into IN O
a DT O
single JJ O
unit NN O
( -LRB- O
Figure NNP O
1C NNP O
and CC O
D NNP O
) -RRB- O
. . O

Using VBG O
the DT O
tip NN O
domain NN O
( , O
residues NNS O
74 CD O
- HYPH O
120 CD O
) -RRB- O
alone RB O
, , O
the DT O
ATPase NNP O
domain NN O
of IN O
bovine JJ B-Species
Hsc70 NNP O
chaperone NN O
shows VBZ O
highest JJS O
structural JJ O
similarity NN O
( , O
PDB NNP O
code NN O
1BA1 NN O
, , O
Z NN O
score NN O
= SYM O
4 CD O
. . O
8 CD O
, , O
r NN O
. . O
m UH O
. . O
s NFP O
. . O
deviation NN O
= SYM O
1 CD O
. . O
7 CD O
A NN O
for IN O
45 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
76 CD O
- HYPH O
120 CD O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
230 CD O
- HYPH O
253 CD O
and CC O
256 CD O
- HYPH O
276 CD O
of IN O
the DT O
Hsc70 NNP O
ATPase NNP O
domain NN O
) -RRB- O
( SYM O
21 CD O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
seem VB O
to TO O
be VB O
any DT O
significant JJ O
functional JJ O
relationship NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

The DT O
alpha JJ O
- HYPH O
helix NN O
- HYPH O
loop NN O
- HYPH O
alpha NN O
- HYPH O
helix NN O
structure NN O
of IN O
the DT O
tip NN O
domain NN O
is VBZ O
reminiscent JJ O
of IN O
the DT O
helix NN O
- HYPH O
hairpin NN O
- HYPH O
helix NN O
( , O
HhH NN O
) -RRB- O
DNA NN O
- HYPH O
binding VBG O
motif NN O
that WDT O
is VBZ O
present JJ O
in IN O
a DT O
number NN O
of IN O
DNA NNP O
repair NN O
enzymes NNS O
( , O
22 CD O
- SYM O
25 CD O
) -RRB- O
. . O

The DT O
HhH NNP O
motifs NNS O
are VBP O
characterized VBN O
by IN O
the DT O
conserved VBN O
sequence NN O
motif NN O
hxxhxGhGxxxAxxxhh NNP O
, , O
where WRB O
h NN O
is VBZ O
any DT O
hydrophobic JJ O
residue NN O
( , O
VILMWFYA NNP O
) -RRB- O
and CC O
x NN O
any DT O
residue NN O
( SYM O
23 CD O
) -RRB- O
. . O

Two CD O
conserved VBN O
glycines NNS O
allow VBP O
a DT O
tight JJ O
turn NN O
between IN O
two CD O
alpha NN O
- HYPH O
helices NNS O
. . O

However RB O
, , O
the DT O
tip NN O
domain NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
protein NN O
does VBZ O
not RB O
have VB O
such PDT O
a DT O
sequence NN O
motif NN O
, , O
and CC O
the DT O
loop NN O
in IN O
the DT O
RdgC NNP O
tip NN O
domain NN O
is VBZ O
much RB O
more RBR O
extended JJ O
than IN O
that DT O
of IN O
the DT O
HhH NNP O
motifs NNS O
. . O

Therefore RB O
, , O
the DT O
RdgC NNP O
tip NN O
domain NN O
is VBZ O
uniquely RB O
folded VBN O
. . O

With IN O
the DT O
base NN O
domain NN O
( , O
residues NNS O
168 CD O
- HYPH O
306 CD O
) -RRB- O
alone RB O
, , O
the DT O
highest JJS O
similarity NN O
is VBZ O
found VBN O
with IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
( , O
unpublished JJ O
deposition NN O
; , O
PDB NNP O
code NN O
2H9C NN O
, , O
Z NN O
score NN O
= SYM O
4 CD O
. . O
0 CD O
, , O
r NN O
. . O
m ADD O
. . O
s NFP O
. . O
deviation NN O
= SYM O
4 CD O
. . O
8 CD O
A NN O
for IN O
51 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
186 CD O
- HYPH O
191 CD O
, , O
237 CD O
- HYPH O
240 CD O
, , O
257 CD O
- HYPH O
272 CD O
and CC O
274 CD O
- SYM O
298 CD O
of IN O
P NN B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
36 CD O
- HYPH O
41 CD O
, , O
50 CD O
- HYPH O
53 CD O
, , O
55 CD O
- SYM O
66 CD O
and CC O
68 CD O
- SYM O
96 CD O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
chain NN O
A NN O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
any DT O
functional JJ O
relationship NN O
between IN O
the DT O
two CD O
proteins NNS O
, , O
and CC O
the DT O
base NN O
domain NN O
of IN O
RdgC NNP O
is VBZ O
uniquely RB O
folded VBN O
. . O

The DT O
101 CD O
- HYPH O
residue NN O
chain NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
is VBZ O
folded VBN O
into IN O
three CD O
alpha NN O
- HYPH O
helices NNS O
, , O
two CD O
of IN O
which WDT O
overlap VBP O
with IN O
two CD O
alpha NN O
- HYPH O
helices NNS O
( , O
alpha NN O
2 CD O
and CC O
alpha NN O
3 CD O
) -RRB- O
of IN O
the DT O
base NN O
domain NN O
of IN O
RdgC NNP O
. . O

Ring NN O
- HYPH O
shaped JJ O
dimer NN O
structure NN O
and CC O
inter JJ O
- HYPH O
subunit NN O
interface NN O

Our PRP$ O
structure NN O
reveals VBZ O
that IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
forms VBZ O
a DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
of IN O
approximate JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
in IN O
the DT O
crystal NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
observation NN O
is VBZ O
consistent JJ O
with IN O
the DT O
results NNS O
of IN O
previous JJ O
gel NN O
filtration NN O
and CC O
sedimentation NN O
equilibrium NN O
experiments NNS O
, , O
which WDT O
suggested VBD O
the DT O
presence NN O
of IN O
dimeric JJ O
species NNS O
of IN O
E NN B-Species
. . I-Species
coli NNP I-Species
RdgC NNP O
in IN O
solution NN O
( : O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Depending VBG O
on IN O
the DT O
concentration NN O
, , O
RdgC NNP O
could MD O
also RB O
exist VB O
in IN O
solution NN O
as IN O
monomers NNS O
, , O
tetramers NNS O
and CC O
higher JJR O
oligomers NNS O
( , O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
crystal NN O
lattice NN O
, , O
no DT O
monomeric JJ O
, , O
trimeric JJ O
or CC O
tetrameric JJ O
species NNS O
exist VBP O
. . O

Our PRP$ O
structure NN O
unequivocally RB O
rules VBZ O
out RP O
the DT O
monomer NN O
- HYPH O
trimer NN O
model NN O
, , O
which WDT O
fits VBZ O
the DT O
sedimentation NN O
equilibrium NN O
data NNS O
approximately RB O
, , O
as RB O
well RB O
as IN O
the DT O
monomer NN O
- HYPH O
dimer NN O
- HYPH O
tetramer NN O
model NN O
( , O
1 CD O
) -RRB- O
. . O

The DT O
RdgC NNP O
dimer NN O
has VBZ O
approximate JJ O
dimensions NNS O
of IN O
80 CD O
A NN O
x SYM O
60 CD O
A NN O
x SYM O
40 CD O
A NN O
, , O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

Only RB O
a DT O
moderate JJ O
amount NN O
of IN O
surface NN O
area NN O
is VBZ O
buried VBN O
upon IN O
the DT O
formation NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
. . O

The DT O
monomer NN O
- HYPH O
monomer NN O
interface NN O
buries VBZ O
a DT O
solvent NN O
- HYPH O
accessible JJ O
surface NN O
area NN O
of IN O
~ $ O
1360 CD O
A NN O
2 CD O
per IN O
monomer NN O
, , O
corresponding VBG O
to IN O
~ $ O
8 CD O
% NN O
of IN O
the DT O
total JJ O
surface NN O
area NN O
of IN O
the DT O
monomer NN O
( , O
Protein NN O
- HYPH O
Protein NN O
Interaction NN O
Server NN O
at IN O
http NN O
: : O
/ SYM O
/ SYM O
www ADD O
. . O
biochem NN O
. . O
ucl NN O
. . O
ac ADD O
. . O
uk NN O
/ SYM O
bsm NN O
/ SYM O
PP NN O
/ SYM O
server NN O
/ , O
) -RRB- O
. . O

Polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
interface NN O
are VBP O
44 CD O
and CC O
56 CD O
% NN O
, , O
respectively RB O
. . O

The DT O
interface NN O
can MD O
be VB O
divided VBN O
into IN O
two CD O
kinds NNS O
: : O
' `` O
interface VB O
A NN O
' '' O
involving VBG O
both CC O
the DT O
tip NN O
domains NNS O
and CC O
center NN O
domains NNS O
, , O
and CC O
' `` O
interface NN O
B NN O
' '' O
involving VBG O
the DT O
base NN O
domains NNS O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

These DT O
two CD O
interfaces NNS O
have VBP O
significantly RB O
different JJ O
characters NNS O
. . O

The DT O
interface NN O
A NN O
is VBZ O
formed VBN O
largely RB O
by IN O
the DT O
crossing NN O
over IN O
of IN O
the DT O
two CD O
tip NN O
domains NNS O
in IN O
the DT O
dimer NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
interface NN O
covers VBZ O
a DT O
surface NN O
area NN O
of IN O
~ $ O
565 CD O
A NN O
2 CD O
and CC O
is VBZ O
largely RB O
nonpolar JJ O
, , O
with IN O
the DT O
polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
the DT O
interface NN O
being VBG O
37 CD O
. . O
5 CD O
and CC O
2 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

Phe120 NNP O
contributes VBZ O
considerably RB O
to IN O
the DT O
nonpolar JJ O
character NN O
of IN O
the DT O
interface NN O
between IN O
the DT O
tip NN O
domains NNS O
, , O
accounting VBG O
for IN O
~ $ O
150 CD O
A NN O
2 CD O
of IN O
the DT O
interface NN O
area NN O
. . O

Phe120 NNP O
is VBZ O
part NN O
of IN O
a DT O
highly RB O
conserved VBN O
sequence NN O
segment NN O
and CC O
lies VBZ O
at IN O
the DT O
boundary NN O
between IN O
the DT O
tip NN O
domain NN O
and CC O
the DT O
center NN O
domain NN O
. . O

The DT O
aromatic JJ O
ring NN O
of IN O
Phe120 NNP O
' '' O
inserts VBZ O
into IN O
a DT O
hydrophobic JJ O
pocket NN O
, , O
which WDT O
is VBZ O
formed VBN O
by IN O
the DT O
hydrophobic JJ O
residues NNS O
Ile74 NNP O
, , O
Leu75 NNP O
, , O
Pro76 NNP O
, , O
Val79 NNP O
, , O
Leu115 NNP O
, , O
Ala119 NNP O
and CC O
Phe120 NNP O
of IN O
the DT O
neighboring VBG O
monomer NN O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
. . O

The DT O
primed VBN O
residue NN O
belongs VBZ O
to IN O
the DT O
adjacent JJ O
subunit NN O
. . O

These DT O
residues NNS O
are VBP O
well RB O
conserved VBN O
in IN O
the DT O
RdgC NNP O
family NN O
( , O
indicated VBN O
by IN O
green JJ O
triangles NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
) -RRB- O
. . O

As IN O
these DT O
hydrophobic JJ O
residues NNS O
are VBP O
located VBN O
near IN O
the DT O
molecular JJ O
2 CD O
- HYPH O
fold NN O
axis NN O
, , O
the DT O
two CD O
clusters NNS O
of IN O
hydrophobic JJ O
side NN O
chains NNS O
are VBP O
merged VBN O
into IN O
a DT O
single JJ O
, , O
large JJ O
cluster NN O
in IN O
the DT O
dimer NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
. . O

Of IN O
the DT O
16 CD O
hydrogen NN O
bonds NNS O
that WDT O
exist VBP O
between IN O
the DT O
two CD O
subunits NNS O
, , O
only RB O
one CD O
is VBZ O
made VBN O
in IN O
this DT O
interface NN O
between IN O
Arg118 NNP O
and CC O
Arg118 NNP O
' '' O
. . O

The DT O
interface NN O
B NN O
is VBZ O
contributed VBN O
to IN O
exclusively RB O
by IN O
the DT O
two CD O
base NN O
domains NNS O
. . O

This DT O
interface NN O
covers VBZ O
a DT O
surface NN O
area NN O
of IN O
~ $ O
795 CD O
A NN O
2 CD O
. . O

The DT O
polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
this DT O
interface NN O
are VBP O
50 CD O
% NN O
each DT O
. . O

The DT O
two CD O
beta NN O
- HYPH O
sheets NNS O
of IN O
the DT O
two CD O
base NN O
domains NNS O
merge VBP O
into IN O
a DT O
single JJ O
ten CD O
- HYPH O
stranded VBN O
antiparallel JJ O
beta NN O
- HYPH O
sheet NN O
in IN O
this DT O
interface NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

Thus RB O
, , O
15 CD O
of IN O
16 CD O
inter JJ O
- HYPH O
subunit NN O
hydrogen NN O
bonds NNS O
are VBP O
clustered VBN O
in IN O
this DT O
interface NN O
. . O

The DT O
hydrogen NN O
bond NN O
networks NNS O
can MD O
be VB O
divided VBN O
into IN O
two CD O
types NNS O
. . O

The DT O
first JJ O
type NN O
involves VBZ O
the DT O
main JJ O
chain NN O
atoms NNS O
of IN O
Val206 NNP O
, , O
Arg208 NNP O
and CC O
Lys210 NNP O
in IN O
strand NN O
beta NN O
9 CD O
; , O
this DT O
strand NN O
associates VBZ O
with IN O
the DT O
equivalent JJ O
strand NN O
from IN O
the DT O
other JJ O
subunit NN O
in IN O
an DT O
antiparallel JJ O
manner NN O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
. . O

The DT O
other JJ O
type NN O
involves VBZ O
both CC O
the DT O
side NN O
chain NN O
and CC O
main JJ O
chain NN O
atoms NNS O
. . O

The DT O
side NN O
chain NN O
of IN O
Arg211 NNP O
' '' O
interacts VBZ O
with IN O
the DT O
backbone NN O
of IN O
Gly204 NNP O
, , O
while IN O
the DT O
side NN O
chain NN O
of IN O
Lys227 NNP O
hydrogen NN O
bonds NNS O
to IN O
those DT O
of IN O
both DT O
Gln212 NNP O
' '' O
and CC O
Glu218 NNP O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
side NN O
chain NN O
of IN O
Gln212 NNP O
' '' O
interacts VBZ O
with IN O
that DT O
of IN O
Asp199 NNP O
and CC O
the DT O
backbone NN O
of IN O
Arg211 NNP O
' '' O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

Arg211 NNP O
, , O
Gln212 NNP O
, , O
Glu218 NNP O
and CC O
Lys227 NNP O
are VBP O
highly RB O
conserved VBN O
among IN O
the DT O
RdgC NNP O
family NN O
members NNS O
. . O

The DT O
residues NNS O
participating VBG O
in IN O
the DT O
hydrogen NN O
bond NN O
networks NNS O
are VBP O
indicated VBN O
by IN O
red JJ O
circles NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
. . O

The DT O
observation NN O
that IN O
conserved VBN O
residues NNS O
play VBP O
important JJ O
roles NNS O
in IN O
forming VBG O
the DT O
dimer NN O
implies VBZ O
that IN O
dimerization NN O
of IN O
RdgC NNP O
is VBZ O
critical JJ O
for IN O
its PRP$ O
function NN O
. . O

If IN O
one CD O
or CC O
both DT O
of IN O
interfaces NNS O
A NN O
and CC O
B NN O
are VBP O
to TO O
be VB O
broken VBN O
for IN O
functional JJ O
reasons NNS O
such JJ O
as IN O
for IN O
allowing VBG O
dsDNA NNP O
to TO O
enter VB O
into IN O
the DT O
central JJ O
hole NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
, , O
we PRP O
can MD O
conceive VB O
of IN O
three CD O
scenarios NNS O
. . O

The DT O
first JJ O
possibility NN O
would MD O
be VB O
a DT O
simultaneous JJ O
breakage NN O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

The DT O
second JJ O
would MD O
be VB O
the DT O
sequential JJ O
disruption NN O
of IN O
the DT O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

The DT O
third JJ O
would MD O
be VB O
the DT O
disruption NN O
of IN O
only RB O
one CD O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

Sedimentation NN O
equilibrium NN O
indicated VBD O
the DT O
presence NN O
of IN O
monomers NNS O
in IN O
solution NN O
( : O
1 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
first JJ O
two CD O
scenarios NNS O
. . O

If IN O
the DT O
third JJ O
scenario NN O
holds VBZ O
, , O
RdgC NNP O
dimers NNS O
could MD O
possibly RB O
exist VB O
in IN O
two CD O
conformations NNS O
in IN O
solution NN O
, , O
i PRP O
. . O
e LS O
. . O
a DT O
closed VBN O
form NN O
as IN O
observed VBN O
in IN O
the DT O
present JJ O
crystal NN O
structure NN O
, , O
and CC O
an DT O
open JJ O
form NN O
, , O
in IN O
which WDT O
one CD O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
is VBZ O
broken VBN O
. . O

A DT O
model NN O
for IN O
DNA NN O
binding NN O
by IN O
RdgC NNP O
and CC O
DNA NNP O
- HYPH O
binding VBG O
assay NN O

The DT O
net JJ O
charge NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
is VBZ O
highly RB O
negative JJ O
, , O
since IN O
each DT O
monomer NN O
contains VBZ O
12 CD O
aspartate NN O
, , O
13 CD O
glutamate NN O
, , O
10 CD O
lysine NN O
, , O
9 CD O
arginine NN O
and CC O
2 CD O
histidine NN O
residues NNS O
. . O

The DT O
net JJ O
charge NN O
of IN O
a DT O
dimer NN O
would MD O
be VB O
- HYPH O
12 CD O
( , O
or CC O
- HYPH O
8 CD O
) -RRB- O
, , O
if IN O
we PRP O
assume VBP O
none NN O
( , O
or CC O
all DT O
) -RRB- O
of IN O
histidines NNS O
to TO O
be VB O
positively RB O
charged VBN O
. . O

The DT O
electrostatic JJ O
potential NN O
at IN O
the DT O
molecular JJ O
surface NN O
of IN O
RdgC NNP O
dimer NN O
shows VBZ O
that IN O
the DT O
charge NN O
distribution NN O
on IN O
the DT O
protein NN O
surface NN O
is VBZ O
highly RB O
nonuniform JJ O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

Since IN O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
rich JJ O
in IN O
conserved JJ O
, , O
positively RB O
charged VBN O
residues NNS O
and CC O
the DT O
diameter NN O
of IN O
the DT O
central JJ O
hole NN O
( , O
~ $ O
30 CD O
A NN O
) -RRB- O
is VBZ O
approximately RB O
similar JJ O
to IN O
that DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
( SYM O
26 CD O
) -RRB- O
, , O
it PRP O
appears VBZ O
likely JJ O
that IN O
RdgC NNP O
dimers NNS O
bind VBP O
dsDNA NNP O
through IN O
the DT O
central JJ O
hole NN O
. . O

Despite IN O
extensive JJ O
co NN O
- HYPH O
crystallization NN O
and CC O
soaking NN O
trials NNS O
with IN O
linear JJ O
dsDNAs NNS O
of IN O
different JJ O
lengths NNS O
( , O
14 CD O
- HYPH O
mer NN O
, , O
16 CD O
- HYPH O
mer NN O
and CC O
18 CD O
- HYPH O
mer NN O
) -RRB- O
, , O
we PRP O
could MD O
not RB O
locate VB O
the DT O
bound VBN O
DNA NNP O
experimentally RB O
. . O

We PRP O
attribute VBP O
this DT O
difficulty NN O
to IN O
the DT O
nature NN O
of IN O
sequence NN O
- HYPH O
nonspecific JJ O
DNA NN O
binding NN O
by IN O
RdgC NNP O
. . O

Therefore RB O
, , O
we PRP O
built VBD O
a DT O
crude JJ O
model NN O
of IN O
a DT O
DNA NNP O
complex NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
by IN O
fitting VBG O
dsDNA NNP O
into IN O
the DT O
central JJ O
hole NN O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

This DT O
model NN O
is VBZ O
supported VBN O
by IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
coupled VBN O
with IN O
mutagenesis NN O
, , O
as IN O
described VBN O
below RB O
. . O

It PRP O
is VBZ O
also RB O
consistent JJ O
with IN O
the DT O
suggested VBN O
binding VBG O
site NN O
size NN O
of IN O
~ $ O
16 CD O
nt NN O
for IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
dimer NN O
( : O
1 CD O
) -RRB- O
and CC O
the DT O
approximate JJ O
thickness NN O
( : O
~ $ O
40 CD O
A NN O
) -RRB- O
of IN O
the DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
dimer NN O
. . O

When WRB O
we PRP O
performed VBD O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
for IN O
dsDNA NNP O
binding NN O
, , O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
did VBD O
not RB O
require VB O
Mg2 NNP O
+ SYM O
ions NNS O
( -LRB- O
Supplementary NNP O
Figure NNP O
2 CD O
) -RRB- O
, , O
unlike IN O
Deinococcus NNP B-Species
radiodurans NNS I-Species
RecR NNP O
, , O
which WDT O
required VBD O
high JJ O
concentrations NNS O
of IN O
Mg2 NNP O
+ CC O
ions NNS O
( SYM O
27 CD O
) -RRB- O
. . O

ATP NNP O
was VBD O
not RB O
required VBN O
for IN O
dsDNA NNP O
binding NN O
by IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
, , O
either RB O
( , O
Supplementary NNP O
Figure NNP O
2 CD O
) -RRB- O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
an DT O
apparent JJ O
lack NN O
of IN O
an DT O
ATP NNP O
- HYPH O
binding VBG O
pocket NN O
in IN O
the DT O
RdgC NNP O
dimer NN O
structure NN O
. . O

In IN O
order NN O
to TO O
identify VB O
the DT O
residues NNS O
that WDT O
are VBP O
important JJ O
for IN O
dsDNA NNP O
binding NN O
, , O
we PRP O
carried VBD O
out RP O
mutational JJ O
analyses NNS O
. . O

The DT O
residues NNS O
for IN O
mutagenesis NN O
were VBD O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
modeled VBN O
complex NN O
between IN O
RdgC NNP O
dimer NN O
and CC O
dsDNA NNP O
, , O
together RB O
with IN O
sequence NN O
conservation NN O
( -LRB- O
Figure NNP O
4C NNP O
) -RRB- O
. . O

We PRP O
prepared VBD O
eleven CD O
point NN O
mutants NNS O
( , O
R4A NNP O
, , O
K70D NNP O
, , O
R81D NNP O
, , O
F120A NNP O
, , O
R122D NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
, , O
R211D NNP O
, , O
Q212A NNP O
and CC O
R252A NN O
) -RRB- O
. . O

These DT O
eleven CD O
mutated VBN O
residues NNS O
are VBP O
well RB O
conserved VBN O
among IN O
RdgC NNP O
proteins NNS O
. . O

Eight CD O
mutants NNS O
( , O
R4A NNP O
, , O
K70D NNP O
, , O
R81D NNP O
, , O
R122D NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
and CC O
R252A NNP O
) -RRB- O
had VBD O
a DT O
lower JJR O
affinity NN O
for IN O
dsDNA NNP O
than IN O
the DT O
wild JJ O
- HYPH O
type NN O
RdgC NN O
( -LRB- O
Figure NN O
4D NN O
) -RRB- O
. . O

These DT O
eight CD O
mutated VBN O
residues NNS O
are VBP O
indicated VBN O
by IN O
blue JJ O
squares NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
. . O

This DT O
result NN O
indicates VBZ O
that IN O
dsDNA NNP O
binds VBZ O
to IN O
the DT O
inside JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
, , O
since IN O
the DT O
mutated VBN O
residues NNS O
are VBP O
located VBN O
on IN O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
. . O

It PRP O
is VBZ O
worth JJ O
mentioning VBG O
that IN O
a DT O
single JJ O
mutation NN O
introduces VBZ O
two CD O
alterations NNS O
per IN O
RdgC NNP O
dimer NN O
. . O

The DT O
three CD O
mutants NNS O
( -LRB- O
F120A NNP O
, , O
R211D NNP O
and CC O
Q212A NNP O
) -RRB- O
were VBD O
prepared VBN O
to TO O
investigate VB O
whether IN O
dimerization NN O
of IN O
RdgC NNP O
is VBZ O
crucial JJ O
for IN O
dsDNA NNP O
binding NN O
. . O

Phe120 NN O
is VBZ O
a DT O
key JJ O
residue NN O
located VBN O
in IN O
the DT O
inter JJ O
- HYPH O
subunit NN O
interface NN O
A NNP O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
, , O
while IN O
Arg211 NNP O
makes VBZ O
hydrogen NN O
bonds NNS O
in IN O
the DT O
interface NN O
B NNP O
( -LRB- O
Figure NNP O
2D NN O
) -RRB- O
and CC O
Gln212 NN O
is VBZ O
involved VBN O
in IN O
both CC O
intra JJ O
- HYPH O
and CC O
inter JJ O
- HYPH O
subunit NN O
interactions NNS O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

dsDNA NNP O
binding NN O
by IN O
the DT O
F120A NNP O
mutant NN O
is VBZ O
considerably RB O
weakened VBN O
, , O
compared VBN O
to IN O
either CC O
the DT O
R211D NNP O
or CC O
Q212A NN O
mutant NN O
( -LRB- O
Figure NNP O
4D NN O
) -RRB- O
. . O

This DT O
result NN O
suggests VBZ O
that IN O
destabilization NN O
of IN O
the DT O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
deleterious JJ O
for IN O
tight JJ O
dsDNA NN O
binding NN O
and CC O
that IN O
interface NN O
A NN O
is VBZ O
probably RB O
more RBR O
important JJ O
than IN O
interface NN O
B NN O
for IN O
dsDNA NNP O
binding NN O
. . O

dsDNA NNP O
- HYPH O
binding VBG O
affinity NN O
of IN O
the DT O
Q212A NNP O
mutant NN O
was VBD O
lower JJR O
than IN O
the DT O
wild JJ O
type NN O
( -LRB- O
Figure NNP O
4D NNP O
) -RRB- O
, , O
whereas IN O
that DT O
of IN O
the DT O
R211D NNP O
mutant NN O
was VBD O
comparable JJ O
to IN O
the DT O
wild JJ O
type NN O
( -LRB- O
Figure NN O
4D NN O
) -RRB- O
. . O

This DT O
result NN O
suggests VBZ O
that IN O
disruption NN O
of IN O
the DT O
inter JJ O
- HYPH O
subunit NN O
interface NN O
B NN O
is VBZ O
also RB O
detrimental JJ O
for IN O
dsDNA NNP O
binding NN O
but CC O
to IN O
a DT O
smaller JJR O
extent NN O
than IN O
disruption NN O
of IN O
the DT O
interface NN O
A NN O
. . O

It PRP O
further RB O
suggests VBZ O
that IN O
the DT O
side NN O
chain NN O
of IN O
Arg211 NNP O
is VBZ O
not RB O
involved VBN O
in IN O
recognizing VBG O
dsDNA NNP O
. . O

It PRP O
is VBZ O
interesting JJ O
that IN O
the DT O
DNA NN O
complex NN O
for IN O
wild JJ O
type NN O
forms VBZ O
a DT O
distinct JJ O
band NN O
( , O
lane NN O
3 CD O
in IN O
Figure NNP O
4D CD O
) -RRB- O
, , O
as IN O
opposed VBN O
to IN O
a DT O
more RBR O
diffuse JJ O
band NN O
as IN O
one PRP O
would MD O
expect VB O
if IN O
the DT O
complexes NNS O
contained VBD O
different JJ O
numbers NNS O
of IN O
RdgC NNP O
dimers NNS O
. . O

Assuming VBG O
a DT O
binding VBG O
site NN O
size NN O
of IN O
~ $ O
16 CD O
nt CD O
( SYM O
1 CD O
) -RRB- O
, , O
the DT O
414 CD O
- HYPH O
bp NN O
duplex NN O
DNA NNP O
would MD O
bind VB O
~ $ O
25 CD O
RdgC NNP O
dimers NNS O
if IN O
it PRP O
is VBZ O
fully RB O
saturated JJ O
. . O

RdgC NNP O
is VBZ O
unique JJ O
among IN O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O

Pseudomonas NNP B-Species
aeruginosa NN I-Species
RdgC NNP O
adds VBZ O
a DT O
unique JJ O
member NN O
to IN O
the DT O
repertoire NN O
of IN O
toroidal NN O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
( , O
26 CD O
) -RRB- O
such JJ O
as IN O
D NNP B-Species
. , I-Species
radiodurans NNS I-Species
RecR NNP O
( -LRB- O
27 CD O
) -RRB- O
and CC O
DNA NN O
polymerase NN O
processivity NN O
factors NNS O
, , O
including VBG O
the DT O
beta NN O
subunit NN O
of IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
polymerase NN O
III NNP O
( , O
28 CD O
) -RRB- O
, , O
gp45 CD O
of IN O
T4 NNP O
DNA NNP O
polymerase NN O
( , O
29 CD O
) -RRB- O
and CC O
PCNA NNP O
of IN O
eukaryotic JJ O
DNA NNP O
polymerase NN O
delta NN O
( SYM O
30 CD O
, , O
31 CD O
) -RRB- O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

These DT O
proteins NNS O
do VBP O
not RB O
have VB O
an DT O
overall JJ O
sequence NN O
similarity NN O
among IN O
themselves PRP O
, , O
and CC O
their PRP$ O
quaternary JJ O
structures NNS O
also RB O
vary VBP O
. . O

P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
and CC O
E NN B-Species
. . I-Species
coli NN I-Species
beta NN O
clamp NN O
are VBP O
homodimers NNS O
, , O
T4 NN O
gp45 CD O
and CC O
eukaryotic JJ O
PCNAs NNS O
are VBP O
homotrimers NNS O
and CC O
D NN B-Species
. . I-Species
radiodurans NNS I-Species
RecR NN O
is VBZ O
a DT O
homotetramer NN O
. . O

In IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
is VBZ O
largely RB O
formed VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
, , O
while IN O
the DT O
outer JJ O
surface NN O
of IN O
the DT O
ring NN O
is VBZ O
mostly RB O
formed VBN O
by IN O
alpha NN O
- HYPH O
helices NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

The DT O
predicted VBN O
DNA NN O
- HYPH O
binding VBG O
site NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
dimer NN O
is VBZ O
primarily RB O
formed VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
and CC O
loops NNS O
. . O

In IN O
contrast NN O
, , O
in IN O
other JJ O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
such JJ O
as IN O
the DT O
beta NN O
subunit NN O
of IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
polymerase NN O
III NNP O
( , O
28 CD O
) -RRB- O
, , O
gp45 CD O
of IN O
T4 NNP O
DNA NNP O
polymerase NN O
( SYM O
29 CD O
) -RRB- O
, , O
PCNA NNP O
of IN O
eukaryotic JJ O
DNA NNP O
polymerases NNS O
delta NN O
( , O
30 CD O
, , O
31 CD O
) -RRB- O
and CC O
D NN B-Species
. . I-Species
radiodurans NNS I-Species
RecR NNP O
( SYM O
27 CD O
) -RRB- O
, , O
alpha NN O
- HYPH O
helices NNS O
are VBP O
located VBN O
toward IN O
the DT O
center NN O
of IN O
the DT O
ring NN O
and CC O
are VBP O
surrounded VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
in IN O
the DT O
outermost JJ O
side NN O
of IN O
the DT O
ring NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Despite IN O
a DT O
superficial JJ O
resemblance NN O
of IN O
the DT O
overall JJ O
ring NN O
- HYPH O
shaped VBN O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
with IN O
those DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
, , O
the DT O
internal JJ O
arrangement NN O
of IN O
the DT O
secondary JJ O
structure NN O
elements NNS O
in IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
strikingly RB O
different JJ O
from IN O
those DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
. . O

Thus RB O
, , O
RdgC NNP O
is VBZ O
unique JJ O
among IN O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
. . O

A DT O
number NN O
of IN O
other JJ O
proteins NNS O
involved VBN O
in IN O
DNA NN O
metabolism NN O
also RB O
adopt VBP O
a DT O
ring NN O
- HYPH O
shaped VBN O
structure NN O
despite IN O
diversity NN O
in IN O
the DT O
molecular JJ O
functions NNS O
( SYM O
26 CD O
) -RRB- O
. . O

They PRP O
include VBP O
NAD NNP O
+ CC O
- HYPH O
dependent JJ O
DNA NNP O
ligase NN O
( : O
25 CD O
) -RRB- O
, , O
lambda NN O
exonuclease NN O
( , O
32 CD O
) -RRB- O
, , O
hexameric JJ O
helicases NNS O
, , O
topoisomerases NNS O
, , O
the DT O
trp NN O
RNA NN O
- HYPH O
binding VBG O
attenuation NN O
protein NN O
, , O
the DT O
bacteriophage NN O
head NN O
- HYPH O
to IN O
- HYPH O
tail NN O
connector NN O
and CC O
translin NN O
( SYM O
26 CD O
) -RRB- O
. . O

There EX O
are VBP O
also RB O
many JJ O
examples NNS O
of IN O
the DT O
proteins NNS O
in IN O
DNA NN O
recombination NN O
pathways NNS O
that WDT O
assemble VBP O
into IN O
multi JJ O
- HYPH O
subunit NN O
toroids NNS O
containing VBG O
a DT O
central JJ O
channel NN O
( SYM O
26 CD O
) -RRB- O
. . O

Electron NN O
microscopy NN O
showed VBD O
that IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RuvB NNP O
protein NN O
, , O
in IN O
the DT O
presence NN O
of IN O
ATP NNP O
, , O
forms VBZ O
a DT O
dodecamer NN O
on IN O
double JJ O
- HYPH O
stranded JJ O
DNA NN O
in IN O
which WDT O
two CD O
stacked VBN O
hexameric JJ O
rings NNS O
encircle VBP O
the DT O
DNA NN O
and CC O
are VBP O
oriented VBN O
in IN O
opposite JJ O
directions NNS O
with IN O
D6 NNP O
symmetry NN O
( SYM O
33 CD O
) -RRB- O
. . O

The DT O
human JJ B-Species
RAD52 NNP O
protein NN O
was VBD O
found VBN O
to TO O
assemble VB O
into IN O
heptameric JJ O
rings NNS O
with IN O
a DT O
large JJ O
funnel NN O
- HYPH O
shaped VBN O
channel NN O
, , O
40 CD O
- SYM O
60 CD O
A NN O
in IN O
diameter NN O
( SYM O
34 CD O
) -RRB- O
. . O

The DT O
human JJ B-Species
DMC1 NNP O
protein NN O
has VBZ O
so RB O
far RB O
been VBN O
detected VBN O
only RB O
as IN O
an DT O
octameric JJ O
ring NN O
( SYM O
35 CD O
) -RRB- O
. . O

Inhibition NN O
mechanism NN O
of IN O
RecA NN O
function NN O
by IN O
RdgC NNP O

RdgC NNP O
inhibits VBZ O
RecA NNP O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
, , O
RecA NNP O
- HYPH O
mediated VBN O
ATPase NNP O
activity NN O
and CC O
RecA NNP O
- HYPH O
dependent JJ O
LexA NNP O
cleavage NN O
( -LRB- O
1 CD O
) -RRB- O
. . O

It PRP O
was VBD O
observed VBN O
that IN O
the DT O
effects NNS O
of IN O
RdgC NNP O
on IN O
RecA NNP O
- HYPH O
promoted VBN O
DNA NNP O
strand NN O
exchange NN O
were VBD O
much RB O
more RBR O
pronounced JJ O
than IN O
the DT O
effects NNS O
of IN O
RdgC NNP O
on IN O
other JJ O
RecA NNP O
functions NNS O
, , O
when WRB O
RdgC NNP O
was VBD O
added VBN O
to IN O
the DT O
reaction NN O
late RB O
( : O
1 CD O
) -RRB- O
. . O

By IN O
examining VBG O
the DT O
effects NNS O
of IN O
the DT O
DinI NNP O
protein NN O
on IN O
RdgC NNP O
- HYPH O
mediated VBN O
inhibition NN O
of IN O
RecA NNP O
activities NNS O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
the DT O
potent JJ O
effect NN O
of IN O
RdgC NNP O
in IN O
the DT O
inhibition NN O
of IN O
strand NN O
exchange NN O
did VBD O
not RB O
primarily RB O
reflect VB O
a DT O
displacement NN O
of IN O
RecA NNP O
in IN O
the DT O
nucleoprotein NN O
filament NN O
by IN O
RdgC NNP O
, , O
but CC O
instead RB O
a DT O
binding NN O
of IN O
RdgC NNP O
to IN O
the DT O
dsDNA NNP O
substrate NN O
so IN O
as IN O
to TO O
make VB O
it PRP O
unavailable JJ O
to IN O
the DT O
filaments NNS O
for IN O
strand NN O
exchange NN O
( , O
1 CD O
) -RRB- O
. . O

Our PRP$ O
work NN O
contributes VBZ O
to IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
inhibition NN O
mechanism NN O
of IN O
RecA NNP O
function NN O
by IN O
RdgC NNP O
. . O

The DT O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
with IN O
a DT O
central JJ O
hole NN O
that WDT O
is VBZ O
suitable JJ O
for IN O
the DT O
binding NN O
of IN O
dsDNA NNP O
lends VBZ O
RdgC NNP O
with IN O
a DT O
capacity NN O
to TO O
hold VB O
dsDNA NNP O
very RB O
tightly RB O
. . O

Therefore RB O
, , O
we PRP O
suggest VBP O
that IN O
RdgC NNP O
dimers NNS O
probably RB O
function VBP O
as IN O
a DT O
tight JJ O
dsDNA NN O
gripper NN O
and CC O
physically RB O
block VBP O
access NN O
to IN O
the DT O
target NN O
dsDNA NNP O
by IN O
RecA NNP O
filaments NNS O
, , O
because IN O
tight JJ O
encircling NN O
of IN O
dsDNA NNP O
by IN O
RdgC NNP O
dimers NNS O
, , O
possibly RB O
as IN O
a DT O
linear JJ O
aggregate NN O
, , O
would MD O
prevent VB O
the DT O
two CD O
strands NNS O
from IN O
dissociating VBG O
. . O

However RB O
, , O
it PRP O
remains VBZ O
unclear JJ O
how WRB O
the DT O
closed JJ O
- HYPH O
ring NN O
structure NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
might MD O
allow VB O
binding NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
RdgC NNP O
dimers NNS O
on IN O
the DT O
duplex JJ O
DNA NNP O
. . O

It PRP O
may MD O
be VB O
conceivable JJ O
that IN O
each DT O
RdgC NNP O
dimer NN O
can MD O
open VB O
temporarily RB O
at IN O
one CD O
or CC O
both DT O
of IN O
its PRP$ O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
so IN O
that IN O
dsDNA NNP O
can MD O
enter VB O
the DT O
central JJ O
hole NN O
. . O

RdgC NNP O
was VBD O
at IN O
its PRP$ O
highest JJS O
level NN O
during IN O
exponential JJ O
phase NN O
, , O
reaching VBG O
its PRP$ O
maximum NN O
of IN O
~ $ O
1000 CD O
dimers NNS O
per IN O
E NNP B-Species
. . I-Species
coli NN I-Species
cell NN O
. . O

Its PRP$ O
level NN O
decreased VBD O
sharply RB O
to IN O
~ $ O
50 CD O
dimers NNS O
per IN O
cell NN O
in IN O
stationary JJ O
phase NN O
( SYM O
2 CD O
) -RRB- O
. . O

Under IN O
normal JJ O
cellular JJ O
conditions NNS O
, , O
RecA NNP O
is VBZ O
maintained VBN O
at IN O
~ $ O
1000 CD O
molecules NNS O
per IN O
cell NN O
( : O
http NN O
: : O
/ : O
/ SYM O
www ADD O
. . O
els NNS O
. . O
net NN O
/ SYM O
) -RRB- O
. . O

Following VBG O
LexA NNP O
repressor NN O
cleavage NN O
, , O
the DT O
level NN O
of IN O
RecA NNP O
protein NN O
in IN O
the DT O
cell NN O
increases VBZ O
by IN O
as RB O
much JJ O
as IN O
20 CD O
- HYPH O
fold NN O
. . O

RdgC NNP O
inhibition NN O
of IN O
the DT O
RecA NNP O
function NN O
by IN O
a DT O
simple JJ O
competition NN O
mechanism NN O
at IN O
the DT O
cellular JJ O
concentration NN O
of IN O
RdgC NNP O
clearly RB O
requires VBZ O
a DT O
much RB O
higher JJR O
affinity NN O
for IN O
DNA NN O
by IN O
RdgC NNP O
than IN O
RecA NNP O
. . O

Possible JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
between IN O
RdgC NNP O
dimers NNS O
might MD O
have VB O
a DT O
profound JJ O
effect NN O
on IN O
the DT O
affinity NN O
for IN O
DNA NN O
, , O
when WRB O
a DT O
large JJ O
number NN O
of IN O
RdgC NNP O
dimers NNS O
are VBP O
bound VBN O
on IN O
a DT O
duplex JJ O
DNA NN O
. . O

If IN O
only RB O
one CD O
of IN O
the DT O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
can MD O
open VB O
up RP O
and CC O
the DT O
2 CD O
- HYPH O
fold NN O
symmetry NN O
axes NNS O
of IN O
the DT O
RdgC NNP O
dimers NNS O
are VBP O
misaligned VBN O
sufficiently RB O
, , O
the DT O
escape NN O
of IN O
DNA NN O
from IN O
a DT O
linear JJ O
array NN O
of IN O
interacting VBG O
RdgC NNP O
dimers NNS O
would MD O
be VB O
extremely RB O
difficult JJ O
. . O

Alternatively RB O
, , O
both CC O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
of IN O
each DT O
dimer NN O
may MD O
open VB O
up RP O
simultaneously RB O
. . O

A DT O
line NN O
of IN O
indirect JJ O
evidence NN O
for IN O
the DT O
possible JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
between IN O
RdgC NNP O
dimers NNS O
is VBZ O
provided VBN O
by IN O
the DT O
cooperative JJ O
binding NN O
of IN O
RdgC NNP O
to IN O
DNA NNP O
( : O
7 CD O
) -RRB- O
. . O

Cooperativity NN O
of IN O
RdgC NNP O
binding NN O
may MD O
be VB O
caused VBN O
by IN O
local JJ O
and CC O
distant JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
( : O
7 CD O
) -RRB- O
. . O

A DT O
kind NN O
of IN O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
interaction NN O
between IN O
two CD O
adjacent JJ O
molecules NNS O
of IN O
RdgC NNP O
dimer NN O
is VBZ O
present JJ O
in IN O
the DT O
crystal NN O
, , O
burying VBG O
an DT O
accessible JJ O
surface NN O
area NN O
of IN O
~ $ O
750 CD O
A NN O
2 CD O
at IN O
the DT O
interface NN O
. . O

The DT O
interaction NN O
involves VBZ O
mostly RB O
the DT O
less JJR O
polar JJ O
side NN O
surface NN O
of IN O
the DT O
dimer NN O
( , O
left JJ O
side NN O
of IN O
Figure NNP O
4A NNP O
) -RRB- O
, , O
with IN O
2 CD O
- HYPH O
fold NN O
symmetry NN O
axes NNS O
of IN O
the DT O
two CD O
interacting VBG O
RdgC NNP O
molecules NNS O
making VBG O
an DT O
angle NN O
of IN O
~ $ O
90 CD O
degrees NNS O
when WRB O
viewed VBN O
down IN O
the DT O
central JJ O
holes NNS O
and CC O
~ $ O
15 CD O
degrees NNS O
when WRB O
viewed VBN O
perpendicular JJ O
to IN O
the DT O
holes NNS O
. . O

This DT O
may MD O
explain VB O
the DT O
observed VBN O
DNA NN O
bending NN O
by IN O
RdgC NNP O
, , O
which WDT O
was VBD O
speculated VBN O
to TO O
be VB O
a DT O
necessary JJ O
step NN O
in IN O
the DT O
working VBG O
mechanism NN O
of IN O
RdgC NNP O
, , O
if IN O
one PRP O
can MD O
assume VB O
that IN O
the DT O
strong JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
in IN O
the DT O
crystal NN O
were VBD O
relevant JJ O
for IN O
protein NN O
- HYPH O
protein NN O
interactions NNS O
in IN O
solution NN O
( : O
7 CD O
) -RRB- O
. . O

RdgC NNP O
protein NN O
was VBD O
shown VBN O
to TO O
have VB O
a DT O
potent JJ O
effect NN O
on IN O
RecA NNP O
protein NN O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
in IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
( -LRB- O
1 CD O
) -RRB- O
. . O

In IN O
a DT O
series NN O
of IN O
experiments NNS O
, , O
RdgC NNP O
was VBD O
added VBN O
after IN O
RecA NNP O
filaments NNS O
had VBD O
formed VBN O
on IN O
the DT O
ssDNA NNP O
and CC O
5 CD O
min NN O
after IN O
the DT O
linear JJ O
dsDNA NNP O
was VBD O
added VBN O
. . O

With IN O
3 CD O
mu NNS O
M NNP O
RecA NNP O
, , O
a DT O
sharp JJ O
reduction NN O
in IN O
DNA NN O
strand NN O
exchange NN O
products NNS O
was VBD O
seen VBN O
with IN O
0 CD O
. . O
4 CD O
mu NNS O
M NNP O
RdgC NNP O
, , O
and CC O
the DT O
generation NN O
of IN O
products NNS O
was VBD O
abolished VBN O
at IN O
0 CD O
. . O
8 CD O
mu NN O
M NNP O
RdgC NNP O
( SYM O
1 CD O
) -RRB- O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
binding VBG O
affinity NN O
of IN O
RdgC NNP O
to IN O
dsDNA NNP O
is VBZ O
considerably RB O
higher JJR O
than IN O
that DT O
of IN O
RecA NNP O
. . O

The DT O
high JJ O
affinity NN O
of IN O
RdgC NNP O
could MD O
be VB O
explained VBN O
by IN O
its PRP$ O
ring NN O
shape NN O
and CC O
the DT O
suggested VBN O
mode NN O
of IN O
DNA NNP O
binding NN O
. . O

Tetrameric JJ O
species NN O
of IN O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
, , O
which WDT O
started VBD O
to TO O
form VB O
at IN O
around IN O
2 CD O
micro NN O
M NN O
concentrations NNS O
, , O
were VBD O
speculated VBN O
to TO O
be VB O
the DT O
species NNS O
with IN O
the DT O
most RBS O
potent JJ O
inhibitory JJ O
effect NN O
, , O
possibly RB O
by IN O
having VBG O
a DT O
higher JJR O
affinity NN O
for IN O
DNA NNP O
( : O
1 CD O
) -RRB- O
. . O

Higher JJR O
affinity NN O
for IN O
DNA NN O
of IN O
the DT O
tetrameric JJ O
species NNS O
could MD O
be VB O
understood VBN O
, , O
if IN O
the DT O
formation NN O
of IN O
a DT O
tetramer NN O
in IN O
solution NN O
involves VBZ O
a DT O
protein NN O
- HYPH O
protein NN O
interaction NN O
similar JJ O
to IN O
the DT O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
interaction NN O
between IN O
two CD O
adjacent JJ O
RdgC NNP O
dimers NNS O
in IN O
the DT O
crystal NN O
, , O
although IN O
there EX O
is VBZ O
no DT O
experimental JJ O
evidence NN O
. . O

Obviously RB O
, , O
there EX O
are VBP O
still RB O
many JJ O
open JJ O
questions NNS O
that WDT O
need VBP O
to TO O
be VB O
addressed VBN O
in IN O
future JJ O
biochemical JJ O
experiments NNS O
. . O

SUMMARY NN O

The DT O
crystal NN O
structure NN O
of IN O
RdgC NNP O
, , O
a DT O
recombination NN O
- HYPH O
associated VBN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
determined VBN O
in IN O
this DT O
study NN O
reveals VBZ O
that IN O
the DT O
polypeptide NN O
chain NN O
is VBZ O
uniquely RB O
folded VBN O
and CC O
two CD O
monomers NNS O
associate VBP O
to TO O
form VB O
a DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
inner JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
is VBZ O
rich JJ O
in IN O
positively RB O
charged VBN O
residues NNS O
. . O

These DT O
structural JJ O
features NNS O
suggest VBP O
that IN O
dsDNA NNP O
runs VBZ O
through IN O
the DT O
central JJ O
hole NN O
when WRB O
it PRP O
binds VBZ O
to IN O
RdgC NNP O
dimers NNS O
. . O

This DT O
idea NN O
is VBZ O
supported VBN O
by IN O
our PRP$ O
mutational JJ O
studies NNS O
, , O
which WDT O
indicate VBP O
that IN O
the DT O
conserved VBN O
, , O
positively RB O
charged VBN O
residues NNS O
around IN O
the DT O
central JJ O
hole NN O
are VBP O
important JJ O
for IN O
dsDNA NNP O
binding NN O
. . O

The DT O
toroidal JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
provides VBZ O
a DT O
sound JJ O
framework NN O
for IN O
a DT O
better JJR O
understanding NN O
of IN O
its PRP$ O
role NN O
in IN O
homologous JJ O
recombination NN O
. . O

Coordinates NNS O

Atomic JJ O
coordinates NNS O
and CC O
the DT O
structure NN O
factor NN O
data NNS O
have VBP O
been VBN O
deposited VBN O
in IN O
the DT O
Protein NNP O
Data NNP O
Bank NNP O
( HYPH O
accession NN O
code NN O
2OWY NNP O
) -RRB- O
. . O

SUPPLEMENTARY NNP O
DATA NNP O

Supplementary JJ O
Data NNS O
are VBP O
available JJ O
at IN O
NAR NNP O
Online NNP O
. . O

Supplementary JJ O
Material NN O

Port NN O
site NN O
herniation NN O
of IN O
the DT O
small JJ O
bowel NN O
following VBG O
laparoscopy NN O
- HYPH O
assisted VBN O
distal JJ O
gastrectomy NN O
: : O
a DT O
case NN O
report NN O

Abstract JJ O

Introduction NN O

Port NN O
- HYPH O
site NN O
herniation NN O
is VBZ O
a DT O
rare JJ O
but CC O
potentially RB O
dangerous JJ O
complication NN O
after IN O
laparoscopic JJ O
surgery NN O
. . O

Closure NN O
of IN O
port NN O
sites NNS O
, , O
especially RB O
those DT O
measuring VBG O
10 CD O
mm NNS O
or CC O
more JJR O
, , O
has VBZ O
been VBN O
recommended VBN O
to TO O
avoid VB O
such PDT O
an DT O
event NN O
. . O

Case NN O
presentation NN O

We PRP O
herein RB O
report VBP O
the DT O
only JJ O
case NN O
of IN O
a DT O
port NN O
site NN O
hernia NN O
among IN O
a DT O
series NN O
52 CD O
consecutive JJ O
cases NNS O
of IN O
laparoscopy NN O
- HYPH O
assisted VBN O
distal NN O
gastrectomy NN O
( , O
LADG NNP O
) -RRB- O
carried VBN O
out RP O
by IN O
our PRP$ O
unit NN O
between IN O
July NNP O
2002 CD O
and CC O
March NNP O
2007 CD O
. . O

In IN O
this DT O
case NN O
the DT O
small JJ O
bowel NN O
herniated VBN O
and CC O
incarcerated VBD O
through IN O
the DT O
port NN O
site NN O
on IN O
day NN O
4 CD O
after IN O
LADG NNP O
despite IN O
closure NN O
of IN O
the DT O
fascia NN O
. . O

Initial JJ O
manifestations NNS O
experienced VBN O
by IN O
the DT O
patient NN B-Species
, , O
possibly RB O
due JJ O
to IN O
obstruction NN O
, , O
and CC O
including VBG O
mild JJ O
abdominal JJ O
pain NN O
and CC O
nausea NN O
, , O
occurred VBD O
on IN O
the DT O
third JJ O
day NN O
postoperatively RB O
. . O

The DT O
definitive JJ O
diagnosis NN O
was VBD O
made VBN O
on IN O
day NN O
4 CD O
based VBN O
on IN O
symptoms NNS O
related VBN O
to IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
, , O
which WDT O
was VBD O
considered VBN O
to TO O
have VB O
developed VBN O
after IN O
severe JJ O
obstruction NN O
of IN O
the DT O
bowel NN O
. . O

Re IN O
- HYPH O
operation NN O
for IN O
reduction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
and CC O
tube NN O
duodenostomy NN O
with IN O
peritoneal JJ O
drainage NN O
were VBD O
required VBN O
to TO O
manage VB O
this DT O
complication NN O
. . O

Conclusion NN O

We PRP O
present VBP O
this DT O
case NN O
report NN O
and CC O
review NN O
of IN O
literature NN O
to TO O
discuss VB O
further RB O
regarding VBG O
methods NNS O
of IN O
fascial JJ O
closure NN O
after IN O
laparoscopic JJ O
surgery NN O
. . O

Introduction NN O

Bowel NN O
herniation NN O
through IN O
the DT O
fascial JJ O
defect NN O
created VBN O
by IN O
the DT O
entry NN O
of IN O
trocars NNS O
is VBZ O
now RB O
recognized VBN O
as IN O
a DT O
rare JJ O
but CC O
potentially RB O
serious JJ O
complication NN O
of IN O
laparoscopic JJ O
surgery NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Although IN O
port NN O
site NN O
herniation NN O
is VBZ O
an DT O
infrequent JJ O
complication NN O
, , O
there EX O
are VBP O
still RB O
some DT O
reports NNS O
of IN O
port NN O
site NN O
herniation NN O
after IN O
these DT O
procedures NNS O
, , O
even RB O
with IN O
closure NN O
of IN O
trocar NN O
sites NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

The DT O
following VBG O
report NN O
describes VBZ O
a DT O
case NN O
of IN O
a DT O
trocar NN O
site NN O
hernia NN O
that WDT O
evolved VBD O
into IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
after IN O
laparoscopy NN O
- HYPH O
assisted VBN O
distal NN O
gastrectomy NN O
( , O
LADG NNP O
) -RRB- O
. . O

Progression NN O
occurred VBD O
because IN O
of IN O
complete JJ O
obstruction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
after IN O
a DT O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NN O
reconstruction NN O
. . O

We PRP O
describe VBP O
the DT O
significance NN O
of IN O
complete JJ O
closure NN O
of IN O
the DT O
fascial JJ O
defect NN O
at IN O
the DT O
trocar NN O
site NN O
including VBG O
the DT O
peritoneum NN O
in IN O
the DT O
prevention NN O
of IN O
this DT O
condition NN O
, , O
as RB O
well RB O
as IN O
the DT O
importance NN O
of IN O
early JJ O
diagnosis NN O
to TO O
avoid VB O
serious JJ O
subsequent JJ O
events NNS O
. . O

Case NN O
presentation NN O

An DT O
80 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
man NN B-Species
was VBD O
found VBN O
to TO O
have VB O
early JJ O
gastric JJ O
cancer NN O
during IN O
his PRP$ O
yearly JJ O
check NN O
- HYPH O
up NN O
by IN O
gastrointestinal JJ O
endoscopy NN O
. . O

He PRP O
was VBD O
158 CD O
cm NNS O
in IN O
height NN O
and CC O
weighed VBD O
62 CD O
kg NNS O
. . O

Gastrointestinal JJ O
endoscopy NN O
showed VBD O
a DT O
depressed JJ O
lesion NN O
that WDT O
was VBD O
diagnosed VBN O
as IN O
early JJ O
gastric JJ O
cancer NN O
by IN O
pathological JJ O
examination NN O
of IN O
biopsy NN O
specimens NNS O
. . O

He PRP O
underwent VBD O
LADG NNP O
with IN O
regional JJ O
lymph JJ O
node NN O
dissection NN O
( , O
D1 NN O
including VBG O
the DT O
nodes NNS O
surrounding VBG O
the DT O
origin NN O
of IN O
left JJ O
gastric JJ O
artery NN O
) -RRB- O
. . O

A DT O
12 CD O
- HYPH O
mm NN O
trocar NN O
for IN O
the DT O
laparoscope NN O
was VBD O
placed VBN O
in IN O
the DT O
umbilicus NN O
. . O

Pneumoperitoneum NN O
was VBD O
then RB O
established VBN O
with IN O
carbon NN O
dioxide NN O
and CC O
the DT O
intraperitoneal JJ O
pressure NN O
was VBD O
maintained VBN O
at IN O
10 CD O
mm NN O
Hg NNP O
. . O

Two CD O
more JJR O
12 CD O
- HYPH O
mm NN O
trocars NNS O
were VBD O
inserted VBN O
in IN O
the DT O
midclavicular JJ O
line NN O
below IN O
the DT O
costal JJ O
margin NN O
and CC O
2 CD O
cm NNS O
above IN O
the DT O
umbilicus NN O
on IN O
each DT O
of IN O
both DT O
flanks NNS O
and CC O
were VBD O
used VBN O
for IN O
active JJ O
surgical JJ O
instruments NNS O
. . O

All DT O
trocars NNS O
used VBN O
were VBD O
the DT O
non AFX O
- HYPH O
bladed JJ O
type NN O
. . O

The DT O
specimen NN O
was VBD O
removed VBN O
through IN O
a DT O
small JJ O
medial JJ O
incision NN O
which WDT O
was VBD O
55 CD O
mm NN O
in IN O
length NN O
placed VBN O
after IN O
resection NN O
of IN O
the DT O
stomach NN O
, , O
and CC O
then RB O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NNP O
reconstruction NN O
( -LRB- O
RY NNP O
) -RRB- O
was VBD O
carried VBN O
out RP O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

A DT O
tubular JJ O
shaped VBN O
drainage NN O
tube NN O
10 CD O
mm NN O
in IN O
diameter NN O
was VBD O
inserted VBN O
and CC O
placed VBN O
through IN O
the DT O
upper JJ O
trocar NN O
site NN O
made VBN O
on IN O
the DT O
right JJ O
flank NN O
. . O

Wound NN O
defect NN O
at IN O
the DT O
umbilical JJ O
port NN O
site NN O
was VBD O
sutured VBN O
completely RB O
including VBG O
the DT O
peritoneum NN O
with IN O
0 CD O
absorbable JJ O
suture NN O
and CC O
fascial JJ O
incisions NNS O
at IN O
all DT O
other JJ O
trocar NN O
insertion NN O
sites NNS O
were VBD O
closed VBN O
with IN O
2 CD O
- HYPH O
0 CD O
absorbable JJ O
sutures NNS O
. . O

Surgical JJ O
duration NN O
was VBD O
263 CD O
min NN O
, , O
and CC O
the DT O
volume NN O
of IN O
blood NN O
loss NN O
was VBD O
less JJR O
than IN O
50 CD O
mL NNS O
with IN O
no DT O
blood NN O
transfusion NN O
. . O

Postoperatively RB O
, , O
the DT O
patient NN B-Species
complained VBD O
of IN O
an DT O
acidic JJ O
feeling NN O
in IN O
his PRP$ O
stomach NN O
; : O
however RB O
, , O
there EX O
were VBD O
no DT O
remarkable JJ O
abnormalities NNS O
on IN O
biochemical JJ O
examination NN O
of IN O
serum NN O
. . O

Radiological JJ O
findings NNS O
did VBD O
not RB O
suggest VB O
bowel NN O
obstruction NN O
until IN O
3 CD O
days NNS O
postoperatively RB O
, , O
although IN O
mild JJ O
symptoms NNS O
such JJ O
as IN O
general JJ O
malaise NN O
and CC O
vague JJ O
abdominal JJ O
pain NN O
were VBD O
reported VBN O
on IN O
day NN O
three CD O
. . O

However RB O
, , O
on IN O
day NN O
4 CD O
, , O
the DT O
patient NN B-Species
started VBD O
to TO O
complain VB O
of IN O
upper JJ O
abdominal JJ O
pain NN O
and CC O
developed VBD O
a DT O
high JJ O
grade NN O
fever NN O
( : O
38 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

Complete JJ O
obstruction NN O
of IN O
the DT O
small JJ O
bowel NN O
and CC O
leakage NN O
of IN O
contrast NN O
media NN O
were VBD O
demonstrated VBN O
by IN O
Gastrografin NNP O
swallow NN O
and CC O
subsequent JJ O
abdominal JJ O
computed VBN O
tomography NN O
( -LRB- O
CT NNP O
) -RRB- O
. . O

CT NNP O
also RB O
showed VBD O
a DT O
mass JJ O
lesion NN O
at IN O
the DT O
trocar NN O
insertion NN O
site NN O
on IN O
the DT O
upper JJ O
left JJ O
flank NN O
, , O
suggesting VBG O
herniation NN O
through IN O
the DT O
port NN O
site NN O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Marked JJ O
dilatation NN O
of IN O
the DT O
duodenum NN O
including VBG O
the DT O
horizontal JJ O
part NN O
and CC O
second JJ O
portion NN O
was VBD O
observed VBN O
. . O

A DT O
diagnosis NN O
of IN O
staple JJ O
failure NN O
of IN O
the DT O
stump NN O
of IN O
the DT O
duodenum NN O
and CC O
port NN O
- HYPH O
site NN O
herniation NN O
of IN O
the DT O
small JJ O
bowel NN O
was VBD O
made VBN O
, , O
and CC O
exploratory JJ O
laparotomy NN O
was VBD O
carried VBN O
out RP O
. . O

A DT O
small JJ O
medial JJ O
incision NN O
that WDT O
had VBD O
been VBN O
made VBN O
at IN O
the DT O
initial JJ O
surgery NN O
was VBD O
extended VBN O
downward RB O
to IN O
the DT O
umbilicus NN O
to TO O
open VB O
the DT O
peritoneal JJ O
cavity NN O
. . O

As IN O
we PRP O
expected VBD O
, , O
the DT O
small JJ O
bowel NN O
was VBD O
incarcerated VBN O
into IN O
the DT O
peritoneal JJ O
defect NN O
in IN O
the DT O
abdominal JJ O
wall NN O
created VBN O
by IN O
the DT O
trocar NN O
placed VBN O
in IN O
the DT O
left JJ O
upper JJ O
flank NN O
leading VBG O
to IN O
complete JJ O
obstruction NN O
of IN O
the DT O
bowel NN O
( , O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

Part NN O
of IN O
the DT O
jejunum NN O
30 CD O
cm NN O
distal NN O
from IN O
the DT O
ligament NN O
of IN O
Treitz NNP O
herniated VBN O
around IN O
the DT O
fascial JJ O
stitch NN O
, , O
which WDT O
still RB O
existed VBD O
at IN O
the DT O
time NN O
of IN O
the DT O
re NN O
- HYPH O
exploration NN O
. . O

The DT O
peritoneal JJ O
cavity NN O
was VBD O
contaminated VBN O
with IN O
intestinal JJ O
juice NN O
. . O

Close JJ O
examination NN O
after IN O
reduction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
did VBD O
not RB O
demonstrate VB O
necrosis NN O
of IN O
the DT O
intestine NN O
, , O
and CC O
thus RB O
, , O
we PRP O
decided VBD O
not RB O
to TO O
resect VB O
this DT O
lesion NN O
. . O

Leakage NN O
of IN O
intestinal JJ O
juice NN O
through IN O
a DT O
pinhole NN O
fistula NN O
at IN O
the DT O
duodenal NN O
stump NN O
was VBD O
also RB O
observed VBN O
. . O

Tube NN O
duodenostomy NN O
was VBD O
performed VBN O
with IN O
an DT O
omental JJ O
patch NN O
used VBN O
for IN O
closure NN O
of IN O
the DT O
fistula NN O
. . O

The DT O
peritoneal JJ O
defect NN O
was VBD O
also RB O
closed VBN O
. . O

The DT O
postoperative JJ O
course NN O
was VBD O
fairly RB O
good JJ O
without IN O
high JJ O
output NN O
of IN O
the DT O
intestinal JJ O
juice NN O
leakage NN O
or CC O
sepsis NNS O
. . O

The DT O
patient NN B-Species
remained VBD O
in IN O
the DT O
intensive JJ O
care NN O
unit NN O
for IN O
5 CD O
days NNS O
after IN O
re NN O
- HYPH O
operation NN O
, , O
and CC O
was VBD O
then RB O
transferred VBN O
to IN O
the DT O
general JJ O
ward NN O
. . O

Discussion NN O

Port NN O
- HYPH O
site NN O
herniation NN O
, , O
which WDT O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
complications NNS O
after IN O
laparoscopic JJ O
procedures NNS O
[ -LRB- O
1 CD O
] -RRB- O
, , O
sometimes RB O
develops VBZ O
into IN O
serious JJ O
complications NNS O
, , O
such JJ O
as IN O
bowel NN O
obstruction NN O
due IN O
to IN O
incarceration NN O
into IN O
the DT O
fascial JJ O
defect NN O
at IN O
the DT O
port NN O
site NN O
. . O

Boughey NNP O
et FW O
al NNP O
. . O
have VBP O
reported VBN O
four CD O
cases NNS O
of IN O
Richter NNP O
' POS O
s NN O
hernia NN O
that WDT O
occurred VBD O
at IN O
a DT O
port NN O
site NN O
after IN O
laparoscopic JJ O
surgery NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

They PRP O
reviewed VBD O
previous JJ O
reports NNS O
and CC O
found VBD O
the DT O
incidence NN O
to TO O
be VB O
0 CD O
. . O
2 CD O
to TO O
3 CD O
% NN O
. . O

A DT O
report NN O
describes VBZ O
the DT O
incidence NN O
of IN O
hernia NN O
as IN O
0 CD O
. . O
23 CD O
% NN O
for IN O
10 CD O
- HYPH O
mm NN O
trocar NN O
use NN O
, , O
rising VBG O
to IN O
3 CD O
. . O
1 CD O
% NN O
for IN O
the DT O
12 CD O
- HYPH O
mm NN O
trocar NN O
[ -LRB- O
2 CD O
] -RRB- O
suggesting VBG O
that IN O
the DT O
wound NN O
created VBN O
by IN O
a DT O
larger JJR O
port NN O
carries VBZ O
a DT O
greater JJR O
risk NN O
of IN O
herniation NN O
. . O

Most JJS O
surgeons NNS O
now RB O
routinely RB O
close VBP O
the DT O
fascia NN O
of IN O
port NN O
sites NNS O
to TO O
prevent VB O
this DT O
complication NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

According VBG O
to IN O
previous JJ O
reports NNS O
, , O
port NN O
site NN O
herniation NN O
apparently RB O
happens VBZ O
more RBR O
often RB O
with IN O
the DT O
use NN O
of IN O
bladed VBN O
type NN O
trocars NNS O
than IN O
non NN O
- HYPH O
bladed JJ O
type NN O
trocars NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Indeed RB O
, , O
Kolata NNP O
demonstrated VBD O
that IN O
the DT O
wounds NNS O
made VBN O
by IN O
the DT O
non NN O
- HYPH O
bladed JJ O
trocar NN O
were VBD O
narrower JJR O
than IN O
those DT O
created VBN O
by IN O
cutting VBG O
tip NN O
trocars NNS O
in IN O
a DT O
pig NN B-Species
experimental JJ O
model NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Several JJ O
reports NNS O
even RB O
concluded VBD O
that IN O
port NN O
sites NNS O
created VBN O
by IN O
non NN O
- HYPH O
bladed JJ O
trocars NNS O
do VBP O
not RB O
require VB O
fascial JJ O
closure NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
current JJ O
case NN O
suggests VBZ O
that IN O
thick JJ O
preperitoneum NN O
is VBZ O
a DT O
potential JJ O
space NN O
that WDT O
allows VBZ O
for IN O
the DT O
development NN O
of IN O
bowel NN O
herniation NN O
even RB O
with IN O
the DT O
use NN O
of IN O
non NN O
- HYPH O
bladed VBN O
type NN O
trocars NNS O
. . O

A DT O
previous JJ O
report NN O
also RB O
described VBD O
port NN O
- HYPH O
site NN O
herniation NN O
, , O
despite IN O
the DT O
closure NN O
of IN O
the DT O
superficial JJ O
layer NN O
of IN O
the DT O
fascial JJ O
defect NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
current JJ O
case NN O
did VBD O
not RB O
demonstrate VB O
any DT O
of IN O
the DT O
risk NN O
factors NNS O
suggested VBN O
previously RB O
[ -LRB- O
6 CD O
] -RRB- O
; , O
1 CD O
) -RRB- O
enlargement NN O
of IN O
a DT O
port NN O
site NN O
to TO O
remove VB O
specimen NN O
; : O
2 CD O
) SYM O
glucose NN O
intolerance NN O
; : O
3 CD O
) SYM O
obesity NN O
; : O
or CC O
4 CD O
) SYM O
extensive JJ O
manipulation NN O
of IN O
the DT O
trocar NN O
during IN O
relatively RB O
prolonged VBN O
surgical JJ O
duration NN O
, , O
which WDT O
might MD O
have VB O
enlarged VBN O
the DT O
trocar NN O
site NN O
and CC O
thus RB O
induced VBN O
bowel NN O
herniation NN O
. . O

Therefore RB O
, , O
we PRP O
recommend VBP O
closing VBG O
the DT O
fascial JJ O
defect NN O
, , O
including VBG O
the DT O
peritoneum NN O
, , O
especially RB O
if IN O
the DT O
trocar NN O
size NN O
is VBZ O
more JJR O
than IN O
10 CD O
- HYPH O
mm NN O
and CC O
in IN O
the DT O
presence NN O
of IN O
any DT O
of IN O
the DT O
risk NN O
factors NNS O
described VBN O
above RB O
. . O

However RB O
, , O
it PRP O
is VBZ O
sometimes RB O
difficult JJ O
to TO O
completely RB O
close VB O
the DT O
defect NN O
, , O
including VBG O
the DT O
peritoneum NN O
, , O
especially RB O
in IN O
obese JJ O
patients NNS B-Species
. . O

Shaher NNP O
reviewed VBD O
different JJ O
wound NN O
closure NN O
techniques NNS O
by IN O
a DT O
literature NN O
search NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
this DT O
review NN O
, , O
old JJ O
methods NNS O
using VBG O
classical JJ O
instruments NNS O
including VBG O
Deschamps NNP O
needle NN O
are VBP O
also RB O
useful JJ O
as RB O
well RB O
as IN O
special JJ O
wound NN O
devices NNS O
designed VBN O
for IN O
port NN O
site NN O
closure NN O
. . O

Elashry NNP O
et FW O
al NNP O
. . O
described VBD O
a DT O
prospective JJ O
randomized JJ O
study NN O
demonstrating VBG O
that IN O
the DT O
Carter NNP O
- HYPH O
Thomason NNP O
device NN O
was VBD O
faster JJR O
and CC O
resulted VBD O
in IN O
fewer JJR O
port NN O
- HYPH O
closure NN O
- HYPH O
related VBN O
complications NNS O
among IN O
eight CD O
different JJ O
techniques NNS O
tested VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Insertion NN O
of IN O
a DT O
SURGICEL NNP O
plug NN O
into IN O
the DT O
muscular JJ O
layer NN O
of IN O
trocar NN O
wounds NNS O
has VBZ O
also RB O
been VBN O
proposed VBN O
by IN O
Chiu NNP O
et FW O
al NNP O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Alternatively RB O
, , O
tangential JJ O
insertion NN O
of IN O
a DT O
trocar NN O
through IN O
the DT O
abdominal JJ O
wall NN O
might MD O
be VB O
effective JJ O
in IN O
reducing VBG O
the DT O
size NN O
of IN O
fascial JJ O
defects NNS O
. . O

Moreover RB O
, , O
recent JJ O
publications NNS O
have VBP O
demonstrated VBN O
that IN O
radially RB O
expanding VBG O
type NN O
trocars NNS O
could MD O
be VB O
useful JJ O
to TO O
avoid VB O
the DT O
necessity NN O
of IN O
closing VBG O
the DT O
fascial JJ O
defect NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Symptoms NNS O
of IN O
trocar NN O
- HYPH O
site NN O
herniation NN O
vary VBP O
depending VBG O
on IN O
the DT O
severity NN O
of IN O
bowel NN O
obstruction NN O
. . O

Mild JJ O
symptoms NNS O
such JJ O
as IN O
slight JJ O
nausea NN O
and CC O
vague JJ O
abdominal JJ O
pain NN O
, , O
both DT O
of IN O
which WDT O
are VBP O
most RBS O
frequently RB O
seen VBN O
in IN O
the DT O
early JJ O
normal JJ O
postoperative JJ O
course NN O
after IN O
abdominal JJ O
surgery NN O
, , O
could MD O
be VB O
the DT O
first JJ O
and CC O
only JJ O
complaints NNS O
at IN O
the DT O
early JJ O
stage NN O
of IN O
this DT O
complication NN O
. . O

Thus RB O
, , O
the DT O
diagnosis NN O
may MD O
be VB O
delayed VBN O
. . O

In IN O
our PRP$ O
case NN O
, , O
mild JJ O
abdominal JJ O
pain NN O
with IN O
general JJ O
malaise NN O
might MD O
have VB O
been VBN O
symptoms NNS O
related VBN O
to IN O
the DT O
early JJ O
stage NN O
of IN O
the DT O
onset NN O
. . O

Abdominal NNP O
CT NNP O
showing VBG O
the DT O
enlarged JJ O
duodenum NN O
also RB O
suggested VBD O
that IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
occurred VBD O
due IN O
to IN O
the DT O
obstruction NN O
of IN O
the DT O
distal JJ O
bowel NN O
. . O

Thus RB O
, , O
severe JJ O
complication NN O
might MD O
have VB O
been VBN O
avoided VBN O
, , O
if IN O
early JJ O
diagnosis NN O
had VBD O
been VBN O
made VBN O
. . O

Although IN O
the DT O
benefit NN O
of IN O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NNP O
is VBZ O
apparent JJ O
[ -LRB- O
11 CD O
] -RRB- O
, , O
the DT O
duodenal JJ O
stump NN O
could MD O
be VB O
vulnerable JJ O
to IN O
leakage NN O
due IN O
to IN O
increased VBN O
intrabowel JJ O
pressure NN O
. . O

Therefore RB O
, , O
careful JJ O
management NN O
of IN O
the DT O
postoperative JJ O
course NN O
is VBZ O
warranted VBN O
, , O
especially RB O
after IN O
procedures NNS O
involving VBG O
division NN O
of IN O
the DT O
bowel NN O
such JJ O
as IN O
LADG NNP O
. . O

Moreover RB O
, , O
special JJ O
attention NN O
should MD O
be VB O
paid VBN O
in IN O
patients NNS B-Species
with IN O
risk NN O
factors NNS O
for IN O
port NN O
site NN O
hernia NN O
such JJ O
as IN O
obesity NN O
, , O
aggressive JJ O
manipulation NN O
through IN O
the DT O
port NN O
sites NNS O
, , O
and CC O
prolonged VBN O
surgery NN O
. . O

Conclusion NN O

Port NN O
- HYPH O
site NN O
herniation NN O
is VBZ O
a DT O
potentially RB O
dangerous JJ O
complication NN O
after IN O
laparoscopic JJ O
procedures NNS O
. . O

Careful JJ O
management NN O
of IN O
the DT O
postoperative JJ O
course NN O
is VBZ O
recommended VBN O
especially RB O
for IN O
patients NNS B-Species
with IN O
risk NN O
factors NNS O
such JJ O
as IN O
obesity NN O
and CC O
extensive JJ O
manipulation NN O
of IN O
the DT O
trocar NN O
during IN O
prolonged VBN O
surgical JJ O
duration NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

TI NNP O
, , O
NF NNP O
, , O
HT NNP O
and CC O
TK NNP O
performed VBD O
the DT O
first JJ O
and CC O
second JJ O
operation NN O
. . O

TI NNP O
and CC O
KK NNP O
were VBD O
responsible JJ O
for IN O
the DT O
postoperative JJ O
management NN O
. . O

TI NNP O
, , O
HT NNP O
, , O
TW NNP O
, , O
and CC O
KN NNP O
were VBD O
involved VBN O
in IN O
editing VBG O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Consent NN O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN B-Species
for IN O
publication NN O
of IN O
this DT O
case NN O
report NN O
and CC O
any DT O
accompanying JJ O
images NNS O
. . O

A DT O
copy NN O
of IN O
the DT O
written JJ O
consent NN O
is VBZ O
available JJ O
for IN O
review NN O
by IN O
the DT O
Editor NNP O
- HYPH O
in IN O
- HYPH O
Chief NNP O
of IN O
this DT O
journal NN O
. . O

Comparison NN O
of IN O
strategies NNS O
for IN O
identification NN O
of IN O
regulatory JJ O
quantitative JJ O
trait NN O
loci NN O
of IN O
transcript NN O
expression NN O
traits NNS O

Abstract JJ O

In IN O
order NN O
to TO O
identify VB O
regulatory JJ O
genes NNS O
, , O
we PRP O
determined VBD O
the DT O
heritability NN O
of IN O
gene NN O
transcripts NNS O
, , O
performed VBD O
linkage NN O
analysis NN O
to TO O
identify VB O
quantitative JJ O
trait NN O
loci NN O
( , O
QTLs NNP O
) -RRB- O
, , O
and CC O
evaluated VBD O
the DT O
evidence NN O
for IN O
shared VBN O
genetic JJ O
effects NNS O
among IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNP O
in IN O
non AFX O
- HYPH O
diseased JJ O
participants NNS B-Species
from IN O
14 CD O
CEPH NNP O
( -LRB- O
Centre NNP O
d FW O
' '' O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O
) , O
Utah NNP O
families NNS O
. . O

Seventy CD O
- HYPH O
six CD O
percent NN O
of IN O
transcripts NNS O
had VBD O
a DT O
significant JJ O
heritability NN O
and CC O
54 CD O
% NN O
of IN O
them PRP O
had VBD O
LOD NN O
score NN O
> : O
= SYM O
1 CD O
. . O
8 CD O
. . O

Bivariate NN O
genetic JJ O
analysis NN O
of IN O
15 CD O
transcripts NNS O
that WDT O
had VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
on IN O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
identified VBD O
significant JJ O
genetic JJ O
correlation NN O
among IN O
some DT O
transcripts NNS O
although IN O
no DT O
improvement NN O
in IN O
the DT O
magnitude NN O
of IN O
LOD NNP O
scores NNS O
in IN O
this DT O
region NN O
was VBD O
noted VBN O
. . O

Similar JJ O
results NNS O
were VBD O
found VBN O
in IN O
analysis NN O
of IN O
12 CD O
transcripts NNS O
, , O
that WDT O
had VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
in IN O
the DT O
13q34 CD O
region NN O
. . O

Principal JJ O
- HYPH O
component NN O
analyses NNS O
did VBD O
not RB O
improve VB O
the DT O
ability NN O
to TO O
identify VB O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
. . O

Background NN O

There EX O
is VBZ O
a DT O
breadth NN O
of IN O
information NN O
being VBG O
generated VBN O
by IN O
the DT O
Human NNP B-Species
Genome NNP O
Project NNP O
and CC O
the DT O
interpretation NN O
of IN O
these DT O
data NNS O
has VBZ O
been VBN O
a DT O
major JJ O
area NN O
of IN O
research NN O
. . O

For IN O
simple JJ O
Mendelian JJ O
disorders NNS O
, , O
the DT O
identification NN O
of IN O
genetic JJ O
effects NNS O
is VBZ O
fairly RB O
straightforward JJ O
due IN O
to IN O
understanding VBG O
the DT O
biology NN O
that WDT O
drives VBZ O
these DT O
disorders NNS O
. . O

However RB O
, , O
for IN O
complex JJ O
oligogenic JJ O
or CC O
polygenic JJ O
disorders NNS O
, , O
understanding VBG O
all PDT O
the DT O
interconnections NNS O
between IN O
genes NNS O
influencing VBG O
a DT O
trait NN O
is VBZ O
a DT O
difficult JJ O
task NN O
because IN O
the DT O
understanding NN O
of IN O
the DT O
biology NN O
of IN O
many JJ O
of IN O
these DT O
disorders NNS O
is VBZ O
still RB O
evolving VBG O
. . O

Multiple JJ O
gene NN O
x NN O
gene NN O
and CC O
gene NN O
x NN O
environment NN O
interactions NNS O
can MD O
influence VB O
the DT O
expression NN O
of IN O
phenotypes NNS O
. . O

Genes NNS O
can MD O
interact VB O
by IN O
modifying VBG O
the DT O
expression NN O
of IN O
other JJ O
genes NNS O
and CC O
therefore RB O
function VB O
as IN O
regulatory JJ O
genes NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

In IN O
an DT O
effort NN O
to TO O
dissect VB O
some DT O
of IN O
these DT O
complexities NNS O
, , O
we PRP O
performed VBD O
linkage NN O
analysis NN O
of IN O
gene NN O
expression NN O
transcripts NNS O
of IN O
members NNS O
of IN O
Centre NNP O
d NNP O
' POS O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O
( , O
CEPH NNP O
) -RRB- O
Utah NNP O
families NNS O
to TO O
determine VB O
the DT O
heritability NN O
of IN O
transcripts NNS O
and CC O
the DT O
evidence NN O
for IN O
regulatory JJ O
quantitative JJ O
trait NN O
loci NN O
( -LRB- O
QTLs NNP O
) -RRB- O
and CC O
we PRP O
performed VBD O
pairwise JJ O
bivariate NN O
linkage NN O
analysis NN O
and CC O
principal JJ O
- HYPH O
component NN O
analysis NN O
( , O
PCA NNP O
) -RRB- O
for IN O
data NN O
- HYPH O
reduction NN O
to TO O
evaluate VB O
the DT O
evidence NN O
for IN O
shared VBN O
genetic JJ O
effects NNS O
. . O

The DT O
ability NN O
to TO O
assess VB O
gene NN O
expression NN O
traits NNS O
simultaneously RB O
and CC O
to TO O
link VB O
them PRP O
to IN O
QTLs NNP O
offers VBZ O
the DT O
possibility NN O
of IN O
identifying VBG O
previously RB O
unknown JJ O
underlying VBG O
molecular JJ O
processes NNS O
for IN O
future JJ O
investigation NN O
. . O

Methods NNS O

Population NN O
and CC O
phenotypes NNS O

We PRP O
used VBD O
the DT O
Genetic NNP O
Analysis NNP O
Workshop NNP O
15 CD O
( , O
GAW NNP O
15 CD O
) -RRB- O
Problem NNP O
1 CD O
microarray NN O
gene NN O
expression NN O
profiles NNS O
for IN O
the DT O
analyses NNS O
. . O

Data NNS O
were VBD O
available JJ O
for IN O
14 CD O
three CD O
- HYPH O
generation NN O
CEPH NNP O
Utah NNP O
families NNS O
. . O

Expression NN O
levels NNS O
of IN O
genes NNS O
were VBD O
obtained VBN O
from IN O
lymphoblastoid JJ O
cells NNS O
using VBG O
the DT O
Affymetrix NNP O
Human NNP B-Species
Focus NNP O
Arrays NNPS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

We PRP O
were VBD O
provided VBN O
with IN O
data NNS O
on IN O
3554 CD O
transcripts NNS O
that WDT O
showed VBD O
greater JJR O
variation NN O
between IN O
individuals NNS O
than IN O
within IN O
the DT O
same JJ O
individual NN O
. . O

Family NN O
members NNS O
were VBD O
genotyped VBN O
for IN O
2882 CD O
autosomal NN O
and CC O
X NNP O
- HYPH O
linked VBN O
single JJ O
- HYPH O
nucleotide NN O
polymorphisms NNS O
( -LRB- O
SNP NNP O
) -RRB- O
generated VBN O
by IN O
the DT O
SNP NNP O
Consortium NNP O
. . O

Genetic JJ O
map NN O
positions NNS O
were VBD O
obtained VBN O
using VBG O
the DT O
SNP NNP O
Mapping NNP O
web NN O
application NN O
developed VBN O
by IN O
the DT O
University NNP O
College NNP O
Dublin NNP O
Conway NNP O
Institute NNP O
of IN O
Biomolecular NNP O
and CC O
Biomedical NNP O
Research NNP O
, , O
which WDT O
uses VBZ O
the DT O
Rutgers NNP O
Combined NNP O
Linkage NNP O
- HYPH O
Physical NNP O
Map NNP O
of IN O
the DT O
Human NNP B-Species
Genome NNP O
and CC O
data NNS O
taken VBN O
from IN O
the DT O
NCBI NNP O
dbSNP NNP O
Build NNP O
123 CD O
( , O
in IN O
Kosambi NNP O
centimorgans NNS O
) -RRB- O
. . O

This DT O
information NN O
was VBD O
used VBN O
to TO O
calculate VB O
multipoint JJ O
identity NN O
by IN O
descent NN O
matrices NNS O
( , O
MIBDs NNP O
) -RRB- O
with IN O
Merlin NNP O
and CC O
Minx NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
after IN O
removal NN O
of IN O
Mendelian JJ O
inconsistencies NNS O
and CC O
double JJ O
recombinants NNS O
with IN O
Preswalk NNP O
( , O
based VBN O
on IN O
Simwalk NNP O
mistyping NN O
probabilities NNS O
) -RRB- O
[ -LRB- O
4 CD O
] -RRB- O
. . O

MIBDs NNS O
were VBD O
used VBN O
for IN O
linkage NN O
analyses NNS O
. . O

Transcript NN O
distributions NNS O
were VBD O
normalized VBN O
using VBG O
an DT O
inverse JJ O
normalization NN O
transformation NN O
of IN O
z NN O
- HYPH O
scores NNS O
of IN O
individual JJ O
transcripts NNS O
regressed VBN O
on IN O
the DT O
mean JJ O
individual JJ O
transcript NN O
level NN O
. . O

We PRP O
further RB O
adjusted VBD O
for IN O
the DT O
effects NNS O
of IN O
age NN O
, , O
age2 NN O
, , O
sex NN O
, , O
age NN O
x NN O
sex NN O
and CC O
age2 NN O
x NN O
sex NN O
interaction NN O
using VBG O
predictive JJ O
linear JJ O
regression NN O
models NNS O
in IN O
SAS NNP O
9 CD O
. . O
1 CD O
( , O
Cary NNP O
, , O
NC NNP O
) -RRB- O
. . O

We PRP O
generated VBD O
these DT O
residuals NNS O
as IN O
part NN O
of IN O
our PRP$ O
processing NN O
of IN O
the DT O
transcripts NNS O
for IN O
linkage NN O
analyses NNS O
. . O

Heritability NN O
estimation NN O
and CC O
linkage NN O
analysis NN O

Heritability NN O
was VBD O
estimated VBN O
using VBG O
maximum JJ O
likelihood NN O
variance NN O
decomposition NN O
methods NNS O
in IN O
SOLAR NNP O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

Genome NN O
scans NNS O
were VBD O
performed VBN O
using VBG O
multipoint JJ O
variance NN O
- HYPH O
components NNS O
models NNS O
that WDT O
test VBP O
for IN O
linkage NN O
between IN O
traits NNS O
and CC O
genetic JJ O
variants NNS O
by IN O
partitioning VBG O
the DT O
variance NN O
of IN O
the DT O
expression NN O
level NN O
into IN O
its PRP$ O
additive JJ O
genetic JJ O
and CC O
environmental JJ O
variance NN O
components NNS O
[ -LRB- O
7 CD O
] -RRB- O
. . O

For IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
, , O
we PRP O
performed VBD O
bivariate NN O
linkage NN O
analysis NN O
to TO O
identify VB O
shared VBN O
genetic JJ O
effects NNS O
. . O

The DT O
bivariate JJ O
polygenic JJ O
model NN O
estimates VBZ O
correlations NNS O
caused VBN O
by IN O
residual JJ O
additive JJ O
genetic JJ O
effects NNS O
( , O
rho FW O
G NNP O
) -RRB- O
and CC O
correlations NNS O
caused VBN O
by IN O
random JJ O
environmental JJ O
effects NNS O
( , O
rho FW O
E NN O
) -RRB- O
[ -LRB- O
8 CD O
] -RRB- O
. . O

To TO O
test VB O
for IN O
additive JJ O
genetic JJ O
correlation NN O
among IN O
pairs NNS O
of IN O
traits NNS O
, , O
the DT O
log NN O
likelihood NN O
of IN O
a DT O
model NN O
in IN O
which WDT O
rho NN O
G NN O
is VBZ O
constrained VBN O
to IN O
0 CD O
( HYPH O
null JJ O
hypothesis NN O
, , O
no DT O
correlation NN O
) , O
or CC O
rho NN O
G NN O
= SYM O
1 CD O
( HYPH O
null JJ O
hypothesis NN O
, , O
complete JJ O
shared VBN O
genetic JJ O
effect NN O
) -RRB- O
is VBZ O
compared VBN O
to IN O
that DT O
of IN O
a DT O
model NN O
in IN O
which WDT O
rho NN O
G NN O
is VBZ O
estimated VBN O
for IN O
the DT O
traits NNS O
. . O

Significant JJ O
differences NNS O
among IN O
the DT O
models NNS O
( , O
rho FW O
G NNP O
! . O
= SYM O
0 CD O
) -RRB- O
suggest VBP O
that IN O
some DT O
of IN O
the DT O
same JJ O
genes NNS O
influence VBP O
both DT O
traits NNS O
. . O

We PRP O
also RB O
performed VBD O
linkage NN O
analysis NN O
using VBG O
the DT O
factors NNS O
obtained VBN O
from IN O
the DT O
PCA NNP O
in IN O
a DT O
sample NN O
of IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
. . O

Principal JJ O
- HYPH O
component NN O
analysis NN O

PCA NNP O
was VBD O
used VBN O
to TO O
reduce VB O
the DT O
number NN O
of IN O
expression NN O
profiles NNS O
into IN O
statistically RB O
meaningful JJ O
groups NNS O
while IN O
retaining VBG O
the DT O
original JJ O
total JJ O
variance NN O
using VBG O
all PDT O
the DT O
expression NN O
profiles NNS O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

We PRP O
selected VBD O
two CD O
different JJ O
chromosomal JJ O
regions NNS O
of IN O
a DT O
length NN O
of IN O
10 CD O
to TO O
12 CD O
MB NN O
in IN O
which WDT O
the DT O
QTLs NNS O
of IN O
at RB O
least RBS O
10 CD O
transcripts NNS O
were VBD O
co RB O
- HYPH O
localized VBN O
. . O

Only JJ O
transcripts NNS O
of IN O
genes NNS O
that WDT O
were VBD O
not RB O
located VBN O
in IN O
these DT O
selected VBN O
chromosomal JJ O
regions NNS O
were VBD O
included VBN O
in IN O
the DT O
analyses NNS O
( , O
trans JJ O
- HYPH O
regulatory JJ O
genes NNS O
) -RRB- O
. . O

Because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
individuals NNS O
in IN O
the DT O
study NN O
and CC O
concerns NNS O
of IN O
overfitting VBG O
the DT O
model NN O
, , O
a DT O
maximum JJ O
sample NN O
of IN O
50 CD O
transcript NN O
values NNS O
were VBD O
considered VBN O
at IN O
one CD O
time NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

The DT O
number NN O
of IN O
factors NNS O
was VBD O
determined VBN O
using VBG O
the DT O
eigenvalue NN O
- HYPH O
one CD O
requirement NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Factors NNS O
are VBP O
interpreted VBN O
by IN O
examining VBG O
the DT O
varimax NN O
- HYPH O
rotated VBN O
factor NN O
loadings NNS O
, , O
which WDT O
are VBP O
the DT O
correlations NNS O
between IN O
each DT O
phenotype NN O
and CC O
the DT O
factor NN O
in IN O
question NN O
. . O

Factor NN O
loadings NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to IN O
0 CD O
. . O
40 CD O
in IN O
absolute JJ O
value NN O
were VBD O
used VBN O
to TO O
interpret VB O
factors NNS O
and CC O
to TO O
characterize VB O
the DT O
factor NN O
structures NNS O
; , O
this DT O
criterion NN O
ensures VBZ O
that IN O
the DT O
individual JJ O
factor NN O
variables NNS O
share VBP O
at RB O
least RBS O
15 CD O
% NN O
of IN O
their PRP$ O
variance NN O
with IN O
the DT O
given VBN O
factor NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
principle JJ O
components NNS O
were VBD O
obtained VBN O
by IN O
calculating VBG O
the DT O
eigenvalues NNS O
of IN O
the DT O
sample NN O
covariance NN O
matrix NN O
, , O
which WDT O
represent VBP O
the DT O
amount NN O
of IN O
variance NN O
contributed VBN O
by IN O
each DT O
factor NN O
. . O

Only RB O
factors NNS O
with IN O
eigenvalues NNS O
higher JJR O
than IN O
1 CD O
were VBD O
considered VBN O
for IN O
linkage NN O
analysis NN O
. . O

Integrating VBG O
data NNS O
from IN O
linkage NN O
analysis NN O
for IN O
gene NN O
co NN O
- HYPH O
expression NN O

Linkage NN O
signals NNS O
of IN O
individual JJ O
transcript NN O
expressions NNS O
were VBD O
recorded VBN O
and CC O
the DT O
location NN O
of IN O
QTLs NNS O
was VBD O
compared VBN O
to IN O
the DT O
location NN O
of IN O
the DT O
transcript NN O
gene NN O
in IN O
order NN O
to TO O
identify VB O
trans JJ O
- HYPH O
regulatory JJ O
sites NNS O
. . O

In IN O
addition NN O
, , O
the DT O
location NN O
and CC O
LOD NN O
scores NNS O
of IN O
QTLs NNS O
identified VBN O
in IN O
single JJ O
individual JJ O
transcript NN O
analysis NN O
( , O
univariate JJ O
analysis NN O
) , O
were VBD O
compared VBN O
with IN O
the DT O
location NN O
of IN O
the DT O
QTLs NNS O
identified VBN O
using VBG O
bivariate NN O
analysis NN O
or CC O
factors NNS O
of IN O
the DT O
PCA NNP O
. . O

This DT O
allowed VBD O
a DT O
determination NN O
of IN O
whether IN O
the DT O
bivariate NN O
analysis NN O
or CC O
PCA NNP O
data NN O
reduction NN O
analysis NN O
improved VBD O
our PRP$ O
evidence NN O
for IN O
linkage NN O
, , O
and CC O
if IN O
so RB O
, , O
a DT O
more JJR O
in IN O
- HYPH O
depth NN O
examination NN O
of IN O
the DT O
transcripts NNS O
included VBN O
in IN O
the DT O
principal JJ O
components NNS O
needs VBZ O
to TO O
be VB O
examined VBN O
for IN O
biologic JJ O
interactions NNS O
on IN O
complex JJ O
disorders NNS O
. . O

Results NNS O

Among IN O
194 CD O
individuals NNS O
from IN O
14 CD O
families NNS O
, , O
17 CD O
individuals NNS O
with IN O
missing VBG O
information NN O
on IN O
age NN O
were VBD O
excluded VBN O
. . O

Seventy CD O
- HYPH O
six CD O
percent NN O
( : O
n CD O
= SYM O
2688 CD O
) -RRB- O
of IN O
the DT O
transcripts NNS O
had VBD O
significant JJ O
heritability NN O
( : O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
and CC O
were VBD O
considered VBN O
for IN O
the DT O
linkage NN O
analysis NN O
. . O

Of IN O
this DT O
, , O
1448 CD O
( SYM O
54 CD O
% NN O
) -RRB- O
transcripts NNS O
displayed VBD O
suggestive JJ O
evidence NN O
of IN O
linkage NN O
( , O
had VBD O
a DT O
maximum JJ O
LOD NN O
score NN O
> NFP O
= SYM O
1 CD O
. . O
8 CD O
[ SYM O
12 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
QTLs NNPS O
of IN O
1661 CD O
transcripts NNS O
( , O
759 CD O
of IN O
which WDT O
with IN O
LOD NNP O
> SYM O
= SYM O
1 CD O
. SYM O
8 CD O
) -RRB- O
were VBD O
localized VBN O
in IN O
a DT O
different JJ O
region NN O
than IN O
the DT O
gene NN O
transcript NN O
( , O
trans JJ O
- HYPH O
regulatory JJ O
sites NNS O
) -RRB- O
. . O

We PRP O
used VBD O
two CD O
different JJ O
chromosomal JJ O
regions NNS O
with IN O
co NN O
- HYPH O
localized VBN O
transcript NN O
QTLs NNS O
, , O
chromosomes NNS O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
and CC O
13q34 CD O
, , O
for IN O
more JJR O
in IN O
- HYPH O
depth NN O
analyses NNS O
. . O

Chromosome NN O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
region NN O

Table NN O
1 CD O
reports VBZ O
the DT O
results NNS O
for IN O
the DT O
chromosome NN O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
region NN O
. . O

Fifteen CD O
transcripts NNS O
co NN O
- HYPH O
localized VBN O
in IN O
this DT O
region NN O
in IN O
the DT O
univariate JJ O
linkage NN O
analysis NN O
, , O
and CC O
the DT O
LOD NNP O
scores NNS O
ranged VBD O
from IN O
1 CD O
. . O
17 CD O
to IN O
3 CD O
. . O
72 CD O
. . O

The DT O
strongest JJS O
linkage NN O
signals NNS O
were VBD O
observed VBN O
for IN O
the DT O
transcripts NNS O
of IN O
the DT O
MX2 NNP O
, , O
NUCB2 NNP O
, , O
and CC O
SNX4 NNP O
genes NNS O
. . O

Using VBG O
PCA NNP O
, , O
we PRP O
obtained VBD O
five CD O
factors NNS O
from IN O
the DT O
15 CD O
transcripts NNS O
with IN O
eigenvalues NNS O
greater JJR O
than IN O
1 CD O
. . O

Only RB O
one CD O
factor NN O
, , O
with IN O
a DT O
high JJ O
positive JJ O
loading NN O
for IN O
the DT O
MX2 NNP O
gene NN O
transcript NN O
, , O
had VBD O
a DT O
significant JJ O
heritability NN O
and CC O
a DT O
LOD NNP O
score NN O
> NFP O
= SYM O
1 CD O
. . O
8 CD O
. . O

The DT O
linkage NN O
analysis NN O
using VBG O
this DT O
factor NN O
identified VBD O
the DT O
chromosome NN O
region NN O
for IN O
the DT O
MX2 NNP O
gene NN O
, , O
but CC O
the DT O
LOD NNP O
score NN O
was VBD O
lower JJR O
than IN O
the DT O
one CD O
obtained VBN O
by IN O
single JJ O
linkage NN O
analysis NN O
of IN O
the DT O
MX2 NNP O
transcript NN O
. . O

We PRP O
then RB O
performed VBD O
bivariate JJ O
analysis NN O
of IN O
all DT O
pairwise JJ O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
on IN O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
and CC O
found VBD O
evidence NN O
for IN O
genetic JJ O
correlation NN O
of IN O
co NN O
- HYPH O
localized VBN O
genes NNS O
, , O
although IN O
without IN O
much JJ O
increase NN O
in IN O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
analysis NN O
identified VBD O
two CD O
networks NNS O
of IN O
gene NN O
expressions NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

We PRP O
obtained VBD O
two CD O
factors NNS O
using VBG O
PCA NNP O
of IN O
the DT O
first JJ O
network NN O
( : O
Group NNP O
1 CD O
, , O
SNX4 NNP O
, , O
YWHAQ NNP O
, , O
ASS NNP O
, , O
MX2 NNP O
, , O
and CC O
ISGF3G NNP O
gene NN O
transcripts NNS O
) -RRB- O
. . O

Both DT O
factors NNS O
had VBD O
significant JJ O
heritability NN O
; : O
however RB O
, , O
only RB O
Factor NNP O
1 CD O
, , O
loading VBG O
heavily RB O
on IN O
the DT O
MX2 NNP O
gene NN O
, , O
localized VBN O
to IN O
the DT O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
region NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
, , O
and CC O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
was VBD O
lower JJR O
than IN O
that DT O
of IN O
the DT O
univariate NN O
MX2 NNP O
gene NN O
transcript NN O
analysis NN O
( , O
LOD NNP O
= SYM O
2 CD O
. . O
28 CD O
) -RRB- O
. . O

The DT O
heritability NN O
of IN O
one CD O
factor NN O
obtained VBD O
using VBG O
PCA NNP O
for IN O
Group NNP O
2 CD O
transcripts NNS O
was VBD O
not RB O
significant JJ O
and CC O
further JJ O
analysis NN O
was VBD O
not RB O
performed VBN O
. . O

Chromosome NN O
13q34 CD O
region NN O

We PRP O
performed VBD O
analysis NN O
in IN O
an DT O
additional JJ O
chromosome NN O
region NN O
of IN O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
, , O
13q34 CD O
region NN O
, , O
and CC O
noted VBD O
similar JJ O
results NNS O
. . O

Using VBG O
univariate JJ O
analysis NN O
, , O
12 CD O
transcripts NNS O
co NN O
- HYPH O
localized VBN O
in IN O
this DT O
region NN O
; : O
and CC O
bivariate NN O
analysis NN O
revealed VBD O
an DT O
intricate JJ O
network NN O
of IN O
correlated VBN O
traits NNS O
( -LRB- O
Table NN O
2 CD O
and CC O
Figure NNP O
2 CD O
) -RRB- O
. . O

Using VBG O
PCA NNP O
, , O
we PRP O
obtained VBD O
five CD O
factors NNS O
, , O
three CD O
of IN O
them PRP O
with IN O
significant JJ O
heritability NN O
. . O

Similar JJ O
to IN O
our PRP$ O
previous JJ O
findings NNS O
on IN O
chomosome NN O
4 CD O
, , O
PCA NNP O
factors NNS O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
scores NNS O
when WRB O
compared VBN O
to IN O
univariate JJ O
analysis NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
of IN O
individual JJ O
transcripts NNS O
and CC O
compared VBD O
the DT O
univariate NN O
and CC O
bivariate NN O
linkage NN O
results NNS O
using VBG O
single JJ O
transcripts NNS O
to IN O
those DT O
using VBG O
factors NNS O
obtained VBN O
from IN O
PCA NNP O
. . O

By IN O
using VBG O
factors NNS O
that WDT O
accounted VBD O
for IN O
the DT O
variance NN O
of IN O
multiple JJ O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
, , O
we PRP O
attempted VBD O
to TO O
reduce VB O
the DT O
number NN O
of IN O
linkage NN O
analyses NNS O
performed VBN O
as RB O
well RB O
as IN O
possibly RB O
identifying VBG O
previously RB O
unknown JJ O
patterns NNS O
of IN O
associated VBN O
gene NN O
expression NN O
profiles NNS O
. . O

The DT O
PCA NNP O
did VBD O
in IN O
fact NN O
reduce VB O
the DT O
number NN O
of IN O
linkage NN O
analyses NNS O
performed VBN O
, , O
but CC O
it PRP O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
signals NNS O
in IN O
the DT O
target NN O
QTLs NNS O
as IN O
compared VBN O
with IN O
univariate NN O
or CC O
bivariate NN O
analyses NNS O
. . O

In IN O
fact NN O
, , O
in IN O
at RB O
least RBS O
one CD O
case NN O
, , O
PCA NNP O
was VBD O
unable JJ O
to TO O
detect VB O
a DT O
linkage NN O
signal NN O
for IN O
the DT O
main JJ O
gene NN O
transcript NN O
loading NN O
in IN O
the DT O
factor NN O
( , O
Table NNP O
1 CD O
, , O
Group NNP O
1 CD O
, , O
Factor NNP O
2 CD O
) -RRB- O
. . O

We PRP O
also RB O
performed VBD O
pairwise JJ O
bivariate NN O
genetic JJ O
analysis NN O
on IN O
those DT O
transcripts NNS O
that WDT O
co NN O
- HYPH O
localized VBN O
to IN O
the DT O
same JJ O
genomic JJ O
region NN O
, , O
presumably RB O
because IN O
this DT O
area NN O
of IN O
the DT O
genome NN O
harbored VBD O
genes NNS O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
these DT O
transcripts NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

We PRP O
detected VBD O
significant JJ O
genetic JJ O
correlation NN O
of IN O
these DT O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
, , O
indicating VBG O
potential JJ O
gene NN O
networks NNS O
operating VBG O
in IN O
these DT O
regions NNS O
. . O

However RB O
, , O
in IN O
most JJS O
cases NNS O
, , O
bivariate NN O
linkage NN O
analysis NN O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
compared VBN O
to IN O
univariate JJ O
analysis NN O
. . O

Most JJS O
traits NNS O
were VBD O
highly RB O
correlated VBN O
( , O
rho FW O
G NNP O
> : O
0 CD O
. . O
60 CD O
) -RRB- O
, , O
and CC O
therefore RB O
they PRP O
may MD O
provide VB O
redundant JJ O
information NN O
that WDT O
may MD O
reduce VB O
the DT O
power NN O
for IN O
detection NN O
of IN O
the DT O
bivariate NN O
signal NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
because IN O
rho `` O
G NN O
is VBZ O
a DT O
test NN O
of IN O
the DT O
overall JJ O
additive JJ O
genetic JJ O
correlation NN O
among IN O
two CD O
traits NNS O
and CC O
not RB O
the DT O
QTL NNP O
- HYPH O
specific JJ O
pleiotropy NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
co NN O
- HYPH O
localized VBN O
linkage NN O
signals NNS O
are VBP O
not RB O
in IN O
fact NN O
genetically RB O
correlated VBN O
. . O

Further JJ O
analysis NN O
is VBZ O
required VBN O
to TO O
address VB O
these DT O
issues NNS O
. . O

The DT O
chromosome NN O
regions NNS O
selected VBN O
for IN O
detailed JJ O
analyses NNS O
were VBD O
arbitrarily RB O
chosen VBN O
as IN O
we PRP O
identified VBD O
multiple JJ O
other JJ O
regions NNS O
with IN O
co NN O
- HYPH O
localized VBN O
linkage NN O
of IN O
gene NN O
expressions NNS O
. . O

The DT O
results NNS O
from IN O
our PRP$ O
univariate JJ O
genome NN O
scan NN O
differ VBP O
markedly RB O
from IN O
those DT O
reported VBN O
by IN O
Morley NNP O
et FW O
al NNP O
. . O

[ -LRB- O
2 LS O
] -RRB- O
because IN O
we PRP O
included VBD O
a DT O
smaller JJR O
sample NN O
of IN O
individuals NNS O
so IN O
that IN O
adjustment NN O
for IN O
covariate NN O
effects NNS O
of IN O
age NN O
could MD O
be VB O
made VBN O
. . O

Our PRP$ O
analysis NN O
strategy NN O
also RB O
adjusted VBD O
for IN O
the DT O
effects NNS O
of IN O
age NN O
and CC O
sex NN O
, , O
which WDT O
could MD O
also RB O
add VB O
to IN O
the DT O
observed VBN O
differences NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Finally RB O
, , O
our PRP$ O
definition NN O
of IN O
genome NN O
window NN O
size NN O
for IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
was VBD O
twice RB O
larger JJR O
than IN O
the DT O
one NN O
described VBN O
in IN O
the DT O
study NN O
of IN O
Morley NNP O
et FW O
al NNP O
. . O

Conclusion NN O

We PRP O
identified VBD O
several JJ O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
trans NN O
- HYPH O
regulatory JJ O
genes NNS O
with IN O
significant JJ O
heritability NN O
. . O

Some DT O
of IN O
these DT O
regulatory JJ O
genes NNS O
displayed VBD O
strong JJ O
additive JJ O
genetic JJ O
correlations NNS O
, , O
and CC O
may MD O
be VB O
part NN O
of IN O
genetic JJ O
networks NNS O
. . O

However RB O
, , O
when WRB O
compared VBN O
to IN O
univariate JJ O
analysis NN O
, , O
linkage NN O
analysis NN O
of IN O
bivariate NN O
phenotypes NNS O
and CC O
factor NN O
scores NNS O
obtained VBN O
from IN O
PCA NNP O
did VBD O
not RB O
improve VB O
the DT O
ability NN O
to TO O
identify VB O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
. . O

List NN O
of IN O
Abbreviations NNS O

CEPH NNP O
: : O
Centre NN O
d NN O
' '' O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O

GAW NN O
: : O
Genetic JJ O
Analysis NN O
Workshop NN O

H2 NN O
: : O
heritability NN O

LOD NN O
: : O
logarithm NN O
of IN O
the DT O
odds NNS O

MIBD NNP O
: : O
multipoint NN O
identity NN O
- HYPH O
by IN O
- HYPH O
descent NN O
matrices NNS O

N NN O
/ SYM O
A NNP O
: : O
not RB O
apply VB O

NCBI NNP O
: : O
National NNP O
Center NNP O
for IN O
Biotechnology NNP O
Information NNP O

PCA NN O
: : O
principal JJ O
- HYPH O
component NN O
analysis NN O

QTL NN O
: : O
quantitative JJ O
trait NN O
loci NN O

SE NNP O
: : O
standard JJ O
error NN O
of IN O
the DT O
mean NN O

SNP NNP O
: : O
single JJ O
- HYPH O
nucleotide NN O
polymorphism NN O

SOLAR NN O
: : O
Sequential JJ O
Oligogenic JJ O
Linkage NN O
Analysis NN O
Routines NNS O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Potentiation NN O
of IN O
Nerve JJ O
Growth NN O
Factor NN O
- HYPH O
Induced VBN O
Neurite JJ O
Outgrowth NN O
by IN O
Fluvoxamine NNP O
: : O
Role NN O
of IN O
Sigma NN O
- HYPH O
1 CD O
Receptors NNS O
, , O
IP3 NN O
Receptors NNS O
and CC O
Cellular JJ O
Signaling NN O
Pathways NNS O

Abstract JJ O

Background NN O

Selective JJ O
serotonin NN O
reuptake NN O
inhibitors NNS O
( -LRB- O
SSRIs NNP O
) -RRB- O
have VBP O
been VBN O
widely RB O
used VBN O
and CC O
are VBP O
a DT O
major JJ O
therapeutic JJ O
advance NN O
in IN O
psychopharmacology NN O
. . O

However RB O
, , O
their PRP$ O
pharmacology NN O
is VBZ O
quite RB O
heterogeneous JJ O
. . O

The DT O
SSRI NNP O
fluvoxamine NN O
, , O
with IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
, , O
is VBZ O
shown VBN O
to TO O
potentiate VB O
nerve JJ O
- HYPH O
growth NN O
factor NN O
( , O
NGF NNP O
) -RRB- O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC NN O
12 CD O
cells NNS O
. . O

However RB O
, , O
the DT O
precise JJ O
cellular JJ O
and CC O
molecular JJ O
mechanisms NNS O
underlying VBG O
potentiation NN O
by IN O
fluvoxamine NN O
are VBP O
not RB O
fully RB O
understood VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
roles NNS O
of IN O
cellular JJ O
signaling NN O
pathways NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
fluvoxamine NN O
and CC O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

Methods NNS O
and CC O
Findings NNS O

The DT O
effects NNS O
of IN O
three CD O
SSRIs NNS O
( , O
fluvoxamine NN O
, , O
sertraline NN O
, , O
paroxetine NN O
) -RRB- O
and CC O
three CD O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( , O
SA4503 CD O
, , O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( , O
PPBP NNP O
) -RRB- O
, , O
and CC O
dehydroepiandrostero NN O
( , O
DHEA NN O
) -RRB- O
- HYPH O
sulfate NN O
) -RRB- O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
were VBD O
examined VBN O
. . O

Also RB O
examined VBN O
were VBD O
the DT O
effects NNS O
of IN O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
, , O
inositol NN O
1 CD O
, , O
4 CD O
, , O
5 CD O
- HYPH O
triphosphate NN O
( , O
IP3 NN O
) -RRB- O
receptor NN O
antagonist NN O
, , O
and CC O
specific JJ O
inhibitors NNS O
of IN O
signaling VBG O
pathways NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
. . O

Fluvoxamine NNP O
( , O
but CC O
not RB O
sertraline NN O
or CC O
paroxetine NN O
) -RRB- O
and CC O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
SA4503 NNP O
, , O
PPBP NNP O
, , O
and CC O
DHEA NNP O
- HYPH O
sulfate NN O
significantly RB O
potentiated VBN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
. . O

The DT O
potentiation NN O
by IN O
fluvoxamine NN O
and CC O
the DT O
three CD O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
was VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
play VBP O
a DT O
role NN O
in IN O
blocking VBG O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Moreover RB O
, , O
the DT O
potentiation NN O
by IN O
SA4503 NNP O
was VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
IP3 NNP O
receptor NN O
antagonist NN O
xestospongin NN O
C NN O
. . O

In IN O
addition NN O
, , O
the DT O
specific JJ O
inhibitors NNS O
of IN O
phospholipase NN O
C NNP O
( HYPH O
PLC NNP O
- HYPH O
gamma NN O
) -RRB- O
, , O
phosphatidylinositol NN O
3 CD O
- HYPH O
kinase NN O
( -LRB- O
PI3K NNP O
) -RRB- O
, , O
p38MAPK NNP O
, , O
c NN O
- HYPH O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
( , O
JNK NNP O
) -RRB- O
, , O
and CC O
the DT O
Ras NNP O
/ SYM O
Raf NNP O
/ SYM O
mitogen NN O
- HYPH O
activated VBN O
protein NN O
kinase NN O
( -LRB- O
MAPK NNP O
) -RRB- O
signaling NN O
pathways NNS O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Conclusion NN O

These DT O
findings NNS O
suggest VBP O
that IN O
stimulation NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
and CC O
subsequent JJ O
interaction NN O
with IN O
IP3 NNP O
receptors NNS O
, , O
PLC NNP O
- HYPH O
gamma NNP O
, , O
PI3K NNP O
, , O
p38MAPK NNP O
, , O
JNK NNP O
, , O
and CC O
the DT O
Ras NNP O
/ SYM O
Raf NNP O
/ SYM O
MAPK NNP O
signaling NN O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanisms NNS O
of IN O
action NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
such JJ O
as IN O
fluvoxamine NN O
and CC O
SA4503 NN O
. . O

Introduction NN O

Selective JJ O
serotonin NN O
( , O
5 CD O
- HYPH O
HT NN O
; : O
5 CD O
- HYPH O
hydroxytryptamine NN O
) , O
reuptake NN O
inhibitors NNS O
( , O
SSRIs NNP O
) -RRB- O
have VBP O
emerged VBN O
as IN O
a DT O
major JJ O
therapeutic JJ O
advance NN O
in IN O
psychopharmacology NN O
. . O

SSRIs NNS O
are VBP O
the DT O
treatment NN O
of IN O
choice NN O
for IN O
many JJ O
indications NNS O
, , O
including VBG O
major JJ O
depressive JJ O
disorder NN O
, , O
dysthymia NN O
, , O
panic NN O
disorder NN O
, , O
obsessive JJ O
- HYPH O
compulsive JJ O
disorder NN O
, , O
eating NN O
disorders NNS O
, , O
and CC O
premenstrual JJ O
dysphoric JJ O
disorder NN O
. . O

In IN O
contrast NN O
, , O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
their PRP$ O
pharmacology NN O
is VBZ O
quite RB O
heterogeneous JJ O
, , O
although IN O
all DT O
of IN O
them PRP O
block VBP O
5 CD O
- HYPH O
HT NNP O
transporters NNS O
, , O
thus RB O
increasing VBG O
5 CD O
- HYPH O
HT NNP O
levels NNS O
throughout IN O
the DT O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
- : O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Accumulating VBG O
evidence NN O
suggests VBZ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
which WDT O
are VBP O
intracellular JJ O
endoplasmic JJ O
reticulum NN O
( , O
ER NN O
) -RRB- O
proteins NNS O
, , O
are VBP O
involved VBN O
in IN O
both CC O
the DT O
neuroplasticity NN O
and CC O
pathophysiology NN O
of IN O
neuropsychiatric JJ O
diseases NNS O
such JJ O
as IN O
major JJ O
depressive JJ O
disorder NN O
, , O
anxiety NN O
, , O
schizophrenia NN O
, , O
and CC O
Alzheimer NNP O
' POS O
s POS O
disease NN O
[ -LRB- O
10 CD O
] -RRB- O
- : O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Previously RB O
, , O
we PRP O
reported VBD O
that IN O
some DT O
SSRIs NNPS O
possess VBP O
high JJ O
to IN O
moderate JJ O
affinities NNS O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
rat NN B-Species
brain NN O
. . O

The DT O
rank NN O
order NN O
of IN O
SSRIs NNP O
affinities NNS O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
is VBZ O
fluvoxamine NN O
( , O
Ki NN O
= SYM O
36 CD O
nM NN O
) -RRB- O
> : O
sertraline NN O
( , O
Ki NN O
= SYM O
57 CD O
nM NN O
) -RRB- O
> NFP O
> SYM O
paroxetine NN O
( -LRB- O
Ki NN O
= SYM O
1893 CD O
nM NN O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
that IN O
fluvoxamine NN O
, , O
but CC O
not RB O
paroxetine NN O
, , O
significantly RB O
ameliorated VBD O
cognitive JJ O
deficits NNS O
in IN O
mice NNS B-Species
after IN O
repeated JJ O
phencyclidine NN O
administration NN O
, , O
and CC O
that IN O
the DT O
effects NNS O
of IN O
fluvoxamine NN O
were VBD O
antagonized VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
[ -LRB- O
20 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
fluvoxamine NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
it PRP O
has VBZ O
been VBN O
demonstrated VBN O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
including VBG O
fluvoxamine NN O
could MD O
potentiate VB O
nerve JJ O
growth NN O
factor NN O
( -LRB- O
NGF NNP O
) -RRB- O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
, , O
and CC O
that IN O
NE NNP O
- HYPH O
100 CD O
blocked VBD O
the DT O
potentiation NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
, , O
suggesting VBG O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
neuroplasticity NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
precise JJ O
cellular JJ O
mechanisms NNS O
underlying VBG O
the DT O
potentiation NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
are VBP O
not RB O
fully RB O
understood VBN O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
21 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
therefore RB O
of IN O
great JJ O
interest NN O
to TO O
study VB O
the DT O
precise JJ O
cellular JJ O
mechanisms NNS O
underlying VBG O
the DT O
enhancement NN O
by IN O
fluvoxamine NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
sprouting NN O
in IN O
PC12 NNP O
cells NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
three CD O
SSRIs NNS O
( , O
fluvoxamine NN O
, , O
sertraline NN O
, , O
paroxetine NN O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
effects NNS O
of IN O
a DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
( , O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( -LRB- O
PPBP NNP O
) -RRB- O
, , O
dehydroepiandrostero NN O
- HYPH O
sulphate NN O
( , O
DHEA NNP O
) -RRB- O
- HYPH O
sulfate NN O
) -RRB- O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
22 CD O
] -RRB- O
- HYPH O
[ -LRB- O
28 CD O
] -RRB- O
and CC O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NNP O
[ -LRB- O
29 CD O
] -RRB- O
, , O
[ -LRB- O
30 CD O
] -RRB- O
, , O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
also RB O
known VBN O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
IP3 NNP O
receptors NNS O
( SYM O
17 CD O
, , O
18 CD O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
NE NNP O
- HYPH O
100 CD O
and CC O
xestospongin NNP O
C NNP O
( , O
a DT O
selective JJ O
inositol NN O
1 CD O
, , O
4 CD O
, , O
5 CD O
- HYPH O
triphosphate NN O
( , O
IP3 NN O
) -RRB- O
receptor NN O
antagonist NN O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
in IN O
order NN O
to TO O
investigate VB O
the DT O
roles NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
and CC O
IP3 NN O
receptors NNS O
in IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Moreover RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
specific JJ O
inhibitors NNS O
of IN O
several JJ O
cellular JJ O
signaling NN O
targets NNS O
on IN O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
since IN O
several JJ O
signal NN O
transduction NN O
molecules NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Materials NNS O
and CC O
Methods NNS O

Drugs NNS O

The DT O
drugs NNS O
were VBD O
obtained VBN O
from IN O
the DT O
following VBG O
sources NNS O
: : O
fluvoxamine NN O
maleate NN O
( , O
Solvay NNP O
Seiyaku NNP O
K NNP O
. . O
K NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
; : O
paroxetine NN O
hydrochloride NN O
, , O
dehydroepiandosteron NN O
- HYPH O
sulfate NN O
( , O
DHEA NNP O
- HYPH O
sulfate NNP O
) -RRB- O
, , O
LY294002 NNP O
( , O
Sigma NNP O
- HYPH O
Aldrich NNP O
, , O
St NNP O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
; , O
sertraline NN O
( , O
Toronto NNP O
Research NNP O
Chemicals NNPS O
Inc NNP O
. . O
, , O
North NNP O
York NNP O
, , O
ON NNP O
, , O
Canada NNP O
) -RRB- O
; : O
SA4503 NNP O
( , O
M NNP O
' POS O
s NNPS O
Science NNP O
Corporation NNP O
, , O
Kobe NNP O
, , O
Japan NNP O
) -RRB- O
; : O
NGF NNP O
( , O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
) -RRB- O
; , O
xestospongin NNP O
C NNP O
, , O
lovastatin NN O
, , O
PD98059 NNP O
, , O
GW5074 NNP O
, , O
SB203580 NNP O
, , O
MEK NNP O
1 CD O
/ SYM O
2 CD O
inhibitor NN O
( -LRB- O
SL327 NNP O
) -RRB- O
, , O
and CC O
SP600125 NN O
( : O
Calbiochem NNP O
- HYPH O
Novabiochem NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

The DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonists NNS O
NE NNP O
- HYPH O
100 CD O
and CC O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( -LRB- O
PPBP NNP O
) -RRB- O
were VBD O
synthesized VBN O
in IN O
our PRP$ O
laboratory NN O
. . O

Other JJ O
drugs NNS O
were VBD O
purchased VBN O
from IN O
commercial JJ O
sources NNS O
. . O

Cell NN O
culture NN O

PC12 NNP O
sells VBZ O
( , O
RIKEN NNP O
Cell NNP O
Bank NNP O
, , O
Tsukuba NNP O
, , O
Japan NNP O
) -RRB- O
were VBD O
cultured VBN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
5 CD O
% NN O
CO2 NN O
with IN O
Dulbecco NNP O
' POS O
s NNS O
modified VBN O
Eagle NNP O
' POS O
s NN O
medium NN O
( , O
DMEM NNP O
) -RRB- O
supplemented VBN O
with IN O
5 CD O
% NN O
heat NN O
- HYPH O
inactivated VBN O
fetal JJ O
bovine NN B-Species
serum NN O
( , O
FBS NNP O
) -RRB- O
, , O
10 CD O
% NN O
heat NN O
- HYPH O
inactivated VBN O
horse NN B-Species
serum NN O
, , O
and CC O
1 CD O
% NN O
penicillin NN O
. . O

The DT O
medium NN O
was VBD O
changed VBN O
two CD O
or CC O
three CD O
times NNS O
a DT O
week NN O
. . O

PC12 NN O
cells NNS O
were VBD O
plated VBN O
onto IN O
24 CD O
- HYPH O
well NN O
tissue NN O
culture NN O
plates NNS O
coated VBN O
with IN O
poly JJ O
- HYPH O
D NN O
- HYPH O
lysine NN O
/ SYM O
laminin NN O
. . O

Cells NNS O
were VBD O
plated VBN O
at IN O
relatively RB O
low JJ O
density NN O
( , O
0 CD O
. . O
25 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
cm2 NN O
) -RRB- O
in IN O
DMEM NNP O
medium NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
FBS NN O
, , O
1 CD O
% NN O
penicillin NN O
streptomycin NN O
. . O

Medium NN O
containing VBG O
a DT O
minimal JJ O
level NN O
of IN O
serum NN O
( , O
0 CD O
. . O
5 CD O
% NN O
FBS NNP O
) -RRB- O
was VBD O
used VBN O
, , O
since IN O
serum NN O
is VBZ O
known VBN O
to TO O
contain VB O
steroid NN O
hormones NNS O
that WDT O
bind VBP O
to IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

First RB O
, , O
we PRP O
examined VBD O
the DT O
optimal JJ O
concentration NN O
of IN O
NGF NNP O
for IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

NGF NNP O
( : O
2 CD O
. . O
5 CD O
, , O
5 CD O
, , O
10 CD O
, , O
20 CD O
, , O
40 CD O
ng CD O
/ SYM O
ml NNP O
) -RRB- O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NN O
cells NNS O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
subsequent JJ O
studies NNS O
, , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
of IN O
NGF NNP O
was VBD O
used VBN O
to TO O
study VB O
the DT O
potentiating VBG O
effects NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Twenty CD O
- HYPH O
four CD O
hours NNS O
after IN O
plating VBG O
, , O
the DT O
medium NN O
was VBD O
replaced VBN O
with IN O
DMEM NNP O
medium NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
FBS NN O
and CC O
1 CD O
% NN O
penicillin NN O
streptomycin NN O
with IN O
NGF NNP O
( : O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
several JJ O
drugs NNS O
. . O

Quantification NN O
of IN O
neurite NN O
sprouting NN O

Five CD O
days NNS O
after IN O
incubation NN O
with IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
the DT O
several JJ O
drugs NNS O
, , O
morphometric JJ O
analysis NN O
was VBD O
performed VBN O
on IN O
digitized VBN O
images NNS O
of IN O
live JJ O
cells NNS O
taken VBN O
under IN O
phase NN O
- HYPH O
contrast NN O
illumination NN O
with IN O
an DT O
inverted JJ O
microscope NN O
linked VBN O
to IN O
a DT O
camera NN O
. . O

Images NNS O
of IN O
three CD O
fields NNS O
per IN O
well NN O
were VBD O
taken VBN O
, , O
with IN O
an DT O
average NN O
of IN O
100 CD O
cells NNS O
per IN O
field NN O
. . O

Differentiated VBN O
cells NNS O
were VBD O
counted VBN O
by IN O
visual JJ O
examination NN O
of IN O
the DT O
field NN O
; : O
only RB O
cells NNS O
that WDT O
had VBD O
at RB O
least RBS O
one CD O
neurite NN O
with IN O
a DT O
length NN O
equal JJ O
to IN O
the DT O
cell NN O
body NN O
diameter NN O
were VBD O
counted VBN O
, , O
and CC O
were VBD O
then RB O
expressed VBN O
as IN O
a DT O
percentage NN O
of IN O
the DT O
total JJ O
cells NNS O
in IN O
the DT O
field NN O
. . O

The DT O
counting NN O
was VBD O
performed VBN O
in IN O
a DT O
blinded JJ O
manner NN O
. . O

Immunocytochemistry NN O

Cells NNS O
were VBD O
fixed VBN O
for IN O
30 CD O
min NN O
at IN O
room NN O
temperature NN O
with IN O
4 CD O
% NN O
paraformaldehyde NN O
then RB O
permeabilized VBN O
with IN O
0 CD O
. . O
2 CD O
% NN O
Triton NN O
and CC O
blocked VBN O
with IN O
1 CD O
. . O
5 CD O
% NN O
normal JJ O
goat NN B-Species
serum NN O
, , O
0 CD O
. . O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
( , O
BSA NN O
) -RRB- O
in IN O
0 CD O
. . O
1 CD O
M NN O
phosphate NN O
- HYPH O
buffer NN O
saline NN O
for IN O
1 CD O
h NN O
to TO O
reduce VB O
nonspecific JJ O
binding NN O
. . O

Cells NNS O
were VBD O
incubated VBN O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
with IN O
anti JJ O
- HYPH O
microtubule NN O
- HYPH O
associated VBN O
protein NN O
2 CD O
( , O
MAP NNP O
- HYPH O
2 CD O
) -RRB- O
antibodies NNS O
( , O
1 CD O
: : O
1000 CD O
dilution NN O
in IN O
blocking NN O
solution NN O
, , O
Chemicon NNP O
International NNP O
, , O
Temecula NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
immunolabeling NN O
was VBD O
visualized VBN O
with IN O
secondary JJ O
antibodies NNS O
conjugated VBN O
to IN O
Alexa NNP O
- HYPH O
488 CD O
( , O
1 CD O
: : O
1000 CD O
; : O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

MAP NNP O
- HYPH O
2 CD O
immuncytochemistry NN O
was VBD O
visualized VBN O
with IN O
a DT O
fluorescence NN O
microscope NN O
( , O
Axiovert NNP O
200 CD O
, , O
Carl NNP O
Zeiss NNP O
, , O
Oberkocken NNP O
, , O
Germany NNP O
) -RRB- O
. . O

Statistical JJ O
analysis NN O

Data NNS O
are VBP O
expressed VBN O
as IN O
means NNS O
+ NFP O
/ SYM O
- HYPH O
S NN O
. . O
E NN O
. . O
M NN O
. . O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
by IN O
using VBG O
one CD O
- HYPH O
way NN O
analysis NN O
of IN O
variance NN O
( -LRB- O
ANOVA NNP O
) -RRB- O
and CC O
the DT O
post FW O
hoc FW O
Bonferroni NNP O
/ SYM O
Dunn NNP O
test NN O
. . O

P NN O
values NNS O
less JJR O
than IN O
0 CD O
. . O
5 CD O
were VBD O
considered VBN O
statistically RB O
significant JJ O
. . O

Results NNS O

Effects NNS O
of IN O
SSRIs NNS O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O

Fluvoxamine NNP O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
in IN O
PC12 NN O
cells NNS O
, , O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
2 CD O
and CC O
4 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
sertraline NN O
( , O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
and CC O
paroxetine NN O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
did VBD O
not RB O
increase VB O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( : O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
. . O

A DT O
higher JJR O
concentration NN O
( -LRB- O
10 CD O
micro NN O
M NN O
) -RRB- O
of IN O
paroxetine NN O
and CC O
sertraline NN O
significantly RB O
decreased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
, , O
suggesting VBG O
the DT O
cellular JJ O
toxicity NN O
of IN O
these DT O
drugs NNS O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Role NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
outgrowth NN O
by IN O
fluvoxamine NN O
and CC O
SA4503 NNP O

The DT O
selective JJ O
and CC O
potent JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
( : O
0 CD O
. . O
1 CD O
, , O
0 CD O
. . O
1 CD O
, , O
or CC O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
in IN O
PC12 NN O
cells NNS O
, , O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
other JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
- : O
PPBP NNP O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NNP O
) -RRB- O
[ -LRB- O
22 CD O
] -RRB- O
- HYPH O
[ -LRB- O
26 CD O
] -RRB- O
and CC O
DHEA NNP O
- HYPH O
sulphate NN O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NNP O
) -RRB- O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
27 CD O
] -RRB- O
, , O
[ -LRB- O
28 CD O
] -RRB- O
- , O
significantly RB O
increased VBN O
the DT O
number NN O
of IN O
such JJ O
cells NNS O
, , O
also RB O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
the DT O
absence NN O
of IN O
NGF NNP O
, , O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
did VBD O
not RB O
produce VB O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
NE NNP O
- HYPH O
100 CD O
( , O
a DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
) -RRB- O
on IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
outgrowth NN O
by IN O
fluvoxamine NN O
, , O
SA4503 NNP O
, , O
PPBP NNP O
, , O
and CC O
DHEA NNP O
- HYPH O
sulphate NN O
. . O

Co NNP O
- HYPH O
administration NN O
of IN O
NE NNP O
- HYPH O
100 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
such JJ O
potentiation NN O
by IN O
fluvoxamine NN O
( : O
10 CD O
micro NN O
M NNP O
) -RRB- O
, , O
SA4503 NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
PPBP NNP O
( , O
10 CD O
micro NN O
M NNP O
) -RRB- O
, , O
or CC O
DHEA NN O
- HYPH O
sulphate NN O
( : O
10 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
2 CD O
and CC O
3 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
administration NN O
of IN O
NE NNP O
- HYPH O
100 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Role NN O
of IN O
IP3 NN O
receptors NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
IP3 NNP O
receptors NNS O
( : O
17 CD O
, , O
18 CD O
, , O
33 CD O
- HYPH O
35 CD O
) -RRB- O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
IP3 NN O
receptors NNS O
in IN O
the DT O
effects NNS O
of IN O
SA4503 NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
xestospongin NNP O
C NNP O
( , O
a DT O
selective JJ O
, , O
reversible JJ O
, , O
and CC O
membrane NN O
- HYPH O
permeable JJ O
inhibitor NN O
of IN O
IP3 NN O
receptors NNS O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
on IN O
the DT O
effects NNS O
of IN O
SA4503 NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Co NN O
- HYPH O
administration NN O
of IN O
xestospongin NNP O
C NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
administration NN O
of IN O
xestospongin NN O
C NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Role NN O
of IN O
signaling VBG O
molecules NNS O
proximal JJ O
to IN O
TrkA NNP O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

Next RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
the DT O
specific JJ O
inhibitors NNS O
of IN O
PLC NNP O
- HYPH O
gamma NN O
, , O
PI3K NNP O
, , O
p38 NN O
MAPK NNP O
, , O
and CC O
c NN O
- HYPH O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
( , O
JNK NNP O
) -RRB- O
, , O
since IN O
these DT O
signaling VBG O
molecules NNS O
are VBP O
activated VBN O
upon IN O
the DT O
addition NN O
of IN O
NGF NNP O
[ -LRB- O
36 CD O
] -RRB- O
. . O

The DT O
PLC NNP O
- HYPH O
gamma NN O
inhibitor NN O
( , O
U73122 NNP O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
PI3K NN O
inhibitor NN O
( , O
LY294002 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
p38 NN O
MAPK NNP O
inhibitor NN O
( -LRB- O
SB203580 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
and CC O
JNK NNP O
inhibitor NN O
( : O
SP600125 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
these DT O
inhibitors NNS O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

Role NNP O
of IN O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
ERK NNP O
/ SYM O
MAPK NNP O
pathway NN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

The DT O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
ERK NNP O
/ SYM O
MAPK NNP O
pathway NN O
is VBZ O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
NGF NNP O
- HYPH O
induced VBN O
outgrowth NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
this DT O
pathway NN O
' POS O
s NNS O
specific JJ O
inhibitors NNS O
. . O

The DT O
Ras NNP O
inhibitor NN O
( , O
GW5074 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
, , O
Raf NNP O
inhibitor NN O
( , O
lovastatin NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
, , O
MEK1 NNP O
/ SYM O
2 CD O
inhibitor NN O
( , O
SL327 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
and CC O
MAPK NNP O
inhibitor NN O
( -LRB- O
PD98059 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
these DT O
inhibitors NNS O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

Discussion NN O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
found VBD O
that IN O
fluvoxamine NN O
( , O
but CC O
not RB O
sertraline NN O
or CC O
paroxetine NN O
) -RRB- O
and CC O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( , O
SA4503 NNP O
, , O
PPBP NNP O
, , O
DHEA NNP O
- HYPH O
sulfate NN O
) -RRB- O
could MD O
potentiate VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
, , O
and CC O
that IN O
the DT O
effects NNS O
of IN O
these DT O
drugs NNS O
were VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
incubation NN O
with IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
agonism NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
for IN O
these DT O
drugs NNS O
is VBZ O
involved VBN O
in IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
drugs NNS O
' POS O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
1 CD O
, , O
NGF NNP O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
, , O
in IN O
a DT O
concentration NN O
dependent JJ O
manner NN O
. . O

To TO O
examine VB O
whether IN O
or CC O
not RB O
the DT O
NGF NNP O
levels NNS O
are VBP O
altered VBN O
by IN O
incubation NN O
with IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
, , O
we PRP O
measured VBD O
the DT O
levels NNS O
of IN O
NGF NNP O
in IN O
PC12 NNP O
cells NNS O
with IN O
or CC O
without IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
. . O

No DT O
differences NNS O
of IN O
NGF NNP O
levels NNS O
were VBD O
shown VBN O
in IN O
the DT O
between IN O
control NN O
group NN O
and CC O
SA4503 NN O
- HYPH O
treated VBN O
group NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

It PRP O
is VBZ O
, , O
therefore RB O
, , O
unlikely JJ O
that IN O
the DT O
potentaition NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
might MD O
be VB O
due IN O
to IN O
increased VBN O
levels NNS O
of IN O
NGF NNP O
. . O

Unlike IN O
fluvoxamine NN O
, , O
sertraline NN O
, , O
which WDT O
has VBZ O
a DT O
moderate JJ O
affinity NN O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

The DT O
reasons NNS O
underlying VBG O
this DT O
discrepancy NN O
between IN O
these DT O
two CD O
SSRIs NNS O
are VBP O
currently RB O
unclear JJ O
. . O

One CD O
possibility NN O
may MD O
involve VB O
the DT O
difference NN O
in IN O
pharmacological JJ O
actions NNS O
( : O
agonist NN O
vs FW O
. . O
antagonist NN O
) -RRB- O
between IN O
these DT O
SSRIs NNS O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
. . O

Interestingly RB O
, , O
we PRP O
recently RB O
found VBD O
that IN O
, , O
in IN O
a DT O
novel JJ O
object NN O
recognition NN O
test NN O
, , O
phencyclidine NN O
- HYPH O
induced VBN O
cognitive JJ O
deficits NNS O
could MD O
be VB O
significantly RB O
improved VBN O
by IN O
subsequent JJ O
subchronic JJ O
( , O
14 CD O
days NNS O
) -RRB- O
administration NN O
of IN O
fluvoxamine NN O
, , O
but CC O
not RB O
of IN O
sertraline NN O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
is VBZ O
involved VBN O
in IN O
fluvoxamine NN O
' '' O
s NNS O
mechanism NN O
of IN O
action NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
Ishima NNP O
et FW O
al NNP O
. . O
, , O
submitted VBN O
. . O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
fluvoxamine NN O
and CC O
sertraline NN O
may MD O
function VB O
as IN O
an DT O
agonist NN O
and CC O
an DT O
antagonist NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
respectively RB O
, , O
although IN O
further JJ O
study NN O
is VBZ O
necessary JJ O
. . O

Another DT O
possibility NN O
may MD O
be VB O
that IN O
other JJ O
pharmacological JJ O
activities NNS O
of IN O
sertraline NN O
mask VBP O
the DT O
effects NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
also RB O
found VBD O
that IN O
high JJ O
concentration NN O
( , O
10 CD O
micro NN O
M NN O
) -RRB- O
of IN O
paroxetine NN O
and CC O
sertraline NN O
, , O
but CC O
not RB O
fluvoxamine NN O
, , O
showed VBD O
cytotoxicity NN O
in IN O
PC12 NNP O
cells NNS O
, , O
suggesting VBG O
that IN O
fluvoxamine NN O
may MD O
be VB O
a DT O
safe JJ O
drug NN O
than IN O
paroxetine NN O
and CC O
sertraline NN O
. . O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
affect VB O
intracellular JJ O
Ca2 NN O
+ CC O
signaling NN O
, , O
although IN O
the DT O
precise JJ O
molecular JJ O
and CC O
cellular JJ O
mechanisms NNS O
underlying VBG O
this DT O
effect NN O
are VBP O
unknown JJ O
. . O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
bind VBP O
to IN O
IP3 NN O
receptors NNS O
in IN O
ER NN O
, , O
and CC O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
regulate VBP O
Ca2 NN O
+ CC O
release NN O
from IN O
intracellular JJ O
Ca2 NN O
+ CC O
storage NN O
sites NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Very RB O
recently RB O
, , O
Hayashi NNP O
and CC O
Su NNP O
[ -LRB- O
17 CD O
] -RRB- O
reported VBD O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
function VBP O
as IN O
novel JJ O
ligand NN O
- HYPH O
operated VBN O
chaperones NNS O
that WDT O
specifically RB O
target VBP O
mitochondrion NN O
- HYPH O
associated VBN O
ER NNP O
membrane NN O
. . O

Furthermore RB O
, , O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
form VBP O
Ca2 NN O
+ SYM O
- HYPH O
sensitive JJ O
chaperone NN O
machinery NN O
with IN O
another DT O
chaperone NN O
, , O
BiP NN O
, , O
and CC O
prolong NN O
Ca2 NN O
+ CC O
signaling NN O
from IN O
ER NN O
into IN O
mitochondria NN O
by IN O
stabilizing VBG O
IP3 NN O
receptors NNS O
at IN O
mitochondrion NN O
- HYPH O
associated VBN O
ER NNP O
membrane NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
IP3 NN O
receptor NN O
antagonist NN O
xestospongin NNP O
C NNP O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
suggesting VBG O
the DT O
role NN O
of IN O
IP3 NN O
receptors NNS O
on IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
- HYPH O
mediated VBN O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
stimulation NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
and CC O
subsequent JJ O
interaction NN O
with IN O
IP3 NNP O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
underlying VBG O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

NGF NNP O
binds VBZ O
to IN O
the DT O
high JJ O
- HYPH O
affinity NN O
tyrosine NN O
receptor NN O
TrkA NNP O
, , O
initiating VBG O
several JJ O
signaling VBG O
pathways NNS O
affecting VBG O
both CC O
morphological JJ O
and CC O
transcriptional JJ O
targets NNS O
[ -LRB- O
32 CD O
] -RRB- O
, , O
[ -LRB- O
36 CD O
] -RRB- O
, , O
[ -LRB- O
37 CD O
] -RRB- O
. . O

The DT O
signaling VBG O
molecules NNS O
, , O
including VBG O
PLC NNP O
- HYPH O
gamma NNP O
, , O
PI3K NNP O
, , O
p38 NN O
MAPK NNP O
, , O
and CC O
JNK NNP O
, , O
are VBP O
activated VBN O
upon IN O
the DT O
addition NN O
of IN O
NGF NNP O
[ -LRB- O
38 CD O
] -RRB- O
. . O

PLC NNP O
- HYPH O
gamma NN O
catalyzes VBZ O
the DT O
hydrolysis NN O
of IN O
phosphatidylinositol NN O
- HYPH O
4 CD O
, , O
5 CD O
- HYPH O
bisphosphate NN O
( , O
PIP2 NN O
) -RRB- O
to IN O
diacylglycerol NN O
( -LRB- O
DAG NN O
) -RRB- O
and CC O
inositol NN O
triphosphate NN O
( -LRB- O
IP3 NN O
) -RRB- O
. . O

DAG NNP O
activates VBZ O
protein NN O
kinase NN O
C NN O
, , O
and CC O
IP3 NN O
promotes VBZ O
transient JJ O
release NN O
of IN O
Ca2 NNP O
+ CC O
from IN O
the DT O
ER NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

The DT O
pathway NN O
via IN O
PLC NNP O
- HYPH O
gamma NN O
is VBZ O
responsible JJ O
for IN O
NGF NNP O
- HYPH O
induced VBN O
cell NN O
differentiation NN O
[ -LRB- O
40 CD O
] -RRB- O
and CC O
neurite JJ O
outgrowth NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
stimulation NN O
of IN O
PI3K NNP O
is VBZ O
reported VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
promotion NN O
of IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
[ -LRB- O
42 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
PLC NNP O
- HYPH O
gamma NN O
inhibitor NN O
U73122 NNP O
and CC O
the DT O
PI3K NNP O
inhibitor NN O
LY294002 NNP O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Moreover RB O
, , O
we PRP O
found VBD O
that IN O
both CC O
the DT O
p38MAPK NNP O
inhibitor NN O
SB203580 NN O
and CC O
the DT O
JNK NNP O
inhibitor NN O
SP600125 NN O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

In IN O
addition NN O
, , O
it PRP O
is VBZ O
also RB O
interesting JJ O
that IN O
neurite JJ O
outgrowth NN O
induced VBN O
by IN O
low JJ O
concentration NN O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
of IN O
NGF NNP O
was VBD O
not RB O
blocked VBN O
by IN O
these DT O
inihibitors NNS O
, , O
consistent JJ O
with IN O
a DT O
previous JJ O
report NN O
[ -LRB- O
43 CD O
] -RRB- O
, , O
[ -LRB- O
44 CD O
] -RRB- O
, , O
suggesting VBG O
the DT O
existence NN O
of IN O
novel JJ O
pathway NN O
( , O
s FW O
) -RRB- O
for IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
PLC NNP O
- HYPH O
gamma NN O
, , O
PI3K NNP O
, , O
p38MAPK NNP O
, , O
and CC O
JNK NNP O
signaling NN O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
specific JJ O
inhibitors NNS O
for IN O
the DT O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
MEK NNP O
/ SYM O
MAPK NNP O
pathways NNS O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
suggesting VBG O
that IN O
these DT O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

Our PRP$ O
recent JJ O
positron NN O
emission NN O
tomography NN O
( , O
PET NNP O
) -RRB- O
study NN O
demonstrated VBD O
that IN O
, , O
after IN O
a DT O
single JJ O
oral JJ O
administration NN O
, , O
fluvoxamine NN O
bound VBN O
to IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
living VBG O
human JJ B-Species
brain NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

This DT O
finding NN O
suggests VBZ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
fluvoxamine NN O
in IN O
the DT O
human JJ B-Species
brain NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
, , O
the DT O
past JJ O
and CC O
present JJ O
findings NNS O
suggest VBP O
that IN O
, , O
unlike IN O
paroxetine NN O
and CC O
sertraline NN O
, , O
the DT O
SSRI NNP O
fluvoxamine NN O
, , O
with IN O
its PRP$ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonistic JJ O
activity NN O
, , O
might MD O
be VB O
a DT O
unique JJ O
therapeutic JJ O
drug NN O
for IN O
neuropsychiatric JJ O
diseases NNS O
. . O

In IN O
conclusion NN O
, , O
the DT O
present JJ O
results NNS O
suggest VBP O
that IN O
, , O
as IN O
a DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
, , O
fluvoxamine NN O
could MD O
potentiate VB O
the DT O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
interaction NN O
with IN O
IP3 NN O
receptors NNS O
and CC O
several JJ O
subsequent JJ O
signaling NN O
molecules NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
underlying VBG O
the DT O
pharmacological JJ O
action NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
such JJ O
as IN O
fluvoxamine NN O
and CC O
DHEA NNP O
- HYPH O
sulfate NN O
, , O
which WDT O
are VBP O
available JJ O
around IN O
the DT O
world NN O
, , O
would MD O
be VB O
unique JJ O
therapeutic JJ O
drugs NNS O
for IN O
neuropsychiatric JJ O
diseases NNS O
. . O

A DT O
novel JJ O
, , O
non RB O
- HYPH O
invasive JJ O
, , O
online RB O
- HYPH O
monitoring NN O
, , O
versatile JJ O
and CC O
easy JJ O
plant NN O
- HYPH O
based VBN O
probe NN O
for IN O
measuring VBG O
leaf NN O
water NN O
status NN O

Abstract JJ O

A DT O
high JJ O
- HYPH O
precision NN O
pressure NN O
probe NN O
is VBZ O
described VBN O
which WDT O
allows VBZ O
non RB O
- HYPH O
invasive JJ O
online RB O
- HYPH O
monitoring NN O
of IN O
the DT O
water NN O
relations NNS O
of IN O
intact JJ O
leaves NNS O
. . O

Real JJ O
- HYPH O
time NN O
recording NN O
of IN O
the DT O
leaf NN O
water NN O
status NN O
occurred VBD O
by IN O
data NNS O
transfer NN O
to IN O
an DT O
Internet NN O
server NN O
. . O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
attenuated JJ O
pressure NN O
, , O
Pp NNP O
, , O
of IN O
a DT O
leaf JJ O
patch NN O
in IN O
response NN O
to IN O
a DT O
constant JJ O
clamp NN O
pressure NN O
, , O
Pclamp NNP O
. . O

Pp NN O
is VBZ O
sensed VBN O
by IN O
a DT O
miniaturized JJ O
silicone NN O
pressure NN O
sensor NN O
integrated VBN O
into IN O
the DT O
device NN O
. . O

The DT O
magnitude NN O
of IN O
Pp NNP O
is VBZ O
dictated VBN O
by IN O
the DT O
transfer NN O
function NN O
of IN O
the DT O
leaf NN O
, , O
Tf NNP O
, , O
which WDT O
is VBZ O
a DT O
function NN O
of IN O
leaf NN O
patch NN O
volume NN O
and CC O
ultimately RB O
of IN O
cell NN O
turgor NN O
pressure NN O
, , O
Pc NNP O
, , O
as IN O
shown VBN O
theoretically RB O
. . O

The DT O
power NN O
function NN O
Tf NNP O
= SYM O
f NNP O
( -LRB- O
Pc NN O
) -RRB- O
theoretically RB O
derived VBD O
was VBD O
experimentally RB O
confirmed VBN O
by IN O
concomitant JJ O
Pp NN O
and CC O
Pc NNP O
measurements NNS O
on IN O
intact JJ O
leaflets NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
under IN O
greenhouse NN O
conditions NNS O
. . O

Simultaneous JJ O
Pp NN O
recordings NNS O
on IN O
leaflets NNS O
up IN O
to IN O
10 CD O
m NN O
height NN O
above IN O
ground NN O
demonstrated VBD O
that IN O
changes NNS O
in IN O
Tf NNP O
induced VBN O
by IN O
Pc NNP O
changes NNS O
due IN O
to IN O
changes NNS O
of IN O
microclimate NN O
and CC O
/ SYM O
or CC O
of IN O
the DT O
irrigation NN O
regime NN O
were VBD O
sensitively RB O
reflected VBN O
in IN O
corresponding VBG O
changes NNS O
of IN O
Pp NNP O
. . O

Analysis NN O
of IN O
the DT O
data NNS O
show VBP O
that IN O
transpirational JJ O
water NN O
loss NN O
during IN O
the DT O
morning NN O
hours NNS O
was VBD O
associated VBN O
with IN O
a DT O
transient JJ O
rise NN O
in IN O
turgor NN O
pressure NN O
gradients NNS O
within IN O
the DT O
leaflets NNS O
. . O

Subsequent JJ O
recovery NN O
of IN O
turgescence NN O
during IN O
the DT O
afternoon NN O
was VBD O
much RB O
faster JJR O
than IN O
the DT O
preceding VBG O
transpiration NN O
- HYPH O
induced VBN O
water NN O
loss NN O
if IN O
the DT O
plants NNS O
were VBD O
well RB O
irrigated JJ O
. . O

Our PRP$ O
data NNS O
show VBP O
the DT O
enormous JJ O
potential NN O
of IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
for IN O
leaf JJ O
water NN O
studies NNS O
including VBG O
unravelling VBG O
of IN O
the DT O
hydraulic JJ O
communication NN O
between IN O
neighbouring VBG O
leaves NNS O
and CC O
over IN O
long JJ O
distances NNS O
within IN O
tall JJ O
plants NNS O
( , O
trees NNS O
) -RRB- O
. . O

Introduction NN O

Optimum JJ O
water NN O
supply NN O
, , O
particularly RB O
at IN O
peak NN O
needs NNS O
of IN O
the DT O
plants NNS O
, , O
is VBZ O
an DT O
important JJ O
issue NN O
for IN O
greenhouse NN O
and CC O
field NN O
vegetable NN O
production NN O
. . O

In IN O
a DT O
greenhouse NN O
on IN O
a DT O
sunny JJ O
day NN O
, , O
evaporation NN O
and CC O
transpiration NN O
( , O
so RB O
- HYPH O
called VBN O
evapotranspiration NN O
) -RRB- O
can MD O
occur VB O
so RB O
rapidly RB O
that IN O
water NN O
loss NN O
can MD O
cause VB O
plant NN O
damage NN O
before IN O
wilting VBG O
symptoms NNS O
are VBP O
visible JJ O
. . O

Even RB O
at IN O
lower JJR O
temperatures NNS O
the DT O
restricted JJ O
rooting NN O
in IN O
greenhouses NNS O
leads VBZ O
frequently RB O
to IN O
plant NN O
water NN O
deficiency NN O
. . O

Thus RB O
, , O
no RB O
matter RB O
how WRB O
slight JJ O
, , O
drought NN O
stress NN O
will MD O
result VB O
in IN O
a DT O
significant JJ O
reduction NN O
in IN O
growth NN O
and CC O
, , O
in IN O
turn NN O
, , O
of IN O
harvest NN O
yield NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
over IN O
- HYPH O
irrigation NN O
must MD O
be VB O
avoided VBN O
and CC O
the DT O
appropriate JJ O
method NN O
of IN O
watering NN O
must MD O
be VB O
selected VBN O
because IN O
wet JJ O
soils NNS O
and CC O
permanent JJ O
moisture NN O
on IN O
plant NN O
organs NNS O
promote VBP O
the DT O
incidence NN O
of IN O
root NN O
mould NN O
, , O
grey JJ O
mould NN O
( , O
Botrytis NNP O
blight NN O
) -RRB- O
, , O
formation NN O
of IN O
leaf NN O
oedema NN O
, , O
and CC O
other JJ O
plant NN O
diseases NNS O
( , O
Sherf NNP O
and CC O
MacNab NNP O
, , O
1986 CD O
) -RRB- O
. . O

Conservation NN O
of IN O
water NN O
is VBZ O
another DT O
important JJ O
issue NN O
in IN O
semi NN O
- HYPH O
arid JJ O
and CC O
arid JJ O
regions NNS O
where WRB O
water NN O
is VBZ O
scarce JJ O
. . O

The DT O
advent NN O
of IN O
( : O
subsurface NN O
) , O
drip NN O
irrigation NN O
has VBZ O
considerably RB O
reduced VBN O
water NN O
consumption NN O
of IN O
agricultural JJ O
, , O
horticultural JJ O
, , O
and CC O
greenhouse NN O
crops NNS O
, , O
but CC O
has VBZ O
also RB O
highlighted VBN O
the DT O
need NN O
for IN O
sensors NNS O
monitoring VBG O
water NN O
deficiency NN O
of IN O
plants NNS O
directly RB O
and CC O
online RB O
( , O
Jones NNP O
, , O
2004 CD O
) -RRB- O
. . O

In IN O
plant NN O
physiology NN O
and CC O
agriculture NN O
the DT O
pressure NN O
bomb NN O
technique NN O
pioneered VBN O
by IN O
Scholander NNP O
et FW O
al NNP O
. . O

( -LRB- O
1965 CD O
) -RRB- O
is VBZ O
a DT O
widely RB O
accepted VBN O
reference NN O
technique NN O
for IN O
measuring VBG O
leaf NN O
water NN O
status NN O
. . O

However RB O
, , O
the DT O
method NN O
is VBZ O
massively RB O
invasive JJ O
, , O
slow JJ O
, , O
labour NN O
- HYPH O
intensive JJ O
( , O
and CC O
therefore RB O
expensive JJ O
) -RRB- O
, , O
unsuitable JJ O
for IN O
automation NN O
, , O
and CC O
gives VBZ O
only RB O
spot NN O
measurements NNS O
. . O

Furthermore RB O
, , O
interpretation NN O
of IN O
the DT O
data NNS O
is VBZ O
still RB O
a DT O
matter NN O
of IN O
debate NN O
( : O
Zimmermann NNP O
U NNP O
et FW O
al NNP O
. . O
, , O
2004 CD O
; : O
Zimmermann NNP O
D NNP O
et FW O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

Leaf JJ O
thickness NN O
is VBZ O
also RB O
sometimes RB O
used VBN O
as IN O
an DT O
indicator NN O
for IN O
water NN O
stress NN O
( , O
Burquez NNP O
, , O
1987 CD O
; : O
McBurney NNP O
, , O
1992 CD O
; : O
Malone NNP O
, , O
1993 CD O
) -RRB- O
. . O

Leaf NN O
thickness NN O
monitoring NN O
devices NNS O
are VBP O
commercially RB O
available JJ O
. . O

They PRP O
are VBP O
non RB O
- HYPH O
invasive JJ O
and CC O
suitable JJ O
for IN O
online JJ O
measurements NNS O
, , O
but CC O
have VBP O
the DT O
disadvantage NN O
that IN O
changes NNS O
in IN O
water NN O
status NN O
are VBP O
frequently RB O
not RB O
reflected VBN O
sensitively RB O
in IN O
changes NNS O
of IN O
leaf NN O
thickness NN O
. . O

The DT O
pressure NN O
probe NN O
technique NN O
pioneered VBN O
by IN O
Zimmermann NNP O
, , O
Tomos NNP O
, , O
and CC O
others NNS O
( , O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
1969 CD O
, , O
2004 CD O
; : O
Tomos NNP O
, , O
1988 CD O
; : O
Balling NNP O
and CC O
Zimmermann NNP O
, , O
1990 CD O
) -RRB- O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
is VBZ O
a DT O
well RB O
established VBN O
technology NN O
for IN O
measuring VBG O
turgor NN O
and CC O
xylem NN O
pressure NN O
on IN O
the DT O
levels NNS O
of IN O
individual JJ O
cells NNS O
and CC O
xylem NN O
vessels NNS O
, , O
respectively RB O
. . O

This DT O
technique NN O
is VBZ O
not RB O
suitable JJ O
for IN O
automation NN O
. . O

Moreover RB O
, , O
the DT O
probe NN O
technique NN O
requires VBZ O
rather RB O
sophisticated JJ O
equipment NN O
and CC O
a DT O
high JJ O
level NN O
of IN O
technical JJ O
skill NN O
. . O

These DT O
disadvantages NNS O
are VBP O
also RB O
shared VBN O
by IN O
the DT O
ball NN O
tonometry NN O
, , O
a DT O
method NN O
which WDT O
allows VBZ O
non RB O
- HYPH O
invasive JJ O
monitoring NN O
of IN O
cell NN O
turgor NN O
pressure NN O
by IN O
application NN O
of IN O
an DT O
external JJ O
pressure NN O
( , O
Lintilhac NNP O
et FW O
al NNP O
. . O
, , O
2000 CD O
; : O
Geitmann NNP O
, , O
2006 CD O
) -RRB- O
. . O

Other JJ O
water NN O
stress NN O
monitoring NN O
devices NNS O
are VBP O
described VBN O
in IN O
the DT O
literature NN O
, , O
but CC O
all DT O
of IN O
them PRP O
have VBP O
various JJ O
disadvantages NNS O
which WDT O
prevented VBD O
their PRP$ O
implementation NN O
for IN O
leaf JJ O
water NN O
status NN O
measurements NNS O
in IN O
greenhouses NNS O
or CC O
in IN O
the DT O
field NN O
( , O
see VBP O
, , O
for IN O
example NN O
, , O
the DT O
review NN O
article NN O
of IN O
Jones NNP O
, , O
2004 CD O
, , O
and CC O
also RB O
Grant NNP O
et FW O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

In IN O
this DT O
communication NN O
a DT O
novel JJ O
, , O
non RB O
- HYPH O
invasive JJ O
, , O
online JJ O
- HYPH O
monitoring NN O
plant NN O
- HYPH O
based VBN O
probe NN O
is VBZ O
described VBN O
that WDT O
meets VBZ O
the DT O
demands NNS O
of IN O
controlling VBG O
horticultural JJ O
and CC O
agricultural JJ O
water NN O
applications NNS O
. . O

The DT O
probe NN O
is VBZ O
characterized VBN O
by IN O
high JJ O
precision NN O
, , O
operating NN O
convenience NN O
, , O
minimum NN O
costs NNS O
, , O
and CC O
by IN O
automation NN O
suitability NN O
. . O

Data NNS O
can MD O
be VB O
transferred VBN O
wireless RB O
to IN O
a DT O
personal JJ O
computer NN O
or CC O
to IN O
an DT O
Internet NN O
server NN O
via IN O
a DT O
mobile JJ O
phone NN O
network NN O
for IN O
real JJ O
- HYPH O
time NN O
evaluation NN O
and CC O
for IN O
the DT O
automatic JJ O
regulation NN O
of IN O
irrigation NN O
. . O

The DT O
technology NN O
includes VBZ O
a DT O
miniaturized JJ O
silicone NN O
pressure NN O
sensor NN O
integrated VBN O
into IN O
a DT O
spring NN O
clamp NN O
that WDT O
is VBZ O
clamped VBN O
to IN O
a DT O
patch NN O
of IN O
an DT O
intact JJ O
plant NN O
leaf NN O
. . O

The DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
attenuated VBN O
pressure NN O
response NN O
of IN O
the DT O
leaf JJ O
patch NN O
upon IN O
the DT O
application NN O
of IN O
a DT O
constant JJ O
, , O
clamped VBN O
pressure NN O
. . O

The DT O
attenuation NN O
of IN O
the DT O
applied VBN O
pressure NN O
depends VBZ O
on IN O
the DT O
transfer NN O
function NN O
of IN O
the DT O
leaf NN O
. . O

The DT O
magnitude NN O
of IN O
the DT O
transfer NN O
function NN O
depends VBZ O
on IN O
two CD O
terms NNS O
, , O
a DT O
turgor NN O
pressure NN O
- HYPH O
independent JJ O
term NN O
( , O
related VBN O
to IN O
the DT O
compression NN O
of IN O
the DT O
cuticle NN O
, , O
cell NN O
walls NNS O
, , O
and CC O
other JJ O
structural JJ O
elements NNS O
) -RRB- O
and CC O
a DT O
turgor NN O
pressure NN O
- HYPH O
dependent JJ O
term NN O
. . O

Theory NN O
shows VBZ O
that IN O
the DT O
turgor NN O
pressure NN O
- HYPH O
dependent JJ O
part NN O
of IN O
the DT O
transfer NN O
function NN O
Tf NNP O
is VBZ O
a DT O
power NN O
function NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
, , O
Pc NNP O
, , O
and CC O
predicts VBZ O
that IN O
Tf NNP O
assumes VBZ O
values NNS O
close JJ O
to IN O
zero CD O
if IN O
Pc NNP O
is VBZ O
high JJ O
and CC O
, , O
vice RB O
versa RB O
, , O
values VBZ O
close RB O
to IN O
unity NN O
if IN O
Pc NNP O
is VBZ O
low JJ O
. . O

This DT O
could MD O
be VB O
verified VBN O
by IN O
combined VBN O
turgor NN O
pressure NN O
probe NN O
and CC O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measurements NNS O
on IN O
leaflets NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
. . O

The DT O
10 CD O
- HYPH O
m NN O
tall JJ O
liana NN O
growing VBG O
in IN O
a DT O
tropical JJ O
greenhouse NN O
was VBD O
selected VBN O
for IN O
the DT O
first JJ O
studies NNS O
because IN O
a DT O
comprehensive JJ O
data NNS O
set VBN O
about IN O
diurnal JJ O
changes NNS O
in IN O
xylem NN O
and CC O
turgor NN O
pressure NN O
gradients NNS O
under IN O
various JJ O
environmental JJ O
conditions NNS O
existed VBD O
for IN O
this DT O
greenhouse NN O
plant NN O
( , O
Benkert NNP O
et FW O
al NNP O
. . O
, , O
1995 CD O
; , O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O
, , O
1999 CD O
; , O
see VB O
also RB O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
2004 CD O
) -RRB- O
. . O

Measurements NNS O
of IN O
diurnal JJ O
changes NNS O
of IN O
the DT O
patch NN O
clamp VBP O
pressure NN O
performed VBN O
here RB O
yielded VBD O
results NNS O
which WDT O
were VBD O
consistent JJ O
with IN O
the DT O
previous JJ O
pressure NN O
probe NN O
work NN O
on IN O
the DT O
liana NN O
. . O

The DT O
data NNS O
also RB O
demonstrated VBD O
that IN O
changes NNS O
in IN O
the DT O
irrigation NN O
regime NN O
and CC O
in IN O
microclimate NN O
can MD O
be VB O
sensed VBN O
by IN O
this DT O
novel JJ O
probe NN O
very RB O
sensitively RB O
and CC O
that IN O
use NN O
of IN O
several JJ O
probes NNS O
allowed VBD O
the DT O
study NN O
of IN O
the DT O
diurnal JJ O
water NN O
transport NN O
at IN O
multiple JJ O
scales NNS O
from IN O
single JJ O
leaves NNS O
to IN O
the DT O
whole JJ O
organism NN O
( , O
Meinzer NNP O
et FW O
al NNP O
. . O
, , O
2001 CD O
) -RRB- O
. . O

This DT O
can MD O
be VB O
done VBN O
without IN O
knowledge NN O
of IN O
the DT O
turgor NN O
pressure NN O
because IN O
the DT O
transfer NN O
function NN O
is VBZ O
a DT O
direct JJ O
measure NN O
of IN O
leaf NN O
water NN O
status NN O
. . O

Materials NNS O
and CC O
methods NNS O

Plant NN O
material NN O

Experiments NNS O
were VBD O
performed VBN O
on IN O
two CD O
specimens NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
, , O
growing VBG O
in IN O
the DT O
c NN O
. . O

12 CD O
m NN O
tall JJ O
tropical JJ O
greenhouse NN O
of IN O
the DT O
University NNP O
of IN O
Salzburg NNP O
, , O
Austria NNP O
. . O

The DT O
ground NN O
ascended VBD O
by IN O
about RB O
5 CD O
m NN O
towards IN O
the DT O
backstage NN O
of IN O
the DT O
greenhouse NN O
. . O

The DT O
height NN O
of IN O
the DT O
plant NN O
in IN O
this DT O
area NN O
was VBD O
about RB O
4 CD O
. . O
5 CD O
m NN O
, , O
whereas IN O
the DT O
height NN O
of IN O
the DT O
plant NN O
in IN O
the DT O
front JJ O
area NN O
reached VBD O
10 CD O
m NNS O
. . O

However RB O
, , O
the DT O
stem NN O
and CC O
the DT O
branches NNS O
of IN O
the DT O
two CD O
plants NNS O
were VBD O
considerably RB O
longer JJR O
, , O
because IN O
the DT O
plants NNS O
had VBD O
grown VBN O
vertically RB O
upwards RB O
and CC O
then RB O
part NN O
of IN O
the DT O
way NN O
downwards RB O
. . O

First JJ O
measurements NNS O
were VBD O
performed VBN O
during IN O
the DT O
last JJ O
week NN O
of IN O
May NNP O
, , O
2007 CD O
. . O

This DT O
week NN O
was VBD O
very RB O
sunny JJ O
and CC O
warm JJ O
. . O

Experiments NNS O
were VBD O
repeated VBN O
during IN O
the DT O
last JJ O
week NN O
of IN O
August NNP O
and CC O
the DT O
first JJ O
week NN O
of IN O
September NNP O
, , O
2007 CD O
. . O

At IN O
this DT O
time NN O
of IN O
the DT O
year NN O
the DT O
weather NN O
conditions NNS O
were VBD O
quite RB O
poor JJ O
. . O

The DT O
weeks NNS O
were VBD O
rainy JJ O
, , O
sunshine NN O
occurred VBD O
only RB O
occasionally RB O
. . O

On IN O
average JJ O
, , O
the DT O
sky NN O
was VBD O
very RB O
cloudy JJ O
. . O

Due IN O
to IN O
the DT O
variable JJ O
weather NN O
conditions NNS O
the DT O
ambient JJ O
temperature NN O
, , O
T NNP O
, , O
in IN O
the DT O
greenhouse NN O
usually RB O
varied VBD O
between IN O
19 CD O
degrees NNS O
C NN O
and CC O
27 CD O
degrees NNS O
C NN O
. . O

By IN O
contrast NN O
, , O
during IN O
the DT O
hot JJ O
week NN O
in IN O
May NNP O
temperatures NNS O
at IN O
the DT O
top NN O
of IN O
the DT O
plants NNS O
could MD O
reach VB O
up IN O
to IN O
44 CD O
degrees NNS O
C NN O
. . O

The DT O
greenhouse NN O
was VBD O
illuminated VBN O
between IN O
7 CD O
. . O
30 CD O
h CD O
and CC O
19 CD O
. . O
0 CD O
h NN O
( , O
CET NNP O
= SYM O
Central NNP O
European NNP O
Time NNP O
) -RRB- O
. . O

During IN O
the DT O
day NN O
- HYPH O
time NN O
, , O
the DT O
artificial JJ O
illumination NN O
was VBD O
switched VBN O
off RP O
automatically RB O
once IN O
the DT O
natural JJ O
irradiance NN O
exceeded VBD O
about IN O
45 CD O
mu NNS O
mol NN O
photons NNS O
m SYM O
- HYPH O
2 CD O
s NNS O
- HYPH O
1 CD O
at IN O
ground NN O
level NN O
. . O

At IN O
full JJ O
sunshine NN O
, , O
the DT O
light JJ O
intensity NN O
was VBD O
limited VBN O
by IN O
automatically RB O
operating VBG O
blinds NNS O
. . O

The DT O
relative JJ O
humidity NN O
( , O
r UH O
. . O
h NN O
. . O
) -RRB- O
of IN O
the DT O
air NN O
was VBD O
regulated VBN O
by IN O
overhead JJ O
misters NNS O
. . O

Despite IN O
attempts NNS O
to TO O
keep VB O
the DT O
r NN O
. . O
h NFP O
. . O
above IN O
60 CD O
- SYM O
70 CD O
% NN O
large JJ O
axial JJ O
r NN O
. . O
h NFP O
. . O
gradients NNS O
along IN O
the DT O
stem NN O
of IN O
the DT O
liana NN O
were VBD O
observed VBN O
during IN O
sunny JJ O
days NNS O
( , O
see VB O
below RB O
) -RRB- O
. . O

The DT O
ambient JJ O
temperature NN O
and CC O
relative JJ O
humidity NN O
at IN O
the DT O
measuring NN O
sites NNS O
were VBD O
determined VBN O
by IN O
using VBG O
thermistors NNS O
( , O
Tinytag NNP O
; : O
RS NNP O
Components NNPS O
GmbH NNP O
, , O
M NNP O
o NNP O
rfelden NNP O
- HYPH O
Walldorf NNP O
, , O
Germany NNP O
) -RRB- O
. . O

Leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
and CC O
data NN O
acquisition NN O

The DT O
pressure NN O
sensor NN O
chip NN O
allows VBZ O
pressure NN O
measurements NNS O
up IN O
to IN O
100 CD O
kPa NN O
. . O

The DT O
sensor NN O
consists VBZ O
of IN O
a DT O
miniature JJ O
piezoresistive JJ O
Wheatstone NNP O
bridge NN O
. . O

The DT O
sensors NNS O
used VBN O
in IN O
this DT O
work NN O
were VBD O
purchased VBN O
from IN O
the DT O
company NN O
' `` O
Raumedic NNP O
' '' O
( : O
Helmbrechts NNP O
, , O
Germany NNP O
) , O
and CC O
from IN O
the DT O
company NN O
' '' O
Keller NNP O
' '' O
( , O
AG NNP O
, , O
Druckmesstechnik NNP O
; : O
Winterthur NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

However RB O
, , O
it PRP O
has VBZ O
to TO O
be VB O
pointed VBN O
out RP O
that IN O
any DT O
other JJ O
miniaturized VBN O
pressure NN O
or CC O
force NN O
sensor NN O
could MD O
be VB O
used VBN O
. . O

The DT O
sensor NN O
chip NN O
was VBD O
integrated VBN O
into IN O
one CD O
of IN O
the DT O
planar NN O
circular JJ O
pads NNS O
of IN O
a DT O
spring NN O
clamp NN O
shown VBN O
schematically RB O
in IN O
Fig NNP O
. . O

1 LS O
. . O

The DT O
spring NN O
clamp NN O
consisted VBD O
of IN O
two CD O
curved JJ O
arms NNS O
bridged VBN O
by IN O
a DT O
spring NN O
in IN O
the DT O
middle NN O
( , O
Wolfcraft NNP O
GmbH NNP O
; : O
microfix NNP O
S NNP O
( -LRB- O
B3630Fz60 NNP O
) -RRB- O
, , O
Kempenich NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
clamp NN O
pressure NN O
exerted VBN O
by IN O
the DT O
spring NN O
on IN O
the DT O
leaf NN O
, , O
Pclamp NNP O
, , O
could MD O
be VB O
varied VBN O
by IN O
a DT O
stiff JJ O
strap NN O
( , O
made VBN O
of IN O
synthetic JJ O
material NN O
) , O
spanned VBN O
between IN O
the DT O
arms NNS O
of IN O
the DT O
spring NN O
clip NN O
at IN O
the DT O
handhold NN O
site NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
length NN O
of IN O
the DT O
strap NN O
and CC O
thus RB O
the DT O
spring NN O
load NN O
acting VBG O
on IN O
the DT O
leaflet NN O
between IN O
the DT O
two CD O
pads NNS O
could MD O
be VB O
varied VBN O
by IN O
regularly RB O
punched VBN O
holes NNS O
( , O
as IN O
in IN O
a DT O
belt NN O
) -RRB- O
. . O

Calibration NN O
of IN O
the DT O
sensor NN O
chips NNS O
was VBD O
performed VBN O
by IN O
pressurization NN O
in IN O
a DT O
pressure NN O
chamber NN O
equipped VBN O
with IN O
an DT O
integrated VBN O
manometer NN O
( , O
LEO NNP O
1 CD O
, , O
Keller NNP O
AG NNP O
, , O
Winterthur NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

The DT O
readings NNS O
of IN O
all DT O
sensors NNS O
used VBN O
in IN O
this DT O
study NN O
increased VBD O
linearly RB O
with IN O
pressure NN O
in IN O
the DT O
range NN O
between IN O
0 CD O
kPa NN O
and CC O
100 CD O
kPa NN O
. . O

The DT O
pressure NN O
sensitivity NN O
of IN O
the DT O
various JJ O
sensors NNS O
was VBD O
found VBN O
to TO O
be VB O
almost RB O
identical JJ O
for IN O
all DT O
probes NNS O
. . O

Before IN O
use NN O
the DT O
probes NNS O
were VBD O
also RB O
tested VBN O
for IN O
temperature NN O
- HYPH O
sensitivity NN O
in IN O
an DT O
accessible JJ O
climate NN O
chamber NN O
because IN O
it PRP O
is VBZ O
well RB O
- HYPH O
known VBN O
that IN O
silicone NN O
- HYPH O
embedded VBN O
sensors NNS O
tend VBP O
to TO O
become VB O
temperature NN O
- HYPH O
sensitive JJ O
during IN O
storage NN O
. . O

Probes NNS O
were VBD O
subject JJ O
to IN O
temperature NN O
regimes NNS O
ranging VBG O
from IN O
10 CD O
degrees NNS O
C NN O
to IN O
35 CD O
degrees NNS O
C NN O
. . O

Probes NNS O
were VBD O
not RB O
used VBN O
if IN O
the DT O
temperature NN O
treatment NN O
induced VBD O
a DT O
pressure NN O
change NN O
larger JJR O
than IN O
0 CD O
. . O
5 CD O
kPa NNP O
. . O

The DT O
signals NNS O
of IN O
the DT O
leaf NN O
patch NN O
clamp VBP O
pressure NN O
probe NN O
were VBD O
transmitted VBN O
by IN O
a DT O
telemetry NN O
system NN O
( , O
teleBITcom NN O
gmbh NN O
, , O
Teltow NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
operating VBG O
distance NN O
between IN O
the DT O
battery NN O
- HYPH O
powered VBN O
wireless JJ O
telemetric JJ O
transmitter NN O
and CC O
the DT O
receiver NN O
base NN O
station NN O
was VBD O
up IN O
to IN O
400 CD O
m NNS O
. . O

Each DT O
transmitter NN O
read VBD O
, , O
amplified VBN O
, , O
and CC O
converted VBN O
the DT O
analogue NN O
signals NNS O
of IN O
the DT O
pressure NN O
sensor NN O
into IN O
digitalized JJ O
signals NNS O
. . O

The DT O
data NNS O
were VBD O
sent VBN O
together RB O
with IN O
the DT O
transmitter NN O
ID NN O
- HYPH O
code NN O
every DT O
90 CD O
s NNS O
via IN O
the DT O
ISM NNP O
band NN O
of IN O
433 CD O
MHz NNP O
to IN O
the DT O
receiver NN O
base NN O
station NN O
which WDT O
logged VBD O
and CC O
transferred VBD O
the DT O
data NNS O
to IN O
a DT O
personal JJ O
computer NN O
or CC O
to IN O
a DT O
GPRS NNP O
modem NN O
linked VBN O
to IN O
an DT O
Internet NN O
server NN O
( , O
NTBB NNP O
Systemtechnik NNP O
GmbH NNP O
, , O
Zeuthen NNP O
, , O
Germany NNP O
) , O
for IN O
analysis NN O
and CC O
archival JJ O
storage NN O
. . O

For IN O
sensor NN O
calibration NN O
and CC O
data NNS O
recording VBG O
the DT O
SENBIT NNP O
software NN O
( -LRB- O
teleBITcom NN O
gmbh NN O
, , O
Teltow NNP O
, , O
Germany NNP O
) -RRB- O
was VBD O
used VBN O
. . O

The DT O
software NN O
allowed VBD O
communication NN O
with IN O
up IN O
to TO O
32 CD O
sensors NNS O
at IN O
regular JJ O
short JJ O
intervals NNS O
( : O
90 CD O
s NNS O
to IN O
5 CD O
min NN O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
up IN O
to TO O
10 CD O
sensor NN O
/ SYM O
transmitter NN O
units NNS O
were VBD O
installed VBN O
at IN O
different JJ O
heights NNS O
on IN O
the DT O
two CD O
lianas NNS O
. . O

Data NNS O
transfer NN O
to IN O
the DT O
Internet NN O
server NN O
operated VBD O
without IN O
any DT O
problem NN O
during IN O
the DT O
entire JJ O
experimental JJ O
period NN O
. . O

However RB O
, , O
for IN O
safety NN O
reasons NNS O
hard RB O
- HYPH O
wired VBN O
conventional JJ O
data NN O
acquisition NN O
was VBD O
also RB O
performed VBN O
using VBG O
dataloggers NNS O
( , O
Raumedic NNP O
, , O
Helmbrechts NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
dataloggers NNS O
were VBD O
controlled VBN O
by IN O
a DT O
computer NN O
program NN O
that WDT O
provided VBD O
functions NNS O
for IN O
data NN O
storage NN O
and CC O
sensor NN O
calibration NN O
. . O

Data NNS O
were VBD O
transferred VBN O
regularly RB O
from IN O
the DT O
dataloggers NNS O
to IN O
a DT O
personal JJ O
computer NN O
. . O

Cell NN O
turgor NN O
pressure NN O
probe NN O

Turgor NN O
pressure NN O
measurements NNS O
were VBD O
performed VBN O
on IN O
leaflets NNS O
of IN O
the DT O
10 CD O
- HYPH O
m NN O
tall JJ O
liana NN O
at IN O
c NN O
. . O

0 NFP O
. . O
2 CD O
m NN O
height NN O
above IN O
the DT O
roots NNS O
. . O

The DT O
construction NN O
and CC O
function NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
has VBZ O
been VBN O
described VBN O
elsewhere RB O
( : O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
1969 CD O
, , O
2004 CD O
) -RRB- O
. . O

Briefly RB O
, , O
the DT O
microcapillary NN O
was VBD O
filled VBN O
with IN O
oil NN O
up IN O
to IN O
the DT O
very JJ O
tip NN O
and CC O
was VBD O
then RB O
inserted VBN O
into IN O
the DT O
upper JJ O
leaflet NN O
surface NN O
between IN O
the DT O
main JJ O
vein NN O
and CC O
the DT O
leaflet NN O
edge NN O
. . O

Insertion NN O
was VBD O
made VBN O
under IN O
a DT O
small JJ O
overpressure JJ O
( , O
about RB O
20 CD O
kPa NN O
) -RRB- O
achieved VBN O
by IN O
appropriate JJ O
displacement NN O
of IN O
the DT O
metal NN O
rod NN O
in IN O
the DT O
probe NN O
in IN O
order NN O
to TO O
avoid VB O
tip NN O
clogging NN O
. . O

Penetration NN O
was VBD O
stopped VBN O
upon IN O
reaching VBG O
the DT O
mesophyll NN O
cell NN O
layer NN O
and CC O
formation NN O
of IN O
a DT O
stable JJ O
oil NN O
/ SYM O
sap NN O
meniscus NN O
within IN O
the DT O
tip NN O
region NN O
of IN O
the DT O
microcapillary NN O
of IN O
the DT O
probe NN O
. . O

During IN O
the DT O
measurements NNS O
it PRP O
was VBD O
regularly RB O
proved VBN O
whether IN O
the DT O
tip NN O
was VBD O
clogged VBN O
or CC O
not RB O
by IN O
appropriate JJ O
displacement NN O
of IN O
the DT O
metal NN O
rod NN O
. . O

Theoretical JJ O
background NN O

The DT O
input NN O
pressure NN O
, , O
Pin NNP O
, , O
experienced VBN O
by IN O
the DT O
cells NNS O
in IN O
a DT O
leaf JJ O
patch NN O
is VBZ O
equal JJ O
to IN O
the DT O
clamp NN O
pressure NN O
, , O
Pclamp NNP O
, , O
only RB O
if IN O
the DT O
pressure NN O
signal NN O
is VBZ O
transferred VBN O
lossless JJ O
to IN O
the DT O
cells NNS O
in IN O
the DT O
leaves NNS O
. . O

However RB O
, , O
losses NNS O
usually RB O
occur VBP O
due IN O
to IN O
the DT O
compressibility NN O
and CC O
the DT O
deformability NN O
of IN O
the DT O
silicone NN O
of IN O
the DT O
pressure NN O
sensor NN O
as RB O
well RB O
as IN O
of IN O
the DT O
compressibility NN O
of IN O
the DT O
cuticle NN O
and CC O
other JJ O
structural JJ O
elements NNS O
of IN O
the DT O
leaf NN O
. . O

Therefore RB O
, , O
theory NN O
shows VBZ O
that IN O
only RB O
a DT O
fraction NN O
of IN O
Pclamp NNP O
may MD O
arrive VB O
at IN O
the DT O
cells NNS O
, , O
i PRP O
. . O
e NFP O
. . O
that IN O
the DT O
attenuation NN O
factor NN O
, , O
Fa NNP O
= , O
Pin NNP O
/ SYM O
Pclamp NNP O
, , O
is VBZ O
smaller JJR O
than IN O
unity NN O
. . O

Fa NNP O
depends VBZ O
on IN O
the DT O
individual JJ O
leaf NN O
properties NNS O
. . O

Fa NNP O
can MD O
be VB O
assumed VBN O
to TO O
be VB O
constant JJ O
( , O
and CC O
leaf NN O
thickness NN O
changes NNS O
are VBP O
negligible JJ O
) , O
if IN O
the DT O
structural JJ O
elements NNS O
are VBP O
completely RB O
pre NN O
- HYPH O
compressed VBN O
by IN O
application NN O
of IN O
an DT O
appropriate JJ O
Pclamp NNP O
. . O

If IN O
Pclamp NNP O
is VBZ O
kept VBN O
constant JJ O
during IN O
the DT O
following VBG O
experimental JJ O
period NN O
, , O
Pin NNP O
is VBZ O
constant JJ O
and CC O
the DT O
output NN O
pressure NN O
, , O
Pp NNP O
, , O
is VBZ O
only RB O
determined VBN O
by IN O
the DT O
cell NN O
transfer NN O
function NN O
, , O
Tf NNP O
( , O
V NN O
) -RRB- O
, , O
where WRB O
V NN O
is VBZ O
the DT O
leaf NN O
patch NN O
volume NN O
. . O

In IN O
other JJ O
words NNS O
, , O
Tf NNP O
( , O
V NNP O
) -RRB- O
determines VBZ O
the DT O
fraction NN O
of IN O
Pin NN O
sensed VBN O
by IN O
the DT O
probe NN O
. . O

It PRP O
is VBZ O
dimensionless JJ O
and CC O
assumes VBZ O
values NNS O
between IN O
zero CD O
and CC O
unity NN O
: : O
( , O
1 CD O
) -RRB- O
Tf NN O
depends VBZ O
on IN O
the DT O
volume NN O
of IN O
the DT O
leaf NN O
patch NN O
, , O
V NN O
, , O
at IN O
constant JJ O
ambient JJ O
temperature NN O
, , O
T NN O
: : O
( : O
2 CD O
) SYM O
delta NN O
V NN O
depends VBZ O
on IN O
changes NNS O
in IN O
cell NN O
turgor NN O
pressure NN O
, , O
delta NN O
Pc NN O
, , O
as IN O
follows VBZ O
: : O
( : O
3 CD O
) NFP O
where WRB O
op NN O
is VBZ O
the DT O
average JJ O
volumetric JJ O
elastic JJ O
modulus NN O
of IN O
the DT O
clamped VBN O
tissue NN O
( , O
Philip NNP O
, , O
1958 CD O
) -RRB- O
. . O

op UH O
is VBZ O
a DT O
very RB O
complex JJ O
parameter NN O
and CC O
will MD O
be VB O
dictated VBN O
by IN O
the DT O
turgor NN O
pressure NN O
in IN O
the DT O
turgescent JJ O
state NN O
. . O

For IN O
a DT O
first JJ O
approximation NN O
it PRP O
is VBZ O
assumed VBN O
that IN O
op NN O
increases VBZ O
linearly RB O
with IN O
Pc NNP O
( , O
support NN O
for IN O
this DT O
assumption NN O
is VBZ O
given VBN O
by IN O
Zimmermann NNP O
and CC O
Steudle NNP O
, , O
1978 CD O
; : O
Zimmermann NNP O
and CC O
H NN O
u NN O
sken NN O
, , O
1980 CD O
; : O
Wendler NNP O
et FW O
al NNP O
. . O
, , O
1983 CD O
) -RRB- O
: : O
( : O
4 CD O
) -RRB- O
where WRB O
a DT O
and CC O
b NN O
are VBP O
constants NNS O
for IN O
individual JJ O
leaf NN O
properties NNS O
. . O

Because IN O
of IN O
the DT O
viscoelastic JJ O
properties NNS O
of IN O
the DT O
cell NN O
wall NN O
, , O
the DT O
magnitude NN O
of IN O
the DT O
constants NNS O
depends VBZ O
on IN O
the DT O
duration NN O
of IN O
the DT O
external JJ O
pressure NN O
application NN O
( , O
Zimmermann NNP O
and CC O
H NN O
u NN O
sken NN O
, , O
1980 CD O
) -RRB- O
. . O

The DT O
constants NNS O
are VBP O
relatively RB O
large JJ O
if IN O
rapid JJ O
turgor NN O
pressure NN O
changes NNS O
are VBP O
induced VBN O
( , O
e LS O
. . O
g LS O
. . O
by IN O
using VBG O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
) -RRB- O
, , O
whereas IN O
slow JJ O
turgor NN O
pressure NN O
changes VBZ O
( , O
e LS O
. . O
g LS O
. . O
under IN O
transpirational JJ O
conditions NNS O
) -RRB- O
result VBP O
in IN O
small JJ O
values NNS O
. . O

Combining VBG O
equations NNS O
2 CD O
- SYM O
4 CD O
leads NNS O
to IN O
equation NN O
5 CD O
. . O
( : O
5 CD O
) NFP O

Equation NN O
5 CD O
can MD O
be VB O
integrated VBN O
by IN O
assuming VBG O
for IN O
a DT O
first JJ O
approximation NN O
that IN O
at IN O
Pc NN O
= SYM O
0 CD O
Tf NN O
= SYM O
1 CD O
and CC O
that IN O
the DT O
internal JJ O
osmotic JJ O
pressure NN O
of IN O
the DT O
cells NNS O
remained VBD O
constant JJ O
. . O

After IN O
appropriate JJ O
re IN O
- HYPH O
arrangements NNS O
equation NN O
6 CD O
is VBZ O
obtained VBN O
: : O
( : O
6 CD O
) NFP O
and CC O
, , O
respectively RB O
, , O
if IN O
the DT O
denominator NN O
is VBZ O
replaced VBN O
by IN O
equation NN O
4 CD O
: : O
( : O
7 CD O
) NFP O

Introducing VBG O
equation NN O
6 CD O
into IN O
equation NN O
1 CD O
yields VBZ O
the DT O
wanted VBN O
relationship NN O
between IN O
the DT O
parameters NNS O
Pp NN O
and CC O
Pin NN O
: : O
( : O
8 CD O
) NFP O

Equation NN O
8 CD O
can MD O
be VB O
verified VBN O
experimentally RB O
. . O

Inspection NN O
of IN O
the DT O
equation NN O
shows VBZ O
that IN O
the DT O
patch NN O
clamp NN O
pressure NN O
, , O
Pp NNP O
, , O
is VBZ O
a DT O
power NN O
function NN O
of IN O
the DT O
turgor NN O
pressure NN O
, , O
Pc NNP O
. . O

The DT O
exponent NN O
of IN O
the DT O
function NN O
is VBZ O
equal JJ O
to IN O
or CC O
smaller JJR O
than IN O
unity NN O
. . O

If IN O
a DT O
= SYM O
1 CD O
and CC O
b NN O
< CC O
< NN O
Pc NN O
, , O
equation NN O
8 CD O
turns VBZ O
into IN O
Pp NN O
= : O
b NN O
/ SYM O
Pc NN O
, , O
i PRP O
. . O
e -RRB- O
. . O
both DT O
parameters NNS O
are VBP O
directly RB O
reciprocally RB O
coupled VBN O
with IN O
each DT O
other JJ O
. . O

Thus RB O
Tf NNP O
assumes VBZ O
low JJ O
values NNS O
if IN O
Pc NNP O
is VBZ O
high JJ O
and CC O
, , O
vice RB O
versa RB O
, , O
a DT O
value NN O
close JJ O
to IN O
unity NN O
if IN O
Pc NNP O
is VBZ O
close JJ O
to IN O
zero CD O
. . O

Using VBG O
appropriate JJ O
values NNS O
for IN O
a DT O
and CC O
b NN O
for IN O
a DT O
given VBN O
leaf NN O
( , O
see VB O
below RB O
) -RRB- O
it PRP O
can MD O
be VB O
shown VBN O
that IN O
below IN O
Pc NNP O
= SYM O
100 CD O
kPa NN O
, , O
Pp NN O
increases VBZ O
dramatically RB O
. . O

This DT O
means VBZ O
that IN O
the DT O
transfer NN O
function NN O
responds VBZ O
very RB O
sensitively RB O
upon IN O
loss NN O
of IN O
complete JJ O
turgor NN O
pressure NN O
. . O

In IN O
the DT O
derivation NN O
of IN O
equation NN O
8 CD O
it PRP O
was VBD O
assumed VBN O
that IN O
op NN O
is VBZ O
temperature NN O
- HYPH O
independent JJ O
. . O

However RB O
, , O
temperature NN O
effects NNS O
on IN O
cell NN O
elasticity NN O
are VBP O
well RB O
- HYPH O
known VBN O
, , O
although IN O
they PRP O
are VBP O
not RB O
very RB O
large JJ O
in IN O
the DT O
temperature NN O
range NN O
investigated VBN O
here RB O
( , O
see VB O
, , O
for IN O
example NN O
, , O
Petersen NNP O
et FW O
al NNP O
. . O
, , O
1982 CD O
; : O
Niklas NNP O
, , O
1992 CD O
; : O
Hogan NNP O
and CC O
Niklas NNP O
, , O
2004 CD O
; : O
Edelmann NNP O
et FW O
al NNP O
. . O
, , O
2005 CD O
) -RRB- O
. . O

Temperature NN O
effects NNS O
on IN O
op NN O
cannot MD O
be VB O
excluded VBN O
if IN O
different JJ O
values NNS O
for IN O
the DT O
Pclamp NNP O
, , O
and CC O
, , O
in IN O
turn NN O
, , O
for IN O
the DT O
input NN O
pressure NN O
, , O
Pin NNP O
, , O
are VBP O
selected VBN O
, , O
as RB O
well RB O
as IN O
if IN O
significantly RB O
different JJ O
values NNS O
for IN O
the DT O
constants NNS O
a DT O
and CC O
b NN O
are VBP O
assumed VBN O
for IN O
optimum JJ O
fitting NN O
of IN O
the DT O
Pp NNP O
= SYM O
f NN O
( -LRB- O
Pc NN O
) -RRB- O
curves NNS O
. . O

Therefore RB O
, , O
in IN O
the DT O
case NN O
of IN O
large JJ O
temperature NN O
gradients NNS O
as IN O
observed VBN O
here RB O
( , O
see VB O
Figs NNP O
2 CD O
and CC O
3 CD O
) , O
only RB O
the DT O
relative NN O
, , O
but CC O
not RB O
the DT O
absolute JJ O
changes NNS O
in IN O
Pp NNP O
measured VBN O
at IN O
the DT O
different JJ O
heights NNS O
can MD O
be VB O
compared VBN O
with IN O
each DT O
other JJ O
. . O

However RB O
, , O
Pp NN O
values NNS O
measured VBN O
at IN O
the DT O
same JJ O
height NN O
are VBP O
still RB O
comparable JJ O
and CC O
give VB O
information NN O
about IN O
the DT O
turgescence NN O
, , O
i PRP O
. . O
e LS O
. . O
about IN O
the DT O
water NN O
status NN O
of IN O
the DT O
leaf NN O
cells NNS O
. . O

Results NNS O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
was VBD O
clamped VBN O
about RB O
2 CD O
cm NNS O
away RB O
from IN O
the DT O
edge NN O
of IN O
a DT O
leaflet NN O
of IN O
the DT O
compound NN O
leaves NNS O
. . O

Leaflets NNS O
of IN O
similar JJ O
size NN O
( : O
176 CD O
+ SYM O
/ SYM O
- HYPH O
58 CD O
cm2 CD O
, , O
n CD O
= SYM O
12 CD O
) -RRB- O
were VBD O
used VBN O
. . O

Inspection NN O
of IN O
the DT O
leaf NN O
patches NNS O
after IN O
removal NN O
of IN O
the DT O
probes NNS O
under IN O
the DT O
microscope NN O
revealed VBD O
no DT O
changes NNS O
in IN O
leaflet NN O
appearance NN O
beneath IN O
the DT O
pads NNS O
, , O
even RB O
after IN O
several JJ O
weeks NNS O
. . O

Lesions NNS O
on IN O
the DT O
leaves NNS O
were VBD O
never RB O
found VBN O
. . O

Only RB O
occasionally RB O
were VBD O
very RB O
slight JJ O
impressions NNS O
of IN O
the DT O
pads NNS O
on IN O
the DT O
leaflet NN O
surface NN O
observed VBN O
. . O

Clamping VBG O
of IN O
the DT O
leaves NNS O
could MD O
be VB O
performed VBN O
at IN O
any DT O
time NN O
of IN O
the DT O
day NN O
. . O

Clamp NN O
pressures NNS O
, , O
Pclamp NNP O
, , O
applied VBN O
to IN O
the DT O
leaves NNS O
were VBD O
of IN O
the DT O
order NN O
of IN O
80 CD O
- SYM O
200 CD O
kPa NN O
. . O

The DT O
optimum JJ O
value NN O
for IN O
Pclamp NNP O
of IN O
a DT O
given VBN O
leaf NN O
has VBZ O
to TO O
be VB O
found VBN O
empirically RB O
. . O

Experience NN O
shows VBZ O
that IN O
Pclamp NNP O
values NNS O
could MD O
be VB O
considered VBN O
as RB O
optimal JJ O
if IN O
the DT O
output NN O
pressure NN O
Pp NNP O
assumed VBD O
values NNS O
between IN O
10 CD O
kPa NN O
and CC O
25 CD O
kPa NN O
upon IN O
clamping VBG O
in IN O
the DT O
early JJ O
morning NN O
( , O
when WRB O
turgor NN O
pressure NN O
was VBD O
high JJ O
) , O
or CC O
between IN O
50 CD O
kPa NN O
and CC O
70 CD O
kPa NN O
upon IN O
clamping VBG O
around IN O
noon NN O
or CC O
towards IN O
early JJ O
afternoon NN O
( , O
when WRB O
turgor NN O
pressure NN O
was VBD O
usually RB O
low JJ O
) -RRB- O
. . O

The DT O
magnitude NN O
of IN O
Pp NNP O
depended VBD O
on IN O
the DT O
compressibility NN O
and CC O
deformability NN O
properties NNS O
of IN O
the DT O
individual JJ O
leaves NNS O
which WDT O
may MD O
vary VB O
considerably RB O
due IN O
to IN O
age NN O
, , O
morphology NN O
, , O
leaf NN O
thickness NN O
, , O
abiotic JJ O
factors NNS O
etc FW O
. . O

The DT O
magnitude NN O
of IN O
Pclamp NNP O
had VBD O
no DT O
effect NN O
on IN O
the DT O
diurnal JJ O
profiles NNS O
of IN O
Pp NNP O
, , O
in IN O
response NN O
to IN O
changes NNS O
in IN O
microclimate NN O
and CC O
/ SYM O
or CC O
changes NNS O
in IN O
the DT O
irrigation NN O
regime NN O
. . O

Probes NNS O
clamped VBD O
on IN O
the DT O
same JJ O
leaflet NN O
or CC O
nearby JJ O
leaflets NNS O
of IN O
leaves NNS O
responded VBD O
almost RB O
identically RB O
upon IN O
temporary JJ O
changes NNS O
in IN O
transpiration NN O
and CC O
/ SYM O
or CC O
water NN O
supply NN O
even RB O
if IN O
the DT O
Pclamp NNP O
values NNS O
were VBD O
different JJ O
due IN O
to IN O
different JJ O
leaf NN O
thickness NN O
as RB O
well RB O
as IN O
local JJ O
compressibility NN O
and CC O
deformability NN O
properties NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

This DT O
was VBD O
found VBN O
over IN O
the DT O
entire JJ O
height NN O
of IN O
the DT O
plants NNS O
. . O

Screening NN O
experiments NNS O
proved VBD O
further RB O
that IN O
a DT O
high JJ O
surface NN O
roughness NN O
prevented VBD O
a DT O
uniform JJ O
contact NN O
between IN O
the DT O
pads NNS O
of IN O
the DT O
probe NN O
and CC O
the DT O
leaf NN O
. . O

Non NNP O
- HYPH O
uniform JJ O
contact NN O
resulted VBD O
in IN O
a DT O
reduced VBN O
pressure NN O
response NN O
of IN O
the DT O
probe NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Thus RB O
, , O
in IN O
order NN O
to TO O
obtain VB O
maximum JJ O
resolution NN O
of IN O
microclimate NN O
- HYPH O
induced VBN O
and CC O
/ SYM O
or CC O
plant NN O
- HYPH O
based VBN O
effects NNS O
on IN O
the DT O
Pp NNP O
values NNS O
, , O
it PRP O
was VBD O
crucial JJ O
that IN O
the DT O
probe NN O
was VBD O
placed VBN O
on IN O
relatively RB O
smooth JJ O
areas NNS O
, , O
i PRP O
. . O
e LS O
. . O
preferentially RB O
between IN O
the DT O
veins NNS O
rather RB O
than IN O
on IN O
the DT O
veins NNS O
in IN O
order NN O
to TO O
guarantee VB O
a DT O
uniform JJ O
pressure NN O
transmission NN O
. . O

It PRP O
also RB O
turned VBD O
out RP O
that IN O
areas NNS O
with IN O
lesions NNS O
or CC O
covered VBN O
with IN O
dust NN O
should MD O
be VB O
avoided VBN O
. . O

Probably RB O
due JJ O
to IN O
the DT O
absence NN O
of IN O
dust NN O
, , O
high JJ O
resolution NN O
results NNS O
were VBD O
obtained VBN O
when WRB O
the DT O
sensor NN O
- HYPH O
containing VBG O
pad NN O
faced VBD O
the DT O
abaxial JJ O
side NN O
, , O
but CC O
not RB O
the DT O
adaxial JJ O
side NN O
of IN O
the DT O
leaf NN O
. . O

Diurnal NNP O
changes VBZ O
in IN O
the DT O
patch NN O
clamp NN O
pressure NN O

Figure NN O
2A NNP O
represents VBZ O
Pp NNP O
recordings NNS O
conducted VBN O
on IN O
the DT O
10 CD O
m NN O
tall JJ O
liana NN O
on IN O
24 CD O
May NNP O
and CC O
25 CD O
May NNP O
, , O
2007 CD O
. . O

The DT O
plant NN O
was VBD O
well RB O
- HYPH O
watered VBN O
before IN O
the DT O
beginning NN O
of IN O
the DT O
measurements NNS O
( , O
22 CD O
May NNP O
) , O
and CC O
was VBD O
also RB O
watered VBN O
regularly RB O
during IN O
the DT O
experimental JJ O
period NN O
. . O

The DT O
sufficient JJ O
supply NN O
of IN O
the DT O
leaves NNS O
with IN O
water NN O
was VBD O
indicated VBN O
by IN O
high JJ O
turgor NN O
pressure NN O
values NNS O
of IN O
c NN O
. . O

500 CD O
kPa NN O
at IN O
predawn NN O
and CC O
guttation NN O
up IN O
to IN O
a DT O
height NN O
of IN O
6 CD O
m NN O
around IN O
sunrise NN O
( , O
see VB O
also RB O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O
, , O
1999 CD O
) -RRB- O
. . O

Diurnal JJ O
changes NNS O
of IN O
the DT O
Pp NN O
values NNS O
were VBD O
recorded VBN O
simultaneously RB O
at IN O
0 CD O
. . O
2 CD O
m CD O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
. . O

The DT O
corresponding VBG O
diurnal JJ O
changes NNS O
in IN O
the DT O
ambient JJ O
temperature NN O
, , O
T NN O
, , O
and CC O
relative JJ O
humidity NN O
, , O
r UH O
. . O
h UH O
. . O
, , O
measured VBN O
close RB O
to IN O
the DT O
sites NNS O
of IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probes NNS O
, , O
are VBP O
given VBN O
in IN O
Fig NNP O
. . O

2B NN O
and CC O
C NN O
. . O

It PRP O
was VBD O
very RB O
sunny JJ O
on IN O
24 CD O
May NNP O
resulting VBG O
in IN O
a DT O
rapid JJ O
heating NN O
- HYPH O
up NN O
of IN O
the DT O
greenhouse NN O
, , O
particularly RB O
in IN O
the DT O
upper JJ O
part NN O
. . O

This DT O
led VBD O
to IN O
the DT O
development NN O
of IN O
large JJ O
vertical JJ O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
along IN O
the DT O
stem NN O
of IN O
the DT O
liana NN O
( , O
Fig NNP O
. . O
2B NN O
, , O
C NN O
) -RRB- O
. . O

Because IN O
sunlight NN O
was VBD O
dimmed VBN O
by IN O
operation NN O
of IN O
the DT O
automatic JJ O
blinds NNS O
at IN O
noon NN O
( , O
see VB O
Materials NNPS O
and CC O
methods NNS O
) , O
the DT O
gradients NNS O
did VBD O
not RB O
reach VB O
maximum JJ O
values NNS O
before IN O
the DT O
afternoon NN O
. . O

Between IN O
15 CD O
. . O
30 CD O
h CD O
and CC O
16 CD O
. . O
30 CD O
h NN O
an DT O
ambient JJ O
temperature NN O
of IN O
44 CD O
degrees NNS O
C NN O
and CC O
a DT O
relative JJ O
humidity NN O
of IN O
20 CD O
% NN O
were VBD O
recorded VBN O
at IN O
the DT O
top NN O
of IN O
the DT O
liana NN O
, , O
whereas IN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
were VBD O
27 CD O
degrees NNS O
C NN O
and CC O
70 CD O
% NN O
, , O
respectively RB O
. . O

The DT O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
disappeared VBD O
at IN O
c NN O
. . O

22 CD O
. . O
0 NFP O
h NN O
. . O

Due IN O
to IN O
the DT O
dense JJ O
foliage NN O
of IN O
the DT O
plant NN O
above IN O
c NN O
. . O

7 CD O
m NN O
and CC O
due IN O
to IN O
light NN O
dimming VBG O
by IN O
the DT O
blinds NNS O
, , O
leaves NNS O
closer RBR O
to IN O
the DT O
ground NN O
only RB O
became VBD O
exposed VBN O
to IN O
direct JJ O
sunshine NN O
towards IN O
the DT O
early JJ O
afternoon NN O
. . O

In IN O
contrast NN O
to IN O
24 CD O
May NNP O
, , O
the DT O
following VBG O
day NN O
was VBD O
cloudy JJ O
until IN O
noon NN O
. . O

Thus RB O
, , O
leaves NNS O
in IN O
the DT O
upper JJ O
part NN O
of IN O
the DT O
liana NN O
became VBD O
fully RB O
exposed VBN O
to IN O
bright JJ O
sunshine NN O
first RB O
around IN O
14 CD O
. . O
0 CD O
h NN O
as IN O
indicated VBN O
by IN O
the DT O
rapid JJ O
increase NN O
in IN O
T NN O
and CC O
the DT O
corresponding VBG O
decrease NN O
of IN O
r NN O
. . O
h ADD O
. . O
above IN O
a DT O
height NN O
of IN O
6 CD O
m NN O
( , O
Fig NN O
. . O
2B NN O
, , O
C NN O
) -RRB- O
. . O

Despite IN O
the DT O
strongly RB O
delayed VBN O
exposure NN O
of IN O
the DT O
leaves NNS O
to IN O
sunshine NN O
, , O
comparable JJ O
maximum NN O
values NNS O
for IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
at IN O
the DT O
three CD O
measuring NN O
sites NNS O
, , O
as RB O
well RB O
as IN O
vertical JJ O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h LS O
. . O
of IN O
comparable JJ O
size NN O
, , O
were VBD O
measured VBN O
between IN O
15 CD O
. . O
30 CD O
h NN O
and CC O
16 CD O
. . O
30 CD O
h NN O
as IN O
on IN O
the DT O
day NN O
before RB O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

2 LS O
shows VBZ O
that IN O
the DT O
diurnal JJ O
changes NNS O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
at IN O
the DT O
three CD O
measuring NN O
sites NNS O
are VBP O
reflected VBN O
in IN O
corresponding VBG O
changes NNS O
of IN O
Pp NNP O
. . O

During IN O
the DT O
nights NNS O
the DT O
Pp NNP O
values NNS O
were VBD O
low JJ O
. . O

After IN O
sunrise NN O
at IN O
4 CD O
. . O
24 CD O
h NN O
the DT O
Pp NN O
values NNS O
remained VBD O
low JJ O
for IN O
further JJ O
4 CD O
- SYM O
5 CD O
h NN O
, , O
except IN O
at IN O
6 CD O
m NN O
height NN O
where WRB O
a DT O
slight JJ O
and CC O
continuous JJ O
increase NN O
in IN O
the DT O
Pp NNP O
values NNS O
was VBD O
very RB O
often RB O
recorded VBN O
. . O

After IN O
about RB O
9 CD O
. . O
0 NFP O
h NN O
the DT O
Pp NN O
values NNS O
increased VBD O
over IN O
the DT O
entire JJ O
height NN O
of IN O
the DT O
liana NN O
. . O

Peaking VBG O
of IN O
the DT O
Pp NNP O
values NNS O
occurred VBD O
between IN O
15 CD O
. . O
30 CD O
h CD O
and CC O
16 CD O
. . O
30 CD O
h NN O
at IN O
all DT O
heights NNS O
when WRB O
the DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
reached VBD O
maximum JJ O
values NNS O
. . O

Towards IN O
the DT O
evening NN O
the DT O
Pp NNP O
values NNS O
decreased VBD O
again RB O
in IN O
order NN O
to TO O
reach VB O
the DT O
original JJ O
low JJ O
values NNS O
at IN O
c NN O
. . O

22 CD O
. . O
0 NFP O
h NN O
. . O

Until IN O
peaking VBG O
in IN O
the DT O
afternoon NN O
, , O
more RBR O
or CC O
less RBR O
pronounced JJ O
fluctuations NNS O
of IN O
the DT O
Pp NNP O
values NNS O
were VBD O
seen VBN O
. . O

A DT O
part NN O
of IN O
these DT O
fluctuations NNS O
seemed VBD O
to TO O
be VB O
correlated VBN O
with IN O
changes NNS O
in IN O
the DT O
local JJ O
ambient JJ O
temperature NN O
, , O
relative JJ O
humidity NN O
and CC O
/ SYM O
or CC O
with IN O
a DT O
temporary JJ O
exposure NN O
of IN O
the DT O
clamped VBN O
leaflet NN O
to IN O
sunshine NN O
( , O
compare VB O
Fig NNP O
. . O
2A NN O
with IN O
Fig NNP O
. . O
2B NN O
, , O
C NNP O
) -RRB- O
. . O

However RB O
, , O
there EX O
was VBD O
also RB O
a DT O
considerable JJ O
number NN O
of IN O
fluctuations NNS O
which WDT O
could MD O
not RB O
be VB O
traced VBN O
back RB O
to IN O
changes NNS O
in IN O
the DT O
microclimate NN O
. . O

An DT O
example NN O
can MD O
be VB O
found VBN O
in IN O
Fig NNP O
. . O

2A NN O
( , O
arrow NN O
) -RRB- O
. . O

The DT O
peaking NN O
of IN O
the DT O
Pp NNP O
value NN O
measured VBN O
at IN O
a DT O
height NN O
of IN O
0 CD O
. . O
2 CD O
m NN O
around IN O
14 CD O
. . O
0 CD O
h NN O
is VBZ O
obviously RB O
not RB O
induced VBN O
by IN O
changes NNS O
in IN O
the DT O
local JJ O
temperature NN O
and CC O
relative JJ O
humidity NN O
or CC O
by IN O
exposure NN O
to IN O
sunshine NN O
. . O

Similar JJ O
diurnal JJ O
changes NNS O
in IN O
Pp NNP O
, , O
T NNP O
, , O
and CC O
r NN O
. . O
h -RRB- O
. . O
were VBD O
also RB O
found VBN O
for IN O
the DT O
4 CD O
. . O
5 CD O
m CD O
tall JJ O
liana NN O
in IN O
the DT O
backstage NN O
of IN O
the DT O
greenhouse NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Figure NN O
3 CD O
shows VBZ O
long JJ O
- HYPH O
term NN O
Pp NN O
, , O
T NN O
, , O
and CC O
r NN O
. . O
h ADD O
. . O
measurements NNS O
performed VBN O
at IN O
0 CD O
. . O
2 CD O
m NN O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
in IN O
late JJ O
summer NN O
2007 CD O
. . O

In IN O
contrast NN O
to IN O
the DT O
experimental JJ O
conditions NNS O
in IN O
late JJ O
spring NN O
( : O
Fig NNP O
. . O
2 CD O
) , O
the DT O
liana NN O
had VBD O
been VBN O
watered VBN O
only RB O
sporadically RB O
during IN O
the DT O
weeks NNS O
before IN O
the DT O
measurements NNS O
. . O

The DT O
soil NN O
was VBD O
extremely RB O
dry JJ O
and CC O
no DT O
guttation NN O
was VBD O
observed VBN O
at IN O
predawn NN O
, , O
even RB O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
performed VBN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
yielded VBD O
values NNS O
below IN O
250 CD O
kPa NNS O
at IN O
predawn NN O
. . O

Continuous JJ O
irrigation NN O
was VBD O
started VBN O
at IN O
10 CD O
. . O
0 CD O
h CD O
on IN O
28 CD O
August NNP O
( : O
c NN O
. . O
400 CD O
l SYM O
d CD O
- HYPH O
1 CD O
) -RRB- O
. . O

Guttation NN O
occurred VBD O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
, , O
but CC O
not RB O
at IN O
6 CD O
m NN O
height NN O
on IN O
1 CD O
September NNP O
. . O

At IN O
sunrise NN O
( , O
5 CD O
. . O
25 CD O
h NN O
) -RRB- O
, , O
turgor NN O
pressures NNS O
of IN O
c NN O
. . O

500 CD O
kPa NNP O
were VBD O
recorded VBN O
at IN O
the DT O
base NN O
of IN O
the DT O
liana NN O
. . O

Guttation NN O
at IN O
6 CD O
m NN O
height NN O
was VBD O
still RB O
not RB O
observed VBN O
on IN O
3 CD O
September NNP O
indicating VBG O
that IN O
the DT O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
was VBD O
still RB O
less JJR O
than IN O
in IN O
the DT O
last JJ O
week NN O
of IN O
May NNP O
. . O

The DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
profiles NNS O
during IN O
the DT O
end NN O
of IN O
summer NN O
were VBD O
also RB O
different JJ O
to IN O
those DT O
in IN O
late JJ O
spring NN O
( , O
compare VBP O
Fig NNP O
. . O
2B NN O
, , O
C NN O
with IN O
Fig NNP O
. . O
3B NN O
, , O
C NNP O
) -RRB- O
. . O

On IN O
28 CD O
August NNP O
when WRB O
irrigation NN O
started VBD O
it PRP O
was VBD O
sunny JJ O
. . O

Similarly RB O
to IN O
May NNP O
, , O
peak NN O
values NNS O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
were VBD O
reached VBN O
at IN O
c NN O
. . O

15 CD O
. . O
30 CD O
h NN O
. . O

However RB O
, , O
temperatures NNS O
at IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
did VBD O
not RB O
exceed VB O
35 CD O
degrees NNS O
C NN O
and CC O
r VB O
. . O
h UH O
. . O
did VBD O
not RB O
drop VB O
below IN O
40 CD O
% NN O
. . O

Accordingly RB O
, , O
the DT O
vertical JJ O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
were VBD O
smaller JJR O
than IN O
those DT O
measured VBN O
at IN O
the DT O
end NN O
of IN O
May NNP O
. . O

On IN O
29 CD O
August NNP O
, , O
when WRB O
it PRP O
became VBD O
very RB O
rainy JJ O
and CC O
light JJ O
irradiance NN O
dropped VBD O
dramatically RB O
, , O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h -RRB- O
. . O
of IN O
slightly RB O
decreased VBN O
size NN O
were VBD O
still RB O
recorded VBN O
. . O

Peaking VBG O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
occurred VBD O
at IN O
c NN O
. . O

14 CD O
. . O
30 CD O
h NN O
. . O

T NN O
and CC O
r NN O
. . O
h UH O
. . O
gradients NNS O
did VBD O
not RB O
develop VB O
in IN O
the DT O
following VBG O
three CD O
days NNS O
which WDT O
were VBD O
very RB O
cloudy JJ O
and CC O
rainy JJ O
. . O

An DT O
almost RB O
constant JJ O
temperature NN O
of IN O
c NN O
. . O

25 CD O
degrees NNS O
C NN O
and CC O
a DT O
relative JJ O
humidity NN O
of IN O
80 CD O
% NN O
were VBD O
measured VBN O
on IN O
the DT O
ground NN O
and CC O
at IN O
the DT O
top NN O
of IN O
the DT O
greenhouse NN O
throughout IN O
the DT O
day NN O
; , O
light JJ O
irradiance NN O
did VBD O
not RB O
exceed VB O
40 CD O
mu NNS O
mol NN O
photons NNS O
m SYM O
- HYPH O
2 CD O
s NN O
- HYPH O
1 CD O
. . O

Only RB O
on IN O
31 CD O
August NNP O
, , O
did VBD O
the DT O
rain NN O
stop VB O
and CC O
the DT O
upper JJ O
part NN O
of IN O
the DT O
liana NN O
was VBD O
exposed VBN O
to IN O
sunshine NN O
for IN O
1 CD O
- SYM O
2 CD O
h NN O
and CC O
thus RB O
small JJ O
T NN O
and CC O
r NN O
. . O
h LS O
. . O
gradients NNS O
developed VBN O
. . O

The DT O
following VBG O
days NNS O
of IN O
2 CD O
and CC O
3 CD O
September NNP O
were VBD O
partly RB O
cloudy JJ O
and CC O
sunny JJ O
and CC O
the DT O
peaking NN O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
occurred VBD O
at IN O
c NN O
. . O

13 CD O
. . O
0 NFP O
h NN O
. . O

The DT O
upper JJ O
, , O
but CC O
not RB O
the DT O
lower JJR O
part NN O
of IN O
the DT O
liana NN O
was VBD O
exposed VBN O
to IN O
sunshine NN O
for IN O
several JJ O
hours NNS O
. . O

This DT O
resulted VBD O
in IN O
the DT O
formation NN O
of IN O
T NN O
and CC O
r NN O
. . O
h UH O
. . O
gradients NNS O
. . O

The DT O
size NN O
of IN O
the DT O
gradients NNS O
was VBD O
similar JJ O
to IN O
that DT O
measured VBN O
on IN O
29 CD O
August NNP O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

3A NN O
indicates VBZ O
that IN O
peaking NN O
of IN O
the DT O
Pp NNP O
values NNS O
coincided VBD O
with IN O
peaking NN O
of IN O
r XX O
. . O
h ADD O
. . O
and CC O
T NN O
in IN O
Fig NN O
. . O

3B NN O
and CC O
C NN O
. . O

Figure NN O
3A NNP O
shows VBZ O
further RBR O
that IN O
the DT O
peak NN O
amplitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
recorded VBN O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
decreased VBD O
continuously RB O
from IN O
28 CD O
August NNP O
whereas IN O
the DT O
low JJ O
Pp NN O
values NNS O
at IN O
the DT O
nights NNS O
remained VBD O
unaltered JJ O
. . O

The DT O
peak NN O
amplitude NN O
measured VBN O
on IN O
29 CD O
August NNP O
was VBD O
only RB O
slightly RB O
lower JJR O
than IN O
that DT O
measured VBN O
on IN O
the DT O
day NN O
before RB O
, , O
the DT O
peak NN O
amplitude NN O
was VBD O
rather RB O
low JJ O
on IN O
30 CD O
August NNP O
. . O

It PRP O
remained VBD O
at IN O
this DT O
low JJ O
level NN O
until IN O
2 CD O
September NNP O
, , O
except IN O
that IN O
on IN O
31 CD O
August NNP O
the DT O
peak NN O
amplitude NN O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
increased VBD O
slightly RB O
, , O
presumably RB O
because IN O
of IN O
the DT O
short JJ O
- HYPH O
time NN O
exposure NN O
of IN O
the DT O
upper JJ O
leaves NNS O
to IN O
sun NN O
( , O
see VB O
above RB O
) -RRB- O
. . O

Comparison NN O
of IN O
the DT O
diurnal JJ O
changes NNS O
in IN O
the DT O
Pp NNP O
values NNS O
with IN O
the DT O
corresponding JJ O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
changes NNS O
in IN O
Fig NNP O
. . O

3B NN O
and CC O
C NN O
indicates VBZ O
that IN O
part NN O
of IN O
the DT O
changes NNS O
in IN O
the DT O
peak NN O
amplitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
were VBD O
induced VBN O
by IN O
changes NNS O
in IN O
the DT O
environmental JJ O
parameters NNS O
. . O

However RB O
, , O
part NN O
of IN O
the DT O
changes NNS O
must MD O
obviously RB O
be VB O
attributed VBN O
to IN O
irrigation NN O
. . O

This DT O
conclusion NN O
can MD O
be VB O
drawn VBN O
if IN O
, , O
for IN O
example NN O
, , O
the DT O
peaking NN O
of IN O
Pp NNP O
on IN O
2 CD O
and CC O
3 CD O
September NNP O
is VBZ O
compared VBN O
with IN O
the DT O
peaking NN O
of IN O
Pp NNP O
on IN O
29 CD O
August NNP O
. . O

Despite IN O
the DT O
comparable JJ O
size NN O
of IN O
the DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
, , O
the DT O
peak NN O
Pp NN O
values NNS O
were VBD O
much RB O
smaller JJR O
, , O
particularly RB O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
, , O
on IN O
2 CD O
and CC O
3 CD O
September NNP O
compared VBN O
with IN O
29 CD O
August NNP O
. . O

Plots NNS O
of IN O
the DT O
Pp NN O
values NNS O
measured VBN O
at IN O
6 CD O
m NN O
and CC O
10 CD O
m NN O
height NN O
on IN O
24 CD O
May NNP O
, , O
28 CD O
August NNP O
, , O
and CC O
2 CD O
September NNP O
against IN O
r NN O
. . O
h ADD O
. . O

( : O
or CC O
against IN O
T NNP O
since IN O
both DT O
parameters NNS O
were VBD O
usually RB O
closely RB O
related VBN O
) , O
also RB O
support VBP O
the DT O
view NN O
that IN O
the DT O
local JJ O
microclimate NN O
is VBZ O
not RB O
the DT O
only JJ O
factor NN O
which WDT O
determined VBD O
the DT O
magnitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
. . O

Figure NN O
4 CD O
shows VBZ O
that IN O
the DT O
Pp NN O
values NNS O
recorded VBN O
at IN O
6 CD O
m CD O
and CC O
10 CD O
m NN O
height NN O
increased VBN O
with IN O
decreasing VBG O
r NN O
. . O
h NFP O
. . O
from IN O
c NN O
. . O

9 CD O
. . O
0 NFP O
h NN O
until IN O
r UH O
. . O
h LS O
. . O
reached VBD O
the DT O
minimum JJ O
value NN O
( : O
and CC O
T NN O
the DT O
maximum JJ O
value NN O
, , O
respectively RB O
) -RRB- O
, , O
when WRB O
with IN O
the DT O
progression NN O
of IN O
the DT O
day NN O
r UH O
. . O
h LS O
. . O
increased VBN O
and CC O
T NN O
decreased VBD O
, , O
Pp NNP O
decreased VBD O
again RB O
. . O

This DT O
decrease NN O
was VBD O
much RB O
faster JJR O
than IN O
expected VBN O
in IN O
the DT O
light NN O
of IN O
the DT O
preceding VBG O
r NN O
. . O
h LS O
. . O
- HYPH O
induced VBN O
increase NN O
of IN O
Pp NNP O
if IN O
the DT O
plant NN O
was VBD O
well RB O
- HYPH O
watered VBN O
( : O
24 CD O
May NNP O
; : O
Fig NNP O
. . O
4A NN O
, , O
B NNP O
) -RRB- O
. . O

Refilling VBG O
of IN O
the DT O
leaf NN O
cells NNS O
was VBD O
apparently RB O
enhanced VBN O
by IN O
the DT O
high JJ O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
. . O

By IN O
contrast NN O
, , O
when WRB O
the DT O
liana NN O
had VBD O
not RB O
been VBN O
irrigated VBN O
well RB O
( : O
28 CD O
August NNP O
, , O
Fig NNP O
. . O
4C NNP O
, , O
D NNP O
) , O
both CC O
kinetics NNS O
of IN O
the DT O
changes NNS O
of IN O
Pp NNP O
with IN O
r XX O
. . O
h ADD O
. . O
were VBD O
comparable JJ O
. . O

The DT O
low JJ O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
apparently RB O
delayed VBD O
cell NN O
refilling NN O
. . O

After IN O
4 CD O
d NN O
irrigation NN O
( , O
2 CD O
September NNP O
) -RRB- O
, , O
the DT O
low JJ O
value NN O
of IN O
Pp NNP O
recovered VBD O
at IN O
relatively RB O
low JJ O
r NN O
. . O
h NFP O
. . O
as IN O
in IN O
May NNP O
at IN O
10 CD O
m NN O
height NN O
( : O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
but CC O
not RB O
at IN O
6 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4E CD O
) -RRB- O
. . O

Recovery NN O
of IN O
the DT O
low JJ O
Pp NN O
values NNS O
at IN O
this DT O
height NN O
occurred VBD O
, , O
however RB O
, , O
at IN O
significantly RB O
lower JJR O
r JJR O
. . O
h LS O
. . O
than IN O
on IN O
28 CD O
August NNP O
, , O
indicating VBG O
that IN O
rehydration NN O
of IN O
the DT O
leaves NNS O
at IN O
this DT O
height NN O
had VBD O
not RB O
been VBN O
completed VBN O
. . O

Evaluation NN O
of IN O
other JJ O
data NNS O
sets NNS O
yielded VBD O
similar JJ O
results NNS O
( , O
not RB O
shown VBN O
) NFP O
. . O

Patch NN O
clamp NN O
pressure NN O
versus IN O
cell NN O
turgor NN O
pressure NN O
measurements NNS O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
pressure NN O
transfer NN O
function NN O
of IN O
a DT O
defined VBN O
leaflet NN O
area NN O
. . O

The DT O
above JJ O
theoretical JJ O
considerations NNS O
have VBP O
shown VBN O
that IN O
the DT O
transfer NN O
function NN O
is VBZ O
mainly RB O
determined VBN O
by IN O
turgor NN O
pressure NN O
provided VBN O
that IN O
the DT O
structural JJ O
elements NNS O
do VBP O
not RB O
contribute VB O
or CC O
constantly RB O
contribute VB O
to IN O
the DT O
pressure NN O
signal NN O
transfer NN O
. . O

In IN O
order NN O
to TO O
prove VB O
the DT O
theory NN O
parallel JJ O
measurements NNS O
of IN O
leaf NN O
patch NN O
clamp NN O
pressure NN O
( , O
Pp NNP O
) -RRB- O
and CC O
cell NN O
turgor NN O
pressure NN O
( -LRB- O
Pc NN O
) -RRB- O
were VBD O
performed VBN O
on IN O
a DT O
leaflet NN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
( : O
Fig NNP O
. . O
5A NN O
) -RRB- O
. . O

Simultaneously RB O
, , O
the DT O
Pp NN O
values NNS O
were VBD O
recorded VBN O
at IN O
6 CD O
m NN O
and CC O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
5B NN O
, , O
C NNP O
) -RRB- O
. . O

Measurements NNS O
were VBD O
performed VBN O
after IN O
several JJ O
days NNS O
of IN O
irrigation NN O
. . O

In IN O
these DT O
experiments NNS O
, , O
the DT O
microcapillary NN O
of IN O
the DT O
turgor NN O
pressure NN O
probe NN O
was VBD O
inserted VBN O
into IN O
parenchymal JJ O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
on IN O
the DT O
abaxial JJ O
side NN O
of IN O
a DT O
leaflet NN O
, , O
i PRP O
. . O
e ADD O
. . O
c NN O
. . O

10 CD O
cm NNS O
away RB O
from IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
near IN O
the DT O
leaflet NN O
periphery NN O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
on IN O
leaf NN O
cells NNS O
of IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
were VBD O
difficult JJ O
to TO O
perform VB O
because IN O
of IN O
the DT O
presence NN O
of IN O
mucilage NN O
. . O

Mucilage NN O
resulted VBD O
in IN O
clogging NN O
of IN O
the DT O
tip NN O
of IN O
the DT O
microcapillary NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
. . O

For IN O
this DT O
reason NN O
, , O
measurements NNS O
with IN O
the DT O
Scholander NNP O
pressure NN O
chamber NN O
were VBD O
not RB O
very RB O
reliable JJ O
. . O

It PRP O
was VBD O
extremely RB O
difficult JJ O
to TO O
determine VB O
exactly RB O
the DT O
balancing VBG O
pressure NN O
at IN O
which WDT O
water NN O
appears VBZ O
at IN O
the DT O
cut VBN O
end NN O
of IN O
the DT O
petiole NN O
of IN O
the DT O
leaf NN O
. . O

In IN O
Fig NNP O
. . O

5A NN O
the DT O
average JJ O
turgor NN O
pressure NN O
values NNS O
are VBP O
plotted VBN O
which WDT O
were VBD O
calculated VBN O
from IN O
3 CD O
- SYM O
8 CD O
min NN O
long JJ O
measurements NNS O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

5A NNP O
- HYPH O
C NNP O
shows VBZ O
that IN O
Pc NNP O
exhibited VBD O
similar JJ O
diurnal JJ O
changes NNS O
as IN O
the DT O
Pp NN O
values NNS O
at IN O
0 CD O
. . O
2 CD O
m CD O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
. . O

Changes NNS O
in IN O
Pc NNP O
after IN O
sunrise NN O
preceded VBD O
changes NNS O
in IN O
Pp NNP O
, , O
most RBS O
likely JJ O
due IN O
to IN O
the DT O
different JJ O
measuring VBG O
sites NNS O
on IN O
the DT O
leaflets NNS O
. . O

After IN O
the DT O
onset NN O
of IN O
transpiration NN O
the DT O
loss NN O
of IN O
turgor NN O
pressure NN O
of IN O
cells NNS O
located VBN O
at IN O
the DT O
periphery NN O
of IN O
the DT O
leaflets NNS O
( , O
where WRB O
Pp NNP O
is VBZ O
recorded VBN O
) -RRB- O
is VBZ O
apparently RB O
immediately RB O
compensated VBN O
by IN O
water NN O
shifting NN O
from IN O
the DT O
xylem NN O
and CC O
the DT O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
( , O
where WRB O
Pc NNP O
is VBZ O
measured VBN O
) -RRB- O
. . O

Consistent JJ O
with IN O
this DT O
explanation NN O
, , O
towards IN O
the DT O
afternoon NN O
when WRB O
all DT O
cells NNS O
throughout IN O
the DT O
leaflets NNS O
exhibit VBP O
low JJ O
turgor NN O
pressure NN O
, , O
the DT O
increase NN O
in IN O
Pc NN O
and CC O
the DT O
decrease NN O
in IN O
Pp NNP O
occurred VBD O
nearly RB O
concomitantly RB O
. . O

Interestingly RB O
, , O
the DT O
delay NN O
between IN O
the DT O
response NN O
of IN O
Pc NNP O
and CC O
Pp NNP O
upon IN O
changes NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h UH O
. . O
in IN O
the DT O
early JJ O
morning NN O
hours NNS O
decreased VBD O
from IN O
about RB O
2 CD O
. . O
5 CD O
h NN O
at IN O
0 CD O
. . O
2 CD O
m CD O
height NN O
to IN O
1 CD O
. . O
5 CD O
h CD O
at IN O
6 CD O
m CD O
height NN O
, , O
and CC O
to IN O
1 CD O
h NN O
at IN O
10 CD O
m NN O
height NN O
. . O

In IN O
Fig NNP O
. . O

5D NN O
the DT O
Pp NN O
values NNS O
measured VBN O
at IN O
the DT O
three CD O
heights NNS O
are VBP O
plotted VBN O
against IN O
the DT O
corresponding JJ O
Pc NN O
values NNS O
( : O
i PRP O
. . O
e -RRB- O
. . O
neglecting VBG O
the DT O
delayed VBN O
response NN O
of IN O
Pp NNP O
) -RRB- O
. . O

The DT O
curves NNS O
could MD O
be VB O
fitted VBN O
quite RB O
well RB O
by IN O
equation NN O
8 CD O
. . O

Fitting VBG O
of IN O
the DT O
curves NNS O
required VBD O
the DT O
assumption NN O
of IN O
different JJ O
values NNS O
for IN O
the DT O
constants NNS O
a DT O
and CC O
b NN O
in IN O
equation NN O
4 CD O
( , O
see VB O
legend NN O
to IN O
Fig NNP O
. . O
5 CD O
) -RRB- O
indicating VBG O
that IN O
the DT O
elastic JJ O
properties NNS O
of IN O
the DT O
leaves NNS O
were VBD O
different JJ O
, , O
presumably RB O
due IN O
to IN O
changes NNS O
of IN O
the DT O
ambient JJ O
temperature NN O
with IN O
height NN O
( , O
see VB O
above RB O
) -RRB- O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
at IN O
5 CD O
m NN O
height NN O
failed VBD O
because IN O
of IN O
abundant JJ O
mucilage NN O
in IN O
the DT O
leaflet NN O
tissue NN O
at IN O
this DT O
time NN O
of IN O
the DT O
year NN O
. . O

Mucilage NN O
in IN O
the DT O
cells NNS O
and CC O
xylem NN O
vessels NNS O
was VBD O
less RBR O
abundant JJ O
when WRB O
turgor NN O
pressure NN O
measurements NNS O
were VBD O
performed VBN O
during IN O
the DT O
summer NN O
of IN O
1999 CD O
. . O

Plot NN O
of IN O
the DT O
Pc NNP O
data NNS O
measured VBN O
by IN O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
at IN O
5 CD O
m NN O
height NN O
against IN O
online JJ O
recordings NNS O
of IN O
Pp NNP O
in IN O
May NNP O
2007 CD O
revealed VBD O
very RB O
good JJ O
agreement NN O
between IN O
both DT O
parameters NNS O
, , O
even RB O
though IN O
the DT O
microcapillary NN O
was VBD O
inserted VBN O
into IN O
cells NNS O
located VBN O
on IN O
the DT O
upper JJ O
leaflet NN O
surface NN O
between IN O
the DT O
main JJ O
vein NN O
and CC O
the DT O
leaflet NN O
edge NN O
( , O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

On IN O
both DT O
measuring VBG O
days NNS O
in IN O
1999 CD O
and CC O
2007 CD O
, , O
similar JJ O
environmental JJ O
conditions NNS O
existed VBD O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

6 CD O
shows VBZ O
that IN O
Pp NNP O
measured VBN O
at IN O
6 CD O
m CD O
height NN O
was VBD O
delayed VBN O
by IN O
c NN O
. . O

1 LS O
. . O
5 CD O
h NN O
. . O

A DT O
plot NN O
of IN O
the DT O
Pp NNP O
values NNS O
against IN O
the DT O
Pc NNP O
values NNS O
according VBG O
to IN O
Fig NNP O
. . O

5D NN O
could MD O
also RB O
be VB O
fitted VBN O
very RB O
well RB O
by IN O
equation NN O
8 CD O
( , O
see VB O
inset NN O
of IN O
Fig NNP O
. . O
6 CD O
) -RRB- O
indicating VBG O
the DT O
validity NN O
of IN O
equation NN O
8 CD O
to TO O
describe VB O
properly RB O
the DT O
relationship NN O
between IN O
Pp NNP O
and CC O
Pc NNP O
. . O

Discussion NN O

The DT O
results NNS O
presented VBN O
here RB O
demonstrate VBP O
that IN O
the DT O
novel JJ O
patch NN O
clamp NN O
pressure NN O
probe NN O
is VBZ O
a DT O
very RB O
sensitive JJ O
, , O
versatile JJ O
, , O
and CC O
easy JJ O
- HYPH O
to TO O
- HYPH O
handle VB O
plant NN O
- HYPH O
based VBN O
tool NN O
for IN O
online JJ O
monitoring NN O
of IN O
the DT O
effects NNS O
of IN O
evapotranspiration NN O
and CC O
/ SYM O
or CC O
of IN O
irrigation NN O
regimes NNS O
on IN O
the DT O
water NN O
relations NNS O
of IN O
leaves NNS O
( : O
Figs NNP O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

The DT O
probe NN O
measures VBZ O
the DT O
output NN O
signal NN O
upon IN O
application NN O
of IN O
a DT O
constantly RB O
clamped VBN O
pressure NN O
, , O
i LS O
. . O
e LS O
. . O
the DT O
pressure NN O
transfer NN O
function NN O
of IN O
leaf NN O
patches NNS O
. . O

Since IN O
the DT O
application NN O
of IN O
the DT O
probe NN O
is VBZ O
not RB O
restricted VBN O
to IN O
special JJ O
leaves NNS O
, , O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
will MD O
readily RB O
show VB O
which WDT O
crop NN O
varieties NNS O
can MD O
be VB O
grown VBN O
with IN O
the DT O
least JJS O
water NN O
for IN O
the DT O
most JJS O
yield NN O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
demonstated VBN O
here RB O
that IN O
the DT O
plant NN O
- HYPH O
based VBN O
data NNS O
can MD O
be VB O
sent VBN O
by IN O
small JJ O
telemetric JJ O
units NNS O
connected VBN O
to IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probes NNS O
to IN O
a DT O
receiver NN O
base NN O
station NN O
which WDT O
logs VBZ O
and CC O
stores VBZ O
the DT O
data NNS O
pending VBG O
transfer NN O
to IN O
a DT O
GPRS NNP O
modem NN O
linked VBN O
to IN O
an DT O
Internet NN O
server NN O
. . O

The DT O
telemetric JJ O
systems NNS O
operated VBD O
faultlessly RB O
. . O

This DT O
is VBZ O
a DT O
very RB O
important JJ O
result NN O
because IN O
there EX O
is VBZ O
agreement NN O
between IN O
scientists NNS O
and CC O
growers NNS O
( , O
Jones NNP O
, , O
2004 CD O
) : O
that IN O
control NN O
of IN O
irrigation NN O
must MD O
be VB O
tied VBN O
to IN O
remote JJ O
sensing NN O
devices NNS O
in IN O
order NN O
to TO O
reduce VB O
manpower NN O
and CC O
to TO O
conserve VB O
water NN O
. . O

The DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
technique NN O
introduced VBN O
here RB O
meets VBZ O
these DT O
demands NNS O
. . O

A DT O
further JJ O
advantage NN O
is VBZ O
that IN O
the DT O
probe NN O
is VBZ O
cheap JJ O
and CC O
easy JJ O
to TO O
handle VB O
. . O

Some DT O
care NN O
is VBZ O
required VBN O
only RB O
when WRB O
clamping VBG O
the DT O
leaf NN O
. . O

Leaves NNS O
must MD O
be VB O
clean JJ O
and CC O
any DT O
rough JJ O
surface NN O
topography NN O
must MD O
be VB O
avoided VBN O
. . O

This DT O
implies VBZ O
that IN O
the DT O
dimensions NNS O
of IN O
the DT O
pads NNS O
of IN O
the DT O
spring NN O
clamp NN O
must MD O
be VB O
adjusted VBN O
to IN O
the DT O
size NN O
of IN O
the DT O
intercostal JJ O
area NN O
since IN O
non JJ O
- HYPH O
uniform JJ O
contact NN O
between IN O
leaf NN O
surface NN O
and CC O
pads NNS O
lowered VBD O
the DT O
output NN O
pressure NN O
signal NN O
. . O

Experience NN O
collected VBN O
with IN O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
on IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
and CC O
on IN O
preliminary JJ O
results NNS O
of IN O
other JJ O
plants NNS O
( , O
e LS O
. . O
g LS O
. . O
grapevines NNS O
, , O
bananas NNS B-Species
, , O
Eucalyptus NNP O
, , O
and CC O
Arabidopsis NNP O
) , O
showed VBD O
that IN O
a DT O
smooth JJ O
intercostal JJ O
leaf NN O
area NN O
for IN O
clamping NN O
can MD O
readily RB O
be VB O
found VBN O
. . O

Equally RB O
, , O
optimum JJ O
values NNS O
for IN O
the DT O
clamp NN O
pressure NN O
can MD O
also RB O
be VB O
relatively RB O
quickly RB O
selected VBN O
empirically RB O
if IN O
the DT O
guidelines NNS O
mentioned VBN O
above RB O
are VBP O
followed VBN O
. . O

For IN O
many JJ O
purposes NNS O
calibration NN O
of IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
against IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
is VBZ O
not RB O
stringent JJ O
. . O

It PRP O
may MD O
be VB O
sufficient JJ O
to TO O
know VB O
that IN O
the DT O
transfer NN O
function NN O
assumes VBZ O
small JJ O
values NNS O
at IN O
full JJ O
turgescence NN O
and CC O
is VBZ O
nearly RB O
unity NN O
at IN O
low JJ O
turgescence NN O
. . O

However RB O
, , O
for IN O
scientific JJ O
reasons NNS O
and CC O
for IN O
the DT O
application NN O
of IN O
the DT O
probe NN O
in IN O
basic JJ O
research NN O
, , O
the DT O
dependency NN O
of IN O
the DT O
transfer NN O
function NN O
on IN O
cell NN O
turgor NN O
pressure NN O
might MD O
be VB O
of IN O
great JJ O
interest NN O
. . O

The DT O
theoretical JJ O
considerations NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
relationship NN O
between IN O
the DT O
transfer NN O
function NN O
and CC O
the DT O
turgor NN O
pressure NN O
can MD O
obviously RB O
be VB O
described VBN O
by IN O
equation NN O
8 CD O
, , O
i PRP O
. . O
e LS O
. . O
by IN O
a DT O
power NN O
function NN O
. . O

Concomitant JJ O
measurements NNS O
of IN O
turgor NN O
pressure NN O
and CC O
patch NN O
clamp NN O
pressure NN O
have VBP O
confirmed VBN O
the DT O
theoretical JJ O
considerations NNS O
( : O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

Analogous JJ O
recordings NNS O
of IN O
turgor NN O
pressure NN O
and CC O
patch NN O
clamp NN O
pressure NN O
on IN O
grapevines NNS O
, , O
bananas NNS B-Species
, , O
and CC O
Eucalyptus NNP B-Species
trees NNS O
also RB O
yielded VBD O
results NNS O
( , O
D NNP O
Zimmermann NNP O
, , O
unpublished JJ O
results NNS O
) , O
which WDT O
were VBD O
consistent JJ O
with IN O
the DT O
predictions NNS O
of IN O
equation NN O
8 CD O
. . O

Patch NN O
clamp NN O
pressure NN O
measurements NNS O
allow VBP O
, , O
therefore RB O
, , O
calculation NN O
of IN O
turgor NN O
pressures NNS O
if IN O
the DT O
constants NNS O
a DT O
and CC O
b VBP O
defined VBN O
by IN O
equation NN O
4 CD O
are VBP O
known VBN O
. . O

These DT O
parameters NNS O
can MD O
be VB O
obtained VBN O
by IN O
numerical JJ O
fitting NN O
of IN O
Pp NNP O
versus IN O
Pc NNP O
curves NNS O
. . O

Online JJ O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
open VBP O
up RP O
new JJ O
possibilities NNS O
to TO O
unravel VB O
the DT O
hydraulic JJ O
communication NN O
among IN O
leaves NNS O
, , O
including VBG O
tall JJ O
trees NNS O
. . O

It PRP O
is VBZ O
shown VBN O
here RB O
that IN O
the DT O
patch NN O
clamp NN O
pressure NN O
can MD O
simultaneously RB O
be VB O
monitored VBN O
in IN O
shaded VBN O
or CC O
sun NN O
- HYPH O
exposed VBN O
leaflets NNS O
at IN O
different JJ O
heights NNS O
under IN O
greenhouse NN O
conditions NNS O
by IN O
using VBG O
several JJ O
probes NNS O
. . O

It PRP O
was VBD O
even RB O
possible JJ O
to TO O
measure VB O
the DT O
turgor NN O
pressure NN O
at IN O
different JJ O
sites NNS O
on IN O
the DT O
leaf NN O
. . O

Therefore RB O
, , O
water NN O
shifting VBG O
between IN O
leaf NN O
cells NNS O
via IN O
the DT O
apoplastic JJ O
and CC O
symplastic JJ O
pathways NNS O
can MD O
be VB O
studied VBN O
. . O

Physically RB O
sound JJ O
theories NNS O
are VBP O
available JJ O
( : O
Molz NNP O
and CC O
Ikenberry NNP O
, , O
1974 CD O
; : O
Molz NNP O
et FW O
al NNP O
. . O
, , O
1979 CD O
) -RRB- O
, , O
but CC O
experimental JJ O
facts NNS O
are VBP O
not RB O
available JJ O
or CC O
are VBP O
mainly RB O
based VBN O
on IN O
speculations NNS O
( , O
Steudle NNP O
and CC O
French NNP O
, , O
1996 CD O
) -RRB- O
. . O

The DT O
first JJ O
evidence NN O
for IN O
the DT O
dynamics NNS O
of IN O
the DT O
hydraulic JJ O
communication NN O
between IN O
leaflets NNS O
at IN O
different JJ O
height NN O
and CC O
within IN O
leaflets NNS O
is VBZ O
given VBN O
here RB O
. . O

Th IN O
u NNP O
rmer FW O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
have VBP O
shown VBN O
by IN O
using VBG O
the DT O
xylem NN O
and CC O
turgor NN O
pressure NN O
probe NN O
that IN O
the DT O
decrease NN O
in IN O
local JJ O
xylem NN O
pressure NN O
after IN O
daybreak NN O
from IN O
positive JJ O
, , O
sub NN O
- HYPH O
atmospheric JJ O
or CC O
slightly RB O
above IN O
- HYPH O
atmospheric JJ O
values NNS O
to IN O
negative JJ O
values NNS O
was VBD O
associated VBN O
with IN O
an DT O
almost RB O
1 CD O
: SYM O
1 CD O
decrease NN O
in IN O
turgor NN O
pressure NN O
of IN O
the DT O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
of IN O
the DT O
leaflets NNS O
( , O
see VB O
also RB O
Zimmermann NNP O
et NN O
al NNP O
. . O
, , O
2004 CD O
) -RRB- O
. . O

Similarly RB O
, , O
in IN O
the DT O
afternoon NN O
, , O
the DT O
increase NN O
of IN O
xylem NN O
pressure NN O
in IN O
non NN O
- HYPH O
cavitated VBN O
vessels NNS O
towards IN O
more JJR O
positive JJ O
values NNS O
correlated VBD O
with IN O
a DT O
1 CD O
: SYM O
1 CD O
increase NN O
in IN O
cell NN O
turgor NN O
pressure NN O
. . O

Obviously RB O
, , O
changes NNS O
in IN O
transpiration NN O
resulted VBD O
in IN O
a DT O
very RB O
rapid JJ O
establishment NN O
of IN O
a DT O
new JJ O
local JJ O
water NN O
equilibrium NN O
state NN O
between IN O
the DT O
xylem NN O
and CC O
the DT O
turgor NN O
pressure NN O
of IN O
the DT O
adjacent JJ O
cells NNS O
. . O

The DT O
turgor NN O
pressure NN O
measurements NNS O
of IN O
Th NNP O
u NNP O
rmer FW O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
were VBD O
performed VBN O
at IN O
1 CD O
m CD O
and CC O
5 CD O
m NN O
height NN O
. . O

No DT O
significant JJ O
differences NNS O
in IN O
the DT O
turgor NN O
pressure NN O
values NNS O
were VBD O
found VBN O
over IN O
the DT O
day NN O
. . O

The DT O
turgor NN O
pressure NN O
measurements NNS O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
reported VBN O
here RB O
confirmed VBD O
the DT O
finding NN O
of IN O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) : O
that IN O
the DT O
turgor NN O
pressure NN O
in IN O
the DT O
cells NNS O
located VBN O
near IN O
the DT O
main JJ O
vein NN O
dropped VBD O
immediately RB O
upon IN O
daybreak NN O
. . O

However RB O
, , O
our PRP$ O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
at IN O
the DT O
periphery NN O
of IN O
the DT O
leaflets NNS O
imply VBP O
that IN O
the DT O
turgor NN O
pressure NN O
of IN O
these DT O
cells NNS O
apparently RB O
had VBD O
a DT O
significantly RB O
delayed VBN O
response NN O
upon IN O
the DT O
onset NN O
of IN O
transpiration NN O
. . O

This DT O
finding NN O
can MD O
be VB O
taken VBN O
as IN O
evidence NN O
that IN O
turgor NN O
pressure NN O
gradients NNS O
are VBP O
temporarily RB O
generated VBN O
within IN O
the DT O
leaf NN O
during IN O
the DT O
early JJ O
morning NN O
hours NNS O
. . O

This DT O
delay NN O
in IN O
the DT O
response NN O
of IN O
patch NN O
clamp NN O
pressure NN O
after IN O
daybreak NN O
was VBD O
c NN O
. . O

1 CD O
h NN O
for IN O
leaves NNS O
at IN O
the DT O
top NN O
, , O
but CC O
c NN O
. . O

2 LS O
. . O
5 CD O
h NN O
for IN O
leaves NNS O
at IN O
the DT O
base NN O
. . O

The DT O
data NNS O
suggest VBP O
that IN O
with IN O
progression NN O
of IN O
the DT O
day NN O
the DT O
gradients NNS O
collapsed VBD O
first RB O
at IN O
the DT O
top NN O
of IN O
the DT O
liana NN O
, , O
where WRB O
transpiration NN O
was VBD O
high JJ O
, , O
before IN O
it PRP O
occurred VBD O
in IN O
leaves NNS O
further RBR O
down RB O
. . O

During IN O
the DT O
afternoon NN O
hours NNS O
the DT O
increase NN O
in IN O
the DT O
turgor NN O
pressure NN O
values NNS O
measured VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
coincided VBN O
with IN O
the DT O
values NNS O
measured VBN O
by IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

The DT O
unbalanced JJ O
osmotic JJ O
pressure NN O
throughout IN O
the DT O
leaflets NNS O
obviously RB O
favoured VBD O
simultaneous JJ O
turgor NN O
pressure NN O
regeneration NN O
in IN O
all DT O
leaflet NN O
cells NNS O
. . O

The DT O
process NN O
seemed VBD O
to TO O
be VB O
very RB O
similar JJ O
to IN O
the DT O
refilling NN O
of IN O
the DT O
cells NNS O
of IN O
the DT O
resurrection NN O
plant NN O
Myrothamnus NNP B-Species
flabellifolia NNP I-Species
with IN O
water NN O
after IN O
desiccation NN O
( , O
Wagner NNP O
et FW O
al NNP O
. . O
, , O
2000 CD O
) -RRB- O
. . O

Uniform JJ O
radial JJ O
refilling NN O
of IN O
cells NNS O
with IN O
water NN O
in IN O
this DT O
species NN O
is VBZ O
also RB O
driven VBN O
by IN O
the DT O
unbalanced JJ O
osmotic JJ O
pressure NN O
throughout IN O
the DT O
tissue NN O
. . O

As IN O
indicated VBN O
by IN O
Fig NNP O
. . O

4A NN O
and CC O
B NN O
, , O
restoration NN O
of IN O
full JJ O
turgescence NN O
in IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
was VBD O
faster JJR O
than IN O
the DT O
preceding VBG O
turgor NN O
pressure NN O
loss NN O
if IN O
the DT O
lianas NNS O
were VBD O
well RB O
- HYPH O
watered JJ O
. . O

By IN O
contrast NN O
, , O
limitations NNS O
in IN O
water NN O
supply NN O
resulted VBD O
in IN O
the DT O
coincidence NN O
of IN O
the DT O
phases NNS O
of IN O
turgor NN O
pressure NN O
loss NN O
and CC O
regeneration NN O
. . O

Interestingly RB O
, , O
watering NN O
of IN O
the DT O
lianas NNS O
after IN O
non JJ O
- HYPH O
irrigation NN O
seemed VBD O
to TO O
lead VB O
preferentially RB O
to IN O
water NN O
shifting VBG O
to IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
, , O
because IN O
, , O
after IN O
3 CD O
d NN O
of IN O
irrigation NN O
, , O
turgor NN O
pressure NN O
regeneration NN O
during IN O
the DT O
afternoon NN O
was VBD O
very RB O
fast JJ O
again RB O
at IN O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
but CC O
not RB O
at IN O
5 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4E CD O
) -RRB- O
. . O

Rapid JJ O
water NN O
movement NN O
to IN O
the DT O
top NN O
is VBZ O
expected VBN O
if IN O
hydrostatic JJ O
pressure NN O
, , O
osmotic JJ O
pressure NN O
, , O
and CC O
/ SYM O
or CC O
gel NN O
- HYPH O
based VBN O
gradients NNS O
throughout IN O
the DT O
vessels NNS O
exist VBP O
or CC O
are VBP O
generated VBN O
rapidly RB O
in IN O
the DT O
afternoon NN O
when WRB O
cavitation NN O
has VBZ O
occurred VBN O
. . O

This DT O
was VBD O
demonstrated VBN O
by IN O
Benkert NNP O
et FW O
al NNP O
. . O

( -LRB- O
1995 CD O
) -RRB- O
and CC O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
by IN O
using VBG O
the DT O
xylem NN O
pressure NN O
probe NN O
. . O

Continuous JJ O
xylem NN O
pressure NN O
gradients NNS O
during IN O
the DT O
morning NN O
hours NNS O
can MD O
also RB O
explain VB O
why WRB O
changes NNS O
in IN O
Pp NNP O
at IN O
lower JJR O
heights NNS O
were VBD O
frequently RB O
found VBN O
which WDT O
could MD O
not RB O
be VB O
correlated VBN O
with IN O
changes NNS O
in IN O
local JJ O
temperature NN O
or CC O
relative JJ O
humidity NN O
. . O

Water NN O
loss NN O
at IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
induces VBZ O
a DT O
drop NN O
in IN O
xylem NN O
pressure NN O
which WDT O
is VBZ O
transferred VBN O
rapidly RB O
to IN O
the DT O
basal JJ O
leaves NNS O
where WRB O
it PRP O
induces VBZ O
a DT O
temporary JJ O
turgor NN O
pressure NN O
loss NN O
that WDT O
is VBZ O
soon RB O
compensated VBN O
by IN O
water NN O
uptake NN O
from IN O
the DT O
roots NNS O
( , O
arrow NN O
in IN O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Even RB O
though IN O
more JJR O
work NN O
is VBZ O
required VBN O
, , O
the DT O
present JJ O
study NN O
shows VBZ O
that IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
is VBZ O
a DT O
promising JJ O
tool NN O
to TO O
elucidate VB O
short JJ O
- HYPH O
and CC O
long JJ O
- HYPH O
distance NN O
water NN O
transport NN O
in IN O
T NNP B-Species
. . I-Species
voinierianum NN I-Species
and CC O
other JJ O
plants NNS O
. . O

CHEK2 NN O
Mutations NNS O
Affecting VBG O
Kinase NN O
Activity NN O
Together RB O
With IN O
Mutations NNS O
in IN O
TP53 NN O
Indicate VBP O
a DT O
Functional JJ O
Pathway NN O
Associated VBN O
with IN O
Resistance NN O
to IN O
Epirubicin NN O
in IN O
Primary JJ O
Breast NN O
Cancer NN O

Abstract JJ O

Background NN O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cure NN O
in IN O
most JJS O
malignant JJ O
diseases NNS O
. . O

Anthracyclines NNS O
are VBP O
among IN O
the DT O
main JJ O
drugs NNS O
used VBN O
for IN O
breast NN O
cancer NN O
therapy NN O
and CC O
in IN O
many JJ O
other JJ O
malignant JJ O
conditions NNS O
. . O

Single JJ O
parameter NN O
analysis NN O
or CC O
global JJ O
gene NN O
expression NN O
profiles NNS O
have VBP O
failed VBN O
to TO O
identify VB O
mechanisms NNS O
causing VBG O
in IN O
vivo NN O
resistance NN O
to IN O
anthracyclines NNS O
. . O

While IN O
we PRP O
previously RB O
found VBD O
TP53 NNP O
mutations NNS O
in IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
, , O
some DT O
tumors NNS O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NN O
were VBD O
also RB O
therapy NN O
resistant JJ O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
; : O
1 LS O
) -RRB- O
To TO O
explore VB O
alterations NNS O
in IN O
the DT O
TP53 NN O
gene NN O
with IN O
respect NN O
to IN O
resistance NN O
to IN O
a DT O
regular JJ O
dose NN O
epirubicin NN O
regimen NN O
( , O
90 CD O
mg NN O
/ SYM O
m2 CD O
every DT O
3 CD O
week NN O
) , O
in IN O
patients NNS B-Species
with IN O
primary JJ O
, , O
locally RB O
advanced JJ O
breast NN O
cancer NN O
; : O
2 CD O
) SYM O
Identify VB O
critical JJ O
mechanisms NNS O
activating VBG O
p53 NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
in IN O
breast NN O
cancer NN O
; : O
3 LS O
) -RRB- O
Evaluate VB O
in IN O
vitro FW O
function NN O
of IN O
Chk2 NNP O
and CC O
p14 NN O
proteins NNS O
corresponding VBG O
to IN O
identified VBN O
mutations NNS O
in IN O
the DT O
CHEK2 NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
genes NNS O
; : O
and CC O
4 LS O
) -RRB- O
Explore VB O
potential JJ O
CHEK2 NN O
or CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
germline NN O
mutations NNS O
with IN O
respect NN O
to IN O
family NN O
cancer NN O
incidence NN O
. . O

Methods NNS O
and CC O
Findings NNS O

Snap VB O
- HYPH O
frozen VBN O
biopsies NNS O
from IN O
109 CD O
patients NNS B-Species
collected VBN O
prior RB O
to IN O
epirubicin NN O
( , O
as IN O
preoperative JJ O
therapy NN O
were VBD O
investigated VBN O
for IN O
TP53 NNP O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
mutations NNS O
by IN O
sequencing VBG O
the DT O
coding VBG O
region NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
promoter NN O
methylations NNS O
. . O

TP53 NN O
mutastions NNS O
were VBD O
associated VBN O
with IN O
chemoresistance NN O
, , O
defined VBN O
as IN O
progressive JJ O
disease NN O
on IN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
358 CD O
; : O
p NN O
= SYM O
0 CD O
. . O
136 CD O
for IN O
mutations NNS O
affecting VBG O
p53 NN O
loop NN O
domains NNS O
L2 NNP O
/ SYM O
L3 NNP O
) -RRB- O
. . O

Germline NNP O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
3 CD O
) -RRB- O
were VBD O
associated VBN O
with IN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
226 CD O
) -RRB- O
. . O

Combined VBN O
, , O
mutations NNS O
affecting VBG O
either CC O
CHEK2 NNP O
or CC O
TP53 NN O
strongly RB O
predicted VBN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
101 CD O
; : O
TP53 NN O
mutations NNS O
restricted VBN O
to IN O
the DT O
L2 NN O
/ SYM O
L3 CD O
domains NNS O
: : O
p NN O
= SYM O
0 CD O
. . O
32 CD O
) -RRB- O
. . O

Two CD O
patients NNS B-Species
progressing VBG O
on IN O
therapy NN O
harbored VBD O
the DT O
CHEK2 NNP O
mutation NN O
, , O
Arg95Ter NNP O
, , O
completely RB O
abrogating VBG O
Chk2 NNP O
protein NN O
dimerization NN O
and CC O
kinase NN O
activity NN O
. . O

One CD O
patient NN B-Species
( -LRB- O
Epi132 NNP O
) -RRB- O
revealed VBD O
family NN O
cancer NN O
occurrence NN O
resembling VBG O
families NNS O
harboring VBG O
CHEK2 NNP O
mutations NNS O
in IN O
general JJ O
, , O
the DT O
other JJ O
patient NN B-Species
( , O
epi203 CD O
) -RRB- O
was VBD O
non RB O
- HYPH O
conclusive JJ O
. . O

No DT O
mutation NN O
or CC O
promoter NN O
hypermethylation NN O
in IN O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
were VBD O
detected VBN O
. . O

Conclusion NN O

This DT O
study NN O
is VBZ O
the DT O
first JJ O
reporting VBG O
an DT O
association NN O
between IN O
CHEK2 NNP O
mutations NNS O
and CC O
therapy NN O
resistance NN O
in IN O
human JJ B-Species
cancers NNS O
and CC O
to TO O
document VB O
mutations NNS O
in IN O
two CD O
genes NNS O
acting VBG O
direct RB O
up IN O
/ SYM O
down RB O
- HYPH O
stream NN O
to IN O
each DT O
other JJ O
to TO O
cause VB O
therapy NN O
failure NN O
, , O
emphasizing VBG O
the DT O
need NN O
to TO O
investigate VB O
functional JJ O
cascades NNS O
in IN O
future JJ O
studies NNS O
. . O

Introduction NN O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cure NN O
in IN O
most JJS O
malignancies NNS O
, , O
including VBG O
breast NN O
cancer NN O
. . O

While IN O
adjuvant JJ O
chemotherapy NN O
may MD O
reduce VB O
the DT O
hazard NN O
rate NN O
of IN O
relapse NN O
by IN O
about RB O
one CD O
third NN O
in IN O
breast NN O
cancer NN O
patients NNS B-Species
[ -LRB- O
1 CD O
] -RRB- O
, , O
the DT O
majority NN O
among IN O
patients NNS B-Species
harboring VBG O
micro NN O
- HYPH O
metastases NNS O
are VBP O
not RB O
cured VBN O
by IN O
today NN O
' POS O
s NN O
standards NNS O
. . O

Considering VBG O
patients NNS B-Species
harboring VBG O
distant JJ O
metastases NNS O
, , O
resistance NN O
and CC O
therapy NN O
failure NN O
inevitably RB O
occurs VBZ O
, , O
in IN O
general JJ O
over IN O
a DT O
time NN O
period NN O
of IN O
less JJR O
than IN O
one CD O
year NN O
for IN O
each DT O
individual JJ O
regimen NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Despite IN O
extensive JJ O
experimental JJ O
research NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
little JJ O
data NNS O
are VBP O
available JJ O
considering VBG O
chemoresistance NN O
in IN O
vivo NN O
. . O

For IN O
anthracycline NN O
therapy NN O
in IN O
breast NN O
cancer NN O
, , O
topoisomerase NN O
- HYPH O
II NN O
amplifications NNS O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
dose NN O
- HYPH O
responsiveness NN O
different JJ O
from IN O
what WP O
is VBZ O
observed VBN O
in IN O
non NN O
- HYPH O
amplified VBN O
tumors NNS O
4 CD O
, , O
5 CD O
. . O

Several JJ O
studies NNS O
have VBP O
tried VBN O
to TO O
generate VB O
"""" `` O
prediction NN O
profiles NNS O
"""" '' O
based VBN O
on IN O
gene NN O
expression NN O
microarrays NNS O
[ -LRB- O
6 CD O
] -RRB- O
, , O
[ -LRB- O
7 CD O
] -RRB- O
, , O
[ -LRB- O
8 CD O
] -RRB- O
, , O
however RB O
, , O
none NN O
of IN O
the DT O
different JJ O
profiles NNS O
generated VBN O
expressed VBN O
a DT O
sensitivity NN O
suitable JJ O
for IN O
clinical JJ O
applications NNS O
, , O
or CC O
have VBP O
been VBN O
successfully RB O
reproduced VBN O
by IN O
others NNS O
( , O
see VB O
references NNS O
to IN O
original JJ O
works NNS O
in IN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

p53 NN O
( , O
the DT O
protein NN O
encoded VBN O
by IN O
the DT O
TP53 NN O
gene NN O
) -RRB- O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
executing VBG O
DNA NN O
- HYPH O
damage NN O
induced VBN O
apoptosis NN O
and CC O
growth NN O
arrest NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Previously RB O
, , O
our PRP$ O
group NN O
reported VBD O
mutations NNS O
in IN O
the DT O
zink NN O
- HYPH O
binding VBG O
domains NNS O
L2 NNP O
( , O
codons NNS O
163 CD O
- SYM O
195 CD O
) -RRB- O
and CC O
L3 NNP O
( , O
codons NNS O
236 CD O
- HYPH O
251 CD O
) -RRB- O
of IN O
p53 NN O
critical JJ O
to IN O
DNA NN O
binding NN O
[ -LRB- O
12 CD O
] -RRB- O
to TO O
be VB O
associated VBN O
with IN O
but CC O
not RB O
fully RB O
predictive JJ O
for IN O
resistance NN O
to IN O
chemotherapy NN O
with IN O
a DT O
low JJ O
- HYPH O
dose NN O
weekly JJ O
anthracycline NN O
[ -LRB- O
13 CD O
] -RRB- O
or CC O
a DT O
mitomycin NN O
plus CC O
5 CD O
- HYPH O
fluoro NN O
- HYPH O
uracil NN O
containing VBG O
[ -LRB- O
14 CD O
] -RRB- O
regimen NN O
. . O

Similar JJ O
findings NNS O
were VBD O
reported VBN O
by IN O
another DT O
group NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
others NNS O
reported VBD O
TP53 NN O
mutations NNS O
to TO O
predict VB O
sensitivity NN O
to IN O
a DT O
dose NN O
- HYPH O
dense JJ O
epirubicin NN O
- HYPH O
cyclophosphamide NN O
regimen NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
finding NN O
that IN O
some DT O
tumors NNS O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NNP O
may MD O
be VB O
resistant JJ O
to IN O
anthracycline NN O
therapy NN O
lead VBP O
us PRP O
to TO O
postulate VB O
that IN O
other JJ O
genes NNS O
involved VBN O
in IN O
the DT O
p53 NN O
pathway NN O
could MD O
be VB O
mutated VBN O
in IN O
these DT O
tumors NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

p53 NN O
is VBZ O
activated VBN O
by IN O
post NN O
- HYPH O
translational JJ O
modifications NNS O
, , O
and CC O
the DT O
protein NN O
is VBZ O
phosphorylated VBN O
at IN O
multiple JJ O
amino NN O
acids NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Phosphorylation NN O
at IN O
Ser NNP O
20 CD O
( , O
Ser NNP O
23 CD O
in IN O
mice NNS B-Species
) -RRB- O
by IN O
the DT O
Chk2 NNP O
protein NN O
( , O
coded VBN O
by IN O
the DT O
CHEK2 NNP O
gene NN O
) -RRB- O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
activates VBZ O
p53 NN O
by IN O
inhibiting VBG O
binding NN O
to IN O
, , O
and CC O
deactivation NN O
by IN O
, , O
the DT O
MDM2 NNP O
( -LRB- O
Mouse NNP B-Species
Minute NNP O
2 CD O
homolog NN O
; : O
HDM2 NNP O
) -RRB- O
protein NN O
[ -LRB- O
18 CD O
] -RRB- O
, , O
[ -LRB- O
19 CD O
] -RRB- O
, , O
[ -LRB- O
20 CD O
] -RRB- O
. . O

While IN O
experimental JJ O
studies NNS O
have VBP O
suggested VBN O
a DT O
critical JJ O
role NN O
of IN O
Chk2 NNP O
in IN O
activating VBG O
p53 NN O
apoptotic JJ O
response NN O
to IN O
genotoxic JJ O
stress NN O
[ -LRB- O
21 CD O
] -RRB- O
, , O
[ -LRB- O
22 CD O
] -RRB- O
, , O
others NNS O
claim VBP O
Chk2 NNP O
to TO O
be VB O
dispensable JJ O
for IN O
p53 NN O
activation NN O
with IN O
respect NN O
to IN O
apoptosis NN O
as RB O
well RB O
as IN O
growth NN O
arrest NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Following VBG O
an DT O
initial JJ O
report NN O
of IN O
a DT O
CHEK2 NNP O
germline NN O
mutation NN O
in IN O
a DT O
family NN O
filling VBG O
the DT O
characteristics NNS O
of IN O
a DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
( -LRB- O
LFS NNP O
) -RRB- O
[ -LRB- O
24 CD O
] -RRB- O
, , O
recent JJ O
papers NNS O
have VBP O
suggested VBN O
germline NN O
mutations NNS O
in IN O
CHEK2 NNP O
to TO O
be VB O
associated VBN O
with IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
colon NN O
cancers NNS O
( , O
see VB O
references NNS O
in IN O
[ -LRB- O
25 CD O
] -RRB- O
) -RRB- O
. . O

Recently RB O
, , O
we PRP O
discovered VBD O
a DT O
somatic JJ O
, , O
nonsense NN O
CHEK2 NN O
mutation NN O
in IN O
a DT O
single JJ O
patient NN B-Species
expressing VBG O
resistance NN O
to IN O
doxorubicin NN O
low JJ O
dose NN O
therapy NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

A DT O
second JJ O
mechanism NN O
of IN O
p53 NN O
activation NN O
is VBZ O
through IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
( , O
p19 NN O
in IN O
mice NNS B-Species
) -RRB- O
function NN O
. . O

p14 NN O
( , O
ARF NNP O
) -RRB- O
does VBZ O
not RB O
phosphorylate VB O
p53 NN O
, , O
but CC O
inhibits VBZ O
MDM2 NN O
dependent JJ O
p53 NN O
degradation NN O
through IN O
direct JJ O
MDM2 NNP O
binding NN O
. . O

While IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
- HYPH O
mediated VBN O
p53 NN O
activation NN O
has VBZ O
been VBN O
linked VBN O
to IN O
oncogene NN O
- HYPH O
induced VBN O
p53 NN O
activation NN O
and CC O
, , O
in IN O
general JJ O
, , O
considered VBN O
not RB O
involved VBN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
( , O
see VB O
references NNS O
in IN O
[ -LRB- O
27 CD O
] -RRB- O
) -RRB- O
, , O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
may MD O
be VB O
activated VBN O
through IN O
the DT O
E2F1 NNP O
/ SYM O
retinoblastoma NN O
pathway NN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

Importantly RB O
, , O
two CD O
recent JJ O
studies NNS O
revealed VBD O
lack NN O
of IN O
p19 NN O
( , O
mouse NN B-Species
homologue NN O
of IN O
human JJ B-Species
p14 NN O
( , O
ARF NN O
) -RRB- O
) , O
function NN O
in IN O
mice NNS B-Species
to TO O
inhibit VB O
p53 NN O
tumor NN O
suppressor NN O
function NN O
in IN O
response NN O
to IN O
ionizing VBG O
radiation NN O
as RB O
well RB O
as IN O
DNA NN O
damaging VBG O
agents NNS O
[ -LRB- O
29 CD O
] -RRB- O
, , O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
1 CD O
) -RRB- O
to TO O
explore VB O
alterations NNS O
in IN O
the DT O
TP53 NN O
gene NN O
with IN O
respect NN O
to IN O
resistance NN O
to IN O
a DT O
regular JJ O
dose NN O
epirubicin NN O
regimen NN O
( , O
90 CD O
mg NN O
/ SYM O
m2 NN O
body NN O
surface NN O
every DT O
3 CD O
week NN O
) , O
in IN O
patient NN B-Species
with IN O
primary JJ O
, , O
locally RB O
advanced JJ O
, , O
breast NN O
cancer NN O
; : O
2 LS O
) -RRB- O
To TO O
explore VB O
defects NNS O
in IN O
potential JJ O
mechanisms NNS O
activating VBG O
p53 NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
in IN O
breast NN O
cancer NN O
as IN O
a DT O
cause NN O
of IN O
drug NN O
resistance NN O
in IN O
wild JJ O
- HYPH O
type NN O
tumors NNS O
. . O

To TO O
do VB O
so RB O
, , O
we PRP O
sequenced VBD O
the DT O
complete JJ O
coding VBG O
regions NNS O
for IN O
the DT O
CHEK2 NNP O
and CC O
p14 NN O
( , O
ARF NN O
) -RRB- O
genes NNS O
and CC O
analyzed VBN O
for IN O
p14 NN O
( , O
ARF NN O
) -RRB- O
promoter NN O
hypermetylations NNS O
; : O
3 CD O
) SYM O
Evaluate NN O
in IN O
vitro FW O
function NN O
of IN O
potential JJ O
Chk2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
protein NN O
translates VBZ O
corresponding VBG O
to IN O
identified VBN O
mutations NNS O
in IN O
the DT O
CHEK2 NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
genes NNS O
; : O
4 CD O
) NFP O
Identify VB O
potential JJ O
TP53 NN O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
mutations NNS O
to TO O
be VB O
germline NN O
, , O
explore VB O
the DT O
incidence NN O
of IN O
different JJ O
cancers NNS O
among IN O
affected JJ O
relatives NNS O
with IN O
respect NN O
to IN O
specific JJ O
mutations NNS O
. . O

By IN O
comparing VBG O
in FW O
vitro FW O
characteristics NNS O
of IN O
specific JJ O
mutations NNS O
to IN O
drug NN O
sensitivity NN O
and CC O
family NN O
cancer NN O
risk NN O
syndromes NNS O
, , O
this DT O
may MD O
add VB O
to IN O
our PRP$ O
understanding NN O
of IN O
the DT O
importance NN O
of IN O
these DT O
gene NN O
cascades NNS O
executing VBG O
response NN O
to IN O
DNA NN O
damage NN O
versus IN O
tumor NN O
suppression NN O
activity NN O
. . O

Analyzing VBG O
tumor NN O
samples NNS O
from IN O
a DT O
total NN O
of IN O
109 CD O
primary JJ O
locally RB O
advanced JJ O
breast NN O
cancer NN O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
90mg CD O
/ SYM O
3 CD O
weekly RB O
, , O
we PRP O
found VBD O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
or CC O
protein NN O
dimerization NN O
, , O
as RB O
well RB O
as IN O
non JJ O
- HYPH O
functional JJ O
CHEK2 NN O
mutations NNS O
abrogating VBG O
dimerization NN O
and CC O
phosphorylation NN O
, , O
to TO O
be VB O
associated VBN O
with IN O
therapy NN O
resistance NN O
; , O
no DT O
mutation NN O
or CC O
promoter NN O
hypermethylations NNS O
of IN O
the DT O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
gene NN O
was VBD O
discovered VBN O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
a DT O
critical JJ O
role NN O
for IN O
Chk2 NNP O
with IN O
respect NN O
to IN O
DNA NN O
- HYPH O
damage NN O
- HYPH O
dependent JJ O
p53 NN O
activation NN O
and CC O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
in IN O
human JJ B-Species
breast NN O
cancer NN O
. . O

Materials NNS O
and CC O
Methods NNS O

Patients NNS B-Species

A DT O
total NN O
of IN O
223 CD O
patients NNS B-Species
with IN O
locally RB O
advanced VBN O
non JJ O
- HYPH O
inflammatory JJ O
breast NN O
cancer NN O
( -LRB- O
T3 NNP O
- HYPH O
4 CD O
and CC O
/ SYM O
or CC O
N2 CD O
) -RRB- O
were VBD O
randomly RB O
allocated VBN O
to IN O
primary JJ O
treatment NN O
either CC O
with IN O
epirubicin NN O
90 CD O
mg NN O
/ SYM O
m2 NN O
or CC O
paclitaxel NN O
200 CD O
mg NNS O
/ SYM O
m2 CD O
. . O

The DT O
primary JJ O
aim NN O
of IN O
the DT O
study NN O
was VBD O
identification NN O
of IN O
markers NNS O
predicting VBG O
drug NN O
resistance NN O
to IN O
the DT O
regimens NNS O
. . O

Thus RB O
, , O
the DT O
reason NN O
for IN O
randomizing VBG O
patients NNS B-Species
was VBD O
not RB O
for IN O
effect NN O
comparison NN O
, , O
but CC O
to TO O
achieve VB O
similar JJ O
patient JJ B-Species
cohorts NNS O
in IN O
the DT O
two CD O
arms NNS O
. . O

Based VBN O
on IN O
the DT O
findings NNS O
of IN O
a DT O
clinical JJ O
lack NN O
of IN O
cross JJ O
- HYPH O
resistance NN O
between IN O
anthracyclines NNS O
and CC O
taxane NN O
therapies NNS O
in IN O
breast NN O
cancer NN O
[ -LRB- O
31 CD O
] -RRB- O
, , O
we PRP O
hypothesized VBD O
the DT O
mechanisms NNS O
of IN O
resistance NN O
to TO O
be VB O
different JJ O
between IN O
the DT O
two CD O
compounds NNS O
. . O

While IN O
the DT O
analysis NN O
of IN O
tumor NN O
samples NNS O
from IN O
the DT O
paclitaxel NN O
is VBZ O
ongoing VBG O
, , O
we PRP O
here RB O
report VBP O
our PRP$ O
findings NNS O
from IN O
the DT O
patients NNS B-Species
allocated VBN O
to IN O
the DT O
epirubicin NN O
arm NN O
. . O

The DT O
epirubicin NN O
arm NN O
included VBD O
a DT O
total NN O
of IN O
109 CD O
patients NNS B-Species
( , O
age NN O
28 CD O
to TO O
70 CD O
years NNS O
, , O
median JJ O
51 CD O
years NNS O
) -RRB- O
. . O

Two CD O
patients NNS B-Species
were VBD O
analyzed VBN O
for IN O
gene NN O
mutations NNS O
but CC O
omitted VBN O
from IN O
statistical JJ O
analysis NN O
as IN O
protocol NN O
violators NNS O
; , O
histopathological JJ O
examination NN O
revealed VBD O
one CD O
patient NN B-Species
( -LRB- O
Epi089 NN O
) -RRB- O
to TO O
harbor VB O
a DT O
sarcomatoid JJ O
tumor NN O
, , O
while IN O
one CD O
patient NN B-Species
Epi232 NNP O
was VBD O
erroneously RB O
enrolled VBN O
with IN O
stage NN O
II NNP O
disease NN O
. . O

The DT O
study NN O
protocol NN O
was VBD O
approved VBN O
by IN O
the DT O
Regional NNP O
Ethical NNP O
Committee NNP O
( , O
Norwegian NNP O
Health NNP O
Region NNP O
III NNP O
) -RRB- O
, , O
including VBG O
formal JJ O
Biobank NNP O
registration NN O
in IN O
accordance NN O
to IN O
Norwegian JJ O
law NN O
. . O

The DT O
study NN O
and CC O
protocol NN O
is VBZ O
registered VBN O
under IN O
the DT O
Norwegian NNP O
Social NNP O
Science NNP O
Data NNP O
services NNPS O
( , O
( -LRB- O
www NN O
. , O
nsd NNP O
/ SYM O
uib NN O
/ SYM O
personvern NN O
/ SYM O
database NN O
/ SYM O
) NFP O
, , O
University NNP O
of IN O
Bergen NNP O
project NN O
no DT O
16297 CD O
and CC O
Helse NNP O
Bergen NNP O
project NN O
no NN O
13025 CD O
) -RRB- O
. . O

Each DT O
patient NN B-Species
gave VBD O
written VBN O
informed JJ O
consent NN O
. . O

Tissue NNP O
Sampling NNP O

Before IN O
commencing VBG O
chemotherapy NN O
, , O
each DT O
patient NN B-Species
had VBD O
an DT O
incisional JJ O
tumor NN O
biopsy NN O
as IN O
described VBN O
previously RB O
[ -LRB- O
14 CD O
] -RRB- O
. . O

All DT O
tissue NN O
samples NNS O
were VBD O
snap NN O
- HYPH O
frozen VBN O
immediately RB O
on IN O
removal NN O
in IN O
the DT O
theatre NN O
. . O

Treatment NN O
Regime NN O
and CC O
Staging NN O

Primary JJ O
treatment NN O
consisted VBD O
of IN O
epirubicin NN O
( : O
90 CD O
mg NNS O
/ SYM O
m2 CD O
) -RRB- O
administered VBN O
as IN O
a DT O
3 CD O
- HYPH O
weekly JJ O
schedule NN O
. . O

Treatment NN O
was VBD O
scheduled VBN O
for IN O
four CD O
cycles NNS O
unless IN O
progression NN O
occurred VBD O
at IN O
an DT O
earlier JJR O
stage NN O
. . O

Clinical JJ O
response NN O
was VBD O
assessed VBN O
before IN O
each DT O
treatment NN O
cycle NN O
, , O
and CC O
the DT O
final JJ O
response NN O
evaluated VBN O
3 CD O
weeks NNS O
after IN O
the DT O
4th JJ O
cycle NN O
for IN O
overall JJ O
response NN O
classification NN O
. . O

Because IN O
the DT O
protocol NN O
was VBD O
implemented VBN O
by IN O
October NNP O
1997 CD O
with IN O
patients NNS B-Species
enrolled VBN O
between IN O
November NNP O
1997 CD O
and CC O
December NNP O
2003 CD O
, , O
responses NNS O
were VBD O
consistently RB O
graded VBN O
by IN O
the DT O
UICC NNP O
system NN O
[ -LRB- O
32 CD O
] -RRB- O
and CC O
not RB O
the DT O
more RBR O
recently RB O
implemented VBN O
"""" `` O
RECIST NNP O
"""" '' O
criteria NNS O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Thus RB O
, , O
responses NNS O
were VBD O
classified VBN O
as IN O
CR NN O
( -LRB- O
Complete NNP O
Response NNP O
, , O
complete JJ O
disappearance NN O
of IN O
all DT O
tumor NN O
lesions NNS O
) -RRB- O
, , O
PR NN O
( , O
Partial NNP O
Response NNP O
, , O
reduction NN O
> : O
= SYM O
50 CD O
% NN O
in IN O
the DT O
sum NN O
of IN O
all DT O
tumor NN O
lesions NNS O
, , O
calculated VBN O
for IN O
each DT O
as IN O
the DT O
product NN O
of IN O
the DT O
largest JJS O
diameter NN O
and CC O
the DT O
one CD O
perpendicular JJ O
to IN O
it PRP O
) -RRB- O
, , O
PD NN O
( , O
Progressive NNP O
Disease NNP O
, , O
increase NN O
in IN O
the DT O
diameter NN O
product NN O
of IN O
any DT O
individual JJ O
tumor NN O
lesion NN O
by IN O
> SYM O
= SYM O
25 CD O
% NN O
) -RRB- O
, , O
and CC O
SD NN O
( : O
Stable NNP O
Disease NNP O
, , O
anything NN O
between IN O
PR NN O
and CC O
PD NN O
) -RRB- O
. . O

To TO O
analyze VB O
for IN O
the DT O
predictive JJ O
value NN O
of IN O
the DT O
different JJ O
parameters NNS O
, , O
similar JJ O
to IN O
our PRP$ O
previous JJ O
studies NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
14 CD O
] -RRB- O
we PRP O
compared VBD O
PD NN O
tumors NNS O
( , O
non JJ O
responders NNS O
) , O
with IN O
the DT O
combined JJ O
group NN O
of IN O
tumors NNS O
classified VBN O
as IN O
SD NNP O
/ SYM O
PR NNP O
/ SYM O
CR NN O
( , O
responders NNS O
) -RRB- O
; : O
the DT O
reason NN O
for IN O
this DT O
approach NN O
is VBZ O
discussed VBN O
in IN O
detail NN O
elsewhere RB O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Median JJ O
follow NN O
- HYPH O
up NN O
time NN O
was VBD O
defined VBN O
from IN O
patient JJ B-Species
inclusion NN O
in IN O
the DT O
study NN O
up IN O
to IN O
October NNP O
31 CD O
, , O
2006 CD O
. . O

Deaths NNS O
attributable JJ O
to IN O
causes NNS O
other JJ O
than IN O
breast NN O
cancer NN O
were VBD O
treated VBN O
as IN O
censored JJ O
observations NNS O
. . O

All DT O
patient JJ B-Species
records NNS O
were VBD O
subject JJ O
to IN O
central JJ O
audit NN O
for IN O
response NN O
classification NN O
( , O
by IN O
E NNP O
. . O
L NNP O
. . O
, , O
B NNP O
. . O
O NN O
. . O
and CC O
P NN O
. . O
E NN O
. . O
L NNP O
. . O
) -RRB- O
. . O

Response NN O
classifications NNS O
were VBD O
completed VBN O
and CC O
approved VBN O
without IN O
any DT O
knowledge NN O
about IN O
result NN O
from IN O
laboratory NN O
analysis NN O
. . O

RNA NNP O
Purification NN O

Total JJ O
RNA NNP O
was VBD O
purified VBN O
by IN O
Trizol NNP O
( : O
Life NNP O
Technologies NNPS O
, , O
Inc NNP O
. . O
) -RRB- O
extraction NN O
from IN O
snap NN O
- HYPH O
frozen VBN O
tissue NN O
samples NNS O
according VBG O
to IN O
manufacturer NN O
' POS O
s NNS O
instructions NNS O
. . O

After IN O
extraction NN O
, , O
the DT O
RNA NNP O
was VBD O
dissolved VBN O
in IN O
100 CD O
micro NN O
l NN O
of IN O
DEPC NNP O
treated VBN O
ddH2O NNP O
. . O

cDNA NNP O
was VBD O
synthesized VBN O
by IN O
reverse JJ O
transcription NN O
using VBG O
Transcriptor NNP O
reverse JJ O
transcriptase NN O
( , O
Roche NNP O
) -RRB- O
, , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

DNA NNP O
Purification NN O

Genomic JJ O
DNA NN O
from IN O
tumor NN O
biopsies NNS O
and CC O
blood NN O
lymphocytes NNS O
was VBD O
isolated VBN O
using VBG O
QIAamp NNP O
DNA NNP O
Mini NNP O
kit NN O
( , O
Qiagen NNP O
, , O
Chatsworth NNP O
, , O
CA NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Mutation NN O
Analysis NNP O

All DT O
mutational JJ O
analysis NN O
was VBD O
performed VBN O
blinded VBN O
to IN O
clinical JJ O
data NNS O
. . O

Mutations NNS O
in IN O
TP53 NNP O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
genes NNS O
were VBD O
analyzed VBN O
by IN O
PCR NNP O
( , O
or CC O
nested VBN O
PCR NN O
) -RRB- O
amplification NN O
and CC O
sequencing NN O
of IN O
PCR NNP O
product NN O
, , O
or CC O
by IN O
cloning NN O
of IN O
PCR NN O
products NNS O
and CC O
sequencing NN O
of IN O
the DT O
resulting VBG O
plasmids NNS O
( , O
all DT O
primers NNS O
described VBN O
in IN O
Table NNP O
1 CD O
) -RRB- O
. . O

Cloning NN O
was VBD O
performed VBN O
using VBG O
the DT O
TOPO NNP O
TA NNP O
Cloning NNP O
kit NN O
( : O
Invitrogen NNP O
) -RRB- O
. . O

Sequencing VBG O
of IN O
clones NNS O
was VBD O
performed VBN O
until IN O
at RB O
least RBS O
10 CD O
different JJ O
sequences NNS O
covered VBD O
all DT O
parts NNS O
of IN O
the DT O
CHEK2 NNP O
coding VBG O
sequence NN O
. . O

DNA NN O
sequencing NN O
was VBD O
carried VBN O
out RP O
directly RB O
on IN O
1 CD O
micro NN O
l NNP O
PCR NNP O
product NN O
or CC O
plasmid NN O
using VBG O
Big NNP O
Dye NNP O
terminator NN O
mix NN O
( : O
Applied NNP O
Biosystems NNPS O
) -RRB- O
. . O

Capillary NN O
gel NN O
electrophoresis NN O
, , O
data NN O
collection NN O
, , O
and CC O
sequence NN O
analysis NN O
were VBD O
done VBN O
on IN O
an DT O
automated JJ O
DNA NN O
sequencer NN O
( : O
ABI NNP O
3700 CD O
) -RRB- O
. . O

When WRB O
a DT O
mutation NN O
was VBD O
detected VBN O
, , O
the DT O
relevant JJ O
exon NN O
was VBD O
amplified VBN O
by IN O
PCR NNP O
from IN O
genomic JJ O
tumor NN O
DNA NN O
and CC O
DNA NN O
from IN O
blood NN O
lymphocytes NNS O
and CC O
sequenced VBN O
for IN O
verification NN O
and CC O
germline NN O
detection NN O
. . O

( : O
Primers NNS O
described VBN O
in IN O
Table NNP O
1 CD O
) -RRB- O
. . O

Loss NNP O
of IN O
Heterozygosity NNP O
( -LRB- O
LOH NNP O
) -RRB- O

Loss NN O
of IN O
heterozygosity NN O
( -LRB- O
LOH NNP O
) , O
in IN O
tumors NNS O
with IN O
mutations NNS O
in IN O
CHEK2 NNP O
was VBD O
assessed VBN O
using VBG O
the DT O
microsatellite NN O
marker NN O
, , O
D22S275 NNP O
, , O
which WDT O
maps VBZ O
to IN O
intron NN O
4 CD O
of IN O
CHEK2 NNP O
. . O

LOH NNP O
in IN O
tumors NNS O
with IN O
mutation NN O
in IN O
TP53 NN O
was VBD O
assessed VBN O
using VBG O
two CD O
markers NNS O
, , O
one CD O
variable JJ O
number NN O
tandem NN O
repeat NN O
in IN O
intron NN O
1 CD O
[ -LRB- O
35 CD O
] -RRB- O
and CC O
a DT O
CA NN O
repeat NN O
close RB O
to IN O
the DT O
TP53 NN O
gene NN O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Fluorescently RB O
end NN O
- HYPH O
labeled VBN O
primers NNS O
were VBD O
used VBN O
in IN O
the DT O
PCR NNP O
, , O
and CC O
the DT O
PCR NNP O
products NNS O
were VBD O
analyzed VBN O
on IN O
an DT O
ABI NNP O
3700 CD O
. . O

LOH NNP O
was VBD O
evaluated VBN O
by IN O
comparing VBG O
the DT O
allele JJ O
peak NN O
- HYPH O
height NN O
ratios NNS O
from IN O
blood NN O
DNA NN O
and CC O
tumor NN O
DNA NN O
. . O

A DT O
sample NN O
was VBD O
scored VBN O
as IN O
having VBG O
AI NNP O
( -LRB- O
Allelic NNP O
Imbalance NNP O
) , O
when WRB O
a DT O
reduction NN O
in IN O
peak NN O
height NN O
of IN O
one CD O
allele NN O
in IN O
tumor NN O
sample NN O
was VBD O
at RB O
least RBS O
18 CD O
% NN O
compared VBN O
with IN O
that DT O
of IN O
blood NN O
DNA NN O
from IN O
the DT O
same JJ O
patient NN B-Species
[ -LRB- O
37 CD O
] -RRB- O
. . O

Analysis NN O
of IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
promoter NN O
methylation NN O

Genomic JJ O
DNA NNP O
was VBD O
subjected VBN O
to IN O
bisulphate NN O
conversion NN O
using VBG O
the DT O
CpGenome NNP O
DNA NNP O
Modification NNP O
Kit NNP O
( -LRB- O
Intergen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Both CC O
the DT O
unmethylated JJ O
- HYPH O
and CC O
methylated JJ O
- HYPH O
specific JJ O
PCRs NNS O
were VBD O
performed VBN O
in IN O
50 CD O
micro JJ O
l NN O
reaction NN O
mixes NNS O
containing VBG O
2 CD O
. . O
5 CD O
U NN O
AmpliTaq NNP O
Gold NNP O
DNA NNP O
Polymerase NNP O
( , O
Applied NNP O
Biosystems NNPS O
) -RRB- O
, , O
1 CD O
x SYM O
PCR NN O
buffer NN O
, , O
1 CD O
. . O
5 CD O
mM NN O
MgCl2 NN O
, , O
0 CD O
. . O
1 CD O
mM NN O
of IN O
each DT O
deoxynucleotide NN O
triphosphate NN O
, , O
0 CD O
. . O
2 CD O
micro NN O
M NN O
of IN O
each DT O
primer NN O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
and CC O
2 CD O
micro NN O
l NN O
of IN O
modified VBN O
genomic JJ O
DNA NN O
. . O

Thermocycling NN O
conditions NNS O
for IN O
both CC O
the DT O
unmethylated JJ O
- HYPH O
and CC O
methylated VBN O
- HYPH O
specific JJ O
PCRs NNS O
were VBD O
an DT O
initial JJ O
step NN O
of IN O
5 CD O
minutes NNS O
at IN O
95 CD O
degrees NNS O
C NN O
followed VBN O
by IN O
35 CD O
cycles NNS O
of IN O
30 CD O
sec NN O
. . O
at IN O
94 CD O
degrees NNS O
C NN O
, , O
30 CD O
sec NN O
. . O
at IN O
60 CD O
. . O
5 CD O
degrees NNS O
C NN O
and CC O
60 CD O
sec NN O
. . O
at IN O
72 CD O
degrees NNS O
C NN O
before IN O
a DT O
final JJ O
elongation NN O
step NN O
at IN O
72 CD O
degrees NNS O
C NN O
for IN O
7 CD O
min NN O
. . O

Chk2 NNP O
Dimerisation NNP O

Chk2 NNP O
mutant NN O
' '' O
s POS O
ability NN O
to TO O
form VB O
dimers NNS O
with IN O
the DT O
wild JJ O
- HYPH O
type NN O
protein NN O
was VBD O
investigated VBN O
by IN O
immunoprecipitation NN O
. . O

U NN O
- HYPH O
2 CD O
- HYPH O
OS NN O
cells NNS O
were VBD O
co NN O
- HYPH O
transfected VBN O
with IN O
expression NN O
vectors NNS O
expressing VBG O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
with IN O
N NNP O
- HYPH O
terminal JJ O
Xpr NNP O
- HYPH O
tag NNP O
( , O
pcDNA4 NNP O
/ SYM O
HisMax NNP O
, , O
Invitrogen NNP O
) -RRB- O
and CC O
mutated VBN O
Chk2 NNP O
forms NNS O
with IN O
C NN O
- HYPH O
terminal NN O
V5 NNP O
- HYPH O
tag NNP O
( : O
pcDNA3 NNP O
. . O
1 CD O
/ SYM O
V5 CD O
- HYPH O
His NN O
, , O
Invitrogen NNP O
) -RRB- O
. . O

Transfection NN O
was VBD O
performed VBN O
using VBG O
FuGene NNP O
6 CD O
. . O
0 CD O
transfection NN O
reagent NN O
( , O
Roche NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Cells NNS O
were VBD O
harvested VBN O
in IN O
lysisbuffer NN O
( , O
50 CD O
mM NN O
TrisHCl NN O
pH NN O
8 CD O
. . O
0 CD O
, , O
150 CD O
mM NN O
NaCl NN O
, , O
0 CD O
. . O
5 CD O
% NN O
NP40 CD O
, , O
5 CD O
mM NN O
EDTA NN O
pH NN O
8 CD O
. . O
0 CD O
) SYM O
48 CD O
hours NNS O
after IN O
transfection NN O
. . O

An DT O
aliquote NN O
of IN O
the DT O
cell NN O
lysate NN O
was VBD O
harvested VBN O
for IN O
subsequent JJ O
Chk2 NNP O
- HYPH O
mutant JJ O
- HYPH O
V5 NNP O
transfection NN O
verification NN O
. . O

Samples NNS O
were VBD O
further RB O
incubated VBN O
with IN O
A NN O
/ SYM O
G NNP O
Pluss NNP O
Agarose NNP O
beads NNS O
( , O
Santa NNP O
Cruz NNP O
Biotechnology NNP O
) -RRB- O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
25 CD O
minutes NNS O
before IN O
the DT O
beads NNS O
were VBD O
removed VBN O
by IN O
centrifugation NN O
at IN O
5000g CD O
for IN O
4 CD O
minutes NNS O
and CC O
the DT O
samples NNS O
were VBD O
incubated VBN O
with IN O
1 CD O
. . O
5 CD O
micro NN O
g NN O
anti AFX O
- HYPH O
V5 NN O
( -LRB- O
Invitrogen NNP O
) -RRB- O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
90 CD O
minutes NNS O
. . O

Fresh JJ O
A NN O
/ SYM O
G NNP O
Pluss NNP O
Agarose NNP O
beads NNS O
were VBD O
added VBN O
and CC O
the DT O
samples NNS O
were VBD O
incubated VBN O
for IN O
another DT O
90 CD O
minutes NNS O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
beads NNS O
were VBD O
washed VBN O
three CD O
times NNS O
with IN O
1 CD O
x SYM O
PBS NN O
, , O
before IN O
being VBG O
separated VBN O
on IN O
a DT O
10 CD O
% NN O
polyacrylamide NN O
gel NN O
and CC O
blotted VBN O
on IN O
to IN O
a DT O
nitrocellulose NN O
membrane NN O
. . O

Chk2 NNP O
- HYPH O
wild JJ O
- HYPH O
type NN O
- HYPH O
Xpr NNP O
co NN O
- HYPH O
precipitated VBN O
with IN O
Chk2 NNP O
- HYPH O
mutant NN O
- HYPH O
V5 NNP O
was VBD O
detected VBN O
through IN O
incubations NNS O
with IN O
anti JJ O
- HYPH O
Xpr NN O
antibody NN O
( , O
Invitrogen NNP O
) -RRB- O
, , O
HRP NN O
- HYPH O
conjugated VBN O
secondary JJ O
antibody NN O
and CC O
ECL NNP O
detection NN O
reagent NN O
( -LRB- O
GE NNP O
Healthcare NNP O
) -RRB- O
. . O

Kinase NNP O
Activity NNP O

Chk2 NNP O
mutant NN O
' '' O
s POS O
ability NN O
to TO O
function VB O
as IN O
kinases NNS O
was VBD O
investigated VBN O
through IN O
an DT O
in FW O
vitro FW O
kinase NN O
assay NN O
. . O

The DT O
V5 NNP O
expression NN O
vectors NNS O
used VBN O
for IN O
the DT O
dimerisation NN O
study NN O
were VBD O
also RB O
used VBN O
to TO O
express VB O
Chk2 NNP O
mutants NNS O
in IN O
the DT O
kinase NN O
assay NN O
. . O

U NN O
- HYPH O
2 CD O
- HYPH O
OS NN O
cells NNS O
were VBD O
transfected VBN O
using VBG O
the DT O
FuGene NNP O
6 CD O
. . O
0 NFP O
transfection NN O
reagent NN O
( , O
Roche NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Cells NNS O
were VBD O
then RB O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
5 CD O
% NN O
CO2 NN O
and CC O
humidified JJ O
atmosphere NN O
. . O

After IN O
24 CD O
hours NNS O
doxorubicin NN O
( -LRB- O
Nycomed NNP O
Pharma NNP O
) -RRB- O
was VBD O
added VBN O
to IN O
the DT O
media NNS O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
50ng CD O
/ SYM O
ml NN O
and CC O
the DT O
cells NNS O
were VBD O
further RBR O
incubated VBN O
for IN O
24 CD O
hours NNS O
before IN O
harvest NN O
. . O

75 CD O
cm2 NN O
of IN O
90 CD O
% NN O
confluent JJ O
cells NNS O
were VBD O
harvested VBN O
in IN O
500 CD O
micro NN O
l NN O
lysis NN O
buffer NN O
( : O
50 CD O
mM NN O
HEPES NNP O
, , O
150 CD O
mM NN O
NaCl NNP O
, , O
10 CD O
% NN O
glycerol NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
2 CD O
mM NN O
MgCl2 NNP O
, , O
5 CD O
mM NN O
EDTA NNP O
) -RRB- O
, , O
and CC O
the DT O
cytosol NN O
was VBD O
incubated VBN O
for IN O
90 CD O
minutes NNS O
at IN O
4 CD O
degrees NNS O
C NN O
with IN O
50 CD O
micro NN O
l NN O
50 CD O
% NN O
Glutathione NNP O
Sepharose NNP O
beads NNS O
( , O
Amersham NNP O
Biosciences NNP O
) -RRB- O
linked VBN O
to IN O
anti JJ O
- HYPH O
V5 NN O
antibody NN O
( , O
Invitrogen NNP O
) -RRB- O
. . O

The DT O
beads NNS O
were VBD O
then RB O
washed VBN O
twice RB O
with IN O
lysisbuffer NN O
containing VBG O
500 CD O
mM NN O
NaCl NNP O
and CC O
twice RB O
with IN O
kinase NN O
assay NN O
buffer NN O
( , O
50 CD O
mM NN O
HEPES NNP O
, , O
10 CD O
mM NN O
MgCl2 NNP O
, , O
5 CD O
mM NN O
MnCl2 NN O
, , O
2 CD O
. . O
5 CD O
mM NN O
EGTA NN O
) -RRB- O
. . O

The DT O
beads NNS O
received VBD O
30 CD O
micro JJ O
l NN O
kinase NN O
assay NN O
buffer NN O
with IN O
7 CD O
. . O
5 CD O
micro NN O
M NN O
cold JJ O
ATP NNP O
, , O
10 CD O
micro JJ O
Ci NN O
32P NN O
- HYPH O
gamma NN O
- HYPH O
ATP NNP O
( -LRB- O
GE NNP O
Healthcare NNP O
) -RRB- O
and CC O
2 CD O
micro NN O
g NN O
isolated VBN O
Cdc25C NN O
peptide NN O
, , O
and CC O
was VBD O
incubated VBN O
at IN O
30 CD O
degrees NNS O
C NN O
for IN O
30 CD O
minutes NNS O
. . O

Samples NNS O
were VBD O
separated VBN O
on IN O
a DT O
12 CD O
. . O
5 CD O
% NN O
polyacrylamide NN O
gel NN O
and CC O
blotted VBN O
on IN O
to IN O
a DT O
nitrocellulose NN O
membrane NN O
. . O

A DT O
radiosensitive JJ O
imaging NN O
plate NN O
was VBD O
exposed VBN O
to IN O
the DT O
membrane NN O
and CC O
the DT O
plate NN O
was VBD O
read VBN O
in IN O
a DT O
FLA200 NN O
imager NN O
( , O
Fuji NNP O
) -RRB- O
. . O

The DT O
kinase NN O
assay NN O
described VBN O
above RB O
was VBD O
also RB O
used VBN O
to TO O
determine VB O
the DT O
Chk2 NNP O
mutants NNS O
' POS O
kinase NN O
activity NN O
after IN O
co NN O
- HYPH O
transfection NN O
of IN O
each DT O
Chk2 NNP O
mutant NN O
and CC O
wild JJ O
- HYPH O
type NN O
Chk2 NN O
in IN O
equal JJ O
amounts NNS O
. . O

Statistical NNP O
Analysis NNP O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
Primer NNP O
of IN O
Biostatistics NNP O
system NN O
, , O
version NN O
5 CD O
. . O
0 CD O
[ -LRB- O
38 CD O
] -RRB- O
. . O

The DT O
differences NNS O
in IN O
the DT O
distribution NN O
of IN O
TP53 NN O
and CC O
CHEK2 NNP O
mutations NNS O
among IN O
patients NNS B-Species
revealing VBG O
a DT O
PD NN O
and CC O
the DT O
responders NNS O
were VBD O
analyzed VBN O
with IN O
use NN O
of IN O
Fisher NNP O
' POS O
s POS O
exact JJ O
test NN O
. . O

P NN O
- HYPH O
values NNS O
are VBP O
reported VBN O
as IN O
accumulated VBN O
two CD O
- HYPH O
sided JJ O
. . O

Because IN O
of IN O
the DT O
limited JJ O
time NN O
of IN O
the DT O
follow NN O
- HYPH O
up NN O
, , O
no DT O
formal JJ O
statistical JJ O
assessment NN O
of IN O
overall JJ O
survival NN O
was VBD O
performed VBN O
. . O

Relapse NN O
- HYPH O
free JJ O
survival NN O
was VBD O
analyzed VBN O
by IN O
the DT O
log NN O
- HYPH O
rank NN O
test NN O
. . O

Details NNS O
regarding VBG O
outcome NN O
in IN O
individual JJ O
patients NNS B-Species
with IN O
mutations NNS O
are VBP O
shown VBN O
in IN O
Table NNP O
2 CD O
and CC O
3 CD O
to TO O
make VB O
them PRP O
available JJ O
to IN O
the DT O
reader NN O
. . O

Results NNS O

TP53 NN O
Mutations NNS O
and CC O
Response NN O
to IN O
Therapy NN O

The DT O
TP53 NNP O
mutations NNS O
identified VBN O
in IN O
the DT O
tumors NNS O
of IN O
the DT O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
together RB O
with IN O
the DT O
clinical JJ O
response NN O
to IN O
therapy NN O
and CC O
follow NN O
- HYPH O
up NN O
data NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

Somatic JJ O
TP53 NN O
mutations NNS O
were VBD O
identified VBN O
in IN O
23 CD O
( SYM O
21 CD O
. . O
5 CD O
% NN O
) -RRB- O
of IN O
the DT O
patients NNS B-Species
. . O

Normal JJ O
tissue NN O
( -LRB- O
WBC NNP O
) -RRB- O
was VBD O
available JJ O
from IN O
18 CD O
of IN O
these DT O
for IN O
germline NN O
characterization NN O
, , O
revealing VBG O
none NN O
of IN O
the DT O
mutations NNS O
identified VBN O
to TO O
be VB O
germline NN O
alterations NNS O
. . O

Of IN O
the DT O
23 CD O
mutations NNS O
detected VBN O
, , O
20 CD O
were VBD O
missense JJ O
and CC O
3 CD O
were VBD O
nonsense NN O
. . O

One CD O
mutation NN O
( -LRB- O
del483CAT NN O
) -RRB- O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
either CC O
in IN O
breast NN O
cancer NN O
or CC O
in IN O
any DT O
other JJ O
tumor NN O
type NN O
( : O
IARC NNP O
database NN O
: : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
iarc NNP O
. . O
fr XX O
/ SYM O
p53 CD O
/ , O
) -RRB- O
. . O

Twelve CD O
of IN O
the DT O
mutations NNS O
directly RB O
or CC O
indirectly RB O
affected VBD O
the DT O
L2 NNP O
/ SYM O
L3 CD O
domains NNS O
of IN O
the DT O
p53 NN O
protein NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
previous JJ O
found VBN O
to TO O
predict VB O
a DT O
poor JJ O
prognosis NN O
[ -LRB- O
39 CD O
] -RRB- O
and CC O
drug NN O
resistance NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
40 CD O
] -RRB- O
. . O

For IN O
statistical JJ O
comparison NN O
, , O
mutation NN O
Gly325Ter NNP O
( -LRB- O
patient NN B-Species
Epi215 NNP O
) -RRB- O
located VBN O
to IN O
the DT O
tetramerization NN O
domain NN O
is VBZ O
grouped VBN O
together RB O
with IN O
the DT O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domain NN O
, , O
since IN O
this DT O
mutation NN O
leads VBZ O
to IN O
truncation NN O
of IN O
the DT O
protein NN O
and CC O
with IN O
loss NN O
of IN O
tetramerization NN O
and CC O
functional JJ O
defects NNS O
similar JJ O
to IN O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

There EX O
was VBD O
a DT O
statistical JJ O
significant JJ O
correlation NN O
between IN O
TP53 NN O
mutation NN O
status NN O
and CC O
lack NN O
of IN O
treatment NN O
response NN O
( -LRB- O
PD NN O
) -RRB- O
( , O
Table NN O
4 CD O
; : O
p NN O
= SYM O
0 CD O
. . O
358 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

When WRB O
tumors NNS O
harboring VBG O
TP53 NNP O
mutations NNS O
affecting VBG O
the DT O
p53 NN O
L2 NNP O
/ SYM O
L3 NNP O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
were VBD O
compared VBN O
to IN O
those DT O
with IN O
wild JJ O
- HYPH O
type NN O
TP53 NN O
or CC O
TP53 NN O
mutations NNS O
outside IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
, , O
this DT O
correlation NN O
was VBD O
further RB O
strengthened VBN O
( : O
p NN O
= SYM O
0 CD O
. . O
136 CD O
) -RRB- O
. . O

The DT O
previously RB O
described VBN O
TP53 NNP O
polymorphism NN O
, , O
Arg72Pro NNP O
[ -LRB- O
42 CD O
] -RRB- O
was VBD O
detected VBN O
in IN O
31 CD O
( SYM O
29 CD O
% NN O
) -RRB- O
of IN O
our PRP$ O
patients NNS B-Species
. . O

No DT O
correlation NN O
was VBD O
found VBN O
between IN O
this DT O
polymorphism NN O
and CC O
lack NN O
of IN O
treatment NN O
response NN O
( , O
p NN O
= SYM O
0 CD O
. . O
2750 CD O
; : O
Fisher NN O
exact JJ O
test NN O
) -RRB- O
or CC O
TP53 NN O
mutational JJ O
status NN O
( : O
p NN O
= SYM O
0 CD O
. . O
2024 CD O
) -RRB- O
. . O

CHEK2 NN O
Mutations NNS O
and CC O
Response NN O
to IN O
Therapy NN O

Table NNP O
3 CD O
presents VBZ O
the DT O
patients NNS B-Species
with IN O
detected VBN O
CHEK2 NNP O
mutations NNS O
together RB O
with IN O
a DT O
description NN O
of IN O
the DT O
clinical JJ O
response NN O
and CC O
follow NN O
up IN O
- HYPH O
data NNS O
. . O

CHEK2 NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
three CD O
out IN O
of IN O
the DT O
109 CD O
patients NNS B-Species
( , O
2 CD O
. . O
8 CD O
% NN O
) -RRB- O
. . O

Notably RB O
, , O
each DT O
of IN O
the DT O
CHEK2 NNP O
mutations NNS O
identified VBN O
was VBD O
also RB O
present JJ O
in IN O
patient JJ B-Species
lymphocyte NN O
DNA NN O
, , O
confirming VBG O
a DT O
germline NN O
origin NN O
. . O

The DT O
Arg95Ter NNP O
( -LRB- O
C283T NNP O
) -RRB- O
mutation NN O
is VBZ O
novel JJ O
. . O

This DT O
mutation NN O
was VBD O
present JJ O
in IN O
two CD O
patients NNS B-Species
( , O
Epi132 NNP O
and CC O
Epi203 NNP O
) -RRB- O
living VBG O
in IN O
different JJ O
parts NNS O
of IN O
Norway NNP O
with IN O
no DT O
known VBN O
family NN O
relationship NN O
. . O

However RB O
, , O
linkage NN O
analysis NN O
using VBG O
microsatellite NN O
markers NNS O
( -LRB- O
D22S275 NNP O
, , O
D22S272 NNP O
, , O
D22S1172 CD O
and CC O
D22S423 CD O
) -RRB- O
suggested VBD O
a DT O
common JJ O
founder NN O
mutation NN O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

The DT O
C283T NNP O
transition NN O
generates VBZ O
a DT O
novel JJ O
stop NN O
codon NN O
in IN O
exon NN O
1 CD O
of IN O
CHEK2 NNP O
, , O
leading VBG O
to IN O
truncation NN O
of IN O
the DT O
Chk2 NNP O
protein NN O
. . O

LOH NNP O
analysis NN O
indicated VBD O
loss NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
CHEK2 NNP O
allele NN O
in IN O
the DT O
both DT O
tumors NNS O
from IN O
the DT O
two CD O
patients NNS B-Species
harboring VBG O
this DT O
mutation NN O
( , O
Epi132 NNP O
and CC O
Epi203 NNP O
) -RRB- O
. . O

Both PDT O
these DT O
tumors NNS O
were VBD O
non RB O
- HYPH O
responsive JJ O
to IN O
epirubicin NN O
therapy NN O
( -LRB- O
PD NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
third JJ O
patient NN B-Species
with IN O
a DT O
germline NN O
CHEK2 NN O
mutation NN O
( -LRB- O
patient JJ B-Species
Epi151 NN O
; : O
point NN O
mutation NN O
at IN O
T1091C NNP O
, , O
Ile364Thr NNP O
) -RRB- O
had VBD O
a DT O
partial JJ O
response NN O
to IN O
epirubicin NN O
therapy NN O
. . O

This DT O
tumor NN O
was VBD O
non RB O
- HYPH O
informative JJ O
with IN O
respect NN O
to IN O
LOH NNP O
. . O

Taking VBG O
all DT O
CHEK2 NNP O
mutations NNS O
together RB O
, , O
they PRP O
predicted VBD O
resistance NN O
to IN O
epirubicin NN O
( , O
p NN O
= SYM O
0 CD O
. . O
226 CD O
) -RRB- O
. . O

The DT O
previously RB O
described VBN O
silent JJ O
Glu84Glu NNP O
( -LRB- O
A252G NNP O
) -RRB- O
polymorphism NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
[ -LRB- O
43 CD O
] -RRB- O
in IN O
exon NN O
1 CD O
was VBD O
detected VBN O
in IN O
two CD O
( SYM O
1 CD O
. . O
9 CD O
% NN O
) -RRB- O
patients NNS B-Species
. . O

No DT O
association NN O
between IN O
this DT O
polymorphism NN O
and CC O
treatment NN O
response NN O
was VBD O
recorded VBN O
. . O

One CD O
of IN O
the DT O
tumors NNS O
( -LRB- O
Epi203 NNP O
) -RRB- O
harboring VBG O
the DT O
C283T NNP O
substitution NN O
( , O
Arg95Ter NNP O
) -RRB- O
also RB O
harbored VBD O
a DT O
somatic JJ O
TP53 NN O
mutation NN O
in IN O
codon NN O
175 CD O
, , O
Arg175His NNP O
, , O
located VBN O
in IN O
the DT O
L2 NNP O
domain NN O
of IN O
p53 NN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

This DT O
mutation NN O
was VBD O
detected VBN O
in IN O
another DT O
four CD O
of IN O
our PRP$ O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
TP53 NNP O
Arg175His NNP O
mutation NN O
was VBD O
recorded VBN O
in IN O
one CD O
patient NN B-Species
of IN O
our PRP$ O
previous JJ O
study NN O
evaluating VBG O
response NN O
to IN O
doxorubicin NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
fact NN O
that IN O
none NN O
of IN O
the DT O
Arg175His NNP O
patients NNS B-Species
presented VBN O
here RB O
or CC O
in IN O
our PRP$ O
previous JJ O
study NN O
revealed VBD O
resistance NN O
to IN O
therapy NN O
( -LRB- O
PD NN O
) -RRB- O
suggests VBZ O
this DT O
mutation NN O
may MD O
not RB O
cause VB O
resistance NN O
to IN O
anthracyclines NNS O
in IN O
breast NN O
cancers NNS O
in IN O
vivo NN O
. . O

Omitting VBG O
the DT O
tumor NN O
harboring VBG O
both CC O
a DT O
CHEK2 NN O
and CC O
a DT O
TP53 NN O
mutation NN O
( -LRB- O
patient NN B-Species
Epi203 NNP O
) -RRB- O
from IN O
statistical JJ O
analysis NN O
, , O
Chk2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
2 CD O
) -RRB- O
were VBD O
non NN O
- HYPH O
significantly RB O
associated VBN O
with IN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
1633 CD O
) -RRB- O
. . O

In IN O
a DT O
previous JJ O
study NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
however RB O
, , O
we PRP O
analyzed VBD O
for IN O
CHEK2 NNP O
mutation NN O
status NN O
in IN O
relation NN O
to IN O
therapy NN O
outcome NN O
in IN O
a DT O
cohort NN O
of IN O
patients NNS B-Species
from IN O
doxorubicin NN O
study NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
that DT O
study NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
we PRP O
detected VBD O
the DT O
previously RB O
identified VBN O
mutation NN O
Ile157Thr NNP O
. . O

In IN O
addition NN O
, , O
we PRP O
detected VBD O
a DT O
novel JJ O
nonsense NN O
somatic JJ O
mutation NN O
( -LRB- O
1368InsA NN O
) -RRB- O
. . O

This DT O
mutation NN O
was VBD O
associated VBN O
with IN O
lack NN O
of IN O
function NN O
in IN O
vitro NN O
; , O
moreover RB O
, , O
it PRP O
was VBD O
associated VBN O
with IN O
drug NN O
resistance NN O
in IN O
vivo NN O
. . O

Analyzing VBG O
our PRP$ O
material NN O
and CC O
this DT O
cohort NN O
[ -LRB- O
26 CD O
] -RRB- O
together RB O
, , O
( , O
n CD O
= SYM O
160 CD O
) -RRB- O
, , O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
5 CD O
in IN O
total NN O
) -RRB- O
predicted VBN O
for IN O
resistance NN O
to IN O
doxorubicin NN O
and CC O
epirubicin NN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
123 CD O
) -RRB- O
. . O

Even RB O
though IN O
, , O
excluding VBG O
patient JJ B-Species
Epi203 NNP O
( , O
harboring VBG O
TP53 NNP O
Arg175His NNP O
and CC O
Arg95Ter NNP O
CHEK2 NNP O
mutation NN O
) , O
as RB O
well RB O
as IN O
other JJ O
patients NNS B-Species
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
( , O
n CD O
= SYM O
129 CD O
) -RRB- O
, , O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
4 CD O
in IN O
total NN O
) -RRB- O
predicted VBN O
for IN O
resistance NN O
to IN O
doxorubicin NN O
and CC O
epirubicin NN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
30 CD O
) -RRB- O
. . O

TP53 NN O
and CC O
CHEK2 NN O
Mutations NNS O
Combined VBN O
and CC O
Response NN O
to IN O
Therapy NN O

Assuming VBG O
that IN O
TP53 NN O
and CC O
CHEK2 NNP O
mutations NNS O
may MD O
substitute VB O
for IN O
each DT O
other JJ O
, , O
we PRP O
analyzed VBD O
for IN O
the DT O
predictive JJ O
effect NN O
of IN O
mutations NNS O
in IN O
both DT O
genes NNS O
. . O

The DT O
occurrence NN O
of IN O
a DT O
mutation NN O
affecting VBG O
either CC O
CHEK2 NNP O
or CC O
TP53 NN O
strongly RB O
predicted VBN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
101 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

When WRB O
tumors NNS O
harboring VBG O
TP53 NNP O
- HYPH O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
and CC O
CHEK2 NNP O
mutations NNS O
were VBD O
compared VBN O
with IN O
those DT O
wild JJ O
- HYPH O
type NN O
or CC O
TP53 NN O
mutations NNS O
outside IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domain NN O
, , O
the DT O
correlation NN O
was VBD O
further RB O
strengthened VBN O
( : O
p NN O
= SYM O
0 CD O
. . O
32 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

The DT O
significance NN O
was VBD O
preserved VBN O
when WRB O
comparing VBG O
patients NNS B-Species
with IN O
a DT O
PD NN O
to IN O
objective JJ O
responders NNS O
( , O
CR NN O
and CC O
PR NN O
) -RRB- O
excluding VBG O
patients NNS B-Species
with IN O
stable JJ O
disease NN O
( -LRB- O
SD NN O
) -RRB- O
from IN O
the DT O
statistical JJ O
analysis NN O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

p14 NN O
( : O
ARF NN O
) -RRB- O
Mutations NNS O
and CC O
Promoter NN O
Methylations NNS O

Neither CC O
mutations NNS O
nor CC O
polymorphisms NNS O
in IN O
the DT O
coding VBG O
region NN O
of IN O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
were VBD O
observed VBN O
among IN O
the DT O
107 CD O
patients NNS B-Species
analyzed VBN O
. . O

Likewise RB O
, , O
no DT O
promoter NN O
methylations NNS O
were VBD O
detected VBN O
. . O

Influence NN O
of IN O
CHEK2 NN O
and CC O
TP53 NN O
Mutation NN O
Status NN O
on IN O
Relapse NN O
- HYPH O
Free JJ O
Survival NN O

Because IN O
of IN O
the DT O
limited JJ O
time NN O
of IN O
the DT O
follow NN O
- HYPH O
up NN O
, , O
no DT O
formal JJ O
statistical JJ O
assessment NN O
of IN O
overall JJ O
survival NN O
was VBD O
performed VBN O
. . O

Details NNS O
regarding VBG O
outcome NN O
for IN O
individual JJ O
patients NNS B-Species
with IN O
mutations NNS O
are VBP O
described VBN O
in IN O
Table NNP O
2 CD O
and CC O
3 CD O
to TO O
make VB O
these DT O
data NNS O
available JJ O
to IN O
the DT O
reader NN O
. . O

Relapse NN O
- HYPH O
free JJ O
survival NN O
is VBZ O
depicted VBN O
in IN O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

Figure NN O
1A NN O
shows VBZ O
relapse NN O
- HYPH O
free JJ O
survival NN O
for IN O
the DT O
patients NNS B-Species
with IN O
TP53 NNP O
and CC O
CHEK2 NNP O
mutations NNS O
( , O
all DT O
mutations NNS O
found VBN O
) , O
compared VBN O
to IN O
patients NNS B-Species
without IN O
any DT O
TP53 NN O
or CC O
CHEK2 NNP O
mutations NNS O
, , O
no DT O
difference NN O
in IN O
relapse NN O
- HYPH O
free JJ O
survival NN O
was VBD O
observed VBN O
. . O

Similar JJ O
, , O
no DT O
difference NN O
was VBD O
seen VBN O
when WRB O
grouping VBG O
TP53 NN O
mutations NNS O
outside IN O
L2 NNP O
/ SYM O
L3 NNP O
and CC O
CHEK2 NNP O
mutation NN O
not RB O
affecting VBG O
kinase NN O
function NN O
( -LRB- O
Ile364Thr NNP O
) -RRB- O
as IN O
wild JJ O
- HYPH O
type NN O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

Grouping VBG O
tumors NNS O
harboring VBG O
a DT O
mutation NN O
in IN O
L2 NNP O
/ SYM O
L3 NNP O
together RB O
with IN O
CHEK2 NNP O
mutations NNS O
affecting VBG O
kinase NN O
domain NN O
( , O
Arg95Ter NNP O
) -RRB- O
in IN O
one CD O
group NN O
, , O
mutations NNS O
outside IN O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
and CC O
Ile364Thr NNP O
as IN O
one CD O
group NN O
and CC O
tumors NNS O
without IN O
any DT O
found VBN O
mutations NNS O
in IN O
TP53 NN O
and CC O
CHEK2 NNP O
separately RB O
, , O
again RB O
no DT O
noticeably RB O
difference NN O
in IN O
relapse NN O
- HYPH O
free JJ O
survival NN O
were VBD O
seen VBN O
( -LRB- O
Figure NNP O
1C NNP O
) -RRB- O
. . O

Notably RB O
, , O
in IN O
addition NN O
to IN O
a DT O
short JJ O
median JJ O
follow NN O
- HYPH O
up NN O
time NN O
, , O
a DT O
total NN O
of IN O
35 CD O
patients NNS B-Species
with IN O
a DT O
sub NN O
- HYPH O
optimal JJ O
response NN O
to IN O
epirubicin NN O
received VBD O
subsequent JJ O
treatment NN O
with IN O
paclitaxel NN O
, , O
which WDT O
may MD O
have VB O
influenced VBN O
the DT O
outcome NN O
. . O

CHEK2 NNP O
Mutant NNP O
' POS O
s NN O
Capability NN O
to TO O
Form VB O
Dimers NNS O

To TO O
investigate VB O
whether IN O
the DT O
identified VBN O
CHEK2 NNP O
mutations NNS O
affect VBP O
the DT O
ability NN O
of IN O
the DT O
Chk2 NNP O
protein NN O
to TO O
form VB O
dimers NNS O
, , O
co NN O
- HYPH O
transfection NN O
and CC O
immunopresipitation NN O
of IN O
V5 NNP O
- HYPH O
tagged VBN O
mutants NNS O
and CC O
Xpress NNP O
- HYPH O
tagged VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
were VBD O
performed VBN O
using VBG O
CHEK2 NNP O
low RB O
- HYPH O
expressing VBG O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
. . O

As IN O
we PRP O
identified VBD O
the DT O
previously RB O
characterized VBN O
CHEK2 NNP O
germline NN O
mutants NNS O
variants NNS O
Arg117His NNP O
( , O
n CD O
= SYM O
2 CD O
and CC O
Ile157Thr NNP O
( , O
n CD O
= SYM O
1 CD O
) -RRB- O
among IN O
patients NNS B-Species
allocated VBN O
to IN O
primary JJ O
treatment NN O
with IN O
paclitaxel NN O
in IN O
our PRP$ O
ongoing JJ O
study NN O
, , O
these DT O
mutants NNS O
were VBD O
evaluated VBN O
together RB O
with IN O
Arg95Ter NNP O
and CC O
Ile364Thr NNP O
. . O

The DT O
results NNS O
presented VBN O
in IN O
Figure NN O
2 CD O
show VBP O
that IN O
all DT O
Chk2 NNP O
variants NNS O
carrying VBG O
a DT O
point NN O
mutation NN O
were VBD O
able JJ O
to TO O
form VB O
dimers NNS O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
, , O
whereas IN O
the DT O
Arg95Ter NNP O
variant NN O
was VBD O
not RB O
. . O

Kinase NNP O
Activity NN O
of IN O
CHEK2 NNP O
Mutants NNPS O

To TO O
investigate VB O
whether IN O
the DT O
identified VBN O
CHEK2 NNP O
mutants NNS O
retained VBD O
the DT O
wild JJ O
- HYPH O
type NN O
kinase NN O
activity NN O
, , O
an DT O
in FW O
vitro FW O
Chk2 NNP O
kinase NN O
assay NN O
with IN O
respect NN O
to IN O
Chk2 NNP O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
was VBD O
performed VBN O
. . O

The DT O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
were VBD O
preferred VBN O
for IN O
this DT O
assay NN O
because IN O
they PRP O
were VBD O
previously RB O
found VBN O
to TO O
express VB O
only RB O
low JJ O
levels NNS O
of IN O
endogenous JJ O
Chk2 NNP O
[ -LRB- O
44 CD O
] -RRB- O
. . O

This DT O
was VBD O
confirmed VBN O
by IN O
us PRP O
using VBG O
an DT O
antibody NN O
recognizing VBG O
endogenous JJ O
protein NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

These DT O
cells NNS O
have VBP O
previously RB O
been VBN O
used VBN O
by IN O
other JJ O
investigators NNS O
to TO O
study VB O
Chk2 NNP O
kinase NN O
activity NN O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
45 CD O
] -RRB- O
, , O
[ -LRB- O
46 CD O
] -RRB- O
. . O

The DT O
two CD O
mutants NNS O
Arg117Gly NNP O
and CC O
Ile157Thr NNP O
were VBD O
previously RB O
tested VBN O
for IN O
in FW O
vitro FW O
kinase NN O
activity NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
but CC O
were VBD O
both DT O
included VBN O
here RB O
, , O
together RB O
with IN O
wild JJ O
- HYPH O
type NN O
CHEK2 NNP O
as IN O
controls NNS O
. . O

Compared VBN O
to IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
, , O
the DT O
Ile157Thr NNP O
mutant NN O
retained VBD O
wild JJ O
- HYPH O
type NN O
kinase NN O
activity NN O
. . O

The DT O
mutant JJ O
Ile364Thr NNP O
showed VBD O
partially RB O
reduced VBN O
kinase NN O
activity NN O
both CC O
in IN O
term NN O
of IN O
Cdc25 NN O
- HYPH O
phosphorylation NN O
and CC O
autophosphorylation NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
mutant NN O
Arg117Gly NNP O
showed VBD O
strongly RB O
reduced VBN O
kinase NN O
activity NN O
while IN O
the DT O
Arg95Ter NNP O
mutant NN O
was VBD O
totally RB O
devoid JJ O
of IN O
any DT O
Chk2 NNP O
kinase NN O
activity NN O
. . O

The DT O
activity NN O
recorded VBN O
for IN O
Ile157Thr NNP O
and CC O
Arg117Gly NNP O
was VBD O
consistent JJ O
with IN O
previously RB O
reported VBN O
results NNS O
for IN O
these DT O
two CD O
mutants NNS O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Notably RB O
, , O
there EX O
was VBD O
an DT O
internal JJ O
consistency NN O
with IN O
respect NN O
to IN O
percentage NN O
activity NN O
reduction NN O
comparing VBG O
individual JJ O
mutants NNS O
with IN O
respect NN O
to IN O
autophosphorylation NN O
and CC O
phosphorylation NN O
of IN O
Cdc25 NNP O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Since IN O
enzymatically RB O
active JJ O
Chk2 NNP O
exists VBZ O
as IN O
dimers NNS O
, , O
it PRP O
was VBD O
important JJ O
to TO O
determine VB O
the DT O
effect NN O
of IN O
Chk2 NNP O
mutants NNS O
on IN O
wild JJ O
- HYPH O
type NN O
/ SYM O
mutant JJ O
heterodimer NN O
kinase NN O
activity NN O
. . O

The DT O
effect NN O
on IN O
Chk2 NNP O
kinase NN O
activities NNS O
( -LRB- O
Chk2 NNP O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
) -RRB- O
of IN O
the DT O
individual JJ O
mutants NNS O
were VBD O
therefore RB O
determined VBN O
after IN O
co NN O
- HYPH O
transfection NN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

The DT O
results NNS O
from IN O
this DT O
co NN O
- HYPH O
transfection NN O
- HYPH O
kinase NN O
assay NN O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
were VBD O
similar JJ O
to IN O
those DT O
of IN O
the DT O
single JJ O
- HYPH O
transfection NN O
assay NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
except IN O
in IN O
the DT O
case NN O
of IN O
the DT O
Arg117Gly NNP O
mutant NN O
, , O
which WDT O
expressed VBD O
a DT O
substantial JJ O
kinase NN O
activity NN O
when WRB O
complexed VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
previous JJ O
data NNS O
indicating VBG O
that IN O
the DT O
Arg117Gly NNP O
mutant NN O
has VBZ O
neglectable JJ O
kinase NN O
activity NN O
itself PRP O
but CC O
dimerizes VBZ O
efficiently RB O
to IN O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
without IN O
strongly RB O
affecting VBG O
the DT O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
activity NN O
. . O

Hence RB O
, , O
the DT O
activity NN O
detected VBN O
is VBZ O
probably RB O
caused VBN O
by IN O
the DT O
co NN O
- HYPH O
transfected VBN O
and CC O
co NN O
- HYPH O
precipitated VBN O
wild JJ O
- HYPH O
type NN O
protein NN O
. . O

To TO O
rule VB O
out RP O
the DT O
possibility NN O
that IN O
endogenously RB O
expressed VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
contributed VBD O
to IN O
observed JJ O
Arg117Gly NNP O
kinase NN O
activity NN O
shown VBN O
in IN O
Figure NNP O
4 CD O
, , O
we PRP O
compared VBD O
the DT O
Arg117Gly NNP O
variant JJ O
activity NN O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
co NN O
- HYPH O
transfected VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
to IN O
the DT O
activities NNS O
of IN O
Arg95Ter NNP O
under IN O
the DT O
same JJ O
conditions NNS O
. . O

The DT O
Arg95Ter NNP O
variant NN O
does VBZ O
not RB O
form VB O
dimers NNS O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
5 CD O
, , O
Arg117Gly NNP O
, , O
which WDT O
forms VBZ O
dimers NNS O
with IN O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
, , O
allows VBZ O
increased JJ O
activity NN O
when WRB O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
as IN O
compared VBN O
to IN O
the DT O
corresponding VBG O
activity NN O
for IN O
the DT O
Arg95Ter NNP O
mutant NN O
. . O

The DT O
fact NN O
that IN O
Arg117Gly NNP O
, , O
when WRB O
transfected VBN O
alone RB O
, , O
displays VBZ O
very RB O
similar JJ O
activity NN O
as IN O
Arg95Ter NNP O
or CC O
negative JJ O
control NN O
( , O
background NN O
levels NNS O
) -RRB- O
, , O
strongly RB O
indicates VBZ O
that IN O
the DT O
contribution NN O
of IN O
endogenous JJ O
Chk2 NNP O
, , O
which WDT O
, , O
similarly RB O
to IN O
exogenously RB O
expressed VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
co NN O
- HYPH O
precipitate NN O
with IN O
Arg117Gly NNP O
is VBZ O
non RB O
- HYPH O
significant JJ O
. . O

Family NN O
Cancer NN O
Incidence NN O
in IN O
Relation NN O
to IN O
CHEK2 NN O
Germline NN O
Mutations NNS O

Following VBG O
an DT O
initial JJ O
report NN O
of IN O
a DT O
family NN O
with IN O
a DT O
CHEK2 NNP O
germline NN O
mutation NN O
expressing VBG O
an DT O
increased JJ O
cancer NN O
incidence NN O
resembling VBG O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
recent JJ O
studies NNS O
have VBP O
revealed VBN O
the DT O
more RBR O
common JJ O
CHEK2 NN O
mutations NNS O
to TO O
be VB O
associated VBN O
with IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
colorectal JJ O
cancers NNS O
. . O

We PRP O
hypothesized VBD O
that IN O
CHEK2 NNP O
mutations NNS O
having VBG O
a DT O
detrimental JJ O
effect NN O
on IN O
drug NN O
sensitivity NN O
could MD O
be VB O
associated VBN O
with IN O
a DT O
more RBR O
aggressive JJ O
, , O
Li NNP O
- HYPH O
Fraumeni NNP O
or CC O
a DT O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
( -LRB- O
LFL NNP O
) , O
cancer NN O
syndrome NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Except IN O
from IN O
the DT O
patient NN B-Species
harboring VBG O
the DT O
Ile364Thr NNP O
mutation NN O
who WP O
did VBD O
not RB O
have VB O
any DT O
known VBN O
congestion NN O
of IN O
cancer NN O
disease NN O
in IN O
the DT O
family NN O
, , O
a DT O
detailed VBN O
assessment NN O
of IN O
family NN O
cancer NN O
history NN O
was VBD O
performed VBN O
for IN O
each DT O
patient NN B-Species
harboring VBG O
a DT O
germline NN O
CHEK2 NNP O
mutation NN O
. . O

The DT O
family NN O
cancer NN O
pedigrees NNS O
are VBP O
depicted VBN O
in IN O
Figure NNP O
6 CD O
. . O

While IN O
patients NNS B-Species
harboring VBG O
CHEK2 NNP O
germline NN O
mutations NNS O
revealed VBD O
different JJ O
types NNS O
of IN O
cancers NNS O
( , O
mainly RB O
breast NN O
and CC O
tumors NNS O
of IN O
the DT O
gastrointestinal JJ O
area NN O
) , O
in IN O
their PRP$ O
family NN O
, , O
surprisingly RB O
, , O
no DT O
distinct JJ O
pattern NN O
discriminating VBG O
families NNS O
harboring VBG O
the DT O
Arg95Ter NNP O
mutation NN O
from IN O
the DT O
other JJ O
CHEK2 NNP O
mutated VBN O
families NNS O
could MD O
be VB O
identified VBN O
. . O

One CD O
of IN O
them PRP O
( , O
Epi203 NNP O
) -RRB- O
, , O
who WP O
inherited VBD O
the DT O
mutation NN O
from IN O
her PRP$ O
father NN O
' POS O
s NNS O
side NN O
of IN O
the DT O
family NN O
, , O
had VBD O
no DT O
accumulation NN O
of IN O
either CC O
breast NN O
or CC O
colorectal JJ O
cancer NN O
on IN O
that DT O
side NN O
. . O

It PRP O
should MD O
be VB O
noted VBN O
, , O
however RB O
, , O
that IN O
two CD O
brothers NNS O
of IN O
her PRP$ O
fathers NNS O
mother NN O
had VBD O
prostate NN O
cancer NN O
, , O
and CC O
two CD O
siblings NNS O
of IN O
his PRP$ O
father NN O
having VBG O
hepatocellular JJ O
carcinoma NN O
and CC O
bladder NN O
cancer NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
the DT O
other JJ O
expressed VBD O
a DT O
disease NN O
pattern NN O
resembling VBG O
what WP O
has VBZ O
been VBN O
seen VBN O
with IN O
the DT O
more RBR O
common JJ O
CHEK2 NNP O
mutations NNS O
, , O
like IN O
del1100C NNP O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Discussion NN O

TP53 NNP O
plays VBZ O
a DT O
key JJ O
role NN O
as IN O
a DT O
tumor NN O
suppressor NN O
gene NN O
. . O

Its PRP$ O
protein NN O
product NN O
activates VBZ O
processes NNS O
such JJ O
as IN O
growth NN O
arrest NN O
, , O
DNA NN O
repair NN O
, , O
apoptosis NN O
and CC O
/ SYM O
or CC O
senescence NN O
in IN O
response NN O
to IN O
genotoxic JJ O
damage NN O
as RB O
well RB O
as IN O
oncogene NN O
activity NN O
[ -LRB- O
49 CD O
] -RRB- O
, , O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Despite IN O
being VBG O
extensively RB O
studied VBN O
, , O
critical JJ O
issues NNS O
regarding VBG O
regulation NN O
of IN O
the DT O
p53 NN O
protein NN O
remain VBP O
poorly RB O
understood VBN O
, , O
and CC O
conflicting VBG O
evidence NN O
obtained VBN O
in IN O
different JJ O
experimental JJ O
systems NNS O
make VBP O
the DT O
clinical JJ O
relevance NN O
of IN O
experimental JJ O
data NNS O
questionable JJ O
. . O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cancer NN O
cure NN O
in IN O
most JJS O
malignancies NNS O
, , O
including VBG O
breast NN O
cancer NN O
. . O

Previously RB O
, , O
we PRP O
found VBD O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
DNA NNP O
binding NN O
domain NN O
to TO O
be VB O
associated VBN O
with IN O
lack NN O
of IN O
responsiveness NN O
to IN O
doxorubicin NN O
monotherapy NN O
[ -LRB- O
13 CD O
] -RRB- O
as RB O
well RB O
as IN O
mitomycin NN O
and CC O
5 CD O
- HYPH O
fluoro NN O
- HYPH O
uracil NN O
in IN O
concert NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

However RB O
, , O
some DT O
tumors NNS O
revealed VBD O
therapy NN O
resistance NN O
despite IN O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NN O
. . O

Postulating VBG O
that IN O
these DT O
tumors NNS O
may MD O
harbor VB O
genetic JJ O
disturbances NNS O
in IN O
genes NNS O
playing VBG O
a DT O
key JJ O
role NN O
in IN O
the DT O
p53 NN O
pathway NN O
, , O
we PRP O
here RB O
sequenced VBD O
TP53 NNP O
along IN O
with IN O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
, , O
the DT O
latter JJ O
two CD O
known VBN O
to TO O
play VB O
a DT O
critical JJ O
role NN O
as IN O
p53 NN O
activators NNS O
, , O
in IN O
tumors NNS O
from IN O
109 CD O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
monotherapy NN O
. . O

Our PRP$ O
results NNS O
confirm VBP O
TP53 NN O
mutations NNS O
, , O
in IN O
particular JJ O
those DT O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
, , O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
. . O

Most RBS O
importantly RB O
, , O
we PRP O
also RB O
found VBD O
CHEK2 NNP O
mutations NNS O
generating VBG O
a DT O
non JJ O
- HYPH O
functional JJ O
protein NN O
in IN O
our PRP$ O
in FW O
vitro FW O
assays NNS O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
. . O

In IN O
contrast NN O
, , O
none NN O
of IN O
our PRP$ O
tumors NNS O
harbored VBD O
either CC O
mutations NNS O
or CC O
expressed VBN O
promoter NN O
hypermethylations NNS O
affecting VBG O
the DT O
p14 NN O
. . O

Based VBN O
on IN O
in FW O
vitro FW O
assays NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
classify VB O
the DT O
different JJ O
Chk2 NNP O
mutants NNS O
with IN O
respect NN O
to IN O
dimerization NN O
capability NN O
as RB O
well RB O
as IN O
kinase NN O
activity NN O
( , O
Chk2 NN O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
kinase NN O
activities NNS O
of IN O
the DT O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
/ SYM O
mutant JJ O
complexes NNS O
were VBD O
monitored VBN O
in IN O
co NN O
- HYPH O
transfection NN O
experiments NNS O
. . O

Notably RB O
, , O
each DT O
point NN O
mutation NN O
( , O
except IN O
for IN O
Arg117Gly NNP O
) -RRB- O
revealed VBD O
similar JJ O
relative JJ O
kinase NN O
efficacy NN O
whether IN O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
or CC O
not RB O
( -LRB- O
Figure NN O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

Cells NNS O
co NN O
- HYPH O
transfected VBN O
with IN O
Arg117Gly NNP O
and CC O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
revealed VBD O
kinase NN O
activity NN O
, , O
probably RB O
due JJ O
to IN O
the DT O
contribution NN O
of IN O
the DT O
wild JJ O
type NN O
protein NN O
in IN O
Chk2 NNP O
mutant JJ O
- HYPH O
wild JJ O
- HYPH O
type NN O
heterodimers NNS O
. . O

In IN O
contrast NN O
, , O
cells NNS O
transfected VBN O
with IN O
Arg95Ter NNP O
revealed VBD O
no DT O
kinase NN O
activity NN O
whether IN O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
or CC O
not RB O
, , O
clearly RB O
distinguishing VBG O
this DT O
mutation NN O
from IN O
the DT O
others NNS O
( -LRB- O
Figure NN O
3 CD O
and CC O
5 CD O
) -RRB- O
. . O

All DT O
in IN O
vitro FW O
assays NNS O
were VBD O
based VBN O
on IN O
transfection NN O
of IN O
the DT O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cell NN O
line NN O
, , O
a DT O
cell NN O
line NN O
known VBN O
to TO O
express VB O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
at IN O
low JJ O
levels NNS O
, , O
and CC O
previously RB O
used VBN O
by IN O
other JJ O
investigators NNS O
to TO O
study VB O
Chk2 NNP O
activity NN O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
45 CD O
] -RRB- O
, , O
[ -LRB- O
46 CD O
] -RRB- O
. . O

Since IN O
we PRP O
were VBD O
not RB O
able JJ O
to TO O
obtain VB O
satisfactory JJ O
technical JJ O
quality NN O
of IN O
the DT O
kinase NN O
assay NN O
in IN O
cell NN O
lines NNS O
negative JJ O
for IN O
Chk2 NNP O
( -LRB- O
HCT NNP O
15 CD O
and CC O
HCT NNP O
116 CD O
) -RRB- O
, , O
we PRP O
assessed VBD O
potential JJ O
background NN O
kinase NN O
activity NN O
due IN O
to IN O
endogenous JJ O
Chk2 NNP O
by IN O
performing VBG O
western JJ O
blot NN O
analysis NN O
revealing VBG O
the DT O
endogenous JJ O
levels NNS O
of IN O
Chk2 NNP O
in IN O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
to TO O
be VB O
non RB O
- HYPH O
significant JJ O
compared VBN O
to IN O
the DT O
exogenously RB O
expressed VBN O
Chk2 NNP O
levels NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
also RB O
performed VBD O
a DT O
separate JJ O
kinase NN O
assay NN O
, , O
directly RB O
comparing VBG O
the DT O
effect NN O
of IN O
binding VBG O
partners NNS O
for IN O
the DT O
dimerizing VBG O
Arg117Gly NNP O
and CC O
the DT O
non AFX O
- HYPH O
dimerizing VBG O
Arg95Ter NNP O
. . O

This DT O
assay NN O
also RB O
revealed VBD O
the DT O
contribution NN O
of IN O
endogenous JJ O
Chk2 NNP O
to TO O
be VB O
non RB O
- HYPH O
significant JJ O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Taking VBG O
our PRP$ O
in FW O
vitro FW O
findings NNS O
together RB O
with IN O
in IN O
vivo NN O
observations NNS O
, , O
our PRP$ O
present JJ O
data NNS O
confirm VBP O
that IN O
the DT O
functionally RB O
defective JJ O
CHEK2 NNP O
Arg95Ter NNP O
mutation NN O
, , O
together RB O
with IN O
LOH NNP O
, , O
is VBZ O
associated VBN O
with IN O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
. . O

In IN O
contrast NN O
, , O
the DT O
patient NN B-Species
harboring VBG O
the DT O
Ile364Thr NNP O
mutation NN O
, , O
moderately RB O
reducing VBG O
phosphorylation NN O
activity NN O
, , O
responded VBD O
well RB O
to IN O
therapy NN O
. . O

The DT O
other JJ O
missense NN O
mutations NNS O
; , O
Arg117Gly NNP O
and CC O
Ile157Thr NNP O
were VBD O
observed VBN O
among IN O
patients NNS B-Species
receiving VBG O
paclitaxel NN O
therapy NN O
only RB O
; : O
thus RB O
, , O
their PRP$ O
influence NN O
on IN O
anthracycline NN O
sensitivity NN O
in IN O
vivo NN O
could MD O
not RB O
be VB O
addressed VBN O
. . O

Yet CC O
, , O
based VBN O
on IN O
the DT O
finding NN O
that IN O
the DT O
Arg117Gly NNP O
mutant NN O
expressed VBD O
no DT O
intrinsic JJ O
activity NN O
, , O
but CC O
readily RB O
dimerized VBN O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
protein NN O
without IN O
abolishing VBG O
its PRP$ O
activity NN O
, , O
we PRP O
hypothesize VBP O
that IN O
this DT O
mutation NN O
and CC O
, , O
probably RB O
, , O
other JJ O
yet CC O
unidentified JJ O
CHEK2 NNP O
mutations NNS O
with IN O
a DT O
similar JJ O
lack NN O
of IN O
intrinsic JJ O
kinase NN O
activity NN O
, , O
may MD O
cause VB O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
if IN O
combined VBN O
with IN O
LOH NNP O
in IN O
breast NN O
cancer NN O
. . O

Our PRP$ O
present JJ O
findings NNS O
have VBP O
two CD O
major JJ O
implications NNS O
. . O

First RB O
, , O
we PRP O
confirm VBP O
that IN O
mutations NNS O
in IN O
genes NNS O
encoding VBG O
proteins NNS O
located VBN O
within IN O
the DT O
same JJ O
functional JJ O
pathway NN O
may MD O
substitute VB O
for IN O
each DT O
other JJ O
with IN O
respect NN O
to IN O
drug NN O
sensitivity NN O
, , O
revealing VBG O
for IN O
the DT O
first JJ O
time NN O
a DT O
functional JJ O
pathway NN O
critical JJ O
to IN O
chemotherapy NN O
response NN O
in IN O
vivo NN O
. . O

Second RB O
, , O
the DT O
identification NN O
of IN O
mutations NNS O
in IN O
the DT O
CHEK2 NNP O
but CC O
not RB O
in IN O
the DT O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
gene NN O
in IN O
resistant JJ O
tumors NNS O
suggests VBZ O
that IN O
Chk2 NNP O
mediated VBN O
phosphorylation NN O
of IN O
p53 NN O
is VBZ O
a DT O
critical JJ O
event NN O
in IN O
executing VBG O
anti JJ O
- HYPH O
tumor NN O
effect NN O
as IN O
a DT O
response NN O
to IN O
DNA NN O
damaging JJ O
agents NNS O
in IN O
breast NN O
cancer NN O
. . O

This DT O
adds VBZ O
to IN O
our PRP$ O
understanding NN O
not RB O
only RB O
of IN O
the DT O
function NN O
of IN O
p53 NN O
but CC O
Chk2 NNP O
as RB O
well RB O
. . O

p53 NN O
undergoes VBZ O
phosphorylation NN O
at IN O
multiple JJ O
sites NNS O
by IN O
different JJ O
kinases NNS O
, , O
including VBG O
Chk2 NNP O
[ -LRB- O
51 CD O
] -RRB- O
. . O

While IN O
activation NN O
of IN O
the DT O
ATM NNP O
leading VBG O
to IN O
direct JJ O
( -LRB- O
Ser NNP O
15 CD O
) -RRB- O
and CC O
Chk2 NN O
- HYPH O
mediated VBN O
( -LRB- O
Ser NNP O
20 CD O
) -RRB- O
phosphorylation NN O
of IN O
p53 NN O
is VBZ O
considered VBN O
an DT O
important JJ O
mechanism NN O
for IN O
triggering VBG O
p53 NN O
activation NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
[ -LRB- O
52 CD O
] -RRB- O
, , O
some DT O
reports NNS O
suggest VBP O
ATM NNP O
[ -LRB- O
53 CD O
] -RRB- O
and CC O
even RB O
Chk2 NNP O
[ -LRB- O
23 CD O
] -RRB- O
to TO O
be VB O
redundant JJ O
to IN O
this DT O
function NN O
. . O

Importantly RB O
, , O
Chk2 NNP O
has VBZ O
been VBN O
shown VBN O
capable JJ O
of IN O
inducing VBG O
ATM NNP O
- HYPH O
independent JJ O
apoptosis NN O
in IN O
vitro FW O
[ -LRB- O
21 CD O
] -RRB- O
. . O

While IN O
Chk2 NNP O
phosphorylates NNS O
p53 NN O
at IN O
Ser NNP O
20 CD O
, , O
thereby RB O
stabilizing VBG O
p53 NN O
by IN O
preventing VBG O
MDM2 NNP O
binding NN O
[ -LRB- O
19 CD O
] -RRB- O
, , O
Chk2 NNP O
also RB O
phosphorylates VBZ O
p53 NN O
at IN O
six CD O
additional JJ O
sites NNS O
, , O
including VBG O
Ser NNP O
313 CD O
and CC O
Ser NNP O
314 CD O
located VBN O
in IN O
the DT O
nuclear JJ O
localization NN O
signal NN O
domain NN O
of IN O
p53 NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
Chk2 NNP O
phosphorylates NNS O
other JJ O
important JJ O
targets NNS O
like IN O
BRCA1 NNP O
, , O
Cdc25A NNP O
and CC O
Cdc25C NNP O
involved VBN O
in IN O
DNA NN O
repair NN O
, , O
G1 NNP O
and CC O
G2 NNP O
arrest NN O
, , O
respectively RB O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Despite IN O
the DT O
wide JJ O
range NN O
of IN O
known VBN O
Chk2 NNP O
substrates NNS O
relevant JJ O
for IN O
DNA NN O
repair NN O
and CC O
cell NN O
cycle NN O
control NN O
, , O
our PRP$ O
present JJ O
findings NNS O
that IN O
CHEK2 NNP O
mutations NNS O
leading VBG O
to IN O
non JJ O
- HYPH O
functional JJ O
Chk2 NNP O
protein NN O
may MD O
substitute VB O
for IN O
p53 NN O
mutations NNS O
strongly RB O
advocate VBP O
a DT O
role NN O
for IN O
Chk2 NNP O
with IN O
respect NN O
to IN O
drug NN O
sensitivity NN O
executed VBN O
through IN O
p53 NN O
activation NN O
. . O

Notably RB O
, , O
one CD O
of IN O
the DT O
tumors NNS O
( -LRB- O
Epi203 NNP O
) -RRB- O
with IN O
the DT O
Arg95Ter NNP O
CHEK2 NNP O
mutation NN O
in IN O
addition NN O
harbored VBD O
a DT O
somatic JJ O
TP53 NN O
mutation NN O
, , O
Arg175His NNP O
, , O
with IN O
allelic JJ O
imbalance NN O
for IN O
the DT O
TP53 NN O
gene NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Importantly RB O
, , O
among IN O
another DT O
four CD O
patients NNS B-Species
in IN O
this DT O
study NN O
( , O
Epi063 NNP O
, , O
Epi071 NNP O
, , O
Epi087 NNP O
, , O
Epi153 NNP O
) -RRB- O
and CC O
one CD O
patient NN B-Species
from IN O
our PRP$ O
previous JJ O
doxorubicin NN O
protocol NN O
[ -LRB- O
13 CD O
] -RRB- O
harboring VBG O
the DT O
Arg175His NNP O
mutation NN O
together RB O
with IN O
allelic JJ O
imbalance NN O
for IN O
TP53 NN O
, , O
all DT O
five CD O
of IN O
these DT O
patients NNS B-Species
responded VBD O
to IN O
anthracycline NN O
therapy NN O
either CC O
with IN O
a DT O
partial JJ O
response NN O
or CC O
stable JJ O
disease NN O
. . O

In IN O
contrast NN O
, , O
Epi132 NNP O
and CC O
the DT O
only JJ O
patient NN B-Species
for IN O
whom WP O
we PRP O
previously RB O
identified VBD O
a DT O
non AFX O
- HYPH O
functional JJ O
CHEK2 NNP O
mutation NN O
( -LRB- O
1368InsA CD O
; : O
coding VBG O
for IN O
a DT O
non JJ O
- HYPH O
functional JJ O
protein NN O
translate NN O
with IN O
cytoplasmic JJ O
location NN O
[ -LRB- O
26 CD O
] -RRB- O
) -RRB- O
expressed VBD O
resistance NN O
to IN O
epirubicin NN O
and CC O
doxorubicin NN O
, , O
respectively RB O
. . O

Arg175His NNP O
is VBZ O
a DT O
p53 NN O
"""" `` O
hot JJ O
- HYPH O
spot NN O
"""" '' O
structural JJ O
mutation NN O
reported VBN O
to TO O
have VB O
defects NNS O
with IN O
respect NN O
to IN O
transcriptional JJ O
activation NN O
and CC O
also RB O
to TO O
negatively RB O
interact VB O
with IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

While IN O
this DT O
mutation NN O
has VBZ O
been VBN O
shown VBN O
to TO O
enhance VB O
chemoresistance NN O
upon IN O
transfection NN O
into IN O
p53 NN O
null NN O
Saos NNP O
- HYPH O
2 CD O
cells NNS O
[ -LRB- O
56 CD O
] -RRB- O
, , O
these DT O
osteosarcoma NN O
- HYPH O
derived VBN O
cells NNS O
may MD O
not RB O
necessarily RB O
be VB O
representative JJ O
for IN O
breast NN O
cancers NNS O
in IN O
vivo NN O
. . O

Recent JJ O
evidence NN O
strongly RB O
support VBP O
p53 NN O
to TO O
be VB O
involved VBN O
also RB O
in IN O
non NN O
- HYPH O
transcriptional JJ O
mediated VBN O
apoptosis NN O
by IN O
interacting VBG O
with IN O
the DT O
Bcl NNP O
- HYPH O
2 CD O
/ SYM O
Bax NNP O
system NN O
[ -LRB- O
57 CD O
] -RRB- O
, , O
and CC O
transcription NN O
- HYPH O
defect NN O
structural JJ O
p53 NN O
mutants NNS O
have VBP O
been VBN O
shown VBN O
to TO O
execute VB O
non JJ O
- HYPH O
transcriptional JJ O
apoptosis NN O
in IN O
experimental JJ O
systems NNS O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Concomitant JJ O
inactivation NN O
of IN O
Chk2 NNP O
and CC O
p53 NN O
in IN O
breast NN O
cancer NN O
has VBZ O
been VBN O
recorded VBN O
by IN O
others NNS O
[ -LRB- O
59 CD O
] -RRB- O
, , O
and CC O
the DT O
finding NN O
that IN O
a DT O
somatic JJ O
mutation NN O
may MD O
generate VB O
a DT O
"""" `` O
growth NN O
advantage NN O
"""" '' O
in IN O
tumor NN O
cells NNS O
already RB O
harboring VBG O
a DT O
germline NN O
CHEK2 NN O
mutation NN O
may MD O
not RB O
implicate VB O
an DT O
effect NN O
on IN O
drug NN O
sensitivity NN O
in IN O
tumors NNS O
not RB O
yet RB O
exposed VBN O
to IN O
cytotoxic JJ O
compounds NNS O
. . O

Rather RB O
, , O
it PRP O
may MD O
indicate VB O
a DT O
growth NN O
advantage NN O
, , O
probably RB O
related VBN O
to IN O
loss NN O
of IN O
p21 NN O
function NN O
. . O

Notably RB O
, , O
in IN O
a DT O
previous JJ O
study NN O
we PRP O
found VBD O
the DT O
p21 NN O
polymorphism NN O
G251A NN O
to TO O
be VB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
developing VBG O
large JJ O
breast NN O
cancers NNS O
but CC O
to TO O
have VB O
no DT O
effect NN O
on IN O
drug NN O
sensitivity NN O
[ -LRB- O
60 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
growth NN O
rate NN O
and CC O
drug NN O
resistance NN O
may MD O
be VB O
regulated VBN O
independently RB O
. . O

Taken VBN O
together RB O
, , O
we PRP O
believe VBP O
our PRP$ O
findings NNS O
advocate VBP O
a DT O
role NN O
for IN O
Chk2 NNP O
in IN O
executing VBG O
cellular JJ O
response NN O
to IN O
anthracycline NN O
- HYPH O
induced VBN O
DNA NNP O
damage NN O
. . O

As IN O
mentioned VBN O
above RB O
, , O
removing VBG O
TP53 NN O
mutated VBN O
tumors NNS O
including VBG O
the DT O
double RB O
- HYPH O
mutated VBN O
Epi203 NNP O
from IN O
statistical JJ O
analysis NN O
, , O
CHEK2 NNP O
mutation NN O
status NN O
still RB O
predicted VBN O
for IN O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
. . O

In IN O
addition NN O
, , O
removing VBG O
the DT O
tumors NNS O
harboring VBG O
the DT O
Arg175His NNP O
mutation NN O
from IN O
the DT O
p53 NN O
"""" `` O
L2 NNP O
/ SYM O
L3 NNP O
"""" '' O
group NN O
strengthened VBD O
the DT O
correlation NN O
to IN O
lack NN O
of IN O
treatment NN O
response NN O
to IN O
epirubicin NN O
( , O
p NN O
= SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Comparing VBG O
the DT O
effects NNS O
of IN O
mutations NNS O
in IN O
the DT O
CHEK2 NNP O
gene NN O
to IN O
TP53 NN O
mutations NNS O
indirectly RB O
underlines VBZ O
the DT O
importance NN O
of IN O
the DT O
role NN O
of IN O
Chk2 NNP O
to IN O
chemoresistance NN O
. . O

Our PRP$ O
present JJ O
findings NNS O
as RB O
well RB O
as IN O
results NNS O
from IN O
our PRP$ O
previous JJ O
studies NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
14 CD O
] -RRB- O
revealed VBD O
that IN O
about RB O
50 CD O
% NN O
of IN O
the DT O
patients NNS B-Species
with IN O
tumors NNS O
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
to TO O
be VB O
non NN O
- HYPH O
responders NNS O
to IN O
primary JJ O
therapy NN O
. . O

In IN O
contrast NN O
, , O
all PDT O
our PRP$ O
three CD O
patients NNS B-Species
harboring VBG O
a DT O
non AFX O
- HYPH O
functional JJ O
CHEK2 NN O
mutation NN O
( , O
the DT O
two CD O
Arg95Ter NNP O
mutated VBN O
patients NNS B-Species
here RB O
and CC O
our PRP$ O
previous JJ O
patient NN B-Species
harboring VBG O
the DT O
1368InsA NNP O
) -RRB- O
expressed VBD O
primary JJ O
resistance NN O
to IN O
therapy NN O
. . O

We PRP O
previously RB O
hypothesized VBD O
that IN O
therapy NN O
response NN O
in IN O
tumors NNS O
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
could MD O
be VB O
due IN O
to IN O
redundant JJ O
pathways NNS O
acting VBG O
in IN O
concert NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Although IN O
no DT O
definite JJ O
conclusion NN O
should MD O
be VB O
drawn VBN O
from IN O
a DT O
limited JJ O
number NN O
of IN O
observation NN O
, , O
the DT O
fact NN O
that IN O
Chk2 NNP O
not RB O
only RB O
phosphorylates VBZ O
p53 NN O
but CC O
also RB O
phosphorylates VBZ O
other JJ O
substrates NNS O
such JJ O
as IN O
Cdc25A NNP O
and CC O
Cdc25C NNP O
[ -LRB- O
54 CD O
] -RRB- O
and CC O
E2F1 NN O
in IN O
response NN O
to IN O
etoposide NN O
- HYPH O
induced VBN O
DNA NNP O
damage NN O
[ -LRB- O
61 CD O
] -RRB- O
may MD O
indicate VB O
that IN O
inactivation NN O
of IN O
redundant JJ O
pathways NNS O
could MD O
take VB O
place NN O
in IN O
parallel NN O
. . O

The DT O
literature NN O
remains VBZ O
inconsistent JJ O
with IN O
respect NN O
to IN O
whether IN O
the DT O
border NN O
amino NN O
acids NNS O
163 CD O
, , O
195 CD O
, , O
236 CD O
and CC O
251 CD O
should MD O
be VB O
included VBN O
in IN O
the DT O
p53 NN O
L2 NNP O
and CC O
L3 NNP O
domains NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Taking VBG O
a DT O
conservative JJ O
approach NN O
, , O
we PRP O
classified VBD O
patient JJ B-Species
Epi56 NNP O
, , O
harboring VBG O
a DT O
mutation NN O
in IN O
codon NN O
163 CD O
, , O
as IN O
a DT O
L2 NNP O
/ SYM O
L3 NNP O
mutant NN O
. . O

The DT O
patient NN B-Species
harboring VBG O
this DT O
mutation NN O
responded VBD O
to IN O
therapy NN O
( -LRB- O
PR NN O
) -RRB- O
. . O

If IN O
this DT O
mutation NN O
was VBD O
classified VBN O
as IN O
outside IN O
the DT O
L2 NNP O
domain NN O
, , O
our PRP$ O
p NN O
- HYPH O
value NN O
had VBD O
been VBN O
strengthened VBN O
from IN O
p NN O
= SYM O
0 CD O
. . O
136 CD O
to IN O
p NN O
= SYM O
0 CD O
. . O
96 CD O
. . O

Germline NN O
mutations NNS O
in IN O
TP53 NNP O
cause VBP O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
and CC O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
cancer NN O
disposition NN O
syndromes NNS O
. . O

However RB O
, , O
while IN O
the DT O
germline NN O
and CC O
somatic JJ O
mutations NNS O
associated VBN O
with IN O
these DT O
syndromes NNS O
reveal VBP O
a DT O
preference NN O
for IN O
the DT O
same JJ O
codons NNS O
[ -LRB- O
48 CD O
] -RRB- O
, , O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
seem VBP O
associated VBN O
with IN O
a DT O
poor JJ O
prognosis NN O
[ -LRB- O
62 CD O
] -RRB- O
, , O
[ -LRB- O
63 CD O
] -RRB- O
, , O
[ -LRB- O
64 CD O
] -RRB- O
and CC O
, , O
in IN O
particular JJ O
, , O
drug NN O
resistance NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
40 CD O
] -RRB- O
in IN O
breast NN O
cancer NN O
. . O

Thus RB O
, , O
tumor NN O
suppression NN O
and CC O
tumor NN O
cell NN O
response NN O
to IN O
chemotherapeutics NNS O
may MD O
involve VB O
different JJ O
parts NNS O
of IN O
p53 NN O
protein NN O
function NN O
. . O

Following VBG O
an DT O
initial JJ O
report NN O
identifying VBG O
a DT O
CHEK2 NNP O
mutation NN O
in IN O
a DT O
family NN O
expressing VBG O
characteristics NNS O
of IN O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
[ -LRB- O
65 CD O
] -RRB- O
, , O
recent JJ O
evidence NN O
has VBZ O
linked VBN O
CHEK2 NNP O
founder NN O
mutations NNS O
to IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
- HYPH O
and CC O
colorectal JJ O
cancers NNS O
with IN O
some DT O
additional JJ O
disposition NN O
for IN O
other JJ O
malignancies NNS O
as RB O
well RB O
[ -LRB- O
66 CD O
] -RRB- O
. . O

However RB O
, , O
cancer NN O
incidence NN O
and CC O
phenotypes NNS O
did VBD O
not RB O
reveal VB O
an DT O
aggressive JJ O
Li NNP O
- HYPH O
Fraumeni NNP O
or CC O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
tumor NN O
pattern NN O
. . O

Similar JJ O
to IN O
the DT O
two CD O
patients NNS B-Species
in IN O
our PRP$ O
paclitaxel NN O
treatment NN O
arm NN O
harboring VBG O
the DT O
rare JJ O
but CC O
previously RB O
characterized VBN O
mutation NN O
Arg117Gly NNP O
and CC O
the DT O
patient NN B-Species
with IN O
the DT O
Ile157Thr NNP O
mutation NN O
, , O
they PRP O
expressed VBD O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
gastrointestinal JJ O
cancers NNS O
( , O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Thus RB O
, , O
CHEK2 NNP O
resembles VBZ O
TP53 NN O
in IN O
as RB O
much JJ O
as IN O
there EX O
seems VBZ O
to TO O
be VB O
no DT O
direct JJ O
correlation NN O
between IN O
effects NNS O
of IN O
individual JJ O
mutations NNS O
with IN O
respect NN O
to IN O
tumor NN O
suppression NN O
and CC O
drug NN O
resistance NN O
. . O

Our PRP$ O
finding NN O
that IN O
TP53 NNP O
mutations NNS O
located VBN O
to IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
predicts VBZ O
drug NN O
resistance NN O
may MD O
indicate VB O
transcriptional JJ O
mechanisms NNS O
to TO O
be VB O
involved VBN O
in IN O
drug NN O
- HYPH O
induced VBN O
cell NN O
death NN O
. . O

p53 NN O
induced VBN O
apoptosis NN O
has VBZ O
been VBN O
associated VBN O
with IN O
transcriptional JJ O
induction NN O
of IN O
genes NNS O
including VBG O
Puma NNP O
and CC O
Noxa NNP O
as RB O
well RB O
as IN O
Bax NNP O
in IN O
experimental JJ O
systems NNS O
[ -LRB- O
55 CD O
] -RRB- O
, , O
[ -LRB- O
67 CD O
] -RRB- O
, , O
[ -LRB- O
68 CD O
] -RRB- O
. . O

Yet CC O
, , O
recent JJ O
evidence NN O
has VBZ O
revealed VBN O
p53 NN O
to TO O
induce VB O
apoptosis NN O
through IN O
non JJ O
- HYPH O
transcriptional JJ O
mechanisms NNS O
by IN O
direct JJ O
protein NN O
interactions NNS O
with IN O
members NNS O
of IN O
the DT O
Bcl NNP O
- HYPH O
2 CD O
/ SYM O
Bax NNP O
system NN O
and CC O
mitochondrial JJ O
release NN O
of IN O
cytochrom NN O
c NN O
[ -LRB- O
57 CD O
] -RRB- O
, , O
[ -LRB- O
69 CD O
] -RRB- O
. . O

In IN O
deed NN O
, , O
there EX O
is VBZ O
evidence NN O
that IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
, , O
in IN O
particular JJ O
the DT O
L3 NNP O
part NN O
of IN O
the DT O
protein NN O
, , O
may MD O
be VB O
critical JJ O
also RB O
to IN O
transcriptional JJ O
- HYPH O
independent JJ O
apoptosis NN O
[ -LRB- O
70 CD O
] -RRB- O
. . O

Of IN O
particular JJ O
note NN O
is VBZ O
the DT O
finding NN O
that IN O
Chk2 NNP O
may MD O
regulate VB O
transcriptional JJ O
- HYPH O
independent JJ O
p53 NN O
- HYPH O
mediated VBN O
apoptosis NN O
in IN O
response NN O
to IN O
DNA NN O
- HYPH O
damage NN O
created VBN O
through IN O
ionizing VBG O
irradiation NN O
[ -LRB- O
71 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
Krajewski NNP O
et FW O
al NNP O
[ -LRB- O
72 CD O
] -RRB- O
reported VBD O
low JJ O
expression NN O
of IN O
Bax NNP O
assessed VBN O
by IN O
immunostaining NN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
low JJ O
response NN O
to IN O
chemotherapy NN O
in IN O
metastatic JJ O
breast NN O
cancer NN O
. . O

Although IN O
no DT O
conclusion NN O
should MD O
be VB O
drawn VBN O
at IN O
this DT O
stage NN O
, , O
together RB O
these DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
the DT O
challenging VBG O
hypothesis NN O
that IN O
transcription NN O
- HYPH O
independent JJ O
activation NN O
of IN O
Bax NNP O
following VBG O
Chk2 NNP O
- HYPH O
phosphorylation NN O
may MD O
represent VB O
a DT O
key JJ O
pathway NN O
in IN O
p53 NN O
dependent JJ O
cell NN O
death NN O
in IN O
breast NN O
cancer NN O
in IN O
vivo NN O
. . O

p14 NN O
acts VBZ O
by IN O
releasing VBG O
p53 NN O
from IN O
MDM2 NNP O
binding NN O
, , O
and CC O
has VBZ O
been VBN O
related VBN O
to IN O
oncogene NN O
- HYPH O
induced VBN O
p53 NN O
activation NN O
[ -LRB- O
73 CD O
] -RRB- O
. . O

Recently RB O
, , O
p14 NN O
was VBD O
shown VBN O
to TO O
affect VB O
p53 NN O
by IN O
additional JJ O
mechanisms NNS O
, , O
including VBG O
acetylations NNS O
[ -LRB- O
74 CD O
] -RRB- O
, , O
response NN O
to IN O
ionizing VBG O
radiation NN O
in IN O
human JJ B-Species
fibroblasts NNS O
[ -LRB- O
75 CD O
] -RRB- O
, , O
and CC O
tumor NN O
- HYPH O
suppression NN O
following VBG O
ionizing VBG O
radiation NN O
in IN O
mice NNS B-Species
[ -LRB- O
76 CD O
] -RRB- O
, , O
[ -LRB- O
77 CD O
] -RRB- O
. . O

These DT O
findings NNS O
further RB O
links VBZ O
the DT O
retinoblastoma NN O
and CC O
p53 NN O
pathways NNS O
[ -LRB- O
28 CD O
] -RRB- O
. . O

As IN O
such JJ O
, , O
we PRP O
believe VBP O
the DT O
negative JJ O
finding NN O
with IN O
respect NN O
to IN O
its PRP$ O
role NN O
in IN O
chemoresistance NN O
adds VBZ O
important JJ O
information NN O
. . O

Contrasting VBG O
earlier JJR O
findings NNS O
by IN O
us PRP O
and CC O
others NNS O
[ -LRB- O
15 CD O
] -RRB- O
, , O
a DT O
recent JJ O
study NN O
revealed VBD O
TP53 NN O
mutations NNS O
to TO O
be VB O
associated VBN O
with IN O
increased VBN O
likelihood NN O
of IN O
having VBG O
a DT O
complete JJ O
response NN O
to IN O
chemotherapy NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

These DT O
results NNS O
may MD O
not RB O
necessarily RB O
be VB O
at IN O
conflict NN O
. . O

In IN O
the DT O
latter JJ O
study NN O
, , O
patients NNS B-Species
received VBD O
treatment NN O
with IN O
a DT O
"""" `` O
dose NN O
- HYPH O
dense JJ O
"""" '' O
chemotherapy NN O
regimen NN O
; : O
if IN O
confirmed VBN O
, , O
the DT O
combined VBN O
data NNS O
may MD O
outline VB O
a DT O
therapeutic JJ O
indication NN O
for IN O
aggressive JJ O
dose NN O
- HYPH O
dense JJ O
therapy NN O
based VBN O
on IN O
tumor NN O
TP53 NNP O
/ SYM O
CHEK2 NN O
status NN O
. . O

So RB O
far RB O
attempts NNS O
to TO O
identify VB O
single JJ O
markers NNS O
and CC O
, , O
more RBR O
recently RB O
, , O
gene NN O
expression NN O
arrays NNS O
predicting VBG O
chemoresistance NN O
have VBP O
not RB O
proved VBN O
successful JJ O
( : O
see VB O
refs NNS O
in IN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
findings NNS O
presented VBN O
here RB O
reveal VBP O
for IN O
the DT O
first JJ O
time NN O
defects NNS O
in IN O
a DT O
functional JJ O
gene NN O
cascade NN O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
in IN O
a DT O
human JJ B-Species
cancer NN O
in IN O
vivo NN O
. . O

Moreover RB O
, , O
the DT O
findings NNS O
are VBP O
made VBN O
in IN O
breast NN O
cancer NN O
, , O
the DT O
most RBS O
frequent JJ O
malignant JJ O
disease NN O
among IN O
women NNS O
in IN O
the DT O
industrialized JJ O
world NN O
, , O
and CC O
relate VBP O
to IN O
resistance NN O
to IN O
anthracyclines NNS O
, , O
the DT O
type NN O
of IN O
cytotoxic JJ O
compounds NNS O
most RBS O
frequently RB O
employed VBN O
for IN O
this DT O
malignancy NN O
. . O

While IN O
the DT O
only JJ O
study NN O
we PRP O
are VBP O
aware JJ O
of IN O
comparing VBG O
TP53 NN O
mutation NN O
status NN O
in IN O
primaries NNS O
and CC O
their PRP$ O
distant JJ O
metastases NNS O
suggested VBD O
an DT O
increasing VBG O
fraction NN O
of IN O
tumors NNS O
to TO O
express VB O
mutated VBN O
TP53 NN O
during IN O
progression NN O
[ -LRB- O
78 CD O
] -RRB- O
, , O
we PRP O
do VBP O
not RB O
know VB O
the DT O
potential JJ O
contribution NN O
of IN O
either CC O
TP53 NN O
or CC O
CHEK2 NN O
mutations NNS O
to IN O
drug NN O
resistance NN O
in IN O
micrometastases NNS O
or CC O
in IN O
metastatic JJ O
disease NN O
. . O

Yet CC O
the DT O
finding NN O
that IN O
one CD O
of IN O
our PRP$ O
non AFX O
- HYPH O
functional JJ O
CHEK2 NNP O
mutations NNS O
associated VBN O
with IN O
chemoresistance NN O
( , O
1368InsA CD O
) -RRB- O
occurred VBD O
as IN O
a DT O
somatic JJ O
, , O
not RB O
germline NN O
mutation NN O
, , O
suggest VBP O
such JJ O
mutations NNS O
may MD O
be VB O
selected VBN O
for IN O
during IN O
tumor NN O
progression NN O
. . O

We PRP O
propose VBP O
the DT O
findings NNS O
presented VBN O
here RB O
provide VBP O
important JJ O
beacons NNS O
identifying VBG O
a DT O
functional JJ O
pathway NN O
[ -LRB- O
3 CD O
] -RRB- O
likely JJ O
to TO O
be VB O
disturbed VBN O
through IN O
different JJ O
mechanisms NNS O
in IN O
relation NN O
to IN O
therapy NN O
resistance NN O
in IN O
advanced JJ O
disease NN O
. . O

In IN O
conclusion NN O
, , O
we PRP O
believe VBP O
our PRP$ O
findings NNS O
here RB O
that IN O
mutations NNS O
in IN O
the DT O
TP53 NNP O
and CC O
CHEK2 NNP O
genes NNS O
each DT O
may MD O
cause VB O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
in IN O
primary JJ O
tumors NNS O
to TO O
have VB O
wide JJ O
implications NNS O
to IN O
future JJ O
research NN O
in IN O
this DT O
area NN O
. . O

While IN O
results NNS O
from IN O
experimental JJ O
systems NNS O
are VBP O
mandatory JJ O
generating VBG O
hypotheses NNS O
, , O
conflicting VBG O
data NNS O
from IN O
in FW O
vitro FW O
studies NNS O
underlines VBZ O
the DT O
pivotal JJ O
role NN O
of IN O
identifying VBG O
defects NNS O
associated VBN O
with IN O
therapy NN O
resistance NN O
in IN O
vivo NN O
. . O

Either CC O
through IN O
mutations NNS O
of IN O
the DT O
genes NNS O
themselves PRP O
, , O
or CC O
inactivation NN O
of IN O
this DT O
functional JJ O
cascade NN O
through IN O
co NN O
- HYPH O
factors NNS O
, , O
we PRP O
believe VBP O
identification NN O
of IN O
the DT O
Chk2 NNP O
- HYPH O
p53 NN O
axis NN O
as IN O
critical JJ O
to IN O
anthracycline NN O
therapy NN O
response NN O
provides VBZ O
a DT O
functional JJ O
clue NN O
for IN O
further JJ O
investigations NNS O
in IN O
this DT O
area NN O
. . O

Host NN O
immunity NN O
in IN O
the DT O
protective JJ O
response NN O
to IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
Burkholderia NNP B-Species
mallei NN I-Species

Abstract JJ O

Background NN O

We PRP O
performed VBD O
initial JJ O
cell NN O
, , O
cytokine NN O
and CC O
complement NN O
depletion NN O
studies NNS O
to TO O
investigate VB O
the DT O
possible JJ O
role NN O
of IN O
these DT O
effectors NNS O
in IN O
response NN O
to IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
Burkholderia NNP B-Species
mallei NN I-Species
in IN O
a DT O
susceptible JJ O
BALB NNP O
/ SYM O
c NNP O
mouse NN B-Species
model NN O
of IN O
infection NN O
. . O

Results NNS O

While IN O
protection NN O
with IN O
heat NN O
- HYPH O
killed VBN O
bacilli NN O
did VBD O
not RB O
result VB O
in IN O
sterilizing VBG O
immunity NN O
, , O
limited JJ O
protection NN O
was VBD O
afforded VBN O
against IN O
an DT O
otherwise RB O
lethal JJ O
infection NN O
and CC O
provided VBD O
insight NN O
into IN O
potential JJ O
host NN O
protective JJ O
mechanisms NNS O
. . O

Our PRP$ O
results NNS O
demonstrated VBD O
that IN O
mice NNS B-Species
depleted VBN O
of IN O
either CC O
B NN O
cells NNS O
, , O
TNF NNP O
- HYPH O
alpha NN O
or CC O
IFN NNP O
- HYPH O
gamma NN O
exhibited VBD O
decreased VBN O
survival NN O
rates NNS O
, , O
indicating VBG O
a DT O
role NN O
for IN O
these DT O
effectors NNS O
in IN O
obtaining VBG O
partial JJ O
protection NN O
from IN O
a DT O
lethal JJ O
challenge NN O
by IN O
the DT O
intraperitoneal JJ O
route NN O
. . O

Additionally RB O
, , O
complement VB O
depletion NN O
had VBD O
no DT O
effect NN O
on IN O
immunoglobulin NN O
production NN O
when WRB O
compared VBN O
to IN O
non NN O
- HYPH O
complement NN O
depleted VBN O
controls NNS O
infected VBN O
intranasally RB O
. . O

Conclusion NN O

The DT O
data NNS O
provide VBP O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
protection NN O
via IN O
vaccination NN O
using VBG O
either CC O
subunit NN O
or CC O
whole JJ O
- HYPH O
organism NN O
vaccine NN O
preparations NNS O
from IN O
lethal JJ O
infection NN O
in IN O
the DT O
experimental JJ O
BALB NNP O
/ SYM O
c NN O
mouse NN B-Species
model NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
participation NN O
of IN O
B220 NN O
+ CC O
cells NNS O
and CC O
pro JJ O
- HYPH O
inflammatory JJ O
cytokines NNS O
IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
protection NN O
following VBG O
HK NNP O
vaccination NN O
. . O

Background NN O

Burkholderia NNP B-Species
mallei NNP I-Species
, , O
the DT O
etiologic JJ O
agent NN O
of IN O
glanders NNS O
, , O
is VBZ O
a DT O
gram NN O
- HYPH O
negative JJ O
, , O
capsulated VBN O
, , O
non NN O
- HYPH O
motile NN O
, , O
facultative JJ O
intracelluar JJ O
bacterium NN O
. . O

Most RBS O
known VBN O
members NNS O
of IN O
the DT O
Burkholderiaceae NNP O
are VBP O
resident JJ O
in IN O
the DT O
soil NN O
; : O
however RB O
, , O
B NNP B-Species
. . I-Species
mallei NNP I-Species
is VBZ O
thought VBN O
to TO O
be VB O
an DT O
obligate JJ O
mammalian JJ O
pathogen NN O
. . O

Horses NNS B-Species
are VBP O
highly RB O
susceptible JJ O
to IN O
infection NN O
and CC O
considered VBN O
the DT O
natural JJ O
reservoir NN O
for IN O
infection NN O
, , O
although IN O
mules NNS B-Species
and CC O
donkeys NNS B-Species
are VBP O
also RB O
susceptible JJ O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Clinically RB O
, , O
glanders NNS O
in IN O
solipeds NNS O
can MD O
present VB O
as IN O
either CC O
a DT O
chronic JJ O
( , O
horses NNS B-Species
) , O
or CC O
acute JJ O
( , O
mules NNS B-Species
and CC O
donkeys NNS B-Species
) -RRB- O
form NN O
. . O

Naturally RB O
acquired VBN O
human JJ B-Species
infection NN O
with IN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
, , O
although IN O
not RB O
seen VBN O
in IN O
the DT O
United NNP O
States NNP O
since IN O
1945 CD O
, , O
has VBZ O
occurred VBN O
rarely RB O
and CC O
sporadically RB O
among IN O
laboratory NN O
workers NNS O
and CC O
those DT O
in IN O
direct JJ O
contact NN O
with IN O
infected JJ O
animals NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

However RB O
, , O
glanders NNS O
is VBZ O
endemic JJ O
among IN O
domestic JJ O
animals NNS O
in IN O
Africa NNP O
, , O
Asia NNP O
, , O
the DT O
Middle NNP O
East NNP O
, , O
and CC O
Central NNP O
and CC O
South NNP O
America NNP O
. . O

The DT O
course NN O
of IN O
infection NN O
is VBZ O
dependent JJ O
on IN O
the DT O
route NN O
of IN O
exposure NN O
. . O

Direct JJ O
contact NN O
with IN O
the DT O
skin NN O
can MD O
lead VB O
to IN O
a DT O
systemic JJ O
infection NN O
. . O

Inhalation NN O
of IN O
aerosol NN O
or CC O
dust NN O
containing VBG O
B NN B-Species
. . I-Species
mallei NN I-Species
can MD O
lead VB O
to IN O
septicemic JJ O
, , O
pulmonary JJ O
, , O
or CC O
chronic JJ O
infections NNS O
of IN O
the DT O
muscle NN O
, , O
liver NN O
and CC O
spleen NN O
. . O

The DT O
disease NN O
has VBZ O
a DT O
95 CD O
% NN O
case NN O
fatality NN O
rate NN O
for IN O
untreated JJ O
septicemic JJ O
infections NNS O
and CC O
a DT O
50 CD O
% NN O
case NN O
fatality NN O
rate NN O
in IN O
antibiotic JJ O
- HYPH O
treated VBN O
individuals NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

There EX O
is VBZ O
no DT O
human JJ B-Species
or CC O
animal NN O
vaccine NN O
available JJ O
for IN O
glanders NNS O
, , O
and CC O
development NN O
of IN O
a DT O
partial JJ O
or CC O
fully RB O
protective JJ O
adaptive JJ O
host NN O
response NN O
to IN O
the DT O
organism NN O
has VBZ O
not RB O
been VBN O
well RB O
- HYPH O
defined VBN O
. . O

Previous JJ O
studies NNS O
with IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
and CC O
the DT O
host NN O
response NN O
have VBP O
shown VBN O
that IN O
a DT O
mixed JJ O
immune JJ O
response NN O
consisting VBG O
of IN O
both DT O
Th1 NN O
and CC O
Th2 NNP O
- HYPH O
associated VBN O
cytokines NNS O
with IN O
a DT O
predominant JJ O
IgG1 NNP O
subclass NN O
does VBZ O
not RB O
correlate VB O
with IN O
protection NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Additional JJ O
studies NNS O
with IN O
passive JJ O
transfer NN O
of IN O
monoclonal JJ O
antibodies NNS O
specific JJ O
for IN O
B NNP B-Species
. . I-Species
mallei NNS I-Species
have VBP O
correlated VBN O
with IN O
early JJ O
protection NN O
from IN O
infection NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Recent JJ O
studies NNS O
have VBP O
also RB O
shown VBN O
the DT O
Th1 NNP O
cytokine NN O
IL NN O
- HYPH O
12 CD O
to TO O
mediate VB O
partial JJ O
protection NN O
to IN O
non NN O
- HYPH O
viable JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
- HYPH O
vaccinated VBN O
mice NNS B-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

Thus RB O
, , O
full JJ O
correlates NNS O
of IN O
protection NN O
mediated VBN O
by IN O
the DT O
adaptive JJ O
immune JJ O
system NN O
against IN O
B NNP B-Species
. . I-Species
mallei NNS I-Species
remain VBP O
to TO O
be VB O
fully RB O
elucidated VBN O
. . O

In IN O
this DT O
series NN O
of IN O
studies NNS O
, , O
we PRP O
sought VBD O
to TO O
address VB O
the DT O
impact NN O
of IN O
depletion NN O
of IN O
the DT O
major JJ O
effector NN O
lymphoid NN O
cell NN O
populations NNS O
( , O
B220 NNP O
+ CC O
B NN O
cells NNS O
, , O
CD4 NNP O
+ CC O
or CC O
CD8 NNP O
+ CC O
T NNP O
cells NNS O
) -RRB- O
and CC O
key JJ O
pro JJ O
- HYPH O
inflammatory NN O
/ SYM O
Type NN O
1 CD O
cytokines NNS O
( , O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
) -RRB- O
on IN O
survival NN O
in IN O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
vaccinated VBN O
with IN O
heat NN O
killed VBN O
( , O
HK NNP O
) -RRB- O
bacilli NN O
followed VBN O
by IN O
an DT O
intraperitoneal JJ O
( , O
i CD O
. . O
p NN O
. . O
) -RRB- O
challenge NN O
with IN O
live JJ O
organism NN O
. . O

In IN O
addition NN O
, , O
studies NNS O
investigating VBG O
the DT O
effect NN O
of IN O
complement NN O
on IN O
opsonization NN O
of IN O
organism NN O
and CC O
antibody NN O
production NN O
were VBD O
assessed VBN O
. . O

Heat NN O
killed VBN O
bacteria NNS O
were VBD O
used VBN O
as IN O
a DT O
model NN O
of IN O
vaccination NN O
to TO O
allow VB O
evaluation NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
specific JJ O
immune JJ O
responses NNS O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
participation NN O
of IN O
B220 NN O
+ CC O
cells NNS O
and CC O
pro JJ O
- HYPH O
inflammatory JJ O
cytokines NNS O
IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
protection NN O
following VBG O
HK NNP O
vaccination NN O
. . O

Results NNS O

Heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
mallei NN I-Species
vaccination NN O
mediates VBZ O
partial JJ O
protection NN O
from IN O
lethal JJ O
challenge NN O

To TO O
begin VB O
to TO O
address VB O
this DT O
issue NN O
in IN O
an DT O
animal NN O
model NN O
of IN O
acute JJ O
infection NN O
, , O
we PRP O
established VBD O
that IN O
immunologically RB O
naive JJ O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
challenged VBN O
i PRP O
. . O
p UH O
. . O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
resulted VBN O
in IN O
death NN O
by IN O
day NN O
4 CD O
- SYM O
6 CD O
, , O
while IN O
i PRP O
. . O
p NN O
. . O
immunization NN O
with IN O
1 CD O
x SYM O
105 CD O
heat NN O
killed VBN O
( -LRB- O
HK NNP O
) -RRB- O
bacteria NNS O
provided VBD O
partial JJ O
protection NN O
against IN O
a DT O
subsequent JJ O
challenge NN O
. . O

Two CD O
independent JJ O
experiments NNS O
resulted VBD O
in IN O
similar JJ O
findings NNS O
of IN O
40 CD O
% NN O
survival NN O
for IN O
HK NNP O
- HYPH O
vaccinated VBN O
mice NNS B-Species
with IN O
a DT O
mean JJ O
survival NN O
time NN O
( -LRB- O
MST NNP O
) -RRB- O
of IN O
8 CD O
days NNS O
versus IN O
4 CD O
days NNS O
in IN O
na FW O
i FW O
ve FW O
mice NNS B-Species
( -LRB- O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
administration NN O
of IN O
vaccines NNS O
for IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
during IN O
an DT O
outbreak NN O
would MD O
mandate VB O
relatively RB O
rapid JJ O
onset NN O
of IN O
protection NN O
for IN O
human JJ B-Species
or CC O
veterinary JJ O
use NN O
. . O

Based VBN O
on IN O
non JJ O
- HYPH O
routine JJ O
use NN O
and CC O
vaccine NN O
implementation NN O
in IN O
the DT O
course NN O
of IN O
an DT O
outbreak NN O
, , O
a DT O
14 CD O
day NN O
window NN O
was VBD O
chosen VBN O
for IN O
assessment NN O
of IN O
protection NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
HK NNP O
vaccination NN O
can MD O
afford VB O
partial JJ O
protection NN O
to IN O
an DT O
otherwise RB O
lethal JJ O
challenge NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
by IN O
the DT O
i NN O
. . O
p UH O
. . O
route NN O
. . O

Effects NNS O
of IN O
cell NN O
depletion NN O
on IN O
HK NNP O
- HYPH O
vaccinated VBN O
survival NN O

To TO O
dissect VB O
the DT O
cellular JJ O
basis NN O
for IN O
protection NN O
mediated VBN O
by IN O
HK NNP O
vaccination NN O
, , O
13 CD O
days NNS O
after IN O
immunization NN O
with IN O
HK NNP O
bacteria NNS O
( : O
day NN O
- HYPH O
1 CD O
) -RRB- O
, , O
and CC O
at IN O
day NN O
of IN O
challenge NN O
, , O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
antibodies NNS O
to TO O
deplete VB O
CD4 NN O
+ CC O
, , O
CD8 NN O
+ CC O
or CC O
B220 NN O
+ CC O
cells NNS O
. . O

Antibody NN O
depletion NN O
of IN O
CD4 NNP O
+ CC O
, , O
CD8 NNP O
+ CC O
, , O
or CC O
B220 NN O
+ CC O
cells NNS O
in IN O
these DT O
mice NNS B-Species
was VBD O
confirmed VBN O
by IN O
flow NN O
cytometric JJ O
analysis NN O
with IN O
depletion NN O
efficiencies NNS O
for IN O
CD4 NNP O
, , O
CD8 NNP O
, , O
and CC O
B220 NN O
populations NNS O
at IN O
99 CD O
. . O
7 CD O
% NN O
, , O
96 CD O
% NN O
, , O
and CC O
95 CD O
% NN O
, , O
respectively RB O
, , O
relative JJ O
to IN O
mice NNS B-Species
treated VBN O
with IN O
isotype NN O
control NN O
monoclonal JJ O
antibodies NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Our PRP$ O
results NNS O
demonstrated VBD O
decreased VBN O
survival NN O
rates NNS O
in IN O
B220 CD O
( , O
p NN O
= SYM O
0 CD O
. . O
3418 CD O
) -RRB- O
, , O
CD4 NN O
+ CC O
( : O
p NN O
= SYM O
0 CD O
. . O
5417 CD O
) -RRB- O
and CC O
CD8 NN O
+ SYM O
( : O
p NN O
= SYM O
0 CD O
. . O
4684 CD O
) -RRB- O
antibody NN O
depleted VBN O
mice NNS B-Species
, , O
compared VBN O
to IN O
isotype NN O
control NN O
antibody NN O
, , O
a DT O
finding NN O
that WDT O
indicated VBD O
a DT O
possible JJ O
role NN O
for IN O
vaccine NN O
induced VBN O
antibody NN O
production NN O
. . O

When WRB O
challenged VBN O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
/ SYM O
mouse NN B-Species
by IN O
the DT O
i NN O
. . O
p NN O
. . O
route NN O
, , O
loss NN O
of IN O
T NN O
cells NNS O
resulted VBD O
in IN O
reduced VBN O
survival NN O
( : O
50 CD O
% NN O
) -RRB- O
relative JJ O
to IN O
the DT O
non AFX O
- HYPH O
specific JJ O
isotype NN O
control NN O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

In IN O
contrast NN O
to IN O
the DT O
loss NN O
of IN O
T NNP O
cells NNS O
, , O
depletion NN O
of IN O
B220 NN O
+ CC O
cells NNS O
resulted VBD O
in IN O
100 CD O
% NN O
mortality NN O
relative JJ O
to IN O
the DT O
non AFX O
- HYPH O
specific JJ O
isotype NN O
control NN O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

To TO O
further RB O
evaluate VB O
the DT O
necessity NN O
of IN O
these DT O
effector NN O
cells NNS O
in IN O
providing VBG O
protection NN O
following VBG O
HK NNP O
vaccination NN O
, , O
relatively RB O
resistant JJ O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
, , O
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
or CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
were VBD O
subjected VBN O
to IN O
an DT O
identical JJ O
HK NNP O
vaccination NN O
and CC O
challenge NN O
regimen NN O
. . O

Mature JJ O
, , O
B NN O
- HYPH O
cell NN O
- HYPH O
deficient JJ O
mice NNS B-Species
demonstrated VBD O
a DT O
50 CD O
% NN O
decreased JJ O
survival NN O
( , O
p NN O
= SYM O
0 CD O
. . O
888 CD O
) -RRB- O
compared VBN O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
with IN O
an DT O
MST NN O
of IN O
35 CD O
. . O
5 CD O
days NNS O
( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
and CC O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
mice NNS B-Species
exhibited VBN O
a DT O
60 CD O
% NN O
( , O
p NN O
= SYM O
0 CD O
. . O
1343 CD O
) -RRB- O
and CC O
0 CD O
% NN O
reduced VBN O
survival NN O
, , O
respectively RB O
( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

Effects NNS O
of IN O
cytokine NN O
depletion NN O
on IN O
HK NNP O
vaccination NN O

Similar JJ O
studies NNS O
were VBD O
performed VBN O
to TO O
determine VB O
the DT O
role NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
acute JJ O
infection NN O
in IN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
immunized VBN O
with IN O
HK NNP O
bacteria NNS O
. . O

Six CD O
hours NNS O
before IN O
challenge NN O
, , O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
antibodies NNS O
that WDT O
neutralize VBP O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
. . O

Individual JJ O
depletion NN O
of IN O
either CC O
TNF NNP O
- HYPH O
alpha NN O
( , O
p NN O
= SYM O
0 CD O
. . O
145 CD O
) -RRB- O
or CC O
IFN NNP O
- HYPH O
gamma NN O
( : O
p NN O
= SYM O
0 CD O
. . O
446 CD O
) -RRB- O
resulted VBD O
in IN O
100 CD O
% NN O
mortality NN O
with IN O
an DT O
MST NNP O
of IN O
3 CD O
and CC O
2 CD O
days NNS O
, , O
respectively RB O
, , O
compared VBN O
to IN O
the DT O
HK NNP O
- HYPH O
vaccinated VBN O
isotype NN O
control NN O
mice NN B-Species
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
40 CD O
% NN O
of IN O
HK NNP O
- HYPH O
vaccinated VBN O
, , O
isotype NN O
control NN O
mice NNS B-Species
survived VBD O
to IN O
at RB O
least RBS O
12 CD O
days NNS O
post NN O
- HYPH O
challenge NN O
( -LRB- O
Fig NNP O
4 CD O
) -RRB- O
. . O

To TO O
further RB O
evaluate VB O
the DT O
host NN O
TNF NNP O
- HYPH O
alpha NN O
response NN O
during IN O
an DT O
established VBN O
B NN B-Species
. . I-Species
mallei NN I-Species
chronic JJ O
infection NN O
, , O
we PRP O
infected VBD O
12 CD O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
by IN O
the DT O
i NN O
. . O
p NN O
. . O
route NN O
with IN O
1 CD O
x SYM O
106 CD O
CFU NN O
B NN B-Species
. . I-Species
mallei NNP I-Species
. . O

One CD O
animal NN O
was VBD O
terminally RB O
ill JJ O
on IN O
day NN O
37 CD O
post NN O
- HYPH O
infection NN O
. . O

On IN O
day NN O
42 CD O
post NN O
- HYPH O
infection NN O
, , O
the DT O
remaining VBG O
11 CD O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
either CC O
anti JJ O
- HYPH O
TNF NNP O
- HYPH O
alpha NN O
( , O
n CD O
= SYM O
6 CD O
) -RRB- O
, , O
or CC O
control NN O
mAb NN O
( , O
AFRC NNP O
Mac NNP O
49 CD O
) -RRB- O
( : O
n CD O
= SYM O
5 CD O
) -RRB- O
. . O

No DT O
further JJ O
deaths NNS O
were VBD O
observed VBN O
in IN O
the DT O
control NN O
mAb NN O
- HYPH O
treated VBN O
mice NNS B-Species
. . O

Rapid JJ O
mortality NN O
was VBD O
observed VBN O
in IN O
the DT O
anti AFX O
- HYPH O
TNF NNP O
- HYPH O
alpha NN O
- HYPH O
treated VBN O
group NN O
, , O
with IN O
all DT O
mice NNS B-Species
dying VBG O
within IN O
7 CD O
days NNS O
of IN O
treatment NN O
( : O
p NN O
= SYM O
0 CD O
. . O
23 CD O
) -RRB- O
relative JJ O
to IN O
the DT O
isotype NN O
- HYPH O
treated VBN O
controls NNS O
( : O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

J774A NNP O
. . O
1 CD O
uptake NN O
of IN O
serum NN O
treated VBN O
B NN B-Species
. . I-Species
mallei NN I-Species

Complement NN O
mediated VBN O
uptake NN O
assays NNS O
were VBD O
performed VBN O
to TO O
evaluate VB O
opsonization NN O
. . O

Results NNS O
indicated VBD O
enhanced VBN O
bacterial JJ O
uptake NN O
in IN O
J774A NNP O
. . O
1 CD O
phagocytes NNS O
inoculated VBN O
with IN O
serum NN O
treated VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
( , O
p NN O
= SYM O
. . O
82 CD O
) -RRB- O
, , O
compared VBN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
alone RB O
, , O
while IN O
heat NN O
- HYPH O
inactivated VBN O
serum NN O
produced VBN O
uptake NN O
percentages NNS O
similar JJ O
to IN O
those DT O
prior RB O
to IN O
serum NN O
addition NN O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
imply VBP O
an DT O
active JJ O
role NN O
for IN O
complement NN O
components NNS O
in IN O
the DT O
uptake NN O
of IN O
organism NN O
by IN O
macrophages NNS O
. . O

Immunoglobulin NN O
production NN O
in IN O
HK NNP O
vaccinated VBN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species

We PRP O
further RB O
characterized VBD O
the DT O
ability NN O
of IN O
HK NNP O
vaccination NN O
to TO O
induce VB O
a DT O
predominant JJ O
IgG NN O
isotype NN O
by IN O
determining VBG O
IgG2a NNP O
/ SYM O
IgG1 NNP O
ratios NNS O
in IN O
i CD O
. . O
p LS O
. . O
and CC O
i LS O
. . O
n LS O
. . O
vaccinated VBN O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
. . O

Pre NNP O
( , O
day NN O
14 CD O
post NN O
vaccination NN O
) -RRB- O
and CC O
post NN O
( HYPH O
day NN O
2 CD O
post NN O
infection NN O
) -RRB- O
exposure NN O
serum NN O
samples NNS O
were VBD O
obtained VBN O
and CC O
evaluated VBN O
for IN O
IgG NN O
isotype NN O
concentrations NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

No DT O
appreciable JJ O
differences NNS O
in IN O
IgG NNP O
pre NN O
- HYPH O
exposure NN O
levels NNS O
were VBD O
seen VBN O
when WRB O
comparing VBG O
i PRP O
. . O
n NFP O
. . O
to IN O
i LS O
. . O
p NN O
. . O
vaccination NN O
. . O

In IN O
addition NN O
, , O
cobra NN O
venom NN O
factor NN O
- HYPH O
treated VBN O
animals NNS O
showed VBD O
no DT O
significant JJ O
differences NNS O
to IN O
non JJ O
- HYPH O
cobra NN O
venom NN O
factor NN O
- HYPH O
treated VBN O
animals NNS O
in IN O
IgG NNP O
pre NN O
- HYPH O
exposure NN O
( HYPH O
challenge NN O
) -RRB- O
levels NNS O
. . O

Conversely RB O
, , O
isotype NN O
switching NN O
in IN O
the DT O
cobra NN O
venom NN O
factor NN O
treated VBD O
animals NNS O
was VBD O
enhanced VBN O
in IN O
post NN O
- HYPH O
exposure NN O
serum NN O
IgG2a NNP O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

Discussion NN O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
a DT O
key JJ O
role NN O
in IN O
protection NN O
from IN O
lethal JJ O
challenge NN O
for IN O
IFN NNP O
- HYPH O
gamma NN O
in IN O
non NN O
- HYPH O
vaccinated VBN O
mice NNS B-Species
from IN O
either CC O
NK NNP O
and CC O
/ SYM O
or CC O
NKT NNP O
cells NNS O
following VBG O
experimental JJ O
exposure NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
and CC O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
. . O

A DT O
similar JJ O
protective JJ O
role NN O
in IN O
the DT O
innate JJ O
response NN O
to IN O
infection NN O
has VBZ O
been VBN O
demonstrated VBN O
for IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
studies NNS O
presented VBN O
here RB O
are VBP O
consistent JJ O
with IN O
the DT O
essential JJ O
role NN O
of IN O
these DT O
factors NNS O
in IN O
the DT O
relative JJ O
levels NNS O
of IN O
protection NN O
conferred VBN O
by IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
pseudomallei NN I-Species
and CC O
would MD O
appear VB O
to TO O
be VB O
viable JJ O
early JJ O
markers NNS O
for IN O
protection NN O
from IN O
lethal JJ O
acute JJ O
infection NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Currently RB O
, , O
there EX O
are VBP O
no DT O
fully RB O
protective JJ O
vaccines NNS O
against IN O
B NN B-Species
. . I-Species
mallei NN I-Species
or CC O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
in IN O
a DT O
murine NN B-Species
model NN O
, , O
particularly RB O
for IN O
the DT O
sensitive JJ O
BALB NNP O
/ SYM O
c NN O
versus IN O
C57BL6 NN O
models NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
also RB O
demonstrated VBN O
that IN O
both CC O
the DT O
humoral JJ O
and CC O
cell NN O
- HYPH O
mediated VBN O
arms NNS O
are VBP O
essential JJ O
for IN O
protection NN O
from IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Thus RB O
, , O
loss NN O
or CC O
reduction NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
and CC O
IFN NNP O
- HYPH O
gamma NN O
levels NNS O
result VBP O
in IN O
significantly RB O
reduced VBN O
survival NN O
rates NNS O
, , O
substantiating VBG O
previous JJ O
reports NNS O
of IN O
the DT O
role NN O
of IN O
these DT O
factors NNS O
in IN O
protection NN O
against IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
[ -LRB- O
7 CD O
] -RRB- O
. . O

Moreover RB O
, , O
we PRP O
demonstrate VBP O
a DT O
role NN O
for IN O
sustained JJ O
TNF NNP O
- HYPH O
alpha NN O
production NN O
in IN O
the DT O
maintenance NN O
of IN O
host NN O
survival NN O
throughout IN O
the DT O
course NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
infection NN O
. . O

Mice NNS B-Species
with IN O
an DT O
established VBN O
B NN B-Species
. . I-Species
mallei NN I-Species
chronic JJ O
infection NN O
rapidly RB O
lost VBD O
the DT O
ability NN O
to TO O
control VB O
the DT O
growth NN O
of IN O
the DT O
bacillus NN O
upon IN O
neutralization NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
. . O

This DT O
would MD O
suggest VB O
a DT O
potential JJ O
role NN O
for IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
the DT O
maintenance NN O
of IN O
productive JJ O
granulomas NNS O
which WDT O
may MD O
limit VB O
the DT O
spread NN O
of IN O
bacteria NNS O
in IN O
chronically RB O
infected JJ O
hosts NNS O
, , O
or CC O
, , O
alternatively RB O
, , O
in IN O
direct JJ O
or CC O
indirect JJ O
microbicidal JJ O
or CC O
bacteriostatic JJ O
activities NNS O
at IN O
the DT O
sites NNS O
of IN O
infection NN O
. . O

Additional JJ O
studies NNS O
are VBP O
underway JJ O
to TO O
determine VB O
more RBR O
precisely RB O
the DT O
role NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
host NN O
protection NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
. . O

Multiple JJ O
innate JJ O
and CC O
adaptive JJ O
cell NN O
types NNS O
may MD O
contribute VB O
to IN O
the DT O
production NN O
of IN O
IFN NN O
- HYPH O
gamma NN O
in IN O
response NN O
to IN O
infection NN O
with IN O
B NN B-Species
. . I-Species
mallei NN I-Species
following VBG O
vaccination NN O
. . O

Our PRP$ O
results NNS O
with IN O
individual JJ O
depletion NN O
of IN O
CD4 NNP O
+ CC O
and CC O
CD8 NNP O
+ CC O
T NN O
cells NNS O
suggests VBZ O
that IN O
both DT O
cell NN O
types NNS O
may MD O
compensate VB O
for IN O
the DT O
functional JJ O
loss NN O
of IN O
the DT O
other JJ O
effector NN O
cell NN O
type NN O
in IN O
the DT O
production NN O
of IN O
this DT O
key JJ O
cytokine NN O
. . O

The DT O
effector NN O
role NN O
for IN O
IFN NNP O
- HYPH O
gamma NN O
in IN O
mediating VBG O
protection NN O
against IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
may MD O
include VB O
both CC O
immunoregulatory JJ O
and CC O
non JJ O
- HYPH O
regulatory JJ O
functions NNS O
. . O

Regardless RB O
, , O
the DT O
requirement NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
, , O
as IN O
demonstrated VBN O
by IN O
administration NN O
of IN O
neutralizing VBG O
antibody NN O
prior RB O
to IN O
infection NN O
, , O
indicates VBZ O
that IN O
stimulation NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
response NN O
is VBZ O
a DT O
desirable JJ O
goal NN O
for IN O
a DT O
B NN B-Species
. . I-Species
mallei NN I-Species
vaccine NN O
. . O

Similarly RB O
, , O
B220 NNP O
- HYPH O
positive JJ O
cells NNS O
appear VBP O
to TO O
play VB O
a DT O
role NN O
in IN O
protection NN O
following VBG O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
. . O

Interestingly RB O
, , O
this DT O
protective JJ O
immunity NN O
, , O
occurring VBG O
in IN O
other JJ O
intracellular JJ O
pathogens NNS O
, , O
is VBZ O
not RB O
exclusively RB O
dependent JJ O
on IN O
B NNP O
cells NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Passive JJ O
protection NN O
has VBZ O
been VBN O
demonstrated VBN O
against IN O
acute JJ O
Burkholderia NNP O
infection NN O
by IN O
monoclonal JJ O
antibodies NNS O
[ -LRB- O
5 CD O
, , O
12 CD O
] -RRB- O
. . O

Protection NN O
against IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
by IN O
anti JJ O
- HYPH O
LPS NNP O
, , O
capsular NN O
polysaccharide NN O
and CC O
proteins NNS O
has VBZ O
been VBN O
short RB O
- HYPH O
lived VBN O
, , O
suggesting VBG O
that IN O
antibody NN O
production NN O
offers VBZ O
limited JJ O
protection NN O
in IN O
the DT O
initial JJ O
stages NNS O
of IN O
infection NN O
by IN O
an DT O
as IN O
- HYPH O
yet CC O
- HYPH O
undefined JJ O
mechanism NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
following VBG O
depletion NN O
of IN O
B220 NNP O
+ SYM O
cells NNS O
, , O
survival NN O
rates NNS O
decreased VBD O
as RB O
much JJ O
as IN O
100 CD O
% NN O
relative JJ O
to IN O
non NN O
- HYPH O
depleted VBN O
controls NNS O
and CC O
individual JJ O
CD4 NN O
/ SYM O
CD8 NN O
- HYPH O
depleted VBN O
mice NNS B-Species
via IN O
the DT O
intraperitoneal JJ O
route NN O
. . O

Results NNS O
from IN O
C57BL NNP O
/ SYM O
6 CD O
mice NN B-Species
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( , O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
or CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
substantiate VBP O
the DT O
requirement NN O
for IN O
B NN O
- HYPH O
cell NN O
involvement NN O
by IN O
evidence NN O
of IN O
mu NN O
MT NNP O
and CC O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
decreased VBN O
survival NN O
. . O

The DT O
lack NN O
of IN O
an DT O
effective JJ O
CTL NNP O
response NN O
to IN O
vaccination NN O
did VBD O
not RB O
appear VB O
to TO O
alter VB O
survival NN O
in IN O
what WP O
would MD O
appear VB O
to TO O
be VB O
a DT O
CD4 NNP O
/ SYM O
B NN O
- HYPH O
cell NN O
( , O
humoral JJ O
) -RRB- O
- HYPH O
driven VBN O
response NN O
. . O

In IN O
CD4 NN O
- HYPH O
deficient JJ O
mice NNS B-Species
, , O
we PRP O
have VBP O
the DT O
additional JJ O
potential JJ O
variable JJ O
that IN O
a DT O
CD4 NN O
- HYPH O
dependent JJ O
antibody NN O
response NN O
might MD O
also RB O
be VB O
inhibited VBN O
during IN O
the DT O
vaccination NN O
phase NN O
relative JJ O
to IN O
mice NNS B-Species
treated VBN O
with IN O
antibody NN O
immediately RB O
prior RB O
to IN O
and CC O
during IN O
the DT O
early JJ O
phases NNS O
of IN O
infection NN O
. . O

Although IN O
not RB O
statistically RB O
significant JJ O
, , O
we PRP O
did VBD O
observe VB O
a DT O
decrease NN O
in IN O
survival NN O
in IN O
mu NNP O
MT NNP O
( , O
mature JJ O
B NN O
cell NN O
) -RRB- O
deficient JJ O
mice NNS B-Species
as RB O
early RB O
as IN O
day NN O
9 CD O
post NN O
challenge NN O
, , O
whereas IN O
CD4 NN O
- HYPH O
deficient JJ O
mice NN B-Species
produced VBD O
similar JJ O
results NNS O
at IN O
day NN O
32 CD O
post NN O
challenge NN O
, , O
indicating VBG O
a DT O
role NN O
for IN O
B NN O
cells NNS O
independent JJ O
of IN O
CD4 NNP O
T NNP O
cell NN O
help NN O
, , O
perhaps RB O
through IN O
a DT O
T NNP O
- HYPH O
independent JJ O
mechanism NN O
of IN O
antibody NN O
production NN O
. . O

Although IN O
CD8 NNP O
- HYPH O
/ SYM O
- HYPH O
C57BL NNP O
/ SYM O
6 CD O
demonstrated VBD O
no DT O
decreased VBN O
survival NN O
in IN O
our PRP$ O
HK NNP O
- HYPH O
vaccinated VBN O
model NN O
, , O
a DT O
lack NN O
of IN O
potential JJ O
endogenous JJ O
protein NN O
production NN O
by IN O
HK NNP O
B NNP B-Species
. . I-Species
mallei NNP I-Species
may MD O
have VB O
contributed VBN O
to IN O
limited JJ O
MHC NNP O
- HYPH O
I PRP O
presentation NN O
. . O

Complement NN O
associated VBN O
studies NNS O
revealed VBD O
increased VBN O
J774A NNP O
. . O
1 CD O
uptake NN O
of IN O
serum NN O
- HYPH O
treated VBN O
B NN B-Species
. . I-Species
mallei NNP I-Species
. . O

Complement NN O
- HYPH O
mediated VBN O
uptake NN O
studies NNS O
of IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
by IN O
polymorphonuclear NN O
leukocytes NNS O
( -LRB- O
PMNs NNP O
) -RRB- O
suggest VBP O
that IN O
capsule NN O
production NN O
contributes VBZ O
to IN O
resistance NN O
of IN O
phagocytosis NN O
by IN O
reducing VBG O
C3b NN O
bacterial JJ O
deposition NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
a DT O
polysaccharide NN O
capsule NN O
is VBZ O
present JJ O
in IN O
B NN B-Species
. . I-Species
mallei NN I-Species
, , O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
although IN O
in IN O
the DT O
present JJ O
study NN O
enhanced VBN O
uptake NN O
with IN O
serum NN O
- HYPH O
treated VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
was VBD O
observed VBN O
. . O

Intracellular JJ O
survival NN O
assays NNS O
of IN O
complement NN O
mediated VBN O
uptake NN O
of IN O
organisms NNS O
were VBD O
not RB O
performed VBN O
in IN O
the DT O
present JJ O
study NN O
, , O
thus RB O
, , O
the DT O
role NN O
of IN O
complement NN O
opsonization NN O
on IN O
intracellular JJ O
survival NN O
is VBZ O
not RB O
fully RB O
resolved VBN O
. . O

Previous JJ O
reports NNS O
have VBP O
demonstrated VBN O
the DT O
ability NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
to TO O
survive VB O
within IN O
macrophage NN O
without IN O
the DT O
aid NN O
of IN O
serum NN O
coating NN O
organisms NNS O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Conversely RB O
, , O
the DT O
idea NN O
of IN O
antibody NN O
mediated VBN O
opsonization NN O
to TO O
facilitate VB O
macrophage NN O
activation NN O
and CC O
clearance NN O
of IN O
intracellular JJ O
organisms NNS O
may MD O
offer VB O
support NN O
to IN O
the DT O
role NN O
of IN O
B NN O
cells NNS O
in IN O
an DT O
effective JJ O
immune JJ O
response NN O
. . O

A DT O
possible JJ O
protective JJ O
mechanism NN O
may MD O
include VB O
HK NNP O
vaccination NN O
induced VBN O
production NN O
of IN O
opsonizing JJ O
antibodies NNS O
which WDT O
may MD O
aid VB O
in IN O
complement NN O
mediated VBN O
uptake NN O
, , O
thereby RB O
limiting VBG O
the DT O
initial JJ O
bacterial JJ O
threshold NN O
below IN O
a DT O
lethal JJ O
level NN O
. . O

Immunoglobulin NN O
responses NNS O
to IN O
HK NNP O
vaccination NN O
resulted VBD O
in IN O
modest JJ O
levels NNS O
of IN O
IgG1 NNP O
following VBG O
2 CD O
weeks NNS O
post NN O
vaccination NN O
, , O
while IN O
post NN O
- HYPH O
exposure NN O
levels NNS O
were VBD O
indicative JJ O
of IN O
efficient JJ O
class NN O
switching NN O
to IN O
a DT O
favorable JJ O
IgG2a NNP O
isotype NN O
. . O

Importantly RB O
, , O
cobra NN O
venom NN O
factor NN O
treatment NN O
of IN O
animals NNS O
at IN O
time NN O
of IN O
vaccination NN O
did VBD O
not RB O
alter VB O
their PRP$ O
ability NN O
to TO O
produce VB O
immunoglobulin NN O
. . O

In IN O
fact NN O
, , O
cobra NN O
venom NN O
factor NN O
treated VBN O
animals NNS O
resulted VBD O
in IN O
higher JJR O
IgG2a NNP O
levels NNS O
when WRB O
compared VBN O
to IN O
non NN O
- HYPH O
treated VBN O
. . O

Complement NN O
activation NN O
can MD O
modulate VB O
both CC O
the DT O
primary JJ O
and CC O
secondary JJ O
immune JJ O
responses NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
enhance VB O
secondary JJ O
immune JJ O
responses NNS O
to IN O
vaccination NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

The DT O
current JJ O
results NNS O
suggest VBP O
that IN O
cobra NN O
venom NN O
factor NN O
treatment NN O
may MD O
affect VB O
the DT O
modulation NN O
of IN O
the DT O
immune JJ O
response NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
infection NN O
through IN O
B NN O
cell NN O
activation NN O
and CC O
/ SYM O
or CC O
memory NN O
B NN O
cell NN O
generation NN O
. . O

Conclusion NN O

In IN O
summary NN O
, , O
our PRP$ O
results NNS O
provide VBP O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
protection NN O
via IN O
vaccination NN O
using VBG O
either CC O
subunit NN O
or CC O
whole JJ O
- HYPH O
organism NN O
vaccine NN O
preparations NNS O
from IN O
lethal JJ O
infection NN O
in IN O
the DT O
experimental JJ O
BALB NNP O
/ SYM O
c NN O
mouse NN B-Species
model NN O
. . O

Understanding VBG O
and CC O
defining VBG O
the DT O
role NN O
of IN O
B NN O
cells NNS O
in IN O
adaptive JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
immunity NN O
will MD O
likely RB O
be VB O
fundamental JJ O
to IN O
the DT O
design NN O
of IN O
an DT O
efficacious JJ O
vaccine NN O
and CC O
important JJ O
goals NNS O
of IN O
future JJ O
research NN O
. . O

Methods NNS O

Bacterial JJ O
strain NN O
and CC O
mice NNS B-Species

B NN B-Species
. . I-Species
mallei NN I-Species
strain NN O
ATCC NNP O
23344 CD O
( , O
China NNP O
7 CD O
) -RRB- O
was VBD O
cultured VBN O
on IN O
Luria NNP O
- HYPH O
Bertani NNP O
agar NN O
supplemented VBN O
with IN O
4 CD O
% NN O
glycerol NN O
( , O
LB NN O
+ SYM O
4 CD O
% NN O
G NN O
) -RRB- O
agar NN O
plates NNS O
for IN O
48 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Isolated JJ O
colonies NNS O
were VBD O
sub NN O
- HYPH O
cultured VBN O
to IN O
LB NNP O
+ SYM O
4 CD O
% NN O
G NN O
broth NN O
, , O
and CC O
cultures NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
until IN O
optical JJ O
density NN O
readings NNS O
at IN O
600 CD O
nm NN O
( SYM O
OD600 CD O
) -RRB- O
reached VBD O
an DT O
exponential JJ O
phase NN O
of IN O
growth NN O
. . O

Bacteria NNS O
were VBD O
pelleted VBN O
by IN O
centrifugation NN O
, , O
washed VBN O
and CC O
re NN O
- HYPH O
suspended VBN O
in IN O
sterile JJ O
1 CD O
x NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
to TO O
obtain VB O
the DT O
desired VBN O
CFU NN O
/ SYM O
ml NNP O
. . O

To TO O
obtain VB O
HK NNP O
inoculums NNS O
, , O
bacterial JJ O
suspensions NNS O
were VBD O
incubated VBN O
at IN O
85 CD O
degrees NNS O
C NN O
for IN O
3 CD O
h NN O
and CC O
stored VBN O
at IN O
4 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

The DT O
absence NN O
of IN O
live JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
organisms NNS O
in IN O
the DT O
HK NNP O
preparations NNS O
was VBD O
confirmed VBN O
after IN O
plating VBG O
10 CD O
% NN O
of IN O
the DT O
total JJ O
inoculums NNS O
( , O
v NN O
/ SYM O
v NN O
) -RRB- O
and CC O
incubating VBG O
these DT O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
48 CD O
h NNS O
. . O

All DT O
procedures NNS O
were VBD O
performed VBN O
under IN O
a DT O
class NN O
II NNP O
biosafety NN O
cabinet NN O
in IN O
a DT O
biosafety NN O
level NN O
3 CD O
laboratory NN O
. . O

Female JJ O
, , O
6 CD O
- HYPH O
to TO O
8 CD O
- HYPH O
week NN O
- HYPH O
old JJ O
, , O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
( : O
n CD O
= SYM O
5 CD O
- HYPH O
7 CD O
) -RRB- O
were VBD O
obtained VBN O
from IN O
Harlan NNP O
Sprague NNP O
Dawley NNP O
, , O
Inc NNP O
. . O

( : O
Indianapolis NNP O
, , O
Indiana NNP O
) -RRB- O
. . O

Female JJ O
, , O
6 CD O
- HYPH O
to TO O
8 CD O
- HYPH O
week NN O
- HYPH O
old JJ O
, , O
C57BL NNP O
/ SYM O
6 CD O
mice NN B-Species
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( , O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
and CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
and CC O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
were VBD O
obtained VBN O
from IN O
The DT O
Jackson NNP O
Laboratory NNP O
( : O
Bar NNP O
Harbor NNP O
, , O
Maine NNP O
) -RRB- O
. . O

Vaccination NN O
and CC O
challenge NN O

BALB NNP O
/ SYM O
c NNP O
and CC O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
were VBD O
grouped VBN O
and CC O
vaccinated VBN O
with IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
of IN O
HK NN O
B NN B-Species
. . I-Species
mallei NNP I-Species
( , O
without IN O
adjuvant NN O
) -RRB- O
by IN O
i PRP O
. . O
p NN O
. . O
injection NN O
using VBG O
a DT O
25 CD O
- HYPH O
gauge NN O
syringe NN O
. . O

Two CD O
weeks NNS O
post NN O
HK NNP O
vaccination NN O
mice NNS B-Species
were VBD O
injected VBN O
i PRP O
. . O
p UH O
. . O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
/ SYM O
100 CD O
mu NNS O
l NN O
of IN O
live JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
( , O
~ $ O
20 CD O
LD50 CD O
) -RRB- O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Complement VB O
depleted VBN O
animals NNS O
were VBD O
challenged VBN O
with IN O
2 CD O
. . O
5 CD O
x SYM O
104 CD O
CFU NN O
/ SYM O
50 CD O
mu NN O
l NN O
( : O
~ $ O
0 CD O
. . O
25 CD O
LD50 CD O
) -RRB- O
by IN O
intranasal NN O
( : O
i CD O
. . O
n NN O
. . O
) -RRB- O
route NN O
. . O

Aliquots NNS O
from IN O
the DT O
inoculums NNS O
were VBD O
plated VBN O
to TO O
confirm VB O
the DT O
infecting VBG O
dose NN O
. . O

All DT O
procedures NNS O
and CC O
animal NN O
protocols NNS O
used VBN O
in IN O
this DT O
study NN O
were VBD O
approved VBN O
by IN O
the DT O
Biosafety NNP O
and CC O
IACUC NNP O
committees NNS O
at IN O
UTMB NNP O
and CC O
conducted VBN O
in IN O
either CC O
BSL NNP O
- HYPH O
3 CD O
or CC O
ABSL NNP O
- HYPH O
3 CD O
laboratories NNS O
. . O

Cell NN O
and CC O
cytokine NN O
depletions NNS O

Acute NN O
in IN O
vivo NN O
cell NN O
/ SYM O
cytokine NN O
depletion NN O
was VBD O
performed VBN O
with IN O
monoclonal JJ O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
CD4 NNP O
( : O
GK1 NNP O
. . O
5 CD O
) -RRB- O
, , O
CD8 NNP O
alpha NN O
( , O
53 CD O
- SYM O
6 CD O
. . O
7 CD O
) -RRB- O
or CC O
B220 CD O
( SYM O
RA3 NNP O
- HYPH O
6B2 CD O
) -RRB- O
obtained VBN O
from IN O
R NNP O
& CC O
D NNP O
Systems NNPS O
, , O
Inc NNP O
. . O

( -LRB- O
Minneapolis NNP O
, , O
MN NNP O
) -RRB- O
by IN O
methods NNS O
similar JJ O
to IN O
those DT O
we PRP O
have VBP O
previously RB O
described VBN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Functional JJ O
grade NN O
purified VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
interferon NN O
- HYPH O
gamma NN O
( , O
IFN NNP O
- HYPH O
gamma NN O
, , O
AN NNP O
- HYPH O
18 CD O
) -RRB- O
was VBD O
obtained VBN O
from IN O
eBioscience NNP O
( , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
and CC O
purified JJ O
anti JJ O
- HYPH O
mouse NN B-Species
tumor NN O
necrosis NN O
factor NN O
( , O
TNF NNP O
- HYPH O
alpha NN O
, , O
MP6 NNP O
- HYPH O
XT3 NNP O
) -RRB- O
from IN O
BD NNP O
Pharmingen NNP O
( : O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
antibodies NNS O
were VBD O
injected VBN O
i PRP O
. . O
p LS O
. . O

6 CD O
h NN O
prior RB O
to IN O
challenge NN O
, , O
200 CD O
mu NN O
g NN O
per IN O
mouse NN B-Species
in IN O
200 CD O
mu NNS O
l CC O
PBS NN O
or CC O
at IN O
later JJ O
time NN O
points NNS O
as IN O
indicated VBN O
. . O

Rat NNP B-Species
IgG NNP O
isotype NN O
control NN O
was VBD O
obtained VBN O
from IN O
Southern NNP O
Biotech NNP O
( : O
Birmingham NNP O
, , O
AL NNP O
) -RRB- O
and CC O
administered VBN O
i NFP O
. . O
p LS O
. . O
on IN O
day NN O
of IN O
challenge NN O
, , O
200 CD O
mu NN O
g NN O
/ SYM O
mouse NN B-Species
. . O

Rat JJ B-Species
anti JJ O
- HYPH O
mouse NNP B-Species
CD4 NNP O
, , O
CD8 NN O
alpha NN O
and CC O
B220 NN O
were VBD O
injected VBN O
i PRP O
. . O
p LS O
. . O
twice RB O
, , O
1 CD O
day NN O
prior RB O
to IN O
challenge NN O
and CC O
on IN O
day NN O
of IN O
challenge NN O
, , O
with IN O
an DT O
equivalent JJ O
dosage NN O
sufficient JJ O
to TO O
deplete VB O
T NN O
or CC O
B NN O
cells NNS O
from IN O
6 CD O
x SYM O
108 CD O
bone NN O
marrow NN O
cells NNS O
per IN O
injection NN O
. . O

The DT O
efficiency NN O
of IN O
depletion NN O
at IN O
time NN O
of IN O
infection NN O
for IN O
CD4 NNP O
+ CC O
, , O
CD8 NNP O
+ CC O
, , O
and CC O
B220 NNP O
+ CC O
cells NNS O
was VBD O
confirmed VBN O
by IN O
flow NN O
cytometry NN O
analysis NN O
immediately RB O
prior RB O
to IN O
infection NN O
. . O

Complement VB O
depletion NN O
with IN O
cobra NN O
venom NN O
factor NN O

Mice NNS B-Species
, , O
six CD O
to TO O
seven CD O
per IN O
group NN O
, , O
were VBD O
vaccinated VBN O
i PRP O
. . O
p UH O
. . O
with IN O
1 CD O
x SYM O
105 CD O
CFU NN O
of IN O
nonviable JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
cell NN O
preparation NN O
in IN O
a DT O
total JJ O
volume NN O
of IN O
0 CD O
. . O
1 CD O
ml NNS O
. . O

Two CD O
weeks NNS O
later RB O
, , O
24 CD O
h NN O
and CC O
1 CD O
h NN O
before IN O
challenge NN O
, , O
complement VBP O
depleted VBN O
mice NNS B-Species
were VBD O
treated VBN O
i : O
. . O
p UH O
. . O
with IN O
12 CD O
. . O
5 CD O
units NNS O
total JJ O
cobra NN O
venom NN O
factor NN O
( : O
Quidel NNP O
Corporation NNP O
Speciality NNP O
Products NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
in IN O
0 CD O
. . O
1 CD O
ml NNS O
of IN O
PBS NNP O
. . O

Complement NN O
depletion NN O
was VBD O
confirmed VBN O
prior RB O
to IN O
challenge NN O
by IN O
micro JJ O
- HYPH O
titer NN O
hemolytic JJ O
complement NN O
activity NN O
( -LRB- O
CH50 NNP O
) -RRB- O
assay NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

B NN B-Species
. . I-Species
mallei NNP I-Species
J774A NNP O
. . O
1 CD O
uptake NN O
assays NNS O

J774A NNP O
. . O
1 CD O
cells NNS O
were VBD O
seeded VBN O
( : O
5 CD O
x SYM O
105 CD O
) -RRB- O
onto IN O
Corning NN O
costar NN O
24 CD O
well NN O
plates NNS O
( , O
Corning NNP O
, , O
NY NNP O
) -RRB- O
with IN O
DMEM NNP O
and CC O
incubated VBN O
overnight RB O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
5 CD O
% NN O
CO2 NN O
. . O

Bacterial JJ O
suspensions NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
45 CD O
minutes NNS O
supplemented VBN O
with IN O
2 CD O
% NN O
mouse NN B-Species
serum NN O
from IN O
Sigma NNP O
- HYPH O
Aldrich NNP O
( : O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
. . O
) -RRB- O
, , O
heat NN O
inactivated VBN O
mouse NN B-Species
serum NN O
( , O
56 CD O
degrees NNS O
C NN O
30 CD O
minutes NNS O
) -RRB- O
, , O
or CC O
bacteria NNS O
alone RB O
and CC O
then RB O
added VBN O
at IN O
an DT O
MOI NNP O
of IN O
10 CD O
: : O
1 CD O
to IN O
J774A NN O
. . O
1 CD O
cells NNS O
in IN O
triplicate NN O
. . O

Inoculated JJ O
wells NNS O
were VBD O
centrifuged VBN O
at IN O
800 CD O
g NN O
for IN O
2 CD O
minutes NNS O
and CC O
incubated VBN O
for IN O
2 CD O
hours NNS O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
5 CD O
% NN O
CO2 NN O
followed VBN O
by IN O
a DT O
PBS NNP O
wash NN O
( : O
x SYM O
2 CD O
) SYM O
and CC O
2 CD O
hour NN O
incubation NN O
with IN O
250 CD O
mu NNS O
g NN O
/ SYM O
ml FW O
kanamycin FW O
. . O

Wells NNS O
were VBD O
washed VBN O
twice RB O
with IN O
PBS NNP O
and CC O
lysed VBN O
with IN O
0 CD O
. . O
1 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
followed VBN O
by IN O
serial JJ O
10 CD O
- HYPH O
fold NN O
dilutions NNS O
plated VBN O
on IN O
LBG NNP O
plates NNS O
and CC O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
days NNS O
. . O

Colony NN O
forming VBG O
units NNS O
were VBD O
enumerated VBN O
and CC O
uptake NN O
expressed VBN O
as IN O
a DT O
percentage NN O
of IN O
initial JJ O
inoculating VBG O
dose NN O
+ SYM O
/ SYM O
- HYPH O
SEM NN O
. . O

Antibodies NNS O
and CC O
flow NN O
cytometry NN O

Flow NN O
cytometric JJ O
analysis NN O
was VBD O
performed VBN O
on IN O
0 CD O
. . O
1 CD O
- HYPH O
ml NN O
blood NN O
samples NNS O
transferred VBN O
to IN O
micro NN O
centrifuge NN O
tubes NNS O
containing VBG O
90 CD O
mu NNS O
l NN O
of IN O
acid NN O
citrate NN O
dextrose NN O
( -LRB- O
ACD NN O
) -RRB- O
solution NN O
. . O

Red JJ O
blood NN O
cells NNS O
were VBD O
lysed VBN O
using VBG O
ACK NNP O
- HYPH O
lysing VBG O
buffer NN O
( , O
Biosource NNP O
International NNP O
, , O
Inc NNP O
. . O
, , O
Camarillo NNP O
, , O
CA NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
instruction NN O
. . O

Antibodies NNS O
used VBN O
for IN O
analysis NN O
of IN O
surface NN O
markers NNS O
included VBD O
: : O
FITC NNP O
- HYPH O
conjugated VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NNP B-Species
CD45R NNP O
/ SYM O
B220 NNP O
( , O
RA3 NNP O
- HYPH O
6B2 CD O
, , O
BD NNP O
Pharmingen NNP O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
for IN O
B NN O
cells NNS O
; : O
FITC NNP O
- HYPH O
conjugated VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
CD8 NNP O
alpha NN O
( : O
53 CD O
- SYM O
6 CD O
. . O
7 CD O
) -RRB- O
and CC O
CD4 NN O
( : O
GK1 NNP O
. . O
5 CD O
, , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
for IN O
CD8 NN O
+ SYM O
or CC O
CD4 NN O
+ SYM O
cells NNS O
, , O
respectively RB O
. . O

Samples NNS O
evaluated VBN O
for IN O
CD4 NNP O
+ CC O
and CC O
CD8 NNP O
alpha NN O
+ CC O
cells NNS O
were VBD O
also RB O
incubated VBN O
with IN O
biotin NN O
- HYPH O
conjugated VBN O
hamster NN O
anti JJ O
- HYPH O
mouse NN B-Species
CD3e NNP O
( -LRB- O
145 CD O
- SYM O
2C11 CD O
) -RRB- O
monoclonal JJ O
antibody NN O
( , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
and CC O
subsequently RB O
with IN O
streptavidin NN O
APC NNP O
Cy7 NNP O
. . O

Isotype NN O
- HYPH O
matched VBN O
, , O
non NNP O
- HYPH O
specific JJ O
controls NNS O
were VBD O
assayed VBN O
in IN O
parallel NN O
( , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

Surface NN O
staining NN O
was VBD O
performed VBN O
according VBG O
to IN O
previously RB O
published VBN O
protocols NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Following VBG O
cell NN O
staining NN O
, , O
the DT O
samples NNS O
were VBD O
fixed VBN O
with IN O
2 CD O
% NN O
buffered VBN O
paraformaldehyde NN O
overnight RB O
prior RB O
to IN O
analysis NN O
by IN O
flow NN O
cytometry NN O
. . O

Samples NNS O
were VBD O
analyzed VBN O
using VBG O
a DT O
FACSCalibur NNP O
flow NN O
cytometer NN O
with IN O
BD NNP O
CellQuest NNP O
Pro NNP O
software NN O
. . O

Antibody NN O
assays NNS O

Immunoglobulin NN O
subclass NN O
IgG1 NNP O
and CC O
IgG2a NNP O
titers NNS O
in IN O
mice NNS B-Species
were VBD O
determined VBN O
by IN O
a DT O
whole JJ O
bacterial JJ O
cell NN O
ELISA NNP O
performed VBN O
in IN O
96 CD O
- HYPH O
well NN O
, , O
Immulon NNP O
2 CD O
HB NNP O
, , O
round JJ O
- HYPH O
bottom NN O
plates NNS O
( , O
Dynex NNP O
Technologies NNPS O
) -RRB- O
. . O

B NN B-Species
. . I-Species
mallei NN I-Species
antigen NN O
was VBD O
diluted VBN O
in IN O
0 CD O
. . O
1 CD O
M NN O
carbonate NN O
buffer NN O
( , O
pH NN O
9 CD O
. . O
5 CD O
) -RRB- O
and CC O
50 CD O
mu NNS O
l NN O
of IN O
diluted VBN O
cells NNS O
placed VBN O
into IN O
wells NNS O
. . O

Plates NNS O
were VBD O
stored VBN O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
plates NNS O
were VBD O
washed VBN O
with IN O
washing NN O
solution NN O
( , O
1 CD O
x SYM O
PBS NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
20 CD O
) -RRB- O
, , O
and CC O
incubated VBN O
with IN O
100 CD O
mu NNS O
l NN O
of IN O
blocking NN O
solution NN O
( , O
1 CD O
x SYM O
PBS NN O
, , O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
20 CD O
) -RRB- O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Dilutions NNS O
of IN O
mouse NNP B-Species
sera NN O
were VBD O
made VBN O
with IN O
blocking NN O
solution NN O
in IN O
duplicate JJ O
and CC O
plates NNS O
were VBD O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Following VBG O
incubation NN O
, , O
plates NNS O
were VBD O
washed VBN O
and CC O
50 CD O
mu NNS O
l NN O
of IN O
anti JJ O
- HYPH O
Ig NN O
- HYPH O
horseradish JJ B-Species
peroxidase NN O
subclass NN O
conjugate NN O
, , O
diluted VBN O
accordingly RB O
to IN O
manufacturer NN O
' '' O
s NN O
instructions NNS O
( -LRB- O
Southern NNP O
Biotechnology NNP O
Associates NNPS O
, , O
Inc NNP O
. . O
Birmingham NNP O
, , O
Ala NNP O
. . O
) -RRB- O
, , O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

After IN O
washing VBG O
, , O
50 CD O
mu NNS O
l NN O
of IN O
2 CD O
, , O
2 CD O
' '' O
- HYPH O
azino NN O
- HYPH O
di NN O
- HYPH O
( , O
3 CD O
- HYPH O
ethylbenzthizoline NN O
) NFP O
- HYPH O
6 CD O
- HYPH O
sulfonate NN O
( , O
ABTS NNP O
) -RRB- O
peroxidase NN O
substrate NN O
( : O
KPL NNP O
, , O
Inc NNP O
. . O
, , O
Gaithersburg NNP O
, , O
Maryland NNP O
) , O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
plates NNS O
incubated VBN O
for IN O
25 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

The DT O
amount NN O
of IN O
bound JJ O
antibody NN O
was VBD O
determined VBN O
colorimetrically RB O
by IN O
absorbance NN O
at IN O
405 CD O
nm NN O
. . O

Statistical JJ O
analysis NN O

Survival JJ O
curves NNS O
were VBD O
calculated VBN O
by IN O
Kaplan NNP O
Meier NNP O
survival NN O
analysis NN O
with IN O
log NN O
- HYPH O
rank NN O
tests NNS O
between IN O
groups NNS O
using VBG O
GraphPad NNP O
Prism NNP O
( , O
V NNP O
. . O
4 CD O
. . O
3 CD O
for IN O
windows NNS O
) -RRB- O
. . O

Statistical JJ O
analysis NN O
was VBD O
generally RB O
performed VBN O
with IN O
the DT O
paired VBN O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
test NN O
. . O

P NN O
value NN O
< : O
= SYM O
0 CD O
. . O
5 CD O
was VBD O
considered VBN O
significant JJ O
. . O

Abbreviations NNS O

HK NN O
: : O
Heat NN O
- HYPH O
killed VBN O
; : O
i PRP O
. . O
p NN O
. . O
: : O
intraperitoneal JJ O
; : O
i PRP O
. . O
n LS O
. . O
: : O
intranasal NN O
. . O

Authors NNS O
' POS O
contributions NNS O

GCW NNP O
designed VBD O
and CC O
conducted VBD O
experiments NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

BMJ NNP O
carried VBD O
out RP O
the DT O
immunoassays NNS O
and CC O
animal NN O
work NN O
. . O

SP NNP O
provided VBD O
analysis NN O
of IN O
data NNS O
and CC O
contributed VBD O
to IN O
design NN O
and CC O
animal NN O
work NN O
. . O

RAL NNP O
participated VBD O
in IN O
the DT O
generation NN O
and CC O
analysis NN O
of IN O
chronic JJ O
TNF NNP O
- HYPH O
alpha NN O
data NNS O
. . O

DME NNP O
conceived VBD O
the DT O
study NN O
, , O
and CC O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

AGT NNP O
participated VBD O
in IN O
the DT O
bacterial JJ O
work NN O
and CC O
drafting NN O
of IN O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

The DT O
ineffectiveness NN O
of IN O
tobramycin NN O
combination NN O
therapy NN O
in IN O
Streptococcus NNP B-Species
faecium NN I-Species
endocarditis NN O
. . O

Abstract JJ O

A DT O
patient NN B-Species
required VBD O
mitral JJ O
valve NN O
replacement NN O
following VBG O
ineffective JJ O
antibiotic JJ O
treatment NN O
of IN O
enterococcal JJ O
endocarditis NN O
caused VBN O
by IN O
Streptococcus NNP B-Species
faecium NN I-Species
. . O

Endocarditis NNP O
had VBD O
relapsed VBN O
despite IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
for IN O
six CD O
weeks NNS O
. . O

A DT O
second JJ O
relapse NN O
had VBD O
occurred VBN O
following VBG O
treatment NN O
with IN O
penicillin NN O
and CC O
gentamicin NN O
. . O

Initial JJ O
failure NN O
of IN O
antibiotic JJ O
therapy NN O
may MD O
be VB O
related VBN O
to IN O
the DT O
known VBN O
lack NN O
of IN O
in FW O
vitro FW O
and CC O
in IN O
vivo NN O
synergy NN O
between IN O
penicillin NN O
and CC O
tobramycin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
. . O

Effective JJ O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
requires VBZ O
considerations NNS O
of IN O
bacterial JJ O
speciation NN O
, , O
determination NN O
of IN O
high JJ O
- HYPH O
level NN O
aminoglycoside NN O
resistance NN O
, , O
and CC O
preferably RB O
adequate JJ O
antibiotic JJ O
synergy NN O
studies NNS O
to TO O
assure VB O
effective JJ O
therapy NN O
. . O

THE DT O
YALE NNP O
JOURNAL NNP O
OF IN O
BIOLOGY NNP O
AND CC O
MEDICINE NNP O
56 CD O
( : O
1983 CD O
) -RRB- O
, , O
243 CD O
- HYPH O
249 CD O

The DT O
Ineffectiveness NN O
of IN O
Tobramycin NN O
Combination NN O
Therapy NN O

in IN O
Streptococcus NN B-Species
Faecium NNP I-Species
Endocarditis NNP O

JUDITH NNP O
A NNP O
. . O

GOLDSTEIN NNP O
, , O
M UH O
. . O
D NNP O
. . O
, , O
a DT O
HOWARD NNP O
COHEN NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
a DT O
AND CC O

FRANK NNP O
J NNP O
. . O

BIA NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
M NNP O
. . O
P NN O
. . O
H NN O
. . O
a DT O
, , O
b NN O

aInfectious NNP O
Disease NNP O
Section NNP O
of IN O
the DT O
Department NNP O
of IN O
Medicine NNP O
, , O
and CC O
bThe NNP O
Department NNP O
of IN O

Laboratory NNP O
Medicine NNP O
, , O
Veterans NNPS O
Administration NNP O
Medical NNP O
Center NNP O
, , O

West NNP O
Haven NNP O
, , O
and CC O
Yale NNP O
University NNP O
School NNP O
of IN O
Medicine NNP O
, , O

New NNP O
Haven NNP O
, , O
Connecticut NNP O

Received VBN O
July NNP O
11 CD O
, , O
1983 CD O

A DT O
patient NN B-Species
required VBD O
mitral JJ O
valve NN O
replacement NN O
following VBG O
ineffective JJ O
antibiotic JJ O
treatment NN O
of IN O
enterococcal JJ O
endocarditis NN O
caused VBN O
by IN O
Streptococcusfaecium NNP B-Species
. . O

Endocarditis NNP O
had VBD O
relapsed VBN O
despite IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
for IN O
six CD O
weeks NNS O
. . O

A DT O
second JJ O
relapse NN O
had VBD O
occurred VBN O
following VBG O
treatment NN O
with IN O
penicillin NN O
and CC O
gentamicin NN O
. . O

Initial JJ O
failure NN O
of IN O
antibiotic JJ O
therapy NN O
may MD O
be VB O
related VBN O
to IN O
the DT O
known VBN O
lack NN O
of IN O
in FW O
vitro FW O
and CC O
in IN O
vivo NN O
synergy NN O
between IN O
penicillin NN O
and CC O
tobramycin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
. . O

Effective JJ O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
requires VBZ O
considerations NNS O
of IN O
bacterial JJ O
speciation NN O
, , O
determination NN O
of IN O
high JJ O
- HYPH O
level NN O
aminoglycoside NN O
resistance NN O
, , O
and CC O
preferably RB O
adequate JJ O
antibiotic JJ O
synergy NN O
studies NNS O
to TO O
assure VB O
effective JJ O
therapy NN O
. . O

INTRODUCTION NN O

Enterococcal JJ O
endocarditis NN O
requires VBZ O
special JJ O
therapeutic JJ O
considerations NNS O
because IN O
the DT O
responsible JJ O
organisms NNS O
are VBP O
relatively RB O
penicillin NN O
- HYPH O
resistant JJ O
streptococci NN O
which WDT O
require VBP O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
to TO O
achieve VB O
acceptable JJ O
cure NN O
rates NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

The DT O
group NN O
D NNP O
enterococci NNP O
include VBP O
three CD O
main JJ O
species NNS O
S NN B-Species
. . I-Species
faecalis NN I-Species
, , O
S NNP B-Species
. . I-Species
faecium NN I-Species
, , O
and CC O
S NNP B-Species
. . I-Species
durans NNS I-Species
. . O

S NN B-Species
. . I-Species
faecium NN I-Species
cause VBP O
a DT O
minority NN O
of IN O
all DT O
cases NNS O
of IN O
enterococcal JJ O
endocarditis NN O
, , O
in IN O
those DT O
instances NNS O
in IN O
which WDT O
enterococci NNS O
have VBP O
been VBN O
speciated VBN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
but CC O
they PRP O
have VBP O
been VBN O
more RBR O
resistant JJ O
both CC O
to IN O
penicillin NN O
and CC O
penicillin NN O
- HYPH O
aminoglycoside NN O
combinations NNS O
than IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
[ -LRB- O
4 CD O
, , O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

We PRP O
describe VBP O
a DT O
64 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
man NN B-Species
with IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
endocarditis NN O
in IN O
whom WP O
a DT O
six CD O
- HYPH O
week NN O
course NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
, , O
followed VBN O
by IN O
additional JJ O
courses NNS O
of IN O
penicillin NN O
and CC O
other JJ O
aminoglycosides NNS O
, , O
failed VBD O
to TO O
eradicate VB O
the DT O
organism NN O
from IN O
the DT O
patient NN B-Species
' POS O
s NNS O
mitral JJ O
valve NN O
. . O

This DT O
case NN O
is VBZ O
of IN O
interest NN O
because IN O
therapeutic JJ O
failure NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
in IN O
S NN B-Species
. . I-Species
faecium NN I-Species
endocarditis NN O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
, , O
but CC O
might MD O
have VB O
been VBN O
predicted VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
studies NNS O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Although IN O
the DT O
need NN O
for IN O
both CC O
a DT O
penicillin NN O
derivative NN O
and CC O
an DT O
aminoglycoside NN O
in IN O
the DT O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
is VBZ O
widely RB O
known VBN O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
distinguish VB O
between IN O
the DT O
differing VBG O
efficacies NNS O
of IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
combinations NNS O
for IN O
treating VBG O
various JJ O
species NNS O
of IN O
enterococci NN O
such JJ O
as IN O
S NN B-Species
. . I-Species
faecium NN I-Species
. . O

243 CD O

Address NN O
reprint NN O
requests NNS O
to IN O
: : O
Judith NNP O
A NNP O
. . O
Goldstein NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
Section NNP O
of IN O
Infectious NNP O
Diseases NNPS O
, , O
Department NNP O
of IN O
Medicine NNP O
, , O
Long NNP O
Island NNP O
Jewish NNP O
- HYPH O
Hillside NNP O
Medical NNP O
Center NNP O
, , O
Queen NNP O
' POS O
s POS O
Hosp NNP O
. . O

Center NNP O
Affiliate NNP O
, , O
82 CD O
- HYPH O
68 CD O
164th JJ O
Street NNP O
, , O
Jamaica NNP O
, , O
NY NNP O
11432 CD O

Copyright NN O
c NN O
1983 CD O
by IN O
The DT O
Yale NNP O
Journal NNP O
of IN O
Biology NNP O
and CC O
Medicine NNP O
, , O
Inc NNP O
. . O

All DT O
rights NNS O
of IN O
reproduction NN O
in IN O
any DT O
form NN O
reserved VBN O
. . O

GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

CASE NN O
REPORT NN O

A DT O
64 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
male NN O
was VBD O
in IN O
good JJ O
health NN O
until IN O
December NNP O
1980 CD O
, , O
when WRB O
he PRP O
noted VBD O
intermittent JJ O
night NN O
sweats NNS O
, , O
malaise NN O
, , O
fever NN O
, , O
and CC O
fatigue NN O
. . O

He PRP O
received VBD O
oral JJ O
erythromycin NN O
for IN O
14 CD O
days NNS O
with IN O
transient JJ O
improvement NN O
of IN O
symptoms NNS O
. . O

However RB O
, , O
after IN O
completing VBG O
therapy NN O
, , O
symptoms NNS O
reappeared VBD O
and CC O
he PRP O
noted VBD O
a DT O
15 CD O
- HYPH O
pound NN O
weight NN O
loss NN O
with IN O
low JJ O
- HYPH O
grade NN O
fever NN O
( : O
99 CD O
- SYM O
100 CD O
. . O
5 CD O
? . O
F NN O
) -RRB- O
during IN O
the DT O
two CD O
months NNS O
preceding VBG O
admission NN O
. . O

There EX O
was VBD O
no DT O
previous JJ O
history NN O
of IN O
rheumatic JJ O
or CC O
congenital JJ O
heart NN O
disease NN O
. . O

In IN O
March NNP O
1981 CD O
, , O
the DT O
patient NN B-Species
was VBD O
admitted VBN O
to IN O
his PRP$ O
community NN O
hospital NN O
where WRB O
evaluation NN O
revealed VBD O
a DT O
new JJ O
apical JJ O
systolic JJ O
murmur NN O
radiating VBG O
to IN O
the DT O
axilla NN O
. . O

There EX O
were VBD O
no DT O
petechiae NN O
, , O
Janeway NNP O
lesions NNS O
, , O
Osler NNP O
' POS O
s NNS O
nodes NNS O
, , O
Roth NNP O
spots NNS O
, , O
or CC O
splenomegaly NN O
. . O

The DT O
hematocrit NN O
was VBD O
34 CD O
. . O
8 CD O
percent NN O
, , O
WBC NNP O
count NN O
9 CD O
, , O
300 CD O
cells NNS O
per IN O
cu NN O
mm NN O
with IN O
a DT O
differential JJ O
count NN O
of IN O
67 CD O
segmented JJ O
forms NNS O
, , O
9 CD O
bands NNS O
, , O
15 CD O
lymphocytes NNS O
, , O
7 CD O
monocytes NNS O
, , O
1 CD O
eosinophil NN O
, , O
and CC O
1 CD O
basophil NN O
. . O

The DT O
erythrocyte NN O
sedimentation NN O
rate NN O
( -LRB- O
ESR NNP O
) -RRB- O
was VBD O
62 CD O
mm NN O
per IN O
hour NN O
( , O
nl NN O
< SYM O
10 CD O
mm NN O
per IN O
hour NN O
) -RRB- O
and CC O
the DT O
serum JJ O
rheumatoid NN O
factor NN O
titer NN O
was VBD O
1 CD O
: SYM O
320 CD O
. . O

Chest NN O
films NNS O
and CC O
electrocardiogram NN O
were VBD O
reportedly RB O
normal JJ O
. . O

Group NNP O
D NNP O
streptococci NNP O
grew VBD O
from IN O
three CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
. . O

Enterococcal JJ O
endocarditis NN O
was VBD O
diagnosed VBN O
and CC O
he PRP O
was VBD O
treated VBN O
with IN O
six CD O
weeks NNS O
of IN O
parenteral JJ O
ampicillin NN O
( : O
12 CD O
grams NNS O
per IN O
day NN O
) , O
and CC O
tobramycin NN O
( : O
3 CD O
mg NN O
per IN O
kg NN O
per IN O
day NN O
) -RRB- O
. . O

Resolution NN O
of IN O
symptoms NNS O
occurred VBD O
within IN O
several JJ O
days NNS O
after IN O
antibiotics NNS O
were VBD O
begun VBN O
. . O

Serum JJ O
bactericidal JJ O
titers NNS O
against IN O
the DT O
organism NN O
, , O
obtained VBN O
during IN O
peak NN O
antibiotic JJ O
levels NNS O
, , O
were VBD O
1 CD O
: SYM O
8 CD O
or CC O
greater JJR O
on IN O
several JJ O
occasions NNS O
, , O
and CC O
blood NN O
cultures NNS O
were VBD O
negative JJ O
while IN O
the DT O
patient NN B-Species
was VBD O
receiving VBG O
antibiotics NNS O
. . O

M NN O
- HYPH O
mode NN O
echocardiography NN O
demonstrated VBD O
left VBN O
atrial JJ O
enlargement NN O
but CC O
no DT O
definable JJ O
abnormalities NNS O
of IN O
the DT O
mitral JJ O
or CC O
aortic JJ O
valves NNS O
. . O

Intravenous JJ O
pyelogram NN O
, , O
oral JJ O
cholecystogram NN O
, , O
cystoscopy NN O
, , O
liver NN O
- HYPH O
spleen NN O
scan NN O
, , O
and CC O
upper JJ O
and CC O
lower JJ O
gastrointestinal JJ O
series NN O
were VBD O
normal JJ O
except IN O
for IN O
a DT O
few JJ O
sigmoid NN O
diverticuli NNS O
. . O

Flexible JJ O
signoidoscopy NN O
demonstrated VBD O
both CC O
a DT O
small JJ O
perianal JJ O
fissure NN O
and CC O
hemorrhoids NNS O
. . O

Blood NN O
cultures NNS O
two CD O
weeks NNS O
after IN O
therapy NN O
were VBD O
negative JJ O
. . O

Second NNP O
Admission NNP O
( : O
June NNP O
19 CD O
- HYPH O
August NNP O
4 CD O
, , O
1981 CD O
) -RRB- O

In IN O
June NNP O
1981 CD O
, , O
he PRP O
again RB O
noted VBD O
intermittent JJ O
fever NN O
, , O
night NN O
sweats NNS O
, , O
and CC O
fatigue NN O
. . O

Group NN O
D NNP O
streptococci NNP O
grew VBD O
from IN O
three CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
and CC O
he PRP O
was VBD O
admitted VBN O
to IN O
the DT O
West NNP O
Haven NNP O
VA NNP O
Medical NNP O
Center NNP O
for IN O
recurrent JJ O
endocarditis NN O
. . O

On IN O
examination NN O
a DT O
somewhat RB O
louder JJR O
apical JJ O
systolic JJ O
murmur NN O
was VBD O
noted VBN O
. . O

The DT O
ESR NNP O
was VBD O
50 CD O
mm NN O
/ SYM O
hour NN O
and CC O
rheumatoid JJ O
factor NN O
titer NN O
was VBD O
1 CD O
: SYM O
320 CD O
. . O

Serum NN O
complement NN O
levels NNS O
were VBD O
normal JJ O
and CC O
cryoglobulins NNS O
were VBD O
not RB O
detectable JJ O
. . O

Chest NN O
films NNS O
, , O
EKG NNP O
, , O
and CC O
urinalysis NN O
were VBD O
normal JJ O
. . O

Cardiac JJ O
M NN O
- HYPH O
mode NN O
echocardiogram NN O
revealed VBD O
a DT O
globular JJ O
mass NN O
attached VBN O
to IN O
the DT O
posterior JJ O
mitral NN O
valve NN O
leaflet NN O
with IN O
prolapse NN O
into IN O
a DT O
slightly RB O
enlarged VBN O
left JJ O
atrium NN O
. . O

A DT O
twodimensional JJ O
echocardiogram NN O
confirmed VBD O
mitral JJ O
valve NN O
prolapse NN O
and CC O
suggested VBD O
a DT O
posterior JJ O
leaflet NN O
vegetation NN O
. . O

Gallium NNP O
citrate NN O
scan NN O
was VBD O
negative JJ O
. . O

Three CD O
separate JJ O
morphologic JJ O
colony NN O
variants NNS O
were VBD O
isolated VBN O
from IN O
blood NN O
, , O
each DT O
identified VBN O
as IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
by IN O
Dr NNP O
. . O
R NNP O
. . O
R NN O
. . O

Facklam NNP O
( : O
Center NNP O
for IN O
Disease NNP O
Control NNP O
, , O
Atlanta NNP O
, , O
Georgia NNP O
) -RRB- O
. . O

The DT O
patient NN B-Species
received VBD O
intravenous JJ O
penicillin NN O
( : O
20 CD O
million CD O
units NNS O
per IN O
day NN O
) , O
and CC O
gentamicin NN O
( : O
3 CD O
mg NN O
per IN O
kg NN O
per IN O
day NN O
) -RRB- O
for IN O
six CD O
weeks NNS O
with IN O
improvement NN O
. . O

Peak NN O
serum NN O
bactericidal JJ O
titers NNS O
of IN O
1 CD O
: SYM O
8 CD O
or CC O
greater JJR O
were VBD O
achieved VBN O
against IN O
two CD O
of IN O
the DT O
colony NN O
variants NNS O
; : O
however RB O
, , O
against IN O
the DT O
large JJ O
colony NN O
morphotype NN O
, , O
a DT O
titer NN O
of IN O
only RB O
1 CD O
: SYM O
2 CD O
was VBD O
obtained VBN O
. . O

An DT O
enlarged JJ O
left JJ O
atrium NN O
with IN O
intermittent JJ O
fluttering NN O
and CC O
prolapse NN O
of IN O
the DT O
mitral JJ O
valve NN O
was VBD O
noted VBN O
on IN O
echocardiography NN O
three CD O
weeks NNS O
into IN O
therapy NN O
. . O

Multiple JJ O
blood NN O
cultures NNS O
taken VBN O
while IN O
the DT O
patient NN B-Species
was VBD O
receiving VBG O
antibiotics NNS O
were VBD O
negative JJ O
, , O
as IN O
were VBD O
those DT O
obtained VBN O
48 CD O
and CC O
72 CD O
hours NNS O
after IN O
discontinuation NN O
of IN O
antibiotics NNS O
. . O

244 CD O

S UH B-Species
. . I-Species

FAECIUM NNP B-Species
ENDOCARDITIS NNP O

Third NNP O
Admission NNP O
( : O
August NNP O
12 CD O
- : O
October NNP O
4 CD O
, , O
1981 CD O
) -RRB- O

Withing VBG O
a DT O
week NN O
following VBG O
discharge NN O
, , O
the DT O
patient NN B-Species
again RB O
developed VBD O
fever NN O
, , O
nocturnal JJ O
sweats NNS O
, , O
and CC O
malaise NN O
. . O

S NNP B-Species
. . I-Species
faecium NN I-Species
( , O
large JJ O
colony NN O
morphotype NN O
, , O
and CC O
poorly RB O
growing VBG O
small JJ O
colony NN O
morphotype NN O
) -RRB- O
grew VBD O
from IN O
six CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
obtained VBN O
on IN O
admission NN O
. . O

Penicillin NNP O
( : O
30 CD O
million CD O
units NNS O
/ SYM O
day NN O
) -RRB- O
and CC O
gentamicin NN O
( , O
3 CD O
mg NN O
/ SYM O
kg NNS O
/ SYM O
day NN O
) -RRB- O
were VBD O
again RB O
administered VBN O
, , O
initially RB O
achieving VBG O
peak NN O
serum NN O
inhibitory NN O
and CC O
bactericidal JJ O
dilutions NNS O
of IN O
1 CD O
: SYM O
16 CD O
and CC O
1 CD O
: SYM O
8 CD O
against IN O
the DT O
organism NN O
, , O
respectively RB O
. . O

However RB O
, , O
the DT O
organism NN O
had VBD O
a DT O
lowlevel JJ O
resistance NN O
to IN O
streptomycin NN O
( , O
MIC NNP O
< SYM O
125 CD O
/ SYM O
Ag NNP O
/ SYM O
ml NNP O
) -RRB- O
, , O
and CC O
streptomycin NN O
( , O
2 CD O
grams NNS O
per IN O
day NN O
) -RRB- O
was VBD O
substituted VBN O
for IN O
gentamicin NN O
two CD O
weeks NNS O
into IN O
antibiotic JJ O
therapy NN O
. . O

Repeat NN O
echocardiograms NNS O
showed VBD O
irregular JJ O
and CC O
shaggy JJ O
densities NNS O
of IN O
both DT O
mitral JJ O
valve NN O
leaflets NNS O
with IN O
partial JJ O
prolapse NN O
. . O

Cardiac JJ O
catheterization NN O
demonstrated VBD O
marked JJ O
mitral JJ O
valve NN O
prolapse NN O
with IN O
mitral JJ O
regurgitation NN O
. . O

A DT O
radiolucent JJ O
filling NN O
defect NN O
was VBD O
noted VBN O
, , O
suggesting VBG O
a DT O
coronary JJ O
artery NN O
embolus VB O
at IN O
the DT O
origin NN O
of IN O
the DT O
left JJ O
anterior JJ O
descending VBG O
( HYPH O
LAD NNP O
) -RRB- O
artery NN O
, , O
causing VBG O
75 CD O
percent NN O
occlusion NN O
of IN O
the DT O
lumen NN O
. . O

The DT O
patient NN B-Species
underwent VBD O
mitral JJ O
valve NN O
replacement NN O
, , O
receiving VBG O
a DT O
number NN O
31 CD O
porcine NN O
Hancock NNP O
bioprosthesis NN O
and CC O
bypass NN O
graft NN O
to IN O
the DT O
midportion NN O
of IN O
the DT O
LAD NNP O
. . O

The DT O
mitral JJ O
valve NN O
was VBD O
thickened VBN O
with IN O
several JJ O
ruptured VBN O
chordae NN O
of IN O
the DT O
posterior JJ O
leaflet NN O
noted VBN O
, , O
but CC O
no DT O
vegetations NNS O
. . O

The DT O
aortic JJ O
valve NN O
appeared VBD O
normal JJ O
, , O
with IN O
no DT O
visible JJ O
septal NN O
or CC O
ring NN O
abscesses NNS O
. . O

The DT O
occlusion NN O
in IN O
the DT O
LAD NNP O
was VBD O
not RB O
approached VBN O
to TO O
avoid VB O
embolizing VBG O
distal JJ O
fragments NNS O
. . O

Histopathologically RB O
the DT O
mitral JJ O
valve NN O
showed VBD O
mild JJ O
fibrosis NN O
and CC O
myxoid NN O
degeneration NN O
without IN O
inflammatory JJ O
changes NNS O
. . O

Bacterial JJ O
and CC O
fungal JJ O
stains NNS O
were VBD O
negative JJ O
but CC O
S NNP B-Species
. . I-Species
faecium NN I-Species
grew VBD O
from IN O
fragments NNS O
of IN O
the DT O
resected VBN O
valve NN O
. . O

Following VBG O
surgery NN O
the DT O
patient NN B-Species
received VBD O
six CD O
additional JJ O
weeks NNS O
parenteral JJ O
penicillin NN O
and CC O
streptomycin NN O
. . O

Repeat NN O
blood NN O
cultures NNS O
on IN O
this DT O
regimen NN O
and CC O
following VBG O
therapy NN O
were VBD O
negative JJ O
. . O

Evaluation NN O
six CD O
months NNS O
following VBG O
discontinuation NN O
of IN O
antibiotics NNS O
showed VBD O
no DT O
evidence NN O
of IN O
recurrent JJ O
endocarditis NN O
. . O

LABORATORY NN O
EVALUATION NN O

The DT O
minimum JJ O
inhibitory JJ O
and CC O
bactericidal JJ O
concentrations NNS O
of IN O
penicillin NN O
, , O
ampicillin NN O
, , O
and CC O
tobramycin NN O
against IN O
the DT O
S NNP B-Species
. , I-Species
faecium NN I-Species
isolated VBN O
from IN O
the DT O
patient NN B-Species
' POS O
s NN O
blood NN O
cultures NNS O

TABLE NN O
1 CD O

Minimum JJ O
Inhibitory NN O
and CC O
Bactericidal NNP O
Concentrations NNPS O
of IN O
Antibiotics NNPS O
, , O

Against IN O
Streptococcus NN B-Species
faecium NN I-Species
Isolates VBZ O
from IN O
Blood NNP O
Cultures NNPS O

Date NN O
Penicillin NN O
Ampicillin NN O
Tobramycin NN O

Organism NN O
Isolated VBN O
MIC NNP O
MIC NNP O
MBC NNP O
MIC NNP O
MBC NNP O
S NNP B-Species
. . I-Species
faecium NN I-Species
, , O
prior RB O
to IN O
ampicillin NN O
/ , O

tobramycin NN O
therapy NN O
3 CD O
/ SYM O
17 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
2 CD O
> SYM O
32 CD O
> SYM O
32 CD O
S NN B-Species
. . I-Species
faecium NN I-Species
, , O
after IN O
ampicillin NN O
/ , O

tobramycin NN O
therapy NN O

a DT O
. . O

Large JJ O
colony NN O

variant JJ O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
1 CD O
> SYM O
32 CD O
> SYM O
32 CD O
b NN O
. . O

Medium JJ O
colony NN O

variant NN O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
2 CD O
32 CD O
32 CD O
c NN O
. . O

Small JJ O
colony NN O

variant NN O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
4 CD O
2 CD O
4 CD O
> SYM O
32 CD O
> SYM O
32 CD O
aMIC NN O
and CC O
MBC NNP O
are VBP O
minimum JJ O
inhibitory NN O
and CC O
bactericidal JJ O
concentrations NNS O
of IN O
antibiotics NNS O
, , O
respectively RB O
, , O
in IN O
tig NN O
/ SYM O
ml NNP O
. . O

245 CD O

GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

FIG NNP O
. . O

1 LS O
. . O

Time NN O
- HYPH O
kill NN O
curve NN O
demonstrat8 NN O
3 CD O
- : O
\ NFP O
"""" '' O
' '' O
' '' O
ing VBG O
the DT O
effects NNS O
of IN O
various JJ O
penicillinO NN O
aminoglycoside NN O
combinations NNS O
on IN O
S NNP O
. . O

{ NFP O
73 CD O
2 CD O
- HYPH O
\ NN O
> NFP O
, , O
faecium NN O
obtained VBN O
from IN O
the DT O
patient NN B-Species
' '' O
s VBZ O

blood NN O
cultures NNS O
immediately RB O
prior RB O
to IN O
mitral JJ O
valve NN O
excision NN O
. . O

Note VB O
the DT O
lack NN O
of IN O
4u CD O
, , O
synergy NN O
between IN O
penicillin NN O
and CC O
tobra25kg NN O
/ SYM O
rm NN O
Streporrrychn NNP O
t NN O
mycin NN O
against IN O
this DT O
organism NN O
when WRB O

/ SYM O
0 CD O
units NNS O
/ SYM O
mI NN O
Penicillin NN O
_ : O
compared VBN O
to IN O
synergistic JJ O
combinations NNS O
0 CD O
4 CD O
8 CD O
12 CD O
6 CD O
20 CD O
24 CD O
of IN O
penicillin NN O
- HYPH O
gentamicin NN O
and CC O
penicillin NN O

HOURS NNS O
streptomycin NN O
. . O

after IN O
initial JJ O
oral JJ O
erythromycin NN O
therapy NN O
, , O
and CC O
prior RB O
to IN O
therapy NN O
for IN O
endocarditis NN O
, , O
are VBP O
shown VBN O
in IN O
Table NNP O
1 CD O
. . O

Following VBG O
combined VBN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
and CC O
relapse NN O
of IN O
endocarditis NN O
, , O
three CD O
morphological JJ O
variants NNS O
were VBD O
isolated VBN O
from IN O
blood NN O
cultures NNS O
and CC O
also RB O
evaluated VBN O
. . O

Twenty CD O
- HYPH O
four CD O
hour NN O
time NN O
- HYPH O
kill NN O
curves NNS O
for IN O
penicillin NN O
in IN O
combination NN O
with IN O
various JJ O
aminoglycosides NNS O
were VBD O
performed VBN O
by IN O
Dr NNP O
. . O
Robert NNP O
Moellering NNP O
on IN O
the DT O
S NNP B-Species
. , I-Species
faecium NN I-Species
isolated VBN O
from IN O
the DT O
patient NN B-Species
' POS O
s NN O
blood NN O
immediately RB O
prior RB O
to IN O
mitral JJ O
valve NN O
excision NN O
and CC O
replacement NN O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Synergy NN O
was VBD O
readily RB O
demonstrable JJ O
against IN O
this DT O
organism NN O
by IN O
penicillin NN O
- HYPH O
streptomycin NN O
and CC O
penicillin NN O
- HYPH O
gentamicin NN O
combinations NNS O
in IN O
vitro NN O
, , O
but CC O
not RB O
by IN O
penicillin NN O
- HYPH O
tobramycin NN O
. . O

DISCUSSION NN O

Among IN O
streptococci NN O
, , O
the DT O
enterococci NNS O
are VBP O
unusual JJ O
in IN O
their PRP$ O
relative JJ O
resistance NN O
to IN O
a DT O
broad JJ O
spectrum NN O
of IN O
antimicrobial JJ O
agents NNS O
, , O
and CC O
single JJ O
- HYPH O
agent NN O
therapy NN O
is VBZ O
rarely RB O
bactericidal JJ O
against IN O
them PRP O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Since IN O
Hunter NNP O
' POS O
s POS O
original JJ O
observations NNS O
in IN O
1947 CD O
, , O
it PRP O
has VBZ O
become VBN O
increasingly RB O
clear JJ O
that IN O
effective JJ O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
are VBP O
necessary JJ O
to TO O
successfully RB O
treat VB O
enterococcal JJ O
endocarditis NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Although IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
represents VBZ O
the DT O
majority NN O
of IN O
clinical JJ O
enterococcal JJ O
isolates NNS O
, , O
S NN B-Species
. . I-Species
faecium NN I-Species
nonetheless RB O
comprises VBZ O
5 CD O
- SYM O
10 CD O
percent NN O
of IN O
these DT O
isolates NNS O
in IN O
some DT O
series NN O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Moreover RB O
, , O
major JJ O
differences NNS O
exist VBP O
in IN O
antimicrobial JJ O
susceptibility NN O
and CC O
resistance NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
between IN O
these DT O
two CD O
enterococcal JJ O
species NNS O
. . O

The DT O
MIC NNP O
of IN O
penicillin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
is VBZ O
higher JJR O
and CC O
this DT O
organism NN O
is VBZ O
more RBR O
resistant JJ O
to IN O
a DT O
number NN O
of IN O
different JJ O
combinations NNS O
of IN O
penicillin NN O
and CC O
various JJ O
aminoglycosides NNS O
than IN O
is VBZ O
S NN B-Species
. . I-Species
faecalis NNS I-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

The DT O
mechanisms NNS O
of IN O
resistance NN O
exhibited VBN O
by IN O
enterococci NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergy NN O
have VBP O
been VBN O
investigated VBN O
. . O

Clinically RB O
achievable JJ O
levels NNS O
of IN O
amino NN O

246 CD O

S UH B-Species
. . I-Species

FAECIUM NNP B-Species
ENDOCARDITIS NNP O

glycosides NNS O
are VBP O
generally RB O
ineffective JJ O
against IN O
enterococci NN O
. . O

This DT O
intrinsic JJ O
low JJ O
- HYPH O
level NN O
resistance NN O
( -LRB- O
MIC NNP O
c NN O
250 CD O
isg NN O
/ SYM O
ml NN O
) -RRB- O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
result NN O
of IN O
poor JJ O
antibiotic JJ O
penetration NN O
of IN O
the DT O
bacterial JJ O
cell NN O
wall NN O
. . O

However RB O
, , O
in IN O
the DT O
presence NN O
of IN O
antibiotics NNS O
that WDT O
interfere VBP O
with IN O
cell NN O
wall NN O
synthesis NN O
, , O
there EX O
is VBZ O
enhanced VBN O
aminoglycoside NN O
uptake NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
concert NN O
, , O
these DT O
events NNS O
are VBP O
the DT O
basis NN O
for IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
. . O

Ribosomal JJ O
resistance NN O
of IN O
the DT O
30S NNP O
subunit NN O
to IN O
streptomycin NN O
and CC O
defective JJ O
uptake NN O
of IN O
gentamicin NN O
in IN O
the DT O
presence NN O
of IN O
penicillin NN O
have VBP O
been VBN O
reported VBN O
mechanisms NNS O
of IN O
resistance NN O
among IN O
enterococcal JJ O
isolates NNS O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

However RB O
, , O
in IN O
the DT O
majority NN O
of IN O
instances NNS O
, , O
failure NN O
of IN O
synergy NN O
involves VBZ O
plasmid NN O
- HYPH O
mediated VBN O
production NN O
of IN O
aminoglycoside NN O
- HYPH O
modifying VBG O
enzymes NNS O
. . O

For IN O
streptomycin NN O
and CC O
kanamycin NN O
, , O
plasmid NN O
- HYPH O
mediated VBN O
enzymatic JJ O
inactivation NN O
confers VBZ O
high JJ O
- HYPH O
level NN O
resistance NN O
( -LRB- O
MIC NNP O
> SYM O
2 CD O
, , O
0 CD O
Ag NN O
/ SYM O
ml NN O
) -RRB- O
and CC O
correlates VBZ O
with IN O
failure NN O
of IN O
these DT O
aminoglycosides NNS O
to TO O
exert VB O
a DT O
synergistic JJ O
effect NN O
when WRB O
combined VBN O
with IN O
penicillin NN O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Plasmid NN O
- HYPH O
mediated VBN O
modifying VBG O
enzymes NNS O
have VBP O
been VBN O
found VBN O
in IN O
both DT O
S NN B-Species
. . I-Species
faecalis NN I-Species
and CC O
S NN B-Species
. . I-Species
faecium NN I-Species
' '' O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Currently RB O
, , O
approximately RB O
one CD O
- HYPH O
half NN O
of IN O
clinical JJ O
enterococcal JJ O
isolates NNS O
demonstrate VBP O
high JJ O
- HYPH O
level NN O
resistance NN O
to IN O
streptomycin NN O
and CC O
kanamycin NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Combinations NNS O
of IN O
penicillin NN O
with IN O
kanamycin NN O
, , O
tobramycin NN O
, , O
sisomicin NN O
, , O
and CC O
netilmicin NN O
have VBP O
consistently RB O
failed VBN O
to TO O
demonstrate VB O
synergistic JJ O
killing NN O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
in IN O
vitro FW O
[ -LRB- O
6 CD O
] -RRB- O
. . O

This DT O
failure NN O
of IN O
synergy NN O
occurs VBZ O
even RB O
when WRB O
high JJ O
- HYPH O
level NN O
resistance NN O
to IN O
these DT O
aminoglycosides NNS O
is VBZ O
not RB O
present JJ O
. . O

The DT O
mechanism NN O
of IN O
resistance NN O
appears VBZ O
to TO O
be VB O
related VBN O
to IN O
the DT O
production NN O
of IN O
an DT O
inactivating VBG O
enzyme NN O
that WDT O
acetylates VBZ O
the DT O
aminoglycoside NN O
substrate NN O
at IN O
the DT O
6 CD O
' '' O
position1 NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

The DT O
genetic JJ O
basis NN O
for IN O
production NN O
of IN O
this DT O
enzyme NN O
has VBZ O
not RB O
been VBN O
well RB O
- HYPH O
defined VBN O
and CC O
plasmid NN O
transfer NN O
experiments NNS O
have VBP O
thus RB O
far RB O
been VBN O
unsucessful JJ O
in IN O
demonstrating VBG O
the DT O
encodement NN O
of IN O
this DT O
enzyme NN O
by IN O
extrachromosomal JJ O
DNA NNP O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Moellering NNP O
et FW O
al NN O
. . O
demonstrated VBN O
in IN O
vivo NN O
, , O
utilizing VBG O
the DT O
rabbit NN B-Species
model NN O
of IN O
endocarditis NN O
, , O
that IN O
penicillin NN O
and CC O
netilmicin NN O
were VBD O
not RB O
efficacious JJ O
in IN O
the DT O
treatment NN O
of IN O
endocarditis NN O
caused VBN O
by IN O
a DT O
low JJ O
- HYPH O
level NN O
aminoglycoside NN O
- HYPH O
resistant JJ O
strain NN O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

Although IN O
combinations NNS O
of IN O
penicillin NN O
with IN O
tobramycin NN O
, , O
kanamycin NN O
, , O
or CC O
sisomicin NN O
were VBD O
not RB O
evaluated VBN O
, , O
the DT O
authors NNS O
postulated VBD O
that IN O
the DT O
same JJ O
ineffectual JJ O
result NN O
would MD O
have VB O
occurred VBN O
. . O

In IN O
the DT O
present JJ O
case NN O
, , O
the DT O
recurrence NN O
of IN O
S NNP B-Species
. , I-Species
faecium NN I-Species
endocarditis NN O
after IN O
six CD O
weeks NNS O
of IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
confirms VBZ O
the DT O
therapeutic JJ O
and CC O
clinical JJ O
significance NN O
of IN O
their PRP$ O
data NNS O
, , O
and CC O
emphasizes VBZ O
that IN O
tobramycin NN O
is VBZ O
not RB O
an DT O
aminoglycoside NN O
to TO O
be VB O
used VBN O
for IN O
treatment NN O
of IN O
serious JJ O
S NN B-Species
. . I-Species
faecium NN I-Species
infections NNS O
. . O

Bacterial JJ O
tolerance NN O
has VBZ O
been VBN O
suggested VBN O
as IN O
a DT O
possible JJ O
basis NN O
for IN O
therapeutic JJ O
failures NNS O
, , O
particularly RB O
in IN O
the DT O
treatment NN O
of IN O
infections NNS O
caused VBN O
by IN O
Staphylococcus NNP B-Species
aureus NN I-Species
with IN O
defects NNS O
in IN O
the DT O
production NN O
of IN O
autolysins NNS O
. . O

MBCs NNS O
are VBP O
generally RB O
several JJ O
- HYPH O
fold NN O
higher JJR O
than IN O
MICs NNS O
and CC O
this DT O
phenomenon NN O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
the DT O
autolysin NN O
defect NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Lorian NNP O
has VBZ O
also RB O
described VBN O
the DT O
formation NN O
of IN O
numerous JJ O
aberrant JJ O
cross NN O
- HYPH O
walls NNS O
by IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
grown VBN O
in IN O
the DT O
presence NN O
of IN O
subinhibitory JJ O
concentrations NNS O
of IN O
penicillin NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

MBCs NNS O
were VBD O
only RB O
slightly RB O
higher JJR O
than IN O
MICs NNS O
for IN O
the DT O
three CD O
S NNS B-Species
. . I-Species
faecium NN I-Species
variants NNS O
obtained VBN O
from IN O
our PRP$ O
patient NN B-Species
, , O
and CC O
they PRP O
did VBD O
not RB O
appear VB O
to TO O
be VB O
tolerant JJ O
strains NNS O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
. . O

There EX O
was VBD O
no DT O
evidence NN O
that IN O
any DT O
of IN O
the DT O
morphological JJ O
variants NNS O
isolated VBN O
were VBD O
unusually RB O
resistant JJ O
to IN O
antibiotics NNS O
. . O

Therefore RB O
, , O
subsequent JJ O
failure NN O
of IN O
therapy NN O
could MD O
not RB O
be VB O
explained VBN O
on IN O
the DT O
basis NN O
of IN O
antibiotic JJ O
resistance NN O
patterns NNS O
. . O

The DT O
initial JJ O
failure NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
therapy NN O
may MD O
have VB O
allowed VBN O
the DT O
infecting VBG O
organism NN O
to TO O
become VB O
better RBR O
established VBN O
and CC O
more RBR O
difficult JJ O
to TO O
eradicate VB O
from IN O
the DT O
valve NN O
. . O

Alternatively RB O
, , O
a DT O

' '' O
Wennersten NNP O
C NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
: : O
Mechanism NN O
of IN O
resistance NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
in IN O
Streptococcus NN B-Species
faecium NN I-Species
. . O

Proceedings NNS O
of IN O
the DT O
1th JJ O
International NNP O
Congress NNP O
of IN O
Chemotherapy NNP O
and CC O
19th JJ O
Interscience NNP O
Conference NNP O
on IN O
Antimicrobial NNP O
Agents NNPS O
and CC O
Chemotherapy NNP O
1 CD O
: : O
710 CD O
- HYPH O
711 CD O
, , O
1979 CD O

247 CD O

248 CD O
GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

persistent JJ O
focus NN O
of IN O
infection NN O
causing VBG O
the DT O
LAD NNP O
lesion NN O
seen VBN O
by IN O
arteriography NN O
may MD O
have VB O
slowly RB O
resolved VBN O
and CC O
accounted VBN O
for IN O
the DT O
apparent JJ O
failure NN O
to TO O
respond VB O
to IN O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
. . O

In IN O
summary NN O
, , O
our PRP$ O
patient NN B-Species
was VBD O
treated VBN O
for IN O
Streptococcusfaecium NN B-Species
endocarditis NN O
with IN O
both CC O
ampicillin NN O
and CC O
the DT O
aminoglycoside NN O
antibiotic NN O
, , O
tobramycin NN O
. . O

Relapse NN O
of IN O
endocarditis NN O
might MD O
have VB O
been VBN O
anticipated VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
experimental JJ O
data NNS O
showing VBG O
lack NN O
of IN O
synergy NN O
when WRB O
tobramycin NN O
is VBZ O
used VBN O
against IN O
this DT O
organism NN O
. . O

This DT O
case NN O
graphically RB O
illustrates VBZ O
the DT O
relevance NN O
of IN O
synergy NN O
studies NNS O
to IN O
therapeutic JJ O
considerations NNS O
in IN O
the DT O
treatment NN O
of IN O
endocarditis NN O
. . O

However RB O
, , O
subsequent JJ O
therapy NN O
with IN O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
did VBD O
not RB O
result VB O
in IN O
cure NN O
. . O

The DT O
data NNS O
do VBP O
not RB O
implicate VB O
tolerant JJ O
organisms NNS O
as IN O
a DT O
cause NN O
for IN O
relapses NNS O
. . O

Failure NN O
of IN O
therapy NN O
may MD O
have VB O
been VBN O
related VBN O
to IN O
the DT O
presence NN O
of IN O
protected VBN O
organisms NNS O
in IN O
vegetations NNS O
which WDT O
were VBD O
seen VBN O
on IN O
echocardiograms NNS O
, , O
and CC O
also RB O
suggested VBN O
by IN O
the DT O
presence NN O
of IN O
a DT O
possible JJ O
coronary JJ O
artery NN O
embolus NN O
seen VBN O
on IN O
coronary JJ O
arteriograms NNS O
. . O

In IN O
conclusion NN O
, , O
speciation NN O
of IN O
isolates NNS O
suspected VBN O
of IN O
causing VBG O
endocarditis NN O
and CC O
adequate JJ O
synergy NN O
studies NNS O
of IN O
antibiotic JJ O
combinations NNS O
are VBP O
indicated VBN O
before IN O
a DT O
long JJ O
and CC O
expensive JJ O
course NN O
of IN O
therapy NN O
with IN O
antimicrobial JJ O
agents NNS O
is VBZ O
undertaken VBN O
for IN O
this DT O
disease NN O
. . O

However RB O
, , O
as IN O
this DT O
case NN O
also RB O
illustrates VBZ O
, , O
demonstration NN O
of IN O
synergism NN O
in IN O
vitro FW O
does VBZ O
not RB O
assure VB O
clinical JJ O
cure NN O
. . O

ACKNOWLEDGEMENTS NNS O

Dr NNP O
. . O
Goldstein NNP O
was VBD O
supported VBN O
by IN O
training NN O
grant NN O
Al NNP O
7033 CD O
- HYPH O
5 CD O
from IN O
the DT O
National NNP O
Institute NNP O
of IN O
Allergy NNP O
and CC O
Infectious NNP O
Diseases NNPS O
. . O

The DT O
authors NNS O
gratefully RB O
acknowledge VBP O
the DT O
advice NN O
, , O
laboratory NN O
assistance NN O
, , O
and CC O
careful JJ O
review NN O
of IN O
this DT O
manuscript NN O
by IN O
Dr NNP O
. . O
Robert NNP O
C NNP O
. . O
Moellering NNP O
, , O
Jr NNP O
. . O

The DT O
authors NNS O
also RB O
wish VBP O
to TO O
thank VB O
Dr NNP O
. . O
Howard NNP O
S NNP O
. . O
Forster NNP O
for IN O
referring VBG O
this DT O
patient NN B-Species
to IN O
us PRP O
, , O
Ms NNP O
. . O
Mary NNP O
Murray NNP O
and CC O
Deborah NNP O
Beauvais NNP O
for IN O
manuscript NN O
preparation NN O
, , O
and CC O
Ms NNP O
. , O
Gertrude NNP O
Barden NNP O
, , O
MT NNP O
( , O
ASCP NNP O
) -RRB- O
, , O
MHS NNP O
, , O
for IN O
technical JJ O
assistance NN O
and CC O
advice NN O
in IN O
evaluation NN O
of IN O
this DT O
patient NN B-Species
. . O

REFERENCES NNS O

1 LS O
. . O

Hunter NNP O
TH NNP O
: : O
Use NN O
of IN O
streptomycin NN O
in IN O
the DT O
treatment NN O
of IN O
bacterial JJ O
endocarditis NN O
. . O

Am NNP O
J NNP O
Med NNP O
2 CD O
: : O
436 CD O
- HYPH O
442 CD O
, , O

1947 CD O

2 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Krogstad NNP O
DJ NNP O
: : O
Antibiotic JJ O
resistance NN O
in IN O
enterococci NN O
. . O

Microbiology NNP O
293 CD O
- HYPH O
298 CD O
, , O
1979 CD O
3 CD O
. . O

Facklam NNP O
RR NNP O
: : O
Recognition NN O
of IN O
group NN O
D NN O
streptococcal JJ O
species NNS O
of IN O
human JJ B-Species
origin NN O
by IN O
biochemical JJ O
and CC O

physiological JJ O
tests NNS O
. . O

Appl NN O
Microbiol NN O
23 CD O
: : O
1131 CD O
- HYPH O
1139 CD O
, , O
1972 CD O

4 LS O
. . O

Toala NNP O
P NNP O
, , O
McDonald NNP O
A NNP O
, , O
Wilcox NNP O
C NNP O
, , O
et NN O
al NN O
: : O
Susceptibility NN O
of IN O
group NN O
D NN O
streptococcus NN O
( , O
enterococcus NN O
) -RRB- O
to IN O
21 CD O

antibiotics NNS O
in IN O
vitro FW O
, , O
with IN O
special JJ O
reference NN O
to IN O
species NNS O
differences NNS O
. . O

Am NNP O
J NNP O
Med NNP O
Sci NNP O
258 CD O
: : O
416 CD O
- HYPH O
430 CD O
, , O
1969 CD O
5 CD O
. . O

Shungu NNP O
DL NNP O
, , O
Cornett NNP O
JB NNP O
, , O
Shockman NN O
GD NN O
: : O
Morphological JJ O
and CC O
physiological JJ O
study NN O
of IN O
autolytic JJ O

defective JJ O
Streptococcus NNP B-Species
faecium NN I-Species
strains NNS O
. . O

J NNP O
Bacteriol NNP O
138 CD O
: : O
598 CD O
- HYPH O
608 CD O
, , O
1979 CD O

6 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Korzeniowski NNP O
OM NNP O
, , O
Sande NNP O
MA NNP O
, , O
et FW O
al NNP O
: : O
Species NNP O
- HYPH O
specific JJ O
resistance NN O
to IN O
antimicrobial JJ O

synergism NN O
in IN O
Streptococcusfaecium NNP B-Species
and CC O
Streptococcusfaecali NNP B-Species
. . O

J NNP O
Infect NNP O
Dis NNP O
140 CD O
: : O
203 CD O
- HYPH O
208 CD O
, , O
1979 CD O

7 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Weinberg NNP O
AN NNP O
: : O
Studies NNS O
on IN O
antibiotic JJ O
synergism NN O
against IN O
enterococci NN O
. . O

11 CD O
. . O

Effect NN O
of IN O

various JJ O
antibiotics NNS O
on IN O
the DT O
uptake NN O
of IN O
' `` O
4C NN O
- HYPH O
labelled VBN O
streptomycin NN O
by IN O
enterococci NNP O
. . O

J NNP O
Clin NNP O
Invest NNP O
50 CD O
: : O
2580 CD O
- HYPH O
2584 CD O
, , O
1971 CD O

8 LS O
. . O

Zimmermann NNP O
RA NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
Weinberg NNP O
AN NNP O
: : O
Mechanisms NNS O
of IN O
resistance NN O
to IN O
antibiotic JJ O

synergism NN O
in IN O
enterococci FW O
. . O

J NNP O
Bacteriol NNP O
105 CD O
: : O
873 CD O
- HYPH O
879 CD O
, , O
1971 CD O

9 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Murray NNP O
BE NNP O
, , O
Schoenbaum NNP O
SC NNP O
, , O
et FW O
al NNP O
: : O
A DT O
novel JJ O
mechanism NN O
of IN O
resistance NN O
to IN O
penicillin NN O

gentamicin NN O
synergism NN O
in IN O
S NN B-Species
. . I-Species
faecalis NNS I-Species
. . O

J NNP O
Infect NNP O
Dis NNP O
141 CD O
: : O
81 CD O
- HYPH O
86 CD O
, , O
1980 CD O

10 CD O
. . O

Krogstad NNP O
DJ NNP O
, , O
Korfhagen NNP O
TR NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Plasmid NNP O
- HYPH O
mediated VBN O
resistance NN O
to IN O
antibiotic JJ O

synergism NN O
in IN O
enterococci FW O
. . O

J NNP O
Clin NNP O
Invest NNP O
61 CD O
: : O
1645 CD O
- HYPH O
1653 CD O
, , O
1978 CD O

11 CD O
. . O

Krogstad NNP O
DJ NNP O
, , O
Korfhagen NNP O
TR NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Aminoglycoside NN O
- HYPH O
inactivating VBG O
enzymes NNS O
in IN O

clinical JJ O
isolates NNS O
of IN O
Streptococcusfaecali NNP B-Species
: : O
An DT O
explanation NN O
for IN O
resistance NN O
to IN O
antibiotic JJ O
synergism NN O
. . O

J NNP O
Clin NNP O
Invest NNP O
62 CD O
: : O
480 CD O
- HYPH O
486 CD O
, , O
1978 CD O

S UH B-Species
. . I-Species

FAECIUM NN B-Species
ENDOCARDITIS NN O
249 CD O

12 CD O
. . O

Courvalin NNP O
PM NNP O
, , O
Shaw NNP O
WV NNP O
, , O
Jacob NNP O
AE NNP O
: : O
Plasmid NNP O
- HYPH O
mediated VBN O
mechanisms NNS O
of IN O
resistance NN O
to IN O

aminoglycoside NN O
- : O
aminocyclitol NN O
antibiotics NNS O
and CC O
to IN O
chloramphenicol NN O
in IN O
group NN O
D NN O
streptococci NN O
. . O

Antimicrob JJ O
Agents NNS O
Chemother NNP O
13 CD O
: : O
716 CD O
- HYPH O
725 CD O
, , O
1978 CD O

13 CD O
. . O

Calderwood NNP O
SA NNP O
, , O
Wennersten NNP O
C NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Resistance NN O
to IN O
six CD O
aminoglycosidic NN O

aminocyclitol NN O
antibiotics NNS O
among IN O
enterococci NN O
: : O
Prevalence NN O
, , O
evolution NN O
, , O
and CC O
relationship NN O
to IN O
synergism NN O
with IN O
penicillin NN O
. . O

Antimicrob JJ O
Agents NNS O
Chemother NNP O
12 CD O
: : O
401 CD O
- HYPH O
405 CD O
, , O
1977 CD O

14 CD O
. . O

Bisno NNP O
AL NNP O
: : O
Treatment NN O
of IN O
infective JJ O
endocarditis NN O
. . O

New NNP O
York NNP O
, , O
Grune NNP O
and CC O
Stratton NNP O
, , O
1981 CD O
, , O
p NN O
90 CD O

15 CD O
. . O

Lorian NNP O
V NNP O
: : O
Effects NNS O
of IN O
subminimum JJ O
inhibitory JJ O
concentrations NNS O
of IN O
antibiotics NNS O
on IN O
bacteria NNS O
. . O

In IN O
Antibiotics NNS O

in IN O
Laboratory NNP O
Medicine NNP O
. . O

Edited VBN O
by IN O
V NNP O
Lorian NNP O
. . O

Baltimore NNP O
, , O
Williams NNP O
and CC O
Wilkins NNP O
, , O
1980 CD O
, , O
p NN O
342 CD O

Structural JJ O
organization NN O
of IN O
a DT O
17 CD O
KB NNP O
segment NN O
of IN O
the DT O
alpha NN O
2 CD O
collagen NN O
gene NN O
: : O
evaluation NN O
by IN O
R NN O
loop NN O
mapping NN O
. . O

Abstract JJ O

A DT O
recombinant JJ O
phage NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
genomic JJ O
DNA NN O
insert NN O
representing VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
portion NN O
of IN O
the DT O
sheep NN B-Species
collagen NN O
alpha NN O
2 CD O
gene NN O
, , O
was VBD O
evaluated VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

A DT O
minimum NN O
of IN O
17 CD O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
and CC O
18 CD O
alpha NN O
2 CD O
coding VBG O
sequences NNS O
( , O
exons NNS O
) -RRB- O
were VBD O
mapped VBN O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
850 CD O
base NN O
pair NN O
exon NN O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
all DT O
exons NNS O
contained VBD O
250 CD O
base NN O
pairs NNS O
or CC O
less JJR O
. . O

The DT O
total JJ O
length NN O
of IN O
all PDT O
the DT O
exons NNS O
in IN O
SpC3 NNP O
was VBD O
3 CD O
, , O
14 CD O
base NN O
pairs NNS O
. . O

The DT O
length NN O
distribution NN O
of IN O
the DT O
17 CD O
introns NNS O
ranged VBD O
from IN O
300 CD O
to IN O
1600 CD O
base NN O
pairs NNS O
; , O
together RB O
, , O
all DT O
of IN O
the DT O
introns NNS O
comprised VBD O
14 CD O
, , O
70 CD O
base NN O
pairs NNS O
of IN O
SpC3 NNP O
DNA NNP O
. . O

Thus RB O
, , O
the DT O
DNA NN O
region NN O
required VBN O
for IN O
coding VBG O
the DT O
interspersed JJ O
3 CD O
kb NN O
of IN O
alpha NN O
2 CD O
collagen NN O
genetic JJ O
information NN O
was VBD O
5 CD O
. . O
6 CD O
fold NN O
longer RBR O
than IN O
the DT O
corresponding JJ O
alpha NN O
2 CD O
mRNA NN O
coding VBG O
sequences NNS O
. . O
Images NNS O

Nucleic NNP O
Acids NNP O
Research NNP O

Structural JJ O
organization NN O
of IN O
a DT O
17 CD O
KB NNP O
segment NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
: : O
evaluation NN O
by IN O
R NNP O
loop NN O
mapping NN O
Millie NNP O
P NNP O
. . O
Schafer NNP O
, , O
Charles NNP O
D NNP O
. . O
Boyd NNP O
, , O
Paul NNP O
Tolstoshev NNP O
and CC O
Ronald NNP O
G NNP O
. . O
Crystal NNP O

Pulmonary NNP O
Branch NNP O
, , O
National NNP O
Heart NNP O
, , O
Lung NNP O
and CC O
Blood NNP O
Institute NNP O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
, , O
Bethesda NNP O
, , O
MD NNP O
20205 CD O
, , O
USA NNP O

Received VBN O
13 CD O
February NNP O
1980 CD O

ABSTRACT NNP O

A DT O
recombinant JJ O
phage NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
genomic JJ O
DNA NN O
insert NN O
rep NN O

resenting VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
portion NN O
of IN O
the DT O
sheep NN B-Species
collagen NN O
a2 NN O
gene NN O
, , O
was VBD O
evaluated VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

A DT O
minimum NN O
of IN O
17 CD O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
and CC O
18 CD O
a2 CD O
coding VBG O
sequences NNS O
( , O
exons NNS O
) -RRB- O
were VBD O

mapped VBN O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
850 CD O
base NN O
pair NN O
exon NN O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
all DT O
exons NNS O
contained VBD O
250 CD O
base NN O
pairs NNS O
or CC O
less JJR O
. . O

The DT O
total JJ O
length NN O
of IN O
all PDT O
the DT O
exons NNS O
in IN O
SpC3 NNP O
was VBD O
3 CD O
, , O
14 CD O
base NN O
pairs NNS O
. . O

The DT O
length NN O
distribution NN O
of IN O
the DT O
17 CD O
introns NNS O
ranged VBD O
from IN O
300 CD O
to IN O
1600 CD O
base NN O
pairs NNS O
; , O
together RB O
, , O
all DT O
of IN O
the DT O
introns NNS O
comprised VBD O
14 CD O
, , O
70 CD O
base NN O
pairs NNS O
of IN O
SpC3 NNP O
DNA NNP O
. . O

Thus RB O
, , O
the DT O
DNA NNP O
region NN O

required VBN O
for IN O
coding VBG O
the DT O
interspersed JJ O
3 CD O
kb NN O
of IN O
a2 CD O
collagen NN O
genetic JJ O
information NN O
was VBD O
5 CD O
. . O
6 CD O
fold NN O
longer RBR O
than IN O
the DT O
corresponding JJ O
a2 CD O
mRNA NN O
coding VBG O
sequences NNS O
. . O

INTRODUCTION NN O

Type NN O
I NN O
collagen NN O
, , O
composed VBN O
of IN O
two CD O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
one CD O
a2 CD O
polypeptide NN O
chains NNS O
, , O
is VBZ O
the DT O
most RBS O
abundant JJ O
of IN O
the DT O
five CD O
known VBN O
mammalian JJ O
collagen NN O
types NNS O
. . O

It PRP O
is VBZ O
a DT O
major JJ O
extracellular JJ O
constituent NN O
of IN O
tissues NNS O
such JJ O
as IN O
bone NN O
, , O
tendon NN O
, , O
skin NN O
and CC O
lung NN O
where WRB O
, , O
because IN O
of IN O
its PRP$ O
great JJ O
tensile JJ O
strength NN O
, , O
it PRP O
plays VBZ O
an DT O
important JJ O

role NN O
in IN O
tissue NN O
structure NN O
and CC O
function NN O
. . O

The DT O
polypeptides NNS O
comprising VBG O
type NN O
I PRP O

collagen NN O
are VBP O
synthesized VBN O
in IN O
long JJ O
, , O
precursor NN O
forms NNS O
, , O
referred VBN O
to IN O
as IN O
pro FW O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
pro FW O
a2 NN O
chains NNS O
, , O
1 CD O
each DT O
containing VBG O
approximately RB O
1500 CD O
amino NN O
acid NN O
residues NNS O
( , O
1 CD O
) -RRB- O
. . O

1 LS O
The DT O
terminology NN O
for IN O
the DT O
primary JJ O
translation NN O
products NNS O
of IN O
the DT O
various JJ O

collagen NN O
messenger NN O
RNAs NNP O
is VBZ O
still RB O
in IN O
a DT O
state NN O
of IN O
flux NN O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
a2 NN O
chains NNS O
are VBP O
synthesized VBN O
in IN O
precursor NN O
forms NNS O
; : O
these DT O
are VBP O
currently RB O
termed VBN O
pro JJ O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
pro JJ O
a2 NN O
chains NNS O
( -LRB- O
1 CD O
) -RRB- O
. . O

However RB O
, , O
recent JJ O
studies NNS O
( , O
43 CD O
, , O
44 CD O
) -RRB- O
have VBP O
shown VBN O
that IN O
the DT O
actual JJ O
primary JJ O
translation NN O
product NN O
of IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
mRNA NNP O
is VBZ O
somewhat RB O
larger JJR O

than IN O
the DT O
pro JJ O
al NNP O
( HYPH O
I NNP O
) -RRB- O
chain NN O
; : O
this DT O
translation NN O
product NN O
has VBZ O
been VBN O
termed VBN O
a DT O
"""" `` O
pre NN O
- HYPH O
pro FW O
al NNP O
( HYPH O
I NNP O
) -RRB- O
chain NN O
. , O
"""" '' O
Although IN O
the DT O
corresponding VBG O
"""" `` O
pre NN O
- HYPH O
pro JJ O
a2 NN O
chain NN O
"""" '' O
likely RB O
exists VBZ O
, , O
it PRP O
has VBZ O
not RB O
yet RB O
been VBN O
characterized VBN O
. . O

For IN O
simplicity NN O
, , O
therefore RB O
, , O
until IN O
the DT O

proper JJ O
terminology NN O
for IN O
the DT O
primary JJ O
translation NN O
product NN O
is VBZ O
clarified VBN O
, , O
we PRP O
have VBP O

chosen VBN O
to TO O
use VB O
the DT O
terms NNS O
"""" `` O
al NNP O
( , O
I NNP O
) -RRB- O
"""" '' O
and CC O
"""" `` O
a2 NN O
"""" '' O
to TO O
refer VB O
to IN O
the DT O
type NN O
I NN O
collagen NN O
mRNAs NNS O
and CC O
collagen NN O
structural JJ O
gene NN O
sequences NNS O
. . O

? . O
) : O
IRL NNP O
Press NNP O
Umited NNP O
, , O
1 CD O
Falconberg NNP O
Court NNP O
, , O
London NNP O
W1V NNP O
5FG NNP O
, , O
U NN O
. . O
K NNP O
. . O

Volurne NNP O
8 CD O
Number NNP O
10 CD O
1980 CD O

2241 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
the DT O
quantities NNS O
of IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
a2 NN O

chains NNS O
produced VBN O
by IN O
cells NNS O
may MD O
be VB O
regulated VBN O
, , O
in IN O
part NN O
, , O
at IN O
the DT O
genomic JJ O
level NN O

( : O
1 CD O
) -RRB- O
. . O

However RB O
, , O
to TO O
understand VB O
the DT O
processes NNS O
which WDT O
mediate VBP O
their PRP$ O
expression NN O
, , O

it PRP O
is VBZ O
necessary JJ O
to TO O
understand VB O
the DT O
structural JJ O
organization NN O
of IN O
these DT O
collagen NN O
genes NNS O
and CC O
the DT O
various JJ O
enzymes NNS O
that WDT O
modify VBP O
the DT O
collagen NN O
chains NNS O
after IN O
its PRP$ O

synthesis NN O
( : O
1 CD O
) -RRB- O
. . O

As IN O
an DT O
initial JJ O
approach NN O
to IN O
this DT O
problem NN O
, , O
we PRP O
have VBP O
recently RB O

isolated VBN O
a DT O
recombinant JJ O
bacteriophage NN O
, , O
termed VBN O
SpC3 NNP O
, , O
containing VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
a2 NN O
gene NN O
for IN O
type NN O
I NN O
collagen NN O
. . O

Partial JJ O
characterization NN O
of IN O
this DT O

a2 NN O
gene NN O
demonstrated VBD O
that IN O
, , O
like IN O
most JJS O
other JJ O
structurally RB O
evaluated VBN O
eukaryotic JJ O
genes NNS O
, , O
the DT O
coding VBG O
sequences NNS O
are VBP O
interspersed VBN O
with IN O
intervening VBG O
sequences NNS O
( , O
2 CD O
) -RRB- O
. . O

The DT O
present JJ O
study NN O
further RB O
characterizes VBZ O
this DT O
portion NN O
of IN O
the DT O
a2 NN O

gene NN O
by IN O
utilizing VBG O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
to TO O
map VB O
the DT O
coding VBG O
regions NNS O
( , O
exons FW O
) -RRB- O
and CC O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
contained VBN O
within IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
of IN O
SpC3 NNP O
. . O

The DT O
data NNS O
suggests VBZ O
that IN O
the DT O
structural JJ O

organization NN O
of IN O
this DT O
portion NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
represents VBZ O
3 CD O
kb NN O
of IN O
coding VBG O
information NN O
that WDT O
is VBZ O
interspersed VBN O
in IN O
a DT O
complex JJ O
fashion NN O
with IN O
17 CD O
introns NNS O
over IN O
17 CD O
kb NN O
of IN O
genome NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Isolation NN O
and CC O
characterization NN O
of IN O
a2 NN O
collagen NN O
recombinant NN O
clone NN O
, , O
SpC3 NNP O
. . O

The DT O
sheep NN B-Species
a2 NN O
collagen NN O
recombinant NN O
clone NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
portion NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
gene NN O
, , O
was VBD O
isolated VBN O
as IN O
previously RB O
described VBN O
( , O
2 CD O
) -RRB- O
. . O

Briefly RB O
, , O

high JJ O
molecular JJ O
weight NN O
fetal JJ O
sheep NN B-Species
liver NN O
DNA NNP O
was VBD O
extracted VBN O
by IN O
the DT O
method NN O
of IN O
Blin NNP O
and CC O
Stafford NNP O
( SYM O
3 CD O
) -RRB- O
, , O
and CC O
15 CD O
- SYM O
20 CD O
kb NN O
DNA NN O
fragments NNS O
, , O
resulting VBG O
from IN O
partial JJ O
Eco NNP O
RI NNP O
digestion NN O
, , O
were VBD O
isolated VBN O
and CC O
ligated VBN O
to IN O
the DT O
left JJ O
and CC O
right JJ O
arms NNS O
of IN O
Charon NNP O
4A NNP O
. . O

The DT O
recombinant JJ O
DNA NNP O
was VBD O
then RB O
packaged VBN O
in IN O
vitro NN O
and CC O
the DT O
sheep NN B-Species

genomic JJ O
library NN O
amplified VBN O
( : O
4 CD O
- HYPH O
6 CD O
) -RRB- O
. . O

Screening NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
library NN O
was VBD O

conducted VBN O
utilizing VBG O
[ -LRB- O
32 CD O
P NN O
] -RRB- O
- HYPH O
labeled VBN O
fetal JJ O
sheep NN B-Species
tendon NN O
type NN O
I NN O
collagen NN O
cDNA NNP O
and CC O

several JJ O
positive JJ O
recombinant JJ O
phages NNS O
were VBD O
isolated VBN O
. . O

One CD O
recombinant NN O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
sheep NN B-Species
genomic JJ O
insert NN O
, , O
was VBD O
demonstrated VBN O
to TO O
have VB O
coding VBG O
sequences NNS O
corresponding VBG O
to IN O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
a2 CD O
mRNA NN O
. . O

Prior JJ O
studies NNS O
showed VBD O
that IN O
the DT O
insert NN O
in IN O
SpC3 NNP O
was VBD O
not RB O
due JJ O
to IN O
ligation NN O
of IN O
noncontiguous JJ O
restriction NN O
fragments NNS O
and CC O
/ SYM O
or CC O
genetic JJ O
rearrangement NN O
during IN O
the DT O
cloning NN O
process NN O
( , O
2 CD O
) -RRB- O
. . O

Electron NN O
mi NN O
croscopy NN O
. . O

To TO O
visualize VB O
the DT O
recombinant JJ O
bacteriophage NN O
DNA NN O
structure NN O
complementary JJ O
to IN O
a2 CD O
collagen NN O
mRNA NN O
, , O
1 CD O
iig NN O
of IN O
SpC3 NNP O
DNA NNP O
was VBD O
lyophilized VBN O
with IN O
1 CD O
ig NN O
or CC O
100 CD O
ng NNS O
of IN O
mRNA NNP O

to TO O
give VB O
DNA NN O
: : O
mRNA NNP O
ratios NNS O
of IN O
1 CD O
: SYM O
1 CD O
and CC O
10 CD O
: SYM O
1 CD O
, , O
respectively RB O
. . O

These DT O
were VBD O
then RB O
dissolved VBN O
in IN O
10 CD O
i1 CD O
of IN O
R NN O
loop NN O
buffer NN O
[ -LRB- O
70 CD O
% NN O
( HYPH O
v NN O
/ SYM O
v NN O
) -RRB- O
deionized VBN O
formamide NN O
, , O
0 CD O
. . O
1 CD O
N NN O
- HYPH O
[ -LRB- O
tris NN O
( , O
hydroxy NN O

2242 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

methyl NN O
) : O
methyl NN O
] -RRB- O
glycine NN O
( , O
tricine NN O
) NFP O
- HYPH O
NaOH NNP O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
0 CD O
. . O
5 CD O
M NN O
NaCl NN O
, , O
and CC O
0 CD O
. . O
1 CD O
M NN O
ethyl NN O

enediaminetetraaceta NNP O
( -LRB- O
EDTA NNP O
) -RRB- O
] -RRB- O
, , O
incubated VBN O
in IN O
sealed VBN O
capillary NN O
tubes NNS O
at IN O
520 CD O
for IN O
14 CD O
hr NNS O
( SYM O
7 CD O
) -RRB- O
, , O
and CC O
then RB O
diluted VBN O
1 CD O
: SYM O
10 CD O
with IN O
R NN O
loop NN O
buffer NN O
. . O

Two CD O
spreading VBG O
methods NNS O
were VBD O
used VBN O
to TO O
subsequently RB O
prepare VB O
the DT O
hybrids NNS O
for IN O
visualization NN O
in IN O
the DT O
electron NN O
microscope NN O
. . O

70 CD O
% NN O
formamide NN O
method NN O
. . O

Immediately RB O
before IN O
spreading VBG O
onto IN O
a DT O
deionized JJ O

water NN O
hypophase NN O
, , O
the DT O
nucleic JJ O
acid NN O
mixtures NNS O
were VBD O
diluted VBN O
an DT O
additional JJ O
10 CD O
- HYPH O
fold NN O
in IN O
R NN O
loop NN O
buffer NN O
and CC O
cytochrome NN O
c NN O
, , O
100 CD O
vg NN O
/ SYM O
ml NNS O
, , O
was VBD O
added VBN O
. . O

Urea NNP O
- HYPH O
formamide NN O
method NN O
. . O

The DT O
nucleic JJ O
acid NN O
solutions NNS O
were VBD O
spread VBN O
using VBG O
a DT O
modification NN O
of IN O
the DT O
method NN O
of IN O
Westphal NNP O
and CC O
Lai NNP O
( , O
8 CD O
, , O
9 CD O
) -RRB- O
. . O

The DT O
hyperphase NN O
contained VBD O
55 CD O
% NN O
formamide NN O
, , O
2 CD O
. . O
6 CD O
M NN O
urea NN O
, , O
0 CD O
. . O
9 CD O
M NN O
EDTA NNP O
, , O
0 CD O
. . O
9 CD O
M NN O
tricine NN O
- HYPH O
NaOH NN O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
and CC O
the DT O
nucleic JJ O
acid NN O
mixture NN O
( , O
approximately RB O
0 CD O
. . O
1 CD O
to TO O
1 CD O
. . O
0 CD O
ig NN O
/ SYM O
ml NN O
) -RRB- O
. . O

The DT O
mixture NN O
was VBD O
heated VBN O
at IN O
40 CD O
? , O
for IN O
30 CD O
sec NN O
, , O
placed VBN O
in IN O
ice NN O
water NN O
, , O
and CC O
then RB O
allowed VBN O
to TO O
reach VB O
room NN O
temperature NN O
. . O

Cytochrome NN O
c NN O
, , O
100 CD O
pg NN O
/ SYM O
ml NNS O
, , O
was VBD O
added VBN O
immediately RB O
before IN O
spreading VBG O
onto IN O
a DT O
deionized VBN O
water NN O
hypophase NN O
. . O

The DT O
nucleic JJ O
acid NN O
- HYPH O
protein NN O
films NNS O
from IN O
both DT O
methods NNS O
were VBD O
absorbed VBN O
onto IN O

parlodion NN O
- HYPH O
coated VBN O
grids NNS O
, , O
stained VBN O
with IN O
uranyl NN O
acetate NN O
( , O
10 CD O
) -RRB- O
, , O
dehydrated VBN O
in IN O
90 CD O
% NN O
ethanol NN O
and CC O
rotary NN O
- HYPH O
shadowed VBN O
with IN O
platinum NN O
- HYPH O
palladium NN O
( , O
80 CD O
: SYM O
20 CD O
) -RRB- O
at IN O
an DT O
angle NN O
of IN O
50 CD O
. . O

Micrographs NNS O
were VBD O
taken VBN O
with IN O
a DT O
Siemens NNP O
Elmiskop NNP O
101 CD O
electron NN O
microscope NN O
at IN O
an DT O
original JJ O
magnification NN O
of IN O
10 CD O
, , O
0 CD O
and CC O
an DT O
accelerating VBG O
voltage NN O
of IN O
60 CD O
kv NN O
. . O

Nucleic JJ O
acid NN O
lengths NNS O
were VBD O
measured VBN O
at IN O
a DT O
final JJ O
magnification NN O
of IN O
43 CD O
, , O
0 CD O
with IN O
a DT O

Hewlett NNP O
- HYPH O
Packard NNP O
9810A NN O
calculator NN O
equipped VBN O
with IN O
a DT O
9864A CD O
digitizer NN O
using VBG O
pBR322 NN O
and CC O
fX NN O
- HYPH O
174 CD O
double JJ O
and CC O
single JJ O
stranded VBN O
DNA NN O
, , O
respectively RB O
, , O
as IN O
internal JJ O
length NN O
standards NNS O
. . O

Approximately RB O
10 CD O
, , O
0 CD O
hybrid JJ O
molecules NNS O
were VBD O
screened VBN O
for IN O
these DT O
studies NNS O
; : O
approximately RB O
200 CD O
represented VBN O
molecules NNS O
containing VBG O
unambiguous JJ O
regions NNS O

appropriate JJ O
for IN O
quantitative JJ O
analysis NN O
. . O

The DT O
mean JJ O
lengths NNS O
of IN O
each DT O
intron NN O
and CC O
exon NN O
were VBD O
determined VBN O
for IN O
each DT O
method NN O
and CC O
the DT O
data NNS O
expressed VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

Nucleic JJ O
acid NN O
lengths NNS O
of IN O
< SYM O
50 CD O
base NN O
pairs NNS O
could MD O
not RB O
be VB O

accurately RB O
determined VBN O
using VBG O
the DT O
methods NNS O
outlined VBN O
above RB O
. . O

Thus RB O
, , O
in IN O
the DT O
cases NNS O

where WRB O
introns NNS O
or CC O
exons NNS O
were VBD O
of IN O
this DT O
length NN O
or CC O
less JJR O
, , O
accurate JJ O
error NN O
estimates NNS O
could MD O
not RB O
be VB O
made VBN O
. . O

Bi NNP O
ohazard FW O
precauti FW O
ons NNS O
. . O

The DT O
construction NN O
and CC O
screening NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
library NN O
together RB O
with IN O
amplification NN O
of IN O
pCg45 NN O
and CC O
preparation NN O
of IN O
high JJ O
titre NN O
lysates NNS O
of IN O
chimaeric JJ O

Charon NNP O
4A NNP O
were VBD O
performed VBN O
under IN O
the DT O
physical JJ O
and CC O
biological JJ O
containment NN O
levels NNS O
specified VBN O
by IN O
the DT O
NIH NNP O
guidelines NNS O
for IN O
recombinant JJ O
DNA NN O
research NN O
( SYM O
11 CD O
) -RRB- O
. . O

2243 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

RESULTS NNS O

Location NN O
and CC O
orientation NN O
of IN O
the DT O
intervening VBG O
and CC O
a2 CD O
mRNA NN O
coding VBG O
sequences NNS O
in IN O
the DT O
SpC3 NNP O
recombinant JJ O
DNA NN O
. . O

Hybridization NN O
of IN O
fetal JJ O
sheep NN B-Species
tendon NN O
type NN O
I NN O
collagen NN O
mRNA NNP O
to IN O
SpC3 NNP O
DNA NNP O

yielded VBD O
a DT O
complex JJ O
R NN O
loop NN O
pattern NN O
in IN O
the DT O
region NN O
where WRB O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
was VBD O
expected VBN O
to TO O
be VB O
ligated VBN O
to IN O
the DT O
arms NNS O
of IN O
the DT O
lambda NN O
vector NN O
, , O
Charon NNP O
4A NNP O
. . O

To TO O

confirm VB O
that IN O
these DT O
hybridization NN O
events NNS O
were VBD O
restricted VBN O
to IN O
the DT O
inserted VBN O
sheep NN B-Species
DNA NN O
fragment NN O
, , O
duplex JJ O
DNA NN O
strands NNS O
on IN O
both DT O
sides NNS O
of IN O
this DT O
hybridization NN O
area NN O
were VBD O
measured VBN O
. . O

Using VBG O
pBR322 CD O
as IN O
an DT O
internal JJ O
length NN O
standard NN O
, , O
the DT O
left JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
found VBN O
to TO O
contain VB O
21 CD O
, , O
780 CD O
? . O

1500 CD O
bp NN O
, , O
and CC O
the DT O
right JJ O
arm NN O
, , O
11 CD O
, , O
950 CD O
? . O

1030 CD O
bp NN O
, , O
corresponding VBG O
to IN O
the DT O
report NN O
values NNS O
for IN O
the DT O
left JJ O
and CC O
right JJ O
arms NNS O
, , O
respectively RB O
, , O
of IN O
Charon NNP O
4A NNP O
DNA NNP O
( , O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

The DT O
hybridization NN O
of IN O
SpC3 NNP O
to IN O
a2 NN O
mRNA NNP O
resulted VBD O
in IN O
the DT O
destabilization NN O
of IN O

the DT O
inserted VBN O
helical JJ O
duplex JJ O
DNA NN O
fragment NN O
such JJ O
that IN O
one CD O
DNA NN O
strand NN O
was VBD O
displaced VBN O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

Occasionally RB O
, , O
the DT O
displaced VBN O
DNA NNP O
strand NN O
was VBD O
mostly RB O
absent JJ O
, , O
probably RB O
due JJ O
to IN O
fragmentation NN O
induced VBN O
by IN O
accidental JJ O
mechanical JJ O
shearing NN O
. . O

This DT O
event NN O
considerably RB O
enhanced VBD O
the DT O
visualization NN O
and CC O
ordering NN O
of IN O
the DT O
introns NNS O
. . O

As IN O
the DT O
a2 NN O
mRNA NNP O
annealed VBD O
to IN O
complementary JJ O
DNA NNP O
regions NNS O
present JJ O
in IN O
one CD O

DNA NN O
strand NN O
, , O
numerous JJ O
single JJ O
- HYPH O
stranded JJ O
loops NNS O
resulted VBD O
. . O

These DT O
loops NNS O
, , O
referred VBD O
to IN O
as IN O
introns NNS O
, , O
represented VBD O
DNA NNP O
sequences NNS O
not RB O
complementary JJ O
to IN O
the DT O
mRNA NNP O
. . O

Although IN O
, , O
by IN O
convention NN O
, , O
introns NNS O
are VBP O
usually RB O
sequentially RB O
labeled VBN O
5 CD O
' '' O
to IN O
3 CD O
' '' O
, , O
an DT O
opposite JJ O
order NN O
had VBD O
to TO O
be VB O
employed VBN O
in IN O
this DT O
case NN O
as IN O
SpC3 NNP O
does VBZ O
not RB O
contain VB O
the DT O
sequences NNS O
coding VBG O
for IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
sheep NN B-Species
a2 NN O
mRNA NN O
. . O

Infrequently RB O
, , O
all DT O
introns NNS O

were VBD O
clearly RB O
observed VBN O
within IN O
the DT O
same JJ O
hybrid NN O
molecule NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
largest JJS O
introns NNS O
were VBD O
towards IN O
the DT O
left JJ O
arm NN O
of IN O
Charon NNP O
4A NNP O
and CC O
were VBD O
more RBR O
clustered VBN O
than IN O
the DT O
introns NNS O
at IN O
the DT O
opposite JJ O
end NN O
of IN O
the DT O
hybrid NN O
. . O

Thus RB O
, , O
much JJ O
of IN O
the DT O
genetic JJ O

information NN O
coding VBG O
for IN O
the DT O
a2 NN O
mRNA NN O
was VBD O
contained VBN O
in IN O
that DT O
half NN O
of IN O
the DT O
hybrid NN O
attached VBN O
to IN O
the DT O
right JJ O
arm NN O
. . O

A DT O
small JJ O
non NN O
- HYPH O
hybridized JJ O
tail NN O
was VBD O
consistently RB O
found VBN O
in IN O
the DT O
region NN O
where WRB O

the DT O
right JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
ligated VBN O
to IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
tail NN O
likely RB O
corresponded VBD O
to IN O
the DT O
3 CD O
' '' O
poly NN O
A DT O
sequence NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
. . O

At IN O

the DT O
extreme JJ O
5 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
a DT O
variable JJ O
length NN O
was VBD O
often RB O
observed VBN O
for IN O
the DT O
remaining VBG O
unhybridized JJ O
mRNA NNP O
strand NN O
. . O

This DT O
was VBD O
most RBS O
likely JJ O
due IN O
to IN O
the DT O
size NN O
heterogeneity NN O
of IN O
the DT O
a2 CD O
mRNA NNP O
used VBN O
in IN O
these DT O
studies NNS O
. . O

Size NN O
determination NN O
and CC O
comparative JJ O
analysis NN O
of IN O
SpC3 NNP O
introns NNS O
. . O

Although IN O
localization NN O
of IN O
exon NN O
and CC O
intron NN O
sequences NNS O
was VBD O
possible JJ O
with IN O
both DT O
the DT O
70 CD O
% NN O
formamide NN O
and CC O
urea NN O
- HYPH O
formamide NN O
spreading VBG O
methods NNS O
, , O
the DT O
probability NN O
of IN O

detecting VBG O
unambiguous JJ O
regions NNS O
in IN O
a DT O
hybrid JJ O
molecule NN O
was VBD O
far RB O
greater JJR O
with IN O
the DT O

2244 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

A DT O
B NN O
' '' O
, , O
: : O
' '' O
14 CD O
. . O
0 NFP O
. . O

13 CD O

7 CD O
1 CD O

- SYM O
5 CD O
13 CD O

. . O
. . O

. . O
. . O

, , O
4 CD O
x2 CD O
% NN O
. . O

N1 NNP O

9 CD O

> NFP O
10 CD O
R NN O
4 CD O

Figure NN O
1 CD O
. . O

Electron NN O
microscopic JJ O
visualization NN O
of IN O
all DT O
17 CD O
introns NNS O
and CC O
18 CD O
exons NNS O

from IN O
hybrid JJ O
molecules NNS O
formed VBN O
between IN O
recombinant JJ O
clone NN O
SpC3 NN O
DNA NN O
and CC O
fetal JJ O
sheep NN B-Species

tendon NN O
a2 NN O
mRNA NN O
. . O

( : O
A DT O
, , O
B NNP O
) , O
Shown VBN O
are VBP O
the DT O
double JJ O
- HYPH O
stranded JJ O
segment NN O
of IN O
the DT O
right JJ O
arm NN O
CR NN O
) -RRB- O
of IN O
Charon NNP O
4A NNP O
; : O
double JJ O
- HYPH O
stranded JJ O
segment NN O
of IN O
the DT O
left JJ O
arm NN O
CL NNP O
) -RRB- O
of IN O
Charon NNP O
4A NNP O
; : O
the DT O

displaced VBN O
single JJ O
- HYPH O
stranded JJ O
DNA NN O
segment NN O
of IN O
the DT O
insert NN O
( , O
5 CD O
) -RRB- O
; : O
single JJ O
- HYPH O
stranded VBN O
DNA NNP O
loops NNS O
representing VBG O
introns NNS O
sequentially RB O
labeled VBN O
1 CD O
through IN O
17 CD O
in IN O
the DT O
3 CD O
' '' O
to IN O
5 CD O
' '' O
direction NN O
; : O
and CC O
18 CD O
regions NNS O
of IN O
insert NN O
DNA NN O
sequences NNS O
hybridized VBN O
to IN O
ct2 NNP O
mRNA NNP O

- : O
- : O
- : O
- : O
) -RRB- O
. . O

( : O
C NN O
, , O
D NN O
) : O
Similar JJ O
to IN O
( : O
A NN O
, , O
B NN O
) -RRB- O
but CC O
the DT O
single JJ O
- HYPH O
stranded VBN O
DNA NN O
segment NN O
( -LRB- O
5 CD O
) -RRB- O
of IN O
the DT O
insert NN O
is VBZ O
mostly RB O
absent JJ O
. . O

The DT O
urea NN O
- HYPH O
formamide NN O
spreading VBG O
method NN O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
, , O
was VBD O
employed VBN O
. . O

2245 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

urea NN O
- HYPH O
formamide JJ O
method NN O
than IN O
with IN O
the DT O
70 CD O
% NN O
formamide NN O
procedure NN O
. . O

For IN O
this DT O
reason NN O
, , O
most JJS O
measurements NNS O
were VBD O
made VBN O
with IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
( -LRB- O
Tables NNP O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

For IN O

example NN O
, , O
the DT O
lowest JJS O
probability NN O
event NN O
, , O
the DT O
detection NN O
of IN O
intron NN O
17 CD O
and CC O
the DT O
surrounding VBG O
small JJ O
exons NNS O
, , O
"""" `` O
q NN O
"""" '' O
and CC O
"""" `` O
r NN O
"""" '' O
, , O
was VBD O
only RB O
observed VBN O
by IN O
way NN O
of IN O
the DT O
ureaformamide NN O
spreading VBG O
procedure NN O
. . O

The DT O
smallest JJS O
introns NNS O
, , O
7 CD O
and CC O
12 CD O
, , O
were VBD O
found VBN O
to TO O
contain VB O
approximately RB O

the DT O
same JJ O
number NN O
of IN O
bases NNS O
. . O

Introns NNP O
1 CD O
through IN O
8 CD O
, , O
representing VBG O
the DT O
DNA NN O
sequences NNS O
which WDT O
split VBD O
the DT O
a2 NN O
coding VBG O
sequence NN O
corresponding VBG O
to IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
a2 NN O
mRNA NN O
, , O
varied VBD O
in IN O
length NN O
over IN O
approximately RB O
a DT O
2 CD O
. . O
4 CD O
- HYPH O
fold NN O
range NN O
. . O

With IN O
the DT O
exception NN O
of IN O

Table NN O
1 CD O
. . O

Electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O

present JJ O
in IN O
SpC3 NNP O
DNA1 NNP O
. . O

of IN O
the DT O
sheep NN B-Species
a2 CD O
introns NNS O

SpC3 NN O
was VBD O
hybridized VBN O
to IN O
sheep NN B-Species
a2 IN O
mRNA NN O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
; , O
intron NN O
lengths NNS O
were VBD O
determined VBN O
by IN O
comparison NN O
with IN O
* NFP O
X NNP O
- HYPH O
174 CD O
DNA NNP O
lengths NNS O
. . O

2 CD O
Introns NNS O
are VBP O
designated VBN O
sequentially RB O
3 CD O
' '' O
to IN O
5 CD O
' '' O
. . O

3 LS O
All DT O
data NNS O
is VBZ O
presented VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

4 CD O
Intron NNP O
17 CD O
was VBD O
visualized VBN O
only RB O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

2246 CD O

70 CD O
% NN O
Formamide NNP O
Method NNP O
Urea NNP O
- HYPH O
Formamide NNP O
Method NNP O

Intron2 JJ O
Number NN O
of IN O
Intron NN O
length NN O
Number NN O
of IN O
Intron NNP O
length NN O

introns NNS O
analyzed VBN O
( , O
bases NNS O
) -RRB- O
introns NNS O
analyzed VBN O
( HYPH O
bases NNS O
) -RRB- O

1 CD O
10 CD O
819 CD O
t NN O
63 CD O
35 CD O
806 CD O
t CD O
76 CD O
2 CD O
12 CD O
771 CD O
? . O

89 CD O
46 CD O
757 CD O
t CD O
78 CD O
3 CD O
11 CD O
458 CD O
? . O

58 CD O
47 CD O
464 CD O
? . O

66 CD O
4 CD O
6 CD O
627 CD O
? . O

53 CD O
41 CD O
611 CD O
? . O

73 CD O
5 CD O
5 CD O
554 CD O
? . O

51 CD O
34 CD O
562 CD O
? . O

76 CD O
6 CD O
6 CD O
675 CD O
? . O

19 CD O
40 CD O
684 CD O
? . O

76 CD O
7 CD O
5 CD O
386 CD O
? . O

48 CD O
50 CD O
342 CD O
? . O

54 CD O
8 CD O
7 CD O
771 CD O
? . O

84 CD O
49 CD O
757 CD O
? . O

82 CD O
9 CD O
8 CD O
1 CD O
, , O
181 CD O
? . O

94 CD O
52 CD O
1 CD O
, , O
124 CD O
? , O
122 CD O
10 CD O
8 CD O
1 CD O
, , O
133 CD O
? , O
106 CD O
53 CD O
1 CD O
, , O
124 CD O
? , O
137 CD O
11 CD O
10 CD O
964 CD O
t CD O
? , O
79 CD O
61 CD O
952 CD O
? . O
105 CD O
12 CD O
9 CD O
362 CD O
? . O

77 CD O
62 CD O
342 CD O
? . O

71 CD O
13 CD O
4 CD O
723 CD O
? . O
222 CD O
53 CD O
806 CD O
? . O
105 CD O
14 CD O
4 CD O
1 CD O
, , O
85 CD O
? , O
142 CD O
53 CD O
1 CD O
, , O
75 CD O
? . O
105 CD O
15 CD O
3 CD O
795 CD O
? . O

60 CD O
47 CD O
806 CD O
? . O
100 CD O
16 CD O
2 CD O
1 CD O
, , O
229 CD O
? . O

48 CD O
43 CD O
1 CD O
, , O
319 CD O
? . O
146 CD O
174 CD O
- HYPH O
- HYPH O
12 CD O
1 CD O
, , O
539 CD O
? . O
166 CD O

1 NFP O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NN O
2 CD O
. . O

Electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
exons NNS O

present JJ O
in IN O
SpC3 NNP O
DNA1 NNP O
. . O

70 CD O
% NN O
Formamide NNP O
Method NNP O
Urea NNP O
- HYPH O
Formamide NNP O
Method NNP O

Exon2 NNP O
Number NN O
of IN O
Exon NNP O
length NN O
Number NNP O
of IN O
Exon NNP O
length NN O

exons NNS O
analyzed VBN O
( HYPH O
base NN O
pairs NNS O
) -RRB- O
exons NNS O
analyzed VBN O
( HYPH O
base NN O
pairs NNS O
) -RRB- O

a DT O
7 CD O
807 CD O
? . O

883 CD O
26 CD O
883 CD O
? . O
132 CD O
b NN O
10 CD O
252 CD O
? . O

35 CD O
41 CD O
234 CD O
? . O

49 CD O
c NN O
11 CD O
151 CD O
? . O

25 CD O
48 CD O
182 CD O
? . O

42 CD O
d NN O
6 CD O
252 CD O
? . O

60 CD O
44 CD O
234 CD O
? . O

62 CD O
e NN O
5 CD O
126 CD O
? . O

45 CD O
37 CD O
129 CD O
? . O

47 CD O
f SYM O
5 CD O
126 CD O
? . O

38 CD O
35 CD O
104 CD O
? . O

41 CD O
9 CD O
5 CD O
176 CD O
? . O

48 CD O
40 CD O
182 CD O
? . O

54 CD O
h CD O
5 CD O
100 CD O
? . O

43 CD O
47 CD O
104 CD O
? . O

31 CD O

7 CD O
100 CD O
? . O

35 CD O
50 CD O
104 CD O
? . O

28 CD O
j NN O
7 CD O
126 CD O
? . O

48 CD O
45 CD O
130 CD O
? . O

47 CD O
k NN O
8 CD O
50 CD O
? . O

48 CD O
51 CD O
52 CD O
? . O

39 CD O
1 CD O
9 CD O
75 CD O
? . O

10 CD O
60 CD O
52 CD O
? . O

44 CD O
m NN O
6 CD O
126 CD O
? . O

43 CD O
51 CD O
182 CD O
? . O

54 CD O
n SYM O
4 CD O
100 CD O
? . O

45 CD O
53 CD O
52 CD O
? . O

42 CD O
o CD O
3 CD O
< SYM O
504 CD O
50 CD O
78 CD O
? . O

36 CD O
p NN O
2 CD O
126 CD O
? . O

71 CD O
47 CD O
104 CD O
? . O

36 CD O
q5 CD O
- HYPH O
_ SYM O
33 CD O
130 CD O
? . O
47 CD O
r5 CD O
r NN O
6 CD O
78 CD O
? . O
36 CD O

SpC3 NNP O
was VBD O
hybridized VBN O
to IN O
sheep NN B-Species
a2 NN O
mRNA NN O
as IN O
described VBN O
in IN O
M4aterials NNPS O
and CC O

Methods NNS O
; : O
exon NN O
lengths NNS O
were VBD O
determined VBN O
by IN O
comparison NN O
with IN O
pBR322 CD O
DNA NN O
lengths NNS O
. . O

2 CD O
Exons NNPS O
are VBP O
designated VBN O
sequentially RB O
3 CD O
' '' O
to IN O
5 CD O
' '' O
. . O

3 LS O
All DT O
data NNS O
is VBZ O
presented VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

4 LS O
5 CD O

No DT O
statistical JJ O
evaluation NN O
was VBD O
possible JJ O
because IN O
of IN O
the DT O
size NN O
of IN O
the DT O
exon NN O
( , O
see VB O
( , O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

Exons NNP O
q NNP O
and CC O
r NN O
were VBD O
only RB O
analyzed VBN O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

intron NN O
1 CD O
, , O
the DT O
nucleotide NN O
size NN O
of IN O
these DT O
introns NNS O
was VBD O
less JJR O
than IN O
800 CD O
bases NNS O
. . O

In IN O
contrast NN O
, , O
introns NNS O
9 CD O
through IN O
17 CD O
varied VBD O
over IN O
a DT O
4 CD O
. . O
5 CD O
- HYPH O
fold NN O
range NN O
. . O

Except IN O
for IN O
intron NN O
12 CD O
, , O
all DT O
of IN O
the DT O
introns NNS O
9 CD O
through IN O
17 CD O
contained VBD O
800 CD O
bases NNS O
or CC O
more JJR O
. . O

Summation NN O
of IN O
introns NNS O
1 CD O
through IN O
16 CD O
for IN O
the DT O
70 CD O
% NN O
formamide NN O
and CC O
urea NN O

formamide NN O
spreading NN O
methods NNS O
yielded VBD O
12 CD O
, , O
533 CD O
and CC O
12 CD O
, , O
531 CD O
bases NNS O
, , O
respectively RB O
. . O

However RB O
, , O
detection NN O
of IN O
intron NN O
17 CD O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
indicates VBZ O
that DT O

the DT O
actual JJ O
summed JJ O
value NN O
for IN O
the DT O
intervening VBG O
sequences NNS O
of IN O
SpC3 NNP O
is VBZ O
14 CD O
, , O
70 CD O
bases NNS O
. . O

2247 CD O

1 NFP O

Nucleic NNP O
Acids NNP O
Research NNP O

Size NN O
determination NN O
and CC O
the DT O
comparative JJ O
analysis NN O
of IN O
SpC3 NNP O
exons NNS O
. . O

Eighteen CD O
exons NNS O
, , O
"""" `` O
a DT O
"""" '' O
through IN O
"""" `` O
r NN O
"""" '' O
, , O
were VBD O
mapped VBN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
largest JJS O
exon NN O
, , O
"""" `` O
a DT O
"""" '' O
, , O
located VBN O
on IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
, , O
contained VBN O

approximately RB O
800 CD O
bp NN O
. . O

With IN O
the DT O
exception NN O
of IN O
exon NN O
"""" `` O
m NN O
"""" '' O
, , O
exons NNS O
larger JJR O
than IN O
150 CD O

base NN O
pairs NNS O
were VBD O
confined VBN O
to IN O
the DT O
genetic JJ O
region NN O
corresponding VBG O
to IN O
the DT O
far RB O
3 CD O
' '' O
end NN O
of IN O
the DT O
a2 CD O
mRNA NN O
. . O

Exon NNP O
"""" `` O
a DT O
"""" '' O
and CC O
exon NN O
"""" `` O
b NN O
"""" '' O
, , O
the DT O
two CD O
exons NNS O
situated VBN O
on IN O
either DT O
side NN O
of IN O
intron NN O
1 CD O
, , O
coded VBN O
for IN O
around IN O
1000 CD O
bases NNS O
of IN O
a2 CD O
collagen NN O
information NN O
; : O
these DT O
two CD O

exons NNS O
contained VBD O
one CD O
- HYPH O
third NN O
of IN O
the DT O
mapped VBN O
3 CD O
, , O
14 CD O
DNA NN O
bases NNS O
complementary JJ O
to IN O
a2 CD O
mRNA NN O
Length NN O
distribution NN O
and CC O
organization NN O
of IN O
the DT O
introns NNS O
and CC O
exons NNS O
in IN O
the DT O
sheep NN B-Species
genomi NN O
c NN O
i NN O
nsert UH O
. . O

There EX O
was VBD O
a DT O
sharp JJ O
contrast NN O
in IN O
the DT O
size NN O
distribution NN O
of IN O
the DT O
exons NNS O
and CC O
introns NNS O
contained VBN O
within IN O
SpC3 NNP O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

While IN O
the DT O
intron NN O
sizes NNS O
varied VBD O

considerably RB O
, , O
the DT O
exons NNS O
, , O
in IN O
general JJ O
, , O
showed VBD O
a DT O
very RB O
narrow JJ O
distribution NN O
of IN O

lengths NNS O
, , O
and CC O
thus RB O
tended VBD O
to TO O
cluster VB O
at IN O
the DT O
lowest JJS O
end NN O
of IN O
the DT O
length NN O
distri NN O

A DT O
. . O

( : O
I PRP O
) -RRB- O

z NN O
6 CD O
0 CD O

z LS O

ZL4 NN O
0 CD O

21 CD O

z LS O

10 CD O

B NN O
. . O

8 CD O

z LS O
0 CD O

16 CD O
0 CD O
z NN O

2 LS O

20 CD O
400 CD O
600 CD O
800 CD O
1000 CD O
1200 CD O
1400 CD O
1600 CD O

LENGTH NN O
IN IN O
NUCLEOTIDES NNS O

Figure NN O
2 CD O
. . O

Length NN O
distribution NN O
of IN O
the DT O
intron NN O
and CC O
exon NN O
mean JJ O
lengths NNS O
measured VBN O
from IN O
micrographs NNS O
prepared VBN O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

( : O
A DT O
) : O
Introns NN O
; : O
( : O
b LS O
) -RRB- O
Exons NNPS O
. . O

See VB O
Tables NNP O
1 CD O
and CC O
2 CD O
for IN O
details NNS O
. . O

2248 CD O

Nucleic JJ O
Acids NN O
Research NN O
bution NN O
graph NN O
. . O

The DT O
exon NN O
in IN O
the DT O
800 CD O
- SYM O
900 CD O
bp NN O
region NN O
was VBD O
unique JJ O
and CC O
was VBD O
the DT O
only JJ O
exon NN O
which WDT O
exhibited VBD O
length NN O
overlap NN O
with IN O
introns NNS O
. . O

The DT O
maps NNS O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
obtained VBN O
with IN O
both DT O
electron NN O
micro NN O

scopic JJ O
spreading NN O
methods NNS O
were VBD O
almost RB O
identical JJ O
( : O
Figure NNP O
3 CD O
) -RRB- O
, , O
except IN O
that IN O
the DT O

region NN O
at IN O
the DT O
extreme NN O
5 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
could MD O
only RB O
be VB O
mapped VBN O
with IN O
the DT O
ureaformamide NN O
method NN O
. . O

From IN O
these DT O
measurements NNS O
we PRP O
concluded VBD O
that IN O
the DT O
length NN O
of IN O
the DT O
a2 NN O
collagen NN O
genetic JJ O
regi NN O
? , O
on IN O
in IN O
SpC3 NNP O
was VBD O
17 CD O
, , O
84 CD O
bases NNS O
long JJ O
with IN O
only RB O
3 CD O
, , O
14 CD O
bases NNS O
actually RB O
coding VBG O
for IN O
a2 CD O
mRNA NN O
. . O

Therefore RB O
, , O
only RB O
18 CD O
% NN O
of IN O
the DT O
mapped VBN O
17 CD O
kb NN O
sheep NN B-Species
genetic JJ O
insert NN O
actually RB O
contained VBD O
a2 DT O
structural JJ O
information NN O
. . O

DISCUSSION NN O

The DT O
organizational JJ O
structure NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
is VBZ O
complex JJ O
. . O

A DT O
minimum NN O
of IN O
17 CD O
introns NNS O
interrupt VBP O
the DT O
3 CD O
kb NN O
of IN O
ca2 NN O
genetic JJ O
information NN O
interspersed VBN O
as IN O
18 CD O
exons NNS O
over IN O
17 CD O
kb NNS O
of IN O
sheep NN B-Species
DNA NNP O
. . O

With IN O
the DT O
exception NN O
of IN O
exon NN O
"""" `` O
a DT O
"""" '' O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
inserted VBN O
a2 NN O
gene NN O
, , O
all DT O
other JJ O
mapped VBN O
exons NNS O
are VBP O
rather RB O
small JJ O
, , O
exhibiting VBG O
a DT O
size NN O
distribution NN O
range NN O
of IN O
50 CD O
to IN O
250 CD O
bp NN O
. . O

In IN O

contrast VB O
, , O
the DT O
intron NN O
sizes NNS O
range VBP O
from IN O
340 CD O
to IN O
1540 CD O
bases NNS O
occupying VBG O
a DT O
total JJ O

of IN O
14 CD O
kb NN O
. . O

Thus RB O
, , O
the DT O
DNA NNP O
region NN O
containing VBG O
the DT O
3 CD O
kb NN O
of IN O
a2 CD O
collagen NN O
genetic JJ O
information NN O
is VBZ O
5 CD O
. . O
6 CD O
fold NN O
longer JJR O
than IN O
the DT O
corresponding JJ O
co2 NN O
mRNA NNP O
sequences NNS O
. . O

Although IN O
the DT O
total JJ O
number NN O
of IN O
introns NNS O
present JJ O
within IN O
the DT O
60 CD O
% NN O
3 CD O
' '' O
portion NN O

of IN O
the DT O
a2 CD O
sheep NN B-Species
gene NN O
was VBD O
determined VBN O
to TO O
be VB O
17 CD O
, , O
variation NN O
in IN O
the DT O
precise JJ O
number NN O

TRANSRIPTlO NNP O

A DT O
5w CD O
r NN O

1 CD O
"""" `` O
2a4 CD O
133 CD O
112s CD O
11 CD O
. . O
17 CD O
0 CD O
. . O

3O CD O
2 CD O
715 CD O
6 CD O
. . O
2 CD O
313 CD O
4 CD O
4 CD O
. . O
2B NN O
3 CD O
. . O
51 CD O
2 CD O
. . O
2 CD O
12 CD O

EXON0 NN O
p NN O
o NN O
n NN O
5 CD O
Ik NN O
h CD O
f NN O
d NN O
4 CD O
. . O

b LS O

WPM300 NN O
16 CD O
16 CD O
14 CD O
13 CD O
12 CD O
11 CD O
10 CD O
9 CD O
6 CD O
7 CD O
6 CD O
5 CD O
4 CD O
3 CD O
2 CD O
1 CD O

B NN O

110 CD O
16 CD O
4 CD O
. . O
2 CD O
13111 CD O
112n CD O
1113104 CD O
3 CD O
. . O
6 CD O
gm74 CD O
2 CD O
6 CD O
. . O

4 CD O
4 CD O
2 CD O
3 CD O
. SYM O
2 CD O
22 CD O
in IN O

1 CD O
a1m03 CD O
133 CD O
1 CD O
. . O
2 CD O
11 CD O
10 CD O
1 CD O
341 CD O
6 CD O
. . O

1 CD O
117 CD O
6 CD O
. . O
2 CD O
4 CD O
12 CD O
417 CD O
3I5 CD O
' '' O
m NN O
2 CD O

DM00 NN O
1 CD O
q5 CD O
p NN O
0 CD O
n NN O
m NN O
I PRP O
k VBP O
. . O

j NN O
i NN O
h NN O
g NN O
f NN O
d NN O
c NN O
b NN O
a NN O
147306 CD O
17 CD O
16 CD O
15 CD O
14 CD O
13 CD O
12 CD O
11 CD O
10 CD O
9 CD O
a CD O
7 CD O
6 CD O
5 CD O
4 CD O
3 CD O
2 CD O
1 CD O

175 CD O
17 CD O
. . O
0 CD O
16 CD O
. . O
6 CD O
& SYM O
16 CD O
' '' O
5 CD O
. . O
5 CD O
15 CD O
. . O
0 CD O
14 CD O
. . O
5 CD O
14 CD O
. . O

13 CD O
. . O
5 CD O
13 CD O
. . O
0 CD O
12 CD O
. . O
5 CD O
12 CD O
. . O
0 CD O
11 CD O
. . O
5 CD O
11 CD O
10 CD O
. . O
5M NN O
10 CD O
. . O
0 CD O
9 CD O
. . O
5 CD O
9 CD O
. . O
0 CD O
8 CD O
. . O

5 CD O
. . O
0 CD O
71 CD O
7 CD O
. . O
0 CD O
6 CD O
. . O
5 CD O
6 CD O
. . O

5 CD O
. . O
5 CD O
50 CD O
4 CD O
. . O
5 CD O
4 CD O
. . O
0 CD O
3 CD O
. . O
5 CD O
3 CD O
. . O
0 CD O
2 CD O
. . O
5 CD O
2 CD O
. . O
0 CD O
1 CD O
. . O
5 CD O
1 CD O
. . O
0 NFP O

KILOBASE NNP O

Fiue3 NNP O
Organization NNP O
of IN O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
collagen NN O
gene NN O
. . O

( : O
A DT O
) : O
} : O
The DT O
exon NN O
( , O
) -RRB- O
and CC O
intron NN O
( -LRB- O
CDJ NNP O
) -RRB- O
order NN O
within IN O
the DT O
a2 NN O
gene NN O
as IN O
determined VBN O
by IN O
R NNP O
loop NN O
analysis NN O
of IN O
SpC3 NNP O
DNA NNP O
- HYPH O
a2 CD O
mRNA NNP O
hybrid NN O
molecules NNS O
visualized VBN O
by IN O
the DT O
electron NN O
microscopic JJ O
70 CD O
% NN O
formamide NN O
spreading NN O
method NN O
. . O

( -LRB- O
B NN O
) : O
The DT O
exon NN O
Um UH O
) . O

and CC O
intron NN O
( -LRB- O
Efl NNP O
) -RRB- O
order NN O
within IN O
the DT O
a2 NN O
gene NN O
as IN O
determined VBN O
by IN O
R NNP O
loop NN O
analysis NN O
of IN O
SpC3 NNP O
DNA NNP O
- HYPH O
a2 CD O
mRNA NNP O
hybrid NN O
molecules NNS O
evaluated VBN O
by IN O
the DT O
electron NN O
microscopic JJ O

urea NN O
- HYPH O
formamide NN O
spreading VBG O
method NN O
. . O

Arrows NNS O
represent VBP O
the DT O
approximate JJ O
location NN O
of IN O
intron NN O
- HYPH O
exon NN O
junctions NNS O
. . O

All DT O
values NNS O
are VBP O
presented VBN O
as IN O
kilobase NN O
pairs NNS O
. . O

2249 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

of IN O
introns NNS O
present JJ O
in IN O
individual JJ O
hybrid NN O
molecules NNS O
was VBD O
observed VBN O
. . O

The DT O
reason NN O

for IN O
this DT O
may MD O
be VB O
due IN O
to IN O
size NN O
heterogeneity NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
used VBN O
as IN O
a DT O
complementary JJ O
probe NN O
. . O

Although IN O
the DT O
a2 NN O
mRNA NNP O
was VBD O
extensively RB O
purified VBN O
( : O
2 CD O
) -RRB- O
, , O
some DT O
degradation NN O
was VBD O
likely RB O
present JJ O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
additional JJ O
introns NNS O
exist VBP O
that WDT O
are VBP O
too RB O
small JJ O
to TO O
be VB O
detected VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

The DT O
most RBS O
likely JJ O
a2 CD O
genetic JJ O
regions NNS O
containing VBG O
such JJ O
introns NNS O
are VBP O
exons NNS O
"""" `` O
g NN O
"""" '' O
and CC O
"""" `` O
m NN O
"""" '' O
. . O

Small JJ O

"""" `` O
protrusions NNS O
"""" '' O
were VBD O
sometimes RB O
observed VBN O
within IN O
these DT O
exons NNS O
that WDT O
could MD O
represent VB O
small JJ O
introns NNS O
. . O

Very RB O
small JJ O
introns NNS O
have VBP O
been VBN O
reported VBN O
for IN O
tRNA NNP O
genes NNS O
( , O
12 CD O
, , O
13 CD O
) -RRB- O
, , O

and CC O
it PRP O
will MD O
be VB O
necessary JJ O
to TO O
sequence VB O
these DT O
regions NNS O
of IN O
SpC3 NNP O
to TO O
determine VB O
if IN O
such JJ O
introns NNS O
are VBP O
present JJ O
within IN O
the DT O
a2 NN O
sheep NN B-Species
genome NN O
. . O

The DT O
existence NN O
of IN O
mRNAs NNS O
comprised VBN O
of IN O
sequences NNS O
complementary JJ O
to IN O
noncontiguous JJ O
regions NNS O
in IN O
a DT O
DNA NNP O
genome NN O
was VBD O
first RB O
described VBN O
for IN O
adenovirus NN B-Species
( , O
14 CD O
, , O
15 CD O
) -RRB- O
and CC O

simian JJ O
virus NN O
( : O
16 CD O
, , O
17 CD O
) CD O
genes NNS O
. . O

Similar JJ O
observations NNS O
were VBD O
soon RB O
reported VBN O
for IN O
eukaryotic JJ O
genes NNS O
, , O
including VBG O
serum JJ O
albumin NN O
( , O
18 CD O
) FW O
, , O
conalbumin NN O
( , O
19 CD O
) , O
, , O
fibroin NN O
( , O
20 CD O
) -RRB- O
, , O
s NNS O

globin NN O
( : O
21 CD O
, , O
22 CD O
) -RRB- O
, , O
growth NN O
hormones NNS O
( , O
23 CD O
, , O
24 CD O
) NN O
, , O
immunoglobulin NN O
( , O
25 CD O
) -RRB- O
, , O
lysozyme NN O
( , O
26 CD O
) -RRB- O
, , O

ovalbumin NNP O
( : O
27 CD O
- SYM O
29 CD O
) -RRB- O
, , O
ovomucoid JJ O
( , O
30 CD O
) -RRB- O
, , O
rRNA NNP O
( , O
31 CD O
- SYM O
34 CD O
) -RRB- O
, , O
tRNA NNP O
( SYM O
12 CD O
, , O
13 CD O
) -RRB- O
, , O
and CC O
vitellogenin NN O
( SYM O
35 CD O
) -RRB- O
. . O

The DT O
precise JJ O
number NN O
or CC O
occurrence NN O
of IN O
introns NNS O
within IN O
these DT O
genes NNS O
does VBZ O
not RB O
seem VB O
to TO O
follow VB O
any DT O
clear JJ O
pattern NN O
. . O

However RB O
, , O
the DT O
genes NNS O
for IN O
albumin NN O
, , O
conalbumin NN O
, , O

lysozyme NN O
, , O
ovalbumin NN O
, , O
and CC O
ovomucoid NN O
exhibit VBP O
a DT O
structural JJ O
organization NN O
comparable JJ O
to IN O
the DT O
a2 NN O
collagen NN O
gene NN O
. . O

All DT O
of IN O
these DT O
genes NNS O
are VBP O
composed VBN O
of IN O
numerous JJ O
small JJ O

exons NNS O
, , O
usually RB O
less JJR O
than IN O
250 CD O
base NN O
pairs NNS O
, , O
and CC O
introns NNS O
which WDT O
show VBP O
a DT O
large JJ O
size NN O
variation NN O
within IN O
an DT O
individual JJ O
gene NN O
. . O

Within IN O
all DT O
of IN O
these DT O
genomes NNS O
, , O
the DT O
DNA NNP O

regions NNS O
required VBN O
for IN O
coding VBG O
structural JJ O
formation NN O
are VBP O
4 CD O
to TO O
7 CD O
times NNS O
longer JJR O
than IN O
the DT O
corresponding VBG O
mRNA NNP O
coding VBG O
sequences NNS O
. . O

As IN O
with IN O
the DT O
a2 NN O
collagen NN O
gene NN O
, , O
a DT O
large JJ O
unique JJ O
exon NN O
at IN O
the DT O
extreme NN O
3 CD O
' '' O
end NN O

is VBZ O
also RB O
present JJ O
in IN O
the DT O
ovalbumin NN O
gene NN O
( : O
36 CD O
, , O
37 CD O
) -RRB- O
. . O

In IN O
the DT O
a2 CD O
gene NN O
, , O
this DT O
exon NN O
was VBD O
800 CD O
to IN O
900 CD O
nucleotides NNS O
in IN O
length NN O
, , O
while IN O
in IN O
the DT O
ovalbumin NN O
gene NN O
the DT O
exon NN O
contained VBD O
1 CD O
, , O
30 CD O
base NN O
pairs NNS O
. . O

Interestingly RB O
, , O
this DT O
ovalbumin JJ O
exon NN O
contained VBD O
634 CD O
- SYM O
650 CD O
base NN O
pairs NNS O
ot IN O
DNA NN O
sequence NN O
to IN O
the DT O
3 CD O
' '' O
side NN O
of IN O
the DT O
terminator NN O

triplet NN O
, , O
suggesting VBG O
the DT O
ovalbumin NN O
mRNA NNP O
has VBZ O
a DT O
large JJ O
untranslated JJ O
region NN O
at IN O
the DT O
3 CD O
' '' O
end NN O
. . O

The DT O
consistent JJ O
appearance NN O
of IN O
a DT O
small JJ O
non NN O
- HYPH O
hybridized JJ O
tail NN O
, , O
approximately RB O
100 CD O
nucleotides NNS O
in IN O
length NN O
, , O
in IN O
the DT O
region NN O
where WRB O
the DT O
right JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
ligated VBN O
to IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
of IN O
SpC3 NNP O
very RB O
likely RB O
corresponded VBD O
to IN O
the DT O

3 CD O
' POS O
poly NN O
A DT O
sequence NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
. . O

This DT O
would MD O
suggest VB O
that IN O
the DT O
a2 NN O
mRNA NNP O
coding VBG O
sequence NN O
terminates VBZ O
very RB O
near RB O
or CC O
at IN O
this DT O
point NN O
in IN O
the DT O
genome NN O
. . O

Previously RB O
published VBN O
biochemical JJ O
evidence NN O
( , O
2 CD O
) -RRB- O
obtained VBD O
from IN O
restriction NN O
mapping NN O
and CC O
Southern JJ O
blot NN O
analysis NN O
using VBG O
[ -LRB- O
32P NN O
] -RRB- O
- HYPH O
labeled VBN O
chick NN O
a2 NN O
cDNA NN O
probe NN O
supports VBZ O

2250 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

this DT O
observation NN O
. . O

It PRP O
is VBZ O
unclear JJ O
what WDT O
role NN O
introns NNS O
play VBP O
in IN O
genetic JJ O
expression NN O
. . O

However RB O
, , O

it PRP O
is VBZ O
known VBN O
that IN O
these DT O
sequences NNS O
are VBP O
tranncribed VBN O
as IN O
part NN O
of IN O
larger JJR O
precursor NN O
mRNAs NNS O
and CC O
the DT O
introns NNS O
are VBP O
then RB O
excised VBN O
and CC O
the DT O
fragmented JJ O
mRNA NN O
chains NNS O

covalently RB O
rejoined VBN O
( SYM O
38 CD O
) -RRB- O
. . O

Some DT O
evidence NN O
has VBZ O
recently RB O
accumulated VBN O
demonstrating VBG O
the DT O
existence NN O
of IN O
precursor NN O
a2 IN O
mRNAs NNS O
( SYM O
39 CD O
, , O
40 CD O
) -RRB- O
. . O

However RB O
, , O
if IN O
the DT O
introns NNS O
in IN O
the DT O
a2 NN O
gene NN O
are VBP O
transcribed VBN O
in IN O
their PRP$ O
entirety NN O
, , O
as IN O
has VBZ O
been VBN O

demonstrated VBN O
for IN O
the DT O
introns NNS O
in IN O
ovalbumin NN O
and CC O
globin NN O
( SYM O
41 CD O
, , O
42 CD O
) -RRB- O
, , O
much RB O
larger JJR O
precursor NN O
a2 CD O
mRNAs NNS O
may MD O
exist VB O
than IN O
those DT O
reported VBN O
to IN O
date NN O
. . O

For IN O
if IN O
the DT O
re NN O

mainder NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
has VBZ O
a DT O
structural JJ O
organization NN O
comparable JJ O
to IN O
the DT O
60 CD O
% NN O
3 CD O
' '' O
portion NN O
that WDT O
has VBZ O
been VBN O
analyzed VBN O
, , O
it PRP O
is VBZ O
probable JJ O
that IN O
the DT O
a2 NN O

collagen NN O
gene NN O
in IN O
its PRP$ O
entirety NN O
is VBZ O
dispersed VBN O
throughout IN O
a DT O
30 CD O
kb NN O
DNA NNP O
segment NN O
. . O

ACKNOWLEDGMENTS NNS O

We PRP O
thank VBP O
Dr NNP O
. . O
John NNP O
Dahlberg NNP O
and CC O
Frances NNP O
Loebenstein NNP O
, , O
Laboratory NNP O
of IN O
Cellular NNP O
and CC O
Molecular NNP O
Biology NNP O
, , O
National NNP O
Cancer NNP O
Institute NNP O
, , O
for IN O
the DT O
generous JJ O
use NN O
of IN O
a DT O

Siemens NNP O
Elmiskop NNP O
101 CD O
electron NN O
microscope NN O
; : O
Dr NNP O
. . O
Ursula NNP O
Heine NNP O
and CC O
Benjamin NNP O
Elliott NNP O
, , O
Laboratory NNP O
of IN O
Viral NNP O
Carcinogenesis NNP O
, , O
National NNP O
Cancer NNP O
Institute NNP O
, , O
for IN O
the DT O
use NN O
of IN O
a DT O
Hewlett NNP O
- HYPH O
Packard NNP O
calculator NN O
equipped VBN O
with IN O
a DT O
digitizer NN O
and CC O
a DT O
Denton NNP O
vacuum NN O

evaporator NN O
, , O
and CC O
Drs NNP O
. . O

Victor NNP O
Ferrans NNP O
and CC O
Oichi NNP O
Kawanami NNP O
, , O
Laboratory NNP O
of IN O
Pathology NNP O
, , O

National NNP O
Heart NNP O
, , O
Lung NNP O
, , O
and CC O
Blood NNP O
Institute NNP O
, , O
for IN O
expert JJ O
assistance NN O
with IN O
photography NN O
. . O

We PRP O
are VBP O
also RB O
grateful JJ O
to IN O
Margery NNP O
Sullivan NNP O
, , O
Laboratory NNP O
of IN O
Molecular NNP O
Genetics NNP O
, , O

National NNP O
Institute NNP O
of IN O
Child NNP B-Species
Health NNP O
and CC O
Human NNP B-Species
Development NNP O
, , O
for IN O
helpful JJ O
discussions NNS O
and CC O
to IN O
Dr NNP O
. . O
Helga NNP O
Boedtker NNP O
, , O
Department NNP O
of IN O
Chemistry NNP O
, , O
Harvard NNP O
University NNP O
, , O
for IN O
making VBG O
available JJ O
the DT O
recombinant JJ O
plasmid NN O
pCg45 NN O
. . O

References NNS O

1 LS O
. . O

Prockop NNP O
, , O
D NNP O
. . O

J NNP O
. . O
, , O
Kivirikko NNP O
, , O
k UH O
. . O

I PRP O
. . O
, , O
Tuderman NNP O
, , O
L NNP O
. . O
, , O
and CC O
Guzman NNP O
, , O
N NNP O
. . O

A DT O
. . O

( -LRB- O
1979 CD O
) SYM O
New NNP O
Engl NNP O
. . O

J NNP O
. . O

Med NNP O
. . O

301 CD O
, , O
13 CD O
- HYPH O
23 CD O
and CC O
77 CD O
- HYPH O
85 CD O
. . O

2 LS O
. . O

Boyd NNP O
, , O
C UH O
. . O

D NNP O
. . O
, , O
Tolstoshev NNP O
, , O
P NNP O
. . O
, , O
Schafer NNP O
, , O
M NNP O
. . O

P UH O
. . O
, , O
Trapnell NNP O
, , O
B NNP O
. . O

C UH O
. . O
, , O
Coon NNP O
, , O

H NN O
. . O

C UH O
. . O
, , O
Kretschmer NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Nienhuis NNP O
, , O
A NNP O
. . O

W UH O
. . O
, , O
and CC O
Crystal NNP O
, , O
R NNP O
. . O

G NNP O
. . O

( : O
1980 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O
, , O
in IN O
press NN O
. . O

3 LS O
. . O

Blin NNP O
, , O
N NNP O
. . O
, , O
and CC O
Stafford NNP O
, , O
D NNP O
. . O

W UH O
. . O

( -LRB- O
1976 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

3 CD O
, , O
2303 CD O
- SYM O
2308 CD O
. . O

4 LS O
. . O

Kretschmer NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Kaufman NNP O
, , O
R NNP O
. . O

E UH O
. . O
, , O
Coon NNP O
, , O
H NNP O
. . O

C UH O
. . O
, , O
Chen NNP O
, , O
M NNP O
. . O

JY NNP O
. . O
, , O
Geist NNP O

C NN O
. . O

E NNP O
. . O
, , O
and CC O
Nienhuis NNP O
, , O
A NNP O
. . O

W UH O
. . O

( : O
1980 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O
, , O
in IN O
press NN O
. . O

5 LS O
. . O

Maniatis NNP O
, , O
T NNP O
. . O
, , O
Hardison NNP O
, , O
R NN O
. . O

C UH O
. . O
, , O
Lacey NNP O
, , O
E NNP O
. . O
, , O
Laver NNP O
, , O
H NNP O
. . O
, , O
O UH O
' '' O
Connell NNP O
, , O
C NNP O
. . O
, , O

Quon NNP O
, , O
D NNP O
. . O
, , O
Sim NNP O
, , O
G NNP O
. . O

K UH O
. . O
, , O
and CC O
Efstratiadis NNP O
, , O
A DT O
. . O

( : O
1975 CD O
) SYM O
Cell NNP O
15 CD O
, , O
687 CD O
- HYPH O
701 CD O
. . O

6 LS O
. . O

Blattner NNP O
, , O
F NNP O
. . O

R NNP O
. . O
, , O
Blechl NNP O
, , O
A NNP O
. . O

E UH O
. . O
, , O
Denniston NNP O
- HYPH O
Thompson NNP O
, , O
K NNP O
. . O
, , O
Faber NNP O
, , O
H NNP O
. . O

E UH O
. . O
, , O

Richards NNP O
, , O
J NNP O
. . O

E UH O
. . O
, , O
Slightom NNP O
, , O
H NNP O
. . O

L NNP O
. . O
, , O
Tucker NNP O
, , O
P NN O
. . O

W UH O
. . O
, , O
and CC O
Smithies NNP O
, , O
0 NFP O
. . O

( : O
1978 CD O
) SYM O
Science NNP O
202 CD O
, , O
1279 CD O
- SYM O
1284 CD O
. . O

7 LS O
. . O

Meyer NNP O
, , O
J NNP O
. . O
, , O
Neuwald NNP O
, , O
P NN O
. . O

D NNP O
. . O
, , O
Lai NNP O
, , O
S NNP O
. . O
, , O
Maizel NNP O
, , O
J NNP O
. . O

V NNP O
. . O
, , O
Jr NNP O
. . O
, , O
and CC O
Westphal NNP O
, , O

H NN O
. . O

( : O
1977 CD O
) SYM O
J NN O
. . O

Virol NNP O
. . O

21 CD O
, , O
1010 CD O
- SYM O
1014 CD O
. . O

2251 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

8 LS O
. . O

Westphal NNP O
, , O
H NNP O
. . O
, , O
and CC O
Lai NNP O
, , O
S NNP O
. . O

P NN O
. . O

( : O
1977 CD O
) SYM O
J NN O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

116 CD O
, , O
525 CD O
- HYPH O
548 CD O
. . O

9 LS O
. . O

Schafer NNP O
, , O
M NNP O
. . O

P UH O
. . O
, , O
Rohrmann NNP O
, , O
G NNP O
. . O
, , O
Heine NNP O
, , O
U NNP O
. . O
, , O
and CC O
Beaudreau NNP O
, , O
G NNP O
. . O

S UH O
. . O

( -LRB- O
1979 CD O
) SYM O
Virol NNP O
. . O

95 CD O
, , O
176 CD O
- SYM O
184 CD O
. . O

10 CD O
. . O

Davis NNP O
, , O
R NNP O
. . O

W UH O
. . O
, , O
Simon NNP O
, , O
M NNP O
. . O

M NNP O
. . O
, , O
and CC O
Davison NNP O
, , O
N NNP O
. . O

( -LRB- O
1971 CD O
) -RRB- O
in IN O
Methods NNPS O
in IN O

Enzymology NNP O
( , O
Grossman NNP O
, , O
L NNP O
. . O
and CC O
Moldave NNP O
, , O
K NNP O
. . O
, , O
eds FW O
) -RRB- O
Vol NNP O
. . O

21 CD O
, , O
pp UH O
. . O

413428 CD O
, , O
Academic NNP O
Press NNP O
, , O
New NNP O
York NNP O
. . O

11 CD O
. . O

Federal NNP O
Register NNP O
( : O
1978 CD O
) SYM O
43 CD O
, , O
60108 CD O
- HYPH O
60131 CD O
. . O

12 CD O
. . O

Goodman NNP O
, , O
H NNP O
. . O

M UH O
. . O
, , O
Olson NNP O
, , O
M NNP O
. . O

V NNP O
. . O
, , O
Hall NNP O
, , O
B NNP O
. . O

D NNP O
. . O

( : O
1977 CD O
) : O
Pro NN O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

74 CD O
, , O
5453 CD O
- HYPH O
5457 CD O
. . O

13 CD O
. . O

Valenzuela NNP O
, , O
P NNP O
. . O
, , O
Venegas NNP O
, , O
A NNP O
. . O
, , O
Weinberg NNP O
, , O
F NNP O
. . O
, , O
Bishop NNP O
, , O
R NNP O
. . O
, , O
Rutter NNP O
, , O

W UH O
. . O

J NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
190 CD O
- SYM O
194 CD O
. . O

14 CD O
. . O

Berget NNP O
, , O
S NNP O
. . O

M NNP O
. . O
, , O
Moore NNP O
, , O
C NNP O
. . O
, , O
and CC O
Sharp NNP O
, , O
P NN O
. . O

A DT O
. . O

( -LRB- O
1977 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

74 CD O
, , O
3171 CD O
- HYPH O
3175 CD O
. . O

15 CD O
. . O

Chow NNP O
, , O
L NNP O
. . O

T UH O
. . O
, , O
Gelinas NNP O
, , O
R NNP O
. . O

E NNP O
. . O
, , O
Broker NNP O
, , O
T NNP O
. . O
, , O
and CC O
Roberts NNP O
, , O
R NNP O
. . O

J NNP O
. . O

( -LRB- O
1977 CD O
) NFP O

Cell NNP O
12 CD O
, , O
1 CD O
- SYM O
8 CD O
. . O

16 CD O
. . O

Berk NNP O
, , O
A UH O
. . O

J NNP O
. . O
, , O
and CC O
Sharp NNP O
, , O
P NN O
. . O

A DT O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1274 CD O
- HYPH O
1278 CD O
. . O

17 CD O
. . O

Bratosin NNP O
, , O
S NNP O
. . O
, , O
Horowitz NNP O
, , O
M NNP O
. . O
, , O
Laub NNP O
, , O
0 CD O
. . O
, , O
and CC O
Aloni NNP O
, , O
Y NNP O
. . O

( -LRB- O
1978 CD O
) NFP O

Cell NNP O
13 CD O
, , O
783 CD O
- HYPH O
790 CD O
. . O

18 CD O
. . O

Sargent NNP O
, , O
T NNP O
. . O

D NNP O
. . O
, , O
Wu NNP O
, , O
J NNP O
. . O

R NNP O
. . O
, , O
Sala NNP O
- HYPH O
Trepat NNP O
, , O
J NNP O
. . O

M UH O
. . O
, , O
Wallace NNP O
, , O
R NNP O
. . O

B UH O
. . O
, , O

Reyes NNP O
, , O
A UH O
. . O

A DT O
. . O
, , O
and CC O
Bonner NNP O
, , O
J NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
3256 CD O
- HYPH O
3260 CD O
. . O

19 CD O
. . O

Perrin NNP O
, , O
F NNP O
. . O
, , O
Cochet NNP O
, , O
M NNP O
. . O
, , O
Gerlinger NNP O
, , O
P NNP O
. . O
, , O
Cami NNP O
, , O
B NNP O
. . O
, , O
LePennec NNP O
, , O
J NNP O
. . O

P UH O
. . O
, , O

and CC O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
2731 CD O
- SYM O
2748 CD O
. . O

20 CD O
. . O

Tsujimoto NNP O
, , O
Y NNP O
. . O
, , O
and CC O
Suzuki NNP O
, , O
Y NNP O
. . O

( : O
1979 CD O
) SYM O
Cell NNP O
16 CD O
425 CD O
- HYPH O
436 CD O
. . O

21 CD O
. . O

Jeffreys NNP O
, , O
A NNP O
. . O

J NNP O
. . O
, , O
and CC O
Flavell NNP O
, , O
R NNP O
. . O

A DT O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NNP O
12 CD O
, , O
1097 CD O
- SYM O
1108 CD O
. . O

22 CD O
. . O

Tilghman NNP O
, , O
S NNP O
. . O

M UH O
. . O
, , O
Tiemeier NNP O
, , O
D NNP O
. . O

C UH O
. . O
, , O
Seidman NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
Matija NNP O
Peterlin NNP O
, , O
B NNP O
. . O
, , O

Sullivan NNP O
, , O
M NNP O
. . O
, , O
Maizel NNP O
, , O
J NNP O
. . O

V NNP O
. . O
, , O
and CC O
Leder NNP O
, , O
P NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
725 CD O
- HYPH O
729 CD O
. . O

23 CD O
. . O

Fiddes NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
Seeburg NNP O
, , O
P NN O
. . O

H UH O
. . O
, , O
DeNoto NNP O
, , O
F NNP O
. . O

M UH O
. . O
, , O
Hallewell NNP O
, , O
R NNP O
. . O

A UH O
. . O
, , O

Baxter NNP O
, , O
J NNP O
. . O

D NNP O
. . O
, , O
and CC O
Goodman NNP O
, , O
H NNP O
. . O

M UH O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
4294 CD O
- HYPH O
4298 CD O
. . O

24 CD O
. . O

Soreq NNP O
, , O
H NNP O
. . O
, , O
Harpold NNP O
, , O
M NNP O
. . O
, , O
Evans NNP O
, , O
R NNP O
. . O
, , O
Darnell NNP O
, , O
Jr NNP O
. . O
, , O
J NNP O
. . O

E UH O
. . O
, , O
and CC O

Bancroft NNP O
, , O
F NNP O
. . O

C NN O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
, , O
2471 CD O
- HYPH O
2482 CD O
. . O

25 CD O
. . O

Tonegawa NNP O
, , O
S NNP O
. . O
, , O
Maxam NNP O
, , O
A NNP O
. . O

M UH O
. . O
, , O
Tizard NNP O
, , O
R NNP O
. . O
, , O
Bernard NNP O
, , O
0 CD O
. . O
, , O
and CC O
Gilbert NNP O
, , O
W NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1485 CD O
- HYPH O
1489 CD O
. . O

26 CD O
. . O

Nguyen NNP O
- HYPH O
Huu NNP O
, , O
M NNP O
. . O

C UH O
. . O
, , O
Stratmann NNP O
, , O
M NNP O
. . O
, , O
Groner NNP O
, , O
B NNP O
. . O
, , O
Wurtz NNP O
, , O
T NNP O
. . O
, , O
Land NNP O
, , O
M NNP O
. . O
, , O

Glesecke NNP O
, , O
K NNP O
. . O
, , O
Sippel NNP O
, , O
A NNP O
. . O

F NNP O
. . O
, , O
and CC O
Schutz NNP O
, , O
G NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
76 CD O
- SYM O
80 CD O
. . O

27 CD O
. . O

Breathnach NNP O
, , O
R NNP O
. . O
, , O
Mandel NNP O
, , O
J NNP O
. . O

L NNP O
. . O
, , O
and CC O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1977 CD O
) SYM O
Nature NNP O
270 CD O
, , O

314 CD O
- HYPH O
319 CD O
. . O

28 CD O
. . O

Dugaiczyk NNP O
, , O
A NNP O
. . O
, , O
Woo UH O
, , O
S NNP O
. . O

L NN O
. . O

C UH O
. . O
, , O
Lai NNP O
, , O
E NNP O
. . O

C UH O
. . O
, , O
Mace NNP O
, , O
M NNP O
. . O

L NNP O
. . O
, , O
Jr NNP O
. . O
, , O

McReynolds NNP O
, , O
L NNP O
. . O
, , O
and CC O
O NNP O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1978 CD O
) SYM O
Nature NNP O
274 CD O
, , O
328 CD O
- HYPH O
333 CD O
. . O

29 CD O
. . O

Weinstock NNP O
, , O
R NNP O
. . O
, , O
Sweet NNP O
, , O
R NNP O
. . O
, , O
Weiss NNP O
, , O
M NNP O
. . O
, , O
Cedar NNP O
, , O
M NNP O
. . O
, , O
and CC O
Axel NNP O
, , O
R NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1299 CD O
- SYM O
1303 CD O
. . O

30 CD O
. . O

Catterall NNP O
, , O
J NNP O
. . O

F NNP O
. . O
, , O
Stein NNP O
, , O
J NNP O
. . O

P UH O
. . O
, , O
Lai NNP O
, , O
E NNP O
. . O

C UH O
. . O
, , O
Woo UH O
, , O
S NNP O
. . O

L NN O
. . O

C UH O
. . O
, , O

Dugaiczyk NNP O
, , O
Mace NNP O
, , O
M NNP O
. . O

L NNP O
. . O
, , O
Means NNP O
, , O
A DT O
. . O

R NNP O
. . O
, , O
and CC O
O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1979 CD O
) SYM O
Nature NNP O
278 CD O
, , O
323 CD O
- HYPH O
327 CD O
. . O

31 CD O
. . O

White JJ O
, , O
R NNP O
. . O

L NNP O
. . O
, , O
and CC O
Hogness NNP O
, , O
D NNP O
. . O

S UH O
. . O

( : O
1977 CD O
) SYM O
Cell NNP O
10 CD O
, , O
177 CD O
- SYM O
192 CD O
. . O

32 CD O
. . O

Glover NNP O
, , O
D NNP O
. . O

M UH O
. . O
, , O
and CC O
Hogness NNP O
, , O
D NNP O
. . O

S UH O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NNP O
16 CD O
, , O
167 CD O
- SYM O
176 CD O
. . O

33 CD O
. . O

Wellauer NNP O
, , O
P NN O
. . O

K UH O
. . O
, , O
and CC O
David NNP O
, , O
I PRP O
. . O

B NN O
. . O

( : O
1977 CD O
) SYM O
Cell NNP O
10 CD O
, , O
193 CD O
- HYPH O
212 CD O
. . O

34 CD O
. . O

Pellegrini NNP O
, , O
M NNP O
. . O
, , O
Manning NNP O
, , O
J NNP O
. . O
, , O
and CC O
Davidson NNP O
, , O
N NNP O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NN O
10 CD O
, , O

213 CD O
- HYPH O
214 CD O
. . O

35 CD O
. . O

Wahli NNP O
, , O
W NNP O
. . O
, , O
David NNP O
, , O
I PRP O
. . O

B NNP O
. . O
, , O
Wyler NNP O
, , O
T NNP O
. . O
, , O
Jaggi NNP O
, , O
R NNP O
. . O

B NNP O
. . O
, , O
Weber NNP O
, , O
R NNP O
. . O
, , O
and CC O

Ryffel NNP O
, , O
G NNP O
. . O

V NN O
. . O

( : O
1979 CD O
) SYM O
Cell NNP O
16 CD O
, , O
535 CD O
- HYPH O
549 CD O
. . O

36 CD O
. . O

McReynolds NNP O
, , O
L NNP O
. . O
, , O
O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O
, , O
Nisbet NNP O
, , O
A NNP O
. . O

D NNP O
. . O
, , O
Fothergill NNP O
, , O
J NNP O
. . O

E UH O
. . O
, , O

2252 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Givol NNP O
, , O
D NNP O
. . O
, , O
Fields NNP O
, , O
S NNP O
. . O
, , O
Robertson NNP O
, , O
M NNP O
. . O
, , O
Brownlee NNP O
, , O
G NNP O
. . O

G NNP O
. . O

( : O
1978 CD O
) SYM O
Nature NNP O
273 CD O
, , O
723 CD O
- HYPH O
728 CD O
. . O

37 CD O
. . O

O UH O
' '' O
Hare NNP O
, , O
K NNP O
. . O
, , O
Breathnach NNP O
, , O
R NNP O
. . O
, , O
Benoist NNP O
, , O
C NNP O
. . O
, , O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1979 CD O
) -RRB- O

Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

7 CD O
, , O
321 CD O
- SYM O
334 CD O
. . O

38 CD O
. . O

Abelson NNP O
, , O
J NNP O
. . O

( : O
1979 CD O
) : O
Ann NNP O
. . O

Rev NNP O
. . O

Biochem NNP O
. . O

48 CD O
, , O
1035 CD O
- SYM O
1069 CD O
. . O

39 CD O
. . O

Adams NNP O
, , O
S NNP O
. . O

L NNP O
. . O
, , O
Alwine NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
de FW O
Chrombrugghe NNP O
, , O
B NNP O
. . O
, , O
and CC O
Pastan NNP O
, , O
I PRP O
. . O

( : O
1979 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

254 CD O
, , O
4935 CD O
- HYPH O
4938 CD O
, , O

40 CD O
. . O

Rave NNP O
, , O
N NNP O
. . O
, , O
Crkvenjakow NNP O
, , O
R NNP O
. . O
, , O
and CC O
Boedtker NNP O
, , O
H NNP O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
, , O
3559 CD O
- HYPH O
3567 CD O
. . O

41 CD O
. . O

Roop NNP O
, , O
D NNP O
. . O

R NNP O
. . O
, , O
Nordstrom NNP O
, , O
J NNP O
. . O

L NNP O
. . O
, , O
Tsai NNP O
, , O
S NNP O
. . O

Y UH O
. . O
, , O
Tsai NNP O
, , O
M NNP O
. . O

J NNP O
. . O
, , O
and CC O

O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1978 CD O
) SYM O
Cell NNP O
15 CD O
, , O
671 CD O
- HYPH O
685 CD O
. . O

42 CD O
. . O

Tilghman NNP O
, , O
S NNP O
. . O

M UH O
. . O
, , O
Curtis NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Tiemeier NNP O
, , O
D NNP O
. . O

C UH O
. . O
, , O
Leder NNP O
, , O
P NNP O
. . O
, , O
and CC O

Weissmann NNP O
, , O
C NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1309 CD O
- HYPH O
1313 CD O
. . O

43 CD O
. . O

Palmiter NNP O
, , O
R NNP O
. . O

D NNP O
. . O
, , O
Davidson NNP O
, , O
J NNP O
. . O

M UH O
. . O
, , O
Gagnon NNP O
, , O
H NNP O
. . O
, , O
Rowe NNP O
, , O
D NNP O
. . O

W UH O
. . O
, , O
and CC O

Bornstein NNP O
, , O
P NN O
. . O

( : O
1979 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

254 CD O
, , O
1433 CD O
- HYPH O
1436 CD O
. . O

44 CD O
. . O

Graves NNP O
, , O
P NN O
. . O

N NNP O
. . O
, , O
Olsen NNP O
, , O
B NNP O
. . O

R NNP O
. . O
, , O
Feitzig NNP O
, , O
P NN O
. . O

P UH O
. . O
, , O
Monson NNP O
, , O
J NNP O
. . O

M UH O
. . O
and CC O

Prockop NNP O
, , O
D NNP O
. . O

J NNP O
. . O

( -LRB- O
1979 CD O
) SYM O
Fed NNP O
. . O

Proc NNP O
. . O

38 CD O
, , O
620 CD O
. . O

2253 CD O

Thumb NN O
force NN O
deficit NN O
after IN O
lower JJR O
median JJ O
nerve NN O
block NN O

Abstract JJ O

Purpose NN O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
characterize VB O
thumb NN O
motor NN O
dysfunction NN O
resulting VBG O
from IN O
simulated VBN O
lower JJR O
median JJ O
nerve NN O
lesions NNS O
at IN O
the DT O
wrist NN O
. . O

Methods NNS O

Bupivacaine NN O
hydrochloride NN O
was VBD O
injected VBN O
into IN O
the DT O
carpal NN O
tunnel NN O
of IN O
six CD O
healthy JJ O
subjects NNS O
to TO O
locally RB O
anesthetize VB O
the DT O
median JJ O
nerve NN O
. . O

Motor NN O
function NN O
was VBD O
subsequently RB O
evaluated VBN O
by IN O
measuring VBG O
maximal JJ O
force NN O
production NN O
in IN O
all DT O
directions NNS O
within IN O
the DT O
transverse NN O
plane NN O
perpendicular JJ O
to IN O
the DT O
longitudinal JJ O
axis NN O
of IN O
the DT O
thumb NN O
. . O

Force NN O
envelopes NNS O
were VBD O
constructed VBN O
using VBG O
these DT O
measured VBN O
multidirectional JJ O
forces NNS O
. . O

Results NNS O

Blockage NN O
of IN O
the DT O
median JJ O
nerve NN O
resulted VBD O
in IN O
decreased VBN O
force NN O
magnitudes NNS O
and CC O
thus RB O
smaller JJR O
force NN O
envelopes NNS O
. . O

The DT O
average JJ O
force NN O
decrease NN O
around IN O
the DT O
force NN O
envelope NN O
was VBD O
27 CD O
. . O
9 CD O
% NN O
. . O

A DT O
maximum JJ O
decrease NN O
of IN O
42 CD O
. . O
4 CD O
% NN O
occurred VBD O
in IN O
a DT O
direction NN O
combining VBG O
abduction NN O
and CC O
slight JJ O
flexion NN O
, , O
while IN O
a DT O
minimum JJ O
decrease NN O
of IN O
10 CD O
. . O
5 CD O
% NN O
occurred VBD O
in IN O
a DT O
direction NN O
combining VBG O
adduction NN O
and CC O
slight JJ O
flexion NN O
. . O

Relative JJ O
decreases NNS O
in IN O
adduction NN O
, , O
extension NN O
, , O
abduction NN O
, , O
and CC O
flexion NN O
were VBD O
17 CD O
. . O
3 CD O
% NN O
, , O
21 CD O
. . O
2 CD O
% NN O
, , O
41 CD O
. . O
2 CD O
% NN O
and CC O
33 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

Areas NNS O
enclosed VBN O
by IN O
pre JJ O
- HYPH O
and CC O
post JJ O
- HYPH O
block NN O
force NN O
envelopes NNS O
were VBD O
20628 CD O
+ CD O
/ SYM O
- HYPH O
7747 CD O
N CD O
. . O
N NN O
, , O
and CC O
10700 CD O
+ SYM O
/ SYM O
- HYPH O
4474 CD O
N CD O
. . O
N CD O
, , O
respectively RB O
, , O
representing VBG O
an DT O
average JJ O
decrease NN O
of IN O
48 CD O
. . O
1 CD O
% NN O
. . O

Relative JJ O
decreases NNS O
in IN O
the DT O
adduction NN O
, , O
extension NN O
, , O
abduction NN O
, , O
and CC O
flexion NN O
quadrant NN O
areas NNS O
were VBD O
31 CD O
. . O
5 CD O
% NN O
, , O
42 CD O
. . O
3 CD O
% NN O
, , O
60 CD O
. . O
9 CD O
% NN O
, , O
and CC O
52 CD O
. . O
3 CD O
% NN O
, , O
respectively RB O
. . O

Conclusion NN O

Lower JJR O
median JJ O
nerve JJ O
lesion NN O
, , O
simulated VBN O
by IN O
a DT O
nerve NN O
block NN O
at IN O
the DT O
wrist NN O
, , O
compromise VBP O
normal JJ O
motor NN O
function NN O
of IN O
the DT O
thumb NN O
. . O

A DT O
median JJ O
nerve NN O
block NN O
results VBZ O
in IN O
force NN O
deficits NNS O
in IN O
all DT O
directions NNS O
, , O
with IN O
the DT O
most RBS O
severe JJ O
impairment NN O
in IN O
abduction NN O
and CC O
flexion NN O
. . O

From IN O
our PRP$ O
results NNS O
, , O
such PDT O
a DT O
means NN O
of IN O
motor NN O
function NN O
assessment NN O
can MD O
potentially RB O
be VB O
applied VBN O
to TO O
functionally RB O
evaluate VB O
peripheral JJ O
neuropathies NNS O
. . O

Introduction NN O

The DT O
thumb NN O
has VBZ O
unique JJ O
anatomical JJ O
and CC O
biomechanical JJ O
characteristics NNS O
that WDT O
are VBP O
required VBN O
to TO O
perform VB O
many JJ O
manipulative JJ O
tasks NNS O
. . O

Thumb NN O
motor NN O
dysfunction NN O
resulting VBG O
from IN O
neuromuscular JJ O
and CC O
musculoskeletal JJ O
pathologies NNS O
severely RB O
hinders VBZ O
the DT O
performance NN O
of IN O
these DT O
daily JJ O
tasks NNS O
. . O

Clinical JJ O
treatment NN O
, , O
prevention NN O
protocols NNS O
, , O
and CC O
rehabilitation NN O
efficacy NN O
requires VBZ O
a DT O
thorough JJ O
understanding NN O
of IN O
thumb NN O
motor NN O
capabilities NNS O
, , O
as RB O
well RB O
as IN O
its PRP$ O
associated JJ O
functional JJ O
deficit NN O
. . O

Investigations NNS O
of IN O
underlying JJ O
pathological JJ O
mechanism NN O
of IN O
the DT O
thumb NN O
help VBP O
advance VB O
clinical JJ O
treatments NNS O
such JJ O
as IN O
tendon NN O
transfers NNS O
[ -LRB- O
1 CD O
] -RRB- O
, , O
functional JJ O
electrical JJ O
stimulation NN O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
plasticity NN O
suppression NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Measurement NN O
of IN O
strength NN O
during IN O
maximum JJ O
voluntary JJ O
contraction NN O
is VBZ O
a DT O
simple JJ O
and CC O
direct JJ O
means NN O
of IN O
assessing VBG O
neuromuscular JJ O
function NN O
. . O

Popular JJ O
instruments NNS O
used VBN O
for IN O
quantitative JJ O
assessment NN O
of IN O
thumb NN O
strength NN O
are VBP O
pinch NN O
dynamometers NNS O
. . O

The DT O
pinch NN O
output NN O
, , O
however RB O
, , O
provides VBZ O
limited JJ O
information NN O
about IN O
thumb NN O
motor NN O
function NN O
in IN O
that IN O
it PRP O
offers VBZ O
a DT O
single JJ O
generic JJ O
force NN O
in IN O
one CD O
specific JJ O
direction NN O
. . O

Each DT O
muscle NN O
/ SYM O
tendon NN O
within IN O
the DT O
thumb NN O
has VBZ O
a DT O
distinct JJ O
anatomical JJ O
origin NN O
and CC O
insertion NN O
, , O
suggesting VBG O
its PRP$ O
external JJ O
force NN O
potential NN O
in IN O
a DT O
particular JJ O
direction NN O
[ -LRB- O
4 CD O
- SYM O
6 CD O
] -RRB- O
. . O

Hence RB O
, , O
evaluation NN O
of IN O
strengths NNS O
in IN O
multiple JJ O
directions NNS O
offers VBZ O
insight NN O
concerning VBG O
the DT O
motor NN O
capacity NN O
of IN O
individual JJ O
muscles NNS O
. . O

Force NN O
production NN O
of IN O
a DT O
digit NN O
has VBZ O
been VBN O
measured VBN O
in IN O
various JJ O
directions NNS O
such JJ O
as IN O
flexion NN O
/ SYM O
extension NN O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
, , O
abduction NN O
/ SYM O
adduction NN O
[ -LRB- O
9 CD O
- SYM O
14 CD O
] -RRB- O
, , O
or CC O
in IN O
combined VBN O
directions NNS O
[ -LRB- O
15 CD O
, , O
16 CD O
] -RRB- O
. . O

Bourbonnais NNP O
et FW O
al NNP O
. . O
developed VBD O
an DT O
apparatus NN O
to TO O
measure VB O
thumb NN O
force NN O
production NN O
in IN O
eight CD O
directions NNS O
in IN O
the DT O
transverse JJ O
plane NN O
of IN O
the DT O
thumb NN O
and CC O
investigated VBN O
force NN O
dependence NN O
on IN O
the DT O
direction NN O
of IN O
effort NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Yokogawa NNP O
and CC O
Hara NNP O
measured VBD O
index NN O
fingertip NN O
forces NNS O
in IN O
various JJ O
directions NNS O
within IN O
the DT O
flexion NN O
/ SYM O
extension NN O
plane NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Recently RB O
, , O
we PRP O
developed VBD O
experimental JJ O
apparatuses NNS O
to TO O
measure VB O
multi JJ O
- HYPH O
directional JJ O
forces NNS O
of IN O
a DT O
digit NN O
in IN O
its PRP$ O
transverse NN O
plane NN O
[ -LRB- O
17 CD O
- HYPH O
19 CD O
] -RRB- O
. . O

From IN O
these DT O
multi JJ O
- HYPH O
directional JJ O
forces NNS O
we PRP O
constructed VBD O
force NN O
envelopes NNS O
representative JJ O
of IN O
the DT O
characteristic JJ O
force NN O
output NN O
pattern NN O
of IN O
a DT O
digit NN O
[ -LRB- O
17 CD O
- SYM O
19 CD O
] -RRB- O
. . O

Disorders NNS O
resulting VBG O
from IN O
traumatic JJ O
injuries NNS O
to IN O
and CC O
various JJ O
diseases NNS O
of IN O
these DT O
nerves NNS O
are VBP O
common JJ O
in IN O
clinical JJ O
practice NN O
. . O

Clinical JJ O
manifestations NNS O
of IN O
hand NN O
dysfunction NN O
are VBP O
distinctive JJ O
depending VBG O
on IN O
the DT O
nerve NN O
involved VBN O
. . O

For IN O
example NN O
, , O
thenar NN O
atrophy NN O
is VBZ O
a DT O
major JJ O
clinical JJ O
observation NN O
affecting VBG O
thumb NN O
function NN O
at IN O
the DT O
later JJ O
stages NNS O
of IN O
compression NN O
neuropathy NN O
of IN O
the DT O
median JJ O
nerve NN O
. . O

Several JJ O
studies NNS O
have VBP O
been VBN O
conducted VBN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
simulated VBN O
peripheral JJ O
neuropathies NNS O
using VBG O
local JJ O
anesthetization NN O
[ -LRB- O
5 CD O
, , O
16 CD O
, , O
20 CD O
, , O
21 CD O
] -RRB- O
. . O

Kozin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
21 CD O
] -RRB- O
studied VBD O
the DT O
effects NNS O
of IN O
median JJ O
and CC O
ulnar JJ O
nerve NN O
blocks NNS O
on IN O
grip NN O
and CC O
pinch NN O
strength NN O
and CC O
showed VBD O
significant JJ O
decreases NNS O
following VBG O
nerve NN O
blockage NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Boatright NNP O
and CC O
Kiebzak NNP O
[ -LRB- O
20 CD O
] -RRB- O
investigated VBD O
the DT O
effects NNS O
of IN O
median JJ O
nerve NN O
block NN O
on IN O
thumb NN O
abduction NN O
strength NN O
. . O

Kaufman NNP O
et FW O
al NNP O
. . O

[ -LRB- O
5 CD O
] -RRB- O
measured VBN O
isometric JJ O
thumb NN O
forces NNS O
in IN O
eight CD O
directions NNS O
together RB O
with IN O
electromyographic JJ O
signals NNS O
of IN O
thumb NN O
muscles NNS O
after IN O
block NN O
of IN O
the DT O
median JJ O
nerve NN O
. . O

Labosky NNP O
and CC O
Waggy NNP O
[ -LRB- O
22 CD O
] -RRB- O
studied VBD O
the DT O
strength NN O
related VBN O
to IN O
grip NN O
, , O
pinch NN O
, , O
thumb NN O
adduction NN O
, , O
thumb NN O
abduction NN O
, , O
and CC O
finger NN O
flexion NN O
after IN O
radial JJ O
nerve NN O
block NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Kuxhaus NNP O
studied VBD O
the DT O
three CD O
dimensional JJ O
feasible JJ O
force NN O
set VBN O
at IN O
the DT O
thumb NN O
- HYPH O
tip NN O
before IN O
and CC O
after IN O
ulnar JJ O
nerve NN O
block NN O
and CC O
reported VBD O
this DT O
to TO O
be VB O
a DT O
reproducible JJ O
and CC O
sensitive JJ O
means NN O
to TO O
detect VB O
impairment NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
utilize VB O
our PRP$ O
developed JJ O
apparatus NN O
and CC O
protocols NNS O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
lower JJR O
median JJ O
nerve NN O
lesion NN O
on IN O
thumb NN O
motor NN O
function NN O
. . O

The DT O
lesion NN O
was VBD O
simulated VBN O
by IN O
blocking VBG O
the DT O
median JJ O
nerve NN O
at IN O
the DT O
wrist NN O
using VBG O
an DT O
anesthetic NN O
. . O

We PRP O
hypothesized VBD O
that IN O
a DT O
median JJ O
nerve NN O
block NN O
would MD O
cause VB O
( : O
1 CD O
) SYM O
a DT O
decrease NN O
in IN O
force NN O
production NN O
, , O
which WDT O
would MD O
be VB O
direction NN O
- HYPH O
dependent JJ O
with IN O
the DT O
most RBS O
severe JJ O
reduction NN O
in IN O
the DT O
abduction NN O
direction NN O
, , O
and CC O
( , O
2 CD O
) , O
a DT O
decrease NN O
in IN O
the DT O
force NN O
envelope NN O
area NN O
and CC O
force NN O
quadrant NN O
area NN O
, , O
with IN O
the DT O
greatest JJS O
decrease NN O
in IN O
the DT O
abduction NN O
quadrant NN O
. . O

Methods NNS O

Subjects NNS O

Six CD O
healthy JJ O
male JJ O
subjects NNS O
( , O
mean JJ O
age NN O
: : O
26 CD O
. . O
9 CD O
+ SYM O
/ SYM O
- HYPH O
5 CD O
. . O
1 CD O
years NNS O
) -RRB- O
participated VBD O
in IN O
this DT O
study NN O
. . O

The DT O
subjects NNS O
had VBD O
no DT O
previous JJ O
history NN O
of IN O
neuromuscular JJ O
or CC O
musculoskeletal JJ O
disorders NNS O
of IN O
the DT O
upper JJ O
extremities NNS O
. . O

Each DT O
subject NN O
signed VBD O
an DT O
informed JJ O
consent NN O
form NN O
approved VBN O
by IN O
the DT O
Institutional NNP O
Review NNP O
Board NNP O
prior RB O
to IN O
participating VBG O
in IN O
the DT O
experiment NN O
. . O

Median JJ O
nerve NN O
block NN O

Injections NNS O
were VBD O
performed VBN O
under IN O
aseptic JJ O
conditions NNS O
while IN O
the DT O
subjects NNS O
sat VBD O
with IN O
the DT O
forearm NN O
supinated VBD O
and CC O
the DT O
wrist NN O
slightly RB O
extended VBD O
. . O

After IN O
the DT O
skin NN O
at IN O
the DT O
palmer NN O
area NN O
of IN O
the DT O
wrist NN O
was VBD O
cleaned VBN O
with IN O
alcohol NN O
, , O
4 CD O
mL NNS O
of IN O
0 CD O
. . O
5 CD O
% NN O
bupivacaine NN O
hydrochloride NN O
( : O
Astra NNP O
Pharmaceuticals NNPS O
, , O
Westborough NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
injected VBN O
into IN O
the DT O
carpal JJ O
tunnel NN O
with IN O
a DT O
sterile JJ O
25 CD O
- HYPH O
gauge NN O
short JJ O
- HYPH O
bevel NN O
needle NN O
. . O

The DT O
needle NN O
was VBD O
inserted VBN O
through IN O
the DT O
transverse JJ O
carpal NN O
ligament NN O
in IN O
line NN O
with IN O
the DT O
radial JJ O
border NN O
of IN O
the DT O
fourth JJ O
digit NN O
slightly RB O
ulnar JJ O
to IN O
the DT O
palmaris NN O
longus NN O
tendon NN O
at IN O
the DT O
level NN O
of IN O
the DT O
distal JJ O
wrist NN O
crease NN O
. . O

Forty CD O
minutes NNS O
was VBD O
allowed VBN O
for IN O
the DT O
median JJ O
nerve NN O
block NN O
to TO O
reach VB O
complete JJ O
effectiveness NN O
[ -LRB- O
23 CD O
] -RRB- O
and CC O
was VBD O
verified VBN O
using VBG O
the DT O
Semmes NNP O
- HYPH O
Weinstein NNP O
monofilament NN O
test NN O
. . O

The DT O
average JJ O
monofilament NN O
score NN O
was VBD O
2 CD O
. . O
85 CD O
across IN O
the DT O
five CD O
digits NNS O
before IN O
nerve NN O
block NN O
. . O

About RB O
40 CD O
minutes NNS O
after IN O
nerve NN O
injection NN O
, , O
little JJ O
sensory JJ O
impairment NN O
occurred VBD O
in IN O
the DT O
ulnar JJ O
distribution NN O
( , O
score NN O
= SYM O
3 CD O
. . O
22 CD O
) -RRB- O
, , O
while IN O
the DT O
sensory JJ O
score NN O
in IN O
the DT O
median JJ O
distribution NN O
was VBD O
greater JJR O
than IN O
6 CD O
. . O
15 CD O
. . O

The DT O
effects NNS O
of IN O
nerve NN O
block NN O
lasted VBD O
more JJR O
than IN O
6 CD O
hours NNS O
with IN O
all DT O
subjects NNS O
regaining VBG O
normal JJ O
hand NN O
function NN O
within IN O
12 CD O
hours NNS O
. . O

Testing NN O
apparatus NN O

The DT O
experimental JJ O
apparatus NN O
was VBD O
designed VBN O
and CC O
constructed VBN O
to TO O
measure VB O
maximum JJ O
voluntary JJ O
contraction NN O
forces NNS O
of IN O
any DT O
digit NN O
at IN O
any DT O
point NN O
along IN O
the DT O
digit NN O
. . O

Force NN O
application NN O
was VBD O
possible JJ O
in IN O
any DT O
direction NN O
within IN O
the DT O
transverse JJ O
plane NN O
of IN O
the DT O
longitudinal JJ O
axis NN O
of IN O
the DT O
digit NN O
. . O

The DT O
apparatus NN O
consisted VBD O
of IN O
position NN O
control NN O
accessories NNS O
, , O
a DT O
force NN O
transducer NN O
, , O
and CC O
a DT O
custom RB O
fitted VBN O
aluminum NN O
ring NN O
attached VBN O
to IN O
the DT O
transducer NN O
( -LRB- O
Figure NNP O
1A NNP O
, , O
1B NNP O
) -RRB- O
. . O

The DT O
transducer NN O
( -LRB- O
Mini40 NNP O
, , O
ATI NNP O
Industrial NNP O
Automation NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
, , O
capable JJ O
of IN O
measuring VBG O
6 CD O
degrees NNS O
of IN O
freedom NN O
forces NNS O
and CC O
moments NNS O
, , O
was VBD O
attached VBN O
to IN O
a DT O
mounting VBG O
clamp NN O
via IN O
an DT O
aluminum NN O
adapter NN O
plate NN O
while IN O
the DT O
aluminum NN O
ring NN O
was VBD O
secured VBN O
to IN O
the DT O
tool NN O
side NN O
of IN O
the DT O
transducer NN O
using VBG O
a DT O
custom JJ O
adapter NN O
. . O

The DT O
ring NN O
served VBD O
as IN O
a DT O
connection NN O
anchor NN O
for IN O
the DT O
transducer NN O
and CC O
the DT O
digit NN O
. . O

The DT O
force NN O
transducer NN O
and CC O
ring NN O
attachment NN O
were VBD O
positioned VBN O
in IN O
a DT O
desired VBN O
orientation NN O
using VBG O
an DT O
aluminum NN O
slide NN O
rail NN O
, , O
tubing NN O
, , O
and CC O
lockable JJ O
mounting NN O
clamps NNS O
( , O
80 CD O
/ SYM O
20 CD O
Inc NNP O
. . O
, , O
Columbia NNP O
City NNP O
, , O
IN NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
slide NN O
rail NN O
was VBD O
secured VBN O
to IN O
an DT O
aluminum NN O
base NN O
plate NN O
. . O

Foam NN O
padded VBN O
wooden JJ O
blocks NNS O
with IN O
two CD O
locking VBG O
straps NNS O
secured VBD O
the DT O
arm NN O
to IN O
the DT O
base NN O
plate NN O
. . O

The DT O
analog NN O
outputs NNS O
from IN O
the DT O
transducer NN O
were VBD O
digitized VBN O
using VBG O
a DT O
16 CD O
- HYPH O
bit NN O
analog NN O
- HYPH O
to IN O
- HYPH O
digital JJ O
converter NN O
( HYPH O
PCI NNP O
- HYPH O
6031 CD O
, , O
National NNP O
Instruments NNPS O
, , O
TX NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
X NNP O
( HYPH O
abduction NN O
/ SYM O
adduction NN O
) -RRB- O
and CC O
Y NNP O
( HYPH O
flexion NN O
/ SYM O
extension NN O
) -RRB- O
force NN O
components NNS O
in IN O
the DT O
transverse NN O
plane NN O
were VBD O
displayed VBN O
on IN O
the DT O
screen NN O
while IN O
the DT O
subject NN O
performed VBD O
a DT O
force NN O
production NN O
task NN O
. . O

The DT O
resolutions NNS O
of IN O
the DT O
force NN O
transducer NN O
in IN O
its PRP$ O
axial JJ O
( , O
flexion NN O
/ SYM O
extension NN O
) -RRB- O
and CC O
horizontal JJ O
( -LRB- O
abduction NN O
/ SYM O
adduction NN O
) -RRB- O
directions NNS O
were VBD O
0 CD O
. . O
16 CD O
N CD O
and CC O
0 CD O
. . O
8 CD O
N CD O
, , O
respectively RB O
. . O

A DT O
personal JJ O
computer NN O
equipped VBN O
with IN O
LabVIEW NNP O
( -LRB- O
National NNP O
Instrument NNP O
, , O
TX NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
force NN O
data NN O
acquisition NN O
, , O
display NN O
, , O
and CC O
processing NN O
. . O

Experimental JJ O
procedures NNS O

Each DT O
subject NN O
was VBD O
tested VBN O
before IN O
and CC O
after IN O
median JJ O
nerve NN O
block NN O
. . O

The DT O
nerve NN O
block NN O
procedures NNS O
were VBD O
performed VBN O
immediately RB O
after IN O
the DT O
completion NN O
of IN O
the DT O
first JJ O
testing NN O
session NN O
. . O

Post NN O
- HYPH O
block NN O
testing NN O
started VBD O
after IN O
the DT O
verification NN O
of IN O
complete JJ O
median JJ O
nerve NN O
block NN O
, , O
approximately RB O
40 CD O
minutes NNS O
after IN O
the DT O
injection NN O
. . O

During IN O
each DT O
test NN O
, , O
the DT O
subject NN O
was VBD O
seated VBN O
in IN O
a DT O
chair NN O
adjacent JJ O
to IN O
the DT O
testing NN O
station NN O
modified VBN O
with IN O
a DT O
wooden JJ O
board NN O
to TO O
align VB O
their PRP$ O
back NN O
vertically RB O
throughout IN O
the DT O
trials NNS O
. . O

The DT O
subjects NNS O
rested VBD O
their PRP$ O
forearm NN O
on IN O
padded VBN O
wooden JJ O
blocks NNS O
positioning VBG O
their PRP$ O
shoulder NN O
in IN O
approximately RB O
60 CD O
degrees NNS O
of IN O
frontal JJ O
plane NN O
abduction NN O
. . O

Nylon NNP O
straps NNS O
fitted VBN O
with IN O
plastic JJ O
snap NN O
locking VBG O
mechanisms NNS O
secured VBD O
the DT O
forearm NN O
and CC O
minimized VBD O
the DT O
intervention NN O
of IN O
the DT O
elbow NN O
and CC O
shoulder NN O
during IN O
thumb NN O
force NN O
application NN O
. . O

Subjects NNS O
grasped VBD O
a DT O
vertical JJ O
dowel NN O
secured VBN O
to IN O
the DT O
distal JJ O
end NN O
of IN O
the DT O
wooden JJ O
blocks NNS O
in IN O
a DT O
midprone JJ O
position NN O
. . O

Formable JJ O
thermoplastic JJ O
braces NNS O
were VBD O
used VBN O
to TO O
fix VB O
the DT O
elbow NN O
in IN O
90 CD O
degrees NNS O
of IN O
flexion NN O
, , O
and CC O
the DT O
wrist NN O
in IN O
20 CD O
degrees NNS O
of IN O
extension NN O
and CC O
0 CD O
degrees NNS O
of IN O
ulnar JJ O
deviation NN O
. . O

A DT O
metallic JJ O
brace NN O
was VBD O
used VBN O
to TO O
fix VB O
the DT O
interphalangeal JJ O
joint NN O
of IN O
the DT O
thumb NN O
in IN O
full JJ O
extension NN O
. . O

The DT O
aluminum NN O
ring NN O
was VBD O
placed VBN O
around IN O
the DT O
middle NN O
of IN O
the DT O
proximal JJ O
phalanx NN O
and CC O
oriented VBN O
to TO O
accommodate VB O
comfortable JJ O
thumb NN O
position NN O
with IN O
the DT O
metacarpophalangeal NN O
joint NN O
flexed VBN O
approximately RB O
15 CD O
degrees NNS O
. . O

Prior RB O
to IN O
testing NN O
, , O
a DT O
line NN O
was VBD O
drawn VBN O
on IN O
the DT O
proximal JJ O
phalange NN O
at IN O
the DT O
midpoint NN O
between IN O
the DT O
interphalangeal JJ O
and CC O
metacarpophalangeal NN O
joints NNS O
. . O

The DT O
alignment NN O
of IN O
the DT O
ring NN O
with IN O
the DT O
circumferential JJ O
line NN O
standardized VBD O
the DT O
location NN O
of IN O
force NN O
application NN O
within IN O
and CC O
between IN O
subjects NNS O
. . O

As IN O
force NN O
application NN O
was VBD O
at IN O
the DT O
middle NN O
of IN O
the DT O
proximal JJ O
phalanx NN O
, , O
mechanical JJ O
action NN O
pertains VBZ O
to IN O
both CC O
the DT O
metacarpophalangeal NN O
and CC O
carpometacarpal NN O
joints NNS O
. . O

We PRP O
chose VBD O
the DT O
terminology NN O
of IN O
flexion NN O
/ SYM O
extension NN O
and CC O
adduction NN O
/ SYM O
adduction NN O
based VBN O
on IN O
the DT O
mechanical JJ O
action NN O
with IN O
respect NN O
to IN O
the DT O
metacarpophalangeal NN O
joint NN O
. . O

With IN O
the DT O
thumb NN O
in IN O
the DT O
ring NN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
, , O
extension NN O
and CC O
flexion NN O
occurred VBD O
in IN O
parallel NN O
with IN O
the DT O
palm NN O
, , O
and CC O
abduction NN O
and CC O
adduction NN O
occurred VBD O
in IN O
a DT O
plane NN O
perpendicular JJ O
to IN O
the DT O
palm NN O
. . O

Each DT O
subject NN O
performed VBD O
15 CD O
circumferential JJ O
MVC NNP O
trials NNS O
with IN O
randomized VBN O
starting NN O
directions NNS O
( -LRB- O
Figure NNP O
1C NNP O
) -RRB- O
. . O

The DT O
subject NN O
was VBD O
allotted VBN O
15 CD O
seconds NNS O
to TO O
complete VB O
each DT O
circumferential JJ O
trial NN O
, , O
and CC O
was VBD O
instructed VBN O
to TO O
use VB O
the DT O
entire JJ O
time NN O
allotted VBN O
to TO O
traverse VB O
the DT O
perimeter NN O
of IN O
the DT O
ring NN O
once RB O
. . O

A DT O
dot NN O
generated VBN O
on IN O
the DT O
computer NN O
screen NN O
was VBD O
programmed VBN O
to TO O
traverse VB O
a DT O
circle NN O
within IN O
15 CD O
seconds NNS O
to TO O
provide VB O
the DT O
subject NN O
with IN O
directional JJ O
feedback NN O
of IN O
their PRP$ O
force NN O
application NN O
. . O

Subjects NNS O
were VBD O
given VBN O
60 CD O
seconds NNS O
of IN O
rest NN O
between IN O
each DT O
circumferential JJ O
trial NN O
. . O

Each DT O
subject NN O
was VBD O
familiarized VBN O
with IN O
the DT O
task NN O
with IN O
a DT O
few JJ O
practice NN O
trials NNS O
. . O

Data NNS O
were VBD O
collected VBN O
from IN O
each DT O
subject NN O
at IN O
100 CD O
samples NNS O
per IN O
second NN O
producing VBG O
a DT O
total NN O
of IN O
22 CD O
, , O
500 CD O
pairs NNS O
of IN O
force NN O
components NNS O
from IN O
the DT O
15 CD O
circumferential JJ O
trials NNS O
. . O

Our PRP$ O
previous JJ O
study NN O
[ -LRB- O
19 CD O
] -RRB- O
indicated VBD O
that IN O
the DT O
testing NN O
protocol NN O
did VBD O
not RB O
cause VB O
noticeable JJ O
fatigue NN O
. . O

Force NN O
envelope NN O
and CC O
quadrants NNS O

Data NNS O
from IN O
multiple JJ O
circumferential JJ O
trials NNS O
were VBD O
accumulated VBN O
to TO O
construct VB O
a DT O
force NN O
envelope NN O
. . O

The DT O
procedures NNS O
to TO O
generate VB O
a DT O
force NN O
envelope NN O
were VBD O
as IN O
follows VBZ O
: : O

Cartesian JJ O
force NN O
coordinates VBZ O
( , O
Xi NNP O
, , O
Yi NNP O
) -RRB- O
were VBD O
transformed VBN O
into IN O
polar JJ O
coordinates NNS O
( , O
R NNP O
alpha NN O
, , O
alpha NN O
) -RRB- O
, , O
where WRB O
R NN O
alpha NN O
was VBD O
the DT O
force NN O
magnitude NN O
at IN O
an DT O
angular JJ O
position NN O
alpha NN O
. . O

Each DT O
alpha NN O
was VBD O
rounded VBN O
to IN O
the DT O
nearest JJS O
integer NN O
ranging VBG O
from IN O
0 CD O
to IN O
359 CD O
degrees NNS O
. . O

The DT O
maximum JJ O
, , O
F NNP O
alpha NN O
, , O
was VBD O
determined VBN O
from IN O
a DT O
string NN O
of IN O
N NNP O
data NNS O
points NNS O
along IN O
each DT O
radial JJ O
line NN O
defined VBN O
by IN O
alpha NN O
. . O

At IN O
the DT O
completion NN O
of IN O
the DT O
15 CD O
trials NNS O
, , O
there EX O
were VBD O
, , O
on IN O
average JJ O
, , O
N CD O
= SYM O
63 CD O
data NNS O
points NNS O
on IN O
each DT O
radial JJ O
line NN O
of IN O
alpha NN O
based VBN O
on IN O
the DT O
distribution NN O
off IN O
the DT O
22 CD O
, , O
500 CD O
data NNS O
points NNS O
around IN O
360 CD O
degrees NNS O
. . O

A DT O
moving VBG O
average NN O
with IN O
an DT O
interval NN O
of IN O
10 CD O
degrees NNS O
was VBD O
applied VBN O
to IN O
the DT O
maximal JJ O
series NN O
data NN O
F NN O
alpha NN O
( , O
alpha NN O
= SYM O
0 CD O
, , O
1 CD O
, , O
2 CD O
, , O
. . O
. , O
. . O
, , O
359 CD O
) -RRB- O
to TO O
obtain VB O
filtered VBN O
maximal JJ O
forces NNS O
. . O

These DT O
forces NNS O
formed VBD O
a DT O
force NN O
envelope NN O
. . O

The DT O
area NN O
formed VBN O
by IN O
a DT O
force NN O
envelope NN O
was VBD O
divided VBN O
into IN O
adduction NN O
- HYPH O
extension NN O
, , O
extension NN O
- HYPH O
abduction NN O
, , O
abduction NN O
- HYPH O
flexion NN O
, , O
and CC O
flexion NN O
- HYPH O
adduction NN O
quadrants NNS O
by IN O
radial JJ O
lines NNS O
oriented VBN O
at IN O
0 CD O
degrees NNS O
, , O
90 CD O
degrees NNS O
, , O
180 CD O
degrees NNS O
, , O
and CC O
270 CD O
degrees NNS O
A DT O
quadrant JJ O
force NN O
was VBD O
represented VBN O
using VBG O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
forces NNS O
in IN O
that DT O
quadrant NN O
. . O

The DT O
areas NNS O
of IN O
the DT O
entire JJ O
envelope NN O
and CC O
each DT O
quadrant NN O
were VBD O
calculated VBN O
by IN O
summing VBG O
the DT O
areas NNS O
of IN O
individual JJ O
arc NN O
sections NNS O
formed VBN O
by IN O
the DT O
polar JJ O
coordinates NNS O
of IN O
the DT O
force NN O
envelope NN O
. . O

( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Statistical NNP O
Analyses NNPS O

One CD O
- HYPH O
and CC O
two CD O
- HYPH O
factor NN O
repeated VBN O
measures NNS O
analyses NNS O
of IN O
variance NN O
( -LRB- O
ANOVA NNP O
) -RRB- O
were VBD O
used VBN O
to TO O
analyze VB O
outcome NN O
measures NNS O
. . O

The DT O
independent JJ O
variables NNS O
were VBD O
testing NN O
SESSION NN O
( : O
n ADD O
= SYM O
2 CD O
, , O
i LS O
. . O
e -RRB- O
. . O
, , O
pre NN O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
) -RRB- O
, , O
force NN O
DIRECTION NN O
( : O
n NN O
= SYM O
16 CD O
) -RRB- O
, , O
and CC O
force VB O
QUADRANT NN O
( : O
n NN O
= SYM O
4 CD O
) -RRB- O
, , O
with IN O
SESSION NN O
as IN O
a DT O
repeated JJ O
variable NN O
. . O

Dependent JJ O
variables NNS O
were VBD O
directional JJ O
force NN O
, , O
individual JJ O
quadrant NN O
area NN O
and CC O
force NN O
envelope NN O
area NN O
. . O

Statistical JJ O
analyses NNS O
were VBD O
performed VBN O
using VBG O
SPSS NNP O
11 CD O
( : O
SPSS NNP O
Inc NNP O
. . O
, , O
Illinois NNP O
) -RRB- O
with IN O
statistical JJ O
significance NN O
set VBN O
at IN O
alpha NN O
= SYM O
0 CD O
. . O
5 CD O
. . O

Results NNS O

Force NN O
envelope NN O
and CC O
directional JJ O
forces NNS O

Figure NN O
3 CD O
shows VBZ O
the DT O
force NN O
envelopes NNS O
produced VBN O
by IN O
each DT O
subject NN O
( -LRB- O
A NN O
to IN O
F NNP O
) -RRB- O
before IN O
and CC O
after IN O
median JJ O
nerve NN O
block NN O
. . O

The DT O
post NN O
- HYPH O
block NN O
force NN O
envelope NN O
was VBD O
inside IN O
the DT O
pre JJ O
- HYPH O
block NN O
envelope NN O
for IN O
each DT O
subject NN O
, , O
indicating VBG O
a DT O
decrease NN O
in IN O
force NN O
magnitude NN O
in IN O
all DT O
directions NNS O
after IN O
nerve NN O
block NN O
. . O

Figure NN O
4 CD O
shows VBZ O
the DT O
average JJ O
pre JJ O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
force NN O
envelope NN O
across IN O
all DT O
subjects NNS O
. . O

Force NN O
magnitudes NNS O
were VBD O
significantly RB O
reduced VBN O
after IN O
nerve NN O
block NN O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
resulting VBG O
in IN O
significantly RB O
smaller JJR O
force NN O
envelopes NNS O
. . O

The DT O
average JJ O
decrease NN O
across IN O
all DT O
directions NNS O
was VBD O
27 CD O
. . O
9 CD O
% NN O
. . O

A DT O
maximum JJ O
decrease NN O
of IN O
42 CD O
. . O
4 CD O
% NN O
occurred VBD O
at IN O
199 CD O
degrees NNS O
, , O
corresponding VBG O
to IN O
a DT O
combined VBN O
direction NN O
of IN O
abduction NN O
and CC O
slight JJ O
flexion NN O
, , O
while IN O
a DT O
minimum JJ O
decrease NN O
of IN O
10 CD O
. . O
5 CD O
% NN O
occurred VBD O
at IN O
328 CD O
degrees NNS O
corresponding VBG O
to IN O
a DT O
combined VBN O
direction NN O
of IN O
adduction NN O
and CC O
slight JJ O
flexion NN O
. . O

Relative JJ O
decreases NNS O
at IN O
0 CD O
degrees NNS O
( , O
adduction NN O
) -RRB- O
, , O
90 CD O
degrees NNS O
( , O
extension NN O
) -RRB- O
, , O
180 CD O
degrees NNS O
( , O
abduction NN O
) -RRB- O
, , O
and CC O
270 CD O
degrees NNS O
( , O
flexion NN O
) -RRB- O
directions NNS O
were VBD O
17 CD O
. . O
3 CD O
% NN O
, , O
21 CD O
. . O
2 CD O
% NN O
, , O
41 CD O
. . O
2 CD O
% NN O
and CC O
33 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

A DT O
single JJ O
force NN O
in IN O
each DT O
quadrant NN O
was VBD O
represented VBN O
using VBG O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
forces NNS O
in IN O
that DT O
quadrant NN O
( , O
see VB O
description NN O
in IN O
the DT O
Methods NNPS O
) -RRB- O
. . O

The DT O
average JJ O
quadrant NN O
forces NNS O
were VBD O
significantly RB O
decreased VBN O
after IN O
nerve NN O
block NN O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
5 CD O
) -RRB- O
. . O

The DT O
amount NN O
of IN O
decrease NN O
was VBD O
also RB O
different JJ O
between IN O
quadrants NNS O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Relative JJ O
decreases NNS O
in IN O
mean JJ O
quadrant JJ O
forces NNS O
were VBD O
24 CD O
. . O
5 CD O
% NN O
, , O
38 CD O
. . O
7 CD O
% NN O
, , O
32 CD O
. . O
1 CD O
% NN O
, , O
and CC O
18 CD O
. . O
1 CD O
% NN O
for IN O
extension NN O
, , O
abduction NN O
, , O
flexion NN O
, , O
and CC O
adduction NN O
, , O
respectively RB O
. . O

The DT O
maximal JJ O
decreases NNS O
in IN O
mean JJ O
quadrant JJ O
force NN O
, , O
38 CD O
. . O
7 CD O
% NN O
, , O
occurred VBD O
in IN O
the DT O
abduction NN O
quadrant NN O
. . O

Force NN O
envelope NN O
areas NNS O
and CC O
quadrant NN O
areas NNS O

Areas NNS O
enclosed VBN O
by IN O
the DT O
post NN O
- HYPH O
block NN O
envelopes NNS O
were VBD O
significantly RB O
smaller JJR O
than IN O
the DT O
pre JJ O
- HYPH O
block NN O
envelopes NNS O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
4 CD O
) -RRB- O
. . O

Post NN O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
, , O
10700 CD O
+ CD O
/ SYM O
- HYPH O
4474 CD O
N NNP O
. . O
N NNP O
, , O
was VBD O
51 CD O
. . O
9 CD O
% NN O
of IN O
pre JJ O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
, , O
20628 CD O
+ CD O
/ SYM O
- HYPH O
7747 CD O
N CD O
. . O
N CD O
. . O

Quadrant NNP O
area NN O
decreased VBD O
significantly RB O
( : O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
6 CD O
) -RRB- O
. . O

The DT O
maximal JJ O
percentage NN O
decrease NN O
in IN O
area NN O
after IN O
nerve NN O
block NN O
was VBD O
60 CD O
. . O
9 CD O
% NN O
in IN O
the DT O
abduction NN O
quadrant NN O
, , O
followed VBN O
by IN O
a DT O
52 CD O
. . O
3 CD O
% NN O
area NN O
decrease NN O
in IN O
the DT O
flexion NN O
quadrant NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
we PRP O
simulated VBD O
a DT O
lower JJR O
median JJ O
nerve NN O
lesion NN O
and CC O
evaluated VBD O
the DT O
resultant JJ O
thumb NN O
motor NN O
function NN O
deficit NN O
. . O

Our PRP$ O
internal JJ O
control NN O
via IN O
pre NN O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
design NN O
offered VBD O
a DT O
particular JJ O
advantage NN O
of IN O
investigating VBG O
the DT O
mechanical JJ O
role NN O
of IN O
muscles NNS O
innervated VBN O
by IN O
a DT O
targeted VBN O
nerve NN O
. . O

The DT O
testing NN O
and CC O
analytical JJ O
methods NNS O
employed VBN O
have VBP O
provided VBN O
advanced JJ O
quantification NN O
of IN O
thumb NN O
motor NN O
function NN O
. . O

The DT O
results NNS O
have VBP O
confirmed VBN O
our PRP$ O
initial JJ O
hypotheses NNS O
that IN O
greatest JJS O
force NN O
decreases NNS O
occurred VBD O
in IN O
directions NNS O
related VBN O
to IN O
abduction NN O
, , O
and CC O
that IN O
the DT O
post JJ O
- HYPH O
block NN O
thumb NN O
force NN O
envelope NN O
area NN O
was VBD O
smaller JJR O
than IN O
the DT O
pre JJ O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
. . O

Preferential JJ O
force NN O
attenuation NN O
in IN O
the DT O
quadrants NNS O
of IN O
abduction NN O
and CC O
flexion NN O
after IN O
median JJ O
nerve NN O
block NN O
are VBP O
in IN O
agreement NN O
with IN O
anatomical JJ O
and CC O
neuromuscular JJ O
features NNS O
of IN O
the DT O
thumb NN O
. . O

The DT O
median JJ O
nerve NN O
innervates VBZ O
the DT O
abductor NN O
pollicis NN O
brevis NN O
, , O
the DT O
opponens NN O
pollicis NN O
and CC O
superficial JJ O
head NN O
of IN O
the DT O
flexor NN O
pollicis NN O
brevis NN O
, , O
all DT O
of IN O
which WDT O
contribute VBP O
to IN O
the DT O
abduction NN O
and CC O
flexion NN O
of IN O
the DT O
thumb NN O
[ -LRB- O
4 CD O
] -RRB- O
; , O
therefore RB O
, , O
denervation NN O
of IN O
these DT O
muscles NNS O
after IN O
median JJ O
nerve NN O
block NN O
would MD O
cause VB O
the DT O
greatest JJS O
force NN O
deficit NN O
related VBN O
to IN O
median JJ O
nerve NN O
function NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Additionally RB O
, , O
as IN O
force NN O
application NN O
moved VBD O
towards IN O
adduction NN O
, , O
the DT O
force NN O
deficit NN O
decreased VBD O
as IN O
neuromuscular JJ O
control NN O
shifted VBD O
from IN O
the DT O
median JJ O
nerve NN O
to IN O
the DT O
ulnar JJ O
nerve NN O
via IN O
the DT O
first JJ O
dorsal JJ O
interosseous JJ O
and CC O
adductor NN O
pollicis NN O
brevis NN O
. . O

Force NN O
deficit NN O
in IN O
extension NN O
was VBD O
also RB O
comparably RB O
small JJ O
as IN O
extension NN O
forces NNS O
are VBP O
mainly RB O
produced VBN O
by IN O
the DT O
extensors NNS O
pollicis NN O
brevis NN O
and CC O
longus NN O
originating VBG O
in IN O
the DT O
forearm NN O
. . O

Our PRP$ O
reported JJ O
force NN O
decreases VBZ O
following VBG O
a DT O
median JJ O
nerve NN O
block NN O
( : O
40 CD O
. . O
9 CD O
% NN O
in IN O
abduction NN O
, , O
34 CD O
. . O
1 CD O
% NN O
in IN O
flexion NN O
) -RRB- O
were VBD O
smaller JJR O
than IN O
those DT O
reported VBN O
in IN O
the DT O
literature NN O
. . O

Kozin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
21 CD O
] -RRB- O
reported VBD O
a DT O
60 CD O
% NN O
decrease NN O
in IN O
pinch NN O
strength NN O
after IN O
a DT O
median JJ O
nerve NN O
block NN O
using VBG O
mepivicaine NN O
hydrochloride NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Boatright NNP O
and CC O
Kiebzak NNP O
[ -LRB- O
20 CD O
] -RRB- O
reported VBD O
an DT O
approximate JJ O
70 CD O
% NN O
decrease NN O
in IN O
thumb NN O
abduction NN O
strength NN O
after IN O
median JJ O
nerve NN O
block NN O
using VBG O
Lidocaine NNP O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Kaufman NNP O
et FW O
al NNP O
. . O

[ -LRB- O
5 CD O
] -RRB- O
stated VBD O
that IN O
a DT O
median JJ O
nerve NN O
block NN O
with IN O
Lidocaine NNP O
almost RB O
completely RB O
diminished VBN O
force NN O
production NN O
in IN O
the DT O
abduction NN O
direction NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
discrepancy NN O
may MD O
be VB O
due IN O
to IN O
the DT O
anesthetic JJ O
used VBN O
and CC O
strength NN O
testing NN O
method NN O
. . O

Although IN O
the DT O
sensory JJ O
block NN O
appeared VBD O
to TO O
be VB O
complete JJ O
for IN O
each DT O
method NN O
, , O
the DT O
motor NN O
capabilities NNS O
of IN O
the DT O
muscles NNS O
associated VBN O
with IN O
the DT O
median JJ O
nerve NN O
might MD O
or CC O
might MD O
not RB O
be VB O
completely RB O
eliminated VBN O
. . O

Such PDT O
a DT O
result NN O
is VBZ O
largely RB O
dependent JJ O
on IN O
a DT O
particular JJ O
anesthetic NN O
, , O
its PRP$ O
concentration NN O
and CC O
dosage NN O
, , O
as RB O
well RB O
as IN O
the DT O
efficacy NN O
of IN O
the DT O
injection NN O
technique NN O
at IN O
immersing VBG O
the DT O
nerve NN O
. . O

The DT O
methods NNS O
of IN O
strength NN O
testing NN O
may MD O
also RB O
help VB O
explain VB O
the DT O
different JJ O
magnitudes NNS O
of IN O
strength NN O
deficit NN O
after IN O
the DT O
nerve NN O
block NN O
. . O

All DT O
previous JJ O
results NNS O
were VBD O
based VBN O
on IN O
forces NNS O
obtained VBN O
in IN O
discrete JJ O
direction NN O
( , O
s NNS O
) -RRB- O
, , O
and CC O
focused VBN O
exertions NNS O
, , O
while IN O
the DT O
current JJ O
study NN O
utilized VBD O
a DT O
method NN O
of IN O
force NN O
production NN O
in IN O
a DT O
continuous JJ O
, , O
circumferential JJ O
and CC O
dynamic JJ O
manner NN O
. . O

Furthermore RB O
, , O
thumb NN O
motor NN O
performance NN O
can MD O
be VB O
maintained VBN O
despite IN O
the DT O
absence NN O
of IN O
certain JJ O
individual JJ O
muscles NNS O
. . O

For IN O
example NN O
, , O
Britto NNP O
and CC O
Elliot NNP O
reported VBD O
that IN O
the DT O
loss NN O
of IN O
abductor NN O
pollicis NN O
longus NN O
and CC O
extensor JJ O
pollicis NN O
brevis NNS O
in IN O
their PRP$ O
two CD O
patients NNS B-Species
did VBD O
not RB O
show VB O
functional JJ O
compromise NN O
of IN O
strength NN O
and CC O
grip NN O
strength NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

In IN O
a DT O
broader JJR O
sense NN O
, , O
the DT O
neuromuscular JJ O
system NN O
has VBZ O
remarkable JJ O
capabilities NNS O
to TO O
accomplish VB O
the DT O
same JJ O
motor NN O
function NN O
goal NN O
using VBG O
different JJ O
effectors NNS O
and CC O
different JJ O
goals NNS O
using VBG O
the DT O
same JJ O
effectors NNS O
, , O
a DT O
phenomenon NN O
so RB O
called VBN O
"""" `` O
motor NN O
equivalence NN O
"""" '' O
[ -LRB- O
25 CD O
] -RRB- O
. . O

An DT O
unexpected JJ O
finding NN O
from IN O
this DT O
study NN O
was VBD O
that IN O
the DT O
force NN O
deficit NN O
occurred VBD O
in IN O
all DT O
directions NNS O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
. . O

In IN O
other JJ O
words NNS O
, , O
the DT O
median JJ O
nerve NN O
block NN O
caused VBD O
reduced VBN O
force NN O
production NN O
by IN O
those DT O
muscles NNS O
not RB O
associated VBN O
with IN O
the DT O
median JJ O
nerve NN O
. . O

Several JJ O
potential JJ O
explanations NNS O
exist VBP O
to TO O
describe VB O
such PDT O
a DT O
phenomenon NN O
. . O

First RB O
, , O
the DT O
injection NN O
into IN O
the DT O
carpal NN O
tunnel NN O
at IN O
the DT O
wrist NN O
, , O
although IN O
localized VBN O
, , O
potentially RB O
diffused VBD O
into IN O
the DT O
intrinsic JJ O
fascia NN O
of IN O
the DT O
hand NN O
partially RB O
compromising VBG O
function NN O
of IN O
the DT O
ulnar JJ O
nerve NN O
, , O
which WDT O
innervates VBZ O
the DT O
adductor NN O
pollicis NN O
. . O

Although IN O
Semmes NNP O
- HYPH O
Weinstein NNP O
monofilament NN O
testing NN O
confirmed VBD O
the DT O
continued VBN O
sensation NN O
of IN O
the DT O
digits NNS O
within IN O
the DT O
ulnar JJ O
nerve NN O
distribution NN O
, , O
it PRP O
is VBZ O
not RB O
inconceivable JJ O
that IN O
the DT O
injection NN O
could MD O
have VB O
contaminated VBN O
the DT O
ulnar JJ O
innervated VBN O
muscles NNS O
, , O
the DT O
first JJ O
dorsal JJ O
interosseous JJ O
and CC O
deep JJ O
head NN O
of IN O
the DT O
flexor NN O
pollicis NN O
brevis NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Secondly RB O
, , O
thumb NN O
force NN O
in IN O
any DT O
direction NN O
is VBZ O
produced VBN O
by IN O
synergistic JJ O
activation NN O
of IN O
the DT O
many JJ O
intrinsic JJ O
muscles NNS O
, , O
and CC O
as IN O
a DT O
result NN O
, , O
the DT O
muscular JJ O
deficiency NN O
associated VBN O
with IN O
one CD O
direction NN O
may MD O
hinder VB O
the DT O
force NN O
production NN O
in IN O
other JJ O
directions NNS O
by IN O
other JJ O
muscles NNS O
[ -LRB- O
5 CD O
, , O
22 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
Kaufman NNP O
et FW O
al NNP O
. . O
demonstrated VBD O
that IN O
thumb NN O
muscles NNS O
not RB O
innervated VBN O
by IN O
the DT O
median JJ O
nerve NN O
displayed VBD O
lower JJR O
electromyographical JJ O
activation NN O
and CC O
shifted VBD O
the DT O
direction NN O
of IN O
maximum JJ O
activation NN O
after IN O
a DT O
median JJ O
nerve NN O
block NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Labosky NNP O
and CC O
Waggy NNP O
showed VBD O
that IN O
a DT O
radial JJ O
nerve NN O
block NN O
caused VBD O
a DT O
53 CD O
% NN O
decrease NN O
in IN O
thumb NN O
abduction NN O
strength NN O
because IN O
of IN O
the DT O
lack NN O
of IN O
stabilization NN O
of IN O
the DT O
radial JJ O
innervated VBN O
extensor JJ O
muscles NNS O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Consequently RB O
, , O
deficiency NN O
of IN O
median JJ O
innervated VBN O
muscles NNS O
inherently RB O
limits VBZ O
force NN O
production NN O
in IN O
other JJ O
directions NNS O
as IN O
neuromuscular JJ O
switching NN O
is VBZ O
necessary JJ O
to TO O
produce VB O
force NN O
in IN O
changing VBG O
directions NNS O
. . O

The DT O
median JJ O
innervated VBN O
muscles NNS O
are VBP O
the DT O
dominant JJ O
abductors NNS O
of IN O
the DT O
thumb NN O
metacarpophalangeal NN O
and CC O
carpometacarpal NN O
joint NN O
. . O

The DT O
more JJR O
than IN O
50 CD O
% NN O
residual JJ O
abduction NN O
force NN O
found VBN O
in IN O
this DT O
study NN O
suggests VBZ O
that IN O
the DT O
injection NN O
did VBD O
not RB O
totally RB O
block VB O
the DT O
motor NN O
function NN O
of IN O
these DT O
muscles NNS O
, , O
even RB O
though IN O
a DT O
complete JJ O
sensory JJ O
loss NN O
was VBD O
verified VBN O
. . O

This DT O
concurs VBZ O
with IN O
clinical JJ O
observations NNS O
of IN O
median JJ O
compression NN O
neuropathy NN O
. . O

Individuals NNS O
with IN O
carpal JJ O
tunnel NN O
syndrome NN O
complain VBP O
of IN O
sensory JJ O
dysfunction NN O
early RB O
in IN O
the DT O
disease NN O
process NN O
( , O
at IN O
the DT O
beginning NN O
) -RRB- O
, , O
while IN O
motor NN O
signs NNS O
of IN O
thenar NN O
wasting NN O
and CC O
thumb NN O
weakness NN O
occur VBP O
as IN O
the DT O
disease NN O
advances VBZ O
. . O

The DT O
concept NN O
that IN O
the DT O
motor NN O
deficit NN O
is VBZ O
more RBR O
resistant JJ O
to IN O
peripheral JJ O
median JJ O
neuropathy NN O
than IN O
sensory JJ O
loss NN O
has VBZ O
been VBN O
well RB O
documented VBN O
[ -LRB- O
23 CD O
, , O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

Butterworth NNP O
et FW O
al NNP O
. . O
studied VBD O
the DT O
temporal JJ O
effects NNS O
on IN O
sensory NN O
and CC O
motor NN O
blockade NN O
after IN O
injection NN O
of IN O
bupivacaine NN O
or CC O
mepivacaine NN O
, , O
and CC O
found VBD O
that IN O
sensory JJ O
loss NN O
was VBD O
complete JJ O
but CC O
about IN O
a DT O
20 CD O
% NN O
compound NN O
motor NN O
action NN O
potential NN O
remained VBD O
after IN O
40 CD O
minutes NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
conclusion NN O
, , O
we PRP O
have VBP O
incorporated VBN O
a DT O
method NN O
for IN O
assessing VBG O
thumb NN O
motor NN O
deficit NN O
based VBN O
on IN O
strength NN O
measurement NN O
with IN O
a DT O
standard JJ O
local JJ O
anesthetic NN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
a DT O
simulated VBN O
median JJ O
neuropathy NN O
on IN O
thumb NN O
motor NN O
function NN O
. . O

Median JJ O
nerve NN O
block NN O
results VBZ O
in IN O
force NN O
deficits NNS O
in IN O
all DT O
directions NNS O
, , O
with IN O
the DT O
most RBS O
severe JJ O
impairment NN O
in IN O
abduction NN O
and CC O
flexion NN O
. . O

Future JJ O
endeavors NNS O
using VBG O
this DT O
methodology NN O
can MD O
potentially RB O
further RB O
elucidate VB O
underlying VBG O
pathomechanisms NNS O
of IN O
peripheral JJ O
neuropathies NNS O
in IN O
all DT O
digits NNS O
of IN O
the DT O
hand NN O
. . O
